Pyrrolopyrimidine derivatives

Information

  • Patent Application
  • 20050277773
  • Publication Number
    20050277773
  • Date Filed
    February 24, 2003
    21 years ago
  • Date Published
    December 15, 2005
    18 years ago
Abstract
The invention provides pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I), and their medically acceptable salts. The compounds of the invention exhibit GSK-3 inhibiting activity and are therefore expected to be useful as therapeutic or prophylactic agents for conditions in which GSK-3 is implicated, such as diabetes, diabetes complications, Alzheimer's disease, neurodegenerative diseases, manic depression, traumatic encephalopathy, alopecia, inflammatory diseases, cancer and immune deficiency.
Description
TECHNICAL FIELD

The present invention relates to novel pyrrolopyrimidine derivatives for medical use having Glycogen Synthase Kinase 3 (GSK-3) inhibiting activity. More specifically, it relates to novel pyrrolo[3,2-d]pyrimidine derivatives which are useful as therapeutic and/or prophylactic agents for diseases in which GSK-3 activity has been implicated, particularly impaired glucose tolerance, type I diabetes, type 2 diabetes, diabetes complications (retinopathy, nephropathy, neuropathy, large artery impairment, etc.), Alzheimer's disease, neurodegenerative diseases (AIDS encephalopathy, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, disseminated sclerosis, etc.), bipolar affective disorder (manic depression), traumatic encephalopathy/spinal injury, epilepsy, obesity, atherosclerosis, hypertension, polycystic ovarian disease, syndrome X, alopecia, inflammatory diseases (deformant arthritis, rheumatism, atopic dermatitis, psoriasis, ulcerative colitis, Crohn's disease, sepsis, generalized inflammation, etc.), cancer, immune deficiency and the like.


BACKGROUND ART

GSK-3 is a serine/threonine kinase, for which two isoforms, α and β, have been identified and found to be coded for by separate genes (see non-patent document 1). Both of the GSK-3 isoforms adopt a monomer structure and are homeostatically activated in resting cells. GSK-3 was first identified as a kinase which inhibits activity of glycogen synthases by direct phosphorylation (see non-patent document 2). It is thought that stimulation by insulin leads to inactivation of GSK-3, thereby permitting activation of glycogen synthases and also eliciting insulin functions such as glucose transport. GSX-3 is further known to be inactivated by growth factors such as IGF-1 and FGF, via signals from receptor tyrosine kinases (see non-patent documents 3, 4, 5).


GSK-3 inhibitors are useful in the treatment of various diseases associated with GSK-3 activation. In addition, since GSK-3 inhibitors mimic activation of growth factor signaling pathways, they are also of use in treatment of diseases associated with inactivation of these signaling pathways. Several diseases for which GSK-3 inhibitors are believed to be effective are described below.


Type I diabetes is caused by autoimmune destruction of the β cells, or insulin-producing cells, of the pancreas, leading to insulin deficiency. Type I diabetes patients therefore require daily insulin injections for life support. Current insulin therapy, however, has not been successful in achieving the strict control of glucose levels accomplished by normal β cells. Type I diabetes therefore often leads to diabetes complications such as retinopathy, nephropathy, neuropathy and large artery impairment.


Type II diabetes is a multifactorial disorder wherein hyperglycemia is produced due to insulin resistance in the liver, skeletal muscle and fatty tissue, as well as insufficient secretion of insulin by the pancreas. This condition also results in numerous diabetes complications such as retinopathy, nephropathy, neuropathy and large artery impairment. Skeletal muscle is the major tissue involved in insulin-mediated glucose uptake, and the glucose taken up into the cells is either, metabolized through the glycolytic pathway/TCA cycle or stored as glycogen. Glycogen storage in the skeletal muscle is an extremely important function for glucose homeostasis, but in type II diabetes patients the glycogen storage volume in skeletal muscle is reduced. GSK-3 acts to inhibit glycogen storage in peripheral tissue by phosphorylating glycogen synthase, and to lower insulin reactivity, leading to increased blood glucose levels.


According to a recent report, accelerated expression of GSK-3 is seen in the skeletal muscle of type II diabetes patients and an inverse correlation has been found between skeletal muscle GSK-30 activity and insulin function (see non-patent document 6). Also, overexpression of GSK-3β and active GSK-3β mutants (S9A, S9E) in HEK-293 cells suppresses glycogen synthase activity (see non-patent document 7). Reduction in insulin function has been observed when GSK-3β is overexpressed in CHO cells expressing insulin receptor and insulin receptor substrate 1 (IRS-1) (see non-patent document 8). A recent study using C57BL/6J mice prone to obese diabetes has demonstrated a connection between accelerated GSK-3 activity and progression of insulin resistance/type II diabetes (see non-patent document 9).


Lithium salts are already known as inhibitors of GSK-3 activity (see non-patent document 10). Treatment using lithium salts is reported to lower glucose levels in both type I and type II diabetes patients and to generally improve their condition (see non-patent document 11). However, lithium salts have also been reported to exhibit various effects on molecular targets other than GSK-3.


In consideration of the above, it is expected that GSK-3 inhibitors can serve as effective drug agents for amelioration of impaired glucose tolerance, type I diabetes, type II diabetes, and their related complications.


A link has also been suggested between GSK-3 and progression of Alzheimer's disease. Alzheimer's disease is characterized by formation of senile plaques in the brain from amyloid D peptide deposits, and subsequent formation of neurofibrillary changes. These neurofibrillary changes result in the deaths of large numbers of neurons, and lead to the symptom of dementia. GSK-3 is believed to contribute to abnormal phosphorylation-of Tau protein, which is connected with neurofibrillary changes, during the course of the disease (see non-patent document 12). It has also been reported that GSK-3 inhibitors prevent neuronal death (see non-patent document 13). These findings suggest that application of GSK-3 inhibitors for Alzheimer's disease may slow progression of the condition. While treatment methods currently exist which employ agents for symptomatic therapy of Alzheimer's disease (see non-patent document 14), no agents are known that prevent neuronal death and slow progression of the condition. It is therefore expected that GSK-3 inhibitors can serve as effective drug agents for amelioration of Alzheimer's dementia.


GSK-3 inhibitors have been reported to suppress neuronal death, and especially neuronal death due to glutamate-mediated hyperexcitation (see non-patent documents 15 and 16). This suggests the possibility that GSK-3 inhibitors may be useful for treatment of bipolar affective disorder (manic depression), epilepsy and a host of neurodegenerative disorders and neural diseases. As neurodegenerative disorders there may be mentioned Alzheimer's disease described above, as well as AIDS encephalopathy, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, disseminated sclerosis, Pick's disease, progressive supranuclear palsy, and the like. Glutamate-mediated hyperexcitation is believed to be a cause of brain disorders in such conditions as cerebral apoplexy (cerebral infarction, encephalorrhagia, subarachnoid hemorrhage), traumatic encephalopathy/spinal injury, bacterial/viral infection and the like, and GSK-3 inhibitors are therefore expected to be useful against these conditions as well. All of these disorders are accompanied by death of neurons, and at the current time no drug exists that can effectively suppress such neuronal death. It is therefore believed that GSK-3 inhibitors can serve as effective drug agents for amelioration of various forms of neurodegenerative disorders, bipolar affective disorder (manic depression), epilepsy, cerebral apoplexy, traumatic encephalopathy/spinal injury, and the like.


In vitro research has also been reported indicating that Wint10B strongly suppresses differentiation of preadipocytes to mature adipocytes (see non-patent document 17). GSK-3 specific inhibitors mimic the Wint10B signal in adipose cells, and particularly stabilize free cytosolic β-catenin to block induction of c/EBPα and PPARγ, thereby inhibiting adipogenesis (see non-patent document 18). These findings have led to expectations for GSK-3 inhibitors as effective agents for treatment of obesity.


β-Catenin is known as a biological substrate of GSK-3. β-Catenin is phosphorylated by GSK-3 and undergoes proteosome-dependent degradation (see non-patent document 19). Since transient β-catenin stabilization is thought to play a role in hair development (see non-patent document 20), this suggests that GSK-3 inhibitors may serve as effective drug agents for alopecia.


In addition, research on fibroblasts from GSK-3β knockout mice has raised the possibility that GSK-3β upregulates activity of transcription factor NFκ-B. (see non-patent document 21). NFκ-B is responsible for cell response to a large number of inflammatory stimuli. It is therefore believed that GSK-3 inhibitors may, through downregulation of NFκ-B activity, serve as effective drug agents for treatment of inflammatory conditions such as deformant arthritis, rheumatism, atopic dermatitis, psoriasis, ulcerative colitis, Crohn's disease, sepsis, generalized inflammatory reaction syndrome, and the like.


The transcription factor NF-AT is dephosphorylated by calcineurin, resulting in a reinforced immune response (see non-patent document 22). GSK-3 instead phosphorylates NF-AT and exports it out of the nucleus, thereby working in a direction to suppress expression of early immune response genes. These findings suggest that GSK-3 inhibitors may serve as effective drug agents promoting immune activation for cancer immunotherapy and the like.


As substances previously known to have GSK-3 inhibiting activity there have been reported hymenialdisine derivatives (see non-patent document 23 and patent document 1), maleinimide derivatives (see non-patent document 24), Paullone derivatives (see non-patent document 25 and patent document 2), purine derivatives (see patent document 3), pyrimidine and pyridine derivatives (see patent document 4), hydroxyflavone derivatives (see patent document 5), pyrimidone derivatives (see patent documents 6, 7, 8, 9, 10, 11, 12 and 13), pyrrole-2,5-dione derivatives (see patent documents 14 and 15), diamino-1,2,4-triazolecarboxylic acid derivatives (see patent document 16), pyrazine derivatives (see patent document 17), bicyclic inhibitors (see patent document 18), indirubin derivatives (see patent document 19), carboxamide derivatives (see patent document 20), peptide inhibitors (see patent document 21), 2,4-diaminothiazole derivatives (see patent document 22), thiadiazolidinedione derivatives (see patent document 23) and aromatic amide derivatives (see patent document 24).

  • Non-patent document 1: Trends Biochem. Sci., 1991, Vol. 16, p. 177.
  • Non-patent document 2: Eur. J. Biochem., 1980, Vol. 107, p. 519.
  • Non-patent document 3: Biochem. J. (UK), 1993, Vol. 294, p. 625.
  • Non-patent document 4: Biochem. J. (UK), 1994, Vol. 303, p. 21.
  • Non-patent document 5: Biochem. J. (UK), 1994, Vol. 303, p. 27.
  • Non-patent document 6: Diabetes USA, 2000, Vol. 49, p. 263.
  • Non-patent document 7: Proc. Natl. Acad. Sci. USA, 1996, Vol. 93, p. 10228.
  • Non-patent document 8: Proc. Natl. Acad. Sci. USA, 1997, Vol. 94, P. 9660.
  • Non-patent document 9: Diabetes USA, 1999, Vol. 48, p. 1662.
  • Non-patent document 10: Proc. Natl. Acad. Sci. USA, 1996, Vol. 93, p. 8455.
  • Non-patent document 11: Biol. Trace Elements Res., 1997, Vol. 60, p. 131.
  • Non-patent document 12: Acta Neuropathol., 2002, Vol. 103, p. 91.
  • Non-patent document 13: J. Neurochem., 2001, Vol. 77, p. 94.
  • Non-patent document 14: Expert Opin. Pharmacother., 1999, Vol. 1, p. 121.
  • Non-patent document 15: Proc. Natl. Acad. Sci. USA, 1998, Vol. 95, p. 2642.
  • Non-patent document 16: J. Neurochem., 2001, Vol. 77, p. 94.
  • Non-patent document 17: Science, 2000, Vol. 289, p. 950.
  • Non-patent document 18: J. Biol. Chem, 2002, Vol. 277, p. 30998.
  • Non-patent document 19: EMBO J., 1998, Vol. 17, p. 1371.
  • Non-patent document 20: Cell, 1998, Vol. 95, p. 605.
  • Non-patent document 21: Nature, 2000, Vol. 406, p. 86.
  • Non-patent document 22: Science, 1997, Vol. 275, p. 1930.
  • Non-patent-document 23: Chemistry & Biology, 2000, Vol. 7, p. 51.
  • Non-patent document 24: Chemistry & Biology, 2000, Vol. 7, p. 793.
  • Non-patent document 25: Eur. J. Biochem., 2000, Vol. 267, p. 5983.
  • Patent document 1: WO01/41768 pamphlet
  • Patent document 2: WO01/60374 pamphlet
  • Patent document 3: WO98/16528 pamphlet
  • Patent document 4: WO99/65897 pamphlet
  • Patent document 5: WO00/17184 pamphlet
  • Patent document 6: WO00/18758 pamphlet
  • Patent document 7: WO01/70683 pamphlet
  • Patent document 8: WO01/70729 pamphlet
  • Patent document 9: WO01/70728 pamphlet
  • Patent document 10: WO01/70727 pamphlet
  • Patent document 11: WO01/70727 pamphlet
  • Patent document 12: WO01/70726 pamphlet
  • Patent document. 13: WO01/70725 pamphlet
  • Patent document 14: WO00/21927 pamphlet
  • Patent document 15: WO01/74771 pamphlet
  • Patent document 16: WO01/09106 pamphlet
  • Patent document 17: WO01/44206 pamphlet
  • Patent document 18: WO01/44246 pamphlet
  • Patent document 19: WO01/37819 pamphlet
  • Patent document 20: WO01/42224 pamphlet
  • Patent document 21: WO01/49709 pamphlet
  • Patent document 22: WO01/56567 pamphlet
  • Patent document 23: WO01/85685 pamphlet
  • Patent document 24: WO01/81345 pamphlet


It is an object of the present invention to provide clinically useful novel compounds with selective and powerful inhibiting action against GSK-3.


DISCLOSURE OF THE INVENTION

As a result of much diligent research directed toward achieving the object stated above, the present inventors have completed the present invention upon discovering that the novel pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I) below and their medically acceptable salts exhibit excellent GSK-3 inhibiting activity.


In other words, the present invention provides (1) A pyrrolo[3,2-d]pyrimidine derivatives represented by the following formula (I), and their medically acceptable salts.
embedded image

[wherein X represents an oxygen atom or sulfur atom;

    • A1 represents a single bond, or a C1-6 aliphatic hydrocarbon group with the bonded nitrogen atom and A2 being bonded on the same or different carbon atoms of A1;
    • A2 represents a single bond or a group binding A1 and G1 in the form of A1-C(═O)-G1, A1-C(═O)O-G1, A1-C(═O)NR101-G1, A1-C(═S)NR102-G1, A1-C(═NR103)-G1, A1-O-G1, A1-OC(═O)-G1, A1-NR104-G1, A1-NR105C(═O)-G1, A1-NR106S(═O)2-G1, A1-NR107C(═O)O-G1, A1-NR108C(═O)NR109-G1, A1-NR110C(═S)-G1, A1-NR111C(═S)NR112-G1, A1-S-G1, A1-S(═O)-G1, A1-S(═O)2-G1 or A1-S(═O)2NR113-G1 (where R101-R113 each independently represent hydrogen or a C1-4 aliphatic hydrocarbon group);
    • G1 represents one group selected from among the following 1) to 4):
    • 1) A single bond.
    • 2) A substituted or unsubstituted C3-8 alicyclic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons and optionally substituted C1-6 aliphatic hydrocarbons.)
    • 3) A substituted or unsubstituted C6-14 aromatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons and optionally substituted C1-6 aliphatic hydrocarbons.)
    • 4) A substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C1-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons and optionally substituted C1-6 aliphatic hydrocarbons.);
    • A3 represents a single bond, or a C1-6 aliphatic hydrocarbon group having G1 and A4 bonded on the same or different carbon atoms;
    • A4 represents a single bond or a group binding A3 and G2 in the form of A3-C(═O)-G2, A3-C(═O)O-G2, A3-C(═O)NR121-G2, A3-C(═S)NR122-G2, A3-C(═NR123)-G2, A3-O-G2, A3-C(═O)-G2, A3-NR124-G2, A3-NR125C(═O)-G2, A3-NR126S(═O)2-G2, A3-NR127C(═O)O-G2, A3-NR128C(═O)NR129-G2, A3-NR130C(═S)-G2, A3-NR131C(═S)NR132-G2, A3-S-G2, A3-S(═O)-G2, A3-S(═O)2-G2, A3-S(═O)2NR133-G2 or A3-S(═O)2O-G2 (where R121-R133 each independently represent hydrogen or a C1-4 aliphatic hydrocarbon group); and
    • G2 represents one group selected from among the following 1) to 5):
    • 1) Hydrogen;
    • 2) A substituted or unsubstituted C1-10 aliphatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C1-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2—, alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)


3) A substituted or unsubstituted C3-8 alicyclic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)

    • 4) A substituted or unsubstituted C6-14 aromatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 5) A substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-1 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)


The above is with the proviso that among the combinations of A1, A2, G1, A3, A4 and G2, when A1 is a single bond, A2, G1, A3 and A4 are all single bonds, that among the combinations of A1, A2, G1, A3, A4 and G2, when A1 is not a single bond and G1 and A3 are both single bonds, the combination including A2 and A4 is A1-C(═O)—C(═O)-G2 or A1-C(═O)NR101-O-G2, and that among the combinations of G1, A3, A4 and G2, when A3 represents a C1-6 aliphatic hydrocarbon group having G1 and A4 bonded on the same or different carbon atoms and G2 represents a substituted or unsubstituted C1-10 aliphatic hydrocarbon group, A4 is not a single bond.


A5 represents a single bond, or a group binding the carbon atom of the pyrrole ring to which A5 is bonded and R2 in the form of R2—NR201-pyrrole ring carbon (where R201 represents hydrogen or a C1-4 aliphatic hydrocarbon group).


R2 represents one group selected from among the following 1) to 6):

    • 1) Hydrogen.
    • 2) Fluorine, chlorine, bromine or iodine.
    • 3) A substituted or unsubstituted C1-10 aliphatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 4) A substituted or unsubstituted C3-8 alicyclic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C1-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2—, alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 5) A substituted or unsubstituted C6-14 aromatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 6) A substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).) The above is with the proviso that among the combinations of R2 and A5, when R2 is fluorine, chlorine, bromine or iodine, A5 is a single bond.].
  • (2) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1), wherein X is an oxygen atom.
  • (3) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1), wherein X is a sulfur atom.
  • (4) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (3), wherein A1 is —(CH2)2—.
  • (5) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (3), wherein A1 is —(CH2)3—.
  • (6) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-O-G1.
  • (7) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-OC(═O)-G1.
  • (8) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NR104-G1.
  • (9) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NR105C(═O)-G1.
  • (10) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NR106S(═O)2-G1.
  • (11) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NR107C(═O)O-G1.
  • (12) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NR108C(═O)NR109-G1.
  • (13) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)-G1.
  • (14) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)O-G′.
  • (15) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)NR101-G1.
  • (16) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═S)NR102-G1.
  • (17) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═NR103)-G1.
  • (18) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NR110C(═S)-G1.
  • (19) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NR111C(═S)NR112-G1.
  • (20) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-S-G1.
  • (21) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-S(═O)-G1.
  • (22) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-S(═O)2-G1.
  • (23) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-S(═O)2NR113-G1.
  • (24) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NH-G1
  • (25) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NHC(═O)-G1.
  • (26) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NHS(═O)2-G1.
  • (27) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A3-A2-G1 bond in the form of A1-NHC(═O)O-G1.
  • (28) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NHC(═O)NH-G1.
  • (29) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)NH-G1.
  • (30) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═S)NH-G1.
  • (31) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═NH)-G1.
  • (32) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-NHC(═S)-G1.
  • (33) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-S(═O)2NH-G1.
  • (34) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A2 is a single bond.
  • (35) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is a single bond.
  • (36) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is a substituted or unsubstituted C6-14 aromatic hydrocarbon group.
  • (37) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is a substituted or unsubstituted C38 alicyclic hydrocarbon group.
  • (38) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (39) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is an unsubstituted C6-14 aromatic hydrocarbon group.
  • (40) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is an unsubstituted C3-8 alicyclic hydrocarbon group.
  • (41) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is an unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (42) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is a substituted C6-14 aromatic hydrocarbon group.
  • (43) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is a substituted C3-8 alicyclic hydrocarbon group.
  • (44) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is a substituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (45) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is an unsubstituted aromatic heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (46) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is a substituted aromatic heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (47) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted furan, unsubstituted pyrrole, unsubstituted pyrrolidine, unsubstituted thiophene, unsubstituted oxazole, unsubstituted thiazole, unsubstituted isooxazole, unsubstituted isothiazole, unsubstituted pyrazole, unsubstituted imidazole, unsubstituted pyridine, unsubstituted pyrimidine, unsubstituted pyrazine, unsubstituted benzothiophene, unsubstituted benzofuran, unsubstituted benzimidazole, unsubstituted indole, unsubstituted quinoline, unsubstituted isoquinoline, unsubstituted quinazoline, unsubstituted purine, unsubstituted phthalazine, unsubstituted cinnoline, unsubstituted 1,8-naphthylidine or unsubstituted pteridine.
  • (48) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted furan, substituted pyrrole, substituted pyrrolidine, substituted thiophene, substituted oxazole, substituted thiazole, substituted isooxazole, substituted isothiazole, substituted pyrazole, substituted imidazole, substituted pyridine, substituted pyrimidine, substituted pyrazine, substituted benzothiophene, substituted benzofuran, substituted benzimidazole, substituted indole, substituted quinoline, substituted isoquinoline, substituted quinazoline, substituted purine, substituted phthalazine, substituted cinnoline, substituted 1,8-naphthylidine or substituted pteridine.
  • (49) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted benzene.
  • (50) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted benzene.
  • (51) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted thiophene.
  • (52) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted thiophene.
  • (53) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted pyridine.
  • (54) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted pyridine.
  • (55) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted furan.
  • (56) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted furan.
  • (57) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted pyrrole.
  • (58) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted pyrrole.
  • (59) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted thiazole.
  • (60) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted thiazole.
  • (61) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted isooxazole.
  • (62) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted isooxazole.
  • (63) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted pyrazole.
  • (64) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted pyrazole.
  • (65) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted pyrimidine.
  • (66) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted pyrimidine.
  • (67) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent substituted quinazoline.
  • (68) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (6) to (34), wherein G1 is divalent unsubstituted quinazoline.
  • (69) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent unsubstituted pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine or piperazine, bonded to A1-C(═O) through the nitrogen atom.
  • (70) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent substituted pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine or piperazine, bonded to A1-C(═O) through the nitrogen atom.
  • (71) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent substituted piperidine, bonded to A1-C(═O) through the nitrogen atom.
  • (72) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in-the form of A1-C(═O)-G1, and G1 is divalent unsubstituted piperidine, bonded to A1-C(═O) through the nitrogen atom.
  • (73) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent substituted piperazine, bonded to A1-C(═O) through the nitrogen atom.
  • (74) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (5), wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent unsubstituted piperazine, bonded to A1-C(═O) through the nitrogen atom.
  • (75) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (35) to (74), wherein A3 is a single bond.
  • (76) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (35) to (74), wherein A3 is —CH2—.
  • (77) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (35) to (74), wherein A3 is —(CH2)2—.
  • (78) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (35) to (74), wherein A3 is —(CH2)3—.
  • (79) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A4 is a single bond.
  • (80) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A3-A4-G2 bond in the form of A3-C(═O)O-G2.
  • (81) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A3-A4-G2 bond in the form of A3-C(═O)-G2.
  • (82) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A3-A4-G2 bond in the form of A3-C(═O)NR121-G2.
  • (83) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to 78, wherein A3-A4-G2 bond in the form of A3-O-G2.
  • (84) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A3-A4-G2 bond in the form of A3-NR124-G2.
  • (85) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A3-A4-G2 bond in the form of A3-NR125C(═O)-G2.
  • (86) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A3-A1-G2 bond in the form of A3-NR126S(═O)2G2.
  • (87) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A3-A4-G2 bond in the form of A3-NR120C(═O)O-G2.
  • (88) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (75) to (78), wherein A3-A4-G2 bond in the form of A3-NR128C(═O)NR129-G2.
  • (89) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (79) to (88), wherein G2 is a hydrogen atom.
  • (90) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (79) to (88), wherein G2 is a substituted or unsubstituted C1-10 aliphatic hydrocarbon group.
  • (91) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (79) to (88), wherein G2 is a substituted or unsubstituted C3-8 alicyclic hydrocarbon group.
  • (92) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (79) to (88), wherein G2 is a substituted or unsubstituted C6-14 aromatic hydrocarbon group.
  • (93) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (79) to (88), wherein G2 is a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (94) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (36) to (74), wherein -A3-A4-G2 collectively represent hydrogen.
  • (95) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (36) to (93), wherein -A3-A4-G2 collectively represent a group other than hydrogen.
  • (96) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (94), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, and G1 is substituted divalent benzene.
  • (97) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (93), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, G1 is unsubstituted divalent benzene, and A3-A4-G2 are collectively a group other than hydrogen.
  • (98) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (94), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, and G1 is a divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (99) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (94), wherein x is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, and G1 is a substituted divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (100) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (93), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, and G1 is an unsubstituted divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and A3-A4-G2 are collectively a group other than hydrogen.
  • (101) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (94), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NH-G1, and G1 is substituted divalent benzene.
  • (102) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (93), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NH-G1, G1 is unsubstituted divalent benzene, and A3-A4-G2 are collectively a group other than hydrogen.
  • (103) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (94), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NH-G1, and G1 is a substituted divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (104) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (93), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G bond in the form of A1-NH-G1, and G1 is an unsubstituted divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and A3-A4-G2 are collectively a group other than hydrogen.
  • (105) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (94), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-C(═O)-G1, G1 is a divalent monocyclic C2-9 heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and G1 is bonded to A1-C(═O)— through a nitrogen atom.
  • (106) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (94), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-C(═O)-G1, G1 is a substituted divalent monocyclic C2-9 heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and G1 is bonded to A1-C(═O)— through a nitrogen atom.
  • (107) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (1) or any one of (75) to (93), wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-C(═O)-G1, G1 is an unsubstituted divalent monocyclic C2-9 heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, G1 is bonded to A1-C(═O)— through a nitrogen atom, and A3-A4-G2 are collectively a group other than hydrogen.
  • (108) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (107), wherein A5 is a single bond.
  • (109) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (107), wherein A5 is a group binding the carbon atom of the pyrrole ring to which A5 is bonded and R2 in the form of R2—NR201-pyrrole ring carbon.
  • (110) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (109), wherein R2 is a hydrogen atom.
  • (111) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (108), wherein R2 is fluorine, chlorine, bromine or iodine.
  • (112) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (108) or (109), wherein R2 is a substituted or unsubstituted C1-10 aliphatic hydrocarbon group.
  • (113) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (108) or (109), wherein R2 is a substituted or unsubstituted C3-8 aliphatic hydrocarbon group.
  • (114) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (108) or (109), wherein R2 is a substituted or unsubstituted C6-14 aromatic hydrocarbon group.
  • (115) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to (108) or (109), wherein R2 is a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (116) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (107), wherein R2-A5- is substituted or unsubstituted isopropylamino, substituted or unsubstituted cyclopropylamino, substituted or unsubstituted cyclopentylamino, substituted or unsubstituted dimethylamino, substituted or unsubstituted N-methyl-ethylamino, substituted or unsubstituted N-methyl-2-propenylamino, substituted or unsubstituted N-methyl-2-propynylamino, substituted or unsubstituted 1-pyrrolidinyl, substituted or unsubstituted 1-piperazinyl, substituted or unsubstituted 1-piperidino, substituted or unsubstituted 1-morpholino or substituted or unsubstituted 1-homopiperidinyl.
  • (117) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (107), wherein R2-A5- is substituted or unsubstituted cyclopropyl, substituted or unsubstituted phenyl, substituted or unsubstituted furyl, substituted or unsubstituted thienyl, substituted or unsubstituted pyrrolyl, substituted or unsubstituted pyrazolyl, substituted or unsubstituted oxazolyl, substituted or unsubstituted isooxazolyl, substituted or unsubstituted thiazolyl, substituted or unsubstituted isothiazolyl, substituted or unsubstituted imidazolyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrazinyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted pyridazinyl, substituted or unsubstituted benzofuranyl or substituted or unsubstituted benzothiophenyl.
  • (118) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (107), wherein R2-A5- is substituted or unsubstituted 2-furyl, substituted or unsubstituted 2-thienyl, substituted or unsubstituted 2-pyrrolyl, substituted or unsubstituted 2-imidazolyl, substituted or unsubstituted 5-imidazolyl, substituted or unsubstituted 2-oxazolyl, substituted or unsubstituted 5-oxazolyl, substituted or unsubstituted 5-isooxazolyl, substituted or unsubstituted 2-thiazolyl, substituted or unsubstituted 5-thiazolyl, substituted or unsubstituted 5-isothiazolyl, substituted or unsubstituted 3-isothiazolyl, substituted or unsubstituted 2-pyridyl, substituted or unsubstituted 2-pyrimidinyl, substituted or unsubstituted 2-benzofuranyl or substituted or unsubstituted 2-benzothiophenyl.
  • (119) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (107), wherein R2-A5- is substituted or unsubstituted 2-furyl, substituted or unsubstituted 2-thienyl or substituted or unsubstituted 2-pyrrolyl.
  • (120) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (107), wherein R2-A5- is 3-methyl(2-furyl), 3-chloro(2-furyl), 3-methyl(2-thienyl), 3-chloro(2-thienyl) or 1-methylpyrrol-2-yl.
  • (121) A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (107), wherein A5 is a group binding the carbon atom of the pyrrole ring to which A5 is bonded and R2 in the form of R2—NR201-pyrrole ring carbon, and R2 is a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • (122) A pharmaceutical composition comprising a pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (121), and a pharmaceutically acceptable carrier.
  • (123) A GSK-3 inhibitor comprising a pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (121).
  • (124) A therapeutic or prophylactic agent for a GSK-3 associated disease, comprising a pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of (1) to (121).
  • (125) A therapeutic or prophylactic agent according to (124), wherein said GSK-3 associated disease is selected from the group consisting of diabetes, diabetes complications, Alzheimer's disease, neurodegenerative diseases, manic depression, traumatic encephalopathy, alopecia, inflammatory diseases, cancer and immune deficiency.
  • (126) A pyrrolo[3,2-d]pyrimidine derivative represented by formula (II):
    embedded image

    [wherein the definitions of A1, A2, A3, A4, A5, G1, G2 and R2 are the same as for-formula (I) above, and X1 represents chlorine, bromine, iodine, C2-10 acylthio, C2-8 alkoxymethylthio or C1-8 alkyl- or arylsulfonyloxy).


(127) A pyrrolo[3,2-d]pyrimidine derivative according (126), wherein X1 is chlorine or trifluoromethanesulfonyloxy.

  • (128) A pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ic):
    embedded image

    [wherein the definitions of A1, A2, A3, A4, A5, G1, G2, R2 and X are the same as for formula (I) above, and R3 represents C2-10 acyl, C2-10 alkoxymethyl or substituted or unsubstituted benzyl].







BEST MODE FOR CARRYING OUT THE INVENTION

In formula (I) above, X represents an oxygen or sulfur atom. That is, the pyrrolo[3,2-d]pyrimidine derivatives of formula (I) above comprise the pyrrolo[3,2-d]pyrimidine derivatives represented by the following formula (Ia):
embedded image

[wherein the definitions of A1, A2, A3, A4, A5, G1, G2 and R2 have the same definitions as A1, A2, A3, A4, A5, G1, G2 and R2 in formula (I) above]


and the following formula (Ib):
embedded image

[wherein the definitions of A1, A2, A3, A4, A5, G1, G2 and R2 have the same definitions as A1, A2, A3, A4, A5, G1 G2 and R2 in formula (I) above].


X is most preferably sulfur.


In formula (I) above, A1 represents a single bond or a C1-6 aliphatic hydrocarbon group with the bonded nitrogen atom and A2 being bonded on the same or different carbon atoms of A1. As examples of C1-6 aliphatic hydrocarbon groups for A1 there may be mentioned methane, ethane, propane, butane, 2-methylpropane, pentane, 2-methylbutane, 2,2-dimethylpropane, hexane, 2-methylpentane, 3-methylpentane, 2,2-dimethylbutane, 2,3-dimethylbutane and 2,2,3-trimethylpropane. As examples of C1-6 aliphatic hydrocarbon groups with the bonded nitrogen atom and A2 being bonded on the same or different carbon atoms of A1, there may be mentioned —CH2—, —(CH2)2—, —(CH2)3—, —(CH2)4—, —(CH2)5—, —(CH2)6—, —CH(CH3)—, —CH(CH3)CH2—, —CH(CH3)CH(CH3)—, —C(CH3)2CH2—, —CH(CH3)(CH2)2—, —CH2CH(CH3)CH2—, —CH(CH3)CH(CH3)CH2—, —CH(CH3)CH2CH(CH3)—, —CH2C(CH3)2CH2—, —CH(CH3)C(CH3)2CH2—, —CH(CH2CH3) (CH2)2—, —CH2CH(CH2CH3)CH2—, —CH(CH2CH3)CH(CH3)CH2—, —CH(CH3)CH(CH2CH3)CH2—, —CH(CH2CH3)CH2CH(CH3)—, —CH(CH3)(CH2)3—, —CH2CH(CH3)(CH2)2—, —CH(CH3)CH(CH3) (CH2)2—, —CH(CH3)CH2CH(CH3)CH2—, —CH2CH(CH3)CH(CH3)CH2—, —CH2C(CH3)2(CH2)2—, —CH(CH3)C(CH3)2(CH2)2—, —CH(CH2CH3) (CH2)3—, —CH2CH(CH2CH3)(CH2)2—, —CH(CH3)(CH2)4—, —CH2CH(CH3)(CH2)3— and —(CH2)2CH(CH3)(CH2)2—. Preferred among these are —CH2—, —(CH2)2—, —(CH2)3—, —(CH2)4—, —CH(CH3)CH2—, —CH(CH3)CH(CH3)—, —CH(CH3) (CH2)2—, —CH2CH(CH3)CH2— and —CH(CH3)CH(CH3)CH2—, with —(CH2)2— and —(CH2)3— being more preferred and —(CH2)2— being especially preferred for A1.


A2 in formula (I) above represents a single bond, or a group binding A1 and G1 in the form of A1-C(═O)-G1, A1-C(═O)O-G1, A1-C(═O)NR11-G1, A1-C(═S)NR102-G1, A1-C(═NR103)-G , A1-O-G1, A1-OC(═O)-G1, A1-NR104-G1, A1-NR105C(═O)-G1, A1-NR106S(═O)2-G1, A1-NR107C(═O)O-G1, A1-NR108C(═O)NR109-G1, A1-NR110C(═S)-G1, A1-NR111C(═S)NR112-G1, A1-S-G1, A1-S(═O)-G1, A1-S(═O)2-G1 or A1-S(═O)2NR113-G1 (where R101-R113 each independently represent hydrogen or a C1-4 aliphatic hydrocarbon group). As examples of C1-4 aliphatic hydrocarbon groups for R101 when A1 and G1 are bonded in the form of A1-C(═O)NR101-G1, there may be mentioned methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl, t-butyl, 2-propenyl, 2-butenyl, 3-butenyl, 2-propynyl, 2-butynyl and 3-butynyl. The C1-4 aliphatic hydrocarbon group may be optionally substituted with one or more substituent selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, methoxy, ethoxy, oxo, cyano, carboxyl, carbamoyl, amino, sulfo and phenyl. As preferred examples of R101 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R102 when A1 and G1 are in the form of A1-C(═S)NR102-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R102 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R103 when A1 and G1 are in the form of A1-C(═NR103)-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R103 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R104 when A1 and G1 are in the form of A1-NR104-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R104 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R105 when A1 and G1 are in the form of A2-NR105C(═O)-G1, there may be mentioned the same ones as mentioned above for R110. As preferred examples of R105 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R106 when A1 and G1 are in the form of A—NR106S(═O)2-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R106 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R107 when A1 and G1 are in the form of A1-NR107C(═O)O-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R107 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R108 and R109 when A1 and G1 are in the form of A1-NR108C(═O)NR109-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R108 and R109 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R110 when A1 and G1 are in the form of A1-NR110C(═S)-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R110 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R111 and R112 when A1 and G1 are in the form of A1-NR111C(═S)NR112-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R111 and R112 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R113 when A1 and G1 are in the form of A1-S(═O)2NR113-G1, there may be mentioned the same ones as mentioned above for R101. As preferred examples of R113 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As preferred examples of A2 there may be mentioned groups such that A1 and G1 are bonded in the form of A1-C(═O)-G1, A1-C(═O)NR101-G1, A1-O-G1, A1-NR104-G1, A1-NR105C(═O)-G1, A1-NR109C(═O)NR109-G1, A1-NR110C(═S)-G1 and A1-NR111C(═S)NR112-G1, with A1-C(═O)-G1, A1-C(═O)NR101G1, A1-NR104-G1, A1-NR105C(═O)-G1 and A1-NR110C(═S)-G1 being particularly preferred (wherein R101, R104, R105, R108, R109, R110, R111 and R112 have the same definitions as above). As even more preferred groups among these there may be mentioned those such that A1 and G1 are bonded in the form of A1-C(═O)-G1, A1-NHC(═O)-G1 and A1-NH-G1. These bonding forms mentioned as preferred and more preferred examples of A2 are even more preferably combined with a structure of formula (I) above wherein X is sulfur and A1 is —(CH2)2—.


In formula (I), A3 represents a single bond, or a C1-6 aliphatic hydrocarbon group having G1 and A4 bonded on the same or different carbon atoms. As examples of C1-6 aliphatic hydrocarbon groups for A3 there may be mentioned the same ones as mentioned above for A1, as well as —CH═CH—, —C(CH3)═CH—, —C(CH3)═C(CH3)—, —C(CH2CH3)═CH—, —C(CH2CH3)═C(CH3)—, —C(CH2CH3)═C(CH2CH3)—, —C(CH2CH2CH3)═CH—, C(CH2CH2CH3)═C(CH3)—, —CH═CHCH2—, —C(CH3)═CHCH2—, —CH═C(CH3)CH2—, —CH═CHCH(CH3)—, —C(CH3)═C(CH3)CH2—, —C(CH3)═CHCH(CH3)—, —C(CH3)═C(CH3)CH(CH3)—, —C(CH3)═CHC(CH3)2—, —C(CH2CH3)═CHCH2—, —CH═C(CH2CH3)CH2—, —CH═CHCH(CH2CH3)—, —C(CH2CH3)═C(CH3)CH2—, —C(CH2CH3)═CHCH(CH3)—, —C(CH3)═C(CH2CH3)CH2—, —CH═C(CH2CH3)CH(CH3)—, —CH═CHCH(CH2CH3)—, —C(CH3)═CHCH(CH2CH3)—, —CH═C(CH3)CH(CH2CH3)—, —CH═CH(CH2)2—, —C(CH3)═CH(CH2)2—, —CH═C(CH3)(CH2)2—, —CH═CHC(CH3)CH2—, —CH═CHCH2CH(CH3)—, —C(CH3)═C(CH3)(CH2)2—, —C(CH3)═CHCH(CH3)CH2—, —C(CH3)═CHCH2CH(CH3)—, —CH2CH═CHCH2—, —CH(CH3)CH═CHCH2—, —CH2C(CH3)═CHCH2—, —CH(CH3)C(CH3)═CHCH2—, —CH(CH3)CH═CHCH(CH3)—, —CH(CH3)CH═C(CH3)CH2—, —CH2C(CH3)═C(CH3)CH2—, —CH(CH2CH3)CH═CHCH2— and —CH2C(CH2CH3)═CHCH2—. As preferred examples of A3 there may be mentioned a single bond, —CH2—, —(CH2)2—, —(CH2)3—, —(CH2)4—, —CH(CH3)CH2—, —CH(CH3)CH(CH3)—, —CH(CH3)(CH2)2—, —CH═CH— and —CH═CHCH2—. As particularly preferred groups there may be mentioned a single bond, —CH2—, —(CH2)2— and —(CH2)3—.


In formula (I), A4 represents a single bond or a group binding A3 and G in the form of A3-C(═O)-G 2, A3-C(═O)O-G2, A3-C(═O)NR121-G2, A3-C(═S)NR122-G2, A3-C(═NR123)-G2, A3-O-G2, A3-OC(═O)-G2, A3-NR124-G2, A3-NR125C(═O)-G2, A3-NR126S(═O)2-G2, A3-NR127C(═O)O-G2, A3-NR128C(═O)NR129-G2, A3-NR130C(═S)-G2, A3-NR131C(═S)NR132-G2, A3-S-G2, A3-S(═O)-G2, A3-S(═O)2-G2, A3-S(═O)2NR133-G2 (where R121-R133 each independently represent hydrogen or a C1-4 aliphatic hydrocarbon group), or A3-S(═O)2O-G2. As examples of C1-4 aliphatic hydrocarbon groups for R121 when A3 and G2 are bonded in the form of A3-C(═O)NR121-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R121 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R122 when A3 and G2 are bonded in the form of A3-C(═S)NR122-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R122 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R123 when A3 and G2 are bonded in the form of A3-C(═NR123)-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R123 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R124 when A3 and G2 are bonded in the form of A3-NR124-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R124 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R125 when A3 and G2 are bonded in the form of A3-NR125C(═O)-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R125 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R126 when A3 and G2 are bonded in the form of A3-NR126S(═O)2-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R126 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R127 when A3 and G2 are bonded in the form of A3-NR127C(═O)O-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R127 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R128 and R129 when A3 and G2 are bonded in the form of A3-NR128C(═O)NR129-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R128 and R129 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R130 when A3 and G2 are bonded in the form of A3-NR130C(═S)-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R130 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R131 and R132 when A3 and G2 are bonded in the form of A3-NR131C(═S)NR132-G2 there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R131 and R132 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As examples of C1-4 aliphatic hydrocarbon groups for R133 when A3 and G2 are bonded in the form of A3-S(═O)2NR133-G2, there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples of R133 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen being particularly preferred. As preferred groups for A4 there may be mentioned a single bond, and groups such that A3 and G2 are bonded in the form of A3-C(═O)-G2, A3-C(═O)O-G2, A3-C(═O)NR121-G2, A3-O-G2, A3-NR124-G2, A3-NR125C(═O)-G2, A3-S(═O)2-G2 and A3-S(═O)2O-G2 (wherein R121, R124 and R125 are as defined above).


In formula (I) above, G1 represents one group selected from among the following 1) to 4):

    • 1) A single bond.
    • 2) A substituted or unsubstituted C3-8 alicyclic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons and optionally substituted C1-6 aliphatic hydrocarbons.)
    • 3) A substituted or unsubstituted C6-14 aromatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons and optionally substituted C1-6 aliphatic hydrocarbons.)
    • 4) A substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1I6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-9 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons and optionally substituted C1-6 aliphatic hydrocarbons.)


As examples of preferred C3-8 alicyclic hydrocarbon groups when G1 in formula (I) is a substituted or unsubstituted C3-8 alicyclic hydrocarbon group, there may be mentioned divalent groups such as cyclopropane, cyclobutane, cyclopentane, cyclopentene, cyclohexane, cyclohexene, cycloheptane, cycloheptene, cyclooctane, bicyclo(2.2.1]heptane, bicyclo[2.2.1]heptene, bicyclo[3.1.1]heptane and bicyclo[2.2.2]octane. As preferred C3-8 alicyclic hydrocarbon groups for G1 there may be mentioned divalent C3-6 monocyclic alicyclic hydrocarbon groups such as cyclopropane, cyclopentane and cyclohexane.


As substituents for the substituted C3-8 alicyclic hydrocarbon groups for G1 there may be mentioned fluorine, chlorine, bromine, iodine, hydroxyl, C1-7 alkoxy groups composed of linear or branched alkyl or cycloalkyl groups and oxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy, isopentyloxy, neopentyloxy, t-pentyloxy, hexyloxy, isohexyloxy, 2-methylpentyloxy, 1-ethylbutoxy, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cyclopropylmethyloxy, cyclopropylethyloxy, cyclopentylmethyloxy and cyclohexylmethyloxy; C6-10 aryloxy groups such as phenoxy, 1-naphthoxy and 2-naphthoxy; C7-9 aralkoxy groups such as benzyloxy, α-phenethyloxy, β-phenethyloxy and phenylpropyloxy; C2-7 acyloxy groups such as acetoxy, propionyloxy, butyryloxy, isobutyryloxy, valeryloxy, isovaleryloxy, pivaloyloxy and hexanoyloxy; oxo; C1-6 alkylsulfonyloxy groups composed of linear or branched alkyl and sulfonyloxy groups, such as methylsulfonyloxy, ethylsulfonyloxy, propylsulfonyloxy, butylsulfonyloxy and t-butylsulfonyloxy; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, pivaloyl and hexanoyl; carboxyl; C2-7 alkoxycarbonyl groups composed of linear or branched alkyl and oxycarbonyl groups, such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl, s-butoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups composed of linear or branched alkyl or cycloalkyl groups and carbamoyl groups, such as N-methylcarbamoyl, N-ethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-isobutylcarbamoyl, N-s-butylcarbamoyl, N-t-butylcarbamoyl, N-pentylcarbamoyl, N-cyclopropylcarbamoyl, N-cyclobutylcarbamoyl, N-cyclopentylcarbamoyl, N-cyclohexylcarbamoyl, N-cycloheptylcarbamoyl, N-cyclopropylmethylcarbamoyl, N,N-dimethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl and N,N-dipropylcarbamoyl; amino; C1-6 alkylamino groups composed of linear or branched alkyl or cycloalkyl groups and amino groups, such as methylamino, ethylamino, propylamino, isopropylamino, butylamino, isobutylamino, s-butylamino, t-butylamino, pentylamino, hexylamino, cyclopropylamino, cyclobutylamino, cyclopentylamino, cyclohexylamino, cyclopropylmethylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, N-methylbutylamino, N-methyl-t-butylamino, N-ethylisopropylamino, dipropylamino, diisopropylamino and ethylbutylamino; C2-7 acylamino groups such as acetylamino, propionylamino, butyrylamino, isobutyrylamino, valerylamino and hexanoylamino; C2-8 alkoxycarbonylamino groups such as methoxycarbonylamino, ethoxycarbonylamino and t-butoxycarbonylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, butylsulfonylamino and t-butylsulfonylamino; cyano; nitro; C1-6 alkylthio groups such as methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, s-butylthio, t-butylthio, pentylthio and hexylthio; C1-6 alkylsulfinyl groups composed of linear or branched alkyl or cycloalkyl groups and sulfinyl groups, such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, butylsulfinyl, isobutylsulfinyl, s-butylsulfinyl, t-butylsulfinyl, pentylsulfinyl and cyclopentylsulfinyl; C1-6 alkylsulfonyl groups composed of linear or branched alkyl groups or cycloalkyl groups and sulfonyl groups, such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, isobutylsulfonyl, s-butylsulfonyl, t-butylsulfonyl, pentylsulfonyl, hexylsulfonyl, cyclopentylsulfonyl and cyclohexylsulfonyl; sulfo; sulfamoyl; C1-6 aminosulfonyl groups composed of linear or branched alkyl or cycloalkyl groups and aminosulfonyl groups, such as methylaminosulfonyl, ethylaminosulfonyl, propylaminosulfonyl, isopropylaminosulfonyl, butylaminosulfonyl, isobutylaminosulfonyl, s-butylaminosulfonyl, pentylaminosulfonyl, dimethylaminosulfonyl, N-ethyl-N-methylaminosulfonyl, diethylaminosulfonyl, dipropylaminosulfonyl, cyclopropylaminosulfonyl, cyclopentylaminosulfonyl, cyclohexylaminosulfonyl and cyclopropylmethylaminosulfonyl; C3-6 alicyclic hydrocarbons such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl; and linear or branched C1-6 aliphatic hydrocarbon groups optionally containing one unsaturated bond, such as methyl, ethyl, vinyl, ethynyl, propyl, 1-propenyl, 2-propenyl, isopropyl, isopropenyl, 1-propynyl, 2-propynyl, butyl, isobutyl, s-butyl, t-butyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-butynyl, 2-butynyl, pentyl, isopentyl, neopentyl, t-pentyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, hexyl, 5-hexenyl, 4-methyl-3-pentenyl, isohexyl, 2-methylpentyl and 1-ethylbutyl.


The term “alkyl” according to the invention refers to linear or branched saturated aliphatic hydrocarbon groups such as methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, isopropyl, isobutyl, s-butyl, t-butyl, isopentyl, neopentyl, t-pentyl and isohexyl.


The term “cycloalkyl” according to the invention refers to saturated alicyclic hydrocarbon groups such as cyclopropyl, cyclobutyl and cyclohexyl.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon and C1-6 aliphatic hydrocarbon groups as substituents for the substituted C3-8 alicyclic hydrocarbon groups for G1 may be in turn substituted with one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C1-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; C1-7 acylamino groups such as trifluoroacetylamino, formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; and cyano.


As examples of C6-14 aromatic hydrocarbon groups when G1 of formula (I) represents a substituted or unsubstituted C6-14 aromatic hydrocarbon group, there may be mentioned divalent groups having at least one aromatic ring in the molecule, such as benzene, indene, indane, naphthalene, 1,2-dihydronaphthalene, 1,2,3,4-tetrahydronaphthalene, azulene, acenaphthylene, acenaphthene, fluorene, phenanthrene and anthracene. As preferred examples of C6-4 aromatic hydrocarbon groups for G1, there may be mentioned divalent benzene, naphthalene and indane. Divalent benzene may be mentioned as the most preferred examples of a C6-14 aromatic hydrocarbon group for G1.


As substituents for the substituted C6-14 aromatic hydrocarbon groups for G1, there may be mentioned fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon groups and optionally substituted C1-6 aliphatic hydrocarbon groups.


The definitions of the substituents for the substituted C6-14 aromatic hydrocarbon groups for G1 are the same as the definitions of the substituents for the substituted C3-8 alicyclic hydrocarbon groups for G1. As specific examples of substituents for the substituted C6-14 aromatic hydrocarbon groups for G1, there may be mentioned the same specific substituents mentioned above for the substituted C3—, alicyclic hydrocarbon groups for G1.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon and C1-6 aliphatic hydrocarbon groups as substituents for the substituted C6-14 aromatic hydrocarbon groups for G1 may be in turn substituted with one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; C1-7 acylamino groups such as trifluoroacetylamino, formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; and cyano.


As preferred examples of substituents for the substituted C6-14 aromatic hydrocarbon groups for G1, there may be mentioned fluorine; chlorine; bromine; C1-6 alkoxy groups composed of linear or branched alkyl groups and oxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy, isopentyloxy, neopentyloxy, t-pentyloxy and hexyloxy; cyano; nitro; carboxyl; hydroxyl; amino; C1-6 mono or dialkylamino groups composed of linear or branched alkyl and amino groups, such as methylamino, ethylamino, propylamino, isopropylamino, butylamino, isobutylamino, s-butylamino, t-butylamino, pentylamino, hexylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, N-methylbutylamino, N-methyl-t-butylamino, N-ethylisopropylamino, dipropylamino, diisopropylamino and ethylbutylamino; carbamoyl; aminosulfonyl; C3-6 alicyclic hydrocarbon groups such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, pivaloyl and hexanoyl; C1-6 alkylthio groups such as methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, s-butylthio, t-butylthio, pentylthio and hexylthio; C1-6 alkylsulfonyl groups such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, isobutylsulfonyl, s-butylsulfonyl, t-butylsulfonyl, pentylsulfonyl and hexylsulfonyl; C2-7 alkoxycarbonyl groups such as acetoxy, propionyloxy, butyryloxy, isobutyryloxy, valeryloxy, isovaleryloxy, pivaloyloxy and hexanoyloxy; C2-7 acylamino groups such as acetylamino, propionylamino, butyrylamino, isobutyrylamino, valerylamino and hexanoylamino; trifluoromethyl; trifluoromethoxy; and linear or branched C1-6 aliphatic hydrocarbon groups optionally containing one unsaturated bond, such as methyl, ethyl, vinyl, ethynyl, propyl, 1-propenyl, 2-propenyl, isopropyl, isopropenyl, 1-propynyl, 2-propynyl, butyl, isobutyl, s-butyl, t-butyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-butynyl, 2-butynyl, pentyl, isopentyl, neopentyl, t-pentyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, hexyl, 5-hexenyl, 4-methyl-3-pentenyl, isohexyl, 2-methylpentyl and 1-ethylbutyl.


As more preferred examples of substituents for substituted C6-14 aromatic hydrocarbon groups for G1 among these groups, there may-be mentioned fluorine, chlorine, bromine, C1-6 alkoxy, cyano, nitro, carboxyl, hydroxyl, amino, C1-6 mono or dialkylamino, carbamoyl, C3-6 alicyclic hydrocarbons, C2-7 acyl, C1-6 alkylsulfonyl, C2-7 alkoxycarboxyl, trifluoromethyl, trifluoromethoxy and C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl, t-butyl, pentyl, isopentyl, neopentyl, t-pentyl, hexyl, isohexyl, 2-methylpentyl and 1-ethylbutyl, and as particularly preferred examples of substituents, there may be mentioned fluorine, chlorine, C1-6 alkoxy, cyano, nitro, carboxyl, hydroxyl, amino, C1-6 mono or dialkylamino, C3-6 alicyclic hydrocarbons, C2-7 acyl, trifluoromethyl, trifluoromethoxy and saturated C1-6 alkyl groups


As examples of heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur, when G1 in formula (I) represents a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur, there may be mentioned divalent monocyclic, bicyclic or tricyclic aromatichetero-cyclic groups such as furan, thiophene, pyrrole, pyrroline, pyrrolidine, oxazole, oxazolidine, isooxazole, isooxazolidine, thiazole, thiazolidine, isothiazole, isothiazolidine, furazan, imidazole, imidazoline, imidazolidine, pyrazole, pyrazoline, pyrazolidine, triazole, thiadiazole, oxadiazole, tetrazole, pyran, tetrahydropyran, thiopyran, tetrahydrothiopyran, tetrahydrofuran, 1,3-dioxolane, 1,4-dioxane, pyridine, pyrazine, pyrimidine, pyridazine, benzofuran, dibenzofuran, 1,4-dioxacycloheptane, benzothiophene, indole, 1,2-methylenedioxybenzene, benzimidazole, benzothiazole, benzoxazole, chromane, isochromane, quinoline, decahydroquinoline, isoquinoline, phthalazine, cinnoline, 1,8-naphthylidine, 1,2,3,4-tetrahydroisoquinoline, quinazoline, quinoxaline, purine, pteridine, azetidine, morpholine, thiomorpholine, piperidine, homopiperidine, piperazine, homopiperazine, indoline, isoindoline, phenoxazine, phenazine, phenothiazine, pyrrolopyrimidine, pyrazolopyrimidine and quinuclidine.


As preferred examples of heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G1, there may be mentioned divalent monocyclic or bicyclic C2-9 aromatic heterocyclic groups having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as furan, pyrrole, thiophene, pyrazole, oxazole, thiazole, isooxazole, isothiazole, pyrazole, imidazole, pyridine, pyrimidine, pyrazine, pyridazine, benzothiophene, benzofuran, 1,2-methylenedioxybenzene, benzimidazole, indole, quinoline, isoquinoline, quinazoline, phthalazine, cinnoline, and 1,8-naphthylidine, or divalent monocyclic C2-9 heterocyclic groups having in the ring 1 to 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine, and piperazine.


A heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G1 bonds to A2 at a carbon atom or nitrogen atom.


As preferred examples of heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur, which bond to A2 at a carbon atom, there may be mentioned divalent monocyclic or bicyclic C3-g aromatic heterocyclic groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as furan, pyrrole, thiophene, pyrazole, oxazole, thiazole, isooxazole, isothiazole, pyrazole, imidazole, pyridine, pyrimidine, pyrazine, pyridazine, benzothiophene, benzofuran, 1,2-methylenedioxybenzene, benzimidazole, indole, quinoline, isoquinoline and quinazoline.


As preferred examples of heterocyclic groups having in the ring 0.1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur which bond to A2 at a nitrogen atom, there may be mentioned divalent monocyclic C2-9 heterocyclic groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine and piperazine. As preferred examples of divalent monocyclic C2-9 heterocyclic groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, there may be mentioned piperidine, homopiperidine, morpholine, homopiperazine and piperazine.


As substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G1, there may be mentioned fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon groups and optionally substituted C1-6 aliphatic hydrocarbon groups.


The definitions of the substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G1 are the same as the definitions of the substituents for the substituted C3-8 alicyclic hydrocarbon groups for G1. As specific examples of substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group-consisting of oxygen, nitrogen and sulfur for G1, there may be mentioned the same specific substituents mentioned above for the substituted C3-8 alicyclic hydrocarbon groups for G1.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon and C1-6 aliphatic hydrocarbon groups as substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G1 may be in turn substituted with one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; C1-7 acylamino groups such as trifluoroacetylamino, formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; and cyano.


As preferred examples of substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G1, there may be mentioned fluorine; chlorine; bromine; C1-6 alkoxy groups composed of linear or branched alkyl groups and oxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy, isopentyloxy, neopentyloxy, t-pentyloxy and hexyloxy; cyano; nitro; carboxyl; hydroxyl; amino; C1-6 mono or dialkylamino groups composed of linear or branched alkyl and amino groups, such as methylamino, ethylamino, propylamino, isopropylamino, butylamino, isobutylamino, s-butylamino, t-butylamino, pentylamino, hexylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, N-methylbutylamino, N-methyl-t-butylamino, N-ethylisopropylamino, dipropylamino, diisopropylamino and ethylbutylamino; carbamoyl; aminosulfonyl; C3-6 alicyclic hydrocarbon groups such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, pivaloyl and hexanoyl; C1-6 alkylthio groups such as methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, s-butylthio, t-butylthio, pentylthio and hexylthio; C1-6 alkylsulfonyl groups such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, isobutylsulfonyl, s-butylsulfonyl, t-butylsulfonyl, pentylsulfonyl and hexylsulfonyl; C2-7 alkoxycarbonyl groups such as acetoxy, propionyloxy, butyryloxy, isobutyryloxy, valeryloxy, isovaleryloxy, pivaloyloxy and hexanoyloxy; C2-7 acylamino groups such as acetylamino, propionylamino, butyrylamino, isobutyrylamino, valerylamino and hexanoylamino; trifluoromethyl; trifluoromethoxy; and linear or branched C1-6 aliphatic hydrocarbon groups optionally containing one unsaturated bond, such as methyl, ethyl, vinyl, ethynyl, propyl, 1-propenyl, 2-propenyl, isopropyl, isopropenyl, 1-propynyl, 2-propynyl, butyl, isobutyl, s-butyl, t-butyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-butynyl, 2-butynyl, pentyl, isopentyl, neopentyl, t-pentyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, hexyl, 5-hexenyl, 4-methyl-3-pentenyl, isohexyl, 2-methylpentyl and 1-ethylbutyl.


As more preferred examples of substituents for substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G1 among these groups, there may be mentioned fluorine, chlorine, bromine, C1-6 alkoxy, cyano, nitro, carboxyl, hydroxyl, amino, C1-6 mono or dialkylamino, carbamoyl, C3-6 alicyclic hydrocarbons, C2-7 acyl, C1-6 alkylsulfonyl, C2-7 alkoxycarboxyl, trifluoromethyl, trifluoromethoxy and saturated C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl, t-butyl, pentyl, isopentyl, neopentyl, t-pentyl, hexyl, isohexyl, 2-methylpentyl and 1-ethylbutyl, and as the particularly preferred example of substituents, there may be mentioned fluorine, chlorine, C1-6 alkoxy, cyano, nitro, carboxyl, hydroxyl, amino, C1-6 mono or dialkylamino, C3-6 alicyclic hydrocarbons, C2-7 acyl, trifluoromethyl, trifluoromethoxy and C1-6 alkyl groups.


As preferred examples for G1, there may be mentioned a benzene, a divalent monocyclic or bicyclic C3-9 aromatic heterocyclic group having in the ring 1 to 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, and a divalent monocyclic C2-9 heterocyclic group having in the ring 1 to 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur. A divalent monocyclic or bicyclic C3-9 aromatic heterocyclic group having in the ring 1 to 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur may be mentioned as a particularly preferred example for G1.


G2 in formula (I) above represents one group selected from among the following 1) to 5):

    • 1) Hydrogen;
    • 2) A substituted or unsubstituted C1-10 aliphatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 3) A substituted or unsubstituted C3-8 alicyclic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-8 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 4) A substituted or unsubstituted C6-14 aromatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2—, alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 5) A substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


As examples of C1-10 aliphatic hydrocarbon groups for G2 when G2 in formula (I) represents a substituted or unsubstituted C1-10 aliphatic hydrocarbon group, there may be mentioned alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl, t-butyl, pentyl, isopentyl, neopentyl, t-pentyl, 2-methylpentyl, 4-methylpentyl, 1-ethylbutyl, hexyl, heptyl, 2-methylhexyl, 5-methylhexyl, 1,1-dimethylpentyl, 6-methylheptyl, octyl, nonyl and decyl; alkenyl groups such as vinyl, 1-methylvinyl, 1-ethylvinyl, 1-propenyl, 2-propenyl, 2-methyl-1-propenyl, 1-butenyl, 2-butenyl, 2-methyl-1-butenyl, 1,3-butadienyl, 1-pentenyl, 2-pentenyl, 4-methyl-1-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1,5-hexadienyl, 2-heptenyl, 2-octenyl, 2-nonenyl and 2-decenyl; and alkynyl groups such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 3-methyl-1-butynyl, 3,3-dimethyl-1-butynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 1-methyl-3-pentynyl, 1-methyl-3-hexynyl, 2-heptynyl, 2-octynyl, 2-nonynyl, 2-decynyl.


As preferred C1-10 aliphatic hydrocarbon groups for G2, there may be mentioned linear or branched C1-6 alkyl groups optionally containing 1 unsaturated bond, such as methyl, ethyl, propyl, isopropyl, butyl, pentyl, hexyl, vinyl, 1-propenyl, 1-butenyl, ethynyl and 1-propynyl, and as particularly preferred groups there may be mentioned linear or branched C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl and hexyl.


As substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2, there may be mentioned fluorine, chlorine, bromine, iodine, hydroxyl, C1-7 alkoxy groups composed of linear or branched alkyl or cycloalkyl groups and oxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy, isopentyloxy, neopentyloxy, t-pentyloxy, hexyloxy, isohexyloxy, 2-methylpentyloxy, 1-ethylbutoxy, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cyclopropylmethyloxy, cyclopropylethyloxy, cyclopentylmethyloxy and cyclohexylmethyloxy; C6-10 aryloxy groups such as phenoxy, 1-naphthoxy and 2-naphthoxy; C7-9 aralkoxy groups such as benzyloxy, α-phenethyloxy, β-phenethyloxy and phenylpropyloxy; C2-7 acyloxy groups such as acetoxy, propionyloxy, butyryloxy, isobutyryloxy, valeryloxy, isovaleryloxy, pivaloyloxy and hexanoyloxy; oxo; C1-6 alkylsulfonyloxy groups composed of linear or branched alkyl groups and sulfonyloxy groups, such as methylsulfonyloxy, ethylsulfonyloxy, propylsulfonyloxy, butylsulfonyloxy and t-butylsulfonyloxy; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, pivaloyl and hexanoyl; carboxyl; C2-7 alkoxycarbonyl groups composed of linear or branched alkyl groups and oxycarbonyl groups, such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl, s-butoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups composed of linear or branched alkyl or cycloalkyl groups and carbamoyl groups, such as N-methylcarbamoyl, N-ethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-isobutylcarbamoyl, N-s-butylcarbamoyl, N-t-butylcarbamoyl, N-pentylcarbamoyl, N-cyclopropylcarbamoyl, N-cyclobutylcarbamoyl, N-cyclopentylcarbamoyl, N-cyclohexylcarbamoyl, N-cycloheptylcarbamoyl, N-cyclopropylmethylcarbamoyl, N,N-dimethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl and N,N-dipropylcarbamoyl; amino; C1-6 alkylamino groups composed of linear or branched alkyl or cycloalkyl groups and amino groups, such as methylamino, ethylamino, propylamino, isopropylamino, butylamino, isobutylamino, s-butylamino, t-butylamino, pentylamino, hexylamino, cyclopropylamino, cyclobutylamino, cyclopentylamino, cyclohexylamino, cyclopropylmethylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, N-methylbutylamino, N-methyl-t-butylamino, N-ethylisopropylamino, dipropylamino, diisopropylamino and ethylbutylamino; C2-7 acylamino groups such as acetylamino, propionylamino, butyrylamino, isobutyrylamino, valerylamino and hexanoylamino; C2-8 alkoxycarbonylamino groups such as methoxycarbonylamino, ethoxycarbonylamino and t-butoxycarbonylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, butylsulfonylamino and t-butylsulfonylamino; cyano; nitro; C1-6 alkylthio groups such as methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, s-butylthio, t-butylthio, pentylthio and hexylthio; C1-6 alkylsulfinyl groups composed of linear or branched alkyl or cycloalkyl groups and sulfinyl groups, such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, butylsulfinyl, isobutylsulfinyl, s-butylsulfinyl, t-butylsulfinyl, pentylsulfinyl and cyclopentylsulfinyl; C1-6 alkylsulfonyl groups composed of linear or branched alkyl or cycloalkyl groups and sulfonyl groups, such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, isobutylsulfonyl, s-butylsulfonyl, t-butylsulfonyl, pentylsulfonyl, hexylsulfonyl, cyclopentylsulfonyl and cyclohexylsulfonyl; sulfo; sulfamoyl; C1-6 aminosulfonyl groups composed of linear or branched alkyl or cycloalkyl groups and aminosulfonyl groups, such as methylaminosulfonyl, ethylaminosulfonyl, propylaminosulfonyl, isopropylaminosulfonyl, butylaminosulfonyl, isobutylaminosulfonyl, s-butylaminosulfonyl, pentylaminosulfonyl, dimethylaminosulfonyl, N-ethyl-N-methylaminosulfonyl, diethylaminosulfonyl, dipropylaminosulfonyl, cyclopropylaminosulfonyl, cyclopentylaminosulfonyl, cyclohexylaminosulfonyl and cyclopropylmethylaminosulfonyl; C3-6 alicyclic hydrocarbon groups such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl; linear or branched C1-6 aliphatic hydrocarbon groups optionally containing one unsaturated bond, such as methyl, ethyl, vinyl, ethynyl, propyl, 1-propenyl, 2-propenyl, isopropyl, isopropenyl, 1-propynyl, 2-propynyl, butyl, isobutyl, s-butyl, t-butyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-butynyl, 2-butynyl, pentyl, isopentyl, neopentyl, t-pentyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, hexyl, 5-hexenyl, 4-methyl-3-pentenyl, isohexyl, 2-methylpentyl and 1-ethylbutyl; monovalent monocyclic, bicyclic or tricyclic C6-14 aromatic hydrocarbons such as benzene, naphthalene, indene, indane, 1,2,3,4-tetrahydronaphthalene and fluorene; and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) which are monovalent monocyclic, bicyclic or tricyclic heterocycles (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur), such as furan, thiophene, pyrrole, pyrroline, pyrrolidine, oxazole, oxazolidine, isooxazole, isooxazolidine, thiazole, thiazolidine, isothiazole, isothiazolidine, imidazole, imidazoline, imidazolidine, pyrazole, pyrazoline, pyrazolidine, triazole, thiadiazole, oxadiazole, tetrazole, pyran, tetrahydropyran, thiopyran, tetrahydrothiopyran, pyridine, pyrazine, pyrimidine, pyridazine, benzofuran, dibenzofuran, benzothiophene, indole, benzimidazole, benzothiazole, benzoxazole, chromane, isochromane, quinoline, decahydroquinoline, isoquinoline, quinazoline, quinoxaline, purine, pteridine, azetidine, morpholine, thiomorpholine, piperidine, homopiperidine, piperazine, homopiperazine, indoline, isoindoline, phenoxazine, phenazine, phenothiazine and quinuclidine.


As preferred examples of substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2 there may be mentioned hydroxyl, optionally substituted C1-7 alkoxy, oxo, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C1-6 alkylsulfonylamino, cyano, C1-6 alkylsulfonyl, sulfamoyl, optionally substituted C6-14 aromatic hydrocarbon groups and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


As more preferred examples of substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2 there may be mentioned hydroxyl, optionally substituted C1-7 alkoxy, carboxyl, amino, optionally substituted C1-5 alkylamino, cyano and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


A heterocyclic group (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as a substituent for a substituted C1-10 aliphatic hydrocarbon group for G2 bonds to the C1-10 aliphatic hydrocarbon group of G2 at a carbon atom or nitrogen atom.


As more preferred examples of heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) to bond to the C1-10 aliphatic hydrocarbon groups of G2 at a carbon atom, there may be mentioned monovalent monocyclic or bicyclic C3-9 aromatic heterocycles having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as furan, pyrrole, thiophene, pyrazole, oxazole, thiazole, isooxazole, isothiazole, pyrazole, imidazole, pyridine, pyrimidine, pyrazine, pyridazine, benzothiophene, benzofuran, 1,2-methylenedioxybenzene, benzimidazole, indole, quinoline, isoquinoline and quinazoline.


As preferred examples of heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) to bond to the C1-10 aliphatic hydrocarbon groups of G2 at a nitrogen atom, there may be mentioned monovalent monocyclic C2-9 aromatic heterocycles having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine and piperazine.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon, C1-6 aliphatic hydrocarbon, C6-14 aromatic hydrocarbon and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2 may be in turn substituted with one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; C1-7 acylamino groups such as trifluoroacetylamino, formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; cyano; C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and t-butyl; trifluoromethyl; and trifluoromethoxy.


As examples of C3-8 alicyclic hydrocarbon groups for G2 when G2 in formula (I) is a substituted or unsubstituted C3—, alicyclic hydrocarbon group, there may be mentioned monovalent cyclopropane, cyclobutane, cyclopentane, cyclopentene, cyclohexane, cyclohexene, cycloheptane, cycloheptene and cyclooctane. As preferred examples of C3-8 alicyclic hydrocarbon groups for G2 there may be mentioned cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, 3-cyclopentenyl, 4-cyclopentenyl, 1-cyclohexenyl, 3-cyclohexenyl, 4-cyclohexenyl and 1-cycloheptenyl.


As substituents for the substituted C3-8 alicyclic hydrocarbon groups for G2 there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylaimino, optionally substituted C2-7 acylamino, C2-9 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon, optionally substituted C1-6 aliphatic hydrocarbon, optionally substituted C6-14 aromatic hydrocarbon and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


The definitions of the substituents for the substituted C3-8 alicyclic hydrocarbon groups for G2 are the same as the definitions of the substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2. As examples of substituents for the substituted C3-8 alicyclic hydrocarbon groups for G2 there may be mentioned the same specific substituents mentioned above for the substituted C1-10 aliphatic hydrocarbon groups for G2.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon, C1-6 aliphatic hydrocarbon, C6-14 aromatic hydrocarbon and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as substituents for the substituted C3-8 alicyclic hydrocarbon groups for G2 may be in turn substituted with one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as-acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; trifluoroacetylamino; C1-7 acylamino groups such as formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; cyano; C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and t-butyl; trifluoromethyl; and trifluoromethoxy.


As examples of C1-14 aromatic hydrocarbon groups for G2 when G2 in formula (I) represents a substituted or unsubstituted C6-14 aromatic hydrocarbon group, there may be mentioned monovalent groups having at least one aromatic ring in the molecule, such as benzene, indene, indane, naphthalene, 1,2-dihydronaphthalene, 1,2,3,4-tetrahydronaphthalene, azulene, acenaphthylene, acenaphthene, fluorene, phenanthrene and anthracene. Phenyl may be mentioned as a preferred example of a C6-14 aromatic hydrocarbon group for G2.


As substituents for the substituted C6-14 aromatic hydrocarbon groups for G2 there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon, optionally substituted C1-6 aliphatic hydrocarbon, optionally substituted C6-14 aromatic hydrocarbon and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


The definitions of the substituents for the substituted C6-14 aromatic hydrocarbon groups for G2 are the same as the definitions of the substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2. As examples of substituents for the substituted C6-14 aromatic hydrocarbon groups for G2 there may be mentioned the same specific substituents mentioned above for the substituted C1-1 aliphatic hydrocarbon groups for G2 The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon, C1-6 aliphatic hydrocarbon, C6-14 aromatic hydrocarbon and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as substituents for the substituted C6-14 aromatic hydrocarbon groups for G2 may be in turn substituted with one or more substituents selected from the group consisting of fluorine; chlorine; bromine; iodine; hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formmyl; trifluoroacetyl; C2-7 acyl groups such-as acetyl, propionfyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; trifluoroacetylamino; C1-7 acylamino groups such as formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro: cyano; C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and t-butyl; trifluoromethyl; and trifluoromethoxy.


As examples of heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G2 when G2 in formula (I) represents a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur, there may be mentioned monovalent monocyclic, bicyclic or tricyclic groups such as furan, thiophene, pyrrole, pyrroline, pyrrolidine, oxazole, oxazolidine, isooxazole, isooxazolidine, thiazole, thiazolidine, isothiazole, isothiazolidine, imidazole, imidazoline, imidazolidine, pyrazole, pyrazoline, pyrazolidine, triazole, thiadiazole, oxadiazole, tetrazole, pyran, tetrahydropyran, thiopyran, tetrahydrothiopyran, pyridine, pyrazine, pyrimidine, pyridazine, benzofuran, dibenzofuran, benzothiophene, indole, 1,2-methylenedioxybenzene, benzimidazole, benzothiazole, benzoxazole, chromane, isochromane, quinoline, decahydroquinoline, isoquinoline, quinazoline, quinoxaline, purine, pteridine, azetidine, morpholine, thiomorpholine, piperidine, homopiperidine, piperazine, homopiperazine, indoline, isoindoline, phenoxazine, phenazine, phenothiazine and quinuclidine. As preferred examples of heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G2 there may be mentioned 2-pyridyl, 3-pyridyl, 4-pyridyl, piperidino, 2-piperidyl, 3-piperidyl, 4-piperidyl, morpholino, 1-homopiperidinyl, 1-pyrrolidinyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 1-imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 3-pyrazolyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3-pyrrolyl, 4-isooxazolyl, 2-pyrimidinyl, 4-pyrimidinyl, 2-pyrazinyl, 4-triazolyl, 5-tetrazolyl, 1-piperazinyl, 4-tetrahydropyranyl, 2-1,3,4-oxadiazolyl, 4-1,2,3-thiadiazolyl, 2-benzofuranyl, 2-benzothiazolyl, 2-indolyl, 3-indolyl, 5-benzimidazolyl and 2-1,2,3,4-tetrahydroisoquinolinyl.


A heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G2 is bonded to A4 at a carbon atom or nitrogen atom.


As more preferred examples of heterocyclic groups for G2 having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur, which bond to A4 at a carbon atom, there may be mentioned monovalent monocyclic or bicyclic C3-9 aromatic heterocyclic groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, such as furan, pyrrole, thiophene, pyrazole, oxazole, thiazole, isooxazole, isothiazole, pyrazole, imidazole, pyridine, pyrimidine, pyrazine, pyridazine, benzothiophene, benzofuran, 1,2-methylenedioxybenzene, benzimidazole, indole, quinoline, isoquinoline and quinazoline.


As preferred examples of heterocyclic groups for G2 having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur which bond to A2 at a nitrogen atom, there may be mentioned monovalent monocyclic C2-9 heterocyclic groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine and piperazine. As more preferred examples of the heterocyclic groups for G2 there may be mentioned monovalent monocyclic C4-6 heterocyclic groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as piperidine, homopiperidine, morpholine, homopiperazine and piperazine.


As substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G2, there may be mentioned one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon, optionally substituted C1-6 aliphatic hydrocarbon, optionally substituted C6-14 aromatic hydrocarbon and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


The definitions of the substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G2 are the same as the definitions of the substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2. As specific examples of substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G2 there may be mentioned the same specific substituents mentioned above for the substituted C1-10 aliphatic hydrocarbon groups for G2.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon, C1-6 aliphatic hydrocarbon, C6-14 aromatic hydrocarbon and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as substituents for the substituted heterocyclic groups for G2 having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur, may be in turn substituted with one or more substituents selected from the group consisting of fluorine; chlorine; bromine; iodine; hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; trifluoroacetylamino; c1-7 acylamino groups such as formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; cyano; C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and t-butyl; trifluoromethyl; and trifluoromethoxy.


The above is with the proviso that among the combinations of A1, A2, G1, A3, A4 and G2 in formula (I) according to the invention, when A1 is a single bond, A2, G1, A3 and A4 are all single bonds.


Also, among the combinations of A1, A2, G1, A3, A4 and G2 in formula (I) according to the invention, when A1 is not a single bond and G1 and A3 are both single bonds, the combination including A2 and A4 is A1-C(═O)—C(═O)-G2 or A1-C(═O)NR101-O-G2 (where R101 has the same definition as above).


Also, among the combinations of G1, A3, A4 and G2 in formula (I) according to the invention, when A3 represents a C1-6 aliphatic hydrocarbon group having G1 and A4 bonded on the same or different carbon atoms and G2 represents a substituted or unsubstituted C1-10 aliphatic hydrocarbon group, A4 is not a single bond.


In formula (I), A5 represents a single bond, or a group binding R2 and the carbon atom of the pyrrole ring to which A5 is bonded in the form of R2—NR201-pyrrole ring carbon (where R201 represents hydrogen or a C1-4 aliphatic hydrocarbon group). As examples of C1-4 aliphatic hydrocarbon groups for R201 when A5 is a group binding R2 and the carbon atom of the pyrrole ring to which A1 is bonded in the form of R2—NR201-pyrrole ring carbon (where R201 represents hydrogen or a C1-4 aliphatic hydrocarbon group), there may be mentioned the same ones as mentioned above for R101 in A2. As preferred examples for R102 there may be mentioned hydrogen, methyl, ethyl and propyl, with hydrogen and methyl being particularly preferred.


As preferred examples for A5 there may be mentioned a single bond, —NH— and —N(CH3)—. A single bond may be mentioned as a particularly preferred example for A5.


R2 in formula (I) above represents one group selected from among the following 1) to 6):

    • 1) Hydrogen.
    • 2) Fluorine, chlorine, bromine or iodine.
    • 3) A substituted or unsubstituted C1-10 aliphatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 4) A substituted or unsubstituted C3-8 alicyclic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 5) A substituted or unsubstituted C6-14 aromatic hydrocarbon group. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)
    • 6) A substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur. (As substituents there may be mentioned one or more selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbons, optionally substituted C1-6 aliphatic hydrocarbons, optionally substituted C6-14 aromatic hydrocarbons and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).)


When R2 in formula (I) is fluorine, chlorine, bromine or iodine, there may be mentioned as preferable chlorine and bromine.


As examples of C1-10 aliphatic hydrocarbon groups for R2 when R2 in formula (I) represents a substituted or unsubstituted C1-10 aliphatic hydrocarbon group, there may be mentioned the same ones as mentioned above as examples for C1-10 aliphatic hydrocarbon groups for G2. As preferred examples of C1-10 aliphatic hydrocarbon groups for R2 there may be mentioned methyl, ethyl, isopropyl, butyl, t-butyl, t-pentyl, vinyl, 2-propenyl and 2-propynyl.


As substituents for the substituted C1-10 aliphatic hydrocarbon groups for R2 there may be mentioned one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon, optionally substituted C1-6 aliphatic hydrocarbon, optionally substituted C6-14 aromatic hydrocarbon and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


The definitions of the substituents for the substituted C1-10 aliphatic hydrocarbon groups for R2 are the same as the above-mentioned definitions of the substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2. As specific examples of substituents for the substituted C1-10 aliphatic hydrocarbon groups for R2 there may be mentioned the same specific substituents mentioned above for the substituted C1-10 aliphatic hydrocarbon groups for G2.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon, C1-6 aliphatic hydrocarbon, C6-14 aromatic hydrocarbon and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as substituents for the substituted C1-10 aliphatic hydrocarbon groups for R2, may be in turn substituted with one or more substituents selected from the group consisting of fluorine; chlorine; bromine; iodine; hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; trifluoroacetylamino; C1-7 acylamino groups such as formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; cyano; C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and t-butyl; trifluoromethyl; and trifluoromethoxy.


As examples of C3-8 alicyclic hydrocarbon groups for R2, when R2 in formula (I) represents a substituted or unsubstituted C3-8 alicyclic hydrocarbon group, there may be mentioned the same ones as mentioned above as examples for the C3-8 alicyclic hydrocarbon groups for G2. As preferred examples of C3—, alicyclic hydrocarbon groups for R2 there may be mentioned cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.


As substituents for the substituted C3-8 alicyclic hydrocarbon groups for R2 there may be mentioned one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C1-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon, optionally substituted C1-6 aliphatic hydrocarbon, optionally substituted C6-14 aromatic hydrocarbon and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


The definitions of the substituents for the substituted C3-8 alicyclic hydrocarbon groups for R2 are the same as the above-mentioned definitions of the substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2. As specific examples of substituents for the substituted C3-8 alicyclic hydrocarbon groups for R2 there may be mentioned the same specific substituents mentioned above for the substituted C1-10 aliphatic hydrocarbon groups for G2.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon, C1-6 aliphatic hydrocarbon, C6-14 aromatic hydrocarbon and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as substituents for the substituted C3-8 alicyclic hydrocarbon groups for R2, may be in turn substituted with one or more substituents selected from the group consisting of fluorine; chlorine; bromine; iodine; hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; trifluoroacetylamino; C1-7 acylamino groups such as formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; cyano; C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and t-butyl; trifluoromethyl; and trifluoromethoxy.


As C6-14 aromatic hydrocarbon groups for R2 when R2 in formula (I) represents a substituted or unsubstituted C6-14 aromatic hydrocarbon group, there may be mentioned the same ones as mentioned above as examples for the C6-14 aromatic hydrocarbon groups for G2. Phenyl may be mentioned as a preferred example of a C6-14 aromatic hydrocarbon group for R2.


As substituents for the substituted C6-14 aromatic hydrocarbon groups for R2 there may be mentioned one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-8 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon, optionally substituted C1-6 aliphatic hydrocarbon, optionally substituted C6-14 aromatic hydrocarbon and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


The definitions of the substituents for the substituted C6-14 aromatic hydrocarbon groups for R2 are the same as the above-mentioned definitions of the substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2. As specific examples of substituents for the substituted C6-14 aromatic hydrocarbon groups for R2 there may be mentioned the same specific substituents mentioned above for the substituted C1-10 aliphatic hydrocarbon groups for G2.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon, C1-6 aliphatic hydrocarbon, C6-14 aromatic hydrocarbon and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as substituents for the substituted C6-14 aromatic hydrocarbon groups for R2, may be in turn substituted with one or more substituents selected from the group consisting of fluorine; chlorine; bromine; iodine; hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; trifluoroacetylamino; C1-7 acylamino groups such as formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; cyano; C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and t-butyl; trifluoromethyl; and trifluoromethoxy.


As examples of heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for R2, when R2 in formula (I) represents a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur, there may be mentioned the same ones as mentioned above as examples for the heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for G2. A heterocyclic group for R2 having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur is bonded to A5 at a carbon atom or nitrogen atom.


As preferred examples of heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur, which bond to A5 at a carbon atom, there may be mentioned monocyclic or bicyclic C3-9 aromatic heterocyclic groups having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, such as furyl, thienyl, pyrrolyl, pyrazolyl, oxazolyl, isooxazolyl, thiazolyl, isothiazolyl, imidazolyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, benzofuranyl, indolyl, benzothienyl, quinolyl, isoquinolyl, quinazolyl, benzimidazolyl and benzooxazolyl. As more preferred groups there may be mentioned monocyclic or bicyclic C3-9 aromatic heterocyclic groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, such as 2-furyl, 2-thienyl, 2-pyrrolyl, 2-imidazolyl, 5-imidazolyl, 2-oxazolyl, 5-oxazolyl, 5-isooxazolyl, 2-thiazolyl, 5-thiazolyl, 5-isothiazolyl, 3-isothiazolyl, 2-pyridyl, 2-pyrimidinyl, 2-benzofuranyl and 2-benzothiophenyl. Particularly preferred among these groups are monocyclic C3-5 aromatic heterocyclic groups having in the ring 1 to 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, among which 2-furyl, 2-thienyl and 2-pyrrolyl are especially preferred.


As preferred examples of heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur which bond to A5 at a nitrogen atom, there may be mentioned 1-pyrrolidinyl, piperidino, morpholino, 1-homopiperidinyl and 1-piperazinyl. When the heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for R2 bonds to A5 at a nitrogen atom, A5 is a single bond.


As substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for R2, there may be mentioned one or more substituents selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl, optionally substituted C1-7 alkoxy, C6-10 aryloxy, C7-9 aralkoxy, C2-7 acyloxy, oxo, C1-6 alkylsulfonyloxy, optionally substituted C2-7 acyl, carboxyl, C2-7 alkoxycarbonyl, carbamoyl, optionally substituted C2-7 alkylcarbamoyl, amino, optionally substituted C1-6 alkylamino, optionally substituted C2-7 acylamino, C2-7 alkoxycarbonylamino, C1-6 alkylsulfonylamino, cyano, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, sulfamoyl, C1-6 alkylaminosulfonyl, sulfo, optionally substituted C3-6 alicyclic hydrocarbon, optionally substituted C1-6 aliphatic hydrocarbon, optionally substituted C6-14 aromatic hydrocarbon and optionally substituted heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur).


The definitions of the substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for R2 are the same as the above-mentioned definitions of the substituents for the substituted C1-10 aliphatic hydrocarbon groups for G2. As specific examples of substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for R2, there may be mentioned the same specific substituents mentioned above for the substituted C1-10 aliphatic hydrocarbon groups for G2.


The C1-7 alkoxy, C2-7 acyl, C2-7 alkylcarbamoyl, C1-6 alkylamino, C2-7 acylamino, C3-6 alicyclic hydrocarbon, C1-6 aliphatic hydrocarbon, C6-14 aromatic hydrocarbon and heterocyclic groups (having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur) as substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms for R2, may be in turn substituted with one or more substituents selected from the group consisting of fluorine; chlorine; bromine; iodine; hydroxyl; C1-6 alkoxy groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy and cyclopropyloxy; methoxymethyloxy; 2-methoxyethoxy; formyl; trifluoroacetyl; C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, valeryl and isovaleryl; oxo; carboxyl; C2-7 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl and t-butoxycarbonyl; carbamoyl; C2-7 alkylcarbamoyl groups such as N-methylcarbamoyl, N,N-dimethylcarbamoyl, N-ethylcarbamoyl, N-ethyl-N-methylcarbamoyl, N,N-diethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-cyclopropylcarbamoyl and N-cyclopropylmethylcarbamoyl; amino; C1-6 alkylamino groups such as methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, cyclopropylamino and cyclopropylmethylamino; C4-6 cyclic amino groups having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as 1-pyrrolidinyl, piperazinyl, 4-methylpiperazinyl, piperidino and morpholino; trifluoroacetylamino; C1-7 acylamino groups such as formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino and valerylamino; C1-6 alkylsulfonylamino groups such as methylsulfonylamino, ethylsulfonylamino, propylsulfonylamino and butylsulfonylamino; nitro; cyano; C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl and t-butyl; trifluoromethyl; and trifluoromethoxy.


Among the examples mentioned as substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for R2 according to the invention, the following may be mentioned as preferred: fluorine; chlorine; bromine; iodine; hydroxyl; cyano; nitro; amino; substituted or unsubstituted C1-6 mono or dialkylamino groups composed of linear or branched alkyl groups and amino groups, such as methylamino, ethylamino, propylamino, isopropylamino, butylamino, isobutylamino, s-butylamino, t-butylamino, pentylamino, hexylamino, dimethylamino, N-ethylmethylamino, diethylamino, N-methylpropylamino, N-methylisopropylamino, N-methylbutylamino, N-methyl-t-butylamino, N-ethylisopropylamino, dipropylamino, diisopropylamino and ethylbutylamino; carboxyl; substituted or unsubstituted saturated C1-6 alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl, t-butyl, pentyl, isopentyl, neopentyl, t-pentyl, hexyl, isohexyl, 2-methylpentyl and 1-ethylbutyl; C3-6 alicyclic hydrocarbons such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl; substituted or unsubstituted C1-6 alkoxy groups composed of linear or branched alkyl groups and oxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, s-butoxy, t-butoxy, pentyloxy, isopentyloxy, neopentyloxy, t-pentyloxy and hexyloxy; substituted or unsubstituted C2-7 acyl groups such as acetyl, propionyl, butyryl, isobutyryl, pivaloyl and hexanoyl; C1-6 alkylthio groups such as methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, s-butylthio, t-butylthio, pentylthio and hexylthio; trifluoromethyl; trifluoromethoxy; substituted or unsubstituted C2-7 acylamino groups such as acetylamino, propionylamino, butyrylamino, isobutyrylamino, valerylamino and hexanoylamino; and substituted or unsubstituted C2-7 alkylcarbamoyl groups composed of linear or branched alkyl groups and carbamoyl groups, such as N-methylcarbamoyl, N-ethylcarbamoyl, N-propylcarbamoyl, N-isopropylcarbamoyl, N-butylcarbamoyl, N-isobutylcarbamoyl, N-s-butylcarbamoyl, N-t-butylcarbamoyl, N-pentylcarbamoyl, N,N-dimethylcarbamoyl, N-ethyl-N-methylcarbamoyl and N,N-diethylcarbamoyl.


As more preferred examples of substituents for the substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur for R2, there may be mentioned fluorine, chlorine, bromine, substituted or unsubstituted C1-6 alkyl groups, hydroxyl, and substituted or unsubstituted C1-6 alkoxy groups.


Among the combinations of R2 and A5 in formula (I) according to the invention, when R2 is fluorine, chlorine, bromine or iodine, A5 is a single bond.


As preferred examples of combinations of R2 and A5 in formula (I) according to the invention, there may be mentioned combinations wherein A1 is a single bond and R2 is a substituted or unsubstituted cyclopropyl, or A5 is a single bond and R2 is a substituted or unsubstituted monocyclic C3-5 aromatic heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur. That is, the group represented by R2-A5- is preferably a substituted or unsubstituted cyclopropyl or a monocyclic C3-5 aromatic heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, such as substituted or unsubstituted 2-furyl, substituted or unsubstituted 2-thienyl, substituted or unsubstituted 2-pyrrolyl, substituted or unsubstituted 2-imidazolyl, substituted or unsubstituted 5-imidazolyl, substituted or unsubstituted 2-oxazolyl, substituted or unsubstituted 5-oxazolyl, substituted or unsubstituted 5-isooxazolyl, substituted or unsubstituted 2-thiazolyl, substituted or unsubstituted 5-thiazolyl, substituted or unsubstituted 5-isothiazolyl, substituted or unsubstituted 3-isothiazolyl, substituted or unsubstituted 2-pyridyl or substituted or unsubstituted 2-pyrimidinyl. Particularly preferred among these are 2-furyl, 2-thienyl and 2-pyrrolyl, and they are preferably substituted with fluorine, chlorine, bromine, substituted or unsubstituted C1-6 alkyl, hydroxyl or substituted or unsubstituted C1-6 alkoxy.


As preferred combinations of -G1-A3-A4-G2 in the pyrrolo[3,2-d]pyrimidine derivatives of formula (I) above, there may be mentioned the groups represented by K1-K822 shown in FIGS. 1 to 24 below. In the structural formulas, the symbol “---” indicates the binding site for A2 and -G1-A3-A4-G2.
embedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded imageembedded image


As specific examples of pyrrolo[3,2-d]pyrimidine derivatives of formula (I) above, there may be mentioned compounds having the groups listed in Tables 1 to 214 below as A1, compounds having the groups listed in Tables 1 to 214 below as A2, compounds having the groups represented by K1-K822 shown in FIGS. 1 to 24 above as -G1-A3-A4-G2, compounds having the groups represented by J1-J243 shown in FIGS. 25 to 31 above or the groups represented by N1-N158 shown in FIGS. 32 to 36 above as -A5-R2, compounds having the groups listed in Tables 1 to 214 below as X, and compounds comprising any desired combinations thereof.


As specific preferred examples there may be mentioned the compounds listed in Tables 1 to 214 below.


The groups K1-K822, J1-J243 and N1-N158 in Tables 1 to 214 below are the respective substituents as defined in FIGS. 1 to 36 above.

TABLE 1CompoundNo.-A1--A2--G1-A3-A4-G2-A5-R2X1-0001single bondsingle bondK240J1O1-0002single bondsingle bondK240J3O1-0003single bondsingle bondK240J3S1-0004single bondsingle bondK240J6O1-0005single bondsingle bondK240J7O1-0006single bondsingle bondK240J8O1-0007single bondsingle bondK240J9O1-0008single bondsingle bondK240J9S1-0009single bondsingle bondK240J10O1-0010single bondsingle bondK240J10S1-0011single bondsingle bondK240J11S1-0012single bondsingle bondK240J11O1-0013single bondsingle bondK240J12O1-0014single bondsingle bondK240J13O1-0015single bondsingle bondK240J14O1-0016single bondsingle bondK240J14S1-0017single bondsingle bondK240J15O1-0018single bondsingle bondK240J16O1-0019single bondsingle bondK240J16S1-0020single bondsingle bondK240J17O1-0021single bondsingle bondK240J18O1-0022single bondsingle bondK240J19O1-0023single bondsingle bondK240J20O1-0024single bondsingle bondK240J21O1-0025single bondsingle bondK240J22O1-0026single bondsingle bondK240J22S1-0027single bondsingle bondK240J23S1-0028single bondsingle bondK240J23O1-0029single bondsingle bondK240J24O1-0030single bondsingle bondK240J24S1-0031single bondsingle bondK240J25O1-0032single bondsingle bondK240J25S














TABLE 2








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0033
single bond
single bond
K240
J26
O


1-0034
single bond
single bond
K240
J26
S


1-0035
single bond
single bond
K240
J27
O


1-0036
single bond
single bond
K240
J28
O


1-0037
single bond
single bond
K240
J28
S


1-0038
single bond
single bond
K240
J29
O


1-0039
single bond
single bond
K240
J29
S


1-0040
single bond
single bond
K240
J30
O


1-0041
single bond
single bond
K240
J31
O


1-0042
single bond
single bond
K240
J32
O


1-0043
single bond
single bond
K240
J33
O


1-0044
single bond
single bond
K240
J34
O


1-0045
single bond
single bond
K240
J34
S


1-0046
single bond
single bond
K240
J35
O


1-0047
single bond
single bond
K240
J35
S


1-0048
single bond
single bond
K240
J36
O


1-0049
single bond
single bond
K240
J37
O


1-0050
single bond
single bond
K240
J37
S


1-0051
single bond
single bond
K240
J38
O


1-0052
single bond
single bond
K240
J39
O


1-0053
single bond
single bond
K240
J40
O


1-0054
single bond
single bond
K240
J41
O


1-0055
single bond
single bond
K240
J42
O


1-0056
single bond
single bond
K240
J43
O


1-0057
single bond
single bond
K240
J43
S


1-0058
single bond
single bond
K240
J44
O


1-0059
single bond
single bond
K240
J45
O


1-0060
single bond
single bond
K240
J46
O


1-0061
single bond
single bond
K240
J47
O


1-0062
single bond
single bond
K240
J48
O


1-0063
single bond
single bond
K240
J49
O


1-0064
single bond
single bond
K240
J50
O





















TABLE 3








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0065
single bond
single bond
K240
J51
O


1-0066
single bond
single bond
K240
J52
O


1-0067
single bond
single bond
K240
J53
O


1-0068
single bond
single bond
K240
J54
O


1-0069
single bond
single bond
K240
J55
O


1-0070
single bond
single bond
K240
J56
O


1-0071
single bond
single bond
K240
J56
S


1-0072
single bond
single bond
K240
J57
O


1-0073
single bond
single bond
K240
J58
O


1-0074
single bond
single bond
K240
J59
O


1-0075
single bond
single bond
K240
J60
O


1-0076
single bond
single bond
K240
J61
O


1-0077
single bond
single bond
K240
J62
O


1-0078
single bond
single bond
K240
J63
O


1-0079
single bond
single bond
K240
J63
S


1-0080
single bond
single bond
K240
J64
O


1-0081
single bond
single bond
K240
J65
O


1-0082
single bond
single bond
K240
J66
O


1-0083
single bond
single bond
K240
J67
O


1-0084
single bond
single bond
K240
J68
O


1-0085
single bond
single bond
K240
J69
O


1-0086
single bond
single bond
K240
J70
O


1-0087
single bond
single bond
K240
J70
S


1-0088
single bond
single bond
K240
J71
O


1-0089
single bond
single bond
K240
J72
O


1-0090
single bond
single bond
K240
J73
O


1-0091
single bond
single bond
K240
J74
O


1-0092
single bond
single bond
K240
J75
O


1-0093
single bond
single bond
K240
J76
O


1-0094
single bond
single bond
K240
J84
O


1-0095
single bond
single bond
K240
J84
S


1-0096
single bond
single bond
K240
J92
O





















TABLE 4











-G1-A3-




Compound No.
-A1-
-A2-
A4-G2
-A5-R2
X







1-0097
single bond
single bond
K240
J92
S


1-0098
—CH2
single bond
K240
J4
O


1-0099
—CH2
single bond
K240
J4
S


1-0100
—CH2
single bond
K240
J9
O


1-0101
—CH2
single bond
K240
J9
S


1-0102
—CH2
single bond
K240
J77
O


1-0103
—(CH2)3
single bond
K240
J9
O


1-0104
—(CH2)3
single bond
K240
J77
O


1-0105
—(CH2)3
single bond
K240
J77
S


1-0106
—CH2—CH(CH3)—CH2
single bond
K240
J9
O


1-0107
—CH2—CH(CH3)—CH2
single bond
K240
J77
O


1-0108
—CH2—CH(CH3)—CH2
single bond
K240
J77
S


1-0109
—(CH2)2—CH(CH3)—CH2
single bond
K240
J4
O


1-0110
—(CH2)2—CH(CH3)—CH2
single bond
K240
J4
S


1-0111
—(CH2)2—CH(CH3)—CH2
single bond
K240
J6
O


1-0112
—(CH2)2—CH(CH3)—CH2
single bond
K240
J6
S


1-0113
—(CH2)2—CH(CH3)—CH2
single bond
K240
J9
O


1-0114
—(CH2)2—CH(CH3)—CH2
single bond
K240
J9
S


1-0115
—(CH2)2—CH(CH3)—CH2
single bond
K240
J23
O


1-0116
—(CH2)2—CH(CH3)—CH2
single bond
K240
J23
S


1-0117
—(CH2)2—CH(CH3)—CH2
single bond
K240
J41
O


1-0118
—(CH2)2—CH(CH3)—CH2
single bond
K240
J41
S


1-0119
—(CH2)2—CH(CH3)—CH2
single bond
K240
J52
O


1-0120
—(CH2)2—CH(CH3)—CH2
single bond
K240
J52
S


1-0121
—(CH2)2—CH(CH3)—CH2
single bond
K240
J77
O


1-0122
—(CH2)2—CH(CH3)—CH2
single bond
K240
J77
S


1-0123
—(CH2)2—CH(CH3)—CH2
single bond
K240
J84
O


1-0124
—(CH2)2—CH(CH3)—CH2
single bond
K240
J84
S


1-0125
—CH2—CH(CH3)—(CH2)2
single bond
K240
J9
O


1-0126
—CH2—CH(CH3)—(CH2)2
single bond
K240
J9
S


1-0127
—CH2—CH(CH3)—(CH2)2
single bond
K240
J77
O


1-0128
—CH2—C(CH3)2—CH2
single bond
K240
J9
O





















TABLE 5








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0129
—CH2—C(CH3)2—CH2
single bond
K240
J9
S


1-0130
—(CH2)4
single bond
K1
J2
O


1-0131
—(CH2)4
single bond
K1
J4
O


1-0132
—(CH2)4
single bond
K1
J9
O


1-0133
—(CH2)4
single bond
K1
J9
S


1-0134
—(CH2)4
single bond
K1
J77
O


1-0135
—(CH2)4
single bond
K1
J77
S


1-0136
—(CH2)2—C(CH3)2—CH2
single bond
K240
J9
O


1-0137
—(CH2)2—C(CH3)2—CH2
single bond
K240
J9
S


1-0138
—(CH2)4
single bond
K87
J96
O


1-0139
—(CH2)4
single bond
K87
J96
S


1-0140
—(CH2)4
single bond
K87
J104
O


1-0141
—(CH2)4
single bond
K87
J104
S


1-0142
—(CH2)4
single bond
K87
J117
O


1-0143
—(CH2)4
single bond
K87
J117
S


1-0144
single bond
single bond
K6
J9
O


1-0145
single bond
single bond
K6
J77
O


1-0146
single bond
single bond
K14
J1
O


1-0147
—(CH2)2
—NH—
K240
J4
O


1-0148
—(CH2)2
—NH—
K240
J4
S


1-0149
—(CH2)2
—NH—
K240
J6
O


1-0150
—(CH2)2
—NH—
K240
J6
S


1-0151
—(CH2)2
—NH—
K240
J9
O


1-0152
—(CH2)2
—NH—
K240
J12
O


1-0153
—(CH2)2
—NH—
K240
J12
S


1-0154
—(CH2)2
—NH—
K240
J23
O


1-0155
—(CH2)2
—NH—
K240
J23
S


1-0156
—(CH2)2
—NH—
K240
J41
O


1-0157
—(CH2)2
—NH—
K240
J41
S


1-0158
—(CH2)2
—NH—
K240
J52
O


1-0159
—(CH2)2
—NH—
K240
J52
S


1-0160
—(CH2)2
—NH—
K240
J84
O





















TABLE 6








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0161
—(CH2)2
—NH—
K240
J84
S


1-0162
—(CH2)3
—NH—
K240
J3
O


1-0163
—(CH2)3
—NH—
K240
J3
S


1-0164
—(CH2)3
—NH—
K240
J9
O


1-0165
—(CH2)3
—NH—
K240
J10
O


1-0166
—(CH2)3
—NH—
K240
J10
S


1-0167
—(CH2)3
—NH—
K240
J22
O


1-0168
—(CH2)3
—NH—
K240
J22
S


1-0169
—(CH2)3
—NH—
K240
J28
O


1-0170
—(CH2)3
—NH—
K240
J28
S


1-0171
—(CH2)3
—NH—
K240
J43
O


1-0172
—(CH2)3
—NH—
K240
J43
S


1-0173
—(CH2)3
—NH—
K240
J84
O


1-0174
—(CH2)3
—NH—
K240
J84
S


1-0175
—(CH2)3
—NH—
K240
J92
O


1-0176
—(CH2)3
—NH—
K240
J92
S


1-0177
—(CH2)2
—O—
K240
J4
O


1-0178
—(CH2)2
—O—
K240
J4
S


1-0179
—(CH2)2
—O—
K240
J6
O


1-0180
—(CH2)2
—O—
K240
J6
S


1-0181
—(CH2)2
—O—
K240
J9
O


1-0182
—(CH2)2
—O—
K240
J12
O


1-0183
—(CH2)2
—O—
K240
J12
S


1-0184
—(CH2)2
—O—
K240
J23
O


1-0185
—(CH2)2
—O—
K240
J23
S


1-0186
—(CH2)2
—O—
K240
J41
O


1-0187
—(CH2)2
—O—
K240
J41
S


1-0188
—(CH2)2
—O—
K240
J52
O


1-0189
—(CH2)2
—O—
K240
J52
S


1-0190
—(CH2)2
—O—
K240
J84
O


1-0191
—(CH2)2
—O—
K240
J84
S


1-0192
—(CH2)3
—O—
K240
J3
O





















TABLE 7








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0193
—(CH2)3
—O—
K240
J3
S


1-0194
—(CH2)3
—O—
K240
J9
O


1-0195
—(CH2)3
—O—
K240
J10
O


1-0196
—(CH2)3
—O—
K240
J10
S


1-0197
—(CH2)3
—O—
K240
J22
O


1-0198
—(CH2)3
—O—
K240
J22
S


1-0199
—(CH2)3
—O—
K240
J28
O


1-0200
—(CH2)3
—O—
K240
J28
S


1-0201
—(CH2)3
—O—
K240
J43
O


1-0202
—(CH2)3
—O—
K240
J43
S


1-0203
—(CH2)3
—O—
K240
J84
O


1-0204
—(CH2)3
—O—
K240
J84
S


1-0205
—(CH2)3
—O—
K240
J92
O


1-0206
—(CH2)3
—O—
K240
J92
S


1-0207
—(CH2)2
—O—
K1
J9
O


1-0208
—(CH2)2
—O—
K1
J9
S


1-0209
—(CH2)2
—O—
K1
J77
O


1-0210
—(CH2)2
—O—
K2
J4
O


1-0211
—(CH2)2
—O—
K2
J4
S


1-0212
—(CH2)2
—O—
K2
J6
O


1-0213
—(CH2)2
—O—
K2
J6
S


1-0214
—(CH2)2
—O—
K2
J9
O


1-0215
—(CH2)2
—O—
K2
J9
S


1-0216
—(CH2)2
—O—
K2
J23
O


1-0217
—(CH2)2
—O—
K2
J23
S


1-0218
—(CH2)2
—O—
K2
J41
O


1-0219
—(CH2)2
—O—
K2
J41
S


1-0220
—(CH2)2
—O—
K2
J52
O


1-0221
—(CH2)2
—O—
K2
J52
S


1-0222
—(CH2)2
—O—
K2
J77
O


1-0223
—(CH2)2
—O—
K2
J84
O


1-0224
—(CH2)2
—O—
K2
J84
S





















TABLE 8








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0225
—(CH2)3
—O—
K1
J2
O


1-0226
—(CH2)3
—O—
K1
J4
O


1-0227
—(CH2)3
—O—
K1
J9
O


1-0228
—(CH2)3
—O—
K1
J9
S


1-0229
—(CH2)3
—O—
K1
J77
O


1-0230
—(CH2)3
—O—
K1
J77
S


1-0231
—(CH2)3
—O—
K2
J2
O


1-0232
—(CH2)3
—O—
K2
J4
O


1-0233
—(CH2)3
—O—
K2
J4
S


1-0234
—(CH2)3
—O—
K2
J9
O


1-0235
—(CH2)3
—O—
K2
J9
S


1-0236
—(CH2)3
—O—
K2
J77
O


1-0237
—(CH2)3
—O—
K2
J77
S


1-0238
—(CH2)3
—O—
K4
J2
O


1-0239
—(CH2)3
—O—
K4
J2
S


1-0240
—(CH2)3
—O—
K4
J3
O


1-0241
—(CH2)3
—O—
K4
J3
S


1-0242
—(CH2)3
—O—
K4
J11
S


1-0243
—(CH2)3
—O—
K4
J4
O


1-0244
—(CH2)3
—O—
K4
J4
S


1-0245
—(CH2)3
—O—
K4
J5
O


1-0246
—(CH2)3
—O—
K4
J5
S


1-0247
—(CH2)3
—O—
K4
J9
O


1-0248
—(CH2)3
—O—
K4
J9
S


1-0249
—(CH2)3
—O—
K4
J22
O


1-0250
—(CH2)3
—O—
K4
J22
S


1-0251
—(CH2)3
—O—
K4
J28
O


1-0252
—(CH2)3
—O—
K4
J28
S


1-0253
—(CH2)3
—O—
K4
J77
O


1-0254
—(CH2)3
—O—
K4
J77
S


1-0255
—(CH2)3
—O—
K4
J84
O


1-0256
—(CH2)3
—O—
K4
J84
S





















TABLE 9








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0257
—(CH2)3
—O—
K4
J96
O


1-0258
—(CH2)3
—O—
K4
J96
S


1-0259
—(CH2)3
—O—
K4
J104
O


1-0260
—(CH2)3
—O—
K4
J104
S


1-0261
—(CH2)3
—O—
K4
J117
O


1-0262
—(CH2)3
—O—
K4
J117
S


1-0263
—(CH2)3
—S—
K1
J9
O


1-0264
—(CH2)3
—S—
K1
J9
S


1-0265
—(CH2)3
—S—
K87
J77
O


1-0266
—(CH2)3
—S—
K87
J119
O


1-0267
—(CH2)3
—S—
K87
J119
S


1-0268
—(CH2)3
—S—
K87
J123
O


1-0269
—(CH2)3
—S—
K87
J123
S


1-0270
—(CH2)3
—S—
K87
J125
O


1-0271
—(CH2)3
—S—
K87
J125
S


1-0272
—CH2
single bond
K530
J9
O


1-0273
—CH2
single bond
K530
J9
S


1-0274
—CH2
single bond
K6
J9
O


1-0275
—CH2
single bond
K6
J9
S


1-0276
—CH2
single bond
K8
J4
O


1-0277
—CH2
single bond
K8
J4
S


1-0278
—CH2
single bond
K8
J6
O


1-0279
—CH2
single bond
K8
J6
S


1-0280
—CH2
single bond
K8
J9
O


1-0281
—CH2
single bond
K8
J9
S


1-0282
—CH2
single bond
K8
J23
O


1-0283
—CH2
single bond
K8
J23
S


1-0284
—CH2
single bond
K8
J41
O


1-0285
—CH2
single bond
K8
J41
S


1-0286
—CH2
single bond
K8
J52
O


1-0287
—CH2
single bond
K8
J52
S


1-0288
—CH2
single bond
K8
J77
O





















TABLE 10








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0289
—CH2
single bond
K8
J77
S


1-0290
—CH2
single bond
K8
J84
O


1-0291
—CH2
single bond
K8
J84
S


1-0292
—CH2
single bond
K460
J9
O


1-0293
—CH2
single bond
K460
J9
S


1-0294
—CH2
single bond
K460
J77
O


1-0295
—CH2
single bond
K460
J77
S


1-0296
—CH2
single bond
K463
J9
O


1-0297
—CH2
single bond
K463
J9
S


1-0298
—CH2
single bond
K463
J77
O


1-0299
—(CH2)2
single bond
K464
J9
O


1-0300
—CH2
single bond
K11
J1
O


1-0301
—CH2
single bond
K11
J1
S


1-0302
—CH2
single bond
K11
J2
O


1-0303
—CH2
single bond
K11
J3
O


1-0304
—CH2
single bond
K11
J3
S


1-0305
—CH2
single bond
K11
J4
O


1-0306
—CH2
single bond
K11
J5
O


1-0307
—CH2
single bond
K11
J9
O


1-0308
—CH2
single bond
K11
J9
S


1-0309
—CH2
single bond
K11
J77
O


1-0310
—CH2
single bond
K11
J77
S


1-0311
—(CH2)2
single bond
K11
J9
O


1-0312
—(CH2)2
single bond
K11
J9
S


1-0313
—(CH2)2
single bond
K11
J77
O


1-0314
—(CH2)2
single bond
K11
J77
S


1-0315
—(CH2)3
single bond
K11
J2
O


1-0316
—(CH2)3
single bond
K11
J2
S


1-0317
—(CH2)3
single bond
K11
J3
S


1-0318
—(CH2)3
single bond
K11
J4
O


1-0319
—(CH2)3
single bond
K11
J5
S


1-0320
—(CH2)3
single bond
K11
J9
O





















TABLE 11








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0321
—(CH2)3
single bond
K11
J9
S


1-0322
—(CH2)3
single bond
K11
J77
O


1-0323
—(CH2)3
single bond
K11
J77
S


1-0324
—(CH2)3
single bond
K11
J3
O


1-0325
—(CH2)3
single bond
K11
J5
O


1-0326
—(CH2)4
single bond
K11
J9
O


1-0327
—CH2
single bond
K468
J9
O


1-0328
—CH2
single bond
K468
J9
S


1-0329
—CH2
single bond
K14
J6
O


1-0330
—CH2
single bond
K283
J4
O


1-0331
—CH2
single bond
K283
J4
S


1-0332
—CH2
single bond
K283
J6
O


1-0333
—CH2
single bond
K283
J6
S


1-0334
—CH2
single bond
K283
J9
O


1-0335
—CH2
single bond
K283
J12
O


1-0336
—CH2
single bond
K283
J12
S


1-0337
—CH2
single bond
K283
J23
O


1-0338
—CH2
single bond
K283
J23
S


1-0339
—CH2
single bond
K283
J41
O


1-0340
—CH2
single bond
K283
J41
S


1-0341
—CH2
single bond
K283
J52
O


1-0342
—CH2
single bond
K283
J52
S


1-0343
—CH2
single bond
K283
J84
O


1-0344
—CH2
single bond
K283
J84
S


1-0345
—CH2
single bond
K24
J9
O


1-0346
—(CH2)2
single bond
K283
J9
O


1-0347
—(CH2)2
single bond
K14
J3
O


1-0348
—(CH2)2
single bond
K14
J3
S


1-0349
—(CH2)2
single bond
K14
J9
O


1-0350
—(CH2)2
single bond
K14
J10
O


1-0351
—(CH2)2
single bond
K14
J10
S


1-0352
—(CH2)2
single bond
K14
J22
O





















TABLE 12








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0353
—(CH2)2
single bond
K14
J22
S


1-0354
—(CH2)2
single bond
K14
J28
O


1-0355
—(CH2)2
single bond
K14
J28
S


1-0356
—(CH2)2
single bond
K14
J43
O


1-0357
—(CH2)2
single bond
K14
J43
S


1-0358
—(CH2)2
single bond
K14
J84
O


1-0359
—(CH2)2
single bond
K14
J84
S


1-0360
—(CH2)2
single bond
K14
J92
O


1-0361
—(CH2)2
single bond
K14
J92
S


1-0362
—(CH2)2
single bond
K24
J9
O


1-0363
—(CH2)2
single bond
K478
J119
O


1-0364
—(CH2)2
single bond
K478
J119
S


1-0365
—(CH2)2
single bond
K478
J123
O


1-0366
—(CH2)2
single bond
K478
J123
S


1-0367
—(CH2)2
single bond
K478
J125
O


1-0368
—(CH2)2
single bond
K478
J125
S


1-0369
—(CH2)2
—O—
K11
J2
O


1-0370
—(CH2)2
—O—
K11
J4
O


1-0371
—(CH2)2
—O—
K11
J9
O


1-0372
—(CH2)2
—O—
K11
J9
S


1-0373
—(CH2)2
—O—
K37
J96
O


1-0374
—(CH2)2
—O—
K37
J96
S


1-0375
—(CH2)2
—O—
K37
J104
O


1-0376
—(CH2)2
—O—
K37
J104
S


1-0377
—(CH2)2
—O—
K37
J117
O


1-0378
—(CH2)2
—O—
K37
J117
S


1-0379
—(CH2)3
—O—
K477
J3
O


1-0380
—(CH2)3
—O—
K477
J3
S


1-0381
—(CH2)3
—O—
K477
J10
O


1-0382
—(CH2)3
—O—
K477
J10
S


1-0383
—(CH2)3
—O—
K477
J22
O


1-0384
—(CH2)3
—O—
K477
J22
S





















TABLE 13








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0385
—(CH2)3
—O—
K477
J28
O


1-0386
—(CH2)3
—O—
K477
J28
S


1-0387
—(CH2)3
—O—
K477
J43
O


1-0388
—(CH2)3
—O—
K477
J43
S


1-0389
—(CH2)3
—O—
K477
J84
O


1-0390
—(CH2)3
—O—
K477
J84
S


1-0391
—(CH2)3
—O—
K477
J92
O


1-0392
—(CH2)3
—O—
K477
J92
S


1-0393
—CH2
single bond
K60
J9
O


1-0394
—CH2
single bond
K60
J9
S


1-0395
—CH2
single bond
K60
J77
O


1-0396
—CH2
single bond
K60
J77
S


1-0397
—CH2
single bond
K62
J9
O


1-0398
—CH2
single bond
K62
J77
O


1-0399
—CH2
single bond
K499
J9
O


1-0400
—CH2
single bond
K499
J77
O


1-0401
—CH2
single bond
K510
J3
O


1-0402
—CH2
single bond
K510
J3
S


1-0403
—CH2
single bond
K510
J10
O


1-0404
—CH2
single bond
K510
J10
S


1-0405
—CH2
single bond
K510
J22
O


1-0406
—CH2
single bond
K510
J22
S


1-0407
—CH2
single bond
K510
J28
O


1-0408
—CH2
single bond
K510
J28
S


1-0409
—CH2
single bond
K510
J43
O


1-0410
—CH2
single bond
K510
J43
S


1-0411
—CH2
single bond
K510
J84
O


1-0412
—CH2
single bond
K510
J84
S


1-0413
—CH2
single bond
K510
J92
O


1-0414
—CH2
single bond
K510
J92
S


1-0415
—(CH2)2
single bond
K62
J9
O


1-0416
—(CH2)2
single bond
K62
J9
S





















TABLE 14








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0417
—(CH2)2
single bond
K62
J77
O


1-0418
—(CH2)2
single bond
K525
J4
O


1-0419
—(CH2)2
single bond
K525
J4
S


1-0420
—(CH2)2
single bond
K525
J6
O


1-0421
—(CH2)2
single bond
K525
J6
S


1-0422
—(CH2)2
single bond
K525
J12
O


1-0423
—(CH2)2
single bond
K525
J12
S


1-0424
—(CH2)2
single bond
K525
J23
O


1-0425
—(CH2)2
single bond
K525
J23
S


1-0426
—(CH2)2
single bond
K525
J41
O


1-0427
—(CH2)2
single bond
K525
J41
S


1-0428
—(CH2)2
single bond
K525
J52
O


1-0429
—(CH2)2
single bond
K525
J52
S


1-0430
—(CH2)2
single bond
K525
J84
O


1-0431
—(CH2)2
single bond
K525
J84
S


1-0432
—(CH2)4
single bond
K528
J119
O


1-0433
—(CH2)4
single bond
K528
J119
S


1-0434
—(CH2)4
single bond
K528
J123
O


1-0435
—(CH2)4
single bond
K528
J123
S


1-0436
—(CH2)4
single bond
K528
J125
O


1-0437
—(CH2)4
single bond
K528
J125
S


1-0438
—CH2
single bond
K529
J9
O


1-0439
—(CH2)2
—NH—
K240
J1
S


1-0440
—(CH2)2
—NH—
K240
J3
S


1-0441
—(CH2)2
—NH—
K240
J9
S


1-0442
—(CH2)2
—NH—
K240
J10
S


1-0443
—(CH2)2
—NH—
K240
J14
S


1-0444
—(CH2)2
—NH—
K240
J19
S


1-0445
—(CH2)2
—NH—
K240
J22
S


1-0446
—(CH2)2
—NH—
K240
J25
S


1-0447
—(CH2)2
—NH—
K240
J29
S


1-0448
—(CH2)2
—NH—
K240
J57
S





















TABLE 15








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0449
—(CH2)2
—NH—
K240
J59
S


1-0450
—(CH2)2
—NH—
K240
J70
S


1-0451
—(CH2)2
—NH—
K240
J72
S


1-0452
—(CH2)2
—NH—
K240
J74
S


1-0453
—(CH2)2
—NH—
K240
J75
S


1-0454
—(CH2)2
—NH—
K240
J77
S


1-0455
—(CH2)2
—NH—
K240
J78
S


1-0456
—(CH2)2
—NH—
K240
J126
S


1-0457
—(CH2)2
—NH—
K240
J129
S


1-0458
—(CH2)2
—NH—
K240
J130
S


1-0459
—(CH2)2
—NH—
K240
J138
S


1-0460
—(CH2)2
—NH—
K240
J140
S


1-0461
—(CH2)2
—NH—
K240
J151
S


1-0462
—(CH2)2
—NH—
K240
J165
S


1-0463
—(CH2)2
—NH—
K240
J168
S


1-0464
—(CH2)2
—NH—
K240
J174
S


1-0465
—(CH2)2
—NH—
K240
J176
S


1-0466
—(CH2)2
—NH—
K240
J177
S


1-0467
—(CH2)2
—NH—
K240
J178
S


1-0468
—(CH2)2
—NH—
K240
J185
S


1-0469
—(CH2)2
—NH—
K240
J191
S


1-0470
—(CH2)2
—NH—
K240
J193
S


1-0471
—(CH2)2
—NH—
K240
J195
S


1-0472
—(CH2)2
—NH—
K240
J197
S


1-0473
—(CH2)2
—O—
K2
J19
S


1-0474
—(CH2)2
—O—
K2
J70
S


1-0475
—(CH2)2
—O—
K2
J78
S


1-0476
—(CH2)2
—O—
K2
J126
S


1-0477
—(CH2)2
—O—
K2
J129
S


1-0478
—(CH2)2
—O—
K2
J130
S


1-0479
—(CH2)2
—O—
K2
J138
S


1-0480
—(CH2)2
—O—
K2
J185
S





















TABLE 16








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0481
—(CH2)2
—O—
K4
J9
S


1-0482
—(CH2)2
—O—
K4
J126
S


1-0483
—(CH2)2
—O—
K4
J129
S


1-0484
—(CH2)2
—O—
K4
J130
S


1-0485
—(CH2)2
—O—
K4
J138
S


1-0486
—(CH2)2
—O—
K4
J140
S


1-0487
—(CH2)2
—O—
K240
J9
S


1-0488
—(CH2)2
—O—
K240
J70
S


1-0489
—(CH2)2
—O—
K240
J78
S


1-0490
—(CH2)2
—O—
K240
J130
S


1-0491
—(CH2)2
—O—
K240
J138
S


1-0492
—(CH2)2
—O—
K240
J185
S


1-0493
—(CH2)2
single bond
K603
J9
S


1-0494
—(CH2)2
single bond
K603
J140
S


1-0495
—(CH2)2
single bond
K604
J9
S


1-0496
—(CH2)2
single bond
K604
J126
S


1-0497
—(CH2)2
single bond
K605
J9
S


1-0498
—(CH2)2
single bond
K605
J129
S


1-0499
—(CH2)2
single bond
K615
J9
S


1-0500
—(CH2)2
single bond
K615
J130
S


1-0501
—(CH2)2
single bond
K616
J9
S


1-0502
—(CH2)2
single bond
K616
J138
S


1-0503
—(CH2)3
—NH—
K240
J9
S


1-0504
—(CH2)3
—NH—
K240
J126
S


1-0505
—(CH2)3
—NH—
K240
J129
S


1-0506
—(CH2)3
—NH—
K240
J130
S


1-0507
—(CH2)3
—NH—
K240
J138
S


1-0508
—(CH2)3
—NH—
K240
J140
S


1-0509
—(CH2)3
—O—
K1
J22
S


1-0510
—(CH2)3
—O—
K2
J22
S


1-0511
—(CH2)3
—O—
K4
J1
S


1-0512
—(CH2)3
—O—
K4
J10
S





















TABLE 17








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0513
—(CH2)3
—O—
K4
J10
O


1-0514
—(CH2)3
—O—
K4
J19
S


1-0515
—(CH2)3
—O—
K4
J57
S


1-0516
—(CH2)3
—O—
K4
J70
S


1-0517
—(CH2)3
—O—
K4
J71
S


1-0518
—(CH2)3
—O—
K4
J78
S


1-0519
—(CH2)3
—O—
K4
J126
S


1-0520
—(CH2)3
—O—
K4
J126
O


1-0521
—(CH2)3
—O—
K4
J129
S


1-0522
—(CH2)3
—O—
K4
J129
O


1-0523
—(CH2)3
—O—
K4
J130
S


1-0524
—(CH2)3
—O—
K4
J134
S


1-0525
—(CH2)3
—O—
K4
J138
S


1-0526
—(CH2)3
—O—
K4
J140
S


1-0527
—(CH2)3
—O—
K4
J178
S


1-0528
—(CH2)2
—O—
K4
J178
S


1-0529
—(CH2)3
—O—
K4
J185
S


1-0530
—(CH2)3
—O—
K4
J186
S


1-0531
—(CH2)3
—O—
K4
J187
S


1-0532
—(CH2)3
—O—
K4
J189
S


1-0533
—(CH2)3
—O—
K4
J190
S


1-0534
—(CH2)3
—O—
K4
J191
S


1-0535
—(CH2)3
—O—
K4
J192
S


1-0536
—(CH2)3
—O—
K4
J193
S


1-0537
—(CH2)3
—O—
K11
J9
S


1-0538
—(CH2)3
—O—
K11
J126
S


1-0539
—(CH2)3
—O—
K11
J129
S


1-0540
—(CH2)3
—O—
K11
J130
S


1-0541
—(CH2)3
—O—
K11
J138
S


1-0542
—(CH2)3
—O—
K11
J140
S


1-0543
—(CH2)3
—O—
K34
J9
S


1-0544
—(CH2)3
—O—
K34
J126
S





















TABLE 18








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0545
—(CH2)3
—O—
K34
J129
S


1-0546
—(CH2)3
—O—
K34
J130
S


1-0547
—(CH2)3
—O—
K34
J138
S


1-0548
—(CH2)3
—O—
K34
J140
S


1-0549
—(CH2)3
—O—
K49
J9
S


1-0550
—(CH2)3
—O—
K49
J126
S


1-0551
—(CH2)3
—O—
K49
J129
S


1-0552
—(CH2)3
—O—
K49
J130
S


1-0553
—(CH2)3
—O—
K49
J138
S


1-0554
—(CH2)3
—O—
K49
J140
S


1-0555
—(CH2)3
—O—
K103
J9
S


1-0556
—(CH2)3
—O—
K103
J126
S


1-0557
—(CH2)3
—O—
K103
J129
S


1-0558
—(CH2)3
—O—
K103
J130
S


1-0559
—(CH2)3
—O—
K103
J138
S


1-0560
—(CH2)3
—O—
K103
J140
S


1-0561
—(CH2)3
—O—
K240
J9
S


1-0562
—(CH2)3
—O—
K240
J70
S


1-0563
—(CH2)3
—O—
K240
J78
S


1-0564
—(CH2)3
—O—
K240
J130
S


1-0565
—(CH2)3
—O—
K240
J138
S


1-0566
—(CH2)3
—O—
K240
J185
S


1-0567
—(CH2)3
—O—
K723
J9
S


1-0568
—(CH2)3
—O—
K723
J126
S


1-0569
—(CH2)3
—O—
K723
J129
S


1-0570
—(CH2)3
—O—
K723
J130
S


1-0571
—(CH2)3
—O—
K723
J138
S


1-0572
—(CH2)3
—O—
K723
J140
S


1-0573
—(CH2)3
—O—
K725
J9
S


1-0574
—(CH2)3
—O—
K725
J126
S


1-0575
—(CH2)3
—O—
K725
J129
S


1-0576
—(CH2)3
—O—
K725
J130
S





















TABLE 19








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0577
—(CH2)3
—O—
K725
J138
S


1-0578
—(CH2)3
—O—
K725
J140
S


1-0579
—(CH2)3
—O—
K99
J9
S


1-0580
—(CH2)3
—O—
K99
J126
S


1-0581
—(CH2)3
—O—
K99
J129
S


1-0582
—(CH2)3
—O—
K99
J130
S


1-0583
—(CH2)3
—O—
K99
J138
S


1-0584
—(CH2)3
—O—
K99
J140
S


1-0585
—(CH2)3
single bond
K603
J9
S


1-0586
—(CH2)3
single bond
K604
J9
S


1-0587
—(CH2)3
single bond
K605
J9
S


1-0588
—(CH2)3
single bond
K606
J9
S


1-0589
single bond
single bond
K1
J1
S


1-0590
single bond
single bond
K1
J3
S


1-0591
single bond
single bond
K1
J6
S


1-0592
single bond
single bond
K1
J9
S


1-0593
single bond
single bond
K1
J10
S


1-0594
single bond
single bond
K1
J14
S


1-0595
single bond
single bond
K1
J19
S


1-0596
single bond
single bond
K1
J22
S


1-0597
single bond
single bond
K1
J25
S


1-0598
single bond
single bond
K1
J29
S


1-0599
single bond
single bond
K1
J57
S


1-0600
single bond
single bond
K1
J59
S


1-0601
single bond
single bond
K1
J70
S


1-0602
single bond
single bond
K1
J71
S


1-0603
single bond
single bond
K1
J72
S


1-0604
single bond
single bond
K1
J74
S


1-0605
single bond
single bond
K1
J75
S


1-0606
single bond
single bond
K1
J77
S


1-0607
single bond
single bond
K1
J78
S


1-0608
single bond
single bond
K1
J105
S





















TABLE 20








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0609
single bond
single bond
K1
J126
S


1-0610
single bond
single bond
K1
J129
S


1-0611
single bond
single bond
K1
J130
S


1-0612
single bond
single bond
K1
J134
S


1-0613
single bond
single bond
K1
J138
S


1-0614
single bond
single bond
K1
J140
S


1-0615
single bond
single bond
K1
J151
S


1-0616
single bond
single bond
K1
J165
S


1-0617
single bond
single bond
K1
J168
S


1-0618
single bond
single bond
K1
J174
S


1-0619
single bond
single bond
K1
J176
S


1-0620
single bond
single bond
K1
J177
S


1-0621
single bond
single bond
K1
J178
S


1-0622
single bond
single bond
K1
J185
S


1-0623
single bond
single bond
K1
J191
S


1-0624
single bond
single bond
K1
J194
S


1-0625
single bond
single bond
K1
J195
S


1-0626
single bond
single bond
K1
J197
S


1-0627
single bond
single bond
K2
J9
S


1-0628
single bond
single bond
K2
J10
S


1-0629
single bond
single bond
K2
J14
S


1-0630
single bond
single bond
K2
J19
S


1-0631
single bond
single bond
K2
J22
S


1-0632
single bond
single bond
K2
J57
S


1-0633
single bond
single bond
K2
J59
S


1-0634
single bond
single bond
K2
J70
S


1-0635
single bond
single bond
K2
J72
S


1-0636
single bond
single bond
K2
J74
S


1-0637
single bond
single bond
K2
J75
S


1-0638
single bond
single bond
K2
J77
S


1-0639
single bond
single bond
K2
J78
S


1-0640
single bond
single bond
K2
J126
S





















TABLE 21








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0641
single bond
single bond
K2
J129
S


1-0642
single bond
single bond
K2
J130
S


1-0643
single bond
single bond
K2
J138
S


1-0644
single bond
single bond
K2
J140
S


1-0645
single bond
single bond
K2
J151
S


1-0646
single bond
single bond
K2
J174
S


1-0647
single bond
single bond
K2
J176
S


1-0648
single bond
single bond
K2
J177
S


1-0649
single bond
single bond
K2
J178
S


1-0650
single bond
single bond
K2
J185
S


1-0651
single bond
single bond
K2
J191
S


1-0652
single bond
single bond
K2
J194
S


1-0653
single bond
single bond
K2
J195
S


1-0654
single bond
single bond
K2
J197
S


1-0655
single bond
single bond
K3
J9
S


1-0656
single bond
single bond
K3
J70
S


1-0657
single bond
single bond
K3
J78
S


1-0658
single bond
single bond
K3
J130
S


1-0659
single bond
single bond
K3
J138
S


1-0660
single bond
single bond
K3
J185
S


1-0661
single bond
single bond
K4
J9
S


1-0662
single bond
single bond
K4
J70
S


1-0663
single bond
single bond
K4
J78
S


1-0664
single bond
single bond
K4
J130
S


1-0665
single bond
single bond
K4
J138
S


1-0666
single bond
single bond
K4
J185
S


1-0667
single bond
single bond
K99
J22
S


1-0668
single bond
single bond
K103
J22
S


1-0669
single bond
single bond
K240
J1
S


1-0670
single bond
single bond
K240
J6
S


1-0671
single bond
single bond
K240
J12
S


1-0672
single bond
single bond
K240
J13
S





















TABLE 22








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0673
single bond
single bond
K240
J15
S


1-0674
single bond
single bond
K240
J17
S


1-0675
single bond
single bond
K240
J18
S


1-0676
single bond
single bond
K240
J19
S


1-0677
—(CH2)3
single bond
K240
J19
S


1-0678
single bond
single bond
K240
J20
S


1-0679
single bond
single bond
K240
J21
S


1-0680
single bond
single bond
K240
J27
S


1-0681
single bond
single bond
K240
J30
S


1-0682
single bond
single bond
K240
J31
S


1-0683
single bond
single bond
K240
J32
S


1-0684
single bond
single bond
K240
J33
S


1-0685
single bond
single bond
K240
J36
S


1-0686
single bond
single bond
K240
J39
S


1-0687
single bond
single bond
K240
J41
S


1-0688
single bond
single bond
K240
J42
S


1-0689
single bond
single bond
K240
J44
S


1-0690
single bond
single bond
K240
J45
S


1-0691
single bond
single bond
K240
J46
S


1-0692
single bond
single bond
K240
J48
S


1-0693
single bond
single bond
K240
J49
S


1-0694
single bond
single bond
K240
J50
S


1-0695
single bond
single bond
K240
J51
S


1-0696
single bond
single bond
K240
J52
S


1-0697
single bond
single bond
K240
J55
S


1-0698
single bond
single bond
K240
J57
S


1-0699
single bond
single bond
K240
J58
S


1-0700
single bond
single bond
K240
J59
S


1-0701
single bond
single bond
K240
J61
S


1-0702
single bond
single bond
K240
J62
S


1-0703
single bond
single bond
K240
J64
S


1-0704
single bond
single bond
K240
J66
S





















TABLE 23








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0705
single bond
single bond
K240
J67
S


1-0706
single bond
single bond
K240
J68
S


1-0707
single bond
single bond
K240
J69
S


1-0708
single bond
single bond
K240
J71
S


1-0709
single bond
single bond
K240
J72
S


1-0710
single bond
single bond
K240
J74
S


1-0711
—(CH2)3
single bond
K240
J74
S


1-0712
single bond
single bond
K240
J75
S


1-0713
single bond
single bond
K240
J77
S


1-0714
single bond
single bond
K240
J78
S


1-0715
single bond
single bond
K240
J90
S


1-0716
single bond
single bond
K240
J126
S


1-0717
single bond
single bond
K240
J129
S


1-0718
single bond
single bond
K240
J130
S


1-0719
single bond
single bond
K240
J138
S


1-0720
single bond
single bond
K240
J140
S


1-0721
single bond
single bond
K240
J143
S


1-0722
single bond
single bond
K240
J145
S


1-0723
single bond
single bond
K240
J146
S


1-0724
single bond
single bond
K240
J147
S


1-0725
single bond
single bond
K240
J148
S


1-0726
single bond
single bond
K240
J149
S


1-0727
single bond
single bond
K240
J150
S


1-0728
single bond
single bond
K240
J151
S


1-0729
single bond
single bond
K240
J153
S


1-0730
single bond
single bond
K240
J154
S


1-0731
single bond
single bond
K240
J155
S


1-0732
single bond
single bond
K240
J156
S


1-0733
single bond
single bond
K240
J157
S


1-0734
single bond
single bond
K240
J158
S


1-0735
single bond
single bond
K240
J159
S


1-0736
single bond
single bond
K240
J163
S





















TABLE 24








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0737
single bond
single bond
K240
J165
S


1-0738
single bond
single bond
K240
J168
S


1-0739
single bond
single bond
K240
J169
S


1-0740
single bond
single bond
K240
J170
S


1-0741
single bond
single bond
K240
J171
S


1-0742
single bond
single bond
K240
J172
S


1-0743
single bond
single bond
K240
J173
S


1-0744
single bond
single bond
K240
J174
S


1-0745
single bond
single bond
K240
J176
S


1-0746
single bond
single bond
K240
J177
S


1-0747
single bond
single bond
K240
J178
S


1-0748
single bond
single bond
K240
J179
S


1-0749
single bond
single bond
K240
J180
S


1-0750
single bond
single bond
K240
J181
S


1-0751
single bond
single bond
K240
J182
S


1-0752
single bond
single bond
K240
J183
S


1-0753
single bond
single bond
K240
J184
S


1-0754
single bond
single bond
K240
J185
S


1-0755
single bond
single bond
K240
J191
S


1-0756
single bond
single bond
K240
J194
S


1-0757
single bond
single bond
K240
J195
S


1-0758
single bond
single bond
K240
J197
S


1-0759
single bond
single bond
K281
J9
S


1-0760
single bond
single bond
K660
J3
S


1-0761
—CH2
single bond
K11
J126
S


1-0762
—CH2
single bond
K11
J129
S


1-0763
—CH2
single bond
K11
J130
S


1-0764
—CH2
single bond
K11
J138
S


1-0765
—CH2
single bond
K11
J140
S


1-0766
—(CH2)2
single bond
K11
J126
S


1-0767
—(CH2)2
single bond
K11
J129
S


1-0768
—(CH2)2
single bond
K11
J130
S





















TABLE 25








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0769
—(CH2)2
single bond
K11
J138
S


1-0770
—(CH2)2
single bond
K11
J140
S


1-0771
—(CH2)3
single bond
K11
J126
S


1-0772
—(CH2)3
single bond
K11
J129
S


1-0773
—(CH2)3
single bond
K11
J130
S


1-0774
—(CH2)3
single bond
K11
J138
S


1-0775
—(CH2)3
single bond
K11
J140
S


1-0776
—(CH2)2
—NH—
K240
J1
O


1-0777
—(CH2)2
—NH—
K240
J3
O


1-0778
—(CH2)2
—NH—
K240
J10
O


1-0779
—(CH2)2
—NH—
K240
J14
O


1-0780
—(CH2)2
—NH—
K240
J19
O


1-0781
—(CH2)2
—NH—
K240
J22
O


1-0782
—(CH2)2
—NH—
K240
J25
O


1-0783
—(CH2)2
—NH—
K240
J29
O


1-0784
—(CH2)2
—NH—
K240
J57
O


1-0785
—(CH2)2
—NH—
K240
J59
O


1-0786
—(CH2)2
—NH—
K240
J70
O


1-0787
—(CH2)2
—NH—
K240
J72
O


1-0788
—(CH2)2
—NH—
K240
J74
O


1-0789
—(CH2)2
—NH—
K240
J75
O


1-0790
—(CH2)2
—NH—
K240
J77
O


1-0791
—(CH2)2
—NH—
K240
J78
O


1-0792
—(CH2)2
—NH—
K240
J126
O


1-0793
—(CH2)2
—NH—
K240
J129
O


1-0794
—(CH2)2
—NH—
K240
J130
O


1-0795
—(CH2)2
—NH—
K240
J138
O


1-0796
—(CH2)2
—NH—
K240
J140
O


1-0797
—(CH2)2
—NH—
K240
J151
O


1-0798
—(CH2)2
—NH—
K240
J165
O


1-0799
—(CH2)2
—NH—
K240
J168
O


1-0800
—(CH2)2
—NH—
K240
J174
O





















TABLE 26








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0801
—(CH2)2
—NH—
K240
J176
O


1-0802
—(CH2)2
—NH—
K240
J177
O


1-0803
—(CH2)2
—NH—
K240
J178
O


1-0804
—(CH2)2
—NH—
K240
J185
O


1-0805
—(CH2)2
—NH—
K240
J191
O


1-0806
—(CH2)2
—NH—
K240
J193
O


1-0807
—(CH2)2
—NH—
K240
J195
O


1-0808
—(CH2)2
—NH—
K240
J197
O


1-0809
—(CH2)2
—O—
K2
J19
O


1-0810
—(CH2)2
—O—
K2
J70
O


1-0811
—(CH2)2
—O—
K2
J78
O


1-0812
—(CH2)2
—O—
K2
J126
O


1-0813
—(CH2)2
—O—
K2
J129
O


1-0814
—(CH2)2
—O—
K2
J130
O


1-0815
—(CH2)2
—O—
K2
J138
O


1-0816
—(CH2)2
—O—
K2
J185
O


1-0817
—(CH2)2
—O—
K4
J9
O


1-0818
—(CH2)2
—O—
K4
J126
O


1-0819
—(CH2)2
—O—
K4
J129
O


1-0820
—(CH2)2
—O—
K4
J130
O


1-0821
—(CH2)2
—O—
K4
J138
O


1-0822
—(CH2)2
—O—
K4
J140
O


1-0823
—(CH2)2
—O—
K240
J70
O


1-0824
—(CH2)2
—O—
K240
J78
O


1-0825
—(CH2)2
—O—
K240
J130
O


1-0826
—(CH2)2
—O—
K240
J138
O


1-0827
—(CH2)2
—O—
K240
J185
O


1-0828
—(CH2)2
single bond
K603
J9
O


1-0829
—(CH2)2
single bond
K603
J140
O


1-0830
—(CH2)2
single bond
K604
J9
O


1-0831
—(CH2)2
single bond
K604
J126
O


1-0832
—(CH2)2
single bond
K605
J9
O





















TABLE 27








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0833
—(CH2)2
single bond
K605
J129
O


1-0834
—(CH2)2
single bond
K615
J9
O


1-0835
—(CH2)2
single bond
K615
J130
O


1-0836
—(CH2)2
single bond
K616
J9
O


1-0837
—(CH2)2
single bond
K616
J138
O


1-0838
—(CH2)3
—NH—
K240
J126
O


1-0839
—(CH2)3
—NH—
K240
J129
O


1-0840
—(CH2)3
—NH—
K240
J130
O


1-0841
—(CH2)3
—NH—
K240
J138
O


1-0842
—(CH2)3
—NH—
K240
J140
O


1-0843
—(CH2)3
—O—
K1
J22
O


1-0844
—(CH2)3
—O—
K2
J22
O


1-0845
—(CH2)3
—O—
K4
J1
O


1-0846
—(CH2)3
—O—
K4
J10
O


1-0847
—(CH2)3
—O—
K4
J10
S


1-0848
—(CH2)3
—O—
K4
J19
O


1-0849
—(CH2)3
—O—
K4
J57
O


1-0850
—(CH2)3
—O—
K4
J70
O


1-0851
—(CH2)3
—O—
K4
J71
O


1-0852
—(CH2)3
—O—
K4
J78
O


1-0853
—(CH2)3
—O—
K4
J126
O


1-0854
—(CH2)3
—O—
K4
J126
S


1-0855
—(CH2)3
—O—
K4
J129
O


1-0856
—(CH2)3
—O—
K4
J129
S


1-0857
—(CH2)3
—O—
K4
J130
O


1-0858
—(CH2)3
—O—
K4
J134
O


1-0859
—(CH2)3
—O—
K4
J138
O


1-0860
—(CH2)3
—O—
K4
J140
O


1-0861
—(CH2)3
—O—
K4
J178
O


1-0862
—(CH2)2
—O—
K4
J178
O


1-0863
—(CH2)3
—O—
K4
J185
O


1-0864
—(CH2)3
—O—
K4
J186
O





















TABLE 28








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0865
—(CH2)3
—O—
K4
J187
O


1-0866
—(CH2)3
—O—
K4
J189
O


1-0867
—(CH2)3
—O—
K4
J190
O


1-0868
—(CH2)3
—O—
K4
J191
O


1-0869
—(CH2)3
—O—
K4
J192
O


1-0870
—(CH2)3
—O—
K4
J193
O


1-0871
—(CH2)3
—O—
K11
J9
O


1-0872
—(CH2)3
—O—
K11
J126
O


1-0873
—(CH2)3
—O—
K11
J129
O


1-0874
—(CH2)3
—O—
K11
J130
O


1-0875
—(CH2)3
—O—
K11
J138
O


1-0876
—(CH2)3
—O—
K11
J140
O


1-0877
—(CH2)3
—O—
K34
J9
O


1-0878
—(CH2)3
—O—
K34
J126
O


1-0879
—(CH2)3
—O—
K34
J129
O


1-0880
—(CH2)3
—O—
K34
J130
O


1-0881
—(CH2)3
—O—
K34
J138
O


1-0882
—(CH2)3
—O—
K34
J140
O


1-0883
—(CH2)3
—O—
K49
J9
O


1-0884
—(CH2)3
—O—
K49
J126
O


1-0885
—(CH2)3
—O—
K49
J129
O


1-0886
—(CH2)3
—O—
K49
J130
O


1-0887
—(CH2)3
—O—
K49
J138
O


1-0888
—(CH2)3
—O—
K49
J140
O


1-0889
—(CH2)3
—O—
K103
J9
O


1-0890
—(CH2)3
—O—
K103
J126
O


1-0891
—(CH2)3
—O—
K103
J129
O


1-0892
—(CH2)3
—O—
K103
J130
O


1-0893
—(CH2)3
—O—
K103
J138
O


1-0894
—(CH2)3
—O—
K103
J140
O


1-0895
—(CH2)3
—O—
K240
J70
O


1-0896
—(CH2)3
—O—
K240
J78
O





















TABLE 29








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0897
—(CH2)3
—O—
K240
J130
O


1-0898
—(CH2)3
—O—
K240
J138
O


1-0899
—(CH2)3
—O—
K240
J185
O


1-0900
—(CH2)3
—O—
K723
J9
O


1-0901
—(CH2)3
—O—
K723
J126
O


1-0902
—(CH2)3
—O—
K723
J129
O


1-0903
—(CH2)3
—O—
K723
J130
O


1-0904
—(CH2)3
—O—
K723
J138
O


1-0905
—(CH2)3
—O—
K723
J140
O


1-0906
—(CH2)3
—O—
K725
J9
O


1-0907
—(CH2)3
—O—
K725
J126
O


1-0908
—(CH2)3
—O—
K725
J129
O


1-0909
—(CH2)3
—O—
K725
J130
O


1-0910
—(CH2)3
—O—
K725
J138
O


1-0911
—(CH2)3
—O—
K725
J140
O


1-0912
—(CH2)3
—O—
K99
J9
O


1-0913
—(CH2)3
—O—
K99
J126
O


1-0914
—(CH2)3
—O—
K99
J129
O


1-0915
—(CH2)3
—O—
K99
J130
O


1-0916
—(CH2)3
—O—
K99
J138
O


1-0917
—(CH2)3
—O—
K99
J140
O


1-0918
—(CH2)3
single bond
K603
J9
O


1-0919
—(CH2)3
single bond
K604
J9
O


1-0920
—(CH2)3
single bond
K605
J9
O


1-0921
—(CH2)3
single bond
K606
J9
O


1-0922
single bond
single bond
K1
J1
O


1-0923
single bond
single bond
K1
J3
O


1-0924
single bond
single bond
K1
J6
O


1-0925
single bond
single bond
K1
J9
O


1-0926
single bond
single bond
K1
J10
O


1-0927
single bond
single bond
K1
J14
O


1-0928
single bond
single bond
K1
J19
O





















TABLE 30








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0929
single bond
single bond
K1
J22
O


1-0930
single bond
single bond
K1
J25
O


1-0931
single bond
single bond
K1
J29
O


1-0932
single bond
single bond
K1
J57
O


1-0933
single bond
single bond
K1
J59
O


1-0934
single bond
single bond
K1
J70
O


1-0935
single bond
single bond
K1
J71
O


1-0936
single bond
single bond
K1
J72
O


1-0937
single bond
single bond
K1
J74
O


1-0938
single bond
single bond
K1
J75
O


1-0939
single bond
single bond
K1
J77
O


1-0940
single bond
single bond
K1
J78
O


1-0941
single bond
single bond
K1
J105
O


1-0942
single bond
single bond
K1
J126
O


1-0943
single bond
single bond
K1
J129
O


1-0944
single bond
single bond
K1
J130
O


1-0945
single bond
single bond
K1
J134
O


1-0946
single bond
single bond
K1
J138
O


1-0947
single bond
single bond
K1
J140
O


1-0948
single bond
single bond
K1
J151
O


1-0949
single bond
single bond
K1
J165
O


1-0950
single bond
single bond
K1
J168
O


1-0951
single bond
single bond
K1
J174
O


1-0952
single bond
single bond
K1
J176
O


1-0953
single bond
single bond
K1
J177
O


1-0954
single bond
single bond
K1
J178
O


1-0955
single bond
single bond
K1
J185
O


1-0956
single bond
single bond
K1
J191
O


1-0957
single bond
single bond
K1
J194
O


1-0958
single bond
single bond
K1
J195
O


1-0959
single bond
single bond
K1
J197
O


1-0960
single bond
single bond
K2
J9
O





















TABLE 31








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0961
single bond
single bond
K2
J10
O


1-0962
single bond
single bond
K2
J14
O


1-0963
single bond
single bond
K2
J19
O


1-0964
single bond
single bond
K2
J22
O


1-0965
single bond
single bond
K2
J57
O


1-0966
single bond
single bond
K2
J59
O


1-0967
single bond
single bond
K2
J70
O


1-0968
single bond
single bond
K2
J72
O


1-0969
single bond
single bond
K2
J74
O


1-0970
single bond
single bond
K2
J75
O


1-0971
single bond
single bond
K2
J77
O


1-0972
single bond
single bond
K2
J78
O


1-0973
single bond
single bond
K2
J126
O


1-0974
single bond
single bond
K2
J129
O


1-0975
single bond
single bond
K2
J130
O


1-0976
single bond
single bond
K2
J138
O


1-0977
single bond
single bond
K2
J140
O


1-0978
single bond
single bond
K2
J151
O


1-0979
single bond
single bond
K2
J174
O


1-0980
single bond
single bond
K2
J176
O


1-0981
single bond
single bond
K2
J177
O


1-0982
single bond
single bond
K2
J178
O


1-0983
single bond
single bond
K2
J185
O


1-0984
single bond
single bond
K2
J191
O


1-0985
single bond
single bond
K2
J194
O


1-0986
single bond
single bond
K2
J195
O


1-0987
single bond
single bond
K2
J197
O


1-0988
single bond
single bond
K3
J9
O


1-0989
single bond
single bond
K3
J70
O


1-0990
single bond
single bond
K3
J78
O


1-0991
single bond
single bond
K3
J130
O


1-0992
single bond
single bond
K3
J138
O





















TABLE 32








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-0993
single bond
single bond
K3
J185
O


1-0994
single bond
single bond
K4
J9
O


1-0995
single bond
single bond
K4
J70
O


1-0996
single bond
single bond
K4
J78
O


1-0997
single bond
single bond
K4
J130
O


1-0998
single bond
single bond
K4
J138
O


1-0999
single bond
single bond
K4
J185
O


1-1000
single bond
single bond
K99
J22
O


1-1001
single bond
single bond
K103
J22
O


1-1002
single bond
single bond
K240
J77
O


1-1003
single bond
single bond
K240
J78
O


1-1004
single bond
single bond
K240
J90
O


1-1005
single bond
single bond
K240
J126
O


1-1006
single bond
single bond
K240
J129
O


1-1007
single bond
single bond
K240
J130
O


1-1008
single bond
single bond
K240
J138
O


1-1009
single bond
single bond
K240
J140
O


1-1010
single bond
single bond
K240
J143
O


1-1011
single bond
single bond
K240
J145
O


1-1012
single bond
single bond
K240
J146
O


1-1013
single bond
single bond
K240
J147
O


1-1014
single bond
single bond
K240
J148
O


1-1015
single bond
single bond
K240
J149
O


1-1016
single bond
single bond
K240
J150
O


1-1017
single bond
single bond
K240
J151
O


1-1018
single bond
single bond
K240
J153
O


1-1019
single bond
single bond
K240
J154
O


1-1020
single bond
single bond
K240
J155
O


1-1021
single bond
single bond
K240
J156
O


1-1022
single bond
single bond
K240
J157
O


1-1023
single bond
single bond
K240
J158
O


1-1024
single bond
single bond
K240
J159
O





















TABLE 33








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-1025
single bond
single bond
K240
J163
O


1-1026
single bond
single bond
K240
J165
O


1-1027
single bond
single bond
K240
J168
O


1-1028
single bond
single bond
K240
J169
O


1-1029
single bond
single bond
K240
J170
O


1-1030
single bond
single bond
K240
J171
O


1-1031
single bond
single bond
K240
J172
O


1-1032
single bond
single bond
K240
J173
O


1-1033
single bond
single bond
K240
J174
O


1-1034
single bond
single bond
K240
J176
O


1-1035
single bond
single bond
K240
J177
O


1-1036
single bond
single bond
K240
J178
O


1-1037
single bond
single bond
K240
J179
O


1-1038
single bond
single bond
K240
J180
O


1-1039
single bond
single bond
K240
J181
O


1-1040
single bond
single bond
K240
J182
O


1-1041
single bond
single bond
K240
J183
O


1-1042
single bond
single bond
K240
J184
O


1-1043
single bond
single bond
K240
J185
O


1-1044
single bond
single bond
K240
J191
O


1-1045
single bond
single bond
K240
J194
O


1-1046
single bond
single bond
K240
J195
O


1-1047
single bond
single bond
K240
J197
O


1-1048
single bond
single bond
K281
J9
O


1-1049
single bond
single bond
K660
J3
O


1-1050
—CH2
single bond
K11
J126
O


1-1051
—CH2
single bond
K11
J129
O


1-1052
—CH2
single bond
K11
J130
O


1-1053
—CH2
single bond
K11
J138
O


1-1054
—CH2
single bond
K11
J140
O


1-1055
—(CH2)2
single bond
K11
J126
O


1-1056
—(CH2)2
single bond
K11
J129
O





















TABLE 34








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







1-1057
—(CH2)2
single bond
K11
J130
O


1-1058
—(CH2)2
single bond
K11
J138
O


1-1059
—(CH2)2
single bond
K11
J140
O


1-1060
—(CH2)3
single bond
K11
J126
O


1-1061
—(CH2)3
single bond
K11
J129
O


1-1062
—(CH2)3
single bond
K11
J130
O


1-1063
—(CH2)3
single bond
K11
J138
O


1-1064
—(CH2)3
single bond
K11
J140
O


1-1065
—(CH2)3
—O—
K99
J9
O


1-1066
—(CH2)3
—O—
K1
J12
O


1-1067
single bond
single bond
K1
J12
O


1-1068
—(CH2)3
—O—
K4
J12
O


1-1069
—(CH2)2
—O—
K2
J12
O


1-1070
single bond
single bond
K103
J12
O


1-1071
single bond
single bond
K99
J12
O


1-1072
—(CH2)3
—O—
K4
J6
O


1-1073
—(CH2)3
—O—
K4
J212
O


1-1074
—(CH2)3
—O—
K1
J10
O


1-1075
—(CH2)3
—O—
K99
J9
S


1-1076
—(CH2)3
—O—
K2
J10
S


1-1077
—(CH2)3
—O—
K4
J209
O


1-1078
—(CH2)3
—O—
K4
J210
S


1-1079
—(CH2)3
—O—
K4
J211
O


1-1080
—(CH2)3
—O—
K4
J211
S


1-1081
—(CH2)3
—NH—
K240
J78
O


1-1082
—(CH2)3
—NH—
K240
J78
S


1-1083
—(CH2)2
—NH—
K1
J9
S





















TABLE 35








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0001
—(CH2)2
—NH—C(═O)—
K4
J4
O


2-0002
—(CH2)2
—NH—C(═O)—
K4
J4
S


2-0003
—(CH2)2
—NH—C(═O)—
K4
J23
O


2-0004
—(CH2)2
—NH—C(═O)—
K4
J23
S


2-0005
—(CH2)2
—NH—C(═O)—
K4
J71
O


2-0006
—(CH2)2
—NH—C(═O)—
K4
J71
S


2-0007
—(CH2)2
—NH—C(═O)—
K11
J9
O


2-0008
—(CH2)2
—NH—C(═O)—
K13
J4
O


2-0009
—(CH2)2
—NH—C(═O)—
K13
J4
S


2-0010
—(CH2)2
—NH—C(═O)—
K13
J9
O


2-0011
—(CH2)2
—NH—C(═O)—
K13
J23
O


2-0012
—(CH2)2
—NH—C(═O)—
K13
J23
S


2-0013
—(CH2)2
—NH—C(═O)—
K13
J71
O


2-0014
—(CH2)2
—NH—C(═O)—
K13
J71
S


2-0015
—(CH2)2
—NH—C(═O)—
K14
J9
O


2-0016
—(CH2)2
—NH—C(═O)—
K28
J9
O


2-0017
—(CH2)2
—NH—C(═O)—
K30
J9
O


2-0018
—(CH2)2
—NH—C(═O)—
K31
J9
O


2-0019
—(CH2)2
—NH—C(═O)—
K24
J9
O


2-0020
—(CH2)2
—NH—C(═O)—
K35
J4
O


2-0021
—(CH2)2
—NH—C(═O)—
K35
J4
S


2-0022
—(CH2)2
—NH—C(═O)—
K35
J23
O


2-0023
—(CH2)2
—NH—C(═O)—
K35
J23
S


2-0024
—(CH2)2
—NH—C(═O)—
K35
J71
O


2-0025
—(CH2)2
—NH—C(═O)—
K35
J71
S


2-0026
—(CH2)2
—NH—C(═O)—
K49
J9
O


2-0027
—(CH2)2
—NH—C(═O)—
K51
J102
O


2-0028
—(CH2)2
—NH—C(═O)—
K51
J102
S


2-0029
—(CH2)2
—NH—C(═O)—
K51
J105
O


2-0030
—(CH2)2
—NH—C(═O)—
K51
J105
S


2-0031
—(CH2)2
—NH—C(═O)—
K60
J9
O


2-0032
—(CH2)2
—NH—C(═O)—
K62
J9
O





















TABLE 36








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0033
—(CH2)2
—NH—C(═O)—
K71
J9
O


2-0034
—(CH2)2
—NH—C(═O)—
K72
J9
O


2-0035
—(CH2)2
—NH—C(═O)—
K82
J9
O


2-0036
—(CH2)2
—NH—C(═O)—
K83
J9
O


2-0037
—(CH2)2
—NH—C(═O)—
K84
J9
O


2-0038
—(CH2)2
—NH—C(═O)—
K110
J4
O


2-0039
—(CH2)2
—NH—C(═O)—
K110
J4
S


2-0040
—(CH2)2
—NH—C(═O)—
K110
J23
O


2-0041
—(CH2)2
—NH—C(═O)—
K110
J23
S


2-0042
—(CH2)2
—NH—C(═O)—
K110
J71
O


2-0043
—(CH2)2
—NH—C(═O)—
K110
J71
S


2-0044
—(CH2)2
—NH—C(═O)—
K114
J102
O


2-0045
—(CH2)2
—NH—C(═O)—
K114
J102
S


2-0046
—(CH2)2
—NH—C(═O)—
K114
J105
O


2-0047
—(CH2)2
—NH—C(═O)—
K114
J105
S


2-0048
—(CH2)2
—NH—C(═O)—
K116
J4
O


2-0049
—(CH2)2
—NH—C(═O)—
K116
J4
S


2-0050
—(CH2)2
—NH—C(═O)—
K116
J23
O


2-0051
—(CH2)2
—NH—C(═O)—
K116
J23
S


2-0052
—(CH2)2
—NH—C(═O)—
K116
J71
O


2-0053
—(CH2)2
—NH—C(═O)—
K116
J71
S


2-0054
—(CH2)2
—NH—C(═O)—
K122
J102
O


2-0055
—(CH2)2
—NH—C(═O)—
K122
J102
S


2-0056
—(CH2)2
—NH—C(═O)—
K122
J105
O


2-0057
—(CH2)2
—NH—C(═O)—
K122
J105
S


2-0058
—(CH2)2
—NH—C(═O)—
K127
J9
O


2-0059
—(CH2)3
—NH—C(═O)—
K7
J9
O


2-0060
—(CH2)3
—NH—C(═O)—
K11
J9
O


2-0061
—(CH2)3
—NH—C(═O)—
K12
J9
O


2-0062
—(CH2)3
—NH—C(═O)—
K13
J9
O


2-0063
—(CH2)3
—NH—C(═O)—
K14
J9
O


2-0064
—(CH2)3
—NH—C(═O)—
K24
J3
O





















TABLE 37








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0065
—(CH2)3
—NH—C(═O)—
K24
J3
S


2-0066
—(CH2)3
—NH—C(═O)—
K24
J22
O


2-0067
—(CH2)3
—NH—C(═O)—
K24
J22
S


2-0068
—(CH2)3
—NH—C(═O)—
K24
J28
O


2-0069
—(CH2)3
—NH—C(═O)—
K24
J28
S


2-0070
—(CH2)3
—NH—C(═O)—
K24
J70
O


2-0071
—(CH2)3
—NH—C(═O)—
K24
J70
S


2-0072
—(CH2)3
—NH—C(═O)—
K28
J9
O


2-0073
—(CH2)3
—NH—C(═O)—
K29
J9
O


2-0074
—(CH2)3
—NH—C(═O)—
K30
J9
O


2-0075
—(CH2)3
—NH—C(═O)—
K31
J9
O


2-0076
—(CH2)3
—NH—C(═O)—
K34
J3
O


2-0077
—(CH2)3
—NH—C(═O)—
K34
J3
S


2-0078
—(CH2)3
—NH—C(═O)—
K34
J22
O


2-0079
—(CH2)3
—NH—C(═O)—
K34
J22
S


2-0080
—(CH2)3
—NH—C(═O)—
K34
J28
O


2-0081
—(CH2)3
—NH—C(═O)—
K34
J28
S


2-0082
—(CH2)3
—NH—C(═O)—
K34
J70
O


2-0083
—(CH2)3
—NH—C(═O)—
K34
J70
S


2-0084
—(CH2)3
—NH—C(═O)—
K36
J3
O


2-0085
—(CH2)3
—NH—C(═O)—
K36
J3
S


2-0086
—(CH2)3
—NH—C(═O)—
K36
J22
O


2-0087
—(CH2)3
—NH—C(═O)—
K36
J22
S


2-0088
—(CH2)3
—NH—C(═O)—
K36
J28
O


2-0089
—(CH2)3
—NH—C(═O)—
K36
J28
S


2-0090
—(CH2)3
—NH—C(═O)—
K36
J70
O


2-0091
—(CH2)3
—NH—C(═O)—
K36
J70
S


2-0092
—(CH2)3
—NH—C(═O)—
K49
J9
O


2-0093
—(CH2)3
—NH—C(═O)—
K71
J9
O


2-0094
—(CH2)3
—NH—C(═O)—
K72
J3
O


2-0095
—(CH2)3
—NH—C(═O)—
K72
J3
S


2-0096
—(CH2)3
—NH—C(═O)—
K72
J9
O





















TABLE 38








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0097
—(CH2)3
—NH—C(═O)—
K72
J22
O


2-0098
—(CH2)3
—NH—C(═O)—
K72
J22
S


2-0099
—(CH2)3
—NH—C(═O)—
K72
J28
O


2-0100
—(CH2)3
—NH—C(═O)—
K72
J28
S


2-0101
—(CH2)3
—NH—C(═O)—
K72
J70
O


2-0102
—(CH2)3
—NH—C(═O)—
K72
J70
S


2-0103
—(CH2)3
—NH—C(═O)—
K72
J103
O


2-0104
—(CH2)3
—NH—C(═O)—
K72
J103
S


2-0105
—(CH2)3
—NH—C(═O)—
K72
J120
O


2-0106
—(CH2)3
—NH—C(═O)—
K72
J120
S


2-0107
—(CH2)3
—NH—C(═O)—
K72
J122
O


2-0108
—(CH2)3
—NH—C(═O)—
K72
J122
S


2-0109
—(CH2)3
—NH—C(═O)—
K74
J3
O


2-0110
—(CH2)3
—NH—C(═O)—
K74
J3
S


2-0111
—(CH2)3
—NH—C(═O)—
K74
J22
O


2-0112
—(CH2)3
—NH—C(═O)—
K74
J22
S


2-0113
—(CH2)3
—NH—C(═O)—
K74
J28
O


2-0114
—(CH2)3
—NH—C(═O)—
K74
J28
S


2-0115
—(CH2)3
—NH—C(═O)—
K74
J70
O


2-0116
—(CH2)3
—NH—C(═O)—
K74
J70
S


2-0117
—(CH2)3
—NH—C(═O)—
K83
J9
O


2-0118
—(CH2)3
—NH—C(═O)—
K86
J3
O


2-0119
—(CH2)3
—NH—C(═O)—
K86
J3
S


2-0120
—(CH2)3
—NH—C(═O)—
K86
J22
O


2-0121
—(CH2)3
—NH—C(═O)—
K86
J22
S


2-0122
—(CH2)3
—NH—C(═O)—
K86
J28
O


2-0123
—(CH2)3
—NH—C(═O)—
K86
J28
S


2-0124
—(CH2)3
—NH—C(═O)—
K86
J70
O


2-0125
—(CH2)3
—NH—C(═O)—
K86
J70
S


2-0126
—(CH2)3
—NH—C(═O)—
K86
J103
O


2-0127
—(CH2)3
—NH—C(═O)—
K86
J103
S


2-0128
—(CH2)3
—NH—C(═O)—
K86
J120
O





















TABLE 39








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0129
—(CH2)3
—NH—C(═O)—
K86
J120
S


2-0130
—(CH2)3
—NH—C(═O)—
K86
J122
O


2-0131
—(CH2)3
—NH—C(═O)—
K86
J122
S


2-0132
—(CH2)3
—NH—C(═O)—
K91
J3
O


2-0133
—(CH2)3
—NH—C(═O)—
K91
J3
S


2-0134
—(CH2)3
—NH—C(═O)—
K91
J22
O


2-0135
—(CH2)3
—NH—C(═O)—
K91
J22
S


2-0136
—(CH2)3
—NH—C(═O)—
K91
J28
O


2-0137
—(CH2)3
—NH—C(═O)—
K91
J28
S


2-0138
—(CH2)3
—NH—C(═O)—
K91
J70
O


2-0139
—(CH2)3
—NH—C(═O)—
K91
J70
S


2-0140
—(CH2)3
—NH—C(═O)—
K91
J103
O


2-0141
—(CH2)3
—NH—C(═O)—
K91
J103
S


2-0142
—(CH2)3
—NH—C(═O)—
K91
J120
O


2-0143
—(CH2)3
—NH—C(═O)—
K91
J120
S


2-0144
—(CH2)3
—NH—C(═O)—
K91
J122
O


2-0145
—(CH2)3
—NH—C(═O)—
K91
J122
S


2-0146
—(CH2)3
—NH—C(═O)—
K100
J9
O


2-0147
—(CH2)3
—NH—C(═O)—
K106
J9
O


2-0148
—(CH2)3
—NH—C(═O)—
K114
J3
O


2-0149
—(CH2)3
—NH—C(═O)—
K114
J3
S


2-0150
—(CH2)3
—NH—C(═O)—
K114
J22
O


2-0151
—(CH2)3
—NH—C(═O)—
K114
J22
S


2-0152
—(CH2)3
—NH—C(═O)—
K114
J28
O


2-0153
—(CH2)3
—NH—C(═O)—
K114
J28
S


2-0154
—(CH2)3
—NH—C(═O)—
K114
J70
O


2-0155
—(CH2)3
—NH—C(═O)—
K114
J70
S


2-0156
—(CH2)3
—NH—C(═O)—
K127
J9
O


2-0157
—(CH2)4
—NH—C(═O)—
K8
J2
O


2-0158
—(CH2)4
—NH—C(═O)—
K8
J2
S


2-0159
—(CH2)4
—NH—C(═O)—
K8
J21
O


2-0160
—(CH2)4
—NH—C(═O)—
K8
J21
S





















TABLE 40








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X




















2-0161
—(CH2)4
—NH—C(═O)—
K8
J76
O


2-0162
—(CH2)4
—NH—C(═O)—
K8
J76
S


2-0163
—(CH2)4
—NH—C(═O)—
K15
J2
O


2-0164
—(CH2)4
—NH—C(═O)—
K15
J2
S


2-0165
—(CH2)4
—NH—C(═O)—
K15
J21
O


2-0166
—(CH2)4
—NH—C(═O)—
K15
J21
S


2-0167
—(CH2)4
—NH—C(═O)—
K15
J76
O


2-0168
—(CH2)4
—NH—C(═O)—
K15
J76
S


2-0169
—(CH2)4
—NH—C(═O)—
K37
J116
O


2-0170
—(CH2)4
—NH—C(═O)—
K37
J116
S


2-0171
—(CH2)4
—NH—C(═O)—
K37
J121
O


2-0172
—(CH2)4
—NH—C(═O)—
K37
J121
S


2-0173
—(CH2)4
—NH—C(═O)—
K37
J124
O


2-0174
—(CH2)4
—NH—C(═O)—
K37
J124
S


2-0175
—(CH2)4
—NH—C(═O)—
K63
J116
O


2-0176
—(CH2)4
—NH—C(═O)—
K63
J116
S


2-0177
—(CH2)4
—NH—C(═O)—
K63
J121
O


2-0178
—(CH2)4
—NH—C(═O)—
K63
J121
S


2-0179
—(CH2)4
—NH—C(═O)—
K63
J124
O


2-0180
—(CH2)4
—NH—C(═O)—
K63
J124
S


2-0181
—(CH2)4
—NH—C(═O)—
K79
J2
O


2-0182
—(CH2)4
—NH—C(═O)—
K79
J2
S


2-0183
—(CH2)4
—NH—C(═O)—
K79
J21
O


2-0184
—(CH2)4
—NH—C(═O)—
K79
J21
S


2-0185
—(CH2)4
—NH—C(═O)—
K79
J76
O


2-0186
—(CH2)4
—NH—C(═O)—
K79
J76
S


2-0187
—(CH2)4
—NH—C(═O)—
K91
J2
O


2-0188
—(CH2)4
—NH—C(═O)—
K91
J2
S


2-0189
—(CH2)4
—NH—C(═O)—
K91
J21
O


2-0190
—(CH2)4
—NH—C(═O)—
K91
J21
S


2-0191
—(CH2)4
—NH—C(═O)—
K91
J76
O


2-0192
—(CH2)4
—NH—C(═O)—
K91
J76
S





















TABLE 41








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







2-0193
—(CH2)4
—NH—C(═O)—
K111
J2
O


2-0194
—(CH2)4
—NH—C(═O)—
K111
J2
S


2-0195
—(CH2)4
—NH—C(═O)—
K111
J21
O


2-0196
—(CH2)4
—NH—C(═O)—
K111
J21
S


2-0197
—(CH2)4
—NH—C(═O)—
K111
J76
O


2-0198
—(CH2)4
—NH—C(═O)—
K111
J76
S


2-0199
—(CH2)2
—NH—C(═O)—O—
K5
J9
O


2-0200
—(CH2)2
—NH—C(═O)—O—
K24
J11
O


2-0201
—(CH2)2
—NH—C(═O)—O—
K24
J11
S


2-0202
—(CH2)2
—NH—C(═O)—O—
K24
J64
O


2-0203
—(CH2)2
—NH—C(═O)—O—
K24
J64
S


2-0204
—(CH2)2
—NH—C(═O)—O—
K116
J11
O


2-0205
—(CH2)2
—NH—C(═O)—O—
K116
J11
S


2-0206
—(CH2)2
—NH—C(═O)—O—
K116
J64
O


2-0207
—(CH2)2
—NH—C(═O)—O—
K116
J64
S


2-0208
—(CH2)3
—NH—C(═O)—O—
K5
J9
O


2-0209
—(CH2)3
—NH—C(═O)—O—
K34
J19
O


2-0210
—(CH2)3
—NH—C(═O)—O—
K34
J19
S


2-0211
—(CH2)3
—NH—C(═O)—O—
K34
J34
O


2-0212
—(CH2)3
—NH—C(═O)—O—
K34
J34
S


2-0213
—(CH2)3
—NH—C(═O)—O—
K91
J19
O


2-0214
—(CH2)3
—NH—C(═O)—O—
K91
J19
S


2-0215
—(CH2)3
—NH—C(═O)—O—
K91
J34
O


2-0216
—(CH2)3
—NH—C(═O)—O—
K91
J34
S


2-0217
—(CH2)4
—NH—C(═O)—O—
K35
J20
O


2-0218
—(CH2)4
—NH—C(═O)—O—
K35
J20
S


2-0219
—(CH2)4
—NH—C(═O)—O—
K35
J82
O


2-0220
—(CH2)4
—NH—C(═O)—O—
K35
J82
S


2-0221
—(CH2)4
—NH—C(═O)—O—
K94
J20
O


2-0222
—(CH2)4
—NH—C(═O)—O—
K94
J20
S


2-0223
—(CH2)4
—NH—C(═O)—O—
K94
J82
O


2-0224
—(CH2)4
—NH—C(═O)—O—
K94
J82
S





















TABLE 42








Com-







pound


-G1-A3-
-A5-


No.
-A1-
-A2-
A4-G2
R2
X







2-0225
—(CH2)2
—NH—C(═O)—NH—
K27
J26
O


2-0226
—(CH2)2
—NH—C(═O)—NH—
K27
J26
S


2-0227
—(CH2)2
—NH—C(═O)—NH—
K27
J31
O


2-0228
—(CH2)2
—NH—C(═O)—NH—
K27
J31
S


2-0229
—(CH2)2
—NH—C(═O)—NH—
K27
J73
O


2-0230
—(CH2)2
—NH—C(═O)—NH—
K27
J73
S


2-0231
—(CH2)2
—NH—C(═O)—NH—
K27
J119
O


2-0232
—(CH2)2
—NH—C(═O)—NH—
K27
J119
S


2-0233
—(CH2)2
—NH—C(═O)—NH—
K27
J123
O


2-0234
—(CH2)2
—NH—C(═O)—NH—
K27
J123
S


2-0235
—(CH2)2
—NH—C(═O)—NH—
K36
J26
O


2-0236
—(CH2)2
—NH—C(═O)—NH—
K36
J26
S


2-0237
—(CH2)2
—NH—C(═O)—NH—
K36
J31
O


2-0238
—(CH2)2
—NH—C(═O)—NH—
K36
J31
S


2-0239
—(CH2)2
—NH—C(═O)—NH—
K36
J73
O


2-0240
—(CH2)2
—NH—C(═O)—NH—
K36
J73
S


2-0241
—(CH2)2
—NH—C(═O)—NH—
K112
J119
O


2-0242
—(CH2)2
—NH—C(═O)—NH—
K112
J119
S


2-0243
—(CH2)2
—NH—C(═O)—NH—
K112
J123
O


2-0244
—(CH2)2
—NH—C(═O)—NH—
K112
J123
S


2-0245
—(CH2)2
—NH—C(═O)—NH—
K119
J26
O


2-0246
—(CH2)2
—NH—C(═O)—NH—
K119
J26
S


2-0247
—(CH2)2
—NH—C(═O)—NH—
K119
J31
O


2-0248
—(CH2)2
—NH—C(═O)—NH—
K119
J31
S


2-0249
—(CH2)2
—NH—C(═O)—NH—
K119
J73
O


2-0250
—(CH2)2
—NH—C(═O)—NH—
K119
J73
S


2-0251
—(CH2)3
—NH—C(═O)—NH—
K35
J3
O


2-0252
—(CH2)3
—NH—C(═O)—NH—
K35
J3
S


2-0253
—(CH2)3
—NH—C(═O)—NH—
K35
J22
O


2-0254
—(CH2)3
—NH—C(═O)—NH—
K35
J22
S


2-0255
—(CH2)3
—NH—C(═O)—NH—
K35
J34
O


2-0256
—(CH2)3
—NH—C(═O)—NH—
K35
J34
S





















TABLE 43








Com-







pound


-G1-A3-


No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0257
—(CH2)3
—NH—C(═O)—NH—
K36
J3
O


2-0258
—(CH2)3
—NH—C(═O)—NH—
K36
J3
S


2-0259
—(CH2)3
—NH—C(═O)—NH—
K36
J22
O


2-0260
—(CH2)3
—NH—C(═O)—NH—
K36
J22
S


2-0261
—(CH2)3
—NH—C(═O)—NH—
K36
J34
O


2-0262
—(CH2)3
—NH—C(═O)—NH—
K36
J34
S


2-0263
—(CH2)3
—NH—C(═O)—NH—
K73
J96
O


2-0264
—(CH2)3
—NH—C(═O)—NH—
K73
J96
S


2-0265
—(CH2)3
—NH—C(═O)—NH—
K73
J104
O


2-0266
—(CH2)3
—NH—C(═O)—NH—
K73
J104
S


2-0267
—(CH2)3
—NH—C(═O)—NH—
K73
J117
O


2-0268
—(CH2)3
—NH—C(═O)—NH—
K73
J117
S


2-0269
—(CH2)3
—NH—C(═O)—NH—
K79
J96
O


2-0270
—(CH2)3
—NH—C(═O)—NH—
K79
J96
S


2-0271
—(CH2)3
—NH—C(═O)—NH—
K79
J104
O


2-0272
—(CH2)3
—NH—C(═O)—NH—
K79
J104
S


2-0273
—(CH2)3
—NH—C(═O)—NH—
K79
J117
O


2-0274
—(CH2)3
—NH—C(═O)—NH—
K79
J117
S


2-0275
—(CH2)3
—NH—C(═O)—NH—
K91
J3
O


2-0276
—(CH2)3
—NH—C(═O)—NH—
K91
J3
S


2-0277
—(CH2)3
—NH—C(═O)—NH—
K91
J22
O


2-0278
—(CH2)3
—NH—C(═O)—NH—
K91
J22
S


2-0279
—(CH2)3
—NH—C(═O)—NH—
K91
J34
O


2-0280
—(CH2)3
—NH—C(═O)—NH—
K91
J34
S


2-0281
—(CH2)3
—NH—C(═O)—NH—
K96
J96
O


2-0282
—(CH2)3
—NH—C(═O)—NH—
K96
J96
S


2-0283
—(CH2)3
—NH—C(═O)—NH—
K96
J104
O


2-0284
—(CH2)3
—NH—C(═O)—NH—
K96
J104
S


2-0285
—(CH2)3
—NH—C(═O)—NH—
K96
J117
O


2-0286
—(CH2)3
—NH—C(═O)—NH—
K96
J117
S


2-0287
—(CH2)3
—NH—C(═O)—NH—
K114
J3
O


2-0288
—(CH2)3
—NH—C(═O)—NH—
K114
J3
S





















TABLE 44








Com-







pound


-G1-A3-


No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0289
—(CH2)3
—NH—C(═O)—NH—
K114
J22
O


2-0290
—(CH2)3
—NH—C(═O)—NH—
K114
J22
S


2-0291
—(CH2)3
—NH—C(═O)—NH—
K114
J34
O


2-0292
—(CH2)3
—NH—C(═O)—NH—
K114
J34
S


2-0293
—(CH2)4
—NH—C(═O)—NH—
K15
J123
O


2-0294
—(CH2)4
—NH—C(═O)—NH—
K15
J123
S


2-0295
—(CH2)4
—NH—C(═O)—NH—
K15
J125
O


2-0296
—(CH2)4
—NH—C(═O)—NH—
K15
J125
S


2-0297
—(CH2)4
—NH—C(═O)—NH—
K24
J4
O


2-0298
—(CH2)4
—NH—C(═O)—NH—
K24
J4
S


2-0299
—(CH2)4
—NH—C(═O)—NH—
K24
J35
O


2-0300
—(CH2)4
—NH—C(═O)—NH—
K24
J35
S


2-0301
—(CH2)4
—NH—C(═O)—NH—
K24
J96
O


2-0302
—(CH2)4
—NH—C(═O)—NH—
K24
J96
S


2-0303
—(CH2)4
—NH—C(═O)—NH—
K106
J123
O


2-0304
—(CH2)4
—NH—C(═O)—NH—
K106
J123
S


2-0305
—(CH2)4
—NH—C(═O)—NH—
K106
J125
O


2-0306
—(CH2)4
—NH—C(═O)—NH—
K106
J125
S


2-0307
—(CH2)4
—NH—C(═O)—NH—
K109
J4
O


2-0308
—(CH2)4
—NH—C(═O)—NH—
K109
J4
S


2-0309
—(CH2)4
—NH—C(═O)—NH—
K109
J35
O


2-0310
—(CH2)4
—NH—C(═O)—NH—
K109
J35
S


2-0311
—(CH2)4
—NH—C(═O)—NH—
K109
J96
O


2-0312
—(CH2)4
—NH—C(═O)—NH—
K109
J96
S


2-0313
—(CH2)4
—NH—C(═O)—NH—
K120
J4
O


2-0314
—(CH2)4
—NH—C(═O)—NH—
K120
J4
S


2-0315
—(CH2)4
—NH—C(═O)—NH—
K120
J35
O


2-0316
—(CH2)4
—NH—C(═O)—NH—
K120
J35
S


2-0317
—(CH2)4
—NH—C(═O)—NH—
K120
J96
O


2-0318
—(CH2)4
—NH—C(═O)—NH—
K120
J96
S


2-0319
—(CH2)2
—NH—
K781
J2
O


2-0320
—(CH2)2
—NH—
K781
J2
S





















TABLE 45








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







2-0321
—(CH2)2
—NH—
K781
J24
O


2-0322
—(CH2)2
—NH—
K781
J24
S


2-0323
—(CH2)2
—NH—
K781
J79
O


2-0324
—(CH2)2
—NH—
K781
J79
S


2-0325
—(CH2)2
—NH—
K782
J2
O


2-0326
—(CH2)2
—NH—
K782
J2
S


2-0327
—(CH2)2
—NH—
K782
J24
O


2-0328
—(CH2)2
—NH—
K782
J24
S


2-0329
—(CH2)2
—NH—
K782
J79
O


2-0330
—(CH2)2
—NH—
K782
J79
S


2-0331
—(CH2)2
—NH—
K783
J96
O


2-0332
—(CH2)2
—NH—
K783
J96
S


2-0333
—(CH2)2
—NH—
K783
J104
O


2-0334
—(CH2)2
—NH—
K783
J104
S


2-0335
—(CH2)2
—NH—
K783
J117
O


2-0336
—(CH2)2
—NH—
K783
J117
S


2-0337
—(CH2)2
—NH—
K784
J2
O


2-0338
—(CH2)2
—NH—
K784
J2
S


2-0339
—(CH2)2
—NH—
K784
J24
O


2-0340
—(CH2)2
—NH—
K784
J24
S


2-0341
—(CH2)2
—NH—
K784
J79
O


2-0342
—(CH2)2
—NH—
K784
J79
S


2-0343
—(CH2)2
—NH—
K785
J2
O


2-0344
—(CH2)2
—NH—
K785
J2
S


2-0345
—(CH2)2
—NH—
K785
J24
O


2-0346
—(CH2)2
—NH—
K785
J24
S


2-0347
—(CH2)2
—NH—
K785
J79
O


2-0348
—(CH2)2
—NH—
K785
J79
S


2-0349
—(CH2)2
—NH—
K786
J96
O


2-0350
—(CH2)2
—NH—
K786
J96
S


2-0351
—(CH2)2
—NH—
K786
J104
O


2-0352
—(CH2)2
—NH—
K786
J104
S





















TABLE 46








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







2-0353
—(CH2)2
—NH—
K786
J117
O


2-0354
—(CH2)2
—NH—
K786
J117
S


2-0355
—(CH2)2
—NH—
K787
J96
O


2-0356
—(CH2)2
—NH—
K787
J96
S


2-0357
—(CH2)2
—NH—
K787
J104
O


2-0358
—(CH2)2
—NH—
K787
J104
S


2-0359
—(CH2)2
—NH—
K787
J117
O


2-0360
—(CH2)2
—NH—
K787
J117
S


2-0361
—(CH2)3
—NH—
K662
J22
O


2-0362
—(CH2)3
—NH—
K662
J22
S


2-0363
—(CH2)3
—NH—
K662
J28
O


2-0364
—(CH2)3
—NH—
K662
J28
S


2-0365
—(CH2)3
—NH—
K662
J76
O


2-0366
—(CH2)3
—NH—
K662
J76
S


2-0367
—(CH2)3
—NH—
K782
J22
O


2-0368
—(CH2)3
—NH—
K782
J22
S


2-0369
—(CH2)3
—NH—
K782
J28
O


2-0370
—(CH2)3
—NH—
K782
J28
S


2-0371
—(CH2)3
—NH—
K782
J76
O


2-0372
—(CH2)3
—NH—
K782
J76
S


2-0373
—(CH2)3
—NH—
K111
J116
O


2-0374
—(CH2)3
—NH—
K111
J116
S


2-0375
—(CH2)3
—NH—
K111
J121
O


2-0376
—(CH2)3
—NH—
K111
J121
S


2-0377
—(CH2)3
—NH—
K111
J124
O


2-0378
—(CH2)3
—NH—
K111
J124
S


2-0379
—(CH2)3
—NH—
K788
J22
O


2-0380
—(CH2)3
—NH—
K788
J22
S


2-0381
—(CH2)3
—NH—
K788
J28
O


2-0382
—(CH2)3
—NH—
K788
J28
S


2-0383
—(CH2)3
—NH—
K788
J76
O


2-0384
—(CH2)3
—NH—
K788
J76
S





















TABLE 47








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







2-0385
—(CH2)3
—NH—
K789
J116
O


2-0386
—(CH2)3
—NH—
K789
J116
S


2-0387
—(CH2)3
—NH—
K789
J121
O


2-0388
—(CH2)3
—NH—
K789
J121
S


2-0389
—(CH2)3
—NH—
K789
J124
O


2-0390
—(CH2)3
—NH—
K789
J124
S


2-0391
—(CH2)3
—NH—
K790
J22
O


2-0392
—(CH2)3
—NH—
K790
J22
S


2-0393
—(CH2)3
—NH—
K790
J28
O


2-0394
—(CH2)3
—NH—
K790
J28
S


2-0395
—(CH2)3
—NH—
K790
J76
O


2-0396
—(CH2)3
—NH—
K790
J76
S


2-0397
—(CH2)3
—NH—
K791
J22
O


2-0398
—(CH2)3
—NH—
K791
J22
S


2-0399
—(CH2)3
—NH—
K791
J28
O


2-0400
—(CH2)3
—NH—
K791
J28
S


2-0401
—(CH2)3
—NH—
K791
J76
O


2-0402
—(CH2)3
—NH—
K791
J76
S


2-0403
—(CH2)3
—NH—
K791
J116
O


2-0404
—(CH2)3
—NH—
K791
J116
S


2-0405
—(CH2)3
—NH—
K791
J121
O


2-0406
—(CH2)3
—NH—
K791
J121
S


2-0407
—(CH2)3
—NH—
K791
J124
O


2-0408
—(CH2)3
—NH—
K791
J124
S


2-0409
—(CH2)3
—NH—
K792
J22
O


2-0410
—(CH2)3
—NH—
K792
J22
S


2-0411
—(CH2)3
—NH—
K792
J28
O


2-0412
—(CH2)3
—NH—
K792
J28
S


2-0413
—(CH2)3
—NH—
K792
J76
O


2-0414
—(CH2)3
—NH—
K792
J76
S


2-0415
—(CH2)3
—NH—
K786
J22
O


2-0416
—(CH2)3
—NH—
K786
J22
S





















TABLE 48








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







2-0417
—(CH2)3
—NH—
K786
J28
O


2-0418
—(CH2)3
—NH—
K786
J28
S


2-0419
—(CH2)3
—NH—
K786
J76
O


2-0420
—(CH2)3
—NH—
K786
J76
S


2-0421
—(CH2)3
—NH—
K793
J22
O


2-0422
—(CH2)3
—NH—
K793
J22
S


2-0423
—(CH2)3
—NH—
K793
J28
O


2-0424
—(CH2)3
—NH—
K793
J28
S


2-0425
—(CH2)3
—NH—
K793
J76
O


2-0426
—(CH2)3
—NH—
K793
J76
S


2-0427
—(CH2)4
—NH—
K695
J16
O


2-0428
—(CH2)4
—NH—
K695
J16
S


2-0429
—(CH2)4
—NH—
K695
J37
O


2-0430
—(CH2)4
—NH—
K695
J37
S


2-0431
—(CH2)4
—NH—
K695
J87
O


2-0432
—(CH2)4
—NH—
K695
J87
S


2-0433
—(CH2)4
—NH—
K101
J16
O


2-0434
—(CH2)4
—NH—
K101
J16
S


2-0435
—(CH2)4
—NH—
K101
J37
O


2-0436
—(CH2)4
—NH—
K101
J37
S


2-0437
—(CH2)4
—NH—
K101
J87
O


2-0438
—(CH2)4
—NH—
K101
J87
S


2-0439
—(CH2)4
—NH—
K666
J120
O


2-0440
—(CH2)4
—NH—
K666
J120
S


2-0441
—(CH2)4
—NH—
K666
J122
O


2-0442
—(CH2)4
—NH—
K666
J122
S


2-0443
—(CH2)4
—NH—
K107
J120
O


2-0444
—(CH2)4
—NH—
K107
J120
S


2-0445
—(CH2)4
—NH—
K107
J122
O


2-0446
—(CH2)4
—NH—
K107
J122
S


2-0447
—(CH2)4
—NH—
K794
J16
O


2-0448
—(CH2)4
—NH—
K794
J16
S





















TABLE 49








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0449
—(CH2)4
—NH—
K794
J37
O


2-0450
—(CH2)4
—NH—
K794
J37
S


2-0451
—(CH2)4
—NH—
K794
J87
O


2-0452
—(CH2)4
—NH—
K794
J87
S


2-0453
—(CH2)4
—NH—
K791
J16
O


2-0454
—(CH2)4
—NH—
K791
J16
S


2-0455
—(CH2)4
—NH—
K791
J37
O


2-0456
—(CH2)4
—NH—
K791
J37
S


2-0457
—(CH2)4
—NH—
K791
J87
O


2-0458
—(CH2)4
—NH—
K791
J87
S


2-0459
—(CH2)2
—NH—S(═O)2
K13
J30
O


2-0460
—(CH2)2
—NH—S(═O)2
K13
J30
S


2-0461
—(CH2)2
—NH—S(═O)2
K13
J72
O


2-0462
—(CH2)2
—NH—S(═O)2
K13
J72
S


2-0463
—(CH2)2
—NH—S(═O)2
K34
J3
O


2-0464
—(CH2)2
—NH—S(═O)2
K34
J3
S


2-0465
—(CH2)2
—NH—S(═O)2
K36
J30
O


2-0466
—(CH2)2
—NH—S(═O)2
K36
J30
S


2-0467
—(CH2)2
—NH—S(═O)2
K36
J72
O


2-0468
—(CH2)2
—NH—S(═O)2
K36
J72
S


2-0469
—(CH2)2
—NH—S(═O)2
K109
J30
O


2-0470
—(CH2)2
—NH—S(═O)2
K109
J30
S


2-0471
—(CH2)2
—NH—S(═O)2
K109
J72
O


2-0472
—(CH2)2
—NH—S(═O)2
K109
J72
S


2-0473
—(CH2)3
—NH—S(═O)2
K34
J28
O


2-0474
—(CH2)3
—NH—S(═O)2
K34
J28
S


2-0475
—(CH2)3
—NH—S(═O)2
K34
J64
O


2-0476
—(CH2)3
—NH—S(═O)2
K34
J64
S


2-0477
—(CH2)3
—NH—S(═O)2
K73
J3
O


2-0478
—(CH2)3
—NH—S(═O)2
K73
J3
S


2-0479
—(CH2)3
—NH—S(═O)2
K73
J28
O


2-0480
—(CH2)3
—NH—S(═O)2
K73
J28
S





















TABLE 50








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0481
—(CH2)3
—NH—S(═O)2
K73
J64
O


2-0482
—(CH2)3
—NH—S(═O)2
K73
J64
S


2-0483
—(CH2)3
—NH—S(═O)2
K107
J3
O


2-0484
—(CH2)3
—NH—S(═O)2
K107
J3
S


2-0485
—(CH2)3
—NH—S(═O)2
K107
J28
O


2-0486
—(CH2)3
—NH—S(═O)2
K107
J28
S


2-0487
—(CH2)3
—NH—S(═O)2
K107
J64
O


2-0488
—(CH2)3
—NH—S(═O)2
K107
J64
S


2-0489
—(CH2)3
—NH—S(═O)2
K114
J3
O


2-0490
—(CH2)3
—NH—S(═O)2
K114
J3
S


2-0491
—(CH2)3
—NH—S(═O)2
K114
J28
O


2-0492
—(CH2)3
—NH—S(═O)2
K114
J28
S


2-0493
—(CH2)3
—NH—S(═O)2
K114
J64
O


2-0494
—(CH2)3
—NH—S(═O)2
K114
J64
S


2-0495
—(CH2)4
—NH—S(═O)2
K15
J27
O


2-0496
—(CH2)4
—NH—S(═O)2
K15
J27
S


2-0497
—(CH2)4
—NH—S(═O)2
K15
J89
O


2-0498
—(CH2)4
—NH—S(═O)2
K15
J89
S


2-0499
—(CH2)4
—NH—S(═O)2
K79
J27
O


2-0500
—(CH2)4
—NH—S(═O)2
K79
J27
S


2-0501
—(CH2)4
—NH—S(═O)2
K79
J89
O


2-0502
—(CH2)4
—NH—S(═O)2
K79
J89
S


2-0503
—(CH2)4
—NH—S(═O)2
K106
J27
O


2-0504
—(CH2)4
—NH—S(═O)2
K106
J27
S


2-0505
—(CH2)4
—NH—S(═O)2
K106
J89
O


2-0506
—(CH2)4
—NH—S(═O)2
K106
J89
S


2-0507
—(CH2)2
—O—C(═O)—
K1
J9
O


2-0508
—(CH2)2
—O—C(═O)—
K11
J9
O


2-0509
—(CH2)2
—O—C(═O)—
K13
J9
O


2-0510
—(CH2)2
—O—C(═O)—
K24
J2
O


2-0511
—(CH2)2
—O—C(═O)—
K24
J2
S


2-0512
—(CH2)2
—O—C(═O)—
K24
J27
O





















TABLE 51








Compound


-G1-




No.
-A1-
-A2-
A3-A4-G2
-A5-R2
X







2-0513
—(CH2)2
—O—C(═O)—
K24
J27
S


2-0514
—(CH2)2
—O—C(═O)—
K49
J9
O


2-0515
—(CH2)2
—O—C(═O)—
K109
J2
O


2-0516
—(CH2)2
—O—C(═O)—
K109
J2
S


2-0517
—(CH2)2
—O—C(═O)—
K109
J27
O


2-0518
—(CH2)2
—O—C(═O)—
K109
J27
S


2-0519
—(CH2)3
—O—C(═O)—
K1
J9
O


2-0520
—(CH2)3
—O—C(═O)—
K7
J9
O


2-0521
—(CH2)3
—O—C(═O)—
K11
J9
O


2-0522
—(CH2)3
—O—C(═O)—
K12
J9
O


2-0523
—(CH2)3
—O—C(═O)—
K13
J9
O


2-0524
—(CH2)3
—O—C(═O)—
K14
J9
O


2-0525
—(CH2)3
—O—C(═O)—
K28
J9
O


2-0526
—(CH2)3
—O—C(═O)—
K30
J9
O


2-0527
—(CH2)3
—O—C(═O)—
K31
J9
O


2-0528
—(CH2)3
—O—C(═O)—
K24
J9
O


2-0529
—(CH2)3
—O—C(═O)—
K49
J9
O


2-0530
—(CH2)3
—O—C(═O)—
K60
J9
O


2-0531
—(CH2)3
—O—C(═O)—
K62
J9
O


2-0532
—(CH2)3
—O—C(═O)—
K63
J43
O


2-0533
—(CH2)3
—O—C(═O)—
K63
J43
S


2-0534
—(CH2)3
—O—C(═O)—
K63
J82
O


2-0535
—(CH2)3
—O—C(═O)—
K63
J82
S


2-0536
—(CH2)3
—O—C(═O)—
K71
J9
O


2-0537
—(CH2)3
—O—C(═O)—
K72
J9
O


2-0538
—(CH2)3
—O—C(═O)—
K82
J9
O


2-0539
—(CH2)3
—O—C(═O)—
K83
J9
O


2-0540
—(CH2)3
—O—C(═O)—
K88
J43
O


2-0541
—(CH2)3
—O—C(═O)—
K88
J43
S


2-0542
—(CH2)3
—O—C(═O)—
K88
J82
O


2-0543
—(CH2)3
—O—C(═O)—
K88
J82
S


2-0544
—(CH2)4
—O—C(═O)—
K23
J28
O





















TABLE 52








Compound


-G1-
-A5-



No.
-A1-
-A2-
A3-A4-G2
R2
X







2-0545
—(CH2)4
—O—C(═O)—
K23
J28
S


2-0546
—(CH2)4
—O—C(═O)—
K23
J84
O


2-0547
—(CH2)4
—O—C(═O)—
K23
J84
S


2-0548
—(CH2)4
—O—C(═O)—
K73
J28
O


2-0549
—(CH2)4
—O—C(═O)—
K73
J28
S


2-0550
—(CH2)4
—O—C(═O)—
K73
J84
O


2-0551
—(CH2)4
—O—C(═O)—
K73
J84
S


2-0552
—(CH2)2
—NH—C(═O)—
K1
J9
S


2-0553
—(CH2)2
—NH—C(═O)—
K1
J126
S


2-0554
—(CH2)2
—NH—C(═O)—
K1
J129
S


2-0555
—(CH2)2
—NH—C(═O)—
K1
J130
S


2-0556
—(CH2)2
—NH—C(═O)—
K1
J138
S


2-0557
—(CH2)2
—NH—C(═O)—
K103
J9
S


2-0558
—(CH2)2
—NH—C(═O)—
K11
J9
S


2-0559
—(CH2)2
—NH—C(═O)—
K11
J126
S


2-0560
—(CH2)2
—NH—C(═O)—
K11
J129
S


2-0561
—(CH2)2
—NH—C(═O)—
K11
J130
S


2-0562
—(CH2)2
—NH—C(═O)—
K11
J138
S


2-0563
—(CH2)2
—NH—C(═O)—
K12
J9
S


2-0564
—(CH2)2
—NH—C(═O)—
K12
J126
S


2-0565
—(CH2)2
—NH—C(═O)—
K12
J129
S


2-0566
—(CH2)2
—NH—C(═O)—
K12
J130
S


2-0567
—(CH2)2
—NH—C(═O)—
K12
J138
S


2-0568
—(CH2)2
—NH—C(═O)—
K13
J9
S


2-0569
—(CH2)2
—NH—C(═O)—
K13
J126
S


2-0570
—(CH2)2
—NH—C(═O)—
K13
J129
S


2-0571
—(CH2)2
—NH—C(═O)—
K13
J130
S


2-0572
—(CH2)2
—NH—C(═O)—
K13
J138
S


2-0573
—(CH2)2
—NH—C(═O)—
K14
J9
S


2-0574
—(CH2)2
—NH—C(═O)—
K14
J126
S


2-0575
—(CH2)2
—NH—C(═O)—
K14
J129
S


2-0576
—(CH2)2
—NH—C(═O)—
K14
J130
S





















TABLE 53








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







2-0577
—(CH2)2
—NH—C(═O)—
K14
J138
S


2-0578
—(CH2)2
—NH—C(═O)—
K15
J9
S


2-0579
—(CH2)2
—NH—C(═O)—
K15
J126
S


2-0580
—(CH2)2
—NH—C(═O)—
K15
J129
S


2-0581
—(CH2)2
—NH—C(═O)—
K15
J130
S


2-0582
—(CH2)2
—NH—C(═O)—
K15
J138
S


2-0583
—(CH2)2
—NH—C(═O)—
K16
J9
S


2-0584
—(CH2)2
—NH—C(═O)—
K17
J9
S


2-0585
—(CH2)2
—NH—C(═O)—
K18
J9
S


2-0586
—(CH2)2
—NH—C(═O)—
K19
J9
S


2-0587
—(CH2)2
—NH—C(═O)—
K20
J9
S


2-0588
—(CH2)2
—NH—C(═O)—
K21
J9
S


2-0589
—(CH2)2
—NH—C(═O)—
K22
J9
S


2-0590
—(CH2)2
—NH—C(═O)—
K23
J9
S


2-0591
—(CH2)2
—NH—C(═O)—
K23
J126
S


2-0592
—(CH2)2
—NH—C(═O)—
K23
J129
S


2-0593
—(CH2)2
—NH—C(═O)—
K23
J130
S


2-0594
—(CH2)2
—NH—C(═O)—
K23
J138
S


2-0595
—(CH2)2
—NH—C(═O)—
K24
J9
S


2-0596
—(CH2)2
—NH—C(═O)—
K24
J126
S


2-0597
—(CH2)2
—NH—C(═O)—
K24
J129
S


2-0598
—(CH2)2
—NH—C(═O)—
K24
J130
S


2-0599
—(CH2)2
—NH—C(═O)—
K24
J138
S


2-0600
—(CH2)2
—NH—C(═O)—
K241
J9
S


2-0601
—(CH2)2
—NH—C(═O)—
K241
J126
S


2-0602
—(CH2)2
—NH—C(═O)—
K241
J129
S


2-0603
—(CH2)2
—NH—C(═O)—
K241
J130
S


2-0604
—(CH2)2
—NH—C(═O)—
K241
J138
S


2-0605
—(CH2)2
—NH—C(═O)—
K241
J14
S


2-0606
—(CH2)2
—NH—C(═O)—
K241
J150
S


2-0607
—(CH2)2
—NH—C(═O)—
K242
J9
S


2-0608
—(CH2)2
—NH—C(═O)—
K242
J126
S





















TABLE 54








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







2-0609
—(CH2)2
—NH—C(═O)—
K242
J129
S


2-0610
—(CH2)2
—NH—C(═O)—
K242
J130
S


2-0611
—(CH2)2
—NH—C(═O)—
K242
J138
S


2-0612
—(CH2)2
—NH—C(═O)—
K242
J16
S


2-0613
—(CH2)2
—NH—C(═O)—
K242
J151
S


2-0614
—(CH2)2
—NH—C(═O)—
K243
J9
S


2-0615
—(CH2)2
—NH—C(═O)—
K243
J126
S


2-0616
—(CH2)2
—NH—C(═O)—
K243
J129
S


2-0617
—(CH2)2
—NH—C(═O)—
K243
J130
S


2-0618
—(CH2)2
—NH—C(═O)—
K243
J138
S


2-0619
—(CH2)2
—NH—C(═O)—
K243
J16
S


2-0620
—(CH2)2
—NH—C(═O)—
K243
J151
S


2-0621
—(CH2)2
—NH—C(═O)—
K244
J9
S


2-0622
—(CH2)2
—NH—C(═O)—
K244
J126
S


2-0623
—(CH2)2
—NH—C(═O)—
K244
J129
S


2-0624
—(CH2)2
—NH—C(═O)—
K244
J130
S


2-0625
—(CH2)2
—NH—C(═O)—
K244
J138
S


2-0626
—(CH2)2
—NH—C(═O)—
K244
J19
S


2-0627
—(CH2)2
—NH—C(═O)—
K244
J152
S


2-0628
—(CH2)2
—NH—C(═O)—
K245
J9
S


2-0629
—(CH2)2
—NH—C(═O)—
K245
J126
S


2-0630
—(CH2)2
—NH—C(═O)—
K245
J129
S


2-0631
—(CH2)2
—NH—C(═O)—
K245
J130
S


2-0632
—(CH2)2
—NH—C(═O)—
K245
J138
S


2-0633
—(CH2)2
—NH—C(═O)—
K245
J19
S


2-0634
—(CH2)2
—NH—C(═O)—
K245
J152
S


2-0635
—(CH2)2
—NH—C(═O)—
K246
J9
S


2-0636
—(CH2)2
—NH—C(═O)—
K246
J126
S


2-0637
—(CH2)2
—NH—C(═O)—
K246
J129
S


2-0638
—(CH2)2
—NH—C(═O)—
K246
J130
S


2-0639
—(CH2)2
—NH—C(═O)—
K246
J138
S


2-0640
—(CH2)2
—NH—C(═O)—
K246
J22
S





















TABLE 55








Compound


-G1-A3
-A5-



No.
-A1-
-A2-
-A4-G2
R2
X







2-0641
—(CH2)2
—NH—C(═O)—
K246
J153
S


2-0642
—(CH2)2
—NH—C(═O)—
K247
J9
S


2-0643
—(CH2)2
—NH—C(═O)—
K247
J126
S


2-0644
—(CH2)2
—NH—C(═O)—
K247
J129
S


2-0645
—(CH2)2
—NH—C(═O)—
K247
J130
S


2-0646
—(CH2)2
—NH—C(═O)—
K247
J138
S


2-0647
—(CH2)2
—NH—C(═O)—
K247
J22
S


2-0648
—(CH2)2
—NH—C(═O)—
K247
J153
S


2-0649
—(CH2)2
—NH—C(═O)—
K248
J9
S


2-0650
—(CH2)2
—NH—C(═O)—
K248
J126
S


2-0651
—(CH2)2
—NH—C(═O)—
K248
J129
S


2-0652
—(CH2)2
—NH—C(═O)—
K248
J130
S


2-0653
—(CH2)2
—NH—C(═O)—
K248
J138
S


2-0654
—(CH2)2
—NH—C(═O)—
K248
J25
S


2-0655
—(CH2)2
—NH—C(═O)—
K248
J154
S


2-0656
—(CH2)2
—NH—C(═O)—
K249
J9
S


2-0657
—(CH2)2
—NH—C(═O)—
K249
J126
S


2-0658
—(CH2)2
—NH—C(═O)—
K249
J129
S


2-0659
—(CH2)2
—NH—C(═O)—
K249
J130
S


2-0660
—(CH2)2
—NH—C(═O)—
K249
J138
S


2-0661
—(CH2)2
—NH—C(═O)—
K249
J25
S


2-0662
—(CH2)2
—NH—C(═O)—
K249
J154
S


2-0663
—(CH2)2
—NH—C(═O)—
K25
J9
S


2-0664
—(CH2)2
—NH—C(═O)—
K250
J9
S


2-0665
—(CH2)2
—NH—C(═O)—
K250
J126
S


2-0666
—(CH2)2
—NH—C(═O)—
K250
J129
S


2-0667
—(CH2)2
—NH—C(═O)—
K250
J130
S


2-0668
—(CH2)2
—NH—C(═O)—
K250
J138
S


2-0669
—(CH2)2
—NH—C(═O)—
K250
J26
S


2-0670
—(CH2)2
—NH—C(═O)—
K250
J155
S


2-0671
—(CH2)2
—NH—C(═O)—
K251
J9
S


2-0672
—(CH2)2
—NH—C(═O)—
K251
J126
S





















TABLE 56








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







2-0673
—(CH2)2
—NH—C(═O)—
K251
J129
S


2-0674
—(CH2)2
—NH—C(═O)—
K251
J130
S


2-0675
—(CH2)2
—NH—C(═O)—
K251
J138
S


2-0676
—(CH2)2
—NH—C(═O)—
K251
J26
S


2-0677
—(CH2)2
—NH—C(═O)—
K251
J155
S


2-0678
—(CH2)2
—NH—C(═O)—
K252
J9
S


2-0679
—(CH2)2
—NH—C(═O)—
K253
J9
S


2-0680
—(CH2)2
—NH—C(═O)—
K254
J9
S


2-0681
—(CH2)2
—NH—C(═O)—
K26
J9
S


2-0682
—(CH2)2
—NH—C(═O)—
K27
J9
S


2-0683
—(CH2)2
—NH—C(═O)—
K27
J126
S


2-0684
—(CH2)2
—NH—C(═O)—
K27
J129
S


2-0685
—(CH2)2
—NH—C(═O)—
K27
J130
S


2-0686
—(CH2)2
—NH—C(═O)—
K27
J138
S


2-0687
—(CH2)2
—NH—C(═O)—
K28
J9
S


2-0688
—(CH2)2
—NH—C(═O)—
K282
J9
S


2-0689
—(CH2)2
—NH—C(═O)—
K282
J126
S


2-0690
—(CH2)2
—NH—C(═O)—
K282
J129
S


2-0691
—(CH2)2
—NH—C(═O)—
K282
J130
S


2-0692
—(CH2)2
—NH—C(═O)—
K282
J138
S


2-0693
—(CH2)2
—NH—C(═O)—
K283
J9
S


2-0694
—(CH2)2
—NH—C(═O)—
K283
J126
S


2-0695
—(CH2)2
—NH—C(═O)—
K283
J129
S


2-0696
—(CH2)2
—NH—C(═O)—
K283
J130
S


2-0697
—(CH2)2
—NH—C(═O)—
K283
J138
S


2-0698
—(CH2)2
—NH—C(═O)—
K284
J9
S


2-0699
—(CH2)2
—NH—C(═O)—
K284
J126
S


2-0700
—(CH2)2
—NH—C(═O)—
K284
J129
S


2-0701
—(CH2)2
—NH—C(═O)—
K284
J130
S


2-0702
—(CH2)2
—NH—C(═O)—
K284
J138
S


2-0703
—(CH2)2
—NH—C(═O)—
K285
J9
S


2-0704
—(CH2)2
—NH—C(═O)—
K286
J9
S





















TABLE 57








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0705
—(CH2)2
—NH—C(═O)—
K287
J9
S


2-0706
—(CH2)2
—NH—C(═O)—
K288
J9
S


2-0707
—(CH2)2
—NH—C(═O)—
K289
J9
S


2-0708
—(CH2)2
—NH—C(═O)—
K29
J9
S


2-0709
—(CH2)2
—NH—C(═O)—
K290
J9
S


2-0710
—(CH2)2
—NH—C(═O)—
K291
J9
S


2-0711
—(CH2)2
—NH—C(═O)—
K292
J9
S


2-0712
—(CH2)2
—NH—C(═O)—
K292
J28
S


2-0713
—(CH2)2
—NH—C(═O)—
K292
J156
S


2-0714
—(CH2)2
—NH—C(═O)—
K293
J9
S


2-0715
—(CH2)2
—NH—C(═O)—
K294
J9
S


2-0716
—(CH2)2
—NH—C(═O)—
K295
J9
S


2-0717
—(CH2)2
—NH—C(═O)—
K295
J28
S


2-0718
—(CH2)2
—NH—C(═O)—
K295
J156
S


2-0719
—(CH2)2
—NH—C(═O)—
K296
J9
S


2-0720
—(CH2)2
—NH—C(═O)—
K296
J126
S


2-0721
—(CH2)2
—NH—C(═O)—
K296
J129
S


2-0722
—(CH2)2
—NH—C(═O)—
K296
J130
S


2-0723
—(CH2)2
—NH—C(═O)—
K296
J138
S


2-0724
—(CH2)2
—NH—C(═O)—
K297
J9
S


2-0725
—(CH2)2
—NH—C(═O)—
K297
J126
S


2-0726
—(CH2)2
—NH—C(═O)—
K297
J129
S


2-0727
—(CH2)2
—NH—C(═O)—
K297
J130
S


2-0728
—(CH2)2
—NH—C(═O)—
K297
J138
S


2-0729
—(CH2)2
—NH—C(═O)—
K298
J9
S


2-0730
—(CH2)2
—NH—C(═O)—
K299
J9
S


2-0731
—(CH2)2
—NH—C(═O)—
K30
J9
S


2-0732
—(CH2)2
—NH—C(═O)—
K300
J9
S


2-0733
—(CH2)2
—NH—C(═O)—
K300
J29
S


2-0734
—(CH2)2
—NH—C(═O)—
K300
J157
S


2-0735
—(CH2)2
—NH—C(═O)—
K301
J9
S


2-0736
—(CH2)2
—NH—C(═O)—
K301
J29
S





















TABLE 58








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0737
—(CH2)2
—NH—C(═O)—
K301
J157
S


2-0738
—(CH2)2
—NH—C(═O)—
K303
J9
S


2-0739
—(CH2)2
—NH—C(═O)—
K304
J9
S


2-0740
—(CH2)2
—NH—C(═O)—
K305
J9
S


2-0741
—(CH2)2
—NH—C(═O)—
K305
J126
S


2-0742
—(CH2)2
—NH—C(═O)—
K305
J129
S


2-0743
—(CH2)2
—NH—C(═O)—
K305
J130
S


2-0744
—(CH2)2
—NH—C(═O)—
K305
J138
S


2-0745
—(CH2)2
—NH—C(═O)—
K305
J31
S


2-0746
—(CH2)2
—NH—C(═O)—
K305
J158
S


2-0747
—(CH2)2
—NH—C(═O)—
K306
J9
S


2-0748
—(CH2)2
—NH—C(═O)—
K306
J126
S


2-0749
—(CH2)2
—NH—C(═O)—
K306
J129
S


2-0750
—(CH2)2
—NH—C(═O)—
K306
J130
S


2-0751
—(CH2)2
—NH—C(═O)—
K306
J138
S


2-0752
—(CH2)2
—NH—C(═O)—
K306
J31
S


2-0753
—(CH2)2
—NH—C(═O)—
K306
J158
S


2-0754
—(CH2)2
—NH—C(═O)—
K307
J9
S


2-0755
—(CH2)2
—NH—C(═O)—
K307
J126
S


2-0756
—(CH2)2
—NH—C(═O)—
K307
J129
S


2-0757
—(CH2)2
—NH—C(═O)—
K307
J130
S


2-0758
—(CH2)2
—NH—C(═O)—
K307
J138
S


2-0759
—(CH2)2
—NH—C(═O)—
K307
J33
S


2-0760
—(CH2)2
—NH—C(═O)—
K307
J159
S


2-0761
—(CH2)2
—NH—C(═O)—
K31
J9
S


2-0762
—(CH2)2
—NH—C(═O)—
K31
J126
S


2-0763
—(CH2)2
—NH—C(═O)—
K31
J129
S


2-0764
—(CH2)2
—NH—C(═O)—
K31
J130
S


2-0765
—(CH2)2
—NH—C(═O)—
K31
J138
S


2-0766
—(CH2)2
—NH—C(═O)—
K32
J9
S


2-0767
—(CH2)2
—NH—C(═O)—
K32
J126
S


2-0768
—(CH2)2
—NH—C(═O)—
K32
J129
S





















TABLE 59








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0769
—(CH2)2
—NH—C(═O)—
K32
J130
S


2-0770
—(CH2)2
—NH—C(═O)—
K32
J138
S


2-0771
—(CH2)2
—NH—C(═O)—
K33
J9
S


2-0772
—(CH2)2
—NH—C(═O)—
K34
J9
S


2-0773
—(CH2)2
—NH—C(═O)—
K34
J126
S


2-0774
—(CH2)2
—NH—C(═O)—
K34
J129
S


2-0775
—(CH2)2
—NH—C(═O)—
K34
J130
S


2-0776
—(CH2)2
—NH—C(═O)—
K34
J138
S


2-0777
—(CH2)2
—NH—C(═O)—
K35
J9
S


2-0778
—(CH2)2
—NH—C(═O)—
K35
J126
S


2-0779
—(CH2)2
—NH—C(═O)—
K35
J129
S


2-0780
—(CH2)2
—NH—C(═O)—
K35
J130
S


2-0781
—(CH2)2
—NH—C(═O)—
K35
J138
S


2-0782
—(CH2)2
—NH—C(═O)—
K36
J9
S


2-0783
—(CH2)2
—NH—C(═O)—
K36
J126
S


2-0784
—(CH2)2
—NH—C(═O)—
K36
J129
S


2-0785
—(CH2)2
—NH—C(═O)—
K36
J130
S


2-0786
—(CH2)2
—NH—C(═O)—
K36
J138
S


2-0787
—(CH2)2
—NH—C(═O)—
K37
J9
S


2-0788
—(CH2)2
—NH—C(═O)—
K37
J126
S


2-0789
—(CH2)2
—NH—C(═O)—
K37
J129
S


2-0790
—(CH2)2
—NH—C(═O)—
K37
J130
S


2-0791
—(CH2)2
—NH—C(═O)—
K37
J138
S


2-0792
—(CH2)2
—NH—C(═O)—
K38
J9
S


2-0793
—(CH2)2
—NH—C(═O)—
K38
J126
S


2-0794
—(CH2)2
—NH—C(═O)—
K38
J129
S


2-0795
—(CH2)2
—NH—C(═O)—
K38
J130
S


2-0796
—(CH2)2
—NH—C(═O)—
K38
J138
S


2-0797
—(CH2)2
—NH—C(═O)—
K39
J9
S


2-0798
—(CH2)2
—NH—C(═O)—
K39
J126
S


2-0799
—(CH2)2
—NH—C(═O)—
K39
J129
S


2-0800
—(CH2)2
—NH—C(═O)—
K39
J130
S





















TABLE 60








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0801
—(CH2)2
—NH—C(═O)—
K39
J138
S


2-0802
—(CH2)2
—NH—C(═O)—
K4
J9
S


2-0803
—(CH2)2
—NH—C(═O)—
K40
J9
S


2-0804
—(CH2)2
—NH—C(═O)—
K41
J9
S


2-0805
—(CH2)2
—NH—C(═O)—
K42
J9
S


2-0806
—(CH2)2
—NH—C(═O)—
K423
J9
S


2-0807
—(CH2)2
—NH—C(═O)—
K423
J33
S


2-0808
—(CH2)2
—NH—C(═O)—
K423
J159
S


2-0809
—(CH2)2
—NH—C(═O)—
K424
J9
S


2-0810
—(CH2)2
—NH—C(═O)—
K424
J34
S


2-0811
—(CH2)2
—NH—C(═O)—
K424
J163
S


2-0812
—(CH2)2
—NH—C(═O)—
K425
J9
S


2-0813
—(CH2)2
—NH—C(═O)—
K425
J34
S


2-0814
—(CH2)2
—NH—C(═O)—
K425
J163
S


2-0815
—(CH2)2
—NH—C(═O)—
K43
J9
S


2-0816
—(CH2)2
—NH—C(═O)—
K44
J9
S


2-0817
—(CH2)2
—NH—C(═O)—
K443
J9
S


2-0818
—(CH2)2
—NH—C(═O)—
K443
J126
S


2-0819
—(CH2)2
—NH—C(═O)—
K443
J129
S


2-0820
—(CH2)2
—NH—C(═O)—
K443
J130
S


2-0821
—(CH2)2
—NH—C(═O)—
K443
J138
S


2-0822
—(CH2)2
—NH—C(═O)—
K444
J9
S


2-0823
—(CH2)2
—NH—C(═O)—
K445
J9
S


2-0824
—(CH2)2
—NH—C(═O)—
K445
J126
S


2-0825
—(CH2)2
—NH—C(═O)—
K445
J129
S


2-0826
—(CH2)2
—NH—C(═O)—
K445
J130
S


2-0827
—(CH2)2
—NH—C(═O)—
K445
J138
S


2-0828
—(CH2)2
—NH—C(═O)—
K449
J9
S


2-0829
—(CH2)2
—NH—C(═O)—
K449
J126
S


2-0830
—(CH2)2
—NH—C(═O)—
K449
J129
S


2-0831
—(CH2)2
—NH—C(═O)—
K449
J130
S


2-0832
—(CH2)2
—NH—C(═O)—
K449
J138
S





















TABLE 61








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0833
—(CH2)2
—NH—C(═O)—
K45
J9
S


2-0834
—(CH2)2
—NH—C(═O)—
K450
J9
S


2-0835
—(CH2)2
—NH—C(═O)—
K450
J126
S


2-0836
—(CH2)2
—NH—C(═O)—
K450
J129
S


2-0837
—(CH2)2
—NH—C(═O)—
K450
J130
S


2-0838
—(CH2)2
—NH—C(═O)—
K450
J138
S


2-0839
—(CH2)2
—NH—C(═O)—
K46
J9
S


2-0840
—(CH2)2
—NH—C(═O)—
K469
J126
S


2-0841
—(CH2)2
—NH—C(═O)—
K469
J129
S


2-0842
—(CH2)2
—NH—C(═O)—
K469
J130
S


2-0843
—(CH2)2
—NH—C(═O)—
K469
J138
S


2-0844
—(CH2)2
—NH—C(═O)—
K47
J9
S


2-0845
—(CH2)2
—NH—C(═O)—
K471
J126
S


2-0846
—(CH2)2
—NH—C(═O)—
K471
J129
S


2-0847
—(CH2)2
—NH—C(═O)—
K471
J130
S


2-0848
—(CH2)2
—NH—C(═O)—
K471
J138
S


2-0849
—(CH2)2
—NH—C(═O)—
K472
J9
S


2-0850
—(CH2)2
—NH—C(═O)—
K473
J9
S


2-0851
—(CH2)2
—NH—C(═O)—
K474
J9
S


2-0852
—(CH2)2
—NH—C(═O)—
K475
J9
S


2-0853
—(CH2)2
—NH—C(═O)—
K476
J9
S


2-0854
—(CH2)2
—NH—C(═O)—
K477
J9
S


2-0855
—(CH2)2
—NH—C(═O)—
K478
J9
S


2-0856
—(CH2)2
—NH—C(═O)—
K478
J126
S


2-0857
—(CH2)2
—NH—C(═O)—
K478
J129
S


2-0858
—(CH2)2
—NH—C(═O)—
K478
J130
S


2-0859
—(CH2)2
—NH—C(═O)—
K478
J138
S


2-0860
—(CH2)2
—NH—C(═O)—
K478
J37
S


2-0861
—(CH2)2
—NH—C(═O)—
K478
J165
S


2-0862
—(CH2)2
—NH—C(═O)—
K479
J9
S


2-0863
—(CH2)2
—NH—C(═O)—
K479
J126
S


2-0864
—(CH2)2
—NH—C(═O)—
K479
J129
S





















TABLE 62








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0865
—(CH2)2
—NH—C(═O)—
K479
J130
S


2-0866
—(CH2)2
—NH—C(═O)—
K479
J138
S


2-0867
—(CH2)2
—NH—C(═O)—
K48
J9
S


2-0868
—(CH2)2
—NH—C(═O)—
K480
J9
S


2-0869
—(CH2)2
—NH—C(═O)—
K481
J9
S


2-0870
—(CH2)2
—NH—C(═O)—
K482
J9
S


2-0871
—(CH2)2
—NH—C(═O)—
K483
J9
S


2-0872
—(CH2)2
—NH—C(═O)—
K484
J9
S


2-0873
—(CH2)2
—NH—C(═O)—
K485
J9
S


2-0874
—(CH2)2
—NH—C(═O)—
K485
J126
S


2-0875
—(CH2)2
—NH—C(═O)—
K485
J129
S


2-0876
—(CH2)2
—NH—C(═O)—
K485
J130
S


2-0877
—(CH2)2
—NH—C(═O)—
K485
J138
S


2-0878
—(CH2)2
—NH—C(═O)—
K485
J37
S


2-0879
—(CH2)2
—NH—C(═O)—
K485
J165
S


2-0880
—(CH2)2
—NH—C(═O)—
K486
J9
S


2-0881
—(CH2)2
—NH—C(═O)—
K487
J9
S


2-0882
—(CH2)2
—NH—C(═O)—
K488
J9
S


2-0883
—(CH2)2
—NH—C(═O)—
K489
J9
S


2-0884
—(CH2)2
—NH—C(═O)—
K49
J9
S


2-0885
—(CH2)2
—NH—C(═O)—
K49
J126
S


2-0886
—(CH2)2
—NH—C(═O)—
K49
J129
S


2-0887
—(CH2)2
—NH—C(═O)—
K49
J130
S


2-0888
—(CH2)2
—NH—C(═O)—
K49
J138
S


2-0889
—(CH2)2
—NH—C(═O)—
K490
J9
S


2-0890
—(CH2)2
—NH—C(═O)—
K491
J9
S


2-0891
—(CH2)2
—NH—C(═O)—
K492
J9
S


2-0892
—(CH2)2
—NH—C(═O)—
K493
J9
S


2-0893
—(CH2)2
—NH—C(═O)—
K494
J9
S


2-0894
—(CH2)2
—NH—C(═O)—
K495
J9
S


2-0895
—(CH2)2
—NH—C(═O)—
K496
J9
S


2-0896
—(CH2)2
—NH—C(═O)—
K497
J9
S





















TABLE 63








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0897
—(CH2)2
—NH—C(═O)—
K497
J126
S


2-0898
—(CH2)2
—NH—C(═O)—
K497
J129
S


2-0899
—(CH2)2
—NH—C(═O)—
K497
J130
S


2-0900
—(CH2)2
—NH—C(═O)—
K497
J138
S


2-0901
—(CH2)2
—NH—C(═O)—
K498
J9
S


2-0902
—(CH2)2
—NH—C(═O)—
K498
J126
S


2-0903
—(CH2)2
—NH—C(═O)—
K498
J129
S


2-0904
—(CH2)2
—NH—C(═O)—
K498
J130
S


2-0905
—(CH2)2
—NH—C(═O)—
K498
J138
S


2-0906
—(CH2)2
—NH—C(═O)—
K499
J9
S


2-0907
—(CH2)2
—NH—C(═O)—
K499
J126
S


2-0908
—(CH2)2
—NH—C(═O)—
K499
J129
S


2-0909
—(CH2)2
—NH—C(═O)—
K499
J130
S


2-0910
—(CH2)2
—NH—C(═O)—
K499
J138
S


2-0911
—(CH2)2
—NH—C(═O)—
K499
J57
S


2-0912
—(CH2)2
—NH—C(═O)—
K499
J166
S


2-0913
—(CH2)2
—NH—C(═O)—
K50
J9
S


2-0914
—(CH2)2
—NH—C(═O)—
K500
J9
S


2-0915
—(CH2)2
—NH—C(═O)—
K500
J126
S


2-0916
—(CH2)2
—NH—C(═O)—
K500
J129
S


2-0917
—(CH2)2
—NH—C(═O)—
K500
J130
S


2-0918
—(CH2)2
—NH—C(═O)—
K500
J138
S


2-0919
—(CH2)2
—NH—C(═O)—
K500
J57
S


2-0920
—(CH2)2
—NH—C(═O)—
K500
J166
S


2-0921
—(CH2)2
—NH—C(═O)—
K501
J9
S


2-0922
—(CH2)2
—NH—C(═O)—
K501
J126
S


2-0923
—(CH2)2
—NH—C(═O)—
K501
J129
S


2-0924
—(CH2)2
—NH—C(═O)—
K501
J130
S


2-0925
—(CH2)2
—NH—C(═O)—
K501
J138
S


2-0926
—(CH2)2
—NH—C(═O)—
K501
J58
S


2-0927
—(CH2)2
—NH—C(═O)—
K501
J167
S


2-0928
—(CH2)2
—NH—C(═O)—
K502
J9
S





















TABLE 64








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0929
—(CH2)2
—NH—C(═O)—
K502
J58
S


2-0930
—(CH2)2
—NH—C(═O)—
K502
J167
S


2-0931
—(CH2)2
—NH—C(═O)—
K503
J9
S


2-0932
—(CH2)2
—NH—C(═O)—
K503
J126
S


2-0933
—(CH2)2
—NH—C(═O)—
K503
J129
S


2-0934
—(CH2)2
—NH—C(═O)—
K503
J130
S


2-0935
—(CH2)2
—NH—C(═O)—
K503
J138
S


2-0936
—(CH2)2
—NH—C(═O)—
K503
J59
S


2-0937
—(CH2)2
—NH—C(═O)—
K503
J168
S


2-0938
—(CH2)2
—NH—C(═O)—
K504
J9
S


2-0939
—(CH2)2
—NH—C(═O)—
K504
J59
S


2-0940
—(CH2)2
—NH—C(═O)—
K504
J168
S


2-0941
—(CH2)2
—NH—C(═O)—
K505
J9
S


2-0942
—(CH2)2
—NH—C(═O)—
K505
J126
S


2-0943
—(CH2)2
—NH—C(═O)—
K505
J129
S


2-0944
—(CH2)2
—NH—C(═O)—
K505
J130
S


2-0945
—(CH2)2
—NH—C(═O)—
K505
J138
S


2-0946
—(CH2)2
—NH—C(═O)—
K505
J70
S


2-0947
—(CH2)2
—NH—C(═O)—
K505
J169
S


2-0948
—(CH2)2
—NH—C(═O)—
K506
J9
S


2-0949
—(CH2)2
—NH—C(═O)—
K506
J126
S


2-0950
—(CH2)2
—NH—C(═O)—
K506
J129
S


2-0951
—(CH2)2
—NH—C(═O)—
K506
J130
S


2-0952
—(CH2)2
—NH—C(═O)—
K506
J138
S


2-0953
—(CH2)2
—NH—C(═O)—
K506
J70
S


2-0954
—(CH2)2
—NH—C(═O)—
K506
J169
S


2-0955
—(CH2)2
—NH—C(═O)—
K507
J9
S


2-0956
—(CH2)2
—NH—C(═O)—
K507
J126
S


2-0957
—(CH2)2
—NH—C(═O)—
K507
J129
S


2-0958
—(CH2)2
—NH—C(═O)—
K507
J130
S


2-0959
—(CH2)2
—NH—C(═O)—
K507
J138
S


2-0960
—(CH2)2
—NH—C(═O)—
K507
J71
S





















TABLE 65








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0961
—(CH2)2
—NH—C(═O)—
K507
J170
S


2-0962
—(CH2)2
—NH—C(═O)—
K508
J9
S


2-0963
—(CH2)2
—NH—C(═O)—
K508
J126
S


2-0964
—(CH2)2
—NH—C(═O)—
K508
J129
S


2-0965
—(CH2)2
—NH—C(═O)—
K508
J130
S


2-0966
—(CH2)2
—NH—C(═O)—
K508
J138
S


2-0967
—(CH2)2
—NH—C(═O)—
K508
J71
S


2-0968
—(CH2)2
—NH—C(═O)—
K508
J170
S


2-0969
—(CH2)2
—NH—C(═O)—
K509
J9
S


2-0970
—(CH2)2
—NH—C(═O)—
K509
J72
S


2-0971
—(CH2)2
—NH—C(═O)—
K509
J171
S


2-0972
—(CH2)2
—NH—C(═O)—
K51
J9
S


2-0973
—(CH2)2
—NH—C(═O)—
K510
J9
S


2-0974
—(CH2)2
—NH—C(═O)—
K510
J126
S


2-0975
—(CH2)2
—NH—C(═O)—
K510
J129
S


2-0976
—(CH2)2
—NH—C(═O)—
K510
J130
S


2-0977
—(CH2)2
—NH—C(═O)—
K510
J138
S


2-0978
—(CH2)2
—NH—C(═O)—
K510
J72
S


2-0979
—(CH2)2
—NH—C(═O)—
K510
J171
S


2-0980
—(CH2)2
—NH—C(═O)—
K511
J9
S


2-0981
—(CH2)2
—NH—C(═O)—
K511
J74
S


2-0982
—(CH2)2
—NH—C(═O)—
K511
J174
S


2-0983
—(CH2)2
—NH—C(═O)—
K512
J9
S


2-0984
—(CH2)2
—NH—C(═O)—
K512
J74
S


2-0985
—(CH2)2
—NH—C(═O)—
K512
J174
S


2-0986
—(CH2)2
—NH—C(═O)—
K513
J9
S


2-0987
—(CH2)2
—NH—C(═O)—
K513
J75
S


2-0988
—(CH2)2
—NH—C(═O)—
K513
J175
S


2-0989
—(CH2)2
—NH—C(═O)—
K514
J9
S


2-0990
—(CH2)2
—NH—C(═O)—
K514
J75
S


2-0991
—(CH2)2
—NH—C(═O)—
K514
J175
S


2-0992
—(CH2)2
—NH—C(═O)—
K515
J9
S





















TABLE 66








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-0993
—(CH2)2
—NH—C(═O)—
K516
J9
S


2-0994
—(CH2)2
—NH—C(═O)—
K516
J76
S


2-0995
—(CH2)2
—NH—C(═O)—
K516
J176
S


2-0996
—(CH2)2
—NH—C(═O)—
K517
J9
S


2-0997
—(CH2)2
—NH—C(═O)—
K517
J126
S


2-0998
—(CH2)2
—NH—C(═O)—
K517
J129
S


2-0999
—(CH2)2
—NH—C(═O)—
K517
J130
S


2-1000
—(CH2)2
—NH—C(═O)—
K517
J138
S


2-1001
—(CH2)2
—NH—C(═O)—
K517
J76
S


2-1002
—(CH2)2
—NH—C(═O)—
K517
J176
S


2-1003
—(CH2)2
—NH—C(═O)—
K518
J9
S


2-1004
—(CH2)2
—NH—C(═O)—
K518
J126
S


2-1005
—(CH2)2
—NH—C(═O)—
K518
J129
S


2-1006
—(CH2)2
—NH—C(═O)—
K518
J130
S


2-1007
—(CH2)2
—NH—C(═O)—
K518
J138
S


2-1008
—(CH2)2
—NH—C(═O)—
K518
J77
S


2-1009
—(CH2)2
—NH—C(═O)—
K518
J177
S


2-1010
—(CH2)2
—NH—C(═O)—
K519
J9
S


2-1011
—(CH2)2
—NH—C(═O)—
K519
J126
S


2-1012
—(CH2)2
—NH—C(═O)—
K519
J129
S


2-1013
—(CH2)2
—NH—C(═O)—
K519
J130
S


2-1014
—(CH2)2
—NH—C(═O)—
K519
J138
S


2-1015
—(CH2)2
—NH—C(═O)—
K519
J77
S


2-1016
—(CH2)2
—NH—C(═O)—
K519
J177
S


2-1017
—(CH2)2
—NH—C(═O)—
K52
J9
S


2-1018
—(CH2)2
—NH—C(═O)—
K520
J9
S


2-1019
—(CH2)2
—NH—C(═O)—
K521
J9
S


2-1020
—(CH2)2
—NH—C(═O)—
K522
J9
S


2-1021
—(CH2)2
—NH—C(═O)—
K523
J9
S


2-1022
—(CH2)2
—NH—C(═O)—
K523
J126
S


2-1023
—(CH2)2
—NH—C(═O)—
K523
J129
S


2-1024
—(CH2)2
—NH—C(═O)—
K523
J130
S





















TABLE 67








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1025
—(CH2)2
—NH—C(═O)—
K523
J138
S


2-1026
—(CH2)2
—NH—C(═O)—
K523
J78
S


2-1027
—(CH2)2
—NH—C(═O)—
K523
J178
S


2-1028
—(CH2)2
—NH—C(═O)—
K524
J9
S


2-1029
—(CH2)2
—NH—C(═O)—
K525
J9
S


2-1030
—(CH2)2
—NH—C(═O)—
K525
J126
S


2-1031
—(CH2)2
—NH—C(═O)—
K525
J129
S


2-1032
—(CH2)2
—NH—C(═O)—
K525
J130
S


2-1033
—(CH2)2
—NH—C(═O)—
K525
J138
S


2-1034
—(CH2)2
—NH—C(═O)—
K525
J78
S


2-1035
—(CH2)2
—NH—C(═O)—
K525
J178
S


2-1036
—(CH2)2
—NH—C(═O)—
K526
J9
S


2-1037
—(CH2)2
—NH—C(═O)—
K526
J126
S


2-1038
—(CH2)2
—NH—C(═O)—
K526
J129
S


2-1039
—(CH2)2
—NH—C(═O)—
K526
J130
S


2-1040
—(CH2)2
—NH—C(═O)—
K526
J138
S


2-1041
—(CH2)2
—NH—C(═O)—
K526
J79
S


2-1042
—(CH2)2
—NH—C(═O)—
K526
J179
S


2-1043
—(CH2)2
—NH—C(═O)—
K527
J9
S


2-1044
—(CH2)2
—NH—C(═O)—
K528
J9
S


2-1045
—(CH2)2
—NH—C(═O)—
K528
J79
S


2-1046
—(CH2)2
—NH—C(═O)—
K528
J179
S


2-1047
—(CH2)2
—NH—C(═O)—
K53
J9
S


2-1048
—(CH2)2
—NH—C(═O)—
K53
J126
S


2-1049
—(CH2)2
—NH—C(═O)—
K53
J129
S


2-1050
—(CH2)2
—NH—C(═O)—
K53
J130
S


2-1051
—(CH2)2
—NH—C(═O)—
K53
J138
S


2-1052
—(CH2)2
—NH—C(═O)—
K531
J9
S


2-1053
—(CH2)2
—NH—C(═O)—
K532
J9
S


2-1054
—(CH2)2
—NH—C(═O)—
K533
J9
S


2-1055
—(CH2)2
—NH—C(═O)—
K533
J126
S


2-1056
—(CH2)2
—NH—C(═O)—
K533
J129
S





















TABLE 68








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1057
—(CH2)2
—NH—C(═O)—
K533
J130
S


2-1058
—(CH2)2
—NH—C(═O)—
K533
J138
S


2-1059
—(CH2)2
—NH—C(═O)—
K534
J9
S


2-1060
—(CH2)2
—NH—C(═O)—
K535
J9
S


2-1061
—(CH2)2
—NH—C(═O)—
K535
J126
S


2-1062
—(CH2)2
—NH—C(═O)—
K535
J129
S


2-1063
—(CH2)2
—NH—C(═O)—
K535
J130
S


2-1064
—(CH2)2
—NH—C(═O)—
K535
J138
S


2-1065
—(CH2)2
—NH—C(═O)—
K536
J9
S


2-1066
—(CH2)2
—NH—C(═O)—
K537
J9
S


2-1067
—(CH2)2
—NH—C(═O)—
K538
J9
S


2-1068
—(CH2)2
—NH—C(═O)—
K539
J9
S


2-1069
—(CH2)2
—NH—C(═O)—
K54
J9
S


2-1070
—(CH2)2
—NH—C(═O)—
K54
J126
S


2-1071
—(CH2)2
—NH—C(═O)—
K54
J129
S


2-1072
—(CH2)2
—NH—C(═O)—
K54
J130
S


2-1073
—(CH2)2
—NH—C(═O)—
K54
J138
S


2-1074
—(CH2)2
—NH—C(═O)—
K540
J9
S


2-1075
—(CH2)2
—NH—C(═O)—
K541
J9
S


2-1076
—(CH2)2
—NH—C(═O)—
K542
J9
S


2-1077
—(CH2)2
—NH—C(═O)—
K542
J126
S


2-1078
—(CH2)2
—NH—C(═O)—
K542
J129
S


2-1079
—(CH2)2
—NH—C(═O)—
K542
J130
S


2-1080
—(CH2)2
—NH—C(═O)—
K542
J138
S


2-1081
—(CH2)2
—NH—C(═O)—
K542
J81
S


2-1082
—(CH2)2
—NH—C(═O)—
K542
J180
S


2-1083
—(CH2)2
—NH—C(═O)—
K543
J9
S


2-1084
—(CH2)2
—NH—C(═O)—
K543
J81
S


2-1085
—(CH2)2
—NH—C(═O)—
K543
J180
S


2-1086
—(CH2)2
—NH—C(═O)—
K544
J9
S


2-1087
—(CH2)2
—NH—C(═O)—
K545
J9
S


2-1088
—(CH2)2
—NH—C(═O)—
K545
J126
S





















TABLE 69








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1089
—(CH2)2
—NH—C(═O)—
K545
J129
S


2-1090
—(CH2)2
—NH—C(═O)—
K545
J130
S


2-1091
—(CH2)2
—NH—C(═O)—
K545
J138
S


2-1092
—(CH2)2
—NH—C(═O)—
K545
J83
S


2-1093
—(CH2)2
—NH—C(═O)—
K545
J181
S


2-1094
—(CH2)2
—NH—C(═O)—
K546
J9
S


2-1095
—(CH2)2
—NH—C(═O)—
K546
J126
S


2-1096
—(CH2)2
—NH—C(═O)—
K546
J129
S


2-1097
—(CH2)2
—NH—C(═O)—
K546
J130
S


2-1098
—(CH2)2
—NH—C(═O)—
K546
J138
S


2-1099
—(CH2)2
—NH—C(═O)—
K546
J83
S


2-1100
—(CH2)2
—NH—C(═O)—
K546
J181
S


2-1101
—(CH2)2
—NH—C(═O)—
K547
J9
S


2-1102
—(CH2)2
—NH—C(═O)—
K547
J126
S


2-1103
—(CH2)2
—NH—C(═O)—
K547
J129
S


2-1104
—(CH2)2
—NH—C(═O)—
K547
J130
S


2-1105
—(CH2)2
—NH—C(═O)—
K547
J138
S


2-1106
—(CH2)2
—NH—C(═O)—
K547
J84
S


2-1107
—(CH2)2
—NH—C(═O)—
K547
J182
S


2-1108
—(CH2)2
—NH—C(═O)—
K548
J9
S


2-1109
—(CH2)2
—NH—C(═O)—
K548
J126
S


2-1110
—(CH2)2
—NH—C(═O)—
K548
J129
S


2-1111
—(CH2)2
—NH—C(═O)—
K548
J130
S


2-1112
—(CH2)2
—NH—C(═O)—
K548
J138
S


2-1113
—(CH2)2
—NH—C(═O)—
K548
J84
S


2-1114
—(CH2)2
—NH—C(═O)—
K548
J182
S


2-1115
—(CH2)2
—NH—C(═O)—
K549
J9
S


2-1116
—(CH2)2
—NH—C(═O)—
K549
J126
S


2-1117
—(CH2)2
—NH—C(═O)—
K549
J129
S


2-1118
—(CH2)2
—NH—C(═O)—
K549
J130
S


2-1119
—(CH2)2
—NH—C(═O)—
K549
J138
S


2-1120
—(CH2)2
—NH—C(═O)—
K549
J87
S





















TABLE 70








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1121
—(CH2)2
—NH—C(═O)—
K549
J185
S


2-1122
—(CH2)2
—NH—C(═O)—
K55
J9
S


2-1123
—(CH2)2
—NH—C(═O)—
K550
J9
S


2-1124
—(CH2)2
—NH—C(═O)—
K550
J126
S


2-1125
—(CH2)2
—NH—C(═O)—
K550
J129
S


2-1126
—(CH2)2
—NH—C(═O)—
K550
J130
S


2-1127
—(CH2)2
—NH—C(═O)—
K550
J138
S


2-1128
—(CH2)2
—NH—C(═O)—
K551
J9
S


2-1129
—(CH2)2
—NH—C(═O)—
K551
J126
S


2-1130
—(CH2)2
—NH—C(═O)—
K551
J129
S


2-1131
—(CH2)2
—NH—C(═O)—
K551
J130
S


2-1132
—(CH2)2
—NH—C(═O)—
K551
J138
S


2-1133
—(CH2)2
—NH—C(═O)—
K552
J9
S


2-1134
—(CH2)2
—NH—C(═O)—
K553
J9
S


2-1135
—(CH2)2
—NH—C(═O)—
K554
J9
S


2-1136
—(CH2)2
—NH—C(═O)—
K554
J126
S


2-1137
—(CH2)2
—NH—C(═O)—
K554
J129
S


2-1138
—(CH2)2
—NH—C(═O)—
K554
J130
S


2-1139
—(CH2)2
—NH—C(═O)—
K554
J138
S


2-1140
—(CH2)2
—NH—C(═O)—
K554
J87
S


2-1141
—(CH2)2
—NH—C(═O)—
K554
J185
S


2-1142
—(CH2)2
—NH—C(═O)—
K555
J9
S


2-1143
—(CH2)2
—NH—C(═O)—
K556
J9
S


2-1144
—(CH2)2
—NH—C(═O)—
K557
J9
S


2-1145
—(CH2)2
—NH—C(═O)—
K558
J9
S


2-1146
—(CH2)2
—NH—C(═O)—
K559
J9
S


2-1147
—(CH2)2
—NH—C(═O)—
K56
J9
S


2-1148
—(CH2)2
—NH—C(═O)—
K560
J9
S


2-1149
—(CH2)2
—NH—C(═O)—
K561
J9
S


2-1150
—(CH2)2
—NH—C(═O)—
K562
J9
S


2-1151
—(CH2)2
—NH—C(═O)—
K563
J9
S


2-1152
—(CH2)2
—NH—C(═O)—
K563
J89
S





















TABLE 71








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1153
—(CH2)2
—NH—C(═O)—
K563
J188
S


2-1154
—(CH2)2
—NH—C(═O)—
K564
J9
S


2-1155
—(CH2)2
—NH—C(═O)—
K564
J126
S


2-1156
—(CH2)2
—NH—C(═O)—
K564
J129
S


2-1157
—(CH2)2
—NH—C(═O)—
K564
J130
S


2-1158
—(CH2)2
—NH—C(═O)—
K564
J138
S


2-1159
—(CH2)2
—NH—C(═O)—
K564
J89
S


2-1160
—(CH2)2
—NH—C(═O)—
K564
J188
S


2-1161
—(CH2)2
—NH—C(═O)—
K565
J9
S


2-1162
—(CH2)2
—NH—C(═O)—
K566
J9
S


2-1163
—(CH2)2
—NH—C(═O)—
K567
J9
S


2-1164
—(CH2)2
—NH—C(═O)—
K567
J126
S


2-1165
—(CH2)2
—NH—C(═O)—
K567
J129
S


2-1166
—(CH2)2
—NH—C(═O)—
K567
J130
S


2-1167
—(CH2)2
—NH—C(═O)—
K567
J138
S


2-1168
—(CH2)2
—NH—C(═O)—
K567
J120
S


2-1169
—(CH2)2
—NH—C(═O)—
K567
J189
S


2-1170
—(CH2)2
—NH—C(═O)—
K568
J9
S


2-1171
—(CH2)2
—NH—C(═O)—
K568
J126
S


2-1172
—(CH2)2
—NH—C(═O)—
K568
J129
S


2-1173
—(CH2)2
—NH—C(═O)—
K568
J130
S


2-1174
—(CH2)2
—NH—C(═O)—
K568
J138
S


2-1175
—(CH2)2
—NH—C(═O)—
K568
J120
S


2-1176
—(CH2)2
—NH—C(═O)—
K568
J189
S


2-1177
—(CH2)2
—NH—C(═O)—
K569
J9
S


2-1178
—(CH2)2
—NH—C(═O)—
K569
J126
S


2-1179
—(CH2)2
—NH—C(═O)—
K569
J129
S


2-1180
—(CH2)2
—NH—C(═O)—
K569
J130
S


2-1181
—(CH2)2
—NH—C(═O)—
K569
J138
S


2-1182
—(CH2)2
—NH—C(═O)—
K569
J121
S


2-1183
—(CH2)2
—NH—C(═O)—
K569
J190
S


2-1184
—(CH2)2
—NH—C(═O)—
K57
J9
S





















TABLE 72








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1185
—(CH2)2
—NH—C(═O)—
K570
J9
S


2-1186
—(CH2)2
—NH—C(═O)—
K570
J121
S


2-1187
—(CH2)2
—NH—C(═O)—
K570
J190
S


2-1188
—(CH2)2
—NH—C(═O)—
K571
J9
S


2-1189
—(CH2)2
—NH—C(═O)—
K571
J126
S


2-1190
—(CH2)2
—NH—C(═O)—
K571
J129
S


2-1191
—(CH2)2
—NH—C(═O)—
K571
J130
S


2-1192
—(CH2)2
—NH—C(═O)—
K571
J138
S


2-1193
—(CH2)2
—NH—C(═O)—
K571
J122
S


2-1194
—(CH2)2
—NH—C(═O)—
K571
J191
S


2-1195
—(CH2)2
—NH—C(═O)—
K572
J9
S


2-1196
—(CH2)2
—NH—C(═O)—
K572
J126
S


2-1197
—(CH2)2
—NH—C(═O)—
K572
J129
S


2-1198
—(CH2)2
—NH—C(═O)—
K572
J130
S


2-1199
—(CH2)2
—NH—C(═O)—
K572
J138
S


2-1200
—(CH2)2
—NH—C(═O)—
K572
J122
S


2-1201
—(CH2)2
—NH—C(═O)—
K572
J191
S


2-1202
—(CH2)2
—NH—C(═O)—
K573
J9
S


2-1203
—(CH2)2
—NH—C(═O)—
K573
J126
S


2-1204
—(CH2)2
—NH—C(═O)—
K573
J129
S


2-1205
—(CH2)2
—NH—C(═O)—
K573
J130
S


2-1206
—(CH2)2
—NH—C(═O)—
K573
J138
S


2-1207
—(CH2)2
—NH—C(═O)—
K573
J123
S


2-1208
—(CH2)2
—NH—C(═O)—
K573
J192
S


2-1209
—(CH2)2
—NH—C(═O)—
K574
J9
S


2-1210
—(CH2)2
—NH—C(═O)—
K574
J126
S


2-1211
—(CH2)2
—NH—C(═O)—
K574
J129
S


2-1212
—(CH2)2
—NH—C(═O)—
K574
J130
S


2-1213
—(CH2)2
—NH—C(═O)—
K574
J138
S


2-1214
—(CH2)2
—NH—C(═O)—
K574
J123
S


2-1215
—(CH2)2
—NH—C(═O)—
K574
J192
S


2-1216
—(CH2)2
—NH—C(═O)—
K575
J9
S





















TABLE 73








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1217
—(CH2)2
—NH—C(═O)—
K575
J126
S


2-1218
—(CH2)2
—NH—C(═O)—
K575
J129
S


2-1219
—(CH2)2
—NH—C(═O)—
K575
J130
S


2-1220
—(CH2)2
—NH—C(═O)—
K575
J138
S


2-1221
—(CH2)2
—NH—C(═O)—
K575
J124
S


2-1222
—(CH2)2
—NH—C(═O)—
K575
J193
S


2-1223
—(CH2)2
—NH—C(═O)—
K576
J9
S


2-1224
—(CH2)2
—NH—C(═O)—
K576
J124
S


2-1225
—(CH2)2
—NH—C(═O)—
K576
J193
S


2-1226
—(CH2)2
—NH—C(═O)—
K577
J9
S


2-1227
—(CH2)2
—NH—C(═O)—
K577
J125
S


2-1228
—(CH2)2
—NH—C(═O)—
K577
J194
S


2-1229
—(CH2)2
—NH—C(═O)—
K578
J9
S


2-1230
—(CH2)2
—NH—C(═O)—
K578
J125
S


2-1231
—(CH2)2
—NH—C(═O)—
K578
J194
S


2-1232
—(CH2)2
—NH—C(═O)—
K579
J9
S


2-1233
—(CH2)2
—NH—C(═O)—
K579
J126
S


2-1234
—(CH2)2
—NH—C(═O)—
K579
J129
S


2-1235
—(CH2)2
—NH—C(═O)—
K579
J130
S


2-1236
—(CH2)2
—NH—C(═O)—
K579
J138
S


2-1237
—(CH2)2
—NH—C(═O)—
K579
J127
S


2-1238
—(CH2)2
—NH—C(═O)—
K579
J195
S


2-1239
—(CH2)2
—NH—C(═O)—
K58
J9
S


2-1240
—(CH2)2
—NH—C(═O)—
K580
J9
S


2-1241
—(CH2)2
—NH—C(═O)—
K580
J126
S


2-1242
—(CH2)2
—NH—C(═O)—
K580
J129
S


2-1243
—(CH2)2
—NH—C(═O)—
K580
J130
S


2-1244
—(CH2)2
—NH—C(═O)—
K580
J138
S


2-1245
—(CH2)2
—NH—C(═O)—
K580
J127
S


2-1246
—(CH2)2
—NH—C(═O)—
K580
J195
S


2-1247
—(CH2)2
—NH—C(═O)—
K581
J9
S


2-1248
—(CH2)2
—NH—C(═O)—
K581
J126
S





















TABLE 74








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1249
—(CH2)2
—NH—C(═O)—
K581
J129
S


2-1250
—(CH2)2
—NH—C(═O)—
K581
J130
S


2-1251
—(CH2)2
—NH—C(═O)—
K581
J138
S


2-1252
—(CH2)2
—NH—C(═O)—
K581
J128
S


2-1253
—(CH2)2
—NH—C(═O)—
K581
J196
S


2-1254
—(CH2)2
—NH—C(═O)—
K582
J9
S


2-1255
—(CH2)2
—NH—C(═O)—
K582
J126
S


2-1256
—(CH2)2
—NH—C(═O)—
K582
J129
S


2-1257
—(CH2)2
—NH—C(═O)—
K582
J130
S


2-1258
—(CH2)2
—NH—C(═O)—
K582
J138
S


2-1259
—(CH2)2
—NH—C(═O)—
K582
J128
S


2-1260
—(CH2)2
—NH—C(═O)—
K582
J196
S


2-1261
—(CH2)2
—NH—C(═O)—
K583
J9
S


2-1262
—(CH2)2
—NH—C(═O)—
K583
J126
S


2-1263
—(CH2)2
—NH—C(═O)—
K583
J129
S


2-1264
—(CH2)2
—NH—C(═O)—
K583
J130
S


2-1265
—(CH2)2
—NH—C(═O)—
K583
J138
S


2-1266
—(CH2)2
—NH—C(═O)—
K583
J131
S


2-1267
—(CH2)2
—NH—C(═O)—
K583
J197
S


2-1268
—(CH2)2
—NH—C(═O)—
K584
J9
S


2-1269
—(CH2)2
—NH—C(═O)—
K584
J126
S


2-1270
—(CH2)2
—NH—C(═O)—
K584
J129
S


2-1271
—(CH2)2
—NH—C(═O)—
K584
J130
S


2-1272
—(CH2)2
—NH—C(═O)—
K584
J138
S


2-1273
—(CH2)2
—NH—C(═O)—
K584
J131
S


2-1274
—(CH2)2
—NH—C(═O)—
K584
J197
S


2-1275
—(CH2)2
—NH—C(═O)—
K585
J9
S


2-1276
—(CH2)2
—NH—C(═O)—
K585
J126
S


2-1277
—(CH2)2
—NH—C(═O)—
K585
J129
S


2-1278
—(CH2)2
—NH—C(═O)—
K585
J130
S


2-1279
—(CH2)2
—NH—C(═O)—
K585
J138
S


2-1280
—(CH2)2
—NH—C(═O)—
K585
J132
S





















TABLE 75








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1281
—(CH2)2
—NH—C(═O)—
K585
J198
S


2-1282
—(CH2)2
—NH—C(═O)—
K586
J9
S


2-1283
—(CH2)2
—NH—C(═O)—
K587
J9
S


2-1284
—(CH2)2
—NH—C(═O)—
K588
J9
S


2-1285
—(CH2)2
—NH—C(═O)—
K589
J9
S


2-1286
—(CH2)2
—NH—C(═O)—
K589
J126
S


2-1287
—(CH2)2
—NH—C(═O)—
K589
J129
S


2-1288
—(CH2)2
—NH—C(═O)—
K589
J130
S


2-1289
—(CH2)2
—NH—C(═O)—
K589
J138
S


2-1290
—(CH2)2
—NH—C(═O)—
K59
J9
S


2-1291
—(CH2)2
—NH—C(═O)—
K59
J126
S


2-1292
—(CH2)2
—NH—C(═O)—
K59
J129
S


2-1293
—(CH2)2
—NH—C(═O)—
K59
J130
S


2-1294
—(CH2)2
—NH—C(═O)—
K59
J138
S


2-1295
—(CH2)2
—NH—C(═O)—
K590
J9
S


2-1296
—(CH2)2
—NH—C(═O)—
K590
J126
S


2-1297
—(CH2)2
—NH—C(═O)—
K590
J129
S


2-1298
—(CH2)2
—NH—C(═O)—
K590
J130
S


2-1299
—(CH2)2
—NH—C(═O)—
K590
J138
S


2-1300
—(CH2)2
—NH—C(═O)—
K590
J132
S


2-1301
—(CH2)2
—NH—C(═O)—
K590
J198
S


2-1302
—(CH2)2
—NH—C(═O)—
K591
J9
S


2-1303
—(CH2)2
—NH—C(═O)—
K591
J126
S


2-1304
—(CH2)2
—NH—C(═O)—
K591
J129
S


2-1305
—(CH2)2
—NH—C(═O)—
K591
J130
S


2-1306
—(CH2)2
—NH—C(═O)—
K591
J138
S


2-1307
—(CH2)2
—NH—C(═O)—
K591
J133
S


2-1308
—(CH2)2
—NH—C(═O)—
K591
J199
S


2-1309
—(CH2)2
—NH—C(═O)—
K592
J9
S


2-1310
—(CH2)2
—NH—C(═O)—
K592
J126
S


2-1311
—(CH2)2
—NH—C(═O)—
K592
J129
S


2-1312
—(CH2)2
—NH—C(═O)—
K592
J130
S





















TABLE 76








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1313
—(CH2)2
—NH—C(═O)—
K592
J138
S


2-1314
—(CH2)2
—NH—C(═O)—
K592
J133
S


2-1315
—(CH2)2
—NH—C(═O)—
K592
J199
S


2-1316
—(CH2)2
—NH—C(═O)—
K593
J9
S


2-1317
—(CH2)2
—NH—C(═O)—
K593
J126
S


2-1318
—(CH2)2
—NH—C(═O)—
K593
J129
S


2-1319
—(CH2)2
—NH—C(═O)—
K593
J130
S


2-1320
—(CH2)2
—NH—C(═O)—
K593
J138
S


2-1321
—(CH2)2
—NH—C(═O)—
K593
J134
S


2-1322
—(CH2)2
—NH—C(═O)—
K593
J200
S


2-1323
—(CH2)2
—NH—C(═O)—
K594
J9
S


2-1324
—(CH2)2
—NH—C(═O)—
K594
J126
S


2-1325
—(CH2)2
—NH—C(═O)—
K594
J129
S


2-1326
—(CH2)2
—NH—C(═O)—
K594
J130
S


2-1327
—(CH2)2
—NH—C(═O)—
K594
J138
S


2-1328
—(CH2)2
—NH—C(═O)—
K594
J134
S


2-1329
—(CH2)2
—NH—C(═O)—
K594
J200
S


2-1330
—(CH2)2
—NH—C(═O)—
K595
J9
S


2-1331
—(CH2)2
—NH—C(═O)—
K595
J126
S


2-1332
—(CH2)2
—NH—C(═O)—
K595
J129
S


2-1333
—(CH2)2
—NH—C(═O)—
K595
J130
S


2-1334
—(CH2)2
—NH—C(═O)—
K595
J138
S


2-1335
—(CH2)2
—NH—C(═O)—
K595
J135
S


2-1336
—(CH2)2
—NH—C(═O)—
K595
J201
S


2-1337
—(CH2)2
—NH—C(═O)—
K596
J9
S


2-1338
—(CH2)2
—NH—C(═O)—
K596
J126
S


2-1339
—(CH2)2
—NH—C(═O)—
K596
J129
S


2-1340
—(CH2)2
—NH—C(═O)—
K596
J130
S


2-1341
—(CH2)2
—NH—C(═O)—
K596
J138
S


2-1342
—(CH2)2
—NH—C(═O)—
K596
J135
S


2-1343
—(CH2)2
—NH—C(═O)—
K596
J201
S


2-1344
—(CH2)2
—NH—C(═O)—
K597
J9
S





















TABLE 77








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1345
—(CH2)2
—NH—C(═O)—
K598
J9
S


2-1346
—(CH2)2
—NH—C(═O)—
K599
J9
S


2-1347
—(CH2)2
—NH—C(═O)—
K6
J9
S


2-1348
—(CH2)2
—NH—C(═O)—
K60
J9
S


2-1349
—(CH2)2
—NH—C(═O)—
K60
J126
S


2-1350
—(CH2)2
—NH—C(═O)—
K60
J129
S


2-1351
—(CH2)2
—NH—C(═O)—
K60
J130
S


2-1352
—(CH2)2
—NH—C(═O)—
K60
J138
S


2-1353
—(CH2)2
—NH—C(═O)—
K600
J9
S


2-1354
—(CH2)2
—NH—C(═O)—
K601
J9
S


2-1355
—(CH2)2
—NH—C(═O)—
K602
J9
S


2-1356
—(CH2)2
—NH—C(═O)—
K608
J136
S


2-1357
—(CH2)2
—NH—C(═O)—
K608
J202
S


2-1358
—(CH2)2
—NH—C(═O)—
K61
J9
S


2-1359
—(CH2)2
—NH—C(═O)—
K61
J126
S


2-1360
—(CH2)2
—NH—C(═O)—
K61
J129
S


2-1361
—(CH2)2
—NH—C(═O)—
K61
J130
S


2-1362
—(CH2)2
—NH—C(═O)—
K61
J138
S


2-1363
—(CH2)2
—NH—C(═O)—
K611
J136
S


2-1364
—(CH2)2
—NH—C(═O)—
K611
J202
S


2-1365
—(CH2)2
—NH—C(═O)—
K618
J9
S


2-1366
—(CH2)2
—NH—C(═O)—
K618
J126
S


2-1367
—(CH2)2
—NH—C(═O)—
K618
J129
S


2-1368
—(CH2)2
—NH—C(═O)—
K618
J130
S


2-1369
—(CH2)2
—NH—C(═O)—
K618
J138
S


2-1370
—(CH2)2
—NH—C(═O)—
K618
J137
S


2-1371
—(CH2)2
—NH—C(═O)—
K618
J203
S


2-1372
—(CH2)2
—NH—C(═O)—
K619
J9
S


2-1373
—(CH2)2
—NH—C(═O)—
K619
J126
S


2-1374
—(CH2)2
—NH—C(═O)—
K619
J129
S


2-1375
—(CH2)2
—NH—C(═O)—
K619
J130
S


2-1376
—(CH2)2
—NH—C(═O)—
K619
J138
S





















TABLE 78








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







2-1377
—(CH2)2
—NH—C(═O)—
K62
J9
S


2-1378
—(CH2)2
—NH—C(═O)—
K62
J126
S


2-1379
—(CH2)2
—NH—C(═O)—
K62
J129
S


2-1380
—(CH2)2
—NH—C(═O)—
K62
J130
S


2-1381
—(CH2)2
—NH—C(═O)—
K62
J138
S


2-1382
—(CH2)2
—NH—C(═O)—
K620
J9
S


2-1383
—(CH2)2
—NH—C(═O)—
K620
J126
S


2-1384
—(CH2)2
—NH—C(═O)—
K620
J129
S


2-1385
—(CH2)2
—NH—C(═O)—
K620
J130
S


2-1386
—(CH2)2
—NH—C(═O)—
K620
J138
S


2-1387
—(CH2)2
—NH—C(═O)—
K621
J9
S


2-1388
—(CH2)2
—NH—C(═O)—
K622
J9
S


2-1389
—(CH2)2
—NH—C(═O)—
K623
J9
S


2-1390
—(CH2)2
—NH—C(═O)—
K623
J126
S


2-1391
—(CH2)2
—NH—C(═O)—
K623
J129
S


2-1392
—(CH2)2
—NH—C(═O)—
K623
J130
S


2-1393
—(CH2)2
—NH—C(═O)—
K623
J138
S


2-1394
—(CH2)2
—NH—C(═O)—
K623
J137
S


2-1395
—(CH2)2
—NH—C(═O)—
K623
J203
S


2-1396
—(CH2)2
—NH—C(═O)—
K624
J9
S


2-1397
—(CH2)2
—NH—C(═O)—
K624
J126
S


2-1398
—(CH2)2
—NH—C(═O)—
K624
J129
S


2-1399
—(CH2)2
—NH—C(═O)—
K624
J130
S


2-1400
—(CH2)2
—NH—C(═O)—
K624
J138
S


2-1401
—(CH2)2
—NH—C(═O)—
K625
J9
S


2-1402
—(CH2)2
—NH—C(═O)—
K625
J126
S


2-1403
—(CH2)2
—NH—C(═O)—
K625
J129
S


2-1404
—(CH2)2
—NH—C(═O)—
K625
J130
S


2-1405
—(CH2)2
—NH—C(═O)—
K625
J138
S


2-1406
—(CH2)2
—NH—C(═O)—
K626
J9
S


2-1407
—(CH2)2
—NH—C(═O)—
K626
J126
S


2-1408
—(CH2)2
—NH—C(═O)—
K626
J129
S





















TABLE 79








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1409
—(CH2)2
—NH—C(═O)—
K626
J130
S


2-1410
—(CH2)2
—NH—C(═O)—
K626
J138
S


2-1411
—(CH2)2
—NH—C(═O)—
K627
J9
S


2-1412
—(CH2)2
—NH—C(═O)—
K627
J126
S


2-1413
—(CH2)2
—NH—C(═O)—
K627
J129
S


2-1414
—(CH2)2
—NH—C(═O)—
K627
J130
S


2-1415
—(CH2)2
—NH—C(═O)—
K627
J138
S


2-1416
—(CH2)2
—NH—C(═O)—
K628
J9
S


2-1417
—(CH2)2
—NH—C(═O)—
K629
J9
S


2-1418
—(CH2)2
—NH—C(═O)—
K63
J9
S


2-1419
—(CH2)2
—NH—C(═O)—
K63
J126
S


2-1420
—(CH2)2
—NH—C(═O)—
K63
J129
S


2-1421
—(CH2)2
—NH—C(═O)—
K63
J130
S


2-1422
—(CH2)2
—NH—C(═O)—
K63
J138
S


2-1423
—(CH2)2
—NH—C(═O)—
K630
J9
S


2-1424
—(CH2)2
—NH—C(═O)—
K631
J9
S


2-1425
—(CH2)2
—NH—C(═O)—
K632
J9
S


2-1426
—(CH2)2
—NH—C(═O)—
K633
J9
S


2-1427
—(CH2)2
—NH—C(═O)—
K633
J126
S


2-1428
—(CH2)2
—NH—C(═O)—
K633
J129
S


2-1429
—(CH2)2
—NH—C(═O)—
K633
J130
S


2-1430
—(CH2)2
—NH—C(═O)—
K633
J138
S


2-1431
—(CH2)2
—NH—C(═O)—
K634
J9
S


2-1432
—(CH2)2
—NH—C(═O)—
K634
J126
S


2-1433
—(CH2)2
—NH—C(═O)—
K634
J129
S


2-1434
—(CH2)2
—NH—C(═O)—
K634
J130
S


2-1435
—(CH2)2
—NH—C(═O)—
K634
J138
S


2-1436
—(CH2)2
—NH—C(═O)—
K634
J139
S


2-1437
—(CH2)2
—NH—C(═O)—
K634
J204
S


2-1438
—(CH2)2
—NH—C(═O)—
K635
J9
S


2-1439
—(CH2)2
—NH—C(═O)—
K635
J126
S


2-1440
—(CH2)2
—NH—C(═O)—
K635
J129
S





















TABLE 80








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1441
—(CH2)2
—NH—C(═O)—
K635
J130
S


2-1442
—(CH2)2
—NH—C(═O)—
K635
J138
S


2-1443
—(CH2)2
—NH—C(═O)—
K635
J139
S


2-1444
—(CH2)2
—NH—C(═O)—
K635
J204
S


2-1445
—(CH2)2
—NH—C(═O)—
K636
J9
S


2-1446
—(CH2)2
—NH—C(═O)—
K636
J126
S


2-1447
—(CH2)2
—NH—C(═O)—
K636
J129
S


2-1448
—(CH2)2
—NH—C(═O)—
K636
J130
S


2-1449
—(CH2)2
—NH—C(═O)—
K636
J138
S


2-1450
—(CH2)2
—NH—C(═O)—
K636
J140
S


2-1451
—(CH2)2
—NH—C(═O)—
K636
J205
S


2-1452
—(CH2)2
—NH—C(═O)—
K637
J9
S


2-1453
—(CH2)2
—NH—C(═O)—
K637
J140
S


2-1454
—(CH2)2
—NH—C(═O)—
K637
J205
S


2-1455
—(CH2)2
—NH—C(═O)—
K638
J9
S


2-1456
—(CH2)2
—NH—C(═O)—
K638
J144
S


2-1457
—(CH2)2
—NH—C(═O)—
K638
J206
S


2-1458
—(CH2)2
—NH—C(═O)—
K639
J9
S


2-1459
—(CH2)2
—NH—C(═O)—
K639
J144
S


2-1460
—(CH2)2
—NH—C(═O)—
K639
J206
S


2-1461
—(CH2)2
—NH—C(═O)—
K64
J9
S


2-1462
—(CH2)2
—NH—C(═O)—
K64
J126
S


2-1463
—(CH2)2
—NH—C(═O)—
K64
J129
S


2-1464
—(CH2)2
—NH—C(═O)—
K64
J130
S


2-1465
—(CH2)2
—NH—C(═O)—
K64
J138
S


2-1466
—(CH2)2
—NH—C(═O)—
K640
J9
S


2-1467
—(CH2)2
—NH—C(═O)—
K641
J9
S


2-1468
—(CH2)2
—NH—C(═O)—
K642
J9
S


2-1469
—(CH2)2
—NH—C(═O)—
K643
J9
S


2-1470
—(CH2)2
—NH—C(═O)—
K644
J9
S


2-1471
—(CH2)2
—NH—C(═O)—
K645
J9
S


2-1472
—(CH2)2
—NH—C(═O)—
K646
J9
S





















TABLE 81








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1473
—(CH2)2
—NH—C(═O)—
K647
J9
S


2-1474
—(CH2)2
—NH—C(═O)—
K648
J9
S


2-1475
—(CH2)2
—NH—C(═O)—
K648
J126
S


2-1476
—(CH2)2
—NH—C(═O)—
K648
J129
S


2-1477
—(CH2)2
—NH—C(═O)—
K648
J130
S


2-1478
—(CH2)2
—NH—C(═O)—
K648
J138
S


2-1479
—(CH2)2
—NH—C(═O)—
K649
J9
S


2-1480
—(CH2)2
—NH—C(═O)—
K65
J9
S


2-1481
—(CH2)2
—NH—C(═O)—
K65
J126
S


2-1482
—(CH2)2
—NH—C(═O)—
K65
J129
S


2-1483
—(CH2)2
—NH—C(═O)—
K65
J130
S


2-1484
—(CH2)2
—NH—C(═O)—
K65
J138
S


2-1485
—(CH2)2
—NH—C(═O)—
K650
J9
S


2-1486
—(CH2)2
—NH—C(═O)—
K651
J9
S


2-1487
—(CH2)2
—NH—C(═O)—
K652
J9
S


2-1488
—(CH2)2
—NH—C(═O)—
K653
J9
S


2-1489
—(CH2)2
—NH—C(═O)—
K654
J9
S


2-1490
—(CH2)2
—NH—C(═O)—
K655
J9
S


2-1491
—(CH2)2
—NH—C(═O)—
K655
J126
S


2-1492
—(CH2)2
—NH—C(═O)—
K655
J129
S


2-1493
—(CH2)2
—NH—C(═O)—
K655
J130
S


2-1494
—(CH2)2
—NH—C(═O)—
K655
J138
S


2-1495
—(CH2)2
—NH—C(═O)—
K655
J147
S


2-1496
—(CH2)2
—NH—C(═O)—
K655
J207
S


2-1497
—(CH2)2
—NH—C(═O)—
K656
J9
S


2-1498
—(CH2)2
—NH—C(═O)—
K657
J9
S


2-1499
—(CH2)2
—NH—C(═O)—
K658
J9
S


2-1500
—(CH2)2
—NH—C(═O)—
K659
J9
S


2-1501
—(CH2)2
—NH—C(═O)—
K66
J9
S


2-1502
—(CH2)2
—NH—C(═O)—
K66
J126
S


2-1503
—(CH2)2
—NH—C(═O)—
K66
J129
S


2-1504
—(CH2)2
—NH—C(═O)—
K66
J130
S





















TABLE 82








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1505
—(CH2)2
—NH—C(═O)—
K66
J138
S


2-1506
—(CH2)2
—NH—C(═O)—
K67
J9
S


2-1507
—(CH2)2
—NH—C(═O)—
K67
J126
S


2-1508
—(CH2)2
—NH—C(═O)—
K67
J129
S


2-1509
—(CH2)2
—NH—C(═O)—
K67
J130
S


2-1510
—(CH2)2
—NH—C(═O)—
K67
J138
S


2-1511
—(CH2)2
—NH—C(═O)—
K68
J9
S


2-1512
—(CH2)2
—NH—C(═O)—
K68
J126
S


2-1513
—(CH2)2
—NH—C(═O)—
K68
J129
S


2-1514
—(CH2)2
—NH—C(═O)—
K68
J130
S


2-1515
—(CH2)2
—NH—C(═O)—
K68
J138
S


2-1516
—(CH2)2
—NH—C(═O)—
K69
J9
S


2-1517
—(CH2)2
—NH—C(═O)—
K69
J126
S


2-1518
—(CH2)2
—NH—C(═O)—
K69
J129
S


2-1519
—(CH2)2
—NH—C(═O)—
K69
J130
S


2-1520
—(CH2)2
—NH—C(═O)—
K69
J138
S


2-1521
—(CH2)2
—NH—C(═O)—
K70
J9
S


2-1522
—(CH2)2
—NH—C(═O)—
K70
J126
S


2-1523
—(CH2)2
—NH—C(═O)—
K70
J129
S


2-1524
—(CH2)2
—NH—C(═O)—
K70
J130
S


2-1525
—(CH2)2
—NH—C(═O)—
K70
J138
S


2-1526
—(CH2)2
—NH—C(═O)—
K71
J9
S


2-1527
—(CH2)2
—NH—C(═O)—
K71
J126
S


2-1528
—(CH2)2
—NH—C(═O)—
K71
J129
S


2-1529
—(CH2)2
—NH—C(═O)—
K71
J130
S


2-1530
—(CH2)2
—NH—C(═O)—
K71
J138
S


2-1531
—(CH2)2
—NH—C(═O)—
K72
J9
S


2-1532
—(CH2)2
—NH—C(═O)—
K72
J126
S


2-1533
—(CH2)2
—NH—C(═O)—
K72
J129
S


2-1534
—(CH2)2
—NH—C(═O)—
K72
J130
S


2-1535
—(CH2)2
—NH—C(═O)—
K72
J138
S


2-1536
—(CH2)2
—NH—C(═O)—
K73
J9
S





















TABLE 83








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X




















2-1537
—(CH2)2
—NH—C(═O)—
K73
J126
S


2-1538
—(CH2)2
—NH—C(═O)—
K73
J129
S


2-1539
—(CH2)2
—NH—C(═O)—
K73
J130
S


2-1540
—(CH2)2
—NH—C(═O)—
K73
J138
S


2-1541
—(CH2)2
—NH—C(═O)—
K74
J9
S


2-1542
—(CH2)2
—NH—C(═O)—
K74
J126
S


2-1543
—(CH2)2
—NH—C(═O)—
K74
J129
S


2-1544
—(CH2)2
—NH—C(═O)—
K74
J130
S


2-1545
—(CH2)2
—NH—C(═O)—
K74
J138
S


2-1546
—(CH2)2
—NH—C(═O)—
K75
J9
S


2-1547
—(CH2)2
—NH—C(═O)—
K75
J126
S


2-1548
—(CH2)2
—NH—C(═O)—
K75
J129
S


2-1549
—(CH2)2
—NH—C(═O)—
K75
J130
S


2-1550
—(CH2)2
—NH—C(═O)—
K75
J138
S


2-1551
—(CH2)2
—NH—C(═O)—
K75
J3
S


2-1552
—(CH2)2
—NH—C(═O)—
K75
J148
S


2-1553
—(CH2)2
—NH—C(═O)—
K76
J9
S


2-1554
—(CH2)2
—NH—C(═O)—
K76
J126
S


2-1555
—(CH2)2
—NH—C(═O)—
K76
J129
S


2-1556
—(CH2)2
—NH—C(═O)—
K76
J130
S


2-1557
—(CH2)2
—NH—C(═O)—
K76
J138
S


2-1558
—(CH2)2
—NH—C(═O)—
K761
J126
S


2-1559
—(CH2)2
—NH—C(═O)—
K761
J129
S


2-1560
—(CH2)2
—NH—C(═O)—
K761
J130
S


2-1561
—(CH2)2
—NH—C(═O)—
K761
J138
S


2-1562
—(CH2)2
—NH—C(═O)—
K761
J147
S


2-1563
—(CH2)2
—NH—C(═O)—
K761
J207
S


2-1564
—(CH2)2
—NH—C(═O)—
K762
J126
S


2-1565
—(CH2)2
—NH—C(═O)—
K762
J129
S


2-1566
—(CH2)2
—NH—C(═O)—
K762
J130
S


2-1567
—(CH2)2
—NH—C(═O)—
K762
J138
S


2-1568
—(CH2)2
—NH—C(═O)—
K77
J9
S





















TABLE 84








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1569
—(CH2)2
—NH—C(═O)—
K77
J126
S


2-1570
—(CH2)2
—NH—C(═O)—
K77
J129
S


2-1571
—(CH2)2
—NH—C(═O)—
K77
J130
S


2-1572
—(CH2)2
—NH—C(═O)—
K77
J138
S


2-1573
—(CH2)2
—NH—C(═O)—
K77
J3
S


2-1574
—(CH2)2
—NH—C(═O)—
K77
J148
S


2-1575
—(CH2)2
—NH—C(═O)—
K78
J9
S


2-1576
—(CH2)2
—NH—C(═O)—
K78
J126
S


2-1577
—(CH2)2
—NH—C(═O)—
K78
J129
S


2-1578
—(CH2)2
—NH—C(═O)—
K78
J130
S


2-1579
—(CH2)2
—NH—C(═O)—
K78
J138
S


2-1580
—(CH2)2
—NH—C(═O)—
K78
J10
S


2-1581
—(CH2)2
—NH—C(═O)—
K78
J149
S


2-1582
—(CH2)2
—NH—C(═O)—
K79
J9
S


2-1583
—(CH2)2
—NH—C(═O)—
K79
J126
S


2-1584
—(CH2)2
—NH—C(═O)—
K79
J129
S


2-1585
—(CH2)2
—NH—C(═O)—
K79
J130
S


2-1586
—(CH2)2
—NH—C(═O)—
K79
J138
S


2-1587
—(CH2)2
—NH—C(═O)—
K79
J10
S


2-1588
—(CH2)2
—NH—C(═O)—
K79
J149
S


2-1589
—(CH2)2
—NH—C(═O)—
K8
J9
S


2-1590
—(CH2)2
—NH—C(═O)—
K80
J9
S


2-1591
—(CH2)2
—NH—C(═O)—
K80
J126
S


2-1592
—(CH2)2
—NH—C(═O)—
K80
J129
S


2-1593
—(CH2)2
—NH—C(═O)—
K80
J130
S


2-1594
—(CH2)2
—NH—C(═O)—
K80
J138
S


2-1595
—(CH2)2
—NH—C(═O)—
K81
J9
S


2-1596
—(CH2)2
—NH—C(═O)—
K81
J126
S


2-1597
—(CH2)2
—NH—C(═O)—
K81
J129
S


2-1598
—(CH2)2
—NH—C(═O)—
K81
J130
S


2-1599
—(CH2)2
—NH—C(═O)—
K81
J138
S


2-1600
—(CH2)2
—NH—C(═O)—
K82
J9
S





















TABLE 85








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1601
—(CH2)2
—NH—C(═O)—
K83
J9
S


2-1602
—(CH2)2
—NH—C(═O)—
K83
J126
S


2-1603
—(CH2)2
—NH—C(═O)—
K83
J129
S


2-1604
—(CH2)2
—NH—C(═O)—
K83
J130
S


2-1605
—(CH2)2
—NH—C(═O)—
K83
J138
S


2-1606
—(CH2)2
—NH—C(═O)—
K83
J14
S


2-1607
—(CH2)2
—NH—C(═O)—
K83
J150
S


2-1608
—(CH2)2
—NH—C(═O)—
K84
J9
S


2-1609
—(CH2)2
—NH—C(═O)—
K85
J9
S


2-1610
—(CH2)2
—NH—C(═O)—
K85
J126
S


2-1611
—(CH2)2
—NH—C(═O)—
K85
J129
S


2-1612
—(CH2)2
—NH—C(═O)—
K85
J130
S


2-1613
—(CH2)2
—NH—C(═O)—
K85
J138
S


2-1614
—(CH2)2
—NH—C(═O)—
K86
J9
S


2-1615
—(CH2)2
—NH—C(═O)—
K86
J126
S


2-1616
—(CH2)2
—NH—C(═O)—
K86
J129
S


2-1617
—(CH2)2
—NH—C(═O)—
K86
J130
S


2-1618
—(CH2)2
—NH—C(═O)—
K86
J138
S


2-1619
—(CH2)2
—NH—C(═O)—
K88
J126
S


2-1620
—(CH2)2
—NH—C(═O)—
K88
J129
S


2-1621
—(CH2)2
—NH—C(═O)—
K88
J130
S


2-1622
—(CH2)2
—NH—C(═O)—
K88
J138
S


2-1623
—(CH2)2
—NH—C(═O)—
K89
J9
S


2-1624
—(CH2)2
—NH—C(═O)—
K89
J126
S


2-1625
—(CH2)2
—NH—C(═O)—
K89
J129
S


2-1626
—(CH2)2
—NH—C(═O)—
K89
J130
S


2-1627
—(CH2)2
—NH—C(═O)—
K89
J138
S


2-1628
—(CH2)2
—NH—C(═O)—
K90
J9
S


2-1629
—(CH2)2
—NH—C(═O)—
K90
J126
S


2-1630
—(CH2)2
—NH—C(═O)—
K90
J129
S


2-1631
—(CH2)2
—NH—C(═O)—
K90
J130
S


2-1632
—(CH2)2
—NH—C(═O)—
K90
J138
S





















TABLE 86








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1633
—(CH2)2
—NH—C(═O)—
K91
J9
S


2-1634
—(CH2)2
—NH—C(═O)—
K91
J126
S


2-1635
—(CH2)2
—NH—C(═O)—
K91
J129
S


2-1636
—(CH2)2
—NH—C(═O)—
K91
J130
S


2-1637
—(CH2)2
—NH—C(═O)—
K91
J138
S


2-1638
—(CH2)2
—NH—C(═O)—
K92
J9
S


2-1639
—(CH2)2
—NH—C(═O)—
K92
J126
S


2-1640
—(CH2)2
—NH—C(═O)—
K92
J129
S


2-1641
—(CH2)2
—NH—C(═O)—
K92
J130
S


2-1642
—(CH2)2
—NH—C(═O)—
K92
J138
S


2-1643
—(CH2)2
—NH—C(═O)—
K93
J9
S


2-1644
—(CH2)2
—NH—C(═O)—
K93
J126
S


2-1645
—(CH2)2
—NH—C(═O)—
K93
J129
S


2-1646
—(CH2)2
—NH—C(═O)—
K93
J130
S


2-1647
—(CH2)2
—NH—C(═O)—
K93
J138
S


2-1648
—(CH2)2
—NH—C(═O)—
K94
J9
S


2-1649
—(CH2)2
—NH—C(═O)—
K94
J126
S


2-1650
—(CH2)2
—NH—C(═O)—
K94
J129
S


2-1651
—(CH2)2
—NH—C(═O)—
K94
J130
S


2-1652
—(CH2)2
—NH—C(═O)—
K94
J138
S


2-1653
—(CH2)2
—NH—C(═O)—
K95
J126
S


2-1654
—(CH2)2
—NH—C(═O)—
K95
J129
S


2-1655
—(CH2)2
—NH—C(═O)—
K95
J130
S


2-1656
—(CH2)2
—NH—C(═O)—
K95
J138
S


2-1657
—(CH2)2
—NH—C(═O)—
K96
J9
S


2-1658
—(CH2)2
—NH—C(═O)—
K96
J126
S


2-1659
—(CH2)2
—NH—C(═O)—
K96
J129
S


2-1660
—(CH2)2
—NH—C(═O)—
K96
J130
S


2-1661
—(CH2)2
—NH—C(═O)—
K96
J138
S


2-1662
—(CH2)2
—NH—C(═O)—
K99
J9
S


2-1663
—(CH2)2
—NH—C(═O)—
K241
J9
O


2-1664
—(CH2)2
—NH—C(═O)—
K241
J126
O





















TABLE 87








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1665
—(CH2)2
—NH—C(═O)—
K241
J129
O


2-1666
—(CH2)2
—NH—C(═O)—
K241
J130
O


2-1667
—(CH2)2
—NH—C(═O)—
K241
J138
O


2-1668
—(CH2)2
—NH—C(═O)—
K241
J3
O


2-1669
—(CH2)2
—NH—C(═O)—
K241
J10
O


2-1670
—(CH2)2
—NH—C(═O)—
K241
J14
O


2-1671
—(CH2)2
—NH—C(═O)—
K241
J16
O


2-1672
—(CH2)2
—NH—C(═O)—
K241
J19
O


2-1673
—(CH2)2
—NH—C(═O)—
K241
J22
O


2-1674
—(CH2)2
—NH—C(═O)—
K241
J25
O


2-1675
—(CH2)2
—NH—C(═O)—
K241
J26
O


2-1676
—(CH2)2
—NH—C(═O)—
K241
J28
O


2-1677
—(CH2)2
—NH—C(═O)—
K241
J29
O


2-1678
—(CH2)2
—NH—C(═O)—
K241
J31
O


2-1679
—(CH2)2
—NH—C(═O)—
K241
J33
O


2-1680
—(CH2)2
—NH—C(═O)—
K241
J34
O


2-1681
—(CH2)2
—NH—C(═O)—
K241
J37
O


2-1682
—(CH2)2
—NH—C(═O)—
K241
J57
O


2-1683
—(CH2)2
—NH—C(═O)—
K241
J58
O


2-1684
—(CH2)2
—NH—C(═O)—
K241
J59
O


2-1685
—(CH2)2
—NH—C(═O)—
K241
J70
O


2-1686
—(CH2)2
—NH—C(═O)—
K241
J71
O


2-1687
—(CH2)2
—NH—C(═O)—
K241
J72
O


2-1688
—(CH2)2
—NH—C(═O)—
K241
J74
O


2-1689
—(CH2)2
—NH—C(═O)—
K241
J75
O


2-1690
—(CH2)2
—NH—C(═O)—
K241
J76
O


2-1691
—(CH2)2
—NH—C(═O)—
K241
J77
O


2-1692
—(CH2)2
—NH—C(═O)—
K241
J78
O


2-1693
—(CH2)2
—NH—C(═O)—
K241
J79
O


2-1694
—(CH2)2
—NH—C(═O)—
K241
J81
O


2-1695
—(CH2)2
—NH—C(═O)—
K241
J83
O


2-1696
—(CH2)2
—NH—C(═O)—
K241
J84
O





















TABLE 88








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1697
—(CH2)2
—NH—C(═O)—
K241
J87
O


2-1698
—(CH2)2
—NH—C(═O)—
K241
J89
O


2-1699
—(CH2)2
—NH—C(═O)—
K241
J120
O


2-1700
—(CH2)2
—NH—C(═O)—
K241
J121
O


2-1701
—(CH2)2
—NH—C(═O)—
K241
J122
O


2-1702
—(CH2)2
—NH—C(═O)—
K241
J123
O


2-1703
—(CH2)2
—NH—C(═O)—
K241
J124
O


2-1704
—(CH2)2
—NH—C(═O)—
K241
J125
O


2-1705
—(CH2)2
—NH—C(═O)—
K241
J127
O


2-1706
—(CH2)2
—NH—C(═O)—
K241
J128
O


2-1707
—(CH2)2
—NH—C(═O)—
K241
J131
O


2-1708
—(CH2)2
—NH—C(═O)—
K241
J132
O


2-1709
—(CH2)2
—NH—C(═O)—
K241
J133
O


2-1710
—(CH2)2
—NH—C(═O)—
K241
J134
O


2-1711
—(CH2)2
—NH—C(═O)—
K241
J135
O


2-1712
—(CH2)2
—NH—C(═O)—
K241
J136
O


2-1713
—(CH2)2
—NH—C(═O)—
K241
J137
O


2-1714
—(CH2)2
—NH—C(═O)—
K241
J139
O


2-1715
—(CH2)2
—NH—C(═O)—
K241
J140
O


2-1716
—(CH2)2
—NH—C(═O)—
K241
J144
O


2-1717
—(CH2)2
—NH—C(═O)—
K241
J147
O


2-1718
—(CH2)2
—NH—C(═O)—
K241
J148
O


2-1719
—(CH2)2
—NH—C(═O)—
K241
J149
O


2-1720
—(CH2)2
—NH—C(═O)—
K241
J150
O


2-1721
—(CH2)2
—NH—C(═O)—
K241
J151
O


2-1722
—(CH2)2
—NH—C(═O)—
K241
J152
O


2-1723
—(CH2)2
—NH—C(═O)—
K241
J153
O


2-1724
—(CH2)2
—NH—C(═O)—
K241
J154
O


2-1725
—(CH2)2
—NH—C(═O)—
K241
J155
O


2-1726
—(CH2)2
—NH—C(═O)—
K241
J156
O


2-1727
—(CH2)2
—NH—C(═O)—
K241
J157
O


2-1728
—(CH2)2
—NH—C(═O)—
K241
J158
O





















TABLE 89








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1729
—(CH2)2
—NH—C(═O)—
K241
J159
O


2-1730
—(CH2)2
—NH—C(═O)—
K241
J163
O


2-1731
—(CH2)2
—NH—C(═O)—
K241
J165
O


2-1732
—(CH2)2
—NH—C(═O)—
K241
J166
O


2-1733
—(CH2)2
—NH—C(═O)—
K241
J167
O


2-1734
—(CH2)2
—NH—C(═O)—
K241
J168
O


2-1735
—(CH2)2
—NH—C(═O)—
K241
J169
O


2-1736
—(CH2)2
—NH—C(═O)—
K241
J170
O


2-1737
—(CH2)2
—NH—C(═O)—
K241
J171
O


2-1738
—(CH2)2
—NH—C(═O)—
K241
J174
O


2-1739
—(CH2)2
—NH—C(═O)—
K241
J175
O


2-1740
—(CH2)2
—NH—C(═O)—
K241
J176
O


2-1741
—(CH2)2
—NH—C(═O)—
K241
J177
O


2-1742
—(CH2)2
—NH—C(═O)—
K241
J178
O


2-1743
—(CH2)2
—NH—C(═O)—
K241
J179
O


2-1744
—(CH2)2
—NH—C(═O)—
K241
J180
O


2-1745
—(CH2)2
—NH—C(═O)—
K241
J181
O


2-1746
—(CH2)2
—NH—C(═O)—
K241
J182
O


2-1747
—(CH2)2
—NH—C(═O)—
K241
J185
O


2-1748
—(CH2)2
—NH—C(═O)—
K241
J188
O


2-1749
—(CH2)2
—NH—C(═O)—
K241
J189
O


2-1750
—(CH2)2
—NH—C(═O)—
K241
J190
O


2-1751
—(CH2)2
—NH—C(═O)—
K241
J191
O


2-1752
—(CH2)2
—NH—C(═O)—
K241
J192
O


2-1753
—(CH2)2
—NH—C(═O)—
K241
J193
O


2-1754
—(CH2)2
—NH—C(═O)—
K241
J194
O


2-1755
—(CH2)2
—NH—C(═O)—
K241
J195
O


2-1756
—(CH2)2
—NH—C(═O)—
K241
J196
O


2-1757
—(CH2)2
—NH—C(═O)—
K241
J197
O


2-1758
—(CH2)2
—NH—C(═O)—
K241
J198
O


2-1759
—(CH2)2
—NH—C(═O)—
K241
J199
O


2-1760
—(CH2)2
—NH—C(═O)—
K241
J200
O





















TABLE 90











-G1-







A3-


Compound


A4-
-A5-


No.
-A1-
-A2-
G2
R2
X







2-1761
—(CH2)2
—NH—C(═O)—
K241
J201
O


2-1762
—(CH2)2
—NH—C(═O)—
K241
J202
O


2-1763
—(CH2)2
—NH—C(═O)—
K241
J203
O


2-1764
—(CH2)2
—NH—C(═O)—
K241
J204
O


2-1765
—(CH2)2
—NH—C(═O)—
K241
J205
O


2-1766
—(CH2)2
—NH—C(═O)—
K241
J206
O


2-1767
—(CH2)2
—NH—C(═O)—
K241
J207
O


2-1768
—(CH2)3
—NH—C(═O)—
K11
J9
S


2-1769
—(CH2)3
—NH—C(═O)—
K49
J9
S


2-1770
—(CH2)3
—NH—C(═O)—
K34
J9
S


2-1771
—(CH2)3
—NH—
K661
J9
S


2-1772
—(CH2)3
—NH—
K663
J9
S


2-1773
—(CH2)3
—NH—
K665
J9
S


2-1774
—(CH2)3
—NH—
K667
J9
S


2-1775
—(CH2)2
—NH—
K99
J9
S


2-1776
—(CH2)2
—NH—C(═O)—NH—
K11
J9
S


2-1777
—(CH2)2
—NH—C(═O)—NH—
K478
J9
S


2-1778
—(CH2)3
—NH—C(═O)—NH—
K11
J9
S


2-1779
—(CH2)3
—NH—C(═O)—NH—
K478
J9
S


2-1780
—(CH2)2
—NH—C(═O)—NH—
K721
J9
S


2-1781
—(CH2)2
—NH—C(═O)—NH—
K722
J9
S


2-1782
—(CH2)2
—NH—C(═O)—NH—
K723
J9
S


2-1783
—(CH2)2
—NH—C(═O)—NH—
K281
J9
S


2-1784
—(CH2)3
—NH—C(═O)—NH—
K721
J9
S


2-1785
—(CH2)3
—NH—C(═O)—NH—
K722
J9
S


2-1786
—(CH2)3
—NH—C(═O)—NH—
K723
J9
S


2-1787
—(CH2)3
—NH—C(═S)—NH—
K281
J9
S


2-1788
—(CH2)2
—NH—C(═O)—NH—
K435
J9
S


2-1789
—(CH2)3
—NH—C(═O)—NH—
K434
J9
S


2-1790
—(CH2)3
—NH—C(═O)—NH—
K435
J9
S


2-1791
—(CH2)3
—NH—C(═O)—NH—
K724
J9
S


2-1792
—(CH2)2
—NH—C(═S)—NH—
K34
J9
S





















TABLE 91











-G1-







A3-


Compound


A4-
-A5-


No.
-A1-
-A2-
G2
R2
X







2-1793
—(CH2)2
—NH—C(═O)—NH—
K15
J9
S


2-1794
—(CH2)2
—NH—C(═O)—NH—
K283
J9
S


2-1795
—(CH2)2
—NH—C(═O)—NH—
K469
J9
S


2-1796
—(CH2)2
—NH—C(═O)—NH—
K19
J9
S


2-1797
—(CH2)2
—NH—C(═O)—NH—
K589
J9
S


2-1798
—(CH2)2
—NH—C(═O)—NH—
K630
J9
S


2-1799
—(CH2)2
—NH—C(═O)—NH—
K47
J9
S


2-1800
—(CH2)2
—NH—C(═O)—NH—
K285
J9
S


2-1801
—(CH2)2
—NH—C(═O)—NH—
K535
J9
S


2-1802
—(CH2)2
—NH—C(═O)—NH—
K646
J9
S


2-1803
—(CH2)3
—NH—C(═O)—
K1
J9
S


2-1804
—(CH2)2
—NH—C(═O)—
K241
J78
S


2-1805
—(CH2)3
—NH—C(═O)—
K241
J78
S


2-1806
—(CH2)2
—NH—C(═O)—
K7
J9
S


2-1807
—(CH2)2
—NH—C(═O)—
K11
J78
S


2-1808
—(CH2)2
—NH—C(═O)—
K99
J78
S


2-1809
—(CH2)2
—NH—C(═O)—
K24
J78
S


2-1810
—(CH2)2
—NH—C(═O)—
K62
J78
S


2-1811
—(CH2)2
—NH—C(═O)—
K72
J78
S


2-1812
—(CH2)2
—NH—C(═O)—NH—
K11
J78
S


2-1813
—(CH2)2
—NH—C(═O)—NH—
K49
J78
S


2-1814
—(CH2)3
—NH—C(═O)—
K11
J78
S


2-1815
—(CH2)3
—NH—C(═O)—
K99
J78
S


2-1816
—(CH2)3
—NH—C(═O)—
K24
J78
S


2-1817
—(CH2)3
—NH—C(═O)—
K62
J78
S


2-1818
—(CH2)3
—NH—C(═O)—
K72
J78
S


2-1819
—(CH2)2
—NH—C(═O)—
K679
J9
S


2-1820
—(CH2)2
—NH—C(═O)—
K106
J9
S


2-1821
—(CH2)2
—NH—C(═O)—
K271
J9
S


2-1822
—(CH2)2
—NH—C(═O)—
K283
K283
S


2-1823
—(CH2)2
—NH—C(═O)—
K5
J9
S


2-1824
—(CH2)2
—NH—C(═O)—
K29
J126
S





















TABLE 92








Com-


-G1-A3-




pound No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1825
—(CH2)2
—NH—C(═O)—
K28
J126
S


2-1826
—(CH2)2
—NH—C(═O)—
K99
J126
S


2-1827
—(CH2)2
—NH—C(═O)—
K309
J9
S


2-1828
—(CH2)2
—NH—C(═O)—
K469
J9
S


2-1829
—(CH2)2
—NH—C(═O)—
K11
J57
S


2-1830
—(CH2)2
—NH—C(═O)—
K463
J9
S


2-1831
—(CH2)2
—NH—C(═O)—
K680
J9
S


2-1832
—(CH2)2
—NH—C(═O)—
K681
J9
S


2-1833
—(CH2)2
—NH—C(═O)—
K682
J9
S


2-1834
—(CH2)2
—NH—C(═O)—
K683
J9
S


2-1835
—(CH2)2
—NH—C(═O)—
K283
J78
S


2-1836
—(CH2)2
—NH—C(═S)—
K11
J57
S


2-1837
—(CH2)2
—NH—C(═O)—
K684
J9
S


2-1838
—(CH2)2
—NH—C(═O)—
K685
J9
S


2-1839
—(CH2)2
—NH—C(═O)—
K686
J9
S


2-1840
—(CH2)2
—NH—C(═O)—
K687
J9
S


2-1841
—(CH2)2
—NH—C(═O)—
K688
J9
S


2-1842
—(CH2)2
single bond
K612
J9
S


2-1843
—(CH2)2
—NH—C(═O)—
K613
J9
S


2-1844
—(CH2)2
—NH—C(═O)—
K675
J9
S


2-1845
—(CH2)2
—NH—C(═O)—
K676
J9
S


2-1846
—(CH2)2
—NH—C(═O)—
K677
J9
S


2-1847
—(CH2)2
—NH—C(═O)—
K678
J9
S


2-1848
—(CH2)2
single bond
K613
J9
S


2-1849
—(CH2)2
single bond
K614
J9
S


2-1850
—(CH2)3
—NH—C(═O)—
K676
J9
S


2-1851
—(CH2)3
—NH—C(═O)—
K546
J9
S


2-1852
—(CH2)3
—NH—C(═O)—
K677
J9
S


2-1853
—(CH2)3
—NH—C(═O)—
K678
J9
S


2-1854
—(CH2)3
single bond
K612
J9
S


2-1855
—(CH2)2
—N(CH3)—C(═O)—
K241
J9
S


2-1856
—(CH2)2
—N(CH3)—C(═O)—
K11
J9
S





















TABLE 93








Com-


-G1-A3-




pound No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1857
—(CH2)2
—N(CH3)—C(═O)—
K243
J9
S


2-1858
—(CH2)2
—N(CH3)—C(═O)—
K545
J9
S


2-1859
—(CH2)2
—N(CH3)—C(═O)—
K284
J9
S


2-1860
—(CH2)2
—NH—C(═O)—
K689
J9
S


2-1861
—(CH2)2
—NH—C(═O)—
K468
J9
S


2-1862
—(CH2)2
—NH—C(═O)—
K134
J9
S


2-1863
—(CH2)2
—NH—C(═O)—
K690
J9
S


2-1864
—(CH2)2
—NH—C(═O)—
K218
J9
S


2-1865
—(CH2)2
—NH—C(═O)—
K691
J9
S


2-1866
—(CH2)2
—NH—C(═O)—
K692
J9
S


2-1867
—(CH2)2
—NH—C(═O)—
K122
J9
S


2-1868
—(CH2)2
—NH—C(═O)—
K693
J9
S


2-1869
—(CH2)2
—NH—C(═O)—
K694
J9
S


2-1870
—(CH2)2
—NH—C(═O)—
K100
J9
S


2-1871
—(CH2)2
—NH—C(═O)—
K695
J9
S


2-1872
—(CH2)2
—NH—C(═O)—
K273
J9
S


2-1873
—(CH2)2
—NH—C(═O)—
K101
J9
S


2-1874
—(CH2)2
—NH—C(═O)—
K672
J9
S


2-1875
—(CH2)2
—NH—C(═O)—
K471
J9
S


2-1876
—(CH2)2
—NH—C(═O)—
K674
J9
S


2-1877
—(CH2)2
—NH—C(═O)—
K697
J9
S


2-1878
—(CH2)2
—NH—C(═O)—
K698
J9
S


2-1879
—(CH2)2
—NH—C(═O)—
K3
J9
S


2-1880
—(CH2)2
—NH—C(═O)—
K87
J9
S


2-1881
—(CH2)2
—NH—C(═O)—
K700
J9
S


2-1882
—(CH2)2
—NH—C(═O)—
K702
J9
S


2-1883
—(CH2)2
—NH—C(═O)—
K704
J9
S


2-1884
—(CH2)2
—NH—C(═O)—
K706
J9
S


2-1885
—(CH2)2
—NH—C(═O)—
K705
J9
S


2-1886
—(CH2)2
—NH—C(═O)—
K703
J9
S


2-1887
—(CH2)2
—NH—C(═O)—
K708
J9
S


2-1888
—(CH2)2
—NH—C(═O)—
K709
J9
S





















TABLE 94








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1889
—(CH2)2
—NH—C(═O)—
K710
J9
S


2-1890
—(CH2)2
—NH—C(═O)—
K711
J9
S


2-1891
—(CH2)2
—NH—C(═O)—
K712
J9
S


2-1892
—(CH2)2
—NH—C(═O)—
K718
J9
S


2-1893
—(CH2)2
—NH—C(═O)—
K714
J9
S


2-1894
—(CH2)2
—NH—C(═O)—
K715
J9
S


2-1895
—(CH2)2
—NH—C(═O)—
K11
J1
S


2-1896
—(CH2)2
—NH—C(═O)—
K11
J178
S


2-1897
—(CH2)2
—NH—C(═O)—
K11
J22
S


2-1898
—(CH2)2
—NH—C(═O)—
K669
J9
S


2-1899
—(CH2)2
—NH—C(═O)—
K716
J9
S


2-1900
—(CH2)2
—NH—C(═O)—
K717
J9
S


2-1901
—(CH2)2
—NH—C(═O)—
K713
J9
S


2-1902
—(CH2)2
—NH—C(═O)—
K719
J9
S


2-1903
—(CH2)2
—NH—C(═O)—
K435
J9
S


2-1904
—(CH2)2
—NH—C(═O)—
K720
J9
S


2-1905
—(CH2)2
—NH—S(═O)2
K11
J9
S


2-1906
—(CH2)2
—NH—C(═O)—
K11
J19
S


2-1907
—(CH2)2
—NH—C(═S)—
K11
J19
S


2-1908
—(CH2)2
—NH—C(═O)—
K11
J151
S


2-1909
—(CH2)2
—NH—C(═O)—
K11
J140
S


2-1910
—(CH2)2
—NH—C(═O)—
K283
J140
S


2-1911
—(CH2)2
—NH—C(═O)—
K49
J140
S


2-1912
—(CH2)2
—NH—C(═O)—
K24
J140
S


2-1913
—(CH2)2
—NH—C(═O)—
K243
J140
S


2-1914
—(CH2)2
—NH—C(═O)—
K247
J140
S


2-1915
—(CH2)2
—NH—C(═O)—
K244
J140
S


2-1916
—(CH2)2
—NH—C(═O)—
K60
J140
S


2-1917
—(CH2)2
—NH—C(═O)—
K62
J140
S


2-1918
—(CH2)2
—NH—C(═O)—
K64
J140
S


2-1919
—(CH2)2
—NH—C(═O)—
K11
J176
S


2-1920
—(CH2)2
—NH—C(═S)—
K11
J176
S





















TABLE 95








Com-







pound


-G1-A3-


No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1921
—(CH2)2
—NH—C(═O)—
K11
J185
S


2-1922
—(CH2)2
—NH—C(═O)—
K11
J49
S


2-1923
—(CH2)2
—NH—C(═O)—
K11
J150
S


2-1924
—(CH2)2
—NH—C(═O)—
K11
J37
S


2-1925
—(CH2)2
—NH—C(═O)—
K11
J169
S


2-1926
—(CH2)2
—NH—C(═O)—
K11
J171
S


2-1927
—(CH2)2
—NH—C(═O)—
K658
J130
S


2-1928
—(CH2)2
—NH—C(═O)—
K543
J130
S


2-1929
—(CH2)2
—NH—C(═O)—
K632
J130
S


2-1930
—(CH2)2
—NH—C(═O)—
K761
J9
S


2-1931
—(CH2)2
—NH—
K661
J9
S


2-1932
—(CH2)2
—NH—
K663
J9
S


2-1933
—(CH2)2
—NH—
K665
J9
S


2-1934
—(CH2)2
—NH—
K667
J9
S


2-1935
—(CH2)2
—NH—
K668
J9
S


2-1936
—(CH2)2
—NH—
K669
J9
S


2-1937
—(CH2)2
—NH—
K670
J9
S


2-1938
—(CH2)2
—NH—C(═O)—NH—
K434
J9
S


2-1939
—(CH2)2
—NH—C(═O)—NH—
K724
J9
S


2-1940
—(CH2)2
—NH—C(═O)—NH—
K34
J9
S


2-1941
—(CH2)2
—NH—C(═O)—NH—
K443
J9
S


2-1942
—(CH2)2
—NH—C(═O)—NH—
K32
J9
S


2-1943
—(CH2)2
—NH—C(═O)—NH—
K287
J9
S


2-1944
—(CH2)3
—NH—C(═O)—
K243
J9
S


2-1945
—(CH2)3
—NH—C(═O)—
K241
J9
S


2-1946
—(CH2)2
—NH—
K617
J129
S


2-1947
—(CH2)3
—NH—C(═O)—
K241
J9
O


2-1948
—(CH2)2
—NH—C(═O)—
K283
J9
O


2-1949
—(CH2)2
—NH—C(═O)—
K283
J126
O


2-1950
—(CH2)2
—NH—C(═O)—
K283
J129
O


2-1951
—(CH2)2
—NH—
K617
J129
O


2-1952
—(CH2)2
—NH—C(═O)—
K283
J1
O





















TABLE 96








Com-


-G1-A3-




pound No.
-A1-
-A2-
A4-G2
-A5-R2
X




















2-1953
—(CH2)2
—NH—C(═O)—
K11
J1
O


2-1954
—(CH2)2
—NH—C(═O)—
K11
J178
O


2-1955
—(CH2)3
—NH—C(═O)—
K241
J78
O


2-1956
—(CH2)2
—NH—C(═O)—
K283
J19
S


2-1957
—(CH2)2
—NH—C(═O)—
K283
J151
S


2-1958
—(CH2)2
—NH—C(═O)—O—
K5
J138
O


2-1959
—(CH2)2
—NH—C(═O)—O—
K5
J78
O


2-1960
—(CH2)2
—NH—C(═O)—O—
K5
J126
O


2-1961
—(CH2)2
—NH—C(═O)—O—
K5
J129
O


2-1962
—(CH2)2
—NH—C(═O)—O—
K5
J130
O


2-1963
—(CH2)3
—NH—C(═O)—O—
K5
J78
O


2-1964
—(CH2)2
—NH—C(═O)—O—
K5
J1
O


2-1965
—(CH2)2
—NH—
K767
J213
S


2-1966
—(CH2)2
—NH—
K775
J214
S


2-1967
—(CH2)2
—NH—
K763
J215
S


2-1968
—(CH2)2
—NH—
K766
J216
S


2-1969
—(CH2)2
—NH—
K813
J217
S


2-1970
—(CH2)2
—NH—
K774
J218
S


2-1971
—(CH2)2
—NH—
K764
J219
S


2-1972
—(CH2)2
—NH—
K769
J220
S


2-1973
—(CH2)2
—NH—
K821
J221
S


2-1974
—(CH2)2
—NH—
K776
J222
S


2-1975
—(CH2)2
—NH—
K778
J223
S


2-1976
—(CH2)2
—NH—
K777
J224
S


2-1977
—(CH2)2
—NH—
K767
J225
S


2-1978
—(CH2)2
—NH—
K766
J226
S


2-1979
—(CH2)2
—NH—
K819
J227
S


2-1980
—(CH2)2
—NH—
K765
J228
S


2-1981
—(CH2)2
—NH—
K780
J229
S


2-1982
—(CH2)2
—NH—
K776
J230
S


2-1983
—(CH2)2
—NH—
K814
J231
S


2-1984
—(CH2)2
—NH—
K775
J232
S





















TABLE 97








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-1985
—(CH2)2
—NH—
K771
J233
S


2-1986
—(CH2)2
—NH—
K765
J234
S


2-1987
—(CH2)2
—NH—
K779
J235
S


2-1988
—(CH2)2
—NH—
K773
J236
S


2-1989
—(CH2)2
—NH—
K768
J237
S


2-1990
—(CH2)2
—NH—
K770
J238
S


2-1991
—(CH2)2
—NH—
K767
J239
S


2-1992
—(CH2)2
—NH—
K811
J240
S


2-1993
—(CH2)2
—NH—
K808
J241
S


2-1994
—(CH2)2
—NH—
K763
J242
S


2-1995
—(CH2)2
—NH—
K772
J243
S


2-1996
—(CH2)2
—NH—C(═O)—
K585
J213
S


2-1997
—(CH2)2
—NH—C(═O)—
K577
J213
S


2-1998
—(CH2)2
—NH—C(═O)—
K516
J214
S


2-1999
—(CH2)2
—NH—C(═O)—
K634
J214
S


2-2000
—(CH2)2
—NH—C(═O)—
K581
J215
S


2-2001
—(CH2)2
—NH—C(═O)—
K618
J215
S


2-2002
—(CH2)2
—NH—C(═O)—
K573
J216
S


2-2003
—(CH2)2
—NH—C(═O)—
K500
J216
S


2-2004
—(CH2)2
—NH—C(═O)—
K513
J217
S


2-2005
—(CH2)2
—NH—C(═O)—
K548
J217
S


2-2006
—(CH2)2
—NH—C(═O)—
K577
J218
S


2-2007
—(CH2)2
—NH—C(═O)—
K629
J218
S


2-2008
—(CH2)2
—NH—C(═O)—
K618
J219
S


2-2009
—(CH2)2
—NH—C(═O)—
K578
J219
S


2-2010
—(CH2)2
—NH—C(═O)—
K585
J220
S


2-2011
—(CH2)2
—NH—C(═O)—
K594
J220
S


2-2012
—(CH2)2
—NH—C(═O)—
K427
J221
S


2-2013
—(CH2)2
—NH—C(═O)—
K583
J221
S


2-2014
—(CH2)2
—NH—C(═O)—
K607
J222
S


2-2015
—(CH2)2
—NH—C(═O)—
K580
J222
S


2-2016
—(CH2)2
—NH—C(═O)—
K297
J223
S





















TABLE 98








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-2017
—(CH2)2
—NH—C(═O)—
K575
J223
S


2-2018
—(CH2)2
—NH—C(═O)—
K247
J224
S


2-2019
—(CH2)2
—NH—C(═O)—
K627
J224
S


2-2020
—(CH2)2
—NH—C(═O)—
K246
J225
S


2-2021
—(CH2)2
—NH—C(═O)—
K243
J225
S


2-2022
—(CH2)2
—NH—C(═O)—
K80
J226
S


2-2023
—(CH2)2
—NH—C(═O)—
K54
J226
S


2-2024
—(CH2)2
—NH—C(═O)—
K623
J227
S


2-2025
—(CH2)2
—NH—C(═O)—
K245
J227
S


2-2026
—(CH2)2
—NH—C(═O)—
K246
J228
S


2-2027
—(CH2)2
—NH—C(═O)—
K582
J228
S


2-2028
—(CH2)2
—NH—C(═O)—
K609
J229
S


2-2029
—(CH2)2
—NH—C(═O)—
K611
J229
S


2-2030
—(CH2)2
—NH—C(═O)—
K576
J230
S


2-2031
—(CH2)2
—NH—C(═O)—
K585
J230
S


2-2032
—(CH2)2
—NH—C(═O)—
K244
J231
S


2-2033
—(CH2)2
—NH—C(═O)—
K82
J231
S


2-2034
—(CH2)2
—NH—C(═O)—
K66
J232
S


2-2035
—(CH2)2
—NH—C(═O)—
K248
J232
S


2-2036
—(CH2)2
—NH—C(═O)—
K639
J233
S


2-2037
—(CH2)2
—NH—C(═O)—
K85
J233
S


2-2038
—(CH2)2
—NH—C(═O)—
K249
J234
S


2-2039
—(CH2)2
—NH—C(═O)—
K245
J234
S


2-2040
—(CH2)2
—NH—C(═O)—
K632
J235
S


2-2041
—(CH2)2
—NH—C(═O)—
K246
J235
S


2-2042
—(CH2)2
—NH—C(═O)—
K242
J236
S


2-2043
—(CH2)2
—NH—C(═O)—
K618
J236
S


2-2044
—(CH2)2
—NH—C(═O)—
K60
J237
S


2-2045
—(CH2)2
—NH—C(═O)—
K581
J237
S


2-2046
—(CH2)2
—NH—C(═O)—
K64
J238
S


2-2047
—(CH2)2
—NH—C(═O)—
K247
J238
S


2-2048
—(CH2)2
—NH—C(═O)—
K577
J239
S





















TABLE 99








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-2049
—(CH2)2
—NH—C(═O)—
K67
J239
S


2-2050
—(CH2)2
—NH—C(═O)—
K573
J240
S


2-2051
—(CH2)2
—NH—C(═O)—
K244
J240
S


2-2052
—(CH2)2
—NH—C(═O)—
K69
J241
S


2-2053
—(CH2)2
—NH—C(═O)—
K583
J241
S


2-2054
—(CH2)2
—NH—C(═O)—
K580
J242
S


2-2055
—(CH2)2
—NH—C(═O)—
K68
J242
S


2-2056
—(CH2)2
—NH—C(═O)—
K245
J243
S


2-2057
—(CH2)2
—NH—C(═O)—
K578
J243
S


2-2058
—(CH2)2
—NH—
K808
J126
S


2-2059
—(CH2)2
—NH—
K808
J129
S


2-2060
—(CH2)2
—NH—
K808
J130
S


2-2061
—(CH2)2
—NH—
K808
J138
S


2-2062
—(CH2)2
—NH—
K809
J126
S


2-2063
—(CH2)2
—NH—
K809
J129
S


2-2064
—(CH2)2
—NH—
K809
J130
S


2-2065
—(CH2)2
—NH—
K809
J138
S


2-2066
—(CH2)2
—NH—
K810
J126
S


2-2067
—(CH2)2
—NH—
K810
J129
S


2-2068
—(CH2)2
—NH—
K810
J130
S


2-2069
—(CH2)2
—NH—
K810
J138
S


2-2070
—(CH2)2
—NH—
K811
J126
S


2-2071
—(CH2)2
—NH—
K811
J129
S


2-2072
—(CH2)2
—NH—
K811
J130
S


2-2073
—(CH2)2
—NH—
K811
J138
S


2-2074
—(CH2)2
—NH—
K812
J126
S


2-2075
—(CH2)2
—NH—
K812
J129
S


2-2076
—(CH2)2
—NH—
K812
J130
S


2-2077
—(CH2)2
—NH—
K812
J138
S


2-2078
—(CH2)2
—NH—
K813
J126
S


2-2079
—(CH2)2
—NH—
K813
J129
S


2-2080
—(CH2)2
—NH—
K813
J130
S





















TABLE 100








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







2-2081
—(CH2)2
—NH—
K813
J138
S


2-2082
—(CH2)2
—NH—
K814
J126
S


2-2083
—(CH2)2
—NH—
K814
J129
S


2-2084
—(CH2)2
—NH—
K814
J130
S


2-2085
—(CH2)2
—NH—
K814
J138
S


2-2086
—(CH2)2
—NH—
K815
J126
S


2-2087
—(CH2)2
—NH—
K815
J129
S


2-2088
—(CH2)2
—NH—
K815
J130
S


2-2089
—(CH2)2
—NH—
K815
J138
S


2-2090
—(CH2)2
—NH—
K816
J126
S


2-2091
—(CH2)2
—NH—
K816
J129
S


2-2092
—(CH2)2
—NH—
K816
J130
S


2-2093
—(CH2)2
—NH—
K816
J138
S


2-2094
—(CH2)2
—NH—
K817
J126
S


2-2095
—(CH2)2
—NH—
K817
J129
S


2-2096
—(CH2)2
—NH—
K817
J130
S


2-2097
—(CH2)2
—NH—
K817
J138
S


2-2098
—(CH2)2
—NH—
K818
J126
S


2-2099
—(CH2)2
—NH—
K818
J129
S


2-2100
—(CH2)2
—NH—
K818
J130
S


2-2101
—(CH2)2
—NH—
K818
J138
S


2-2102
—(CH2)2
—NH—
K819
J126
S


2-2103
—(CH2)2
—NH—
K819
J129
S


2-2104
—(CH2)2
—NH—
K819
J130
S


2-2105
—(CH2)2
—NH—
K819
J138
S


2-2106
—(CH2)2
—NH—
K820
J126
S


2-2107
—(CH2)2
—NH—
K820
J129
S


2-2108
—(CH2)2
—NH—
K820
J130
S


2-2109
—(CH2)2
—NH—
K820
J138
S


2-2110
—(CH2)2
—NH—
K821
J126
S


2-2111
—(CH2)2
—NH—
K821
J129
S


2-2112
—(CH2)2
—NH—
K821
J130
S





















TABLE 101








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-2113
—(CH2)2
—NH—
K821
J138
S


2-2114
—(CH2)2
—NH—C(═O)—
K797
J126
S


2-2115
—(CH2)2
—NH—C(═O)—
K797
J129
S


2-2116
—(CH2)2
—NH—C(═O)—
K797
J130
S


2-2117
—(CH2)2
—NH—C(═O)—
K797
J138
S


2-2118
—(CH2)2
—NH—C(═O)—
K798
J126
S


2-2119
—(CH2)2
—NH—C(═O)—
K798
J129
S


2-2120
—(CH2)2
—NH—C(═O)—
K798
J130
S


2-2121
—(CH2)2
—NH—C(═O)—
K798
J138
S


2-2122
—(CH2)2
—NH—C(═O)—
K799
J126
S


2-2123
—(CH2)2
—NH—C(═O)—
K799
J129
S


2-2124
—(CH2)2
—NH—C(═O)—
K799
J130
S


2-2125
—(CH2)2
—NH—C(═O)—
K799
J138
S


2-2126
—(CH2)2
—NH—C(═O)—
K800
J126
S


2-2127
—(CH2)2
—NH—C(═O)—
K800
J129
S


2-2128
—(CH2)2
—NH—C(═O)—
K800
J130
S


2-2129
—(CH2)2
—NH—C(═O)—
K800
J138
S


2-2130
—(CH2)2
—NH—C(═O)—
K801
J126
S


2-2131
—(CH2)2
—NH—C(═O)—
K801
J129
S


2-2132
—(CH2)2
—NH—C(═O)—
K801
J130
S


2-2133
—(CH2)2
—NH—C(═O)—
K801
J138
S


2-2134
—(CH2)2
—NH—C(═O)—
K802
J126
S


2-2135
—(CH2)2
—NH—C(═O)—
K802
J129
S


2-2136
—(CH2)2
—NH—C(═O)—
K802
J130
S


2-2137
—(CH2)2
—NH—C(═O)—
K802
J138
S


2-2138
—(CH2)2
—NH—C(═O)—
K803
J126
S


2-2139
—(CH2)2
—NH—C(═O)—
K803
J129
S


2-2140
—(CH2)2
—NH—C(═O)—
K803
J130
S


2-2141
—(CH2)2
—NH—C(═O)—
K803
J138
S


2-2142
—(CH2)2
—NH—C(═O)—
K804
J126
S


2-2143
—(CH2)2
—NH—C(═O)—
K804
J129
S


2-2144
—(CH2)2
—NH—C(═O)—
K804
J130
S





















TABLE 102








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







2-2145
—(CH2)2
—NH—C(═O)—
K804
J138
S


2-2146
—(CH2)2
—NH—C(═O)—
K805
J126
S


2-2147
—(CH2)2
—NH—C(═O)—
K805
J129
S


2-2148
—(CH2)2
—NH—C(═O)—
K805
J130
S


2-2149
—(CH2)2
—NH—C(═O)—
K805
J138
S


2-2150
—(CH2)2
—NH—C(═O)—
K806
J126
S


2-2151
—(CH2)2
—NH—C(═O)—
K806
J129
S


2-2152
—(CH2)2
—NH—C(═O)—
K806
J130
S


2-2153
—(CH2)2
—NH—C(═O)—
K806
J138
S


2-2154
—(CH2)2
—NH—C(═O)—
K807
J126
S


2-2155
—(CH2)2
—NH—C(═O)—
K807
J129
S


2-2156
—(CH2)2
—NH—C(═O)—
K807
J130
S


2-2157
—(CH2)2
—NH—C(═O)—
K807
J138
S


2-2158
—(CH2)2
—NH—C(═O)—
K822
J9
S


2-2159
—(CH2)2
—NH—C(═O)—
K88
J9
S





















TABLE 103








Com-







pound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







3-0001
—(CH2)2
—C(═O)—NH—
K240
J9
S


3-0002
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
J1
S


3-0003
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
J6
S


3-0004
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
J9
S


3-0005
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
J22
S


3-0006
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
J30
S


3-0007
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
J70
S


3-0008
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
J77
S


3-0009
—(CH2)2
—C(═O)—NH—
K4
J9
S


3-0010
—(CH2)2
—C(═O)—NH—
K4
J10
S


3-0011
—(CH2)2
—C(═O)—NH—
K4
J13
S


3-0012
—(CH2)2
—C(═O)—NH—
K256
J9
S


3-0013
—(CH2)2
—C(═O)—NH—
K256
J42
S


3-0014
—(CH2)2
—C(═O)—NH—
K256
J43
S


3-0015
—(CH2)2
—C(═O)—NH—
K256
J59
S


3-0016
—(CH2)2
—C(═O)—NH—
K257
J9
S


3-0017
—(CH2)2
—C(═O)—NH—
k257
J132
S


3-0018
—(CH2)2
—C(═O)—NH—
K257
J133
S


3-0019
—(CH2)2
—C(═O)—NH—
K258
J9
S


3-0020
—(CH2)2
—C(═O)—NH—
K260
J9
S


3-0021
—(CH2)2
—C(═O)—NH—
K262
J9
S


3-0022
—(CH2)2
—C(═O)—NH—
K262
J134
S


3-0023
—(CH2)2
—C(═O)—NH—
K262
J137
S


3-0024
—(CH2)2
—C(═O)—NH—
K262
J154
S


3-0025
—(CH2)2
—C(═O)—NH—
K262
J157
S


3-0026
—(CH2)2
—C(═O)—NH—
K262
J168
S


3-0027
—(CH2)2
—C(═O)—NH—
K262
J174
O


3-0028
—(CH2)2
—C(═O)—NH—
K262
J177
S


3-0029
—(CH2)2
—C(═O)—NH—
K263
J9
S


3-0030
—(CH2)2
—C(═O)—NH—
K263
J11
S


3-0031
—(CH2)2
—C(═O)—NH—
K263
J20
O


3-0032
—(CH2)2
—C(═O)—NH—
K263
J48
O





















TABLE 104








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







3-0033
—(CH2)2
—C(═O)—NH—
K263
J51
S


3-0034
—(CH2)2
—C(═O)—NH—
K263
J52
S


3-0035
—(CH2)2
—C(═O)—NH—
K263
J87
O


3-0036
—(CH2)2
—C(═O)—NH—
K264
J9
S


3-0037
—(CH2)2
—C(═O)—N(CH3)—
K268
J9
S


3-0038
—(CH2)2
—C(═O)—NH—
K7
J9
S


3-0039
—(CH2)2
—C(═O)—NH—
K7
J105
S


3-0040
—(CH2)2
—C(═O)—NH—
K7
J127
S


3-0041
—(CH2)2
—C(═O)—NH—
K7
J129
O


3-0042
—(CH2)2
—C(═O)—NH—
K7
J138
O


3-0043
—(CH2)2
—C(═O)—NH—
K7
J147
S


3-0044
—(CH2)2
—C(═O)—NH—
K7
J165
S


3-0045
—(CH2)2
—C(═O)—NH—
K7
J178
O


3-0046
—(CH2)2
—C(═O)—NH—
K8
J73
S


3-0047
—(CH2)2
—C(═O)—NH—
K8
J74
S


3-0048
—(CH2)2
—C(═O)—NH—
K8
J75
O


3-0049
—(CH2)2
—C(═O)—NH—
K8
J81
O


3-0050
—(CH2)2
—C(═O)—NH—
K8
J82
S


3-0051
—(CH2)2
—C(═O)—NH—
K8
J83
S


3-0052
—(CH2)2
—C(═O)—NH—
K8
J92
O


3-0053
—(CH2)2
—C(═O)—NH—
K9
J9
S


3-0054
—(CH2)2
—C(═O)—NH—
K271
J1
S


3-0055
—(CH2)2
—C(═O)—NH—
K271
J6
S


3-0056
—(CH2)2
—C(═O)—NH—
K271
J22
S


3-0057
—(CH2)2
—C(═O)—NH—
K271
J30
S


3-0058
—(CH2)2
—C(═O)—NH—
K271
J70
S


3-0059
—(CH2)2
—C(═O)—NH—
K271
J77
S


3-0060
—(CH2)2
—C(═O)—NH—
K273
J3
S


3-0061
—(CH2)2
—C(═O)—NH—
K273
J9
S


3-0062
—(CH2)2
—C(═O)—NH—
K273
J78
S


3-0063
—(CH2)2
—C(═O)—NH—
K273
J130
S


3-0064
—(CH2)2
—C(═O)—N(CH3)—
K274
J9
S





















TABLE 105








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







3-0065
—(CH2)2
—C(═O)—NH—
K275
J9
S


3-0066
—(CH2)2
—C(═O)—NH—
K279
J10
S


3-0067
—(CH2)2
—C(═O)—NH—
K279
J13
S


3-0068
—(CH2)2
—C(═O)—NH—
K279
J19
S


3-0069
—(CH2)2
—C(═O)—NH—
K279
J57
S


3-0070
—(CH2)2
—C(═O)—NH—
K279
J126
S


3-0071
—(CH2)2
—C(═O)—NH—
K279
J128
S


3-0072
—(CH2)2
—C(═O)—NH—
K279
J140
S


3-0073
—(CH2)2
—C(═O)—NH—
K11
J9
S


3-0074
—(CH2)2
—C(═O)—NH—
K11
J78
S


3-0075
—(CH2)2
—C(═O)—NH—
K37
J1
S


3-0076
—(CH2)2
—C(═O)—NH—
K37
J6
S


3-0077
—(CH2)2
—C(═O)—NH—
K37
J22
S


3-0078
—(CH2)2
—C(═O)—NH—
K37
J30
S


3-0079
—(CH2)2
—C(═O)—NH—
K37
J70
S


3-0080
—(CH2)2
—C(═O)—NH—
K37
J77
S


3-0081
—(CH2)2
—C(═O)—NH—
K19
J9
S


3-0082
—(CH2)2
—C(═O)—NH—
K283
J9
S


3-0083
—(CH2)2
—C(═O)—NH—
K14
J9
S


3-0084
—(CH2)2
—C(═O)—NH—
K284
J9
S


3-0085
—(CH2)2
—C(═O)—NH—
K23
J9
S


3-0086
—(CH2)2
—C(═O)—NH—
K45
J9
S


3-0087
—(CH2)2
—C(═O)—NH—
K286
J9
S


3-0088
—(CH2)2
—C(═O)—NH—
K286
J10
S


3-0089
—(CH2)2
—C(═O)—NH—
K286
J13
S


3-0090
—(CH2)2
—C(═O)—NH—
K32
J9
S


3-0091
—(CH2)2
—C(═O)—NH—
K287
J9
S


3-0092
—(CH2)2
—C(═O)—NH—
K287
J42
S


3-0093
—(CH2)2
—C(═O)—NH—
K287
J43
S


3-0094
—(CH2)2
—C(═O)—NH—
K287
J49
S


3-0095
—(CH2)2
—C(═O)—NH—
K287
J50
S


3-0096
—(CH2)2
—C(═O)—NH—
K287
J58
S





















TABLE 106








Com-







pound


-G1-A3-


No.
-A1-
-A2-
A4-G2
-A5-R2
X







3-0097
—(CH2)2
—C(═O)—NH—
K287
J59
S


3-0098
—(CH2)2
—C(═O)—NH—
K287
J64
S


3-0099
—(CH2)2
—C(═O)—N(CH3)—
K11
J9
S


3-0100
—(CH2)2
—C(═O)—N(CH3)—
K24
J9
S


3-0101
—(CH2)2
—C(═O)—N(CH3)—
K24
J96
S


3-0102
—(CH2)2
—C(═O)—N(CH3)—
K24
J100
S


3-0103
—(CH2)2
—C(═O)—N(CH3)—
K24
J104
S


3-0104
—(CH2)2
—C(═O)—N(CH3)—
K24
J119
S


3-0105
—(CH2)2
—C(═O)—N(CH3)—
K24
J120
S


3-0106
—(CH2)2
—C(═O)—N(CH3)—
K294
J42
S


3-0107
—(CH2)2
—C(═O)—N(CH3)—
K294
J43
S


3-0108
—(CH2)2
—C(═O)—N(CH3)—
K294
J59
S


3-0109
—(CH2)2
—C(═O)—NH—
K70
J9
S


3-0110
—(CH2)2
—C(═O)—NH—
K72
J9
S


3-0111
—(CH2)2
—C(═O)—NH—
K72
J137
S


3-0112
—(CH2)2
—C(═O)—NH—
K68
J9
S


3-0113
—(CH2)2
—C(═O)—NH—
K68
J20
S


3-0114
—(CH2)2
—C(═O)—NH—
K68
J48
S


3-0115
—(CH2)2
—C(═O)—NH—
K302
J9
S


3-0116
—(CH2)2
—C(═O)—NH—
K99
J9
S


3-0117
—(CH2)2
—C(═O)—NH—
K99
J78
S


3-0118
—(CH2)2
—C(═O)—NH—
K308
J9
S


3-0119
—(CH2)2
—C(═O)—NH—
K309
J9
S


3-0120
—(CH2)2
—C(═O)—NH—
K309
J138
S


3-0121
—(CH2)2
—C(═O)—NH—
K309
J147
O


3-0122
—(CH2)2
—C(═O)—NH—
K309
J165
O


3-0123
—(CH2)2
—C(═O)—NH—
K309
J178
S


3-0124
—(CH2)2
—C(═O)—NH—
K103
J9
S


3-0125
—(CH2)2
—C(═O)—NH—
K105
J9
S


3-0126
—(CH2)2
—C(═O)—NH—
K106
J9
S


3-0127
—(CH2)2
—C(═O)—NH—
K106
J73
S


3-0128
—(CH2)2
—C(═O)—NH—
K106
J74
O





















TABLE 107








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







3-0129
—(CH2)2
—C(═O)—NH—
K106
J75
S


3-0130
—(CH2)2
—C(═O)—NH—
K106
J81
S


3-0131
—(CH2)2
—C(═O)—NH—
K106
J82
O


3-0132
—(CH2)2
—C(═O)—NH—
K106
J83
O


3-0133
—(CH2)2
—C(═O)—NH—
K106
J92
S


3-0134
—(CH2)2
—C(═O)—NH—
K109
J9
S


3-0135
—(CH2)2
—C(═O)—NH—
K109
J78
S


3-0136
—(CH2)2
—C(═O)—NH—
K110
J9
S


3-0137
—(CH2)2
—C(═O)—NH—
K110
J78
S


3-0138
—(CH2)2
—C(═O)—NH—
K120
J9
O


3-0139
—(CH2)2
—C(═O)—NH—
K120
J9
S


3-0140
—(CH2)2
—C(═O)—NH—
K120
J78
S


3-0141
—(CH2)2
—C(═O)—N(CH3)—
K99
J1
S


3-0142
—(CH2)2
—C(═O)—N(CH3)—
K99
J6
S


3-0143
—(CH2)2
—C(═O)—N(CH3)—
K99
J9
S


3-0144
—(CH2)2
—C(═O)—N(CH3)—
K99
J22
S


3-0145
—(CH2)2
—C(═O)—N(CH3)—
K99
J30
S


3-0146
—(CH2)2
—C(═O)—N(CH3)—
K99
J70
S


3-0147
—(CH2)2
—C(═O)—N(CH3)—
K99
J77
S


3-0148
—(CH2)2
—C(═O)—
K314
J9
S


3-0149
—(CH2)2
—C(═O)—
K314
J10
S


3-0150
—(CH2)2
—C(═O)—
K314
J13
S


3-0151
—(CH2)2
—C(═O)—
K315
J3
S


3-0152
—(CH2)2
—C(═O)—
K315
J9
S


3-0153
—(CH2)2
—C(═O)—
K315
J42
S


3-0154
—(CH2)2
—C(═O)—
K315
J43
S


3-0155
—(CH2)2
—C(═O)—
K315
J59
S


3-0156
—(CH2)2
—C(═O)—
K315
J78
S


3-0157
—(CH2)2
—C(═O)—
K315
J130
S


3-0158
—(CH2)2
—C(═O)—
K316
J132
S


3-0159
—(CH2)2
—C(═O)—
K316
J133
S


3-0160
—(CH2)2
—C(═O)—
K317
J9
S





















TABLE 108








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0161
—(CH2)2
—C(═O)—
K317
J134
S


3-0162
—(CH2)2
—C(═O)—
K317
J137
S


3-0163
—(CH2)2
—C(═O)—
K317
J154
S


3-0164
—(CH2)2
—C(═O)—
K317
J157
S


3-0165
—(CH2)2
—C(═O)—
K317
J168
S


3-0166
—(CH2)2
—C(═O)—
K317
J174
O


3-0167
—(CH2)2
—C(═O)—
K317
J177
O


3-0168
—(CH2)2
—C(═O)—
K318
J9
S


3-0169
—(CH2)2
—C(═O)—
K318
J11
S


3-0170
—(CH2)2
—C(═O)—
K318
J20
S


3-0171
—(CH2)2
—C(═O)—
K318
J48
O


3-0172
—(CH2)2
—C(═O)—
K318
J51
S


3-0173
—(CH2)2
—C(═O)—
K318
J52
S


3-0174
—(CH2)2
—C(═O)—
K318
J87
O


3-0175
—(CH2)2
—C(═O)—
K319
J9
S


3-0176
—(CH2)2
—C(═O)—
K319
J19
S


3-0177
—(CH2)2
—C(═O)—
K319
J57
S


3-0178
—(CH2)2
—C(═O)—
K319
J105
O


3-0179
—(CH2)2
—C(═O)—
K319
J126
S


3-0180
—(CH2)2
—C(═O)—
K319
J127
S


3-0181
—(CH2)2
—C(═O)—
K319
J128
S


3-0182
—(CH2)2
—C(═O)—
K319
J129
S


3-0183
—(CH2)2
—C(═O)—
K319
J140
S


3-0184
—(CH2)2
—C(═O)—
K320
J9
S


3-0185
—(CH2)2
—C(═O)—
K325
J1
S


3-0186
—(CH2)2
—C(═O)—
K325
J3
S


3-0187
—(CH2)2
—C(═O)—
K325
J6
S


3-0188
—(CH2)2
—C(═O)—
K325
J9
S


3-0189
—(CH2)2
—C(═O)—
K325
J22
S


3-0190
—(CH2)2
—C(═O)—
K325
J30
S


3-0191
—(CH2)2
—C(═O)—
K325
J70
S


3-0192
—(CH2)2
—C(═O)—
K325
J77
S





















TABLE 109








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0193
—(CH2)2
—C(═O)—
K325
J78
S


3-0194
—(CH2)2
—C(═O)—
K325
J130
S


3-0195
—(CH2)2
—C(═O)—
K329
J10
S


3-0196
—(CH2)2
—C(═O)—
K329
J13
S


3-0197
—(CH2)2
—C(═O)—
K330
J9
S


3-0198
—(CH2)2
—C(═O)—
K331
J9
S


3-0199
—(CH2)2
—C(═O)—
K331
J42
S


3-0200
—(CH2)2
—C(═O)—
K331
J43
S


3-0201
—(CH2)2
—C(═O)—
K331
J49
S


3-0202
—(CH2)2
—C(═O)—
K331
J50
S


3-0203
—(CH2)2
—C(═O)—
K331
J58
S


3-0204
—(CH2)2
—C(═O)—
K331
J59
S


3-0205
—(CH2)2
—C(═O)—
K331
J64
S


3-0206
—(CH2)2
—C(═O)—
K332
J9
S


3-0207
—(CH2)2
—C(═O)—
K332
J78
S


3-0208
—(CH2)2
—C(═O)—
K332
J96
S


3-0209
—(CH2)2
—C(═O)—
K332
J100
S


3-0210
—(CH2)2
—C(═O)—
K332
J104
S


3-0211
—(CH2)2
—C(═O)—
K332
J119
S


3-0212
—(CH2)2
—C(═O)—
K332
J120
S


3-0213
—(CH2)2
—C(═O)—
K332
J132
S


3-0214
—(CH2)2
—C(═O)—
K332
J133
S


3-0215
—(CH2)2
—C(═O)—
K334
J134
S


3-0216
—(CH2)2
—C(═O)—
K334
J137
S


3-0217
—(CH2)2
—C(═O)—
K335
J9
S


3-0218
—(CH2)2
—C(═O)—
K335
J20
O


3-0219
—(CH2)2
—C(═O)—
K335
J48
S


3-0220
—(CH2)2
—C(═O)—
K336
J9
S


3-0221
—(CH2)2
—C(═O)—
K336
J19
S


3-0222
—(CH2)2
—C(═O)—
K336
J57
S


3-0223
—(CH2)2
—C(═O)—
K336
J126
S


3-0224
—(CH2)2
—C(═O)—
K336
J128
S





















TABLE 110








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0225
—(CH2)2
—C(═O)—
K336
J138
S


3-0226
—(CH2)2
—C(═O)—
K336
J140
S


3-0227
—(CH2)2
—C(═O)—
K336
J147
S


3-0228
—(CH2)2
—C(═O)—
K336
J165
O


3-0229
—(CH2)2
—C(═O)—
K336
J178
S


3-0230
—(CH2)2
—C(═O)—
K337
J3
S


3-0231
—(CH2)2
—C(═O)—
K337
J9
S


3-0232
—(CH2)2
—C(═O)—
K337
J73
S


3-0233
—(CH2)2
—C(═O)—
K337
J74
O


3-0234
—(CH2)2
—C(═O)—
K337
J75
O


3-0235
—(CH2)2
—C(═O)—
K337
J78
S


3-0236
—(CH2)2
—C(═O)—
K337
J81
S


3-0237
—(CH2)2
—C(═O)—
K337
J82
S


3-0238
—(CH2)2
—C(═O)—
K337
J83
O


3-0239
—(CH2)2
—C(═O)—
K337
J92
S


3-0240
—(CH2)2
—C(═O)—
K337
J130
S


3-0241
—(CH2)2
—C(═O)—
K338
J9
S


3-0242
—(CH2)2
—C(═O)—
K338
J78
S


3-0243
—(CH2)2
—C(═O)—
K339
J9
S


3-0244
—(CH2)2
—C(═O)—
K340
J9
S


3-0245
—(CH2)2
—C(═O)—
K343
J9
S


3-0246
—(CH2)2
—C(═O)—
K344
J9
O


3-0247
—(CH2)2
—C(═O)—
K346
J1
S


3-0248
—(CH2)2
—C(═O)—
K346
J6
S


3-0249
—(CH2)2
—C(═O)—
K346
J22
S


3-0250
—(CH2)2
—C(═O)—
K346
J30
S


3-0251
—(CH2)2
—C(═O)—
K346
J70
S


3-0252
—(CH2)2
—C(═O)—
K346
J77
S


3-0253
—(CH2)2
—C(═O)—
K349
J10
S


3-0254
—(CH2)2
—C(═O)—
K349
J13
S


3-0255
—(CH2)2
—C(═O)—
K350
J42
S


3-0256
—(CH2)2
—C(═O)—
K350
J43
S





















TABLE 111








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0257
—(CH2)2
—C(═O)—
K350
J59
S


3-0258
—(CH2)2
—C(═O)—
K352
J137
S


3-0259
—(CH2)2
—C(═O)—
K352
J154
S


3-0260
—(CH2)2
—C(═O)—
K352
J157
S


3-0261
—(CH2)2
—C(═O)—
K352
J168
S


3-0262
—(CH2)2
—C(═O)—
K352
J174
S


3-0263
—(CH2)2
—C(═O)—
K352
J177
O


3-0264
—(CH2)2
—C(═O)—
K353
J11
S


3-0265
—(CH2)2
—C(═O)—
K353
J20
S


3-0266
—(CH2)2
—C(═O)—
K353
J48
O


3-0267
—(CH2)2
—C(═O)—
K353
J51
O


3-0268
—(CH2)2
—C(═O)—
K353
J52
S


3-0269
—(CH2)2
—C(═O)—
K353
J87
S


3-0270
—(CH2)2
—C(═O)—
K354
J19
S


3-0271
—(CH2)2
—C(═O)—
K354
J57
S


3-0272
—(CH2)2
—C(═O)—
K354
J105
O


3-0273
—(CH2)2
—C(═O)—
K354
J126
S


3-0274
—(CH2)2
—C(═O)—
K354
J127
S


3-0275
—(CH2)2
—C(═O)—
K354
J128
S


3-0276
—(CH2)2
—C(═O)—
K354
J129
S


3-0277
—(CH2)2
—C(═O)—
K354
J138
O


3-0278
—(CH2)2
—C(═O)—
K354
J140
S


3-0279
—(CH2)2
—C(═O)—
K354
J147
O


3-0280
—(CH2)2
—C(═O)—
K354
J165
S


3-0281
—(CH2)2
—C(═O)—
K354
J178
S


3-0282
—(CH2)2
—C(═O)—
K355
J3
S


3-0283
—(CH2)2
—C(═O)—
K355
J9
S


3-0284
—(CH2)2
—C(═O)—
K355
J73
O


3-0285
—(CH2)2
—C(═O)—
K355
J74
S


3-0286
—(CH2)2
—C(═O)—
K355
J75
S


3-0287
—(CH2)2
—C(═O)—
K355
J78
S


3-0288
—(CH2)2
—C(═O)—
K355
J81
O





















TABLE 112








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0289
—(CH2)2
—C(═O)—
K355
J82
O


3-0290
—(CH2)2
—C(═O)—
K355
J83
S


3-0291
—(CH2)2
—C(═O)—
K355
J92
S


3-0292
—(CH2)2
—C(═O)—
K355
J130
S


3-0293
—(CH2)2
—C(═O)—
K356
J9
O


3-0294
—(CH2)2
—C(═O)—
K358
J9
S


3-0295
—(CH2)2
—C(═O)—
K358
J19
S


3-0296
—(CH2)2
—C(═O)—
K358
J57
S


3-0297
—(CH2)2
—C(═O)—
K358
J78
S


3-0298
—(CH2)2
—C(═O)—
K358
J126
S


3-0299
—(CH2)2
—C(═O)—
K358
J128
S


3-0300
—(CH2)2
—C(═O)—
K358
J140
S


3-0301
—(CH2)2
—C(═O)—
K359
J1
S


3-0302
—(CH2)2
—C(═O)—
K359
J6
S


3-0303
—(CH2)2
—C(═O)—
K359
J22
S


3-0304
—(CH2)2
—C(═O)—
K359
J30
S


3-0305
—(CH2)2
—C(═O)—
K359
J70
S


3-0306
—(CH2)2
—C(═O)—
K359
J77
S


3-0307
—(CH2)2
—C(═O)—
K360
J10
S


3-0308
—(CH2)2
—C(═O)—
K360
J13
S


3-0309
—(CH2)2
—C(═O)—
K361
J42
S


3-0310
—(CH2)2
—C(═O)—
K361
J43
S


3-0311
—(CH2)2
—C(═O)—
K361
J49
S


3-0312
—(CH2)2
—C(═O)—
K361
J50
S


3-0313
—(CH2)2
—C(═O)—
K361
J58
S


3-0314
—(CH2)2
—C(═O)—
K361
J59
S


3-0315
—(CH2)2
—C(═O)—
K361
J64
S


3-0316
—(CH2)2
—C(═O)—
K362
J96
S


3-0317
—(CH2)2
—C(═O)—
K362
J100
S


3-0318
—(CH2)2
—C(═O)—
K362
J104
S


3-0319
—(CH2)2
—C(═O)—
K362
J119
S


3-0320
—(CH2)2
—C(═O)—
K362
J120
S





















TABLE 113








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0321
—(CH2)2
—C(═O)—
K362
J132
S


3-0322
—(CH2)2
—C(═O)—
K362
J133
S


3-0323
—(CH2)2
—C(═O)—
K363
J134
S


3-0324
—(CH2)2
—C(═O)—
K363
J137
S


3-0325
—(CH2)2
—C(═O)—
K364
J9
S


3-0326
—(CH2)2
—C(═O)—
K364
J20
O


3-0327
—(CH2)2
—C(═O)—
K364
J48
S


3-0328
—(CH2)2
—C(═O)—
K364
J51
S


3-0329
—(CH2)2
—C(═O)—
K364
J52
O


3-0330
—(CH2)2
—C(═O)—
K364
J87
O


3-0331
—(CH2)2
—C(═O)—
K365
J9
S


3-0332
—(CH2)2
—C(═O)—
K365
J105
S


3-0333
—(CH2)2
—C(═O)—
K365
J127
S


3-0334
—(CH2)2
—C(═O)—
K365
J129
O


3-0335
—(CH2)2
—C(═O)—
K365
J138
S


3-0336
—(CH2)2
—C(═O)—
K365
J147
S


3-0337
—(CH2)2
—C(═O)—
K365
J165
O


3-0338
—(CH2)2
—C(═O)—
K365
J178
O


3-0339
—(CH2)2
—C(═O)—
K367
J9
S


3-0340
—(CH2)2
—C(═O)—
K368
J9
S


3-0341
—(CH2)2
—C(═O)—
K368
J73
S


3-0342
—(CH2)2
—C(═O)—
K368
J74
S


3-0343
—(CH2)2
—C(═O)—
K368
J75
O


3-0344
—(CH2)2
—C(═O)—
K368
J81
S


3-0345
—(CH2)2
—C(═O)—
K368
J82
S


3-0346
—(CH2)2
—C(═O)—
K368
J83
O


3-0347
—(CH2)2
—C(═O)—
K368
J92
O


3-0348
—(CH2)2
—C(═O)—
K369
J9
S


3-0349
—(CH2)2
—C(═O)—
K371
J9
S


3-0350
—(CH2)2
—C(═O)—
K372
J9
S


3-0351
—(CH2)2
—C(═O)—
K373
J9
S


3-0352
—(CH2)2
—C(═O)—
K374
J9
S





















TABLE 114








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0353
—(CH2)2
—C(═O)—
K377
J9
S


3-0354
—(CH2)2
—C(═O)—
K380
J9
S


3-0355
—(CH2)2
—C(═O)—
K381
J1
S


3-0356
—(CH2)2
—C(═O)—
K381
J6
S


3-0357
—(CH2)2
—C(═O)—
K381
J9
S


3-0358
—(CH2)2
—C(═O)—
K381
J22
S


3-0359
—(CH2)2
—C(═O)—
K381
J30
S


3-0360
—(CH2)2
—C(═O)—
K381
J70
S


3-0361
—(CH2)2
—C(═O)—
K381
J77
S


3-0362
—(CH2)2
—C(═O)—
K381
J78
S


3-0363
—(CH2)2
—C(═O)—
K382
J3
S


3-0364
—(CH2)2
—C(═O)—
K382
J9
S


3-0365
—(CH2)2
—C(═O)—
K382
J10
S


3-0366
—(CH2)2
—C(═O)—
K382
J13
S


3-0367
—(CH2)2
—C(═O)—
K382
J78
S


3-0368
—(CH2)2
—C(═O)—
K382
J130
S


3-0369
—(CH2)2
—C(═O)—
K383
J42
S


3-0370
—(CH2)2
—C(═O)—
K383
J43
S


3-0371
—(CH2)2
—C(═O)—
K383
J59
S


3-0372
—(CH2)2
—C(═O)—
K384
J132
S


3-0373
—(CH2)2
—C(═O)—
K384
J133
S


3-0374
—(CH2)2
—C(═O)—
K385
J134
S


3-0375
—(CH2)2
—C(═O)—
K385
J137
S


3-0376
—(CH2)2
—C(═O)—
K385
J154
S


3-0377
—(CH2)2
—C(═O)—
K385
J157
S


3-0378
—(CH2)2
—C(═O)—
K385
J168
S


3-0379
—(CH2)2
—C(═O)—
K385
J174
S


3-0380
—(CH2)2
—C(═O)—
K385
J177
O


3-0381
—(CH2)2
—C(═O)—
K386
J11
O


3-0382
—(CH2)2
—C(═O)—
K386
J20
S


3-0383
—(CH2)2
—C(═O)—
K386
J48
S


3-0384
—(CH2)2
—C(═O)—
K387
J138
S





















TABLE 115








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0385
—(CH2)2
—C(═O)—
K387
J147
O


3-0386
—(CH2)2
—C(═O)—
K387
J165
S


3-0387
—(CH2)2
—C(═O)—
K387
J178
S


3-0388
—(CH2)2
—C(═O)—
K388
J73
O


3-0389
—(CH2)2
—C(═O)—
K388
J74
O


3-0390
—(CH2)2
—C(═O)—
K388
J75
S


3-0391
—(CH2)2
—C(═O)—
K388
J81
S


3-0392
—(CH2)2
—C(═O)—
K388
J82
O


3-0393
—(CH2)2
—C(═O)—
K388
J83
S


3-0394
—(CH2)2
—C(═O)—
K388
J92
S


3-0395
—(CH2)2
—C(═O)—
K389
J9
O


3-0396
—(CH2)2
—C(═O)—
K391
J9
O


3-0397
—(CH2)2
—C(═O)—
K391
J9
S


3-0398
—(CH2)2
—C(═O)—
K392
J9
S


3-0399
—(CH2)2
—C(═O)—
K393
J9
S


3-0400
—(CH2)2
—C(═O)—
K394
J1
S


3-0401
—(CH2)2
—C(═O)—
K394
J6
S


3-0402
—(CH2)2
—C(═O)—
K394
J19
S


3-0403
—(CH2)2
—C(═O)—
K394
J22
S


3-0404
—(CH2)2
—C(═O)—
K394
J30
S


3-0405
—(CH2)2
—C(═O)—
K394
J57
S


3-0406
—(CH2)2
—C(═O)—
K394
J70
S


3-0407
—(CH2)2
—C(═O)—
K394
J77
S


3-0408
—(CH2)2
—C(═O)—
K394
J126
S


3-0409
—(CH2)2
—C(═O)—
K394
J128
S


3-0410
—(CH2)2
—C(═O)—
K394
J140
S


3-0411
—(CH2)2
—C(═O)—
K395
J10
S


3-0412
—(CH2)2
—C(═O)—
K395
J13
S


3-0413
—(CH2)2
—C(═O)—
K396
J42
S


3-0414
—(CH2)2
—C(═O)—
K396
J43
S


3-0415
—(CH2)2
—C(═O)—
K396
J49
S


3-0416
—(CH2)2
—C(═O)—
K396
J50
S





















TABLE 116








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







3-0417
—(CH2)2
—C(═O)—
K396
J58
S


3-0418
—(CH2)2
—C(═O)—
K396
J59
S


3-0419
—(CH2)2
—C(═O)—
K396
J64
S


3-0420
—(CH2)2
—C(═O)—
K397
J3
S


3-0421
—(CH2)2
—C(═O)—
K397
J9
S


3-0422
—(CH2)2
—C(═O)—
K397
J78
S


3-0423
—(CH2)2
—C(═O)—
K397
J96
S


3-0424
—(CH2)2
—C(═O)—
K397
J100
S


3-0425
—(CH2)2
—C(═O)—
K397
J104
S


3-0426
—(CH2)2
—C(═O)—
K397
J119
S


3-0427
—(CH2)2
—C(═O)—
K397
J120
S


3-0428
—(CH2)2
—C(═O)—
K397
J130
S


3-0429
—(CH2)2
—C(═O)—
K398
J137
S


3-0430
—(CH2)2
—C(═O)—NH—
K399
J9
S


3-0431
—(CH2)2
—C(═O)—NH—
K402
J20
O


3-0432
—(CH2)2
—C(═O)—NH—
K402
J48
O


3-0433
—(CH2)2
—C(═O)—NH—
K402
J51
S


3-0434
—(CH2)2
—C(═O)—NH—
K402
J52
S


3-0435
—(CH2)2
—C(═O)—NH—
K402
J87
O


3-0436
—(CH2)2
—C(═O)—NH—
K167
J105
S


3-0437
—(CH2)2
—C(═O)—NH—
K167
J127
S


3-0438
—(CH2)2
—C(═O)—NH—
K167
J129
O


3-0439
—(CH2)2
—C(═O)—
K412
J1
S


3-0440
—(CH2)2
—C(═O)—
K412
J6
S


3-0441
—(CH2)2
—C(═O)—
K412
J22
S


3-0442
—(CH2)2
—C(═O)—
K412
J30
S


3-0443
—(CH2)2
—C(═O)—
K412
J70
S


3-0444
—(CH2)2
—C(═O)—
K412
J77
S


3-0445
—(CH2)2
—C(═O)—
K413
J10
S


3-0446
—(CH2)2
—C(═O)—
K413
J13
S


3-0447
—(CH2)2
—C(═O)—
K414
J42
S


3-0448
—(CH2)2
—C(═O)—
K414
J43
S





















TABLE 117








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







3-0449
—(CH2)2
—C(═O)—
K414
J59
S


3-0450
—(CH2)2
—C(═O)—
K415
J132
S


3-0451
—(CH2)2
—C(═O)—
K415
J133
S


3-0452
—(CH2)2
—C(═O)—
K416
J134
S


3-0453
—(CH2)2
—C(═O)—
K416
J137
S


3-0454
—(CH2)2
—C(═O)—
K416
J154
S


3-0455
—(CH2)2
—C(═O)—
K416
J157
S


3-0456
—(CH2)2
—C(═O)—
K416
J168
O


3-0457
—(CH2)2
—C(═O)—
K416
J174
S


3-0458
—(CH2)2
—C(═O)—
K416
J177
S


3-0459
—(CH2)2
—C(═O)—
K417
J11
O


3-0460
—(CH2)2
—C(═O)—
K417
J20
S


3-0461
—(CH2)2
—C(═O)—
K417
J48
S


3-0462
—(CH2)2
—C(═O)—
K418
J3
S


3-0463
—(CH2)2
—C(═O)—
K418
J9
S


3-0464
—(CH2)2
—C(═O)—
K418
J78
S


3-0465
—(CH2)2
—C(═O)—
K418
J130
S


3-0466
—(CH2)2
—C(═O)—
K418
J138
S


3-0467
—(CH2)2
—C(═O)—
K418
J147
O


3-0468
—(CH2)2
—C(═O)—
K418
J165
O


3-0469
—(CH2)2
—C(═O)—
K418
J178
S


3-0470
—(CH2)2
—C(═O)—
K419
J73
S


3-0471
—(CH2)2
—C(═O)—
K419
J74
O


3-0472
—(CH2)2
—C(═O)—
K419
J75
S


3-0473
—(CH2)2
—C(═O)—
K419
J81
S


3-0474
—(CH2)2
—C(═O)—
K419
J82
O


3-0475
—(CH2)2
—C(═O)—
K419
J83
O


3-0476
—(CH2)2
—C(═O)—
K419
J92
S


3-0477
—(CH2)2
—C(═O)—
K420
J9
S


3-0478
—(CH2)2
—C(═O)—
K421
J9
O


3-0479
—(CH2)2
—C(═O)—N(CH3)—
K422
J1
S


3-0480
—(CH2)2
—C(═O)—N(CH3)—
K422
J6
S





















TABLE 118








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







3-0481
—(CH2)2
—C(═O)—N(CH3)—
K422
J19
S


3-0482
—(CH2)2
—C(═O)—N(CH3)—
K422
J22
S


3-0483
—(CH2)2
—C(═O)—N(CH3)—
K422
J30
S


3-0484
—(CH2)2
—C(═O)—N(CH3)—
K422
J57
S


3-0485
—(CH2)2
—C(═O)—N(CH3)—
K422
J70
S


3-0486
—(CH2)2
—C(═O)—N(CH3)—
K422
J77
S


3-0487
—(CH2)2
—C(═O)—N(CH3)—
K422
J126
S


3-0488
—(CH2)2
—C(═O)—N(CH3)—
K422
J128
S


3-0489
—(CH2)2
—C(═O)—N(CH3)—
K422
J140
S


3-0490
—(CH2)2
—C(═O)—NH—
K422
J10
S


3-0491
—(CH2)2
—C(═O)—NH—
K422
J13
S


3-0492
—(CH2)2
—C(═O)—N(CH3)—
K186
J42
S


3-0493
—(CH2)2
—C(═O)—N(CH3)—
K186
J43
S


3-0494
—(CH2)2
—C(═O)—N(CH3)—
K186
J49
S


3-0495
—(CH2)2
—C(═O)—N(CH3)—
K186
J50
S


3-0496
—(CH2)2
—C(═O)—N(CH3)—
K186
J58
S


3-0497
—(CH2)2
—C(═O)—N(CH3)—
K186
J59
S


3-0498
—(CH2)2
—C(═O)—N(CH3)—
K186
J64
S


3-0499
—(CH2)2
—C(═O)—NH—
K34
J96
S


3-0500
—(CH2)2
—C(═O)—NH—
K34
J100
S


3-0501
—(CH2)2
—C(═O)—NH—
K34
J104
S


3-0502
—(CH2)2
—C(═O)—NH—
K34
J119
S


3-0503
—(CH2)2
—C(═O)—NH—
K34
J120
S


3-0504
—(CH2)2
—C(═O)—NH—
K34
J132
S


3-0505
—(CH2)2
—C(═O)—NH—
K34
J133
S


3-0506
—(CH2)2
—C(═O)—NH—
K423
J134
S


3-0507
—(CH2)2
—C(═O)—NH—
K423
J137
S


3-0508
—(CH2)2
—C(═O)—NH—
K424
J20
S


3-0509
—(CH2)2
—C(═O)—NH—
K424
J48
O


3-0510
—(CH2)2
—C(═O)—NH—
K424
J51
S


3-0511
—(CH2)2
—C(═O)—NH—
K424
J52
S


3-0512
—(CH2)2
—C(═O)—NH—
K424
J87
O





















TABLE 119








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







3-0513
—(CH2)2
—C(═O)—NH—
K425
J105
O


3-0514
—(CH2)2
—C(═O)—NH—
K425
J127
S


3-0515
—(CH2)2
—C(═O)—NH—
K425
J129
S


3-0516
—(CH2)2
—C(═O)—NH—
K425
J138
O


3-0517
—(CH2)2
—C(═O)—NH—
K425
J147
S


3-0518
—(CH2)2
—C(═O)—NH—
K425
J165
S


3-0519
—(CH2)2
—C(═O)—NH—
K425
J178
O


3-0520
—(CH2)2
—C(═O)—NH—
K426
J73
O


3-0521
—(CH2)2
—C(═O)—NH—
K426
J74
S


3-0522
—(CH2)2
—C(═O)—NH—
K426
J75
S


3-0523
—(CH2)2
—C(═O)—NH—
K426
J81
O


3-0524
—(CH2)2
—C(═O)—NH—
K426
J82
S


3-0525
—(CH2)2
—C(═O)—NH—
K426
J83
S


3-0526
—(CH2)2
—C(═O)—NH—
K426
J92
O


3-0527
—(CH2)2
—C(═O)—NH—
K427
J9
O


3-0528
—(CH2)3
—C(═O)—NH—
K4
J2
S


3-0529
—(CH2)3
—C(═O)—NH—
K4
J4
S


3-0530
—(CH2)3
—C(═O)—NH—
K4
J28
S


3-0531
—(CH2)3
—C(═O)—NH—
K4
J31
S


3-0532
—(CH2)3
—C(═O)—NH—
K256
J9
S


3-0533
—(CH2)3
—C(═O)—NH—
K256
J50
S


3-0534
—(CH2)3
—C(═O)—NH—
K256
J58
S


3-0535
—(CH2)3
—C(═O)—NH—
K256
J64
S


3-0536
—(CH2)3
—C(═O)—NH—
K257
J96
S


3-0537
—(CH2)3
—C(═O)—NH—
K257
J100
S


3-0538
—(CH2)3
—C(═O)—NH—
K257
J104
S


3-0539
—(CH2)3
—C(═O)—NH—
K257
J119
S


3-0540
—(CH2)3
—C(═O)—NH—
K257
J120
S


3-0541
—(CH2)3
—C(═O)—N(CH3)—
K132
J9
S


3-0542
—(CH2)3
—C(═O)—N(CH3)—
K268
J9
S


3-0543
—(CH2)3
—C(═O)—NH—
K7
J9
S


3-0544
—(CH2)3
—C(═O)—N(CH3)—
K274
J9
S





















TABLE 120








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







3-0545
—(CH2)3
—C(═O)—NH—
K275
J9
S


3-0546
—(CH2)3
—C(═O)—NH—
K279
J2
S


3-0547
—(CH2)3
—C(═O)—NH—
K279
J4
S


3-0548
—(CH2)3
—C(═O)—NH—
K279
J28
S


3-0549
—(CH2)3
—C(═O)—NH—
K279
J31
S


3-0550
—(CH2)3
—C(═O)—NH—
K281
J9
S


3-0551
—(CH2)3
—C(═O)—NH—
K11
J9
S


3-0552
—(CH2)3
—C(═O)—NH—
K282
J9
S


3-0553
—(CH2)3
—C(═O)—NH—
K35
J9
S


3-0554
—(CH2)3
—C(═O)—NH—
K37
J9
S


3-0555
—(CH2)3
—C(═O)—NH—
K15
J9
S


3-0556
—(CH2)3
—C(═O)—NH—
K283
J9
S


3-0557
—(CH2)3
—C(═O)—NH—
K13
J9
S


3-0558
—(CH2)3
—C(═O)—NH—
K14
J9
S


3-0559
—(CH2)3
—C(═O)—NH—
K284
J9
S


3-0560
—(CH2)3
—C(═O)—NH—
K23
J9
S


3-0561
—(CH2)3
—C(═O)—NH—
K30
J9
S


3-0562
—(CH2)3
—C(═O)—NH—
K286
J2
S


3-0563
—(CH2)3
—C(═O)—NH—
K286
J4
S


3-0564
—(CH2)3
—C(═O)—NH—
K286
J9
S


3-0565
—(CH2)3
—C(═O)—NH—
K286
J28
S


3-0566
—(CH2)3
—C(═O)—NH—
K286
J31
S


3-0567
—(CH2)3
—C(═O)—NH—
K32
J9
S


3-0568
—(CH2)3
—C(═O)—NH—
K289
J9
S


3-0569
—(CH2)3
—C(═O)—N(CH3)—
K24
J132
S


3-0570
—(CH2)3
—C(═O)—N(CH3)—
K24
J133
S


3-0571
—(CH2)3
—C(═O)—N(CH3)—
K294
J49
S


3-0572
—(CH2)3
—C(═O)—N(CH3)—
K294
J50
S


3-0573
—(CH2)3
—C(═O)—N(CH3)—
K294
J58
S


3-0574
—(CH2)3
—C(═O)—N(CH3)—
K294
J64
S


3-0575
—(CH2)3
—C(═O)—NH—
K70
J9
S


3-0576
—(CH2)3
—C(═O)—NH—
K71
J9
S





















TABLE 121








Compound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







3-0577
—(CH2)3
—C(═O)—NH—
K72
J9
S


3-0578
—(CH2)3
—C(═O)—NH—
K72
J134
S


3-0579
—(CH2)3
—C(═O)—NH—
K72
J154
S


3-0580
—(CH2)3
—C(═O)—NH—
K72
J157
S


3-0581
—(CH2)3
—C(═O)—NH—
K72
J168
O


3-0582
—(CH2)3
—C(═O)—NH—
K72
J174
S


3-0583
—(CH2)3
—C(═O)—NH—
K72
J177
S


3-0584
—(CH2)3
—C(═O)—NH—
K68
J9
S


3-0585
—(CH2)3
—C(═O)—NH—
K68
J11
O


3-0586
—(CH2)3
—C(═O)—NH—
K68
J51
O


3-0587
—(CH2)3
—C(═O)—NH—
K68
J52
O


3-0588
—(CH2)3
—C(═O)—NH—
K68
J87
S


3-0589
—(CH2)3
—C(═O)—NH—
K99
J9
S


3-0590
—(CH2)3
—C(═O)—NH—
K100
J9
S


3-0591
—(CH2)3
—C(═O)—NH—
K308
J9
S


3-0592
—(CH2)3
—C(═O)—NH—
K309
J9
S


3-0593
—(CH2)3
—C(═O)—NH—
K309
J105
S


3-0594
—(CH2)3
—C(═O)—NH—
K309
J127
O


3-0595
—(CH2)3
—C(═O)—NH—
K309
J129
S


3-0596
—(CH2)3
—C(═O)—NH—
K103
J9
S


3-0597
—(CH2)3
—C(═O)—NH—
K310
J9
S


3-0598
—(CH2)3
—C(═O)—NH—
K105
J9
S


3-0599
—(CH2)3
—C(═O)—NH—
K106
J9
S


3-0600
—(CH2)3
—C(═O)—NH—
K109
J9
S


3-0601
—(CH2)3
—C(═O)—
K314
J2
S


3-0602
—(CH2)3
—C(═O)—
K314
J4
S


3-0603
—(CH2)3
—C(═O)—
K314
J28
S


3-0604
—(CH2)3
—C(═O)—
K314
J31
S


3-0605
—(CH2)3
—C(═O)—
K315
J9
S


3-0606
—(CH2)3
—C(═O)—
K315
J49
S


3-0607
—(CH2)3
—C(═O)—
K315
J50
S


3-0608
—(CH2)3
—C(═O)—
K315
J58
S





















TABLE 122








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0609
—(CH2)3
—C(═O)—
K315
J64
S


3-0610
—(CH2)3
—C(═O)—
K316
J96
S


3-0611
—(CH2)3
—C(═O)—
K316
J100
S


3-0612
—(CH2)3
—C(═O)—
K316
J104
S


3-0613
—(CH2)3
—C(═O)—
K316
J119
S


3-0614
—(CH2)3
—C(═O)—
K316
J120
S


3-0615
—(CH2)3
—C(═O)—
K318
J9
S


3-0616
—(CH2)3
—C(═O)—
K319
J9
S


3-0617
—(CH2)3
—C(═O)—
K319
J138
O


3-0618
—(CH2)3
—C(═O)—
K319
J147
S


3-0619
—(CH2)3
—C(═O)—
K319
J165
S


3-0620
—(CH2)3
—C(═O)—
K319
J178
O


3-0621
—(CH2)3
—C(═O)—
K320
J73
O


3-0622
—(CH2)3
—C(═O)—
K320
J74
S


3-0623
—(CH2)3
—C(═O)—
K320
J75
S


3-0624
—(CH2)3
—C(═O)—
K320
J81
O


3-0625
—(CH2)3
—C(═O)—
K320
J82
S


3-0626
—(CH2)3
—C(═O)—
K320
J83
S


3-0627
—(CH2)3
—C(═O)—
K320
J92
O


3-0628
—(CH2)3
—C(═O)—
K322
J9
O


3-0629
—(CH2)3
—C(═O)—
K322
J9
S


3-0630
—(CH2)3
—C(═O)—
K329
J2
S


3-0631
—(CH2)3
—C(═O)—
K329
J4
S


3-0632
—(CH2)3
—C(═O)—
K329
J28
S


3-0633
—(CH2)3
—C(═O)—
K329
J31
S


3-0634
—(CH2)3
—C(═O)—
K330
J9
S


3-0635
—(CH2)3
—C(═O)—
K331
J9
S


3-0636
—(CH2)3
—C(═O)—
K332
J9
S


3-0637
—(CH2)3
—C(═O)—
K334
J154
S


3-0638
—(CH2)3
—C(═O)—
K334
J157
S


3-0639
—(CH2)3
—C(═O)—
K334
J168
O


3-0640
—(CH2)3
—C(═O)—
K334
J174
S





















TABLE 123








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0641
—(CH2)3
—C(═O)—
K334
J177
S


3-0642
—(CH2)3
—C(═O)—
K335
J9
S


3-0643
—(CH2)3
—C(═O)—
K335
J11
O


3-0644
—(CH2)3
—C(═O)—
K335
J51
S


3-0645
—(CH2)3
—C(═O)—
K335
J52
O


3-0646
—(CH2)3
—C(═O)—
K335
J87
S


3-0647
—(CH2)3
—C(═O)—
K336
J9
S


3-0648
—(CH2)3
—C(═O)—
K336
J105
S


3-0649
—(CH2)3
—C(═O)—
K336
J127
O


3-0650
—(CH2)3
—C(═O)—
K336
J129
O


3-0651
—(CH2)3
—C(═O)—
K339
J9
S


3-0652
—(CH2)3
—C(═O)—
K340
J9
S


3-0653
—(CH2)3
—C(═O)—
K341
J9
S


3-0654
—(CH2)3
—C(═O)—
K342
J9
S


3-0655
—(CH2)3
—C(═O)—
K349
J2
S


3-0656
—(CH2)3
—C(═O)—
K349
J4
S


3-0657
—(CH2)3
—C(═O)—
K349
J28
S


3-0658
—(CH2)3
—C(═O)—
K349
J31
S


3-0659
—(CH2)3
—C(═O)—
K350
J49
S


3-0660
—(CH2)3
—C(═O)—
K350
J50
S


3-0661
—(CH2)3
—C(═O)—
K350
J58
S


3-0662
—(CH2)3
—C(═O)—
K350
J64
S


3-0663
—(CH2)3
—C(═O)—
K351
J96
S


3-0664
—(CH2)3
—C(═O)—
K351
J100
S


3-0665
—(CH2)3
—C(═O)—
K351
J104
S


3-0666
—(CH2)3
—C(═O)—
K351
J119
S


3-0667
—(CH2)3
—C(═O)—
K351
J120
S


3-0668
—(CH2)3
—C(═O)—
K351
J132
S


3-0669
—(CH2)3
—C(═O)—
K351
J133
S


3-0670
—(CH2)3
—C(═O)—
K352
J134
S


3-0671
—(CH2)3
—C(═O)—
K360
J2
S


3-0672
—(CH2)3
—C(═O)—
K360
J4
S





















TABLE 124








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0673
—(CH2)3
—C(═O)—
K360
J28
S


3-0674
—(CH2)3
—C(═O)—
K360
J31
S


3-0675
—(CH2)3
—C(═O)—
K363
J154
S


3-0676
—(CH2)3
—C(═O)—
K363
J157
S


3-0677
—(CH2)3
—C(═O)—
K363
J168
O


3-0678
—(CH2)3
—C(═O)—
K363
J174
O


3-0679
—(CH2)3
—C(═O)—
K363
J177
S


3-0680
—(CH2)3
—C(═O)—
K364
J9
S


3-0681
—(CH2)3
—C(═O)—
K364
J11
S


3-0682
—(CH2)3
—C(═O)—
K365
J9
S


3-0683
—(CH2)3
—C(═O)—
K367
J9
S


3-0684
—(CH2)3
—C(═O)—
K368
J9
S


3-0685
—(CH2)3
—C(═O)—
K369
J9
S


3-0686
—(CH2)3
—C(═O)—
K372
J9
S


3-0687
—(CH2)3
—C(═O)—
K373
J9
S


3-0988
—(CH2)3
—C(═O)—
K374
J9
S


3-0689
—(CH2)3
—C(═O)—
K377
J9
S


3-0690
—(CH2)3
—C(═O)—
K381
J9
S


3-0691
—(CH2)3
—C(═O)—
K382
J2
S


3-0692
—(CH2)3
—C(═O)—
K382
J4
S


3-0693
—(CH2)3
—C(═O)—
K382
J28
S


3-0694
—(CH2)3
—C(═O)—
K382
J31
S


3-0695
—(CH2)3
—C(═O)—
K383
J49
S


3-0696
—(CH2)3
—C(═O)—
K383
J50
S


3-0697
—(CH2)3
—C(═O)—
K383
J58
S


3-0698
—(CH2)3
—C(═O)—
K383
J64
S


3-0699
—(CH2)3
—C(═O)—
K384
J96
S


3-0700
—(CH2)3
—C(═O)—
K384
J100
S


3-0701
—(CH2)3
—C(═O)—
K384
J104
S


3-0702
—(CH2)3
—C(═O)—
K384
J119
S


3-0703
—(CH2)3
—C(═O)—
K384
J120
S


3-0704
—(CH2)3
—C(═O)—
K386
J51
O





















TABLE 125








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







3-0705
—(CH2)3
—C(═O)—
K386
J52
S


3-0706
—(CH2)3
—C(═O)—
K386
J87
S


3-0707
—(CH2)3
—C(═O)—
K387
J105
O


3-0708
—(CH2)3
—C(═O)—
K387
J127
O


3-0709
—(CH2)3
—C(═O)—
K387
J129
S


3-0710
—(CH2)3
—C(═O)—
K391
J9
S


3-0711
—(CH2)3
—C(═O)—
K393
J9
S


3-0712
—(CH2)3
—C(═O)—
K395
J2
S


3-0713
—(CH2)3
—C(═O)—
K395
J4
S


3-0714
—(CH2)3
—C(═O)—
K395
J28
S


3-0715
—(CH2)3
—C(═O)—
K395
J31
S


3-0716
—(CH2)3
—C(═O)—
K397
J132
S


3-0717
—(CH2)3
—C(═O)—
K397
J133
S


3-0718
—(CH2)3
—C(═O)—
K398
J134
S


3-0719
—(CH2)3
—C(═O)—
K398
J154
S


3-0720
—(CH2)3
—C(═O)—
K398
J157
S


3-0721
—(CH2)3
—C(═O)—
K398
J168
S


3-0722
—(CH2)3
—C(═O)—
K398
J174
O


3-0723
—(CH2)3
—C(═O)—
K398
J177
S


3-0724
—(CH2)3
—C(═O)—NH—
K399
J9
S


3-0725
—(CH2)3
—C(═O)—NH—
K400
J9
S


3-0726
—(CH2)3
—C(═O)—NH—
K24
J9
S


3-0727
—(CH2)3
—C(═O)—NH—
K401
J9
S


3-0728
—(CH2)3
—C(═O)—NH—
K402
J11
S


3-0729
—(CH2)3
—C(═O)—NH—
K167
J138
O


3-0730
—(CH2)3
—C(═O)—NH—
K167
J147
S


3-0731
—(CH2)3
—C(═O)—NH—
K167
J165
S


3-0732
—(CH2)3
—C(═O)—NH—
K167
J178
O


3-0733
—(CH2)3
—C(═O)—
K405
J73
S


3-0734
—(CH2)3
—C(═O)—
K405
J74
S


3-0735
—(CH2)3
—C(═O)—
K405
J75
O


3-0736
—(CH2)3
—C(═O)—
K405
J81
O





















TABLE 126








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







3-0737
—(CH2)3
—C(═O)—
K405
J82
S


3-0738
—(CH2)3
—C(═O)—
K405
J83
S


3-0739
—(CH2)3
—C(═O)—
K405
J92
O


3-0740
—(CH2)3
—C(═O)—
K406
J9
S


3-0741
—(CH2)3
—C(═O)—
K411
J9
S


3-0742
—(CH2)3
—C(═O)—
K413
J2
S


3-0743
—(CH2)3
—C(═O)—
K413
J4
S


3-0744
—(CH2)3
—C(═O)—
K413
J28
S


3-0745
—(CH2)3
—C(═O)—
K413
J31
S


3-0746
—(CH2)3
—C(═O)—
K414
J49
S


3-0747
—(CH2)3
—C(═O)—
K414
J50
S


3-0748
—(CH2)3
—C(═O)—
K414
J58
S


3-0749
—(CH2)3
—C(═O)—
K414
J64
S


3-0750
—(CH2)3
—C(═O)—
K415
J96
S


3-0751
—(CH2)3
—C(═O)—
K415
J100
S


3-0752
—(CH2)3
—C(═O)—
K415
J104
S


3-0753
—(CH2)3
—C(═O)—
K415
J119
S


3-0754
—(CH2)3
—C(═O)—
K415
J120
S


3-0755
—(CH2)3
—C(═O)—
K417
J51
O


3-0756
—(CH2)3
—C(═O)—
K417
J52
O


3-0757
—(CH2)3
—C(═O)—
K417
J87
S


3-0758
—(CH2)3
—C(═O)—
K418
J105
S


3-0759
—(CH2)3
—C(═O)—
K418
J127
O


3-0760
—(CH2)3
—C(═O)—
K418
J129
S


3-0761
—(CH2)3
—C(═O)—NH—
K422
J2
S


3-0762
—(CH2)3
—C(═O)—NH—
K422
J4
S


3-0763
—(CH2)3
—C(═O)—NH—
K422
J28
S


3-0764
—(CH2)3
—C(═O)—NH—
K422
J31
S


3-0765
—(CH2)3
—C(═O)—NH—
K423
J154
S


3-0766
—(CH2)3
—C(═O)—NH—
K423
J157
S


3-0767
—(CH2)3
—C(═O)—NH—
K423
J168
S


3-0768
—(CH2)3
—C(═O)—NH—
K423
J174
O





















TABLE 127








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







3-0769
—(CH2)3
—C(═O)—NH—
K423
J177
O


3-0770
—(CH2)3
—C(═O)—NH—
K424
J11
S


3-0771
—(CH2)2
—C(═O)—
K314
J3
S


3-0772
—(CH2)2
—C(═O)—
K316
J3
S


3-0773
—(CH2)2
—C(═O)—
K317
J3
S


3-0774
—(CH2)2
—C(═O)—
K318
J3
S


3-0775
—(CH2)2
—C(═O)—
K319
J3
S


3-0776
—(CH2)2
—C(═O)—
K320
J3
S


3-0777
—(CH2)2
—C(═O)—
K321
J3
S


3-0778
—(CH2)2
—C(═O)—
K322
J3
S


3-0779
—(CH2)2
—C(═O)—
K323
J3
S


3-0780
—(CH2)2
—C(═O)—
K324
J3
S


3-0781
—(CH2)2
—C(═O)—
K326
J3
S


3-0782
—(CH2)2
—C(═O)—
K327
J3
S


3-0783
—(CH2)2
—C(═O)—
K328
J3
S


3-0784
—(CH2)2
—C(═O)—
K329
J3
S


3-0785
—(CH2)2
—C(═O)—
K330
J3
S


3-0786
—(CH2)2
—C(═O)—
K331
J3
S


3-0787
—(CH2)2
—C(═O)—
K332
J3
S


3-0788
—(CH2)2
—C(═O)—
K333
J3
S


3-0789
—(CH2)2
—C(═O)—
K334
J3
S


3-0790
—(CH2)2
—C(═O)—
K335
J3
S


3-0791
—(CH2)2
—C(═O)—
K336
J3
S


3-0792
—(CH2)2
—C(═O)—
K338
J3
S


3-0793
—(CH2)2
—C(═O)—
K339
J3
S


3-0794
—(CH2)2
—C(═O)—
K340
J3
S


3-0795
—(CH2)2
—C(═O)—
K341
J3
S


3-0796
—(CH2)2
—C(═O)—
K342
J3
S


3-0797
—(CH2)2
—C(═O)—
K343
J3
S


3-0798
—(CH2)2
—C(═O)—
K344
J3
S


3-0799
—(CH2)2
—C(═O)—
K345
J3
S


3-0800
—(CH2)2
—C(═O)—
K346
J3
S





















TABLE 128








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0801
—(CH2)2
—C(═O)—
K347
J3
S


3-0802
—(CH2)2
—C(═O)—
K348
J3
S


3-0803
—(CH2)2
—C(═O)—
K349
J3
S


3-0804
—(CH2)2
—C(═O)—
K350
J3
S


3-0805
—(CH2)2
—C(═O)—
K351
J3
S


3-0806
—(CH2)2
—C(═O)—
K352
J3
S


3-0807
—(CH2)2
—C(═O)—
K353
J3
S


3-0808
—(CH2)2
—C(═O)—
K354
J3
S


3-0809
—(CH2)2
—C(═O)—
K356
J3
S


3-0810
—(CH2)2
—C(═O)—
K357
J3
S


3-0811
—(CH2)2
—C(═O)—
K358
J3
S


3-0812
—(CH2)2
—C(═O)—
K359
J3
S


3-0813
—(CH2)2
—C(═O)—
K360
J3
S


3-0814
—(CH2)2
—C(═O)—
K361
J3
S


3-0815
—(CH2)2
—C(═O)—
K362
J3
S


3-0816
—(CH2)2
—C(═O)—
K363
J3
S


3-0817
—(CH2)2
—C(═O)—
K364
J3
S


3-0818
—(CH2)2
—C(═O)—
K365
J3
S


3-0819
—(CH2)2
—C(═O)—
K366
J3
S


3-0820
—(CH2)2
—C(═O)—
K367
J3
S


3-0821
—(CH2)2
—C(═O)—
K368
J3
S


3-0822
—(CH2)2
—C(═O)—
K369
J3
S


3-0823
—(CH2)2
—C(═O)—
K370
J3
S


3-0824
—(CH2)2
—C(═O)—
K371
J3
S


3-0825
—(CH2)2
—C(═O)—
K372
J3
S


3-0826
—(CH2)2
—C(═O)—
K373
J3
S


3-0827
—(CH2)2
—C(═O)—
K374
J3
S


3-0828
—(CH2)2
—C(═O)—
K375
J3
S


3-0829
—(CH2)2
—C(═O)—
K376
J3
S


3-0830
—(CH2)2
—C(═O)—
K377
J3
S


3-0831
—(CH2)2
—C(═O)—
K378
J3
S


3-0832
—(CH2)2
—C(═O)—
K379
J3
S





















TABLE 129








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0833
—(CH2)2
—C(═O)—
K380
J3
S


3-0834
—(CH2)2
—C(═O)—
K381
J3
S


3-0835
—(CH2)2
—C(═O)—
K383
J3
S


3-0836
—(CH2)2
—C(═O)—
K384
J3
S


3-0837
—(CH2)2
—C(═O)—
K385
J3
S


3-0838
—(CH2)2
—C(═O)—
K386
J3
S


3-0839
—(CH2)2
—C(═O)—
K387
J3
S


3-0840
—(CH2)2
—C(═O)—
K388
J3
S


3-0841
—(CH2)2
—C(═O)—
K389
J3
S


3-0842
—(CH2)2
—C(═O)—
K390
J3
S


3-0843
—(CH2)2
—C(═O)—
K391
J3
S


3-0844
—(CH2)2
—C(═O)—
K392
J3
S


3-0845
—(CH2)2
—C(═O)—
K393
J3
S


3-0846
—(CH2)2
—C(═O)—
K394
J3
S


3-0847
—(CH2)2
—C(═O)—
K395
J3
S


3-0848
—(CH2)2
—C(═O)—
K396
J3
S


3-0849
—(CH2)2
—C(═O)—
K398
J3
S


3-0850
—(CH2)2
—C(═O)—
K405
J3
S


3-0851
—(CH2)2
—C(═O)—
K406
J3
S


3-0852
—(CH2)2
—C(═O)—
K407
J3
S


3-0853
—(CH2)2
—C(═O)—
K408
J3
S


3-0854
—(CH2)2
—C(═O)—
K409
J3
S


3-0855
—(CH2)2
—C(═O)—
K410
J3
S


3-0856
—(CH2)2
—C(═O)—
K411
J3
S


3-0857
—(CH2)2
—C(═O)—
K412
J3
S


3-0858
—(CH2)2
—C(═O)—
K413
J3
S


3-0859
—(CH2)2
—C(═O)—
K414
J3
S


3-0860
—(CH2)2
—C(═O)—
K415
J3
S


3-0861
—(CH2)2
—C(═O)—
K416
J3
S


3-0862
—(CH2)2
—C(═O)—
K417
J3
S


3-0863
—(CH2)2
—C(═O)—
K419
J3
S


3-0864
—(CH2)2
—C(═O)—
K420
J3
S





















TABLE 130








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0865
—(CH2)2
—C(═O)—
K421
J3
S


3-0866
—(CH2)2
—C(═O)—
K726
J3
S


3-0867
—(CH2)2
—C(═O)—
K727
J3
S


3-0868
—(CH2)2
—C(═O)—
K728
J3
S


3-0869
—(CH2)2
—C(═O)—
K729
J3
S


3-0870
—(CH2)2
—C(═O)—
K730
J3
S


3-0871
—(CH2)2
—C(═O)—
K731
J3
S


3-0872
—(CH2)2
—C(═O)—
K732
J3
S


3-0873
—(CH2)2
—C(═O)—
K733
J3
S


3-0874
—(CH2)2
—C(═O)—
K734
J3
S


3-0875
—(CH2)2
—C(═O)—
K735
J3
S


3-0876
—(CH2)2
—C(═O)—
K736
J3
S


3-0877
—(CH2)2
—C(═O)—
K737
J3
S


3-0878
—(CH2)2
—C(═O)—
K738
J3
S


3-0879
—(CH2)2
—C(═O)—
K739
J3
S


3-0880
—(CH2)2
—C(═O)—
K740
J3
S


3-0881
—(CH2)2
—C(═O)—
K741
J3
S


3-0882
—(CH2)2
—C(═O)—
K742
J3
S


3-0883
—(CH2)2
—C(═O)—
K743
J3
S


3-0884
—(CH2)2
—C(═O)—
K744
J3
S


3-0885
—(CH2)2
—C(═O)—
K745
J3
S


3-0886
—(CH2)2
—C(═O)—
K746
J3
S


3-0887
—(CH2)2
—C(═O)—
K747
J3
S


3-0888
—(CH2)2
—C(═O)—
K748
J3
S


3-0889
—(CH2)2
—C(═O)—
K749
J3
S


3-0890
—(CH2)2
—C(═O)—
K750
J3
S


3-0891
—(CH2)2
—C(═O)—
K751
J3
S


3-0892
—(CH2)2
—C(═O)—
K752
J3
S


3-0893
—(CH2)2
—C(═O)—
K753
J3
S


3-0894
—(CH2)2
—C(═O)—
K754
J3
S


3-0895
—(CH2)2
—C(═O)—
K755
J3
S


3-0896
—(CH2)2
—C(═O)—
K756
J3
S





















TABLE 131








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0897
—(CH2)2
—C(═O)—
K757
J3
S


3-0898
—(CH2)2
—C(═O)—
K316
J9
S


3-0899
—(CH2)2
—C(═O)—
K321
J9
S


3-0900
—(CH2)2
—C(═O)—
K322
J9
S


3-0901
—(CH2)2
—C(═O)—
K323
J9
S


3-0902
—(CH2)2
—C(═O)—
K324
J9
S


3-0903
—(CH2)2
—C(═O)—
K326
J9
S


3-0904
—(CH2)2
—C(═O)—
K327
J9
S


3-0905
—(CH2)2
—C(═O)—
K328
J9
S


3-0906
—(CH2)2
—C(═O)—
K329
J9
S


3-0907
—(CH2)2
—C(═O)—
K333
J9
S


3-0908
—(CH2)2
—C(═O)—
K334
J9
S


3-0909
—(CH2)2
—C(═O)—
K341
J9
S


3-0910
—(CH2)2
—C(═O)—
K342
J9
S


3-0911
—(CH2)2
—C(═O)—
K344
J9
S


3-0912
—(CH2)2
—C(═O)—
K345
J9
S


3-0913
—(CH2)2
—C(═O)—
K346
J9
S


3-0914
—(CH2)2
—C(═O)—
K347
J9
S


3-0915
—(CH2)2
—C(═O)—
K348
J9
S


3-0916
—(CH2)2
—C(═O)—
K349
J9
S


3-0917
—(CH2)2
—C(═O)—
K350
J9
S


3-0918
—(CH2)2
—C(═O)—
K351
J9
S


3-0919
—(CH2)2
—C(═O)—
K352
J9
S


3-0920
—(CH2)2
—C(═O)—
K353
J9
S


3-0921
—(CH2)2
—C(═O)—
K354
J9
S


3-0922
—(CH2)2
—C(═O)—
K356
J9
S


3-0923
—(CH2)2
—C(═O)—
K357
J9
S


3-0924
—(CH2)2
—C(═O)—
K359
J9
S


3-0925
—(CH2)2
—C(═O)—
K360
J9
S


3-0926
—(CH2)2
—C(═O)—
K361
J9
S


3-0927
—(CH2)2
—C(═O)—
K362
J9
S


3-0928
—(CH2)2
—C(═O)—
K363
J9
S





















TABLE 132








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0929
—(CH2)2
—C(═O)—
K366
J9
S


3-0930
—(CH2)2
—C(═O)—
K370
J9
S


3-0931
—(CH2)2
—C(═O)—
K375
J9
S


3-0932
—(CH2)2
—C(═O)—
K376
J9
S


3-0933
—(CH2)2
—C(═O)—
K378
J9
S


3-0934
—(CH2)2
—C(═O)—
K379
J9
S


3-0935
—(CH2)2
—C(═O)—
K383
J9
S


3-0936
—(CH2)2
—C(═O)—
K384
J9
S


3-0937
—(CH2)2
—C(═O)—
K385
J9
S


3-0938
—(CH2)2
—C(═O)—
K386
J9
S


3-0939
—(CH2)2
—C(═O)—
K387
J9
S


3-0940
—(CH2)2
—C(═O)—
K388
J9
S


3-0941
—(CH2)2
—C(═O)—
K389
J9
S


3-0942
—(CH2)2
—C(═O)—
K390
J9
S


3-0943
—(CH2)2
—C(═O)—
K394
J9
S


3-0944
—(CH2)2
—C(═O)—
K395
J9
S


3-0945
—(CH2)2
—C(═O)—
K396
J9
S


3-0946
—(CH2)2
—C(═O)—
K398
J9
S


3-0947
—(CH2)2
—C(═O)—
K405
J9
S


3-0948
—(CH2)2
—C(═O)—
K406
J9
S


3-0949
—(CH2)2
—C(═O)—
K407
J9
S


3-0950
—(CH2)2
—C(═O)—
K408
J9
S


3-0951
—(CH2)2
—C(═O)—
K409
J9
S


3-0952
—(CH2)2
—C(═O)—
K410
J9
S


3-0953
—(CH2)2
—C(═O)—
K411
J9
S


3-0954
—(CH2)2
—C(═O)—
K412
J9
S


3-0955
—(CH2)2
—C(═O)—
K413
J9
S


3-0956
—(CH2)2
—C(═O)—
K414
J9
S


3-0957
—(CH2)2
—C(═O)—
K415
J9
S


3-0958
—(CH2)2
—C(═O)—
K416
J9
S


3-0959
—(CH2)2
—C(═O)—
K417
J9
S


3-0960
—(CH2)2
—C(═O)—
K419
J9
S





















TABLE 133








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0961
—(CH2)2
—C(═O)—
K421
J9
S


3-0962
—(CH2)2
—C(═O)—
K726
J9
S


3-0963
—(CH2)2
—C(═O)—
K727
J9
S


3-0964
—(CH2)2
—C(═O)—
K728
J9
S


3-0965
—(CH2)2
—C(═O)—
K729
J9
S


3-0966
—(CH2)2
—C(═O)—
K730
J9
S


3-0967
—(CH2)2
—C(═O)—
K731
J9
S


3-0968
—(CH2)2
—C(═O)—
K732
J9
S


3-0969
—(CH2)2
—C(═O)—
K733
J9
S


3-0970
—(CH2)2
—C(═O)—
K734
J9
S


3-0971
—(CH2)2
—C(═O)—
K735
J9
S


3-0972
—(CH2)2
—C(═O)—
K736
J9
S


3-0973
—(CH2)2
—C(═O)—
K737
J9
S


3-0974
—(CH2)2
—C(═O)—
K738
J9
S


3-0975
—(CH2)2
—C(═O)—
K739
J9
S


3-0976
—(CH2)2
—C(═O)—
K740
J9
S


3-0977
—(CH2)2
—C(═O)—
K741
J9
S


3-0978
—(CH2)2
—C(═O)—
K742
J9
S


3-0979
—(CH2)2
—C(═O)—
K743
J9
S


3-0980
—(CH2)2
—C(═O)—
K744
J9
S


3-0981
—(CH2)2
—C(═O)—
K745
J9
S


3-0982
—(CH2)2
—C(═O)—
K746
J9
S


3-0983
—(CH2)2
—C(═O)—
K747
J9
S


3-0984
—(CH2)2
—C(═O)—
K748
J9
S


3-0985
—(CH2)2
—C(═O)—
K749
J9
S


3-0986
—(CH2)2
—C(═O)—
K750
J9
S


3-0987
—(CH2)2
—C(═O)—
K751
J9
S


3-0988
—(CH2)2
—C(═O)—
K752
J9
S


3-0989
—(CH2)2
—C(═O)—
K753
J9
S


3-0990
—(CH2)2
—C(═O)—
K754
J9
S


3-0991
—(CH2)2
—C(═O)—
K755
J9
S


3-0992
—(CH2)2
—C(═O)—
K756
J9
S





















TABLE 134








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-0993
—(CH2)2
—C(═O)—
K757
J9
S


3-0994
—(CH2)2
—C(═O)—
K314
J126
S


3-0995
—(CH2)2
—C(═O)—
K315
J126
S


3-0996
—(CH2)2
—C(═O)—
K316
J126
S


3-0997
—(CH2)2
—C(═O)—
K317
J126
S


3-0998
—(CH2)2
—C(═O)—
K318
J126
S


3-0999
—(CH2)2
—C(═O)—
K320
J126
S


3-1000
—(CH2)2
—C(═O)—
K321
J126
S


3-1001
—(CH2)2
—C(═O)—
K322
J126
S


3-1002
—(CH2)2
—C(═O)—
K323
J126
S


3-1003
—(CH2)2
—C(═O)—
K324
J126
S


3-1004
—(CH2)2
—C(═O)—
K325
J126
S


3-1005
—(CH2)2
—C(═O)—
K326
J126
S


3-1006
—(CH2)2
—C(═O)—
K327
J126
S


3-1007
—(CH2)2
—C(═O)—
K328
J126
S


3-1008
—(CH2)2
—C(═O)—
K329
J126
S


3-1009
—(CH2)2
—C(═O)—
K330
J126
S


3-1010
—(CH2)2
—C(═O)—
K331
J126
S


3-1011
—(CH2)2
—C(═O)—
K332
J126
S


3-1012
—(CH2)2
—C(═O)—
K333
J126
S


3-1013
—(CH2)2
—C(═O)—
K334
J126
S


3-1014
—(CH2)2
—C(═O)—
K335
J126
S


3-1015
—(CH2)2
—C(═O)—
K337
J126
S


3-1016
—(CH2)2
—C(═O)—
K338
J126
S


3-1017
—(CH2)2
—C(═O)—
K339
J126
S


3-1018
—(CH2)2
—C(═O)—
K340
J126
S


3-1019
—(CH2)2
—C(═O)—
K341
J126
S


3-1020
—(CH2)2
—C(═O)—
K342
J126
S


3-1021
—(CH2)2
—C(═O)—
K343
J126
S


3-1022
—(CH2)2
—C(═O)—
K344
J126
S


3-1023
—(CH2)2
—C(═O)—
K345
J126
S


3-1024
—(CH2)2
—C(═O)—
K346
J126
S





















TABLE 135








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1025
—(CH2)2
—C(═O)—
K347
J126
S


3-1026
—(CH2)2
—C(═O)—
K348
J126
S


3-1027
—(CH2)2
—C(═O)—
K349
J126
S


3-1028
—(CH2)2
—C(═O)—
K350
J126
S


3-1029
—(CH2)2
—C(═O)—
K351
J126
S


3-1030
—(CH2)2
—C(═O)—
K352
J126
S


3-1031
—(CH2)2
—C(═O)—
K353
J126
S


3-1032
—(CH2)2
—C(═O)—
K355
J126
S


3-1033
—(CH2)2
—C(═O)—
K356
J126
S


3-1034
—(CH2)2
—C(═O)—
K357
J126
S


3-1035
—(CH2)2
—C(═O)—
K359
J126
S


3-1036
—(CH2)2
—C(═O)—
K360
J126
S


3-1037
—(CH2)2
—C(═O)—
K361
J126
S


3-1038
—(CH2)2
—C(═O)—
K362
J126
S


3-1039
—(CH2)2
—C(═O)—
K363
J126
S


3-1040
—(CH2)2
—C(═O)—
K364
J126
S


3-1041
—(CH2)2
—C(═O)—
K365
J126
S


3-1042
—(CH2)2
—C(═O)—
K366
J126
S


3-1043
—(CH2)2
—C(═O)—
K367
J126
S


3-1044
—(CH2)2
—C(═O)—
K368
J126
S


3-1045
—(CH2)2
—C(═O)—
K369
J126
S


3-1046
—(CH2)2
—C(═O)—
K370
J126
S


3-1047
—(CH2)2
—C(═O)—
K371
J126
S


3-1048
—(CH2)2
—C(═O)—
K372
J126
S


3-1049
—(CH2)2
—C(═O)—
K373
J126
S


3-1050
—(CH2)2
—C(═O)—
K374
J126
S


3-1051
—(CH2)2
—C(═O)—
K375
J126
S


3-1052
—(CH2)2
—C(═O)—
K376
J126
S


3-1053
—(CH2)2
—C(═O)—
K377
J126
S


3-1054
—(CH2)2
—C(═O)—
K378
J126
S


3-1055
—(CH2)2
—C(═O)—
K379
J126
S


3-1056
—(CH2)2
—C(═O)—
K380
J126
S





















TABLE 136








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1057
—(CH2)2
—C(═O)—
K383
J78
S


3-1058
—(CH2)2
—C(═O)—
K384
J78
S


3-1059
—(CH2)2
—C(═O)—
K385
J78
S


3-1060
—(CH2)2
—C(═O)—
K386
J78
S


3-1061
—(CH2)2
—C(═O)—
K387
J78
S


3-1062
—(CH2)2
—C(═O)—
K388
J78
S


3-1063
—(CH2)2
—C(═O)—
K389
J78
S


3-1064
—(CH2)2
—C(═O)—
K390
J78
S


3-1065
—(CH2)2
—C(═O)—
K391
J78
S


3-1066
—(CH2)2
—C(═O)—
K392
J78
S


3-1067
—(CH2)2
—C(═O)—
K393
J78
S


3-1068
—(CH2)2
—C(═O)—
K394
J78
S


3-1069
—(CH2)2
—C(═O)—
K395
J78
S


3-1070
—(CH2)2
—C(═O)—
K396
J78
S


3-1071
—(CH2)2
—C(═O)—
K398
J78
S


3-1072
—(CH2)2
—C(═O)—
K405
J78
S


3-1073
—(CH2)2
—C(═O)—
K406
J78
S


3-1074
—(CH2)2
—C(═O)—
K407
J78
S


3-1075
—(CH2)2
—C(═O)—
K408
J78
S


3-1076
—(CH2)2
—C(═O)—
K409
J78
S


3-1077
—(CH2)2
—C(═O)—
K410
J78
S


3-1078
—(CH2)2
—C(═O)—
K411
J78
S


3-1079
—(CH2)2
—C(═O)—
K412
J78
S


3-1080
—(CH2)2
—C(═O)—
K413
J78
S


3-1081
—(CH2)2
—C(═O)—
K414
J78
S


3-1082
—(CH2)2
—C(═O)—
K415
J78
S


3-1083
—(CH2)2
—C(═O)—
K416
J78
S


3-1084
—(CH2)2
—C(═O)—
K417
J78
S


3-1085
—(CH2)2
—C(═O)—
K419
J78
S


3-1086
—(CH2)2
—C(═O)—
K420
J78
S


3-1087
—(CH2)2
—C(═O)—
K421
J78
S


3-1088
—(CH2)2
—C(═O)—
K726
J78
S





















TABLE 137








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1089
—(CH2)2
—C(═O)—
K727
J78
S


3-1090
—(CH2)2
—C(═O)—
K728
J78
S


3-1091
—(CH2)2
—C(═O)—
K729
J78
S


3-1092
—(CH2)2
—C(═O)—
K730
J78
S


3-1093
—(CH2)2
—C(═O)—
K731
J78
S


3-1094
—(CH2)2
—C(═O)—
K732
J78
S


3-1095
—(CH2)2
—C(═O)—
K733
J78
S


3-1096
—(CH2)2
—C(═O)—
K734
J78
S


3-1097
—(CH2)2
—C(═O)—
K735
J78
S


3-1098
—(CH2)2
—C(═O)—
K736
J78
S


3-1099
—(CH2)2
—C(═O)—
K737
J78
S


3-1100
—(CH2)2
—C(═O)—
K738
J78
S


3-1101
—(CH2)2
—C(═O)—
K739
J78
S


3-1102
—(CH2)2
—C(═O)—
K740
J78
S


3-1103
—(CH2)2
—C(═O)—
K741
J78
S


3-1104
—(CH2)2
—C(═O)—
K742
J78
S


3-1105
—(CH2)2
—C(═O)—
K743
J78
S


3-1106
—(CH2)2
—C(═O)—
K744
J78
S


3-1107
—(CH2)2
—C(═O)—
K745
J78
S


3-1108
—(CH2)2
—C(═O)—
K746
J78
S


3-1109
—(CH2)2
—C(═O)—
K747
J78
S


3-1110
—(CH2)2
—C(═O)—
K748
J78
S


3-1111
—(CH2)2
—C(═O)—
K749
J78
S


3-1112
—(CH2)2
—C(═O)—
K750
J78
S


3-1113
—(CH2)2
—C(═O)—
K751
J78
S


3-1114
—(CH2)2
—C(═O)—
K752
J78
S


3-1115
—(CH2)2
—C(═O)—
K753
J78
S


3-1116
—(CH2)2
—C(═O)—
K754
J78
S


3-1117
—(CH2)2
—C(═O)—
K755
J78
S


3-1118
—(CH2)2
—C(═O)—
K756
J78
S


3-1119
—(CH2)2
—C(═O)—
K757
J78
S


3-1120
—(CH2)2
—C(═O)—
K314
J129
S





















TABLE 138








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1121
—(CH2)2
—C(═O)—
K315
J129
S


3-1122
—(CH2)2
—C(═O)—
K316
J129
S


3-1123
—(CH2)2
—C(═O)—
K317
J129
S


3-1124
—(CH2)2
—C(═O)—
K318
J129
S


3-1125
—(CH2)2
—C(═O)—
K320
J129
S


3-1126
—(CH2)2
—C(═O)—
K321
J129
S


3-1127
—(CH2)2
—C(═O)—
K322
J129
S


3-1128
—(CH2)2
—C(═O)—
K323
J129
S


3-1129
—(CH2)2
—C(═O)—
K324
J129
S


3-1130
—(CH2)2
—C(═O)—
K325
J129
S


3-1131
—(CH2)2
—C(═O)—
K326
J129
S


3-1132
—(CH2)2
—C(═O)—
K327
J129
S


3-1133
—(CH2)2
—C(═O)—
K328
J129
S


3-1134
—(CH2)2
—C(═O)—
K329
J129
S


3-1135
—(CH2)2
—C(═O)—
K330
J129
S


3-1136
—(CH2)2
—C(═O)—
K331
J129
S


3-1137
—(CH2)2
—C(═O)—
K332
J129
S


3-1138
—(CH2)2
—C(═O)—
K333
J129
S


3-1139
—(CH2)2
—C(═O)—
K334
J129
S


3-1140
—(CH2)2
—C(═O)—
K335
J129
S


3-1141
—(CH2)2
—C(═O)—
K336
J129
S


3-1142
—(CH2)2
—C(═O)—
K337
J129
S


3-1143
—(CH2)2
—C(═O)—
K338
J129
S


3-1144
—(CH2)2
—C(═O)—
K339
J129
S


3-1145
—(CH2)2
—C(═O)—
K340
J129
S


3-1146
—(CH2)2
—C(═O)—
K341
J129
S


3-1147
—(CH2)2
—C(═O)—
K342
J129
S


3-1148
—(CH2)2
—C(═O)—
K343
J129
S


3-1149
—(CH2)2
—C(═O)—
K344
J129
S


3-1150
—(CH2)2
—C(═O)—
K345
J129
S


3-1151
—(CH2)2
—C(═O)—
K346
J129
S


3-1152
—(CH2)2
—C(═O)—
K347
J129
S





















TABLE 139








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1153
—(CH2)2
—C(═O)—
K348
J129
S


3-1154
—(CH2)2
—C(═O)—
K349
J129
S


3-1155
—(CH2)2
—C(═O)—
K350
J129
S


3-1156
—(CH2)2
—C(═O)—
K351
J129
S


3-1157
—(CH2)2
—C(═O)—
K352
J129
S


3-1158
—(CH2)2
—C(═O)—
K353
J129
S


3-1159
—(CH2)2
—C(═O)—
K355
J129
S


3-1160
—(CH2)2
—C(═O)—
K356
J129
S


3-1161
—(CH2)2
—C(═O)—
K357
J129
S


3-1162
—(CH2)2
—C(═O)—
K358
J129
S


3-1163
—(CH2)2
—C(═O)—
K359
J129
S


3-1164
—(CH2)2
—C(═O)—
K360
J129
S


3-1165
—(CH2)2
—C(═O)—
K361
J129
S


3-1166
—(CH2)2
—C(═O)—
K362
J129
S


3-1167
—(CH2)2
—C(═O)—
K363
J129
S


3-1168
—(CH2)2
—C(═O)—
K364
J129
S


3-1169
—(CH2)2
—C(═O)—
K365
J129
S


3-1170
—(CH2)2
—C(═O)—
K366
J129
S


3-1171
—(CH2)2
—C(═O)—
K367
J129
S


3-1172
—(CH2)2
—C(═O)—
K368
J129
S


3-1173
—(CH2)2
—C(═O)—
K369
J129
S


3-1174
—(CH2)2
—C(═O)—
K370
J129
S


3-1175
—(CH2)2
—C(═O)—
K371
J129
S


3-1176
—(CH2)2
—C(═O)—
K372
J129
S


3-1177
—(CH2)2
—C(═O)—
K373
J129
S


3-1178
—(CH2)2
—C(═O)—
K374
J129
S


3-1179
—(CH2)2
—C(═O)—
K375
J129
S


3-1180
—(CH2)2
—C(═O)—
K376
J129
S


3-1181
—(CH2)2
—C(═O)—
K377
J129
S


3-1182
—(CH2)2
—C(═O)—
K378
J129
S


3-1183
—(CH2)2
—C(═O)—
K379
J129
S


3-1184
—(CH2)2
—C(═O)—
K380
J129
S





















TABLE 140








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1185
—(CH2)2
—C(═O)—
K381
J130
S


3-1186
—(CH2)2
—C(═O)—
K383
J130
S


3-1187
—(CH2)2
—C(═O)—
K384
J130
S


3-1188
—(CH2)2
—C(═O)—
K385
J130
S


3-1189
—(CH2)2
—C(═O)—
K386
J130
S


3-1190
—(CH2)2
—C(═O)—
K387
J130
S


3-1191
—(CH2)2
—C(═O)—
K388
J130
S


3-1192
—(CH2)2
—C(═O)—
K389
J130
S


3-1193
—(CH2)2
—C(═O)—
K390
J130
S


3-1194
—(CH2)2
—C(═O)—
K391
J130
S


3-1195
—(CH2)2
—C(═O)—
K392
J130
S


3-1196
—(CH2)2
—C(═O)—
K393
J130
S


3-1197
—(CH2)2
—C(═O)—
K394
J130
S


3-1198
—(CH2)2
—C(═O)—
K395
J130
S


3-1199
—(CH2)2
—C(═O)—
K396
J130
S


3-1200
—(CH2)2
—C(═O)—
K398
J130
S


3-1201
—(CH2)2
—C(═O)—
K405
J130
S


3-1202
—(CH2)2
—C(═O)—
K406
J130
S


3-1203
—(CH2)2
—C(═O)—
K407
J130
S


3-1204
—(CH2)2
—C(═O)—
K408
J130
S


3-1205
—(CH2)2
—C(═O)—
K409
J130
S


3-1206
—(CH2)2
—C(═O)—
K410
J130
S


3-1207
—(CH2)2
—C(═O)—
K411
J130
S


3-1208
—(CH2)2
—C(═O)—
K412
J130
S


3-1209
—(CH2)2
—C(═O)—
K413
J130
S


3-1210
—(CH2)2
—C(═O)—
K414
J130
S


3-1211
—(CH2)2
—C(═O)—
K415
J130
S


3-1212
—(CH2)2
—C(═O)—
K416
J130
S


3-1213
—(CH2)2
—C(═O)—
K417
J130
S


3-1214
—(CH2)2
—C(═O)—
K419
J130
S


3-1215
—(CH2)2
—C(═O)—
K420
J130
S


3-1216
—(CH2)2
—C(═O)—
K421
J130
S





















TABLE 141








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1217
—(CH2)2
—C(═O)—
K726
J130
S


3-1218
—(CH2)2
—C(═O)—
K727
J130
S


3-1219
—(CH2)2
—C(═O)—
K728
J130
S


3-1220
—(CH2)2
—C(═O)—
K729
J130
S


3-1221
—(CH2)2
—C(═O)—
K730
J130
S


3-1222
—(CH2)2
—C(═O)—
K731
J130
S


3-1223
—(CH2)2
—C(═O)—
K732
J130
S


3-1224
—(CH2)2
—C(═O)—
K733
J130
S


3-1225
—(CH2)2
—C(═O)—
K734
J130
S


3-1226
—(CH2)2
—C(═O)—
K735
J130
S


3-1227
—(CH2)2
—C(═O)—
K736
J130
S


3-1228
—(CH2)2
—C(═O)—
K737
J130
S


3-1229
—(CH2)2
—C(═O)—
K738
J130
S


3-1230
—(CH2)2
—C(═O)—
K739
J130
S


3-1231
—(CH2)2
—C(═O)—
K740
J130
S


3-1232
—(CH2)2
—C(═O)—
K741
J130
S


3-1233
—(CH2)2
—C(═O)—
K742
J130
S


3-1234
—(CH2)2
—C(═O)—
K743
J130
S


3-1235
—(CH2)2
—C(═O)—
K744
J130
S


3-1236
—(CH2)2
—C(═O)—
K745
J130
S


3-1237
—(CH2)2
—C(═O)—
K746
J130
S


3-1238
—(CH2)2
—C(═O)—
K747
J130
S


3-1239
—(CH2)2
—C(═O)—
K748
J130
S


3-1240
—(CH2)2
—C(═O)—
K749
J130
S


3-1241
—(CH2)2
—C(═O)—
K750
J130
S


3-1242
—(CH2)2
—C(═O)—
K751
J130
S


3-1243
—(CH2)2
—C(═O)—
K752
J130
S


3-1244
—(CH2)2
—C(═O)—
K753
J130
S


3-1245
—(CH2)2
—C(═O)—
K754
J130
S


3-1246
—(CH2)2
—C(═O)—
K755
J130
S


3-1247
—(CH2)2
—C(═O)—
K756
J130
S


3-1248
—(CH2)2
—C(═O)—
K757
J130
S





















TABLE 142








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1249
—(CH2)2
—C(═O)—
K314
J130
S


3-1250
—(CH2)2
—C(═O)—
K316
J130
S


3-1251
—(CH2)2
—C(═O)—
K317
J130
S


3-1252
—(CH2)2
—C(═O)—
K318
J130
S


3-1253
—(CH2)2
—C(═O)—
K319
J130
S


3-1254
—(CH2)2
—C(═O)—
K320
J130
S


3-1255
—(CH2)2
—C(═O)—
K321
J130
S


3-1256
—(CH2)2
—C(═O)—
K322
J130
S


3-1257
—(CH2)2
—C(═O)—
K323
J130
S


3-1258
—(CH2)2
—C(═O)—
K324
J130
S


3-1259
—(CH2)2
—C(═O)—
K326
J130
S


3-1260
—(CH2)2
—C(═O)—
K327
J130
S


3-1261
—(CH2)2
—C(═O)—
K328
J130
S


3-1262
—(CH2)2
—C(═O)—
K329
J130
S


3-1263
—(CH2)2
—C(═O)—
K330
J130
S


3-1264
—(CH2)2
—C(═O)—
K331
J130
S


3-1265
—(CH2)2
—C(═O)—
K332
J130
S


3-1266
—(CH2)2
—C(═O)—
K333
J130
S


3-1267
—(CH2)2
—C(═O)—
K334
J130
S


3-1268
—(CH2)2
—C(═O)—
K335
J130
S


3-1269
—(CH2)2
—C(═O)—
K336
J130
S


3-1270
—(CH2)2
—C(═O)—
K338
J130
S


3-1271
—(CH2)2
—C(═O)—
K339
J130
S


3-1272
—(CH2)2
—C(═O)—
K340
J130
S


3-1273
—(CH2)2
—C(═O)—
K341
J130
S


3-1274
—(CH2)2
—C(═O)—
K342
J130
S


3-1275
—(CH2)2
—C(═O)—
K343
J130
S


3-1276
—(CH2)2
—C(═O)—
K344
J130
S


3-1277
—(CH2)2
—C(═O)—
K345
J130
S


3-1278
—(CH2)2
—C(═O)—
K346
J130
S


3-1279
—(CH2)2
—C(═O)—
K347
J130
S


3-1280
—(CH2)2
—C(═O)—
K348
J130
S





















TABLE 143








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1281
—(CH2)2
—C(═O)—
K349
J130
S


3-1282
—(CH2)2
—C(═O)—
K350
J130
S


3-1283
—(CH2)2
—C(═O)—
K351
J130
S


3-1284
—(CH2)2
—C(═O)—
K352
J130
S


3-1285
—(CH2)2
—C(═O)—
K353
J130
S


3-1286
—(CH2)2
—C(═O)—
K354
J130
S


3-1287
—(CH2)2
—C(═O)—
K356
J130
S


3-1288
—(CH2)2
—C(═O)—
K357
J130
S


3-1289
—(CH2)2
—C(═O)—
K358
J130
S


3-1290
—(CH2)2
—C(═O)—
K359
J130
S


3-1291
—(CH2)2
—C(═O)—
K360
J130
S


3-1292
—(CH2)2
—C(═O)—
K361
J130
S


3-1293
—(CH2)2
—C(═O)—
K362
J130
S


3-1294
—(CH2)2
—C(═O)—
K363
J130
S


3-1295
—(CH2)2
—C(═O)—
K364
J130
S


3-1296
—(CH2)2
—C(═O)—
K365
J130
S


3-1297
—(CH2)2
—C(═O)—
K366
J130
S


3-1298
—(CH2)2
—C(═O)—
K367
J130
S


3-1299
—(CH2)2
—C(═O)—
K368
J130
S


3-1300
—(CH2)2
—C(═O)—
K369
J130
S


3-1301
—(CH2)2
—C(═O)—
K370
J130
S


3-1302
—(CH2)2
—C(═O)—
K371
J130
S


3-1303
—(CH2)2
—C(═O)—
K372
J130
S


3-1304
—(CH2)2
—C(═O)—
K373
J130
S


3-1305
—(CH2)2
—C(═O)—
K374
J130
S


3-1306
—(CH2)2
—C(═O)—
K375
J130
S


3-1307
—(CH2)2
—C(═O)—
K376
J130
S


3-1308
—(CH2)2
—C(═O)—
K377
J130
S


3-1309
—(CH2)2
—C(═O)—
K378
J130
S


3-1310
—(CH2)2
—C(═O)—
K379
J130
S


3-1311
—(CH2)2
—C(═O)—
K380
J130
S


3-1312
—(CH2)2
—C(═O)—
K381
J138
S





















TABLE 144








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1313
—(CH2)2
—C(═O)—
K382
J138
S


3-1314
—(CH2)2
—C(═O)—
K383
J138
S


3-1315
—(CH2)2
—C(═O)—
K384
J138
S


3-1316
—(CH2)2
—C(═O)—
K385
J138
S


3-1317
—(CH2)2
—C(═O)—
K386
J138
S


3-1318
—(CH2)2
—C(═O)—
K388
J138
S


3-1319
—(CH2)2
—C(═O)—
K389
J138
S


3-1320
—(CH2)2
—C(═O)—
K390
J138
S


3-1321
—(CH2)2
—C(═O)—
K391
J138
S


3-1322
—(CH2)2
—C(═O)—
K392
J138
S


3-1323
—(CH2)2
—C(═O)—
K393
J138
S


3-1324
—(CH2)2
—C(═O)—
K394
J138
S


3-1325
—(CH2)2
—C(═O)—
K395
J138
S


3-1326
—(CH2)2
—C(═O)—
K396
J138
S


3-1327
—(CH2)2
—C(═O)—
K397
J138
S


3-1328
—(CH2)2
—C(═O)—
K398
J138
S


3-1329
—(CH2)2
—C(═O)—
K405
J138
S


3-1330
—(CH2)2
—C(═O)—
K406
J138
S


3-1331
—(CH2)2
—C(═O)—
K407
J138
S


3-1332
—(CH2)2
—C(═O)—
K408
J138
S


3-1333
—(CH2)2
—C(═O)—
K409
J138
S


3-1334
—(CH2)2
—C(═O)—
K410
J138
S


3-1335
—(CH2)2
—C(═O)—
K411
J138
S


3-1336
—(CH2)2
—C(═O)—
K412
J138
S


3-1337
—(CH2)2
—C(═O)—
K413
J138
S


3-1338
—(CH2)2
—C(═O)—
K414
J138
S


3-1339
—(CH2)2
—C(═O)—
K415
J138
S


3-1340
—(CH2)2
—C(═O)—
K416
J138
S


3-1341
—(CH2)2
—C(═O)—
K417
J138
S


3-1342
—(CH2)2
—C(═O)—
K419
J138
S


3-1343
—(CH2)2
—C(═O)—
K420
J138
S


3-1344
—(CH2)2
—C(═O)—
K421
J138
S





















TABLE 145








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1345
—(CH2)2
—C(═O)—
K726
J138
S


3-1346
—(CH2)2
—C(═O)—
K727
J138
S


3-1347
—(CH2)2
—C(═O)—
K728
J138
S


3-1348
—(CH2)2
—C(═O)—
K729
J138
S


3-1349
—(CH2)2
—C(═O)—
K730
J138
S


3-1350
—(CH2)2
—C(═O)—
K731
J138
S


3-1351
—(CH2)2
—C(═O)—
K732
J138
S


3-1352
—(CH2)2
—C(═O)—
K733
J138
S


3-1353
—(CH2)2
—C(═O)—
K734
J138
S


3-1354
—(CH2)2
—C(═O)—
K735
J138
S


3-1355
—(CH2)2
—C(═O)—
K736
J138
S


3-1356
—(CH2)2
—C(═O)—
K737
J138
S


3-1357
—(CH2)2
—C(═O)—
K738
J138
S


3-1358
—(CH2)2
—C(═O)—
K739
J138
S


3-1359
—(CH2)2
—C(═O)—
K740
J138
S


3-1360
—(CH2)2
—C(═O)—
K741
J138
S


3-1361
—(CH2)2
—C(═O)—
K742
J138
S


3-1362
—(CH2)2
—C(═O)—
K743
J138
S


3-1363
—(CH2)2
—C(═O)—
K744
J138
S


3-1364
—(CH2)2
—C(═O)—
K745
J138
S


3-1365
—(CH2)2
—C(═O)—
K746
J138
S


3-1366
—(CH2)2
—C(═O)—
K747
J138
S


3-1367
—(CH2)2
—C(═O)—
K748
J138
S


3-1368
—(CH2)2
—C(═O)—
K749
J138
S


3-1369
—(CH2)2
—C(═O)—
K750
J138
S


3-1370
—(CH2)2
—C(═O)—
K751
J138
S


3-1371
—(CH2)2
—C(═O)—
K752
J138
S


3-1372
—(CH2)2
—C(═O)—
K753
J138
S


3-1373
—(CH2)2
—C(═O)—
K754
J138
S


3-1374
—(CH2)2
—C(═O)—
K755
J138
S


3-1375
—(CH2)2
—C(═O)—
K756
J138
S


3-1376
—(CH2)2
—C(═O)—
K757
J138
S





















TABLE 146








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1377
—(CH2)2
—C(═O)—
K314
J1
S


3-1378
—(CH2)2
—C(═O)—
K315
J1
S


3-1379
—(CH2)2
—C(═O)—
K316
J2
S


3-1380
—(CH2)2
—C(═O)—
K317
J2
S


3-1381
—(CH2)2
—C(═O)—
K318
J4
S


3-1382
—(CH2)2
—C(═O)—
K319
J4
S


3-1383
—(CH2)2
—C(═O)—
K320
J10
S


3-1384
—(CH2)2
—C(═O)—
K321
J10
S


3-1385
—(CH2)2
—C(═O)—
K322
J19
S


3-1386
—(CH2)2
—C(═O)—
K323
J19
S


3-1387
—(CH2)2
—C(═O)—
K324
J14
S


3-1388
—(CH2)2
—C(═O)—
K325
J14
S


3-1389
—(CH2)2
—C(═O)—
K326
J22
S


3-1390
—(CH2)2
—C(═O)—
K327
J22
S


3-1391
—(CH2)2
—C(═O)—
K328
J72
S


3-1392
—(CH2)2
—C(═O)—
K329
J72
S


3-1393
—(CH2)2
—C(═O)—
K330
J74
S


3-1394
—(CH2)2
—C(═O)—
K331
J74
S


3-1395
—(CH2)2
—C(═O)—
K332
J75
S


3-1396
—(CH2)2
—C(═O)—
K333
J75
S


3-1397
—(CH2)2
—C(═O)—
K334
J77
S


3-1398
—(CH2)2
—C(═O)—
K335
J77
S


3-1399
—(CH2)2
—C(═O)—
K336
J96
S


3-1400
—(CH2)2
—C(═O)—
K337
J96
S


3-1401
—(CH2)2
—C(═O)—
K338
J174
S


3-1402
—(CH2)2
—C(═O)—
K339
J174
S


3-1403
—(CH2)2
—C(═O)—
K340
J176
S


3-1404
—(CH2)2
—C(═O)—
K341
J176
S


3-1405
—(CH2)2
—C(═O)—
K342
J177
S


3-1406
—(CH2)2
—C(═O)—
K343
J177
S


3-1407
—(CH2)2
—C(═O)—
K344
J189
S


3-1408
—(CH2)2
—C(═O)—
K345
J189
S





















TABLE 147








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1409
—(CH2)2
—C(═O)—
K346
J182
S


3-1410
—(CH2)2
—C(═O)—
K347
J182
S


3-1411
—(CH2)2
—C(═O)—
K348
J183
S


3-1412
—(CH2)2
—C(═O)—
K349
J183
S


3-1413
—(CH2)2
—C(═O)—
K350
J1
S


3-1414
—(CH2)2
—C(═O)—
K351
J1
S


3-1415
—(CH2)2
—C(═O)—
K352
J2
S


3-1416
—(CH2)2
—C(═O)—
K353
J2
S


3-1417
—(CH2)2
—C(═O)—
K354
J4
S


3-1418
—(CH2)2
—C(═O)—
K355
J4
S


3-1419
—(CH2)2
—C(═O)—
K356
J10
S


3-1420
—(CH2)2
—C(═O)—
K357
J10
S


3-1421
—(CH2)2
—C(═O)—
K359
J19
S


3-1422
—(CH2)2
—C(═O)—
K360
J14
S


3-1423
—(CH2)2
—C(═O)—
K361
J14
S


3-1424
—(CH2)2
—C(═O)—
K362
J22
S


3-1425
—(CH2)2
—C(═O)—
K363
J22
S


3-1426
—(CH2)2
—C(═O)—
K364
J72
S


3-1427
—(CH2)2
—C(═O)—
K365
J72
S


3-1428
—(CH2)2
—C(═O)—
K366
J74
S


3-1429
—(CH2)2
—C(═O)—
K367
J74
S


3-1430
—(CH2)2
—C(═O)—
K368
J75
S


3-1431
—(CH2)2
—C(═O)—
K369
J75
S


3-1432
—(CH2)2
—C(═O)—
K370
J77
S


3-1433
—(CH2)2
—C(═O)—
K371
J77
S


3-1434
—(CH2)2
—C(═O)—
K372
J96
S


3-1435
—(CH2)2
—C(═O)—
K373
J96
S


3-1436
—(CH2)2
—C(═O)—
K374
J174
S


3-1437
—(CH2)2
—C(═O)—
K375
J174
S


3-1438
—(CH2)2
—C(═O)—
K376
J176
S


3-1439
—(CH2)2
—C(═O)—
K377
J176
S


3-1440
—(CH2)2
—C(═O)—
K378
J177
S





















TABLE 148








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1441
—(CH2)2
—C(═O)—
K379
J177
S


3-1442
—(CH2)2
—C(═O)—
K380
J189
S


3-1443
—(CH2)2
—C(═O)—
K381
J189
S


3-1444
—(CH2)2
—C(═O)—
K382
J182
S


3-1445
—(CH2)2
—C(═O)—
K383
J182
S


3-1446
—(CH2)2
—C(═O)—
K384
J183
S


3-1447
—(CH2)2
—C(═O)—
K385
J183
S


3-1448
—(CH2)2
—C(═O)—
K386
J191
S


3-1449
—(CH2)2
—C(═O)—
K387
J191
S


3-1450
—(CH2)2
—C(═O)—
K388
J192
S


3-1451
—(CH2)2
—C(═O)—
K389
J192
S


3-1452
—(CH2)2
—C(═O)—
K390
J193
S


3-1453
—(CH2)2
—C(═O)—
K391
J193
S


3-1454
—(CH2)2
—C(═O)—
K392
J194
S


3-1455
—(CH2)2
—C(═O)—
K393
J194
S


3-1456
—(CH2)2
—C(═O)—
K394
J197
S


3-1457
—(CH2)2
—C(═O)—
K395
J197
S


3-1458
—(CH2)2
—C(═O)—
K396
J140
S


3-1459
—(CH2)2
—C(═O)—
K397
J140
S


3-1460
—(CH2)2
—C(═O)—
K398
J140
S


3-1461
—(CH2)2
—C(═O)—
K405
J140
S


3-1462
—(CH2)2
—C(═O)—
K406
J140
S


3-1463
—(CH2)2
—C(═O)—
K407
J140
S


3-1464
—(CH2)2
—C(═O)—
K408
J140
S


3-1465
—(CH2)2
—C(═O)—
K409
J140
S


3-1466
—(CH2)2
—C(═O)—
K410
J140
S


3-1467
—(CH2)2
—C(═O)—
K411
J140
S


3-1468
—(CH2)2
—C(═O)—
K412
J140
S


3-1469
—(CH2)2
—C(═O)—
K413
J140
S


3-1470
—(CH2)2
—C(═O)—
K414
J140
S


3-1471
—(CH2)2
—C(═O)—
K415
J140
S


3-1472
—(CH2)2
—C(═O)—
K416
J140
S





















TABLE 149








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1473
—(CH2)2
—C(═O)—
K417
J140
S


3-1474
—(CH2)2
—C(═O)—
K418
J140
S


3-1475
—(CH2)2
—C(═O)—
K419
J140
S


3-1476
—(CH2)2
—C(═O)—
K420
J140
S


3-1477
—(CH2)2
—C(═O)—
K421
J140
S


3-1478
—(CH2)2
—C(═O)—
K726
J140
S


3-1479
—(CH2)2
—C(═O)—
K727
J140
S


3-1480
—(CH2)2
—C(═O)—
K728
J140
S


3-1481
—(CH2)2
—C(═O)—
K729
J140
S


3-1482
—(CH2)2
—C(═O)—
K730
J140
S


3-1483
—(CH2)2
—C(═O)—
K731
J140
S


3-1484
—(CH2)2
—C(═O)—
K732
J140
S


3-1485
—(CH2)2
—C(═O)—
K733
J140
S


3-1486
—(CH2)2
—C(═O)—
K734
J140
S


3-1487
—(CH2)2
—C(═O)—
K735
J140
S


3-1488
—(CH2)2
—C(═O)—
K736
J140
S


3-1489
—(CH2)2
—C(═O)—
K737
J140
S


3-1490
—(CH2)2
—C(═O)—
K738
J140
S


3-1491
—(CH2)2
—C(═O)—
K739
J140
S


3-1492
—(CH2)2
—C(═O)—
K740
J140
S


3-1493
—(CH2)2
—C(═O)—
K741
J140
S


3-1494
—(CH2)2
—C(═O)—
K742
J140
S


3-1495
—(CH2)2
—C(═O)—
K743
J140
S


3-1496
—(CH2)2
—C(═O)—
K744
J140
S


3-1497
—(CH2)2
—C(═O)—
K745
J140
S


3-1498
—(CH2)2
—C(═O)—
K746
J140
S


3-1499
—(CH2)2
—C(═O)—
K747
J140
S


3-1500
—(CH2)2
—C(═O)—
K748
J140
S


3-1501
—(CH2)2
—C(═O)—
K749
J140
S


3-1502
—(CH2)2
—C(═O)—
K750
J140
S


3-1503
—(CH2)2
—C(═O)—
K751
J140
S


3-1504
—(CH2)2
—C(═O)—
K752
J140
S





















TABLE 150








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1505
—(CH2)2
—C(═O)—
K753
J140
S


3-1506
—(CH2)2
—C(═O)—
K754
J140
S


3-1507
—(CH2)2
—C(═O)—
K755
J140
S


3-1508
—(CH2)2
—C(═O)—
K756
J140
S


3-1509
—(CH2)2
—C(═O)—
K757
J140
S


3-1510
—(CH2)2
—C(═O)—
K314
J3
O


3-1511
—(CH2)2
—C(═O)—
K315
J3
O


3-1512
—(CH2)2
—C(═O)—
K316
J3
O


3-1513
—(CH2)2
—C(═O)—
K317
J3
O


3-1514
—(CH2)2
—C(═O)—
K318
J3
O


3-1515
—(CH2)2
—C(═O)—
K319
J3
O


3-1516
—(CH2)2
—C(═O)—
K320
J3
O


3-1517
—(CH2)2
—C(═O)—
K321
J3
O


3-1518
—(CH2)2
—C(═O)—
K322
J3
O


3-1519
—(CH2)2
—C(═O)—
K323
J3
O


3-1520
—(CH2)2
—C(═O)—
K324
J3
O


3-1521
—(CH2)2
—C(═O)—
K325
J3
O


3-1522
—(CH2)2
—C(═O)—
K326
J3
O


3-1523
—(CH2)2
—C(═O)—
K327
J3
O


3-1524
—(CH2)2
—C(═O)—
K328
J3
O


3-1525
—(CH2)2
—C(═O)—
K329
J3
O


3-1526
—(CH2)2
—C(═O)—
K330
J3
O


3-1527
—(CH2)2
—C(═O)—
K331
J3
O


3-1528
—(CH2)2
—C(═O)—
K332
J3
O


3-1529
—(CH2)2
—C(═O)—
K333
J3
O


3-1530
—(CH2)2
—C(═O)—
K334
J9
O


3-1531
—(CH2)2
—C(═O)—
K335
J9
O


3-1532
—(CH2)2
—C(═O)—
K336
J9
O


3-1533
—(CH2)2
—C(═O)—
K337
J9
O


3-1534
—(CH2)2
—C(═O)—
K338
J9
O


3-1535
—(CH2)2
—C(═O)—
K339
J9
O


3-1536
—(CH2)2
—C(═O)—
K340
J9
O





















TABLE 151








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1537
—(CH2)2
—C(═O)—
K341
J9
O


3-1538
—(CH2)2
—C(═O)—
K342
J9
O


3-1539
—(CH2)2
—C(═O)—
K343
J9
O


3-1540
—(CH2)2
—C(═O)—
K345
J9
O


3-1541
—(CH2)2
—C(═O)—
K346
J9
O


3-1542
—(CH2)2
—C(═O)—
K347
J9
O


3-1543
—(CH2)2
—C(═O)—
K348
J9
O


3-1544
—(CH2)2
—C(═O)—
K349
J9
O


3-1545
—(CH2)2
—C(═O)—
K350
J9
O


3-1546
—(CH2)2
—C(═O)—
K351
J9
O


3-1547
—(CH2)2
—C(═O)—
K352
J9
O


3-1548
—(CH2)2
—C(═O)—
K353
J9
O


3-1549
—(CH2)2
—C(═O)—
K354
J126
O


3-1550
—(CH2)2
—C(═O)—
K355
J126
O


3-1551
—(CH2)2
—C(═O)—
K356
J126
O


3-1552
—(CH2)2
—C(═O)—
K357
J126
O


3-1553
—(CH2)2
—C(═O)—
K358
J126
O


3-1554
—(CH2)2
—C(═O)—
K359
J126
O


3-1555
—(CH2)2
—C(═O)—
K360
J126
O


3-1556
—(CH2)2
—C(═O)—
K361
J126
O


3-1557
—(CH2)2
—C(═O)—
K362
J126
O


3-1558
—(CH2)2
—C(═O)—
K363
J126
O


3-1559
—(CH2)2
—C(═O)—
K364
J126
O


3-1560
—(CH2)2
—C(═O)—
K365
J126
O


3-1561
—(CH2)2
—C(═O)—
K366
J126
O


3-1562
—(CH2)2
—C(═O)—
K367
J126
O


3-1563
—(CH2)2
—C(═O)—
K368
J126
O


3-1564
—(CH2)2
—C(═O)—
K369
J126
O


3-1565
—(CH2)2
—C(═O)—
K370
J126
O


3-1566
—(CH2)2
—C(═O)—
K371
J126
O


3-1567
—(CH2)2
—C(═O)—
K372
J126
O


3-1568
—(CH2)2
—C(═O)—
K373
J126
O





















TABLE 152








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1569
—(CH2)2
—C(═O)—
K374
J129
O


3-1570
—(CH2)2
—C(═O)—
K375
J129
O


3-1571
—(CH2)2
—C(═O)—
K376
J129
O


3-1572
—(CH2)2
—C(═O)—
K377
J129
O


3-1573
—(CH2)2
—C(═O)—
K378
J129
O


3-1574
—(CH2)2
—C(═O)—
K379
J129
O


3-1575
—(CH2)2
—C(═O)—
K380
J129
O


3-1576
—(CH2)2
—C(═O)—
K381
J129
O


3-1577
—(CH2)2
—C(═O)—
K382
J129
O


3-1578
—(CH2)2
—C(═O)—
K383
J129
O


3-1579
—(CH2)2
—C(═O)—
K384
J129
O


3-1580
—(CH2)2
—C(═O)—
K385
J129
O


3-1581
—(CH2)2
—C(═O)—
K386
J129
O


3-1582
—(CH2)2
—C(═O)—
K387
J129
O


3-1583
—(CH2)2
—C(═O)—
K388
J129
O


3-1584
—(CH2)2
—C(═O)—
K389
J129
O


3-1585
—(CH2)2
—C(═O)—
K390
J129
O


3-1586
—(CH2)2
—C(═O)—
K391
J129
O


3-1587
—(CH2)2
—C(═O)—
K392
J129
O


3-1588
—(CH2)2
—C(═O)—
K393
J129
O


3-1589
—(CH2)2
—C(═O)—
K394
J130
O


3-1590
—(CH2)2
—C(═O)—
K395
J130
O


3-1591
—(CH2)2
—C(═O)—
K396
J130
O


3-1592
—(CH2)2
—C(═O)—
K397
J130
O


3-1593
—(CH2)2
—C(═O)—
K398
J130
O


3-1594
—(CH2)2
—C(═O)—
K405
J130
O


3-1595
—(CH2)2
—C(═O)—
K406
J130
O


3-1596
—(CH2)2
—C(═O)—
K407
J130
O


3-1597
—(CH2)2
—C(═O)—
K408
J130
O


3-1598
—(CH2)2
—C(═O)—
K409
J130
O


3-1599
—(CH2)2
—C(═O)—
K410
J130
O


3-1600
—(CH2)2
—C(═O)—
K411
J130
O





















TABLE 153








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1601
—(CH2)2
—C(═O)—
K412
J130
O


3-1602
—(CH2)2
—C(═O)—
K413
J130
O


3-1603
—(CH2)2
—C(═O)—
K414
J130
O


3-1604
—(CH2)2
—C(═O)—
K415
J130
O


3-1605
—(CH2)2
—C(═O)—
K416
J130
O


3-1606
—(CH2)2
—C(═O)—
K417
J130
O


3-1607
—(CH2)2
—C(═O)—
K418
J130
O


3-1608
—(CH2)2
—C(═O)—
K419
J130
O


3-1609
—(CH2)2
—C(═O)—
K420
J138
O


3-1610
—(CH2)2
—C(═O)—
K421
J138
O


3-1611
—(CH2)2
—C(═O)—
K726
J138
O


3-1612
—(CH2)2
—C(═O)—
K727
J138
O


3-1613
—(CH2)2
—C(═O)—
K728
J138
O


3-1614
—(CH2)2
—C(═O)—
K729
J138
O


3-1615
—(CH2)2
—C(═O)—
K730
J138
O


3-1616
—(CH2)2
—C(═O)—
K731
J138
O


3-1617
—(CH2)2
—C(═O)—
K732
J138
O


3-1618
—(CH2)2
—C(═O)—
K733
J138
O


3-1619
—(CH2)2
—C(═O)—
K734
J138
O


3-1620
—(CH2)2
—C(═O)—
K735
J138
O


3-1621
—(CH2)2
—C(═O)—
K736
J138
O


3-1622
—(CH2)2
—C(═O)—
K737
J138
O


3-1623
—(CH2)2
—C(═O)—
K738
J138
O


3-1624
—(CH2)2
—C(═O)—
K739
J138
O


3-1625
—(CH2)2
—C(═O)—
K740
J138
O


3-1626
—(CH2)2
—C(═O)—
K741
J138
O


3-1627
—(CH2)2
—C(═O)—
K742
J138
O


3-1628
—(CH2)2
—C(═O)—
K743
J138
O


3-1629
—(CH2)2
—C(═O)—
K744
J140
O


3-1630
—(CH2)2
—C(═O)—
K745
J140
O


3-1631
—(CH2)2
—C(═O)—
K746
J140
O


3-1632
—(CH2)2
—C(═O)—
K747
J140
O





















TABLE 154








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1633
—(CH2)2
—C(═O)—
K748
J140
O


3-1634
—(CH2)2
—C(═O)—
K749
J140
O


3-1635
—(CH2)2
—C(═O)—
K750
J140
O


3-1636
—(CH2)2
—C(═O)—
K751
J140
O


3-1637
—(CH2)2
—C(═O)—
K752
J140
O


3-1638
—(CH2)2
—C(═O)—
K753
J140
O


3-1639
—(CH2)2
—C(═O)—
K754
J140
O


3-1640
—(CH2)2
—C(═O)—
K755
J140
O


3-1641
—(CH2)2
—C(═O)—
K756
J140
O


3-1642
—(CH2)2
—C(═O)—
K757
J140
O


3-1643
—(CH2)3
—C(═O)—
K314
J1
S


3-1644
—(CH2)3
—C(═O)—
K315
J1
S


3-1645
—(CH2)3
—C(═O)—
K316
J2
S


3-1646
—(CH2)3
—C(═O)—
K317
J2
S


3-1647
—(CH2)3
—C(═O)—
K318
J4
S


3-1648
—(CH2)3
—C(═O)—
K319
J4
S


3-1649
—(CH2)3
—C(═O)—
K320
J10
S


3-1650
—(CH2)3
—C(═O)—
K321
J10
S


3-1651
—(CH2)3
—C(═O)—
K322
J19
S


3-1652
—(CH2)3
—C(═O)—
K323
J19
S


3-1653
—(CH2)3
—C(═O)—
K324
J14
S


3-1654
—(CH2)3
—C(═O)—
K325
J14
S


3-1655
—(CH2)3
—C(═O)—
K326
J22
S


3-1656
—(CH2)3
—C(═O)—
K327
J22
S


3-1657
—(CH2)3
—C(═O)—
K328
J72
S


3-1658
—(CH2)3
—C(═O)—
K329
J72
S


3-1659
—(CH2)3
—C(═O)—
K330
J74
S


3-1660
—(CH2)3
—C(═O)—
K331
J74
S


3-1661
—(CH2)3
—C(═O)—
K332
J75
S


3-1662
—(CH2)3
—C(═O)—
K333
J75
S


3-1663
—(CH2)3
—C(═O)—
K334
J77
S


3-1664
—(CH2)3
—C(═O)—
K335
J77
S





















TABLE 155








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1665
—(CH2)3
—C(═O)—
K336
J96
S


3-1666
—(CH2)3
—C(═O)—
K337
J96
S


3-1667
—(CH2)3
—C(═O)—
K338
J174
S


3-1668
—(CH2)3
—C(═O)—
K339
J174
S


3-1669
—(CH2)3
—C(═O)—
K340
J176
S


3-1670
—(CH2)3
—C(═O)—
K341
J176
S


3-1671
—(CH2)3
—C(═O)—
K342
J177
S


3-1672
—(CH2)3
—C(═O)—
K343
J177
S


3-1673
—(CH2)3
—C(═O)—
K344
J189
S


3-1674
—(CH2)3
—C(═O)—
K345
J189
S


3-1675
—(CH2)3
—C(═O)—
K346
J182
S


3-1676
—(CH2)3
—C(═O)—
K347
J182
S


3-1677
—(CH2)3
—C(═O)—
K348
J183
S


3-1678
—(CH2)3
—C(═O)—
K349
J183
S


3-1679
—(CH2)3
—C(═O)—
K350
J1
S


3-1680
—(CH2)3
—C(═O)—
K351
J1
S


3-1681
—(CH2)3
—C(═O)—
K352
J2
S


3-1682
—(CH2)3
—C(═O)—
K353
J2
S


3-1683
—(CH2)3
—C(═O)—
K354
J4
S


3-1684
—(CH2)3
—C(═O)—
K355
J4
S


3-1685
—(CH2)3
—C(═O)—
K356
J10
S


3-1686
—(CH2)3
—C(═O)—
K357
J10
S


3-1687
—(CH2)3
—C(═O)—
K358
J19
S


3-1688
—(CH2)3
—C(═O)—
K359
J19
S


3-1689
—(CH2)3
—C(═O)—
K360
J14
S


3-1690
—(CH2)3
—C(═O)—
K361
J14
S


3-1691
—(CH2)3
—C(═O)—
K362
J22
S


3-1692
—(CH2)3
—C(═O)—
K363
J22
S


3-1693
—(CH2)3
—C(═O)—
K364
J72
S


3-1694
—(CH2)3
—C(═O)—
K365
J72
S


3-1695
—(CH2)3
—C(═O)—
K366
J74
S


3-1696
—(CH2)3
—C(═O)—
K367
J74
S





















TABLE 156








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1697
—(CH2)3
—C(═O)—
K368
J75
S


3-1698
—(CH2)3
—C(═O)—
K369
J75
S


3-1699
—(CH2)3
—C(═O)—
K370
J77
S


3-1700
—(CH2)3
—C(═O)—
K371
J77
S


3-1701
—(CH2)3
—C(═O)—
K372
J96
S


3-1702
—(CH2)3
—C(═O)—
K373
J96
S


3-1703
—(CH2)3
—C(═O)—
K374
J174
S


3-1704
—(CH2)3
—C(═O)—
K375
J174
S


3-1705
—(CH2)3
—C(═O)—
K376
J176
S


3-1706
—(CH2)3
—C(═O)—
K377
J176
S


3-1707
—(CH2)3
—C(═O)—
K378
J177
S


3-1708
—(CH2)3
—C(═O)—
K379
J177
S


3-1709
—(CH2)3
—C(═O)—
K380
J189
S


3-1710
—(CH2)3
—C(═O)—
K381
J189
S


3-1711
—(CH2)3
—C(═O)—
K382
J182
S


3-1712
—(CH2)3
—C(═O)—
K383
J182
S


3-1713
—(CH2)3
—C(═O)—
K384
J183
S


3-1714
—(CH2)3
—C(═O)—
K385
J183
S


3-1715
—(CH2)3
—C(═O)—
K386
J191
S


3-1716
—(CH2)3
—C(═O)—
K387
J191
S


3-1717
—(CH2)3
—C(═O)—
K388
J192
S


3-1718
—(CH2)3
—C(═O)—
K389
J192
S


3-1719
—(CH2)3
—C(═O)—
K390
J193
S


3-1720
—(CH2)3
—C(═O)—
K391
J193
S


3-1721
—(CH2)3
—C(═O)—
K392
J194
S


3-1722
—(CH2)3
—C(═O)—
K393
J194
S


3-1723
—(CH2)3
—C(═O)—
K394
J197
S


3-1724
—(CH2)3
—C(═O)—
K395
J197
S


3-1725
—(CH2)3
—C(═O)—
K396
J126
S


3-1726
—(CH2)3
—C(═O)—
K397
J126
S


3-1727
—(CH2)3
—C(═O)—
K398
J126
S


3-1728
—(CH2)3
—C(═O)—
K405
J126
S





















TABLE 157








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1729
—(CH2)3
—C(═O)—
K406
J126
S


3-1730
—(CH2)3
—C(═O)—
K407
J126
S


3-1731
—(CH2)3
—C(═O)—
K408
J126
S


3-1732
—(CH2)3
—C(═O)—
K409
J126
S


3-1733
—(CH2)3
—C(═O)—
K410
J126
S


3-1734
—(CH2)3
—C(═O)—
K411
J126
S


3-1735
—(CH2)3
—C(═O)—
K412
J129
S


3-1736
—(CH2)3
—C(═O)—
K413
J129
S


3-1737
—(CH2)3
—C(═O)—
K414
J129
S


3-1738
—(CH2)3
—C(═O)—
K415
J129
S


3-1739
—(CH2)3
—C(═O)—
K416
J129
S


3-1740
—(CH2)3
—C(═O)—
K417
J129
S


3-1741
—(CH2)3
—C(═O)—
K419
J129
S


3-1742
—(CH2)3
—C(═O)—
K420
J129
S


3-1743
—(CH2)3
—C(═O)—
K421
J129
S


3-1744
—(CH2)3
—C(═O)—
K726
J130
S


3-1745
—(CH2)3
—C(═O)—
K727
J130
S


3-1746
—(CH2)3
—C(═O)—
K728
J130
S


3-1747
—(CH2)3
—C(═O)—
K729
J130
S


3-1748
—(CH2)3
—C(═O)—
K730
J130
S


3-1749
—(CH2)3
—C(═O)—
K731
J130
S


3-1750
—(CH2)3
—C(═O)—
K732
J130
S


3-1751
—(CH2)3
—C(═O)—
K733
J130
S


3-1752
—(CH2)3
—C(═O)—
K734
J130
S


3-1753
—(CH2)3
—C(═O)—
K735
J130
S


3-1754
—(CH2)3
—C(═O)—
K736
J138
S


3-1755
—(CH2)3
—C(═O)—
K737
J138
S


3-1756
—(CH2)3
—C(═O)—
K738
J138
S


3-1757
—(CH2)3
—C(═O)—
K739
J138
S


3-1758
—(CH2)3
—C(═O)—
K740
J138
S


3-1759
—(CH2)3
—C(═O)—
K741
J138
S


3-1760
—(CH2)3
—C(═O)—
K742
J138
S





















TABLE 158








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







3-1761
—(CH2)3
—C(═O)—
K743
J138
S


3-1762
—(CH2)3
—C(═O)—
K744
J138
S


3-1763
—(CH2)3
—C(═O)—
K745
J138
S


3-1764
—(CH2)3
—C(═O)—
K746
J138
S


3-1765
—(CH2)3
—C(═O)—
K747
J138
S


3-1766
—(CH2)3
—C(═O)—
K748
J140
S


3-1767
—(CH2)3
—C(═O)—
K749
J140
S


3-1768
—(CH2)3
—C(═O)—
K750
J140
S


3-1769
—(CH2)3
—C(═O)—
K751
J140
S


3-1770
—(CH2)3
—C(═O)—
K752
J140
S


3-1771
—(CH2)3
—C(═O)—
K753
J140
S


3-1772
—(CH2)3
—C(═O)—
K754
J140
S


3-1773
—(CH2)3
—C(═O)—
K755
J140
S


3-1774
—(CH2)3
—C(═O)—
K756
J140
S


3-1775
—(CH2)3
—C(═O)—
K757
J140
S


3-1776
—(CH2)2
—C(═O)—NH—
K11
J126
S


3-1777
—(CH2)2
—C(═O)—NH—
K110
J126
S


3-1778
—(CH2)2
—C(═O)—NH—
K332
J126
S


3-1779
—(CH2)2
—C(═O)—NH—
K315
J126
S


3-1780
—(CH2)2
—C(═O)—NH—
K759
J9
S


3-1781
—(CH2)2
—C(═O)—NH—
K760
J9
S


3-1782
—(CH2)2
—C(═O)—NH—
K713
J9
S


3-1783
—(CH2)2
—C(═O)—NH—
K87
J9
S


3-1784
—(CH2)2
—C(═O)—NH—
K259
J9
S


3-1785
—(CH2)2
—C(═O)—N(CH2CH(CH3)2)—
K87
J9
S


3-1786
—(CH2)2
—C(═O)—N(CH2CH3)—
K728
J9
S


3-1787
—(CH2)2
—C(═O)—N(CH3)—
K264
J9
S


3-1788
—(CH2)2
—C(═O)—N(CH2C6H5)—
K266
J9
S


3-1789
—(CH2)2
—C(═O)—N(CH2CH2CH3)—
K3
J9
S


3-1790
—(CH2)2
—C(═O)—N(CH2CH2CH2CH3)—
K699
J9
S


3-1791
—(CH2)2
—C(═O)—NH—
K1
J9
S


3-1792
—(CH2)2
—C(═O)—NH—
K2
J9
S





















TABLE 159








Com-







pound No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







3-1793
—(CH2)2
—C(═O)—NH—
K3
J9
S


3-1794
—(CH2)2
—C(═O)—N(CH3)—
K795
J9
S


3-1795
—(CH2)2
—C(═O)—NH—
K723
J9
S


3-1796
—(CH2)2
—C(═O)—NH—
K731
J9
S


3-1797
—(CH2)2
—C(═O)—NH—
K281
J9
S


3-1798
—(CH2)2
—C(═O)—NH—
K722
J9
S


3-1799
—(CH2)2
—C(═O)—N(CH3)—
K1
J9
S


3-1800
—(CH2)2
—C(═O)—N(CH2C6H5)—
K4
J9
S


3-1801
—(CH2)2
—C(═O)—N(CH3)—
K736
J9
S


3-1802
—(CH2)2
—C(═O)—N(CH3)—
K430
J9
S


3-1803
—(CH2)2
—C(═O)—N(CH3)—
K660
J9
S


3-1804
—(CH2)2
—C(═O)—N(CH2C6H5)—
K99
J9
S


3-1805
—(CH2)2
—C(═O)—N(CH3)—
K739
J9
S


3-1806
—(CH2)2
—C(═O)—N(CH3)—
K740
J9
S


3-1807
—(CH2)2
—C(═O)—N(CH3)—
K694
J9
S


3-1808
—(CH2)2
—C(═O)—N(CH2CH═CH2)—
K7
J9
S


3-1809
—(CH2)2
—C(═O)—N(CH(CH3)2)—
K4
J9
S


3-1810
—(CH2)2
—C(═O)—N(CH3)—
K2
J9
S


3-1811
—(CH2)2
—C(═O)—N(CH3)—
K8
J9
S


3-1812
—(CH2)2
—C(═O)—N(CH3)—
K699
J9
S


3-1813
—(CH2)2
—C(═O)—N(CH2CH3)—
K3
J9
S


3-1814
—(CH2)2
—C(═O)—N(CH3)—
K259
J9
S


3-1815
—(CH2)2
—C(═O)—N(CH3)—
K4
J9
S


3-1816
—(CH2)2
—C(═O)—NH—
K758
J9
S


3-1817
—(CH2)2
—C(═O)—NH—
K49
J9
S


3-1818
—(CH2)2
—C(═O)—NH—
K288
J9
S


3-1819
—(CH2)2
—C(═O)—NH—
K553
J9
S


3-1820
—(CH2)2
—C(═O)—NH—
K36
J9
S


3-1821
—(CH2)2
—C(═O)—NH—
K305
J9
S


3-1822
—(CH2)2
—C(═O)—NH—
K291
J9
S


3-1823
—(CH2)2
—C(═O)—NH—
K590
J9
S


3-1824
—(CH2)2
—C(═O)—NH—
K30
J9
S





















TABLE 160








Compound







No.
—A1
—A2
—G1—A3—A4—G2
—A5—R2
X







3-1825
—(CH2)2
—C(═O)—NH—
K591
J9
S


3-1826
—(CH2)2
—C(═O)—NH—
K11 
J3
S





















TABLE 161








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0001
—(CH2)2
—C(═O)—O—
K240
J9
S


4-0002
—(CH2)2
—C(═O)—O—
K240
J78
S


4-0003
—(CH2)2
—C(═O)—O—
K2
J6
S


4-0004
—(CH2)2
—C(═O)—O—
K2
J9
O


4-0005
—(CH2)2
—C(═O)—O—
K2
J9
S


4-0006
—(CH2)3
—C(═O)—O—
K2
J9
S


4-0007
—(CH2)2
—C(═O)—O—
K2
J78
S


4-0008
—(CH2)2
—C(═O)—O—
K4
J3
S


4-0009
—(CH2)2
—C(═O)—O—
K428
J19
S


4-0010
—(CH2)2
—C(═O)—O—
K257
J9
S


4-0011
—(CH2)2
—C(═O)—O—
K257
J22
S


4-0012
—(CH2)2
—C(═O)—O—
K260
J57
S


4-0013
—(CH2)2
—C(═O)—O—
K264
J126
S


4-0014
—(CH2)2
—C(═O)—O—
K8
J9
S


4-0015
—(CH2)2
—C(═O)—O—
K269
J9
S


4-0016
—(CH2)2
—C(═O)—O—
K160
J9
S


4-0017
—(CH2)2
—C(═O)—O—
K441
J9
S


4-0018
—(CH2)2
—C(═O)—O—
K441
J128
S


4-0019
—(CH2)2
—C(═O)—O—
K99
J9
S


4-0020
—(CH2)2
—C(═O)—O—
K100
J9
S


4-0021
—(CH2)2
—C(═O)—O—
K309
J131
S


4-0022
—(CH2)2
—C(═O)—O—
K446
J140
S


4-0023
—(CH2)2
—C(═O)—O—
K110
J9
O


4-0024
—(CH2)2
—C(═O)—O—
K111
J9
S


4-0025
—(CH2)2
—C(═O)—O—
K111
J78
O


4-0026
—(CH2)2
—C(═O)—O—
K302
J9
S


4-0027
—(CH2)2
—C(═O)—O—
K302
J130
O


4-0028
—(CH2)2
—C(═O)—O—
K448
J1
S


4-0029
—(CH2)3
—C(═O)—O—
K240
J9
S


4-0030
—(CH2)3
—C(═O)—O—
K2
J9
O


4-0031
—(CH2)3
—C(═O)—O—
K2
J9
S


4-0032
—(CH2)3
—C(═O)—O—
K8
J30
S





















TABLE 162








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0033
—(CH2)3
—C(═O)—O—
K269
J70
S


4-0034
—(CH2)3
—C(═O)—O—
K160
J77
S


4-0035
—(CH2)3
—C(═O)—O—
K441
J3
S


4-0036
—(CH2)3
—C(═O)—O—
K281
J9
O


4-0037
—(CH2)3
—C(═O)—O—
K99
J78
O


4-0038
—(CH2)3
—C(═O)—O—
K100
J130
O


4-0039
—(CH2)2
—C(═O)—O—
K1
J1
S


4-0040
—(CH2)2
—C(═O)—O—
K1
J3
S


4-0041
—(CH2)2
—C(═O)—O—
K1
J6
S


4-0042
—(CH2)2
—C(═O)—O—
K1
J9
S


4-0043
—(CH2)2
—C(═O)—O—
K1
J10
S


4-0044
—(CH2)2
—C(═O)—O—
K1
J14
S


4-0045
—(CH2)2
—C(═O)—O—
K1
J19
S


4-0046
—(CH2)2
—C(═O)—O—
K1
J22
S


4-0047
—(CH2)2
—C(═O)—O—
K1
J25
S


4-0048
—(CH2)2
—C(═O)—O—
K1
J29
S


4-0049
—(CH2)2
—C(═O)—O—
K1
J57
S


4-0050
—(CH2)2
—C(═O)—O—
K1
J59
S


4-0051
—(CH2)2
—C(═O)—O—
K1
J70
S


4-0052
—(CH2)2
—C(═O)—O—
K1
J72
S


4-0053
—(CH2)2
—C(═O)—O—
K1
J74
S


4-0054
—(CH2)2
—C(═O)—O—
K1
J75
S


4-0055
—(CH2)2
—C(═O)—O—
K1
J77
S


4-0056
—(CH2)2
—C(═O)—O—
K1
J78
S


4-0057
—(CH2)2
—C(═O)—O—
K1
J126
S


4-0058
—(CH2)2
—C(═O)—O—
K1
J129
S


4-0059
—(CH2)2
—C(═O)—O—
K1
J130
S


4-0060
—(CH2)2
—C(═O)—O—
K1
J138
S


4-0061
—(CH2)2
—C(═O)—O—
K1
J140
S


4-0062
—(CH2)2
—C(═O)—O—
K1
J151
S


4-0063
—(CH2)2
—C(═O)—O—
K1
J165
S


4-0064
—(CH2)2
—C(═O)—O—
K1
J168
S





















TABLE 163








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0065
—(CH2)2
—C(═O)—O—
K1
J174
S


4-0066
—(CH2)2
—C(═O)—O—
K1
J176
S


4-0067
—(CH2)2
—C(═O)—O—
K1
J177
S


4-0068
—(CH2)2
—C(═O)—O—
K1
J178
S


4-0069
—(CH2)2
—C(═O)—O—
K1
J185
S


4-0070
—(CH2)2
—C(═O)—O—
K1
J191
S


4-0071
—(CH2)2
—C(═O)—O—
K1
J193
S


4-0072
—(CH2)2
—C(═O)—O—
K1
J195
S


4-0073
—(CH2)2
—C(═O)—O—
K1
J197
S


4-0074
—(CH2)2
—C(═O)—O—
K5
J9
S


4-0075
—(CH2)2
—C(═O)—O—
K5
J140
S


4-0076
—(CH2)2
—C(═O)—O—
K5
J78
S


4-0077
—(CH2)2
—C(═O)—O—
K5
J130
S


4-0078
—(CH2)2
—C(═O)—O—
K5
J138
S


4-0079
—(CH2)2
—C(═O)—O—
K5
J129
S


4-0080
—(CH2)2
—C(═O)—O—
K11
J9
S


4-0081
—(CH2)2
—C(═O)—O—
K11
J140
S


4-0082
—(CH2)2
—C(═O)—O—
K11
J78
S


4-0083
—(CH2)2
—C(═O)—O—
K11
J130
S


4-0084
—(CH2)2
—C(═O)—O—
K11
J138
S


4-0085
—(CH2)2
—C(═O)—O—
K11
J129
S


4-0086
—(CH2)2
—C(═O)—O—
K99
J140
S


4-0087
—(CH2)2
—C(═O)—O—
K99
J78
S


4-0088
—(CH2)2
—C(═O)—O—
K99
J130
S


4-0089
—(CH2)2
—C(═O)—O—
K99
J138
S


4-0090
—(CH2)2
—C(═O)—O—
K99
J129
S


4-0091
—(CH2)2
—C(═O)—O—
K240
J1
S


4-0092
—(CH2)2
—C(═O)—O—
K240
J3
S


4-0093
—(CH2)2
—C(═O)—O—
K240
J6
S


4-0094
—(CH2)2
—C(═O)—O—
K240
J10
S


4-0095
—(CH2)2
—C(═O)—O—
K240
J14
S


4-0096
—(CH2)2
—C(═O)—O—
K240
J19
S





















TABLE 164








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0097
—(CH2)2
—C(═O)—O—
K240
J22
S


4-0098
—(CH2)2
—C(═O)—O—
K240
J25
S


4-0099
—(CH2)2
—C(═O)—O—
K240
J29
S


4-0100
—(CH2)2
—C(═O)—O—
K240
J57
S


4-0101
—(CH2)2
—C(═O)—O—
K240
J59
S


4-0102
—(CH2)2
—C(═O)—O—
K240
J70
S


4-0103
—(CH2)2
—C(═O)—O—
K240
J72
S


4-0104
—(CH2)2
—C(═O)—O—
K240
J74
S


4-0105
—(CH2)2
—C(═O)—O—
K240
J75
S


4-0106
—(CH2)2
—C(═O)—O—
K240
J77
S


4-0107
—(CH2)2
—C(═O)—O—
K240
J126
S


4-0108
—(CH2)2
—C(═O)—O—
K240
J129
S


4-0109
—(CH2)2
—C(═O)—O—
K240
J130
S


4-0110
—(CH2)2
—C(═O)—O—
K240
J138
S


4-0111
—(CH2)2
—C(═O)—O—
K240
J140
S


4-0112
—(CH2)2
—C(═O)—O—
K240
J151
S


4-0113
—(CH2)2
—C(═O)—O—
K240
J165
S


4-0114
—(CH2)2
—C(═O)—O—
K240
J168
S


4-0115
—(CH2)2
—C(═O)—O—
K240
J174
S


4-0116
—(CH2)2
—C(═O)—O—
K240
J176
S


4-0117
—(CH2)2
—C(═O)—O—
K240
J177
S


4-0118
—(CH2)2
—C(═O)—O—
K240
J178
S


4-0119
—(CH2)2
—C(═O)—O—
K240
J185
S


4-0120
—(CH2)2
—C(═O)—O—
K240
J191
S


4-0121
—(CH2)2
—C(═O)—O—
K240
J193
S


4-0122
—(CH2)2
—C(═O)—O—
K240
J195
S


4-0123
—(CH2)2
—C(═O)—O—
K240
J197
S


4-0124
—(CH2)3−
—C(═O)—O—
K1
J9
S


4-0125
—(CH2)3−
—C(═O)—O—
K1
J140
S


4-0126
—(CH2)3−
—C(═O)—O—
K1
J78
S


4-0127
—(CH2)3−
—C(═O)—O—
K1
J130
S


4-0128
—(CH2)3−
—C(═O)—O—
K1
J138
S





















TABLE 165








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0129
—(CH2)3−
—C(═O)—O—
K1
J129
S


4-0130
—(CH2)3−
—C(═O)—O—
K5
J9
S


4-0131
—(CH2)3−
—C(═O)—O—
K5
J140
S


4-0132
—(CH2)3−
—C(═O)—O—
K5
J78
S


4-0133
—(CH2)3−
—C(═O)—O—
K5
J130
S


4-0134
—(CH2)3−
—C(═O)—O—
K5
J138
S


4-0135
—(CH2)3−
—C(═O)—O—
K5
J129
S


4-0136
—(CH2)3−
—C(═O)—O—
K11
J9
S


4-0137
—(CH2)3−
—C(═O)—O—
K11
J140
S


4-0138
—(CH2)3−
—C(═O)—O—
K11
J78
S


4-0139
—(CH2)3−
—C(═O)—O—
K11
J130
S


4-0140
—(CH2)3−
—C(═O)—O—
K11
J138
S


4-0141
—(CH2)3−
—C(═O)—O—
K11
J129
S


4-0142
—(CH2)3−
—C(═O)—O—
K99
J9
S


4-0143
—(CH2)3−
—C(═O)—O—
K99
J140
S


4-0144
—(CH2)3−
—C(═O)—O—
K99
J78
S


4-0145
—(CH2)3−
—C(═O)—O—
K99
J130
S


4-0146
—(CH2)3−
—C(═O)—O—
K99
J138
S


4-0147
—(CH2)3−
—C(═O)—O—
K99
J129
S


4-0148
—(CH2)3−
—C(═O)—O—
K240
J1
S


4-0149
—(CH2)3−
—C(═O)—O—
K240
J3
S


4-0150
—(CH2)3−
—C(═O)—O—
K240
J6
S


4-0151
—(CH2)3−
—C(═O)—O—
K240
J10
S


4-0152
—(CH2)3−
—C(═O)—O—
K240
J14
S


4-0153
—(CH2)3−
—C(═O)—O—
K240
J19
S


4-0154
—(CH2)3−
—C(═O)—O—
K240
J22
S


4-0155
—(CH2)3−
—C(═O)—O—
K240
J25
S


4-0156
—(CH2)3−
—C(═O)—O—
K240
J29
S


4-0157
—(CH2)3−
—C(═O)—O—
K240
J57
S


4-0158
—(CH2)3−
—C(═O)—O—
K240
J59
S


4-0159
—(CH2)3−
—C(═O)—O—
K240
J70
S


4-0160
—(CH2)3−
—C(═O)—O—
K240
J72
S





















TABLE 166








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0161
—(CH2)3−
—C(═O)—O—
K240
J74
S


4-0162
—(CH2)3−
—C(═O)—O—
K240
J75
S


4-0163
—(CH2)3−
—C(═O)—O—
K240
J77
S


4-0164
—(CH2)3−
—C(═O)—O—
K240
J78
S


4-0165
—(CH2)3−
—C(═O)—O—
K240
J126
S


4-0166
—(CH2)3−
—C(═O)—O—
K240
J129
S


4-0167
—(CH2)3−
—C(═O)—O—
K240
J130
S


4-0168
—(CH2)3−
—C(═O)—O—
K240
J138
S


4-0169
—(CH2)3−
—C(═O)—O—
K240
J140
S


4-0170
—(CH2)3−
—C(═O)—O—
K240
J151
S


4-0171
—(CH2)3−
—C(═O)—O—
K240
J165
S


4-0172
—(CH2)3−
—C(═O)—O—
K240
J168
S


4-0173
—(CH2)3−
—C(═O)—O—
K240
J174
S


4-0174
—(CH2)3−
—C(═O)—O—
K240
J176
S


4-0175
—(CH2)3−
—C(═O)—O—
K240
J177
S


4-0176
—(CH2)3−
—C(═O)—O—
K240
J178
S


4-0177
—(CH2)3−
—C(═O)—O—
K240
J185
S


4-0178
—(CH2)3−
—C(═O)—O—
K240
J191
S


4-0179
—(CH2)3−
—C(═O)—O—
K240
J193
S


4-0180
—(CH2)3−
—C(═O)—O—
K240
J195
S


4-0181
—(CH2)3−
—C(═O)—O—
K240
J197
S


4-0182
—(CH2)2
—C(═O)—O—
K1
J1
O


4-0183
—(CH2)2
—C(═O)—O—
K1
J3
O


4-0184
—(CH2)2
—C(═O)—O—
K1
J6
O


4-0185
—(CH2)2
—C(═O)—O—
K1
J9
O


4-0186
—(CH2)2
—C(═O)—O—
K1
J10
O


4-0187
—(CH2)2
—C(═O)—O—
K1
J14
O


4-0188
—(CH2)2
—C(═O)—O—
K1
J19
O


4-0189
—(CH2)2
—C(═O)—O—
K1
J22
O


4-0190
—(CH2)2
—C(═O)—O—
K1
J25
O


4-0191
—(CH2)2
—C(═O)—O—
K1
J29
O


4-0192
—(CH2)2
—C(═O)—O—
K1
J57
O





















TABLE 167








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0193
—(CH2)2
—C(═O)—O—
K1
J59
O


4-0194
—(CH2)2
—C(═O)—O—
K1
J70
O


4-0195
—(CH2)2
—C(═O)—O—
K1
J72
O


4-0196
—(CH2)2
—C(═O)—O—
K1
J74
O


4-0197
—(CH2)2
—C(═O)—O—
K1
J75
O


4-0198
—(CH2)2
—C(═O)—O—
K1
J77
O


4-0199
—(CH2)2
—C(═O)—O—
K1
J78
O


4-0200
—(CH2)2
—C(═O)—O—
K1
J126
O


4-0201
—(CH2)2
—C(═O)—O—
K1
J129
O


4-0202
—(CH2)2
—C(═O)—O—
K1
J130
O


4-0203
—(CH2)2
—C(═O)—O—
K1
J138
O


4-0204
—(CH2)2
—C(═O)—O—
K1
J140
O


4-0205
—(CH2)2
—C(═O)—O—
K1
J151
O


4-0206
—(CH2)2
—C(═O)—O—
K1
J165
O


4-0207
—(CH2)2
—C(═O)—O—
K1
J168
O


4-0208
—(CH2)2
—C(═O)—O—
K1
J174
O


4-0209
—(CH2)2
—C(═O)—O—
K1
J176
O


4-0210
—(CH2)2
—C(═O)—O—
K1
J177
O


4-0211
—(CH2)2
—C(═O)—O—
K1
J178
O


4-0212
—(CH2)2
—C(═O)—O—
K1
J185
O


4-0213
—(CH2)2
—C(═O)—O—
K1
J191
O


4-0214
—(CH2)2
—C(═O)—O—
K1
J193
O


4-0215
—(CH2)2
—C(═O)—O—
K1
J195
O


4-0216
—(CH2)2
—C(═O)—O—
K1
J197
O


4-0217
—(CH2)2
—C(═O)—O—
K5
J9
O


4-0218
—(CH2)2
—C(═O)—O—
K5
J140
O


4-0219
—(CH2)2
—C(═O)—O—
K5
J78
O


4-0220
—(CH2)2
—C(═O)—O—
K5
J130
O


4-0221
—(CH2)2
—C(═O)—O—
K5
J138
O


4-0222
—(CH2)2
—C(═O)—O—
K5
J129
O


4-0223
—(CH2)2
—C(═O)—O—
K11
J9
O


4-0224
—(CH2)2
—C(═O)—O—
K11
J140
O





















TABLE 168








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0225
—(CH2)2
—C(═O)—O—
K11
J78
O


4-0226
—(CH2)2
—C(═O)—O—
K11
J130
O


4-0227
—(CH2)2
—C(═O)—O—
K11
J138
O


4-0228
—(CH2)2
—C(═O)—O—
K11
J129
O


4-0229
—(CH2)2
—C(═O)—O—
K99
J9
O


4-0230
—(CH2)2
—C(═O)—O—
K99
J140
O


4-0231
—(CH2)2
—C(═O)—O—
K99
J78
O


4-0232
—(CH2)2
—C(═O)—O—
K99
J130
O


4-0233
—(CH2)2
—C(═O)—O—
K99
J138
O


4-0234
—(CH2)2
—C(═O)—O—
K99
J129
O


4-0235
—(CH2)2
—C(═O)—O—
K240
J1
O


4-0236
—(CH2)2
—C(═O)—O—
K240
J3
O


4-0237
—(CH2)2
—C(═O)—O—
K240
J6
O


4-0238
—(CH2)2
—C(═O)—O—
K240
J9
O


4-0239
—(CH2)2
—C(═O)—O—
K240
J10
O


4-0240
—(CH2)2
—C(═O)—O—
K240
J14
O


4-0241
—(CH2)2
—C(═O)—O—
K240
J19
O


4-0242
—(CH2)2
—C(═O)—O—
K240
J22
O


4-0243
—(CH2)2
—C(═O)—O—
K240
J25
O


4-0244
—(CH2)2
—C(═O)—O—
K240
J29
O


4-0245
—(CH2)2
—C(═O)—O—
K240
J57
O


4-0246
—(CH2)2
—C(═O)—O—
K240
J59
O


4-0247
—(CH2)2
—C(═O)—O—
K240
J70
O


4-0248
—(CH2)2
—C(═O)—O—
K240
J72
O


4-0249
—(CH2)2
—C(═O)—O—
K240
J74
O


4-0250
—(CH2)2
—C(═O)—O—
K240
J75
O


4-0251
—(CH2)2
—C(═O)—O—
K240
J77
O


4-0252
—(CH2)2
—C(═O)—O—
K240
J78
O


4-0253
—(CH2)2
—C(═O)—O—
K240
J126
O


4-0254
—(CH2)2
—C(═O)—O—
K240
J129
O


4-0255
—(CH2)2
—C(═O)—O—
K240
J130
O


4-0256
—(CH2)2
—C(═O)—O—
K240
J138
O





















TABLE 169








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0257
—(CH2)2
—C(═O)—O—
K240
J140
O


4-0258
—(CH2)2
—C(═O)—O—
K240
J151
O


4-0259
—(CH2)2
—C(═O)—O—
K240
J165
O


4-0260
—(CH2)2
—C(═O)—O—
K240
J168
O


4-0261
—(CH2)2
—C(═O)—O—
K240
J174
O


4-0262
—(CH2)2
—C(═O)—O—
K240
J176
O


4-0263
—(CH2)2
—C(═O)—O—
K240
J177
O


4-0264
—(CH2)2
—C(═O)—O—
K240
J178
O


4-0265
—(CH2)2
—C(═O)—O—
K240
J185
O


4-0266
—(CH2)2
—C(═O)—O—
K240
J191
O


4-0267
—(CH2)2
—C(═O)—O—
K240
J193
O


4-0268
—(CH2)2
—C(═O)—O—
K240
J195
O


4-0269
—(CH2)2
—C(═O)—O—
K240
J197
O


4-0270
—(CH2)3−
—C(═O)—O—
K1
J9
O


4-0271
—(CH2)3−
—C(═O)—O—
K1
J140
O


4-0272
—(CH2)3−
—C(═O)—O—
K1
J78
O


4-0273
—(CH2)3−
—C(═O)—O—
K1
J130
O


4-0274
—(CH2)3−
—C(═O)—O—
K1
J138
O


4-0275
—(CH2)3−
—C(═O)—O—
K1
J129
O


4-0276
—(CH2)3−
—C(═O)—O—
K5
J9
O


4-0277
—(CH2)3−
—C(═O)—O—
K5
J140
O


4-0278
—(CH2)3−
—C(═O)—O—
K5
J78
O


4-0279
—(CH2)3−
—C(═O)—O—
K5
J130
O


4-0280
—(CH2)3−
—C(═O)—O—
K5
J138
O


4-0281
—(CH2)3−
—C(═O)—O—
K5
J129
O


4-0282
—(CH2)3−
—C(═O)—O—
K11
J9
O


4-0283
—(CH2)3−
—C(═O)—O—
K11
J140
O


4-0284
—(CH2)3−
—C(═O)—O—
K11
J78
O


4-0285
—(CH2)3−
—C(═O)—O—
K11
J130
O


4-0286
—(CH2)3−
—C(═O)—O—
K11
J138
O


4-0287
—(CH2)3−
—C(═O)—O—
K11
J129
O


4-0288
—(CH2)3−
—C(═O)—O—
K99
J9
O





















TABLE 170








Compound


-G1-




No.
-A1-
-A2-
A3-A4-G2
-A5-R2
X







4-0289
—(CH2)3−
—C(═O)—O—
K99
J140
O


4-0290
—(CH2)3−
—C(═O)—O—
K99
J130
O


4-0291
—(CH2)3−
—C(═O)—O—
K99
J138
O


4-0292
—(CH2)3−
—C(═O)—O—
K99
J129
O


4-0293
—(CH2)3−
—C(═O)—O—
K240
J1
O


4-0294
—(CH2)3−
—C(═O)—O—
K240
J3
O


4-0295
—(CH2)3−
—C(═O)—O—
K240
J6
O


4-0296
—(CH2)3−
—C(═O)—O—
K240
J9
O


4-0297
—(CH2)3−
—C(═O)—O—
K240
J10
O


4-0298
—(CH2)3−
—C(═O)—O—
K240
J14
O


4-0299
—(CH2)3−
—C(═O)—O—
K240
J19
O


4-0300
—(CH2)3−
—C(═O)—O—
K240
J22
O


4-0301
—(CH2)3−
—C(═O)—O—
K240
J25
O


4-0302
—(CH2)3−
—C(═O)—O—
K240
J29
O


4-0303
—(CH2)3−
—C(═O)—O—
K240
J57
O


4-0304
—(CH2)3−
—C(═O)—O—
K240
J59
O


4-0305
—(CH2)3−
—C(═O)—O—
K240
J70
O


4-0306
—(CH2)3−
—C(═O)—O—
K240
J72
O


4-0307
—(CH2)3−
—C(═O)—O—
K240
J74
O


4-0308
—(CH2)3−
—C(═O)—O—
K240
J75
O


4-0309
—(CH2)3−
—C(═O)—O—
K240
J77
O


4-0310
—(CH2)3−
—C(═O)—O—
K240
J78
O


4-0311
—(CH2)3−
—C(═O)—O—
K240
J126
O


4-0312
—(CH2)3−
—C(═O)—O—
K240
J129
O


4-0313
—(CH2)3−
—C(═O)—O—
K240
J130
O


4-0314
—(CH2)3−
—C(═O)—O—
K240
J138
O


4-0315
—(CH2)3−
—C(═O)—O—
K240
J140
O


4-0316
—(CH2)3−
—C(═O)—O—
K240
J151
O


4-0317
—(CH2)3−
—C(═O)—O—
K240
J165
O


4-0318
—(CH2)3−
—C(═O)—O—
K240
J168
O


4-0319
—(CH2)3−
—C(═O)—O—
K240
J174
O


4-0320
—(CH2)3−
—C(═O)—O—
K240
J176
O





















TABLE 171








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







4-0321
—(CH2)3−
—C(═O)—O—
K240
J177
O


4-0322
—(CH2)3−
—C(═O)—O—
K240
J178
O


4-0323
—(CH2)3−
—C(═O)—O—
K240
J185
O


4-0324
—(CH2)3−
—C(═O)—O—
K240
J191
O


4-0325
—(CH2)3−
—C(═O)—O—
K240
J193
O


4-0326
—(CH2)3−
—C(═O)—O—
K240
J195
O


4-0327
—(CH2)3−
—C(═O)—O—
K240
J197
O


4-0328
—(CH2)2
—C(═O)—O—
K2
J126
O


4-0329
—(CH2)2
—C(═O)—O—
K2
J126
S





















TABLE 172








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







5-0001
—(CH2)2
—C(═O)—
K1
J9
S


5-0002
—(CH2)2
—C(═O)—
K1
J10
S


5-0003
—(CH2)2
—C(═O)—
K1
J51
O


5-0004
—(CH2)2
—C(═O)—
K1
J78
S


5-0005
—(CH2)2
—C(═O)—
K8
J9
S


5-0006
—(CH2)2
—C(═O)—
K11
J9
S


5-0007
—(CH2)2
—C(═O)—
K24
J70
S


5-0008
—(CH2)2
—C(═O)—
K34
J78
S


5-0009
—(CH2)2
—C(═O)—
K34
J131
S


5-0010
—(CH2)2
—C(═O)—
K36
J128
S


5-0011
—(CH2)2
—C(═O)—
K36
J149
S


5-0012
—(CH2)2
—C(═O)—
K48
J126
S


5-0013
—(CH2)2
—C(═O)—
K48
J140
O


5-0014
—(CH2)2
—C(═O)—
K74
J19
S


5-0015
—(CH2)2
—C(═O)—
K74
J70
O


5-0016
—(CH2)2
—C(═O)—
K99
J9
S


5-0017
—(CH2)2
—C(═O)—
K101
J30
S


5-0018
—(CH2)2
—C(═O)—
K107
J19
S


5-0019
—(CH2)2
—C(═O)—
K110
J51
S


5-0020
—(CH2)2
—C(═O)—
K110
J78
O


5-0021
—(CH2)2
—C(═O)—
K110
J131
S


5-0022
—(CH2)2
—C(═O)—
K160
J126
S


5-0023
—(CH2)2
—C(═O)—
K167
J70
S


5-0024
—(CH2)2
—C(═O)—
K175
J10
S


5-0025
—(CH2)2
—C(═O)—
K175
J131
O


5-0026
—(CH2)2
—C(═O)—
K176
J128
S


5-0027
—(CH2)2
—C(═O)—
K176
J149
S


5-0028
—(CH2)2
—C(═O)—
K180
J126
O


5-0029
—(CH2)2
—C(═O)—
K180
J140
S


5-0030
—(CH2)2
—C(═O)—
K183
J19
O


5-0031
—(CH2)2
—C(═O)—
K185
J30
S


5-0032
—(CH2)2
—C(═O)—
K189
J3
S





















TABLE 173








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







5-0033
—(CH2)2
—C(═O)—
K189
J30
S


5-0034
—(CH2)2
—C(═O)—
K190
J78
S


5-0035
—(CH2)2
—C(═O)—
K190
J131
S


5-0036
—(CH2)2
—C(═O)—
K193
J128
O


5-0037
—(CH2)2
—C(═O)—
K193
J149
S


5-0038
—(CH2)2
—C(═O)—
K205
J9
S


5-0039
—(CH2)2
—C(═O)—
K205
J126
S


5-0040
—(CH2)2
—C(═O)—
K205
J140
O


5-0041
—(CH2)2
—C(═O)—
K206
J9
S


5-0042
—(CH2)2
—C(═O)—
K207
J19
S


5-0043
—(CH2)2
—C(═O)—
K207
J70
S


5-0044
—(CH2)2
—C(═O)—
K215
J10
S


5-0045
—(CH2)2
—C(═O)—
K215
J51
S


5-0046
—(CH2)2
—C(═O)—
K217
J128
S


5-0047
—(CH2)2
—C(═O)—
K217
J149
O


5-0048
—(CH2)2
—C(═O)—
K229
J140
S


5-0049
—(CH2)3
—C(═O)—
K1
J9
S


5-0050
—(CH2)3
—C(═O)—
K1
J131
O


5-0051
—(CH2)3
—C(═O)—
K8
J9
S


5-0052
—(CH2)3
—C(═O)—
K8
J128
O


5-0053
—(CH2)3
—C(═O)—
K8
J149
S


5-0054
—(CH2)3
—C(═O)—
K11
J9
S


5-0055
—(CH2)3
—C(═O)—
K13
J126
S


5-0056
—(CH2)3
—C(═O)—
K13
J140
S


5-0057
—(CH2)3
—C(═O)—
K24
J19
O


5-0058
—(CH2)3
—C(═O)—
K34
J10
S


5-0059
—(CH2)3
—C(═O)—
K34
J51
S


5-0060
—(CH2)3
—C(═O)—
K99
J9
S


5-0061
—(CH2)3
—C(═O)—
K101
J3
S


5-0062
—(CH2)3
—C(═O)—
K107
J70
O


5-0063
—(CH2)3
—C(═O)—
K110
J10
O


5-0064
—(CH2)3
—C(═O)—
K150
J128
S





















TABLE 174








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







5-0065
—(CH2)3
—C(═O)—
K150
J149
O


5-0066
—(CH2)3
—C(═O)—
K160
J140
S


5-0067
—(CH2)3
—C(═O)—
K167
J19
S


5-0068
—(CH2)3
—C(═O)—
K175
J51
S


5-0069
—(CH2)3
—C(═O)—
K175
J78
S


5-0070
—(CH2)3
—C(═O)—
K183
J70
S


5-0071
—(CH2)3
—C(═O)—
K185
J3
S


5-0072
—(CH2)3
—C(═O)—
K190
J10
S


5-0073
—(CH2)3
—C(═O)—
K190
J51
O


5-0074
—(CH2)3
—C(═O)—
K205
J9
S


5-0075
—(CH2)3
—C(═O)—
K215
J78
O


5-0076
—(CH2)3
—C(═O)—
K215
J131
S


5-0077
—(CH2)3
—C(═O)—
K229
J126
S


5-0078
—(CH2)2
—C(═O)—
K1
J126
S


5-0079
—(CH2)2
—C(═O)—
K1
J129
S


5-0080
—(CH2)2
—C(═O)—
K1
J130
S


5-0081
—(CH2)2
—C(═O)—
K1
J138
S


5-0082
—(CH2)2
—C(═O)—
K1
J140
S


5-0083
—(CH2)2
—C(═O)—
K2
J9
S


5-0084
—(CH2)2
—C(═O)—
K2
J126
S


5-0085
—(CH2)2
—C(═O)—
K2
J129
S


5-0086
—(CH2)2
—C(═O)—
K2
J130
S


5-0087
—(CH2)2
—C(═O)—
K2
J138
S


5-0088
—(CH2)2
—C(═O)—
K2
J140
S


5-0089
—(CH2)2
—C(═O)—
K3
J9
S


5-0090
—(CH2)2
—C(═O)—
K3
J126
S


5-0091
—(CH2)2
—C(═O)—
K3
J129
S


5-0092
—(CH2)2
—C(═O)—
K3
J130
S


5-0093
—(CH2)2
—C(═O)—
K3
J138
S


5-0094
—(CH2)2
—C(═O)—
K3
J140
S


5-0095
—(CH2)2
—C(═O)—
K4
J9
S


5-0096
—(CH2)2
—C(═O)—
K4
J126
S





















TABLE 175








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







5-0097
—(CH2)2
—C(═O)—
K4
J129
S


5-0098
—(CH2)2
—C(═O)—
K4
J130
S


5-0099
—(CH2)2
—C(═O)—
K4
J138
S


5-0100
—(CH2)2
—C(═O)—
K4
J140
S


5-0101
—(CH2)2
—C(═O)—
K11
J126
S


5-0102
—(CH2)2
—C(═O)—
K11
J129
S


5-0103
—(CH2)2
—C(═O)—
K11
J130
S


5-0104
—(CH2)2
—C(═O)—
K11
J138
S


5-0105
—(CH2)2
—C(═O)—
K11
J140
S


5-0106
—(CH2)2
—C(═O)—
K99
J126
S


5-0107
—(CH2)2
—C(═O)—
K99
J129
S


5-0108
—(CH2)2
—C(═O)—
K99
J130
S


5-0109
—(CH2)2
—C(═O)—
K99
J138
S


5-0110
—(CH2)2
—C(═O)—
K99
J140
S


5-0111
—(CH2)2
—C(═O)—
K1
J9
O


5-0112
—(CH2)2
—C(═O)—
K1
J126
O


5-0113
—(CH2)2
—C(═O)—
K1
J129
O


5-0114
—(CH2)2
—C(═O)—
K1
J130
O


5-0115
—(CH2)2
—C(═O)—
K1
J138
O


5-0116
—(CH2)2
—C(═O)—
K1
J140
O


5-0117
—(CH2)2
—C(═O)—
K2
J9
O


5-0118
—(CH2)2
—C(═O)—
K2
J126
O


5-0119
—(CH2)2
—C(═O)—
K2
J129
O


5-0120
—(CH2)2
—C(═O)—
K2
J130
O


5-0121
—(CH2)2
—C(═O)—
K2
J138
O


5-0122
—(CH2)2
—C(═O)—
K2
J140
O


5-0123
—(CH2)2
—C(═O)—
K3
J9
O


5-0124
—(CH2)2
—C(═O)—
K3
J126
O


5-0125
—(CH2)2
—C(═O)—
K3
J129
O


5-0126
—(CH2)2
—C(═O)—
K3
J130
O


5-0127
—(CH2)2
—C(═O)—
K3
J138
O


5-0128
—(CH2)2
—C(═O)—
K3
J140
O





















TABLE 176








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







5-0129
—(CH2)2
—C(═O)—
K4
J9
O


5-0130
—(CH2)2
—C(═O)—
K4
J126
O


5-0131
—(CH2)2
—C(═O)—
K4
J129
O


5-0132
—(CH2)2
—C(═O)—
K4
J130
O


5-0133
—(CH2)2
—C(═O)—
K4
J138
O


5-0134
—(CH2)2
—C(═O)—
K4
J140
O


5-0135
—(CH2)2
—C(═O)—
K11
J9
O


5-0136
—(CH2)2
—C(═O)—
K11
J126
O


5-0137
—(CH2)2
—C(═O)—
K11
J129
O


5-0138
—(CH2)2
—C(═O)—
K11
J130
O


5-0139
—(CH2)2
—C(═O)—
K11
J138
O


5-0140
—(CH2)2
—C(═O)—
K11
J140
O


5-0141
—(CH2)2
—C(═O)—
K99
J9
O


5-0142
—(CH2)2
—C(═O)—
K99
J126
O


5-0143
—(CH2)2
—C(═O)—
K99
J129
O


5-0144
—(CH2)2
—C(═O)—
K99
J130
O


5-0145
—(CH2)2
—C(═O)—
K99
J138
O


5-0146
—(CH2)2
—C(═O)—
K99
J140
O


5-0147
—(CH2)3
—C(═O)—
K1
J9
O


5-0148
—(CH2)3
—C(═O)—
K1
J126
O


5-0149
—(CH2)3
—C(═O)—
K1
J129
O


5-0150
—(CH2)3
—C(═O)—
K1
J130
O


5-0151
—(CH2)3
—C(═O)—
K1
J138
O


5-0152
—(CH2)3
—C(═O)—
K1
J140
O


5-0153
—(CH2)3
—C(═O)—
K2
J9
O


5-0154
—(CH2)3
—C(═O)—
K2
J126
O


5-0155
—(CH2)3
—C(═O)—
K2
J129
O


5-0156
—(CH2)3
—C(═O)—
K2
J130
O


5-0157
—(CH2)3
—C(═O)—
K2
J138
O


5-0158
—(CH2)3
—C(═O)—
K2
J140
O


5-0159
—(CH2)3
—C(═O)—
K3
J9
O


5-0160
—(CH2)3
—C(═O)—
K3
J126
O





















TABLE 177








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







5-0161
—(CH2)3
—C(═O)—
K3
J129
O


5-0162
—(CH2)3
—C(═O)—
K3
J130
O


5-0163
—(CH2)3
—C(═O)—
K3
J138
O


5-0164
—(CH2)3
—C(═O)—
K3
J140
O


5-0165
—(CH2)3
—C(═O)—
K4
J9
S


5-0166
—(CH2)3
—C(═O)—
K4
J126
S


5-0167
—(CH2)3
—C(═O)—
K4
J129
S


5-0168
—(CH2)3
—C(═O)—
K4
J130
S


5-0169
—(CH2)3
—C(═O)—
K4
J138
S


5-0170
—(CH2)3
—C(═O)—
K4
J140
S


5-0171
—(CH2)3
—C(═O)—
K11
J126
S


5-0172
—(CH2)3
—C(═O)—
K11
J129
S


5-0173
—(CH2)3
—C(═O)—
K11
J130
S


5-0174
—(CH2)3
—C(═O)—
K11
J138
S


5-0175
—(CH2)3
—C(═O)—
K11
J140
S


5-0176
—(CH2)3
—C(═O)—
K99
J126
S


5-0177
—(CH2)3
—C(═O)—
K99
J129
S


5-0178
—(CH2)3
—C(═O)—
K99
J130
S


5-0179
—(CH2)3
—C(═O)—
K99
J138
S


5-0180
—(CH2)3
—C(═O)—
K99
J140
S


5-0181
—(CH2)2
—C(═O)—
K699
J9
S





















TABLE 178








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







6-0001
single bond
single bond
K1
N1
O


6-0002
single bond
single bond
K1
N1
S


6-0003
single bond
single bond
K1
N2
O


6-0004
single bond
single bond
K1
N2
S


6-0005
single bond
single bond
K1
N9
S


6-0006
single bond
single bond
K1
N12
S


6-0007
single bond
single bond
K1
N24
S


6-0008
single bond
single bond
K1
N40
S


6-0009
single bond
single bond
K1
N115
S


6-0010
single bond
single bond
K1
N128
S


6-0011
single bond
single bond
K1
N130
S


6-0012
single bond
single bond
K1
N140
S


6-0013
single bond
single bond
K1
N149
S


6-0014
single bond
single bond
K1
N150
S


6-0015
single bond
single bond
K2
N9
S


6-0016
single bond
single bond
K2
N24
S


6-0017
single bond
single bond
K2
N69
S


6-0018
single bond
single bond
K2
N115
S


6-0019
single bond
single bond
K2
N128
S


6-0020
single bond
single bond
K2
N140
S


6-0021
single bond
single bond
K2
N149
S


6-0022
single bond
single bond
K2
N150
S


6-0023
single bond
single bond
K11
N1
S


6-0024
single bond
single bond
K11
N2
S


6-0025
single bond
single bond
K11
N3
S


6-0026
single bond
single bond
K11
N4
S


6-0027
single bond
single bond
K11
N5
S


6-0028
single bond
single bond
K11
N24
S


6-0029
single bond
single bond
K11
N69
S


6-0030
single bond
single bond
K11
N115
S


6-0031
single bond
single bond
K11
N128
S


6-0032
single bond
single bond
K11
N140
S





















TABLE 179








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







6-0033
single bond
single bond
K11
N149
S


6-0034
single bond
single bond
K11
N150
S


6-0035
single bond
single bond
K99
N2
S


6-0036
single bond
single bond
K99
N4
S


6-0037
single bond
single bond
K99
N9
S


6-0038
single bond
single bond
K99
N24
S


6-0039
single bond
single bond
K99
N69
S


6-0040
single bond
single bond
K99
N115
S


6-0041
single bond
single bond
K99
N130
S


6-0042
single bond
single bond
K99
N140
S


6-0043
single bond
single bond
K99
N149
S


6-0044
single bond
single bond
K99
N150
S


6-0045
single bond
single bond
K103
N4
S


6-0046
single bond
single bond
K103
N9
S


6-0047
single bond
single bond
K103
N128
S


6-0048
single bond
single bond
K103
N140
S


6-0049
single bond
single bond
K103
N149
S


6-0050
single bond
single bond
K240
N1
S


6-0051
single bond
single bond
K240
N2
S


6-0052
single bond
single bond
K240
N3
S


6-0053
single bond
single bond
K240
N4
S


6-0054
single bond
single bond
K240
N5
S


6-0055
single bond
single bond
K240
N69
S


6-0056
single bond
single bond
K240
N115
S


6-0057
single bond
single bond
K240
N128
S


6-0058
single bond
single bond
K240
N130
S


6-0059
single bond
single bond
K240
N140
S


6-0060
single bond
single bond
K240
N145
S


6-0061
single bond
single bond
K240
N149
S


6-0062
single bond
single bond
K240
N150
S


6-0063
single bond
single bond
K240
N151
S


6-0064
single bond
single bond
K240
N152
S





















TABLE 180








Compound


-G1-A3-A4-




No.
-A1-
-A2-
G2
-A5-R2
X







6-0065
single bond
single bond
K240
N153
S


6-0066
single bond
single bond
K240
N154
S


6-0067
single bond
single bond
K240
N150
O


6-0068
—(CH2)2
—O—
K1
N1
O


6-0069
—(CH2)2
—O—
K1
N1
S


6-0070
—(CH2)2
—O—
K4
N2
S


6-0071
—(CH2)2
—O—
K11
N2
S


6-0072
—(CH2)2
—O—
K99
N2
S


6-0073
—(CH2)2
—O—
K1
N3
O


6-0074
—(CH2)2
—O—
K1
N3
S


6-0075
—(CH2)2
—O—
K4
N3
S


6-0076
—(CH2)2
—O—
K11
N3
S


6-0077
—(CH2)2
—O—
K99
N3
S


6-0078
—(CH2)2
—O—
K1
N4
O


6-0079
—(CH2)2
—O—
K1
N4
S


6-0080
—(CH2)2
—O—
K4
N4
S


6-0081
—(CH2)2
—O—
K99
N4
S


6-0082
—(CH2)2
—O—
K1
N9
O


6-0083
—(CH2)2
—O—
K1
N9
S


6-0084
—(CH2)2
—O—
K1
N10
S


6-0085
—(CH2)2
—O—
K1
N11
S


6-0086
—(CH2)2
—O—
K1
N12
S


6-0087
—(CH2)2
—O—
K1
N12
O


6-0088
—(CH2)2
—O—
K1
N13
S


6-0089
—(CH2)2
—O—
K1
N14
S


6-0090
—(CH2)2
—O—
K1
N15
S


6-0091
—(CH2)2
—O—
K1
N16
S


6-0092
—(CH2)2
—O—
K1
N17
S


6-0093
—(CH2)2
—O—
K1
N18
S


6-0094
—(CH2)2
—O—
K1
N19
S


6-0095
—(CH2)2
—O—
K1
N20
S


6-0096
—(CH2)2
—O—
K1
N21
S





















TABLE 181








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0097
—(CH2)2
—O—
K1
N22
S


6-0098
—(CH2)2
—O—
K1
N23
S


6-0099
—(CH2)2
—O—
K1
N24
O


6-0100
—(CH2)2
—O—
K1
N24
S


6-0101
—(CH2)2
—O—
K2
N24
S


6-0102
—(CH2)2
—O—
K4
N24
S


6-0103
—(CH2)2
—O—
K11
N24
S


6-0104
—(CH2)2
—O—
K99
N24
S


6-0105
—(CH2)2
—O—
K1
N25
S


6-0106
—(CH2)2
—O—
K1
N26
S


6-0107
—(CH2)2
—O—
K1
N27
S


6-0108
—(CH2)2
—O—
K1
N28
S


6-0109
—(CH2)2
—O—
K1
N29
S


6-0110
—(CH2)2
—O—
K1
N30
S


6-0111
—(CH2)2
—O—
K1
N31
S


6-0112
—(CH2)2
—O—
K1
N32
S


6-0113
—(CH2)2
—O—
K1
N33
S


6-0114
—(CH2)2
—O—
K1
N34
S


6-0115
—(CH2)2
—O—
K1
N35
S


6-0116
—(CH2)2
—O—
K1
N36
S


6-0117
—(CH2)2
—O—
K1
N37
S


6-0118
—(CH2)2
—O—
K1
N38
S


6-0119
—(CH2)2
—O—
K1
N39
S


6-0120
—(CH2)2
—O—
K1
N40
S


6-0121
—(CH2)2
—O—
K1
N41
S


6-0122
—(CH2)2
—O—
K1
N42
S


6-0123
—(CH2)2
—O—
K1
N43
S


6-0124
—(CH2)2
—O—
K1
N44
S


6-0125
—(CH2)2
—O—
K1
N45
S


6-0126
—(CH2)2
—O—
K1
N46
S


6-0127
—(CH2)2
—O—
K1
N47
S


6-0128
—(CH2)2
—O—
K1
N48
S





















TABLE 182








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0129
—(CH2)2
—O—
K1
N49
S


6-0130
—(CH2)2
—O—
K1
N50
S


6-0131
—(CH2)2
—O—
K1
N51
S


6-0132
—(CH2)2
—O—
K1
N52
S


6-0133
—(CH2)2
—O—
K1
N53
S


6-0134
—(CH2)2
—O—
K1
N54
S


6-0135
—(CH2)2
—O—
K1
N55
S


6-0136
—(CH2)2
—O—
K1
N56
S


6-0137
—(CH2)2
—O—
K1
N57
S


6-0138
—(CH2)2
—O—
K1
N58
S


6-0139
—(CH2)2
—O—
K1
N59
S


6-0140
—(CH2)2
—O—
K1
N60
S


6-0141
—(CH2)2
—O—
K1
N61
S


6-0142
—(CH2)2
—O—
K1
N62
O


6-0143
—(CH2)2
—O—
K1
N63
S


6-0144
—(CH2)2
—O—
K1
N64
S


6-0145
—(CH2)2
—O—
K1
N65
S


6-0146
—(CH2)2
—O—
K1
N66
S


6-0147
—(CH2)2
—O—
K1
N67
S


6-0148
—(CH2)2
—O—
K1
N68
S


6-0149
—(CH2)2
—O—
K1
N69
S


6-0150
—(CH2)2
—O—
K1
N70
S


6-0151
—(CH2)2
—O—
K1
N71
S


6-0152
—(CH2)2
—O—
K1
N72
S


6-0153
—(CH2)2
—O—
K1
N73
S


6-0154
—(CH2)2
—O—
K1
N74
S


6-0155
—(CH2)2
—O—
K1
N75
S


6-0156
—(CH2)2
—O—
K1
N76
S


6-0157
—(CH2)2
—O—
K1
N77
S


6-0158
—(CH2)2
—O—
K1
N78
S


6-0159
—(CH2)2
—O—
K1
N79
S


6-0160
—(CH2)2
—O—
K1
N80
S





















TABLE 183








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0161
—(CH2)2
—O—
K1
N81
S


6-0162
—(CH2)2
—O—
K1
N82
S


6-0163
—(CH2)2
—O—
K1
N83
S


6-0164
—(CH2)2
—O—
K1
N84
S


6-0165
—(CH2)2
—O—
K1
N85
S


6-0166
—(CH2)2
—O—
K1
N86
S


6-0167
—(CH2)2
—O—
K1
N87
S


6-0168
—(CH2)2
—O—
K1
N88
S


6-0169
—(CH2)2
—O—
K1
N89
S


6-0170
—(CH2)2
—O—
K1
N90
S


6-0171
—(CH2)2
—O—
K1
N91
S


6-0172
—(CH2)2
—O—
K1
N92
S


6-0173
—(CH2)2
—O—
K1
N93
S


6-0174
—(CH2)2
—O—
K1
N94
S


6-0175
—(CH2)2
—O—
K1
N95
O


6-0176
—(CH2)2
—O—
K1
N96
S


6-0177
—(CH2)2
—O—
K1
N97
S


6-0178
—(CH2)2
—O—
K1
N98
S


6-0179
—(CH2)2
—O—
K1
N99
S


6-0180
—(CH2)2
—O—
K1
N100
S


6-0181
—(CH2)2
—O—
K1
N101
S


6-0182
—(CH2)2
—O—
K1
N102
S


6-0183
—(CH2)2
—O—
K1
N103
S


6-0184
—(CH2)2
—O—
K1
N104
S


6-0185
—(CH2)2
—O—
K1
N105
S


6-0186
—(CH2)2
—O—
K1
N106
S


6-0187
—(CH2)2
—O—
K1
N107
S


6-0188
—(CH2)2
—O—
K1
N108
S


6-0189
—(CH2)2
—O—
K1
N109
S


6-0190
—(CH2)2
—O—
K1
N110
S


6-0191
—(CH2)2
—O—
K1
N111
S


6-0192
—(CH2)2
—O—
K1
N112
S





















TABLE 184








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0193
—(CH2)2
—O—
K1
N113
S


6-0194
—(CH2)3
—O—
K1
N114
S


6-0195
—(CH2)3
—O—
K1
N115
S


6-0196
—(CH2)3
—O—
K1
N116
S


6-0197
—(CH2)3
—O—
K1
N117
S


6-0198
—(CH2)3
—O—
K1
N118
S


6-0199
—(CH2)3
—O—
K1
N119
S


6-0200
—(CH2)2
—O—
K1
N120
S


6-0201
—(CH2)2
—O—
K1
N121
S


6-0202
—(CH2)2
—O—
K1
N122
S


6-0203
—(CH2)2
—O—
K1
N123
S


6-0204
—(CH2)2
—O—
K1
N124
S


6-0205
—(CH2)2
—O—
K1
N125
S


6-0206
—(CH2)2
—O—
K1
N126
S


6-0207
—(CH2)2
—O—
K1
N127
S


6-0208
—(CH2)2
—O—
K1
N128
O


6-0209
—(CH2)2
—O—
K1
N128
S


6-0210
—(CH2)2
—O—
K2
N128
S


6-0211
—(CH2)2
—O—
K4
N128
S


6-0212
—(CH2)2
—O—
K11
N128
S


6-0213
—(CH2)2
—O—
K99
N128
S


6-0214
—(CH2)2
—O—
K1
N129
S


6-0215
—(CH2)2
—O—
K1
N130
S


6-0216
—(CH2)2
—O—
K1
N131
S


6-0217
—(CH2)2
—O—
K1
N132
S


6-0218
—(CH2)2
—O—
K1
N133
S


6-0219
—(CH2)2
—O—
K1
N134
S


6-0220
—(CH2)2
—O—
K1
N135
S


6-0221
—(CH2)2
—O—
K1
N136
S


6-0222
—(CH2)2
—O—
K1
N137
S


6-0223
—(CH2)2
—O—
K1
N138
S


6-0224
—(CH2)2
—O—
K1
N139
S





















TABLE 185








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0225
—(CH2)2
—O—
K1
N140
S


6-0226
—(CH2)2
—O—
K1
N141
S


6-0227
—(CH2)2
—O—
K1
N142
S


6-0228
—(CH2)2
—O—
K1
N143
S


6-0229
—(CH2)2
—O—
K1
N144
S


6-0230
—(CH2)2
—O—
K1
N145
S


6-0231
—(CH2)2
—O—
K1
N146
S


6-0232
—(CH2)2
—O—
K1
N147
S


6-0233
—(CH2)2
—O—
K1
N132
O


6-0234
—(CH2)2
—O—
K1
N133
O


6-0235
—(CH2)2
—O—
K1
N134
O


6-0236
—(CH2)2
—O—
K1
N135
O


6-0237
—(CH2)2
—O—
K1
N136
O


6-0238
—(CH2)2
—O—
K1
N137
O


6-0239
—(CH2)2
—O—
K1
N138
O


6-0240
—(CH2)2
—O—
K1
N139
O


6-0241
—(CH2)2
—O—
K1
N140
O


6-0242
—(CH2)2
—O—
K1
N141
O


6-0243
—(CH2)2
—O—
K1
N142
O


6-0244
—(CH2)2
—O—
K1
N143
O


6-0245
—(CH2)2
—O—
K1
N144
O


6-0246
—(CH2)2
—O—
K1
N145
O


6-0247
—(CH2)2
—O—
K1
N146
O


6-0248
—(CH2)2
—O—
K1
N147
O


6-0249
—(CH2)2
—O—
K1
N148
S


6-0250
—(CH2)2
—O—
K1
N149
S


6-0251
—(CH2)2
—O—
K99
N149
S


6-0252
—(CH2)2
—O—
K1
N150
S


6-0253
—(CH2)2
—O—
K99
N150
S


6-0254
—(CH2)2
—O—
K1
N151
S


6-0255
—(CH2)2
—O—
K1
N152
S


6-0256
—(CH2)2
—O—
K99
N152
S





















TABLE 186








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0257
—(CH2)2
—O—
K1
N153
O


6-0258
—(CH2)2
—O—
K1
N153
S


6-0259
—(CH2)2
—O—
K99
N153
S


6-0260
—(CH2)2
—O—
K1
N154
O


6-0261
—(CH2)2
—O—
K1
N154
S


6-0262
—(CH2)2
—O—
K1
N155
S


6-0263
—(CH2)2
—O—
K1
N156
S


6-0264
—(CH2)2
—O—
K1
N157
S


6-0265
—(CH2)2
—O—
K1
N158
S


6-0266
—(CH2)3
—O—
K1
N4
O


6-0267
—(CH2)3
—O—
K1
N4
S


6-0268
—(CH2)3
—O—
K4
N4
S


6-0269
—(CH2)3
—O—
K11
N4
S


6-0270
—(CH2)3
—O—
K99
N4
S


6-0271
—(CH2)3
—O—
K1
N9
O


6-0272
—(CH2)3
—O—
K1
N9
S


6-0273
—(CH2)3
—O—
K4
N9
S


6-0274
—(CH2)3
—O—
K11
N9
S


6-0275
—(CH2)3
—O—
K99
N9
S


6-0276
—(CH2)3
—O—
K1
N11
O


6-0277
—(CH2)3
—O—
K1
N11
S


6-0278
—(CH2)3
—O—
K4
N11
S


6-0279
—(CH2)3
—O—
K11
N11
S


6-0280
—(CH2)3
—O—
K99
N11
S


6-0281
—(CH2)3
—O—
K1
N16
O


6-0282
—(CH2)3
—O—
K1
N16
S


6-0283
—(CH2)3
—O—
K4
N16
S


6-0284
—(CH2)3
—O—
K11
N16
S


6-0285
—(CH2)3
—O—
K99
N16
S


6-0286
—(CH2)3
—O—
K1
N24
O


6-0287
—(CH2)3
—O—
K1
N24
S


6-0288
—(CH2)3
—O—
K4
N24
S





















TABLE 187








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0289
—(CH2)3
—O—
K11
N24
S


6-0290
—(CH2)3
—O—
K99
N24
S


6-0291
—(CH2)3
—O—
K1
N53
O


6-0292
—(CH2)3
—O—
K1
N53
S


6-0293
—(CH2)3
—O—
K4
N53
S


6-0294
—(CH2)3
—O—
K11
N53
S


6-0295
—(CH2)3
—O—
K99
N53
S


6-0296
—(CH2)3
—O—
K1
N65
O


6-0297
—(CH2)3
—O—
K1
N65
S


6-0298
—(CH2)3
—O—
K4
N65
S


6-0299
—(CH2)3
—O—
K1
N69
S


6-0300
—(CH2)3
—O—
K4
N69
S


6-0301
—(CH2)3
—O—
K11
N69
S


6-0302
—(CH2)3
—O—
K99
N69
S


6-0303
—(CH2)3
—O—
K1
N70
S


6-0304
—(CH2)3
—O—
K4
N70
S


6-0305
—(CH2)3
—O—
K11
N70
S


6-0306
—(CH2)3
—O—
K99
N70
S


6-0307
—(CH2)3
—O—
K1
N76
S


6-0308
—(CH2)3
—O—
K4
N76
S


6-0309
—(CH2)3
—O—
K11
N76
S


6-0310
—(CH2)3
—O—
K99
N76
S


6-0311
—(CH2)3
—O—
K1
N77
S


6-0312
—(CH2)3
—O—
K4
N77
S


6-0313
—(CH2)3
—O—
K11
N77
S


6-0314
—(CH2)3
—O—
K99
N77
S


6-0315
—(CH2)3
—O—
K1
N100
S


6-0316
—(CH2)3
—O—
K4
N100
S


6-0317
—(CH2)3
—O—
K11
N100
S


6-0318
—(CH2)3
—O—
K99
N100
S


6-0319
—(CH2)3
—O—
K1
N115
O


6-0320
—(CH2)3
—O—
K4
N115
S





















TABLE 188








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0321
—(CH2)3
—O—
K11
N115
S


6-0322
—(CH2)3
—O—
K99
N115
S


6-0323
—(CH2)3
—O—
K1
N116
O


6-0324
—(CH2)3
—O—
K4
N116
S


6-0325
—(CH2)3
—O—
K11
N116
S


6-0326
—(CH2)3
—O—
K99
N116
S


6-0327
—(CH2)3
—O—
K1
N122
S


6-0328
—(CH2)3
—O—
K4
N122
S


6-0329
—(CH2)3
—O—
K11
N122
S


6-0330
—(CH2)3
—O—
K99
N122
S


6-0331
—(CH2)3
—O—
K4
N123
S


6-0332
—(CH2)3
—O—
K1
N128
S


6-0333
—(CH2)3
—O—
K4
N128
S


6-0334
—(CH2)3
—O—
K11
N128
S


6-0335
—(CH2)3
—O—
K99
N128
S


6-0336
—(CH2)3
—O—
K1
N129
S


6-0337
—(CH2)3
—O—
K4
N129
S


6-0338
—(CH2)3
—O—
K11
N129
S


6-0339
—(CH2)3
—O—
K99
N129
S


6-0340
—(CH2)3
—O—
K1
N130
S


6-0341
—(CH2)3
—O—
K4
N130
S


6-0342
—(CH2)3
—O—
K1
N135
S


6-0343
—(CH2)3
—O—
K4
N135
S


6-0344
—(CH2)3
—O—
K1
N139
S


6-0345
—(CH2)3
—O—
K4
N139
S


6-0346
—(CH2)3
—O—
K1
N140
S


6-0347
—(CH2)3
—O—
K4
N140
S


6-0348
—(CH2)3
—O—
K1
N141
S


6-0349
—(CH2)3
—O—
K4
N141
S


6-0350
—(CH2)3
—O—
K11
N141
S


6-0351
—(CH2)3
—O—
K99
N141
S


6-0352
—(CH2)3
—O—
K1
N142
S





















TABLE 189








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0353
—(CH2)3
—O—
K4
N142
S


6-0354
—(CH2)3
—O—
K11
N142
S


6-0355
—(CH2)3
—O—
K99
N142
S


6-0356
—(CH2)3
—O—
K1
N143
S


6-0357
—(CH2)3
—O—
K4
N143
S


6-0358
—(CH2)3
—O—
K11
N143
S


6-0359
—(CH2)3
—O—
K99
N143
S


6-0360
—(CH2)3
—O—
K1
N144
S


6-0361
—(CH2)3
—O—
K4
N144
S


6-0362
—(CH2)3
—O—
K11
N144
S


6-0363
—(CH2)3
—O—
K99
N144
S


6-0364
—(CH2)3
—O—
K1
N145
S


6-0365
—(CH2)3
—O—
K1
N146
S


6-0366
—(CH2)3
—O—
K4
N146
S


6-0367
—(CH2)3
—O—
K11
N146
S


6-0368
—(CH2)3
—O—
K99
N146
S


6-0369
—(CH2)3
—O—
K1
N147
S


6-0370
—(CH2)3
—O—
K4
N147
S


6-0371
—(CH2)3
—O—
K11
N147
S


6-0372
—(CH2)3
—O—
K99
N147
S


6-0373
—(CH2)3
—O—
K1
N148
S


6-0374
—(CH2)3
—O—
K4
N148
S


6-0375
—(CH2)3
—O—
K11
N148
S


6-0376
—(CH2)3
—O—
K99
N148
S


6-0377
—(CH2)3
—O—
K1
N149
S


6-0378
—(CH2)3
—O—
K4
N149
S


6-0379
—(CH2)3
—O—
K11
N149
S


6-0380
—(CH2)3
—O—
K99
N149
S


6-0381
—(CH2)3
—O—
K1
N150
S


6-0382
—(CH2)3
—O—
K4
N150
S


6-0383
—(CH2)3
—O—
K11
N150
S


6-0384
—(CH2)3
—O—
K99
N150
S





















TABLE 190








Com-







pound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0385
—(CH2)3
—O—
K1
N151
S


6-0386
—(CH2)3
—O—
K4
N152
S


6-0387
—(CH2)3
—O—
K11
N153
S


6-0388
—(CH2)3
—O—
K99
N154
S


6-0389
—(CH2)3
—O—
K1
N155
S


6-0390
—(CH2)3
—O—
K4
N155
S


6-0391
—(CH2)3
—O—
K11
N155
S


6-0392
—(CH2)3
—O—
K99
N155
S


6-0393
—(CH2)3
—O—
K1
N156
S


6-0394
—(CH2)3
—O—
K4
N156
S


6-0395
—(CH2)3
—O—
K11
N156
S


6-0396
—(CH2)3
—O—
K1
N157
S


6-0397
—(CH2)3
—O—
K1
N158
S


6-0398
—(CH2)2
—NH—C(═O)—
K1
N3
S


6-0399
—(CH2)2
—NH—C(═O)—
K1
N9
S


6-0400
—(CH2)2
—NH—C(═O)—
K1
N69
S


6-0401
—(CH2)2
—NH—C(═O)—
K1
N12
S


6-0402
—(CH2)2
—NH—C(═O)—
K1
N115
S


6-0403
—(CH2)2
—NH—C(═O)—
K1
N116
S


6-0404
—(CH2)2
—NH—C(═O)—
K1
N128
S


6-0405
—(CH2)2
—NH—C(═O)—
K1
N140
S


6-0406
—(CH2)2
—NH—C(═O)—
K1
N150
S


6-0407
—(CH2)2
—NH—C(═O)—
K1
N153
S


6-0408
—(CH2)2
—NH—C(═O)—
K8
N3
S


6-0409
—(CH2)2
—NH—C(═O)—
K8
N9
S


6-0410
—(CH2)2
—NH—C(═O)—
K8
N69
S


6-0411
—(CH2)2
—NH—C(═O)—
K8
N115
S


6-0412
—(CH2)2
—NH—C(═O)—
K11
N3
S


6-0413
—(CH2)2
—NH—C(═O)—
K11
N9
S


6-0414
—(CH2)2
—NH—C(═S)—
K11
N9
S


6-0415
—(CH2)2
—NH—C(═O)—
K11
N69
S


6-0416
—(CH2)2
—NH—C(═O)—
K11
N115
S





















TABLE 191








Com-







pound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0417
—(CH2)2
—NH—C(═O)—
K11
N116
S


6-0418
—(CH2)2
—NH—C(═O)—
K11
N128
S


6-0419
—(CH2)2
—NH—C(═O)—
K11
N140
S


6-0420
—(CH2)2
—NH—C(═O)—
K11
N150
S


6-0421
—(CH2)2
—NH—C(═O)—
K11
N153
S


6-0422
—(CH2)2
—NH—C(═O)—
K13
N3
S


6-0423
—(CH2)2
—NH—C(═O)—
K13
N9
S


6-0424
—(CH2)2
—NH—C(═O)—
K13
N69
S


6-0425
—(CH2)2
—NH—C(═O)—
K13
N115
S


6-0426
—(CH2)2
—NH—C(═O)—
K14
N3
S


6-0427
—(CH2)2
—NH—C(═O)—
K14
N9
S


6-0428
—(CH2)2
—NH—C(═O)—
K14
N69
S


6-0429
—(CH2)2
—NH—C(═O)—
K14
N115
S


6-0430
—(CH2)2
—NH—C(═O)—
K14
N128
S


6-0431
—(CH2)2
—NH—C(═O)—
K15
N3
S


6-0432
—(CH2)2
—NH—C(═O)—
K15
N9
S


6-0433
—(CH2)2
—NH—C(═O)—
K15
N115
S


6-0434
—(CH2)2
—NH—C(═O)—
K16
N3
S


6-0435
—(CH2)2
—NH—C(═O)—
K16
N9
S


6-0436
—(CH2)2
—NH—C(═O)—
K16
N115
S


6-0437
—(CH2)2
—NH—C(═O)—
K19
N3
S


6-0438
—(CH2)2
—NH—C(═O)—
K19
N9
S


6-0439
—(CH2)2
—NH—C(═O)—
K19
N115
S


6-0440
—(CH2)2
—NH—C(═O)—
K23
N3
S


6-0441
—(CH2)2
—NH—C(═O)—
K23
N9
S


6-0442
—(CH2)2
—NH—C(═O)—
K23
N115
S


6-0443
—(CH2)2
—NH—C(═O)—
K24
N3
S


6-0444
—(CH2)2
—NH—C(═O)—
K24
N9
S


6-0445
—(CH2)2
—NH—C(═O)—
K24
N115
S


6-0446
—(CH2)2
—NH—C(═O)—
K34
N3
S


6-0447
—(CH2)2
—NH—C(═O)—
K34
N9
S


6-0448
—(CH2)2
—NH—C(═O)—
K34
N115
S





















TABLE 192








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0449
—(CH2)2
—NH—C(═O)—
K35
N3
S


6-0450
—(CH2)2
—NH—C(═O)—
K35
N9
S


6-0451
—(CH2)2
—NH—C(═O)—
K35
N115
S


6-0452
—(CH2)2
—NH—C(═O)—
K37
N3
S


6-0453
—(CH2)2
—NH—C(═O)—
K37
N9
S


6-0454
—(CH2)2
—NH—C(═O)—
K37
N115
S


6-0455
—(CH2)2
—NH—C(═O)—
K39
N3
S


6-0456
—(CH2)2
—NH—C(═O)—
K39
N9
S


6-0457
—(CH2)2
—NH—C(═O)—
K39
N115
S


6-0458
—(CH2)2
—NH—C(═O)—
K46
N3
S


6-0459
—(CH2)2
—NH—C(═O)—
K46
N9
S


6-0460
—(CH2)2
—NH—C(═O)—
K46
N115
S


6-0461
—(CH2)2
—NH—C(═O)—
K47
N3
S


6-0462
—(CH2)2
—NH—C(═O)—
K47
N9
S


6-0463
—(CH2)2
—NH—C(═O)—
K47
N115
S


6-0464
—(CH2)2
—NH—C(═O)—
K50
N3
S


6-0465
—(CH2)2
—NH—C(═O)—
K50
N9
S


6-0466
—(CH2)2
—NH—C(═O)—
K50
N115
S


6-0467
—(CH2)2
—NH—C(═O)—
K53
N3
S


6-0468
—(CH2)2
—NH—C(═O)—
K53
N9
S


6-0469
—(CH2)2
—NH—C(═O)—
K53
N115
S


6-0470
—(CH2)2
—NH—C(═O)—
K54
N3
S


6-0471
—(CH2)2
—NH—C(═O)—
K54
N9
S


6-0472
—(CH2)2
—NH—C(═O)—
K54
N115
S


6-0473
—(CH2)2
—NH—C(═O)—
K56
N3
S


6-0474
—(CH2)2
—NH—C(═O)—
K56
N9
S


6-0475
—(CH2)2
—NH—C(═O)—
K56
N115
S


6-0476
—(CH2)2
—NH—C(═O)—
K50
N3
O


6-0477
—(CH2)2
—NH—C(═O)—
K60
N9
S


6-0478
—(CH2)2
—NH—C(═O)—
K60
N115
S


6-0479
—(CH2)2
—NH—C(═O)—
K62
N3
S


6-0480
—(CH2)2
—NH—C(═O)—
K62
N9
S





















TABLE 193








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0481
—(CH2)2
—NH—C(═O)—
K62
N115
S


6-0482
—(CH2)2
—NH—C(═O)—
K63
N3
S


6-0483
—(CH2)2
—NH—C(═O)—
K63
N9
S


6-0484
—(CH2)2
—NH—C(═O)—
K63
N115
S


6-0485
—(CH2)2
—NH—C(═O)—
K64
N3
S


6-0486
—(CH2)2
—NH—C(═O)—
K64
N9
S


6-0487
—(CH2)2
—NH—C(═O)—
K64
N115
S


6-0488
—(CH2)2
—NH—C(═O)—
K75
N3
S


6-0489
—(CH2)2
—NH—C(═O)—
K75
N9
S


6-0490
—(CH2)2
—NH—C(═O)—
K75
N115
S


6-0491
—(CH2)2
—NH—C(═O)—
K77
N3
S


6-0492
—(CH2)2
—NH—C(═O)—
K77
N9
S


6-0493
—(CH2)2
—NH—C(═O)—
K77
N115
S


6-0494
—(CH2)2
—NH—C(═O)—
K99
N3
S


6-0495
—(CH2)2
—NH—C(═O)—
K99
N9
S


6-0496
—(CH2)2
—NH—C(═O)—
K99
N115
S


6-0497
—(CH2)2
—NH—C(═O)—
K100
N3
S


6-0498
—(CH2)2
—NH—C(═O)—
K100
N9
S


6-0499
—(CH2)2
—NH—C(═O)—
K100
N115
S


6-0500
—(CH2)2
—NH—C(═O)—
K102
N3
S


6-0501
—(CH2)2
—NH—C(═O)—
K102
N9
S


6-0502
—(CH2)2
—NH—C(═O)—
K102
N115
S


6-0503
—(CH2)2
—NH—C(═O)—
K241
N3
S


6-0504
—(CH2)2
—NH—C(═O)—
K241
N9
S


6-0505
—(CH2)2
—NH—C(═O)—
K241
N115
S


6-0506
—(CH2)2
—NH—C(═O)—
K242
N3
S


6-0507
—(CH2)2
—NH—C(═O)—
K242
N9
S


6-0508
—(CH2)2
—NH—C(═O)—
K242
N115
S


6-0509
—(CH2)2
—NH—C(═O)—
K243
N3
S


6-0510
—(CH2)2
—NH—C(═O)—
K243
N9
S


6-0511
—(CH2)2
—NH—C(═O)—
K243
N115
S


6-0512
—(CH2)2
—NH—C(═O)—
K244
N3
S





















TABLE 194








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0513
—(CH2)2
—NH—C(═O)—
K244
N9
S


6-0514
—(CH2)2
—NH—C(═O)—
K244
N115
S


6-0515
—(CH2)2
—NH—C(═O)—
K245
N3
S


6-0516
—(CH2)2
—NH—C(═O)—
K245
N9
S


6-0517
—(CH2)2
—NH—C(═O)—
K245
N115
S


6-0518
—(CH2)2
—NH—C(═O)—
K246
N3
S


6-0519
—(CH2)2
—NH—C(═O)—
K246
N9
S


6-0520
—(CH2)2
—NH—C(═O)—
K246
N115
S


6-0521
—(CH2)2
—NH—C(═O)—
K247
N3
S


6-0522
—(CH2)2
—NH—C(═O)—
K247
N9
S


6-0523
—(CH2)2
—NH—C(═O)—
K247
N115
S


6-0524
—(CH2)2
—NH—C(═O)—
K248
N3
S


6-0525
—(CH2)2
—NH—C(═O)—
K248
N9
S


6-0526
—(CH2)2
—NH—C(═O)—
K248
N115
S


6-0527
—(CH2)2
—NH—C(═O)—
K249
N115
S


6-0528
—(CH2)2
—NH—C(═O)—
K253
N115
S


6-0529
—(CH2)2
—NH—C(═O)—
K254
N115
S


6-0530
—(CH2)3
—NH—C(═O)—
K1
N1
S


6-0531
—(CH2)3
—NH—C(═O)—
K1
N3
S


6-0532
—(CH2)3
—NH—C(═O)—
K1
N9
S


6-0533
—(CH2)3
—NH—C(═O)—
K1
N69
S


6-0534
—(CH2)3
—NH—C(═O)—
K1
N12
S


6-0535
—(CH2)3
—NH—C(═O)—
K1
N115
S


6-0536
—(CH2)3
—NH—C(═O)—
K1
N116
S


6-0537
—(CH2)3
—NH—C(═O)—
K1
N128
S


6-0538
—(CH2)3
—NH—C(═O)—
K1
N140
S


6-0539
—(CH2)3
—NH—C(═O)—
K1
N150
S


6-0540
—(CH2)3
—NH—C(═O)—
K1
N153
S


6-0541
—(CH2)3
—NH—C(═O)—
K11
N1
S


6-0542
—(CH2)3
—NH—C(═O)—
K11
N3
S


6-0543
—(CH2)3
—NH—C(═O)—
K11
N9
S


6-0544
—(CH2)3
—NH—C(═O)—
K11
N69
S





















TABLE 195








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0545
—(CH2)3
—NH—C(═O)—
K11
N12
S


6-0546
—(CH2)3
—NH—C(═O)—
K11
N115
S


6-0547
—(CH2)3
—NH—C(═O)—
K11
N116
S


6-0548
—(CH2)3
—NH—C(═O)—
K11
N128
S


6-0549
—(CH2)3
—NH—C(═O)—
K11
N140
S


6-0550
—(CH2)3
—NH—C(═O)—
K11
N150
S


6-0551
—(CH2)3
—NH—C(═O)—
K11
N153
S


6-0552
—(CH2)3
—NH—C(═O)—
K35
N1
S


6-0553
—(CH2)3
—NH—C(═O)—
K35
N3
S


6-0554
—(CH2)3
—NH—C(═O)—
K35
N9
S


6-0555
—(CH2)3
—NH—C(═O)—
K35
N69
S


6-0556
—(CH2)3
—NH—C(═O)—
K35
N12
S


6-0557
—(CH2)3
—NH—C(═O)—
K35
N115
S


6-0558
—(CH2)3
—NH—C(═O)—
K35
N116
S


6-0559
—(CH2)3
—NH—C(═O)—
K35
N128
S


6-0560
—(CH2)3
—NH—C(═O)—
K35
N140
S


6-0561
—(CH2)3
—NH—C(═O)—
K35
N150
S


6-0562
—(CH2)3
—NH—C(═O)—
K35
N153
S


6-0563
—(CH2)3
—NH—C(═O)—
K37
N1
S


6-0564
—(CH2)3
—NH—C(═O)—
K37
N3
S


6-0565
—(CH2)3
—NH—C(═O)—
K37
N9
S


6-0566
—(CH2)3
—NH—C(═O)—
K37
N69
S


6-0567
—(CH2)3
—NH—C(═O)—
K37
N12
S


6-0568
—(CH2)3
—NH—C(═O)—
K37
N115
S


6-0569
—(CH2)3
—NH—C(═O)—
K37
N116
S


6-0570
—(CH2)3
—NH—C(═O)—
K37
N128
S


6-0571
—(CH2)3
—NH—C(═O)—
K37
N140
S


6-0572
—(CH2)3
—NH—C(═O)—
K37
N150
S


6-0573
—(CH2)3
—NH—C(═O)—
K37
N153
S


6-0574
—(CH2)3
—NH—C(═O)—
K50
N1
S


6-0575
—(CH2)3
—NH—C(═O)—
K50
N3
S


6-0576
—(CH2)3
—NH—C(═O)—
K50
N9
S





















TABLE 196








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0577
—(CH2)3
—NH—C(═O)—
K50
N69
S


6-0578
—(CH2)3
—NH—C(═O)—
K50
N12
S


6-0579
—(CH2)3
—NH—C(═O)—
K50
N115
S


6-0580
—(CH2)3
—NH—C(═O)—
K50
N116
S


6-0581
—(CH2)3
—NH—C(═O)—
K50
N128
S


6-0582
—(CH2)3
—NH—C(═O)—
K50
N140
S


6-0583
—(CH2)3
—NH—C(═O)—
K50
N150
S


6-0584
—(CH2)3
—NH—C(═O)—
K50
N153
S


6-0585
—(CH2)3
—NH—C(═O)—
K62
N1
S


6-0586
—(CH2)3
—NH—C(═O)—
K62
N3
S


6-0587
—(CH2)3
—NH—C(═O)—
K62
N9
S


6-0588
—(CH2)3
—NH—C(═O)—
K62
N69
S


6-0589
—(CH2)3
—NH—C(═O)—
K62
N12
S


6-0590
—(CH2)3
—NH—C(═O)—
K62
N115
S


6-0591
—(CH2)3
—NH—C(═O)—
K62
N116
S


6-0592
—(CH2)3
—NH—C(═O)—
K62
N128
S


6-0593
—(CH2)3
—NH—C(═O)—
K62
N140
S


6-0594
—(CH2)3
—NH—C(═O)—
K62
N150
S


6-0595
—(CH2)3
—NH—C(═O)—
K62
N153
S


6-0596
—(CH2)3
—NH—C(═O)—
K72
N1
S


6-0597
—(CH2)3
—NH—C(═O)—
K72
N3
S


6-0598
—(CH2)3
—NH—C(═O)—
K72
N9
S


6-0599
—(CH2)3
—NH—C(═O)—
K72
N69
S


6-0600
—(CH2)3
—NH—C(═O)—
K72
N12
S


6-0601
—(CH2)3
—NH—C(═O)—
K72
N115
S


6-0602
—(CH2)3
—NH—C(═O)—
K72
N116
S


6-0603
—(CH2)3
—NH—C(═O)—
K72
N128
S


6-0604
—(CH2)3
—NH—C(═O)—
K72
N140
S


6-0605
—(CH2)3
—NH—C(═O)—
K72
N150
S


6-0606
—(CH2)3
—NH—C(═O)—
K72
N153
S


6-0607
—(CH2)3
—NH—C(═O)—
K78
N1
S


6-0608
—(CH2)3
—NH—C(═O)—
K78
N3
S





















TABLE 197








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0609
—(CH2)3
—NH—C(═O)—
K78
N9
S


6-0610
—(CH2)3
—NH—C(═O)—
K78
N69
S


6-0611
—(CH2)3
—NH—C(═O)—
K78
N12
S


6-0612
—(CH2)3
—NH—C(═O)—
K78
N115
S


6-0613
—(CH2)3
—NH—C(═O)—
K78
N116
S


6-0614
—(CH2)3
—NH—C(═O)—
K78
N128
S


6-0615
—(CH2)3
—NH—C(═O)—
K78
N140
S


6-0616
—(CH2)3
—NH—C(═O)—
K78
N150
S


6-0617
—(CH2)3
—NH—C(═O)—
K78
N153
S


6-0618
—(CH2)3
—NH—C(═O)—
K99
N1
S


6-0619
—(CH2)3
—NH—C(═O)—
K99
N3
S


6-0620
—(CH2)3
—NH—C(═O)—
K99
N9
S


6-0621
—(CH2)3
—NH—C(═O)—
K99
N69
S


6-0622
—(CH2)3
—NH—C(═O)—
K99
N12
S


6-0623
—(CH2)3
—NH—C(═O)—
K99
N115
S


6-0624
—(CH2)3
—NH—C(═O)—
K99
N116
S


6-0625
—(CH2)3
—NH—C(═O)—
K99
N128
S


6-0626
—(CH2)3
—NH—C(═O)—
K99
N140
S


6-0627
—(CH2)3
—NH—C(═O)—
K99
N150
S


6-0628
—(CH2)3
—NH—C(═O)—
K99
N153
S


6-0629
—(CH2)3
—NH—C(═O)—
K241
N1
S


6-0630
—(CH2)3
—NH—C(═O)—
K241
N3
S


6-0631
—(CH2)3
—NH—C(═O)—
K241
N9
S


6-0632
—(CH2)3
—NH—C(═O)—
K241
N69
S


6-0633
—(CH2)3
—NH—C(═O)—
K241
N12
S


6-0634
—(CH2)3
—NH—C(═O)—
K241
N115
S


6-0635
—(CH2)3
—NH—C(═O)—
K241
N116
S


6-0636
—(CH2)3
—NH—C(═O)—
K241
N128
S


6-0637
—(CH2)3
—NH—C(═O)—
K241
N140
S


6-0638
—(CH2)3
—NH—C(═O)—
K241
N150
S


6-0639
—(CH2)3
—NH—C(═O)—
K241
N153
S


6-0640
—(CH2)3
—NH—C(═O)—
K242
N1
S





















TABLE 198








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0641
—(CH2)3
—NH—C(═O)—
K242
N3
S


6-0642
—(CH2)3
—NH—C(═O)—
K242
N9
S


6-0643
—(CH2)3
—NH—C(═O)—
K242
N69
S


6-0644
—(CH2)3
—NH—C(═O)—
K242
N12
S


6-0645
—(CH2)3
—NH—C(═O)—
K242
N115
S


6-0646
—(CH2)3
—NH—C(═O)—
K242
N116
S


6-0647
—(CH2)3
—NH—C(═O)—
K242
N128
S


6-0648
—(CH2)3
—NH—C(═O)—
K242
N140
S


6-0649
—(CH2)3
—NH—C(═O)—
K242
N150
S


6-0650
—(CH2)3
—NH—C(═O)—
K242
N153
S


6-0651
—(CH2)3
—NH—C(═O)—
K245
N1
S


6-0652
—(CH2)3
—NH—C(═O)—
K245
N3
S


6-0653
—(CH2)3
—NH—C(═O)—
K245
N9
S


6-0654
—(CH2)3
—NH—C(═O)—
K245
N69
S


6-0655
—(CH2)3
—NH—C(═O)—
K245
N12
S


6-0656
—(CH2)3
—NH—C(═O)—
K245
N115
S


6-0657
—(CH2)3
—NH—C(═O)—
K245
N116
S


6-0658
—(CH2)3
—NH—C(═O)—
K245
N128
S


6-0659
—(CH2)3
—NH—C(═O)—
K245
N140
S


6-0660
—(CH2)3
—NH—C(═O)—
K245
N150
S


6-0661
—(CH2)3
—NH—C(═O)—
K245
N153
S


6-0662
—(CH2)3
—NH—C(═O)—
K246
N1
S


6-0663
—(CH2)3
—NH—C(═O)—
K246
N3
S


6-0664
—(CH2)3
—NH—C(═O)—
K246
N9
S


6-0665
—(CH2)3
—NH—C(═O)—
K246
N69
S


6-0666
—(CH2)3
—NH—C(═O)—
K246
N12
S


6-0667
—(CH2)3
—NH—C(═O)—
K246
N115
S


6-0668
—(CH2)3
—NH—C(═O)—
K246
N116
S


6-0669
—(CH2)3
—NH—C(═O)—
K246
N128
S


6-0670
—(CH2)3
—NH—C(═O)—
K246
N140
S


6-0671
—(CH2)3
—NH—C(═O)—
K246
N150
S


6-0672
—(CH2)3
—NH—C(═O)—
K246
N153
S





















TABLE 199








Com-







pound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







6-0673
—(CH2)3
—NH—C(═O)—
K248
N1
S


6-0674
—(CH2)3
—NH—C(═O)—
K248
N3
S


6-0675
—(CH2)3
—NH—C(═O)—
K248
N9
S


6-0676
—(CH2)3
—NH—C(═O)—
K248
N69
S


6-0677
—(CH2)3
—NH—C(═O)—
K248
N12
S


6-0678
—(CH2)3
—NH—C(═O)—
K248
N115
S


6-0679
—(CH2)3
—NH—C(═O)—
K248
N116
S


6-0680
—(CH2)3
—NH—C(═O)—
K248
N128
S


6-0681
—(CH2)3
—NH—C(═O)—
K248
N140
S


6-0682
—(CH2)3
—NH—C(═O)—
K248
N150
S


6-0683
—(CH2)3
—NH—C(═O)—
K248
N153
S


6-0684
—(CH2)3
—NH—C(═O)—
K250
N1
S


6-0685
—(CH2)3
—NH—C(═O)—
K250
N3
S


6-0686
—(CH2)3
—NH—C(═O)—
K250
N9
S


6-0687
—(CH2)3
—NH—C(═O)—
K250
N69
S


6-0688
—(CH2)3
—NH—C(═O)—
K250
N12
S


6-0689
—(CH2)3
—NH—C(═O)—
K250
N115
S


6-0690
—(CH2)3
—NH—C(═O)—
K250
N116
S


6-0691
—(CH2)3
—NH—C(═O)—
K250
N128
S


6-0692
—(CH2)3
—NH—C(═O)—
K250
N140
S


6-0693
—(CH2)3
—NH—C(═S)—
K250
N150
S


6-0694
—(CH2)3
—NH—C(═S)—
K250
N153
S


6-0695
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N1
S


6-0696
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N3
S


6-0697
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N9
S


6-0698
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N69
S


6-0699
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N12
S


6-0700
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N115
S


6-0701
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N116
S


6-0702
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N128
S


6-0703
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N140
S


6-0704
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N150
S





















TABLE 200








Com-







pound


-G1-A3-
-A5-



No.
-A1-
-A2-
A4-G2
R2
X







6-0705
—(CH2)2
—C(═O)—N(CH2CH3)—
K2
N153
S


6-0706
—(CH2)2
—C(═O)—N(CH3)—
K1
N1
S


6-0707
—(CH2)2
—C(═O)—N(CH3)—
K1
N3
S


6-0708
—(CH2)2
—C(═O)—N(CH3)—
K1
N9
S


6-0709
—(CH2)2
—C(═O)—N(CH3)—
K1
N69
S


6-0710
—(CH2)2
—C(═O)—N(CH3)—
K1
N12
S


6-0711
—(CH2)2
—C(═O)—N(CH3)—
K1
N115
S


6-0712
—(CH2)2
—C(═O)—N(CH3)—
K1
N116
S


6-0713
—(CH2)2
—C(═O)—N(CH3)—
K1
N128
S


6-0714
—(CH2)2
—C(═O)—N(CH3)—
K1
N140
S


6-0715
—(CH2)2
—C(═O)—N(CH3)—
K1
N150
S


6-0716
—(CH2)2
—C(═O)—N(CH3)—
K1
N153
S


6-0717
—(CH2)2
—C(═O)—N(CH3)—
K132
N1
S


6-0718
—(CH2)2
—C(═O)—NH—
K8
N3
S


6-0719
—(CH2)2
—C(═O)—NH—
K8
N9
S


6-0720
—(CH2)2
—C(═O)—NH—
K8
N69
S


6-0721
—(CH2)2
—C(═O)—NH—
K8
N12
S


6-0722
—(CH2)2
—C(═O)—NH—
K8
N115
S


6-0723
—(CH2)2
—C(═O)—NH—
K8
N116
S


6-0724
—(CH2)2
—C(═O)—NH—
K8
N128
S


6-0725
—(CH2)2
—C(═O)—NH—
K8
N140
S


6-0726
—(CH2)2
—C(═O)—NH—
K8
N150
S


6-0727
—(CH2)2
—C(═O)—NH—
K8
N153
S


6-0728
—(CH2)2
—NH—C(═O)—NH—
K11
N1
S


6-0729
—(CH2)2
—NH—C(═O)—NH—
K11
N3
S


6-0730
—(CH2)2
—NH—C(═O)—NH—
K11
N9
S


6-0731
—(CH2)2
—NH—C(═O)—NH—
K11
N69
S


6-0732
—(CH2)2
—NH—C(═O)—NH—
K11
N12
S


6-0733
—(CH2)2
—NH—C(═O)—NH—
K11
N115
S


6-0734
—(CH2)2
—NH—C(═O)—NH—
K11
N116
S


6-0735
—(CH2)2
—NH—C(═O)—NH—
K11
N128
S


6-0736
—(CH2)2
—NH—C(═O)—NH—
K11
N140
S





















TABLE 201








Com-







pound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0737
—(CH2)2
—NH—C(═O)—NH—
K11
N150
S


6-0738
—(CH2)2
—NH—C(═O)—NH—
K11
N153
S


6-0739
—(CH2)2
—C(═O)—NH—
K62
N1
S


6-0740
—(CH2)2
—C(═O)—NH—
K62
N3
S


6-0741
—(CH2)2
—C(═O)—NH—
K62
N9
S


6-0742
—(CH2)2
—C(═O)—NH—
K62
N69
S


6-0743
—(CH2)2
—C(═O)—NH—
K62
N12
S


6-0744
—(CH2)2
—C(═O)—NH—
K62
N115
S


6-0745
—(CH2)2
—C(═O)—NH—
K62
N116
S


6-0746
—(CH2)2
—C(═O)—NH—
K62
N128
S


6-0747
—(CH2)2
—C(═O)—NH—
K62
N140
S


6-0748
—(CH2)2
—C(═O)—NH—
K62
N150
S


6-0749
—(CH2)2
—C(═O)—NH—
K62
N153
S


6-0750
—(CH2)2
—C(═O)—N(CH3)—
K99
N1
S


6-0751
—(CH2)2
—C(═O)—N(CH3)—
K99
N3
S


6-0752
—(CH2)2
—C(═O)—N(CH3)—
K99
N9
S


6-0753
—(CH2)2
—C(═O)—N(CH3)—
K99
N69
S


6-0754
—(CH2)2
—C(═O)—N(CH3)—
K99
N12
S


6-0755
—(CH2)2
—C(═O)—N(CH3)—
K99
N115
S


6-0756
—(CH2)2
—C(═O)—N(CH3)—
K99
N116
S


6-0757
—(CH2)2
—C(═O)—N(CH3)—
K99
N128
S


6-0758
—(CH2)2
—C(═O)—N(CH3)—
K99
N140
S


6-0759
—(CH2)2
—C(═O)—N(CH3)—
K99
N150
S


6-0760
—(CH2)2
—C(═O)—N(CH3)—
K99
N153
S


6-0761
—(CH2)2
—C(═O)—
K315
N1
S


6-0762
—(CH2)2
—C(═O)—
K315
N3
S


6-0763
—(CH2)2
—C(═O)—
K315
N9
S


6-0764
—(CH2)2
—C(═O)—
K315
N69
S


6-0765
—(CH2)2
—C(═O)—
K315
N12
S


6-0766
—(CH2)2
—C(═O)—
K315
N115
S


6-0767
—(CH2)2
—C(═O)—
K315
N116
S


6-0768
—(CH2)2
—C(═O)—
K315
N128
S





















TABLE 202








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0769
—(CH2)2
—C(═O)—
K315
N140
S


6-0770
—(CH2)2
—C(═O)—
K315
N150
S


6-0771
—(CH2)2
—C(═O)—
K315
N153
S


6-0772
—(CH2)2
—C(═O)—
K332
N1
S


6-0773
—(CH2)2
—C(═O)—
K332
N3
S


6-0774
—(CH2)2
—C(═O)—
K332
N9
S


6-0775
—(CH2)2
—C(═O)—
K332
N69
S


6-0776
—(CH2)2
—C(═O)—
K332
N12
S


6-0777
—(CH2)2
—C(═O)—
K332
N115
S


6-0778
—(CH2)2
—C(═O)—
K332
N116
S


6-0779
—(CH2)2
—C(═O)—
K332
N128
S


6-0780
—(CH2)2
—C(═O)—
K332
N140
S


6-0781
—(CH2)2
—C(═O)—
K332
N150
S


6-0782
—(CH2)2
—C(═O)—
K332
N153
S


6-0783
—(CH2)2
—C(═O)—
K336
N1
S


6-0784
—(CH2)2
—C(═O)—
K336
N3
S


6-0785
—(CH2)2
—C(═O)—
K336
N9
S


6-0786
—(CH2)2
—C(═O)—
K336
N69
S


6-0787
—(CH2)2
—C(═O)—
K336
N12
S


6-0788
—(CH2)2
—C(═O)—
K336
N115
S


6-0789
—(CH2)2
—C(═O)—
K336
N116
S


6-0790
—(CH2)2
—C(═O)—
K336
N128
S


6-0791
—(CH2)2
—C(═O)—
K336
N140
S


6-0792
—(CH2)2
—C(═O)—
K336
N150
S


6-0793
—(CH2)2
—C(═O)—
K336
N153
S


6-0794
—(CH2)2
—C(═O)—
K337
N1
S


6-0795
—(CH2)2
—C(═O)—
K337
N3
S


6-0796
—(CH2)2
—C(═O)—
K337
N9
S


6-0797
—(CH2)2
—C(═O)—
K337
N69
S


6-0798
—(CH2)2
—C(═O)—
K337
N12
S


6-0799
—(CH2)2
—C(═O)—
K337
N115
S


6-0800
—(CH2)2
—C(═O)—
K337
N116
S





















TABLE 203








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0801
—(CH2)2
—C(═O)—
K337
N128
S


6-0802
—(CH2)2
—C(═O)—
K337
N140
S


6-0803
—(CH2)2
—C(═O)—
K337
N150
S


6-0804
—(CH2)2
—C(═O)—
K337
N153
S


6-0805
—(CH2)2
—C(═O)—
K338
N1
S


6-0806
—(CH2)2
—C(═O)—
K338
N3
S


6-0807
—(CH2)2
—C(═O)—
K338
N9
S


6-0808
—(CH2)2
—C(═O)—
K338
N69
S


6-0809
—(CH2)2
—C(═O)—
K338
N12
S


6-0810
—(CH2)2
—C(═O)—
K338
N115
S


6-0811
—(CH2)2
—C(═O)—
K338
N116
S


6-0812
—(CH2)2
—C(═O)—
K338
N128
S


6-0813
—(CH2)2
—C(═O)—
K338
N140
S


6-0814
—(CH2)2
—C(═O)—
K338
N150
S


6-0815
—(CH2)2
—C(═O)—
K338
N153
S


6-0816
—(CH2)2
—C(═O)—
K377
N1
S


6-0817
—(CH2)2
—C(═O)—
K377
N3
S


6-0818
—(CH2)2
—C(═O)—
K377
N9
S


6-0819
—(CH2)2
—C(═O)—
K377
N69
S


6-0820
—(CH2)2
—C(═O)—
K377
N12
S


6-0821
—(CH2)2
—C(═O)—
K377
N115
S


6-0822
—(CH2)2
—C(═O)—
K377
N116
S


6-0823
—(CH2)2
—C(═O)—
K377
N128
S


6-0824
—(CH2)2
—C(═O)—
K377
N140
S


6-0825
—(CH2)2
—C(═O)—
K377
N150
S


6-0826
—(CH2)2
—C(═O)—
K377
N153
S


6-0827
—(CH2)2
—C(═O)—
K378
N1
S


6-0828
—(CH2)2
—C(═O)—
K378
N3
S


6-0829
—(CH2)2
—C(═O)—
K378
N9
S


6-0830
—(CH2)2
—C(═O)—
K378
N69
S


6-0831
—(CH2)2
—C(═O)—
K378
N12
S


6-0832
—(CH2)2
—C(═O)—
K378
N115
S





















TABLE 204








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0833
—(CH2)2
—C(═O)—
K378
N116
S


6-0834
—(CH2)2
—C(═O)—
K378
N128
S


6-0835
—(CH2)2
—C(═O)—
K378
N140
S


6-0836
—(CH2)2
—C(═O)—
K378
N150
S


6-0837
—(CH2)2
—C(═O)—
K378
N153
S


6-0838
—(CH2)2
—C(═O)—
K381
N1
S


6-0839
—(CH2)2
—C(═O)—
K381
N3
S


6-0840
—(CH2)2
—C(═O)—
K381
N9
S


6-0841
—(CH2)2
—C(═O)—
K381
N69
S


6-0842
—(CH2)2
—C(═O)—
K381
N12
S


6-0843
—(CH2)2
—C(═O)—
K381
N115
S


6-0844
—(CH2)2
—C(═O)—
K381
N116
S


6-0845
—(CH2)2
—C(═O)—
K381
N128
S


6-0846
—(CH2)2
—C(═O)—
K381
N140
S


6-0847
—(CH2)2
—C(═O)—
K381
N150
S


6-0848
—(CH2)2
—C(═O)—
K381
N153
S


6-0849
—(CH2)2
—C(═O)—
K382
N1
S


6-0850
—(CH2)2
—C(═O)—
K382
N3
S


6-0851
—(CH2)2
—C(═O)—
K382
N9
S


6-0852
—(CH2)2
—C(═O)—
K382
N69
S


6-0853
—(CH2)2
—C(═O)—
K382
N12
S


6-0854
—(CH2)2
—C(═O)—
K382
N115
S


6-0855
—(CH2)2
—C(═O)—
K382
N116
S


6-0856
—(CH2)2
—C(═O)—
K382
N128
S


6-0857
—(CH2)2
—C(═O)—
K382
N140
S


6-0858
—(CH2)2
—C(═O)—
K382
N150
S


6-0859
—(CH2)2
—C(═O)—
K382
N153
S


6-0860
—(CH2)2
—C(═O)—
K384
N1
S


6-0861
—(CH2)2
—C(═O)—
K384
N3
S


6-0862
—(CH2)2
—C(═O)—
K384
N9
S


6-0863
—(CH2)2
—C(═O)—
K384
N69
S


6-0864
—(CH2)2
—C(═O)—
K384
N12
S





















TABLE 205








Com-







pound


-G1-A3-
-A5-


No.
-A1-
-A2-
A4-G2
R2
X







6-0865
—(CH2)2
—C(═O)—
K384
N115
S


6-0866
—(CH2)2
—C(═O)—
K384
N116
S


6-0867
—(CH2)2
—C(═O)—
K384
N128
S


6-0868
—(CH2)2
—C(═O)—
K384
N140
S


6-0869
—(CH2)2
—C(═O)—
K384
N150
S


6-0870
—(CH2)2
—C(═O)—
K384
N153
S


6-0871
—(CH2)2
—C(═O)—
K396
N1
S


6-0872
—(CH2)2
—C(═O)—
K396
N3
S


6-0873
—(CH2)2
—C(═O)—
K396
N9
S


6-0874
—(CH2)2
—C(═O)—
K396
N69
S


6-0875
—(CH2)2
—C(═O)—
K396
N12
S


6-0876
—(CH2)2
—C(═O)—
K396
N115
S


6-0877
—(CH2)2
—C(═O)—
K396
N116
S


6-0878
—(CH2)2
—C(═O)—
K396
N128
S


6-0879
—(CH2)2
—C(═O)—
K396
N140
S


6-0880
—(CH2)2
—C(═O)—
K396
N150
S


6-0881
—(CH2)2
—C(═O)—
K396
N153
S


6-0882
—(CH2)2
—C(═O)—
K419
N1
S


6-0883
—(CH2)2
—C(═O)—
K419
N3
S


6-0884
—(CH2)2
—C(═O)—
K419
N9
S


6-0885
—(CH2)2
—C(═O)—
K419
N69
S


6-0886
—(CH2)2
—C(═O)—
K419
N12
S


6-0887
—(CH2)2
—C(═O)—
K419
N115
S


6-0888
—(CH2)2
—C(═O)—
K419
N116
S


6-0889
—(CH2)2
—C(═O)—
K419
N128
S


6-0890
—(CH2)2
—C(═O)—
K419
N140
S


6-0891
—(CH2)2
—C(═O)—
K419
N150
S


6-0892
—(CH2)2
—C(═O)—
K419
N153
S


6-0893
—(CH2)3
—C(═O)—N(CH2CH3)—
K2
N3
S


6-0894
—(CH2)3
—C(═O)—N(CH2CH3)—
K2
N9
S


6-0895
—(CH2)3
—C(═O)—N(CH2CH3)—
K2
N115
S


6-0896
—(CH2)3
—C(═O)—N(CH2CH3)—
K2
N128
S





















TABLE 206








Com-







pound


-G1-A3-
-A5-


No.
-A1-
-A2-
A4-G2
R2
X







6-0897
—(CH2)3
—C(═O)—N(CH2CH3)—
K2
N140
S


6-0898
—(CH2)3
—C(═O)—N(CH2CH3)—
K2
N144
S


6-0899
—(CH2)3
—C(═O)—N(CH3)—
K1
N3
S


6-0900
—(CH2)3
—C(═O)—N(CH3)—
K1
N9
S


6-0901
—(CH2)3
—C(═O)—N(CH3)—
K1
N115
S


6-0902
—(CH2)3
—C(═O)—N(CH3)—
K1
N128
S


6-0903
—(CH2)3
—C(═O)—N(CH3)—
K1
N140
S


6-0904
—(CH2)3
—C(═O)—N(CH3)—
K1
N144
S


6-0905
—(CH2)3
—C(═O)—NH—
K8
N3
S


6-0906
—(CH2)3
—C(═O)—NH—
K8
N9
S


6-0907
—(CH2)3
—C(═O)—NH—
K8
N115
S


6-0908
—(CH2)3
—C(═O)—NH—
K8
N128
S


6-0909
—(CH2)3
—C(═O)—NH—
K8
N140
S


6-0910
—(CH2)3
—C(═O)—NH—
K8
N144
S


6-0911
—(CH2)3
—NH—C(═O)—NH—
K11
N3
S


6-0912
—(CH2)3
—NH—C(═O)—NH—
K11
N9
S


6-0913
—(CH2)3
—NH—C(═O)—NH—
K11
N115
S


6-0914
—(CH2)3
—NH—C(═O)—NH—
K11
N128
S


6-0915
—(CH2)3
—NH—C(═O)—NH—
K11
N140
S


6-0916
—(CH2)3
—NH—C(═O)—NH—
K11
N144
S


6-0917
—(CH2)3
—C(═O)—NH—
K62
N3
S


6-0918
—(CH2)3
—C(═O)—NH—
K62
N9
S


6-0919
—(CH2)3
—C(═O)—NH—
K62
N115
S


6-0920
—(CH2)3
—C(═O)—NH—
K62
N128
S


6-0921
—(CH2)3
—C(═O)—NH—
K62
N140
S


6-0922
—(CH2)3
—C(═O)—NH—
K62
N144
S


6-0923
—(CH2)3
—C(═O)—N(CH3)—
K99
N3
S


6-0924
—(CH2)3
—C(═O)—N(CH3)—
K99
N9
S


6-0925
—(CH2)3
—C(═O)—N(CH3)—
K99
N115
S


6-0926
—(CH2)3
—C(═O)—
K315
N3
S


6-0927
—(CH2)3
—C(═O)—
K315
N9
S


6-0928
—(CH2)3
—C(═O)—
K315
N115
S





















TABLE 207








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-0929
—(CH2)3
—C(═O)—
K315
N128
S


6-0930
—(CH2)3
—C(═O)—
K315
N140
S


6-0931
—(CH2)3
—C(═O)—
K315
N144
S


6-0932
—(CH2)3
—C(═O)—
K316
N3
S


6-0933
—(CH2)3
—C(═O)—
K316
N9
S


6-0934
—(CH2)3
—C(═O)—
K316
N115
S


6-0935
—(CH2)3
—C(═O)—
K316
N128
S


6-0936
—(CH2)3
—C(═O)—
K316
N140
S


6-0937
—(CH2)3
—C(═O)—
K316
N144
S


6-0938
—(CH2)3
—C(═O)—
K318
N3
S


6-0939
—(CH2)3
—C(═O)—
K318
N9
S


6-0940
—(CH2)3
—C(═O)—
K318
N115
S


6-0941
—(CH2)3
—C(═O)—
K318
N128
S


6-0942
—(CH2)3
—C(═O)—
K319
N3
S


6-0943
—(CH2)3
—C(═O)—
K319
N9
S


6-0944
—(CH2)3
—C(═O)—
K319
N115
S


6-0945
—(CH2)3
—C(═O)—
K319
N128
S


6-0946
—(CH2)3
—C(═O)—
K332
N3
S


6-0947
—(CH2)3
—C(═O)—
K332
N9
S


6-0948
—(CH2)3
—C(═O)—
K332
N115
S


6-0949
—(CH2)3
—C(═O)—
K332
N128
S


6-0950
—(CH2)3
—C(═O)—
K336
N3
S


6-0951
—(CH2)3
—C(═O)—
K336
N9
S


6-0952
—(CH2)3
—C(═O)—
K336
N115
S


6-0953
—(CH2)3
—C(═O)—
K336
N128
S


6-0954
—(CH2)3
—C(═O)—
K337
N1
S


6-0955
—(CH2)3
—C(═O)—
K337
N3
S


6-0956
—(CH2)3
—C(═O)—
K337
N9
S


6-0957
—(CH2)3
—C(═O)—
K337
N115
S


6-0958
—(CH2)3
—C(═O)—
K337
N128
S


6-0959
—(CH2)2
—C(═O)—
K1
N128
S


6-0960
—(CH2)2
—C(═O)—
K2
N128
S





















TABLE 208








Com-







pound


-G1-A3-


No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0961
—(CH2)2
—C(═O)—
K8
N128
S


6-0962
—(CH2)2
—C(═O)—
K11
N128
S


6-0963
—(CH2)2
—C(═O)—
K99
N128
S


6-0964
—(CH2)2
—C(═O)—
K206
N128
S


6-0965
—(CH2)2
—C(═O)—O—
K1
N128
S


6-0966
—(CH2)2
—C(═O)—O—
K11
N128
S


6-0967
—(CH2)2
—C(═O)—O—
K99
N128
S


6-0968
—(CH2)2
—NH—C(═O)—O—
K99
N115
S


6-0969
—(CH2)2
—NH—C(═O)—O—
K5
N115
O


6-0970
—(CH2)2
—NH—C(═O)—O—
K5
N115
S


6-0971
—(CH2)2
—NH—C(═O)—NH—
K1
N115
S


6-0972
—(CH2)2
—NH—C(═O)—NH—
K4
N115
S


6-0973
—(CH2)2
—NH—C(═O)—NH—
K8
N115
S


6-0974
—(CH2)2
—NH—C(═O)—NH—
K11
N115
O


6-0975
—(CH2)2
—NH—C(═O)—NH—
K14
N115
S


6-0976
—(CH2)2
—NH—C(═O)—NH—
K32
N115
S


6-0977
—(CH2)2
—NH—C(═O)—NH—
K4
N115
O


6-0978
—(CH2)2
—NH—C(═S)—NH—
K11
N115
S


6-0979
—(CH2)2
—NH—S(═O)2
K1
N115
S


6-0980
—(CH2)2
—NH—S(═O)2
K11
N115
S


6-0981
—(CH2)2
—NH—S(═O)2
K99
N115
S


6-0982
—(CH2)2
—NH—
K1
N115
S


6-0983
—(CH2)2
—NH—
K2
N115
S


6-0984
—(CH2)2
—NH—
K3
N115
S


6-0985
—(CH2)2
—NH—
K99
N115
S


6-0986
—(CH2)2
—NH—
K100
N115
S


6-0987
—(CH2)2
—NH—
K101
N115
S


6-0988
—(CH2)2
—NH—
K102
N115
S


6-0989
—(CH2)2
—NH—
K103
N115
S


6-0990
—(CH2)2
—NH—
K105
N115
S


6-0991
—(CH2)2
—NH—
K106
N115
S


6-0992
—(CH2)3
—C(═O)—
K1
N128
S





















TABLE 209








Com-







pound


-G1-A3-


No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-0993
—(CH2)3
—C(═O)—
K2
N128
S


6-0994
—(CH2)3
—C(═O)—
K8
N128
S


6-0995
—(CH2)3
—C(═O)—
K11
N128
S


6-0996
—(CH2)3
—C(═O)—
K99
N128
S


6-0997
—(CH2)3
—C(═O)—
K206
N128
S


6-0998
—(CH2)3
—C(═O)—O—
K1
N128
S


6-0999
—(CH2)3
—C(═O)—O—
K11
N128
S


6-1000
—(CH2)3
—C(═O)—O—
K99
N128
S


6-1001
—(CH2)3
—NH—C(═O)—O—
K99
N115
S


6-1002
—(CH2)3
—NH—C(═O)—O—
K5
N115
O


6-1003
—(CH2)3
—NH—C(═O)—O—
K5
N115
S


6-1004
—(CH2)3
—NH—C(═O)—NH—
K1
N115
S


6-1005
—(CH2)3
—NH—C(═O)—NH—
K4
N115
S


6-1006
—(CH2)3
—NH—C(═O)—NH—
K8
N115
S


6-1007
—(CH2)3
—NH—C(═O)—NH—
K11
N115
O


6-1008
—(CH2)3
—NH—C(═O)—NH—
K14
N115
S


6-1009
—(CH2)3
—NH—C(═O)—NH—
K32
N115
S


6-1010
—(CH2)3
—NH—C(═O)—NH—
K4
N115
O


6-1011
—(CH2)3
—NH—C(═S)—NH—
K11
N115
S


6-1012
—(CH2)3
—NH—S(═O)2
K1
N115
S


6-1013
—(CH2)3
—NH—S(═O)2
K11
N115
S


6-1014
—(CH2)3
—NH—S(═O)2
K99
N115
S


6-1015
—(CH2)3
—NH—
K1
N115
S


6-1016
—(CH2)3
—NH—
K2
N115
S


6-1017
—(CH2)3
—NH—
K3
N115
S


6-1018
—(CH2)3
—NH—
K99
N115
S


6-1019
—(CH2)3
—NH—
K100
N115
S


6-1020
—(CH2)3
—NH—
K101
N115
S


6-1021
—(CH2)3
—NH—
K102
N115
S


6-1022
—(CH2)3
—NH—
K103
N115
S


6-1023
—(CH2)3
—NH—
K105
N115
S


6-1024
—(CH2)3
—NH—
K106
N115
S





















TABLE 210








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-1025
—(CH2)2
—NH—C(═O)—
K283
N4
S


6-1026
—(CH2)2
—NH—C(═O)—
K283
N9
S


6-1027
—(CH2)2
—NH—C(═O)—
K283
N10
S


6-1028
—(CH2)2
—NH—C(═O)—
K283
N41
S


6-1029
—(CH2)2
—NH—C(═O)—
K283
N69
S


6-1030
—(CH2)2
—NH—C(═O)—
K283
N81
S


6-1031
—(CH2)2
—NH—C(═O)—
K283
N115
S


6-1032
—(CH2)2
—NH—C(═O)—
K283
N109
S


6-1033
—(CH2)2
—NH—C(═O)—
K283
N116
S


6-1034
—(CH2)2
—NH—C(═O)—
K83
N128
S


6-1035
—(CH2)2
—NH—C(═O)—
K283
N144
S


6-1036
—(CH2)2
—NH—C(═O)—
K242
N4
S


6-1037
—(CH2)2
—NH—C(═O)—
K243
N9
O


6-1038
—(CH2)2
—NH—C(═O)—
K244
N10
S


6-1039
—(CH2)2
—NH—C(═O)—
K245
N41
S


6-1040
—(CH2)2
—NH—C(═O)—
K246
N69
S


6-1041
—(CH2)2
—NH—C(═O)—
K247
N81
S


6-1042
—(CH2)2
—NH—C(═O)—
K248
N84
S


6-1043
—(CH2)2
—NH—C(═O)—
K249
N109
S


6-1044
—(CH2)2
—NH—C(═O)—
K250
N116
S


6-1045
—(CH2)2
—NH—C(═O)—
K251
N128
S


6-1046
—(CH2)2
—NH—C(═O)—
K292
N144
S


6-1047
—(CH2)2
—NH—C(═O)—
K295
N4
S


6-1048
—(CH2)2
—NH—C(═O)—
K300
N9
S


6-1049
—(CH2)2
—NH—C(═O)—
K301
N10
S


6-1050
—(CH2)2
—NH—C(═O)—
K305
N41
S


6-1051
—(CH2)2
—NH—C(═O)—
K306
N69
S


6-1052
—(CH2)2
—NH—C(═O)—
K307
N81
S


6-1053
—(CH2)2
—NH—C(═O)—
K423
N84
S


6-1054
—(CH2)2
—NH—C(═O)—
K424
N109
S


6-1055
—(CH2)2
—NH—C(═O)—
K425
N116
S


6-1056
—(CH2)2
—NH—C(═O)—
K478
N128
S





















TABLE 211








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-1057
—(CH2)2
—NH—C(═O)—
K485
N144
S


6-1058
—(CH2)2
—NH—C(═O)—
K499
N4
S


6-1059
—(CH2)2
—NH—C(═O)—
K500
N9
S


6-1060
—(CH2)2
—NH—C(═O)—
K501
N10
S


6-1061
—(CH2)2
—NH—C(═O)—
K502
N41
S


6-1062
—(CH2)2
—NH—C(═O)—
K503
N69
S


6-1063
—(CH2)2
—NH—C(═O)—
K504
N81
S


6-1064
—(CH2)2
—NH—C(═O)—
K505
N84
S


6-1065
—(CH2)2
—NH—C(═O)—
K506
N109
S


6-1066
—(CH2)2
—NH—C(═O)—
K507
N116
S


6-1067
—(CH2)2
—NH—C(═O)—
K508
N128
S


6-1068
—(CH2)2
—NH—C(═O)—
K509
N144
S


6-1069
—(CH2)2
—NH—C(═O)—
K510
N4
S


6-1070
—(CH2)2
—NH—C(═O)—
K511
N9
S


6-1071
—(CH2)2
—NH—C(═O)—
K512
N10
S


6-1072
—(CH2)2
—NH—C(═O)—
K513
N41
S


6-1073
—(CH2)2
—NH—C(═O)—
K514
N69
S


6-1074
—(CH2)2
—NH—C(═O)—
K516
N81
S


6-1075
—(CH2)2
—NH—C(═O)—
K517
N84
S


6-1076
—(CH2)2
—NH—C(═O)—
K518
N109
S


6-1077
—(CH2)2
—NH—C(═O)—
K519
N116
S


6-1078
—(CH2)2
—NH—C(═O)—
K523
N128
S


6-1079
—(CH2)2
—NH—C(═O)—
K525
N144
S


6-1080
—(CH2)2
—NH—C(═O)—
K526
N4
S


6-1081
—(CH2)2
—NH—C(═O)—
K528
N9
S


6-1082
—(CH2)2
—NH—C(═O)—
K542
N10
S


6-1083
—(CH2)2
—NH—C(═O)—
K543
N41
S


6-1084
—(CH2)2
—NH—C(═O)—
K545
N69
S


6-1085
—(CH2)2
—NH—C(═O)—
K546
N81
S


6-1086
—(CH2)2
—NH—C(═O)—
K547
N84
S


6-1087
—(CH2)2
—NH—C(═O)—
K548
N109
S


6-1088
—(CH2)2
—NH—C(═O)—
K549
N116
S





















TABLE 212








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-1089
—(CH2)2
—NH—C(═O)—
K554
N128
S


6-1090
—(CH2)2
—NH—C(═O)—
K563
N144
S


6-1091
—(CH2)2
—NH—C(═O)—
K564
N4
S


6-1092
—(CH2)2
—NH—C(═O)—
K567
N9
S


6-1093
—(CH2)2
—NH—C(═O)—
K568
N10
S


6-1094
—(CH2)2
—NH—C(═O)—
K569
N41
S


6-1095
—(CH2)2
—NH—C(═O)—
K570
N69
S


6-1096
—(CH2)2
—NH—C(═O)—
K571
N81
S


6-1097
—(CH2)2
—NH—C(═O)—
K572
N84
S


6-1098
—(CH2)2
—NH—C(═O)—
K573
N109
S


6-1099
—(CH2)2
—NH—C(═O)—
K574
N116
S


6-1100
—(CH2)2
—NH—C(═O)—
K575
N128
S


6-1101
—(CH2)2
—NH—C(═O)—
K576
N144
S


6-1102
—(CH2)2
—NH—C(═O)—
K577
N4
S


6-1103
—(CH2)2
—NH—C(═O)—
K578
N9
S


6-1104
—(CH2)2
—NH—C(═O)—
K579
N10
S


6-1105
—(CH2)2
—NH—C(═O)—
K580
N41
S


6-1106
—(CH2)2
—NH—C(═O)—
K581
N69
S


6-1107
—(CH2)2
—NH—C(═O)—
K582
N81
S


6-1108
—(CH2)2
—NH—C(═O)—
K583
N84
S


6-1109
—(CH2)2
—NH—C(═O)—
K584
N109
S


6-1110
—(CH2)2
—NH—C(═O)—
K585
N116
S


6-1111
—(CH2)2
—NH—C(═O)—
K590
N128
S


6-1112
—(CH2)2
—NH—C(═O)—
K591
N144
S


6-1113
—(CH2)2
—NH—C(═O)—
K592
N4
S


6-1114
—(CH2)2
—NH—C(═O)—
K593
N9
S


6-1115
—(CH2)2
—NH—C(═O)—
K594
N10
S


6-1116
—(CH2)2
—NH—C(═O)—
K595
N41
S


6-1117
—(CH2)2
—NH—C(═O)—
K596
N69
S


6-1118
—(CH2)2
—NH—C(═O)—
K608
N81
S


6-1119
—(CH2)2
—NH—C(═O)—
K611
N84
S


6-1120
—(CH2)2
—NH—C(═O)—
K618
N109
S





















TABLE 213








Compound


-G1-A3-




No.
-A1-
-A2-
A4-G2
-A5-R2
X







6-1121
—(CH2)2
—NH—C(═O)—
K623
N116
S


6-1122
—(CH2)2
—NH—C(═O)—
K634
N128
S


6-1123
—(CH2)2
—NH—C(═O)—
K635
N144
S


6-1124
—(CH2)2
—NH—C(═O)—
K636
N4
S


6-1125
—(CH2)2
—NH—C(═O)—
K637
N9
S


6-1126
—(CH2)2
—NH—C(═O)—
K638
N10
S


6-1127
—(CH2)2
—NH—C(═O)—
K639
N41
S


6-1128
—(CH2)2
—NH—C(═O)—
K655
N69
S


6-1129
—(CH2)2
—NH—C(═O)—
K761
N81
S


6-1130
—(CH2)2
—NH—
K70
N84
S


6-1131
—(CH2)2
—NH—
K73
N109
S


6-1132
—(CH2)2
—NH—
K74
N116
S


6-1133
—(CH2)2
—NH—
K96
N128
S


6-1134
—(CH2)2
—NH—
K498
N144
S


6-1135
—(CH2)2
—NH—
K617
N4
S


6-1136
—(CH2)2
—NH—
K642
N9
S


6-1137
—(CH2)2
—NH—
K763
N10
S


6-1138
—(CH2)2
—NH—
K764
N41
S


6-1139
—(CH2)2
—NH—
K765
N69
S


6-1140
—(CH2)2
—NH—
K766
N81
S


6-1141
—(CH2)2
—NH—
K767
N84
S


6-1142
—(CH2)2
—NH—
K768
N109
S


6-1143
—(CH2)2
—NH—
K769
N116
S


6-1144
—(CH2)2
—NH—
K770
N128
S


6-1145
—(CH2)2
—NH—
K771
N144
S


6-1146
—(CH2)2
—NH—
K772
N4
S


6-1147
—(CH2)2
—NH—
K773
N9
S


6-1148
—(CH2)2
—NH—
K774
N10
S


6-1149
—(CH2)2
—NH—
K775
N41
S


6-1150
—(CH2)2
—NH—
K776
N69
S


6-1151
—(CH2)2
—NH—
K777
N81
S


6-1152
—(CH2)2
—NH—
K778
N84
S





















TABLE 214








Compound







No.
-A1-
-A2-
-G1-A3-A4-G2
-A5-R2
X







6-1153
—(CH2)2
—NH—
K779
N109
S


6-1154
—(CH2)2
—NH—
K780
N116
S


6-1155
—(CH2)2
—C(═O)—
K337
N144
S


6-1156
—(CH2)2
—C(═O)—
K337
N4
S


6-1157
—(CH2)2
—C(═O)—
K337
N10
S


6-1158
—(CH2)2
—C(═O)—
K321
N4
S


6-1159
—(CH2)2
—C(═O)—
K321
N9
S


6-1160
—(CH2)2
—C(═O)—
K321
N69
S


6-1161
—(CH2)2
—C(═O)—
K321
N12
S


6-1162
—(CH2)2
—C(═O)—
K321
N115
S


6-1163
—(CH2)2
—C(═O)—
K321
N116
S


6-1164
—(CH2)2
—C(═O)—
K321
N128
S


6-1165
—(CH2)2
—C(═O)—
K321
N140
S


6-1166
—(CH2)2
—C(═O)—
K321
N150
S


6-1167
—(CH2)2
—C(═O)—
K321
N153
S


6-1168
—(CH2)2
—C(═O)—
K315
N4
S


6-1169
—(CH2)2
—C(═O)—
K377
N4
S


6-1170
—(CH2)2
—C(═O)—
K379
N69
S


6-1171
—(CH2)2
—C(═O)—
K380
N12
S


6-1172
—(CH2)2
—C(═O)—
K383
N128
S


6-1173
—(CH2)2
—C(═O)—
K385
N150
S


6-1174
—(CH2)2
—C(═O)—
K386
N153
S


6-1175
—(CH2)2
—C(═O)—
K387
N4
S


6-1176
—(CH2)2
—C(═O)—
K388
N9
S


6-1177
—(CH2)2
—C(═O)—
K389
N69
S


6-1178
—(CH2)2
—C(═O)—
K390
N12
S


6-1179
—(CH2)2
—C(═O)—
K391
N115
S


6-1180
—(CH2)2
—C(═O)—
K392
N116
S


6-1181
—(CH2)2
—C(═O)—
K393
N128
S


6-1182
—(CH2)2
—C(═O)—
K394
N140
S


6-1183
—(CH2)2
—C(═O)—
K395
N150
S


6-1184
—(CH2)2
—C(═O)—
K741
N9
S









As preferred combinations of the groups mentioned as preferred examples of X, A1, A2, G1, A3, A4 and G2 in formula (I) according to the invention, there may be mentioned the following combinations 1) to 12).


1) In formula (I), when X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bonds in the form of A1-NHC(═O)-G1 and G1 is a divalent benzene group, the divalent benzene group as G1 is preferably substituted with one or more substituents selected from among those mentioned above as preferred examples of substituents for the substituted C6-14 aromatic hydrocarbon groups for G1.


2) In formula (I), when X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bonds in the form of A1-NHC(═O)-G1, G1 is a divalent benzene group and the divalent benzene group as G1 is not substituted, -A3-A4-G2 collectively represent a group other than hydrogen.


3) In formula (I), when X is sulfur, A1 is —(CH2)2— and A1-A2-G1 bonds in the form of A1-NHC(═O)-G1, G1 is a divalent monocyclic or bicyclic C3-9 aromatic heterocycle having in the ring 1 to 3 and preferably 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.


4) In formula (I), when X is sulfur, A1 is —(CH2)2— and A1-A2-G1 bonds in the form of A1-NHC(═O)-G1, G1 is a divalent monocyclic or bicyclic C29 aromatic heterocycle having in the ring 1 to 3 and preferably 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and the divalent aromatic heterocycle as G1 is more preferably substituted with one or more substituents selected from among those mentioned as preferred examples of substituents for substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms for G1.


5) In formula (I), when X is sulfur, A1 is —(CH2)2— and A1-A2-G1 bonds in the form of A1-NHC(═O)-G1, G1 is a divalent monocyclic or bicyclic C2-9 aromatic heterocycle having in the ring 1 to 3 and preferably 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and more preferably, when the divalent aromatic heterocycle as G1 is not substituted, -A3-A4-G2 collectively represent a group other than hydrogen.


6) In formula (I), when X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bonds in the form of A1-NH-G1 and G1 is a divalent benzene group, the divalent benzene group as G1 is preferably substituted with one or more substituents selected from among those mentioned above as preferred examples of substituents for the substituted C6-14 aromatic hydrocarbon groups for G1.


7) In formula (I), when X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bonds in the form of A1-NH-G1, G1 is a divalent benzene group and the divalent benzene group as G1 is not substituted, -A3-A4-G2 collectively represent a group other than hydrogen.


8) In formula (I), when X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bonds in the form of A1-NH-G1, and G1 is a divalent monocyclic or bicyclic C2-9 aromatic heterocycle having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, the aromatic heterocycle is preferably substituted with one or more substituents selected from among those mentioned as preferred examples of substituents for substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms for G1.


9) In formula (I), when X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bonds in the form of A1-NH-G1, G1 is a divalent monocyclic or bicyclic C2-9 aromatic heterocycle having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and the aromatic heterocycle is not substituted, -A3-A4-G2 collectively represent a group other than hydrogen.


10) In formula (I), when X is sulfur, A1 is —(CH2)2— and A1-A2-G1 bonds in the form of A1-C(═O)-G1, G1 is preferably a divalent monocyclic C2-9 heterocycle having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, such as pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine or piperazine, and G1 is preferably bonded to A1-C(═O)— at a nitrogen atom.


11) In formula (I), when X is sulfur, A1 is —(CH2)2— and A1-A2-G1 bonds in the form of A1-C(═O)-G1, G1 is preferably a divalent monocyclic C2-9 heterocycle having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, such as pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine or piperazine, and G1 is preferably bonded to A1-C(═O)— at a nitrogen atom, where the divalent monocyclic C2-9 heterocycle having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms for G1 is preferably substituted with one or more substituents selected from among those mentioned as preferred examples of substituents for substituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms for G1.


12) In formula (I), when X is sulfur, A1 is —(CH2)2— and A1-A2-G1 bonds in the form of A1-C(═O)-G1, G1 is preferably a divalent monocyclic C2-9 heterocycle having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, such as pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine or piperazine, and G1 is preferably bonded to A1-C(═O)— at a nitrogen atom, and when the divalent monocyclic C2-9 heterocycle having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms for G1 is not substituted, -A3-A4-G2 collectively represent a group other than hydrogen.


The preferred combinations for X, A1, A2, G1, A3, A4 and G2 in formula (I) according to the invention, described by 1) to 12) above, are also preferably in combination with the preferred groups represented by R2-A5-, that is, R2-A5 groups wherein A1 is a single bond and R2 is a substituted or unsubstituted monocyclic C3-5 aromatic heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.


The pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I) above exist as tautomers represented by the following formula (III):
embedded image

[wherein A1, A2, A3, A4, A5, G1, G2, R2 and X have the same definitions as A1, A2, A3, A4, A5, G1, G2, R2 and X in formula (I)],


and their tautomers are also encompassed within the scope of the present invention.


When the atoms forming the molecules of the pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I) are in an asymmetrical relationship, the optically active isomers and mixtures thereof in any proportion are also encompassed within the scope of the invention.


The pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I) may contain basic groups in their molecules, in which case they may be converted to medically acceptable acid-addition salts if necessary. As acids there may be mentioned inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid and carbonic acid, or organic acids such as acetic acid, citric acid, malic acid, oxalic acid, tartaric acid, lactic acid, maleic acid, fumaric acid and methanesulfonic acid.


The pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I) may also contain acidic groups in their molecules, in which case they may be converted to medically acceptable salts if necessary. As such salts there may be mentioned non-toxic cation salts, and specifically there may be mentioned salts with alkali metal ions such as Na+ and K+, alkaline earth metal ions such as Mg2+ and Ca2+, metal ions such as Al3+ and Zn2+, or organic bases such as ammonia, triethylamine, ethylenediamine, propanediamine, pyrrolidine, piperidine, piperazine, pyridine, lysine, choline, ethanolamine, N,N-dimethylethanolamine, 4-hydroxypiperidine, glucosamine and N-methylglucamine.


The definitions of A1, A2, A3, A4, A5, G1 G2 and R2 in formula (II) above are the same as the respective definitions of A1, A2, A3, A4, A5, G1, G2 and R2 in formula (I), and as examples there may be mentioned the same ones as mentioned above.


In formula (II), X1 represents chlorine, bromine, iodine, C2-10 acylthio, C2-8 alkoxymethylthio or C1-8 alkyl- or arylsulfonyloxy. As examples of C2-10 acylthio groups when X1 represents a C2-10 acylthio group, there may be mentioned acetylthio, trifluoroacetylthio, propionylthio, butyrylthio, isobutyrylthio, valerylthio, isovalerylthio, pivaloylthio, hexanoylthio, benzoylthio, phenylacetylthio, phenylpropionylthio and cinnamoylthio. As examples of C2-8 alkoxymethylthio groups when X1 represents a C2-8 alkoxymethylthio group, there may be mentioned methoxymethylthio, methoxyethoxymethylthio, t-butoxymethylthio, 2-(trimethylsilyl)ethoxymethylthio, benzyloxymethylthio, p-methoxybenzyloxymethylthio, p-nitrobenzyloxymethylthio, o-nitrobenzyloxymethylthio and 4-methoxyphenoxymethylthio. As examples of C1-8 alkyl- or arylsulfonyloxy groups when X1 represents a C1-8 alkyl- or arylsulfonyloxy group, there may be mentioned sulfonyloxy groups comprising optionally substituted C1-8 alkyl or aryl groups with sulfonyl groups, such as methylsulfonyloxy, trifluoromethylsulfonyloxy, ethylsulfonyloxy, propylsulfonyloxy, butylsulfonyloxy, t-butylsulfonyloxy, nonafluorobutylsulfonyloxy, phenylsulfonyloxy, p-bromophenylsulfonyloxy, p-toluylsulfonyloxy, benzylsulfonyloxy, α-phenethylsulfonyloxy and β-phenethylsulfonyloxy. As preferred examples of X1 there may be mentioned chlorine, bromine, iodine and trifluoromethylsulfonyloxy, with chlorine and trifluoromethylsulfonyloxy being particularly preferred.


The definitions of A1, A2, A3, A4, A5, G1, G2, R2 and X in formula (Ic) above are the same as the respective definitions of A1, A2, A3, A4, A5, G1 G2, R2 and X in formula (I), and as examples there may be mentioned the same ones as mentioned above.


In formula (Ic), R3 represents C2-10 acyl, C2—, alkoxymethyl or substituted or unsubstituted benzyl. As examples of C2-10 acyl groups when R3 represents a C2-10 acyl group, there may be mentioned acetyl, trifluoroacetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, pivaloyl, hexanoyl, benzoyl, phenylacetyl, phenylpropionyl and cinnamoyl. As examples of C2-10 alkoxymethyl groups when R3 represents a C2-10 alkoxymethyl group, there may be mentioned methoxymethyl, methoxyethoxymethyl, t-butoxymethyl, 2-(trimethylsilyl)ethoxymethyl, benzyloxymethyl, p-methoxybenzyloxymethyl, p-nitrobenzyloxymethyl, o-nitrobenzyloxymethyl and 4-methoxyphenoxymethyl. As examples of substituted or unsubstituted benzyl groups when R3 represents a substituted or unsubstituted benzyl group, there may be mentioned benzyl, p-methoxybenzyl, 3,4-dimethoxybenzyl, o-nitrobenzyl, p-nitrobenzyl and p-cyanobenzyl. As a preferred example for R3 there may be mentioned 2-(trimethylsilyl)ethoxymethyl.


A pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ia) above may be synthesized from a pyrrolo[3,2-d]pyrimidine derivative represented by formula (II), by the following Synthesis Scheme A.
embedded image

[wherein A1, A2, A3, A4, A5, G1, G2 and R2 have the same definitions as A1, A2, A3, A4, A5, G1, G2 and R2 in formula (I) above, and X10 represents chlorine, bromine, iodine or C1-8 alkyl- or arylsulfonyloxy].


Specifically, a pyrrolo[3,2-d]pyrimidine derivative (Ia-A) of the invention may be synthesized by reacting a pyrrolo[3,2-d]pyrimidine derivative (II-A) of the invention with thiourea. The thiooxo conversion with thiourea may be carried out, for example, by reaction in a solvent such as dioxane, ethanol or 2-propanol in a temperature range from 0-150° C.


Of the pyrrolo[3,2-d]pyrimidine derivatives represented by formula (II) above, a pyrrolo[3,2-d]pyrimidine derivative represented by the following formula (II-B) may be synthesized from a pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ib), by the following Synthesis Scheme (B).
embedded image

[wherein A1, A2, A3, A4, A5, G1, G2 and R2 have the same definitions as A1, A2, A3, A4, A5, G1, G2 and R2 in formula (I) above, and X10 is as defined above].


Specifically, when X10 is chlorine, for example, a pyrrolo[3,2-d]pyrimidine derivative (Ib-B) of the invention may be reacted with phosphorus oxychloride to synthesize a pyrrolo[3,2-d]pyrimidine derivative (II-B) of the invention. The chlorination reaction with phosphorus oxychloride may be conducted under ordinary chlorine reaction conditions, for example, in the presence or absence of triethylamine, 4-dimethylaminopyridine or dimethylaniline, in the presence or absence of a solvent such as acetonitrile, and in a temperature range from 0-150° C.


Or, for example, when X10 is a trifluoromethanesulfonyloxy group, the pyrrolo[3,2-d]pyrimidine derivative (Ib-B) of the invention may be reacted with trifluoromethanesulfonic anhydride to synthesize a pyrrolo[3,2-d]pyrimidine derivative (II-B) of the invention. The trifluoromethanesulfonyloxy conversion with trifluoromethanesulfonic anhydride may be conducted together with an amine such as pyridine or triethylamine, in the presence or absence of a solvent such as dichloromethane, and in a temperature range from 0-100° C.


Of the pyrrolo[3,2-d]pyrimidine derivatives represented by formula (Ib) above, a pyrrolo[3,2-d]pyrimidine derivative represented by (Ib-C2) below may be synthesized from a pyrrolo[3,2-d]pyrimidine derivative represented by (Ib-C1) below by the following Synthesis Scheme (C).
embedded image

[wherein A1, A2, A3, A4, A5, G1, G2 and X have the same definitions as A1, A2, A3, A4, A5, G1, G2 and X in formula (I) above, R2C1 represents chlorine or bromine, when A1 is —NR201— (where R201 has the same definition as R201 in formula (I)), R2C2 represents a group as defined for R2 of formula (I) except for fluorine, chlorine, bromine or iodine, and when A5 is a single bond, R2C2 represents a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, bonded to As at a nitrogen atom].


Specifically, a pyrrolo[3,2-d]pyrimidine derivative (Ib-C1) of the invention may be reacted with a primary or secondary amine to synthesize a pyrrolo[3,2-d]pyrimidine derivative (Ib-C2) of the invention. The aminating reaction with a primary or secondary amine may be carried out under solventless conditions or using a solvent such as dimethylsulfoxide, dimethylformamide, dioxane, tetrahydrofuran or toluene, in the presence or absence of a base such as pyridine, triethylamine, diisopropylethylamine, 4-dimethylaminopyridine or sodium carbonate, in the presence or absence of a transition metal complex catalyst produced by mixing a palladium salt such as palladium acetate with a phosphorus ligand such as triphenylphosphine, and in a temperature range of 0-150° C.


Of the pyrrolo[3,2-d]pyrimidine derivatives represented by formula (Ib), a pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ib-D2) below may be synthesized from a pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ib-D1) below by the following Synthesis Scheme (D).
embedded image

[wherein A1, A2, A3, A4, G1 and G2 have the same definitions as A1, A2, A3, A4, G1 and G2 in formula (I) above, R2D1 represents chlorine or bromine, and R2D2 represents a substituted or unsubstituted C6-14 aromatic hydrocarbon group].


Specifically, a pyrrolo[3,2-d]pyrimidine derivative (Ib-D1) of the invention may be reacted with, for example, a boronic acid derivative [R2D2-B(OH)2, where R2D2 has the same definition as in Synthesis Scheme (D) above], to synthesize a pyrrolo[3,2-d]pyrimidine derivative (Ib-D2) of the invention. The reaction with the boronic acid derivative may be conducted under conditions for an ordinary Suzuki reaction, for example, using a solvent such as 2-propanol and/or water, using palladium acetate or the like as a catalyst in the presence of an inorganic base such as sodium carbonate, with addition of triphenylphosphine or the like as a ligand, and in a temperature range of 0-150° C.


Of the pyrrolo[3,2-d]pyrimidine derivatives represented by formula (Ib), a pyrrolo[3,2-d]pyrimidine derivative represented by (Ib-E2) below may be synthesized from a pyrrolo[3,2-d]pyrimidine derivative represented by (Ib-E1) below, by the following Synthesis Scheme (E)).
embedded image

[wherein A1, A2, A3, A4, G1 and G2 have the same definitions as A1, A2, A3, A4, G1 and G2 in formula (I) above, and R2E represents chlorine, bromine or iodine].


Specifically, a pyrrolo[3,2-d]pyrimidine derivative (Ib-E1) of the invention may be subjected to halogenation reaction to obtain a pyrrolo[3,2-d]pyrimidine derivative (Ib-E2) of the invention. The halogenation reaction may be carried out, for example, using a halogenating reagent such as N-chlorosuccinimide, N-bromosuccinimide or the like, in the presence of a solvent such as dimethylformamide, dioxane or tetrahydrofuran, and in a temperature range of −20° C. to 150° C.


Of the pyrrolo[3,2-d]pyrimidine derivatives represented by formula (Ib), a pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ib-F) below may be synthesized from a pyrrole derivative represented by formula (IV-F) below, by the following Synthesis Scheme (F).
embedded image

[wherein A1, A2, A3, A4, G1 and G2 have the same definitions as A1, A2, A3, A4, G1 and G2 in formula (I) above, and R2F represents a group as defined for R2 of formula (I) except for fluorine, chlorine, bromine, iodine and substituted or unsubstituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, bonded at a nitrogen atom to the carbon of the pyrrole ring to which R2F is bonded].


Specifically, a pyrrole derivative represented by formula (IV-F) above may be subjected to cyclization reaction using formamidine or formamide, to synthesize a pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ib-F) of the invention. A cyclization reaction using formamidine may be conducted, for example, using formamidine acetate, using a solvent such as 2-propanol, and in a temperature range of 0-150° C. A cyclization reaction using formamide may be smoothly carried out, for example, using a base such as formamide or sodium methoxide, in the presence or absence of dimethylsulfoxide or dimethoxyethane, and in a temperature range of 0-150° C.


Of the pyrrolo[3,2-d]pyrimidine derivatives represented by formula (II), a pyrrolo[3,2-d]pyrimidine derivative represented by formula (II-G) below may be synthesized from a pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ib-G) below, by the following Synthesis Scheme (G).
embedded image

[wherein A1, A2, A3, A4, A5, G1, G2 and R2 have the same definitions as A1, A2, A3, A4, A5, G-, G2 and R2 in formula (I) above, and X11 represents a C2-10 acylthio or C2-8 alkoxymethylthio group].


Specifically, when X11 is an acylthio group, for example, a pyrrolo[3,2-d]pyrimidine derivative (Ib-G) of the invention may be reacted with an acyl halide to synthesize a pyrrolo[3,2-d]pyrimidine derivative (II-G) of the invention. The acylation reaction with the acyl halide may be conducted under ordinary acylating conditions, for example, in the presence of triethylamine or pyridine and in a temperature range of 0-100° C.


Also, when X11 is an alkoxymethylthio group, for example, a pyrrolo[3,2-d]pyrimidine derivative (Ib-G) of the invention may be reacted with an alkoxymethyl halide to synthesize a pyrrolo[3,2-d]pyrimidine derivative (II-G) of the invention. The alkoxymethylating reaction with the alkoxymethyl halide may be conducted under ordinary alkoxymethylating conditions, for example, in the presence of triethylamine or pyridine and in a temperature range of 0-100° C.


The groups A1, A2, A3, A4, A5, G1, G2 and/or R in a pyrrolo[3,2-d]pyrimidine derivative (II-G) of the invention obtained in this manner may be subjected to conversion reactions which are well known to those skilled in the art. The pyrrolo[3,2-d]pyrimidine derivative (II-G) may be subjected to hydrolysis reaction under neutral or basic conditions when X11 is acylthio or under acidic conditions with trifluoroacetic acid or the like when X“ ” is alkoxymethylthio, for conversion to a pyrrolo[3,2-d]pyrimidine derivative (Ib-G) of the invention.


A pyrrolo[3,2-d]pyrimidine derivative represented by formula (Ic) may be synthesized from a pyrrolo[3,2-d]pyrimidine derivative represented by formula (I-H) below, by the following Synthesis Scheme (H).
embedded image

[wherein A1, A2, A3, A4, A5, G1, G2 and R2 have the same definitions as A1, A2, A3, A4, A5, G1, G2 and R2 in formula (I) above, and R3 represents a C2-10 acyl, C2-10 alkoxymethyl or substituted or unsubstituted benzyl group].


Specifically, when R3 is an acyl group, for example, a pyrrolo[3,2-d]pyrimidine derivative (I-H) of the invention may be reacted with an acyl halide to synthesize a pyrrolo[3,2-d]pyrimidine derivative (Ic-H) of the invention. The acylation reaction with the acyl halide may be conducted under ordinary acylating conditions, for example, in the presence of triethylamine or pyridine and in a temperature range of 0-100° C.


Also, when R3 is an alkoxymethyl or benzyl group, for example, a pyrrolo[3,2-d]pyrimidine derivative (1-H) of the invention may be reacted with an alkoxymethyl halide or benzyl halide to synthesize a pyrrolo[3,2-d]pyrimidine derivative (Ic-H) of the invention. The reaction with the alkoxymethyl halide or benzyl halide may be conducted, for example, in the presence of sodium hydride, and in a temperature range of 0-100° C.


The groups A1, A2, A3, A4, A5, G1, G2 and/or R2 in a pyrrolo[3,2-d]pyrimidine derivative (Ic-H) of the invention obtained in this manner may be subjected to conversion reactions which are well known to those skilled in the art. The pyrrolo[3,2-d]pyrimidine derivative (Ic-H) may be subjected to hydrolysis reaction under neutral or basic conditions when R3 is an acyl group, to hydrolysis reaction under acidic conditions with trifluoroacetic acid or the like when R3 is an alkoxymethyl group, or to hydrogenation reaction when R3 is a benzyl group, for conversion to a pyrrolo[3,2-d]pyrimidine derivative (1-H) of the invention.


When the pyrrolo[3,2-d]pyrimidine derivatives of the invention synthesized according to Synthesis Schemes (A), (B), (C), (D), (E), (F), (G) and (H) above have easily convertible substituents such as alkoxycarbonyl, acyloxy, aromatic nitro groups or the like, they may be converted to pyrrolo[3,2-d]pyrimidine derivatives of the invention having groups such as carboxyl, hydroxy, amino or the like by carrying out reactions well known to those skilled in the art.


When the pyrrolo[3,2-d]pyrimidine derivatives of the invention synthesized according to Synthesis Schemes (A), (B), (C), (D), (E), (F), (G) and (H) above have carboxyl groups, they may be converted to pyrrolo[3,2-d]pyrimidine derivatives of the invention having groups such as alkoxycarbonyl, carbamoyl or N-alkylcarbamoyl, by carrying out condensation reactions well known to those skilled in the art.


When the pyrrolo[3,2-d]pyrimidine derivatives of the invention synthesized according to Synthesis Schemes (A), (B), (C), (D), (E), (F), (G) and (H) above have amino groups, they may be converted to pyrrolo[3,2-d]pyrimidine derivatives of the invention having groups such as acylamino or alkylsulfonylamino, by carrying out condensation reactions well known to those skilled in the art.


Alternatively when the derivatives have amino groups, they may be converted to pyrrolo[3,2-d]pyrimidine derivatives of the invention having groups such as monoalkylamino or dialkylamino, by carrying out reductive alkylation reactions well known to those skilled in the art.


When the pyrrolo[3,2-d]pyrimidine derivatives of the invention synthesized according to Synthesis Schemes (A), (B), (C), (D), (E), (F), (G) and (H) above have hydroxy groups, they may be converted to pyrrolo[3,2-d]pyrimidine derivatives of the invention having groups such as acyloxy or the like, by carrying out condensation reactions well known to those skilled in the art.


When the pyrrolo[3,2-d]pyrimidine derivatives of the invention synthesized according to Synthesis Schemes (A), (B), (C), (D), (E), (F), (G) and (H) above have formyl groups, they may be converted to pyrrolo[3,2-d]pyrimidine derivatives of the invention having groups such as alkylaminomethyl or the like, by carrying out reductive alkylation reactions well known to those skilled in the art.


A pyrrole derivative represented by formula (IV-F) above used as the starting material in a synthesis scheme for a pyrrolo[3,2-d]pyrimidine derivative represented by formula (I) may be synthesized, for example, from an alkoxymethylenemalononitrile derivative represented by formula (VI-J) below, by the following Synthesis Scheme (J).
embedded image

[wherein R1 is a group that can be converted to A1-A2-G1-A3-A4-G2 in formula (I), and R2J represents a group as defined for R2 of formula (I) except for fluorine, chlorine, bromine, iodine and substituted or unsubstituted heterocyclic groups having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, bonded at a nitrogen atom to the carbon of the pyrrole ring to which R2J is bonded].


Specifically, an alkoxymethylenemalononitrile (VI-J) may be reacted with a primary amine (R1—NH2, where R1 has the same definition as R1 in Synthesis Scheme (J) above), to synthesize an aminomethylenemalononitrile derivative (V-J). This aminomethylenemalononitrile derivative (V-J) may be reacted with methyl bromoacetate in the presence of a base and then cyclized to synthesize a pyrrole derivative (IV-J).


The reaction between the alkoxymethylenemalononitrile derivative (VI-J) and the primary amine may be conducted, for example, using a solvent such as methanol or ethanol, and in a temperature range of 0-100° C.


The reaction between the aminomethylenemalononitrile derivative (V-J) and the methyl bromoacetate may be conducted, for example, using potassium carbonate or the like as a base, using a solvent such as acetonitrile, and in a temperature range of 0-150° C.


Pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I) obtained in the manner described above have effects of inhibiting GSK-3 activity, and may therefore be used as clinically effective prophylactic and/or treatment agents for GSK-3 activity inhibition. As conditions that are treatable with GSK-3 activity inhibitors there may be mentioned diabetes, diabetes complications, atherosclerosis, hypertension, obesity, syndrome X, Alzheimer's disease, neurodegenerative diseases (AIDS encephalopathy, Huntington's disease, Parkinson's disease, cerebral ischemia), manic depression, traumatic encephalopathy, alopecia, inflammatory diseases, cancer, immune deficiency and the like.


The pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I) and their medically acceptable salts may be prepared as pharmaceutical compositions using pharmaceutically acceptable carriers and/or diluents. The pharmaceutical compositions may be administered either orally or parenterally, in any of various dosage forms. As modes of parenteral administration there may be mentioned, for example, intravenous, subcutaneous, intramuscular, percutaneous and rectal administration.


As oral dosage forms there may be mentioned, for example, tablets, pills, granules, powders, liquids, suspensions, syrups, capsules and the like.


Tablets may be molded by ordinary methods using pharmaceutically acceptable carriers such as an excipients, binders, disintegrators and the like. Pills, granules and powders may also be molded by ordinary methods using excipients and the like, as for tablets.


The preparation method for a liquid, suspension or syrup may be an ordinary method using a glycerin ester, alcohol, water and/or vegetable oil. A preparation method for capsules may entail filling granules, powder or a liquid into capsules of gelatin or the like.


For a parenteral agent to be administered intravenously, subcutaneously or intramuscularly, the administered agent may be in the form of an injection.


Injections include, for example, those dissolved in water-soluble liquids such as physiological brine, and those dissolved in non-water-soluble liquids comprising organic esters such as propylene glycol, polyethylene glycol, vegetable oils, and the like.


The dosage form for percutaneous administration may be an ointment, cream or the like. An ointment may be prepared by admixture with a fat or oil, vaseline or the like, and a cream may be prepared by admixture with an emulsifier.


If necessary, pharmaceutically acceptable carriers such as isotonizing agents, preservatives, antiseptics, humidifiers, buffers, emulsifiers, dispersing agents, stabilizers and the like may be added to these various preparation forms.


The various preparation forms may also, if necessary, be sterilized by appropriate means such as filtration using a bacteria capturing filter or addition of antimicrobial agents.


The dosage of a pyrrolo[3,2-d]pyrimidine derivative represented by formula (I) or a medically acceptable salt thereof will differ depending on the type of condition, the route of administration and the symptoms, age, gender and body weight of the patient, but in most cases it may be about 1-500 mg/day/patient for oral administration.


In the case of parenteral administration such as intravenous, subcutaneous, intramuscular or percutaneous administration, it may be about 0.1-100 mg/day/patient.


EXAMPLES

The invention will now be explained in greater detail by the following examples, with the understanding that the scope of the invention is not in any sense restricted by these examples. The numbers assigned to each of the compounds in the examples correspond to the Compound Nos. of the compounds listed as preferred examples in Tables 1 to 214 above.


The “HPLC Retention time” data for the compounds synthesized in the examples are the retention times (minutes) for the compounds in HPLC analysis carried out under the following conditions.


HPLC (High Performance Liquid Chromatography) Conditions System: Hewlett-Packard 1100 HPLC




  • Column: Cadenza CD-C18 (Imtakt) 100 mm×4.6 mmφ

  • Solvent:
    • A: H2O/acetonitrile=95/5
      • (0.05% trifluoroacetic acid)
    • B: H2O/acetonitrile=5/95
      • (0.05% trifluoroacetic acid)

  • Flow rate: 1.0 mL/min

  • Gradient:

  • 0-1 min, solvent B: 10% solvent A: 90% 1-14 min, solvent B: 10%→100% solvent A: 90%→0% 14-16 min, solvent B: 100% solvent A: 0%

  • Calculation of purity: Area % of UV absorption (254 nm)



Reference Example 1
Synthesis of (1-hydroxy-2-phenylethylidene)methane-1,1-dicarbonitrile



embedded image


A suspension of sodium hydride (12.5 g) in tetrahydrofuran (188 mL) was cooled to 0° C. A solution of malononitrile (10.3 g) in tetrahydrofuran (65 mL) was added dropwise thereto over a period of 1 hour. After stirring the reaction mixture at room temperature for 1 hour, it was again cooled to 0° C., and then a solution of 2-phenylacetyl chloride (24.2 g) in tetrahydrofuran (52 mL) was added dropwise thereto over a period of 80 minutes. After stirring the reaction mixture at room temperature for 49 hours, water (26 mL) was added to the reaction solution. The solvent was distilled off under reduced pressure, diethyl ether (130 mL) and 1 mol/L hydrochloric acid (130 mL) were added to the residue and extraction was performed with diethyl ether. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure to obtain the title compound as a crude product (31.2 g).


[Hydroxy(1-methylpyrrol-2-yl)methylene]methane-1,1-dicarbonitrile was synthesized in the same manner using malononitrile and 1-methylpyrrole-2-carbonylchloride. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 174.2 (M++H, C9H7N3O)


(2-Furylhydroxymethylene)methane-1,1-dicarbonitrile was obtained in the same manner using malononitrile and furan-2-carbonylchloride. The ESI/MS data for this compound are shown below.


ESI/MS m/e: (M++H, C8H4N2O2)


[Hydroxy(3-methyl(2-furyl))methylene]methane-1,1-dicarbonitrile was obtained in the same manner using malononitrile and 3-methylfuran-2-carbonylchloride. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CD3OD)δ(ppm): 2.29 (s, 3H), 6.34 (s, 1H), 7.41 (s, 1H).


ESI/MS m/e: (M++H, C9H6N2O2)


[Hydroxy(3-methyl(2-thienyl))methylene]methane-1,1-dicarbonitrile was obtained in the same manner using malononitrile and 3-methylthiophene-2-carbonylchloride. The ESI/MS data for this compound are shown below.


ESI/MS m/e: (M++H, C9H6N2O)


[(3-Chloro(2-thienyl))hydroxymethylene]methane-1,1-dicarbonitrile was obtained in the same manner using malononitrile and 3-chlorothiophene-2-carbonylchloride. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CD3OD) δ (ppm): 6.92 (d, J=5.1, 1H), 7.51 (d, J=5.4, 1H)


ESI/MS m/e: (M++H, COH3ClN2OS)


Reference Example 2
Synthesis of (1-methoxy-2-phenylethylidenemethane-1,1-dicarbonitrile



embedded image


A suspension of sodium hydride (6.3 g) in tetrahydrofuran (100 mL) was cooled to 0° C. A solution of the crude (1-hydroxy-2-phenylethylidene)methane-1,1-dicarbonitrile (31.2 g) in tetrahydrofuran (130 mL) was added dropwise thereto over a period of 30 minutes. After stirring the reaction mixture at room temperature for 20 minutes, it was cooled to 0° C., and then a solution of dimethyl sulfate (19.7 g) in tetrahydrofuran (100 mL) was added dropwise thereto over a period of 1 hour. The mixture was heated to reflux for 21 hours and then cooled to room temperature, and the solvent was distilled off under reduced pressure. Ethyl acetate (100 mL) and aqueous saturated sodium bicarbonate (100 mL) were added to the residue and extraction was performed with ethyl acetate. The organic layer was washed with saturated brine, and then the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane/ethyl acetate=2/1) to obtain the title compound (4.6 g, 15%) as a brown solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 4.02 (s, 2H), 4.03 (s, 3H), 7.24-7.42 (m, 5H).


ESI/MS m/e: 199.2 (M++H, C12HON2O)


[Methoxy(1-methylpyrrol-2-yl)methylene]methane-1,1-dicarbonitrile was synthesized in the same manner using [hydroxy(1-methylpyrrol-2-yl)methylene]methane-1,1-dicarbonitrile. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 188.1 (M++H, CIoH9N3O)


(2-Furylmethoxymethylene)methane-1,1-dicarbonitrile was synthesized in the same manner using (2-furylhydroxymethylene)methane-1,1-dicarbonitrile. The ESI/MS data for this compound are shown below.


ESI/MS m/e: (M++H, C9H6N2O2)


[Methoxy(3-methyl(2-furyl))methylene]methane-1,1-dicarbonitrile was synthesized in the same manner using [hydroxy(3-methyl(2-furyl))methylene]methane-1,1-dicarbonitrile. The ESI/MS data for this compound are shown below.


ESI/MS m/e: (M++H, C10H8N2O2)


[Methoxy(3-methyl(2-thienyl))methylene]methane-1,1-dicarbonitrile was obtained in the same manner using [hydroxy(3-methyl(2-thienyl))methylene]methane-1,1-dicarbonitrile. The ESI/MS data for this compound are shown below.


ESI/MS m/e: (M++H, C10H8N2OS)


[(3-Chloro(2-thienyl))methoxymethylene]methane-1,1-dicarbonitrile was obtained in the same manner using [(3-chloro(2-thienyl))hydroxymethylene]methane-1,1-dicarbonitrile. The ESI/MS data for this compound are shown below.


ESI/MS m/e: (M++H, C9H5ClN2OS)


(1-Methoxy-3-phenylpropylidene)methane-1,1-dicarbonitrile was synthesized using malononitrile and 3-phenylpropionyl chloride, in the same manner as Reference Example 1 and Reference Example 2. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 2.91-2.98 (m, 4H), 4.07 (s, 3H), 7.19-7.36 (m, 5H).


(1-Methoxy-3-methylbutylidene)methane-1,1-dicarbonitrile was synthesized in the same manner as Reference Example 1 and Reference Example 2 using malononitrile and isopentanoyl chloride. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ(ppm): 1.03-1.09 (m, 6H), 1.99-2.13 (m, 1H), 2.54 (d, J=7.6, 2H), 4.15 (s, 3H).


(Cyclopropylmethoxymethylene)methane-1,1-dicarbonitrile was synthesized in the same manner as Reference Example 1 and Reference Example 2 using malononitrile and cyclopropanecarbonyl chloride. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 1.10-1.22 (m, 4H), 2.10-2.22 (m, 1H), 4.27 (s, 3H).


[(2-Bromophenyl)methoxymethylene]methane-1,1-dicarbonitrile was synthesized in the same manner as Reference Examples 1 and 2 using 2-bromobenzoyl chloride. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 263.0, 265.3 (M+H, C11H7BrN2O)


Reference Example 3
Synthesis of methyl 3-amino-4-cyanopyrrole-2-carboxylate



embedded image


After dissolving dimethyl 2-aminomalonate (25.0 g) in methanol (300 mL), a solution of ethoxymethylene-malononitrile (16.6 g) and triethylamine (15.1 g) in methanol (50 mL) was added. The reaction mixture was stirred at room temperature for 18 hours and then cooled to 0° C., and a mixed solution of 28% sodium methoxide/methanol (31.5 g) and methanol (50 mL) was added dropwise thereto over a period of 10 minutes. The reaction mixture was stirred at room temperature for 49 hours and then cooled to 0° C., and acetic acid (10.3 g) was added. The solvent was distilled off under reduced pressure, ethyl acetate (200 mL) and water (200 mL) were added to the residue and extraction was performed with ethyl acetate. A saturated aqueous sodium bicarbonate solution was added to the organic layer until it exhibited a pH of 8, and extraction was performed with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=1/1) to obtain the title compound (13.7 g, 61%) as a brown solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.77 (s, 3H), 5.52 (brs, 2H), 7.29 (s, 1H), 11.70 (brs, 1H).


ESI/MS m/e: 199.2 (M++H, C7H7N3O2)


Reference Example 4
Synthesis of N-{2-[(2,2-dicyanovinyl)amino]ethyl}(4-fluorophenyl)carboxamide



embedded image


After adding acetonitrile (100 mL) and ethoxymethylenemalononitrile (4.5 g) to N-(2-aminoethyl)(4-fluorophenyl)carboxamide hydrochloride (8.3 g), a solution of triethylamine (4.5 g) in acetonitrile (20 mL) was added thereto. After stirring at room temperature for 15 minutes, the solvent was distilled off under reduced pressure, water and ethyl acetate were added to the residue, and the mixture was stirred. The precipitated solid was filtered out to obtain the crude title compound (6.5 g) as a brown solid.


ESI/MS m/e: 259.2 (M++H, C13H11FN4O)


Reference Example 5
Synthesis of (methoxyphenylmethylene)methane-1,1-dicarbonitrile



embedded image


Trimethylorthobenzoic acid (5.01 g) and malononitrile (2.18 g) were added to acetic anhydride (50 mL) and the mixture was heated to reflux for 4 hours. After confirming complete consumption of the trimethylorthobenzoic acid by thin-layer chromatography (hexane/ethyl acetate=3/1), the mixture was cooled to room temperature and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=5/1→3/1) to obtain the title compound (3.44 g, yield: 68%) as a light yellow oil. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 3.93 (s, 3H), 7.48-7.65 (m, 5H).


ESI/MS m/e: 185.0 (M++H, C11H8N2O)


Reference Example 6
Synthesis of [(methylaminol phenylmethylene]methane-1,1-dicarbonitrile



embedded image


A 40% methanol solution (15 mL) containing methylamine was added to a solution of (methoxyphenylmethylene)methane-1,1-dicarbonitrile (3.44 g) in ethanol (50 mL), and the mixture was stirred for 10 minutes at room temperature and then for 1 hour while heating to reflux. After cooling to room temperature, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=3/1→1/1) to obtain the title compound (2.74 g, yield: 80%) as a white solid. The NMR and ESI/MS data for this compound are shown below.


H-NMR (400 MHz, CDCl3) δ (ppm): 2.65 (d, J=4.9 Hz, 1.3H), 3.21 (d, J=5.1 Hz, 1.7H), 7.44-7.58 (m, 5H), 8.97-9.03 (m, 2H).


ESI/MS m/e: 184.2 (M++H, C11H9N3)


[(Methylamino)methylene]methane-1,1-dicarbonitrile was synthesized in the same manner using (ethoxymethylene)methane-1,1-dicarbonitrile and methylamine. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 1.95 (s, 3H), 7.87 (s, 1H), 8.94 (brs, 1H).


[(Methylamino)ethylidene)methane-1,1-dicarbonitrile was synthesized in the same manner using (ethoxyethylidene)methane-1,1-dicarbonitrile and methylamine. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 1.08 (s, 0.8H), 2.15 (s, 2.2H), 2.89 (s, 2.1H), 3.07 (s, 0.9H), 8.69 (brs, 1H).


{[Benzylamino]methylene}methane-1,1-dicarbonitrile was synthesized in the same manner using (ethoxymethylene)methane-1,1-dicarbonitrile and benzylamine. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 1.44 (s, 2H), 7.28-7.39 (s, 5H), 8.09 (s, 1H), 9.60 (brs, 1H).


{[(4-Chlorophenyl)amino]methylene}methane-1,1-dicarbonitrile was synthesized in the same manner using (ethoxymethylene)methane-1,1-dicarbonitrile and 4-chloroaniline. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 7.44 (s, 4H), 8.50 (s, 1H), 11.15 (s, 1H).


N-(2-{[2,2-dicyano-1-(1-methylpyrrol-2-yl)vinyl]amino}ethyl)(tert-butoxy)carboxamide was synthesized in the same manner using [methoxy(1-methylpyrrol-2-yl)methylene]methane-1,1-dicarbonitrile and tert-butyl N-(2-aminoethyl)carbamate. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 316.1 (M++H, C16H21N5O2)


N-{2-[(2,2-dicyano-1-(2-furyl)vinyl)amino]ethyl}(tert-butoxy)carboxamide was synthesized in the same manner using (2-furylmethoxymethylene)methane-1,1-dicarbonitrile and tert-butyl N-(2-aminoethyl)carbamate. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 303.4 (M++H, C15H18N4O3)


N-(2-{[2,2-dicyano-1-(3-methyl(2-furyl))vinyl]amino}ethyl)(tert-butoxy)carboxamide was synthesized in the same manner using [methoxy(3-methyl(2-furyl))methylene]methane-1,1-dicarbonitrile and tert-butyl N-(2-aminoethyl)carbamate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CD3OD) δ (ppm): 1.43(S, 9H), 2.23 (brs, 3H), 3.23-3.34 (brs, 4H), 3.75 (brs, 1H), 6.52 (s, 1H), 7.70 (brs, 1H).


ESI/MS m/e: 317.4 (M++H, C16H20N4O3)


N-(2-{[2,2-dicyano-1-(3-methyl(2-thienyl))vinyl) aminoethyl)(tert-butoxy)carboxamide was obtained in the same manner using [methoxy(3-methyl(2-thienyl))methylene]methane-1,1-dicarbonitrile and tert-butyl N-(2-aminoethyl)carbamate. The ESI/MS data for this compound are shown below.


ESI/MS m/e: (M++H, C16H20N4O2S) (tert-Butoxy)-N-(2-{[1-(3-chloro(2-thienyl))-2,2-dicyanovinyl]aminolethyl)carboxamide was obtained in the same manner using [(3-chloro(2-thienyl))methoxymethylene) methane-1,1-dicarbonitrile and tert-butyl N-(2-aminoethyl)carbamate. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 352.9 (M++H, C15H17ClN4O2S)


N-{3-[(2,2-dicyano-1-(2-furyl)vinyl)amino]propyl}(tert-butoxy)carboxamide was synthesized in the same manner using (2-furylmethoxymethylene)methane-1,1-dicarbonitrile and tert-butyl N-(2-aminopropyl)carbamate. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 317.3 (M++H, C16H20N4O3)


Reference Example 7
Synthesis of methyl 3-amino-4-cyano-1-methyl-5-phenylpyrrole-2-carboxylate



embedded image


[(Methylamino)phenylmethylene]methane-1,1-dicarbonitrile (3.00 g) and anhydrous potassium carbonate (4.51 g) were added to acetonitrile (200 mL). A solution of methyl bromoacetate (3.09 mL) in acetonitrile (10 mL) was added thereto, and the mixture was heated to reflux for 3 hours. After cooling the mixture to room temperature, it was allowed to stand, the supernatant was separated by decantation, and the solvent was distilled off under reduced pressure. The concentrated residue was combined with the solid portion remaining after decantation, ethyl acetate and water were added, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was recrystallized (hexane/ethyl acetate=1/1) to obtain the title compound (1.15 g) as a white solid. The recrystallized residue was purified by silica gel column chromatography (hexane/ethyl acetate=3/1→2/1) to obtain the title compound (1.21 g, (total of 2.36 g with the recrystallized portion), yield: 56%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 3.72 (s, 3H), 3.89 (s, 3H), 4.95 (brs, 2H), 7.42-7.51 (m, 5H).


ESI/MS m/e: 256.2 (M++H, C14H13N3O2)


Methyl 3-amino-4-cyano-1-methylpyrrole-2-carboxylate was synthesized in the same manner using [(methylamino)methylene]methane-1,1-dicarbonitrile. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 2.80 (s, 3H), 3.86 (s, 3H), 4.86 (brs, 2H), 5.91 (s, 1H).


Methyl 3-amino-4-cyano-1,5-dimethylpyrrole-2-carboxylate was synthesized in the same manner using [(methylamino)ethylidene)methane-1,1-dicarbonitrile. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 2.30 (s, 3H), 3.71 (s, 3H), 3.84 (s, 3H), 4.84 (brs, 2H).


Methyl 3-amino-4-cyano-1-benzylpyrrole-2-carboxylate was synthesized in the same manner using {[benzylamino]methylene}methane-1,1-dicarbonitrile. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 3.79 (s, 3H), 4.91 (brs, 2H), 5.37 (s, 2H), 6.98 (s, 1H), 7.10-7.12 (m, 2H), 7.30-7.36 (m, 3H).


Methyl 3-amino-1-(4-chlorophenyl)-4-cyanopyrrole-2-carboxylate was synthesized in the same manner using {[(4-chlorophenyl)amino]methylene}methane-1,1-dicarbonitrile. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 3.68 (s, 3H), 5.03 (brs, 2H), 7.04 (s, 1H), 7.18-7.20 (m, 2H), 7.39-7.41 (m, 2H).


Methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino]ethyl}-4-cyano-5-(1-methylpyrrol-2-yl)pyrrole-2-carboxylate was synthesized in the same manner using N-(2-{[2,2-dicyano-1-(1-methylpyrrol-2-yl)vinyl]amino}ethyl)(tert-butoxy)carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 388.3 (M++H, C19H25N5O4)


Methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino]ethyl}-4-cyano-5-(2-furyl)pyrrole-2-carboxylate was synthesized in the same manner using N-{2-[(2,2-dicyano-1-(2-furyl)vinyl)aminoethyl}(tert-butoxy)carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 375.3 (M++H, C18H22N4O5)


Methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino) ethyl}-4-cyano-5-(3-methyl(2-furyl))pyrrole-2-carboxylate was synthesized in the same manner using N-(2-{[2,2-dicyano-1-(3-methyl(2-furyl))vinyl]amino}ethyl)(tert-butoxy)carboxamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHZ, CD3OD) δ (ppm): 1.33 (s, 9H), 2.15 (s, 3H), 3.24-3.34 (m, 2H), 3.87 (s, 3H), 4.28 (m, 2H), 6.48 (s, 1H), 7.62 (s, 1H).


ESI/MS m/e: 389.4 (M++H, C19H24N4O5)


Methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino) ethyl}-4-cyano-5-(3-methyl(2-thienyl))pyrrole-2-carboxylate was synthesized in the same manner using N-(2-{[2,2-dicyano-1-(3-methyl(2-thienyl))vinyl]amino}ethyl)(tert-butoxy)carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: (M++H, C19H24N4O4S) Methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino]ethyl}-5-(3-chloro(2-thienyl))-4-cyanopyrrole-2-carboxylate was synthesized in the same manner using (tert-butoxy)-N-(2-{[1-(3-chloro(2-thienyl))-2,2-dicyanovinyl]amino}ethyl)carboxamide. The ESIIMS data for this compound are shown below.


ESI/MS m/e: 425.2 (M++H, C18H21ClN4O4S)


Methyl 3-amino-4-cyano-1-{2-((4-fluorophenyl)carbonylamino]ethyl}pyrrole-2-carboxylate was synthesized in the same manner using N-{2-[(2,2-dicyanovinyl)amino]ethyl}(4-fluorophenyl)carboxamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.52 (m, 2H), 3.74 (s, 3H), 4.30 (m, 2H), 5.83 (brs, 2H), 7.29 (m, 2H), 7.45 (s, 1H), 7.84 (m, 2H), 8.52 (m, 1H).


ESI/MS m/e: 331.2 (M++H, C16H15FN4O3)


Methyl 3-amino-1-{3-[(tert-butoxy)carbonylamino]propyl}-4-cyano-5-(2-furyl)pyrrole-2-carboxylate was synthesized in the same manner using N-{3-[(2,2-dicyano-1-(2-furyl)vinyl)amino]propyl}(tert-butoxy)carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 389.4 (M++H, C19H24N4O5)


Reference Example 8
Synthesis of methyl 3-amino-1-{2[(tert-butoxy)carbonylaminolethyl}-4-cyano-5-phenylpyrrole-2-carboxylate



embedded image


tert-Butyl N-(2-aminoethyl)carbamate (10.6 g) was added to a solution of (methoxyphenylmethylene)methane-1,1-dicarbonitrile (10.4 g) in acetonitrile (350 mL), and the mixture was stirred for 10 minutes. Anhydrous cesium carbonate (65.1 g) and methyl bromoacetate (13.5 mL) were added, and the mixture was heated to reflux for 1 hour. After cooling the mixture to room temperature, it was allowed to stand, the supernatant was separated by decantation, and the solvent was distilled off under reduced pressure. The concentrated residue was combined with the solid portion remaining after decantation, ethyl acetate and water were added, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate 2/1) to obtain the title compound (20.6 g, yield: 95%) as a yellow transparent oil. The NMR and ESI/MS data for this compound-are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 1.35 (s, 9H), 3.30-3.31 (m, 2H), 3.90 (s, 3H), 4.30 (t, J=5.7, 2H), 4.40 (brs, 1H), 4.96 (brs, 2H), 7.41-7.52 (m, 5H).


ESI/MS m/e: 385.3 (M++H, C20H24N4O4)


Reference Example 9
Synthesis of methyl 3-amino-1-{2-[(tert-butoxy]carbonylaminolethyl}-4-cyanopyrrole-2-carboxylate



embedded image


After dissolving ethoxymethylenemalononitrile (5.1 g) and tert-butyl N-(aminoethyl)carbamate (7.5 g) in acetonitrile (50 mL), a solution of triethylamine (830 mg) in acetonitrile (50 mL) was added and the mixture was stirred for 10 minutes at room temperature. After confirming complete consumption of the ethoxymethylene-malononitrile by thin-layer chromatography (hexane/ethyl acetate=1/1), the solvent was distilled off under reduced pressure. Acetonitrile(160 mL) and cesium carbonate (26.7 g) were added to the residue, and then a solution of methyl bromoacetate (12.9 g) in acetonitrile (12 mL) was added dropwise over a period of 30 minutes. The mixture was heated to reflux for 90 minutes and then cooled to room temperature, the supernatant was separated by decantation, and the solvent was distilled off under reduced pressure. The concentrated residue was combined with the solid portion remaining after decantation, ethyl acetate and water were added, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine in that order and then dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the resultant brown oil (17.9 g) was purified by silica gel column chromatography (hexane/ethyl acetate=3/2) to obtain the title compound (9.3 g, 74%).


Reference Example 10
Synthesis of ethyl 3-[4-amino-3-cyano-5-(methoxycarbonyl)-2-phenylpyrrolyl]propionate



embedded image


After dissolving (methoxyphenylmethylene)methane-1,1-dicarbonitrile (15.10 g) and β-alanine ethyl ester hydrochloride (15.11 g) in acetonitrile (300 mL), triethylamine (23.00 mL) was added and the mixture was stirred for 10 minutes at room temperature. After confirming complete consumption of the (methoxyphenyl-methylene)methane-1,1-dicarbonitrile by thin-layer chromatography (hexane/ethyl acetate=3/1), the solvent was distilled off under reduced pressure. Ethyl acetate and water were added to the residue, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. Acetonitrile (700 mL) and anhydrous cesium carbonate (53.65 g) were added to the residue. Methyl bromoacetate (16.00 mL) was added thereto and the mixture was heated to reflux for 40 minutes. After cooling the mixture to room temperature, it was allowed to stand, the supernatant was separated by decantation, and the solvent was distilled off under reduced pressure. The residue was combined with the solid portion remaining after decantation, ethyl acetate and water were added, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was passed through a chromatography column packed with a small amount of silica gel (elution with dichloromethane), for removal of the highly polar impurities, to obtain the title compound as a crude product (35.31 g).


Reference Example 11
Synthesis of (phenyl{[2-(1,1,2,2-tetramethyl-1-silapropoxy)ethyl]amino}methylene)methane-1,1-dicarbonitrile



embedded image


After dissolving (methoxyphenylmethylene)methane-1,1-dicarbonitrile (5.02 g) and aminoethanol (2.05 g) in methanol (50 mL), the solution was stirred for 10 minutes at room temperature. The solvent was distilled off under reduced pressure, a solution was prepared in tetrahydrofuran, and the solvent was distilled off under reduced pressure again to total distillation of the methanol. The residue was dissolved in tetrahydrofuran (60 mL), and then imidazole (3.87 g) and tert-butyldimethylsilyl chloride (7.39 g) were added thereto and the mixture was stirred for 8 hours at room temperature. After distilling off the solvent under reduced pressure, ethyl acetate and saturated aqueous ammonium chloride were added to the residue and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=4/1) to obtain the title compound (6.47 g, yield: 73%) as a colorless transparent oil. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 0.098 (s, 6H), 0.93 (s, 9H), 3.24 (m, 2H), 3.64 (t, J=4.88, 2H), 6.65 (brs, 1H), 7.37-7.39 (m, 2H), 7.52-7.54 (m, 3H).


ESI/MS m/e: 328.2 (M++H, C18H25N3OSi)


Reference Example 12
Synthesis of methyl 3-amino-4-cyano-5-phenyl-1-[2-(1,1,1,2-tetramethyl-1-silapropoxy)ethyl)pyrrole-2-carboxylate



embedded image


(Phenyl{[2-(1,1,2,2-tetramethyl-1-silapropoxy)ethyl]amino}methylene)methane-1,1-dicarbonitrile (6.47 g) and anhydrous cesium carbonate (12.9 g) were added to acetonitrile (150 mL). Methyl bromoacetate (3.8 mL) was added thereto, and the mixture was heated to reflux for 3 hours. After cooling the mixture to room temperature, it was allowed to stand, the supernatant was separated by decantation, and the solvent was distilled off under reduced pressure. The concentrated residue was combined with the solid portion remaining after decantation, ethyl acetate and water were added, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was recrystallized (hexane/ethyl acetate=1/1) to obtain the title compound (5.13 g, yield: 65%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): −0.11 (s, 6H), 0.78 (s, 9H), 3.73 (t, J=5.6, 2H), 3.88 (s, 3H), 4.33 (t, J=5.6, 2H), 4.96 (brs, 2H), 7.47-7.52 (m, 5H).


ESI/MS m/e 400.3 (M++H, C21H29N3O3Si)


Methyl 3-amino-4-cyano-5-phenyl-1-[3-(1,1,2,2-tetramethyl-1-silapropoxy)propyl]pyrrole-2-carboxylate as synthesized in the same manner as Reference Example 11 and Reference Example 12 using (methoxyphenylmethylene)methane-1,1-dicarbonitrile and 3-amino-1-propanol. The NMR data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): −0.084 (s, 6H), 0.76 (s, 9H), 1.75-1.82 (m, 2H), 3.48 (t, J=6.0, 2H), 3.88 (s, 3H), 4.25 (t, J=7.6, 2H), 4.97 (brs, 2H), 7.40-7.43 (m, 2H), 7.47-7.49 (m, 3H).


Example 1
Synthesis of 5-methyl-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0925)



embedded image


Methyl 3-amino-4-cyano-1-methyl-5-phenylpyrrole-2-carboxylate (1.74 g) and formamidine acetate (2.84 g) were added to 2-propanol (100 mL) and the mixture was heated to reflux for 72 hours. After cooling to room temperature, the produced precipitate was filtered out and washed with ethanol. This solid was recrystallized from ethanol to obtain the title compound (1.37 g, yield: 80%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.95 (s, 3H), 7.61-7.67 (m, 5H), 8.01 (s, 1H), 12.43 (brs, 1H).


ESI/MS m/e: 251.1 (M++H, C14H10N4O)


Example 2
Synthesis of 5-methyl-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0592)



embedded image


5-Methyl-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (101.8 mg) was added to phosphorus oxychloride (2 mL) and the mixture was heated to reflux at 100° C. for 1 hour. After cooling to room temperature, the excess phosphorus oxychloride was distilled off under reduced pressure. The residue was dissolved in 2-propanol (2 mL), thiourea (47 mg) was added and the mixture was heated to reflux at 100° C. for 1 hour. After cooling to room temperature, the solvent was distilled off under reduced pressure. The residue was recrystallized from ethanol to obtain the title compound (80.3 mg, yield: 74%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 4.22 (s, 3H), 7.63-7.70 (m, 5H), 8.16 (d, J=3.7, 1H), 13.7 (brs, 1H).


ESI/MS m/e: 267.1 (M++H, C14H10N4S)


Example 3
Synthesis of 5-(2-hydroxyethyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0181)



embedded image


Formamide (20 mL) and a 28% solution of sodium methoxide in methanol (20 mL) were added to a solution of methyl 3-amino-4-cyano-5-phenyl-1-[2-(1,1,2,2-tetramethyl-1-silapropoxy)ethyl]pyrrole-2-carboxylate (5.00 g) in dimethylsulfoxide (20 mL), and the mixture was heated to reflux at 100° C. for 4 hours. After cooling to room temperature, water (100 mL) and 2 mol/L hydrochloric acid (100 mL) were added to acidify the solution. After stirring the mixture at room temperature for a while, the produced solid was filtered out. It was dissolved in ethanol (100 mL), and then a 4 mol/L hydrochloric acid/1,4-dioxane solution (10 mL) was added, and the mixture was stirred for 1 hour at room temperature. After distilling off the solvent under reduced pressure, the residue was recrystallized (ethanol/ethyl acetate/hexane=1/1/2) to obtain the title compound (2.77 g, yield: 77%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.61 (m, 2H), 4.36 (t, J=5.6, 2H), 4.85 (brs, 1H), 7.59-7.62 (m, 3H), 7.67-7.69 (m, 2H), 8.04 (s, 1H), 12.45 (brs, 1H).


ESI/MS m/e: 281.2 (M++H, C15H12N4O2)


Example 4
Synthesis of 5-(3-hydroxyrropyl-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0194)



embedded image


The title compound was synthesized in the same manner as Example 3 using methyl 3-amino-4-cyano-5-phenyl-1-[3-(1,1,2,2-tetramethyl-1-silapropoxy)propyl]pyrrole-2-carboxylate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.70-1.82 (m, 2H), 3.17-3.27 (m, 2H), 4.35-4.47 (m, 2H), 7.55-7.68 (m, 5H), 8.02 (d, J=1.0, 1H), 12.46 (brs, 1H).


ESI/MS m/e: 295.2 (M++H, C16H14N4O2)


Example 5
Synthesis of 5-[3-(methylethoxy)propyl]-6-(4-nitrophenyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-1077)



embedded image


The title compound was synthesized in the same manner as Example 3 using methyl 3-amino-4-cyano-1-[3-(methylethoxy)propyl]-5-(4-nitrophenyl)pyrrole-2-carboxylate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 0.75-0.92 (m, 6H), 1.72-1.85 (m, 2H), 3.12 (t, J=5.1, 2H), 3.16-3.26 (m, 1H), 4.46 (t, J=6.8, 2H), 7.96 (dd, J=1.2, J=8.8, 2H), 8.06 (d, J=1.2, 1H), 8.45 (dd, J=1.2, J=8.8, 2H).


ESI/MS m/e: 382.2 (M++H, C19H19N5O4)


Example 6
Synthesis of 2-(7-cyano-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)ethylbenzoate (Compound No: 2-05081



embedded image


5-(2-Hydroxyethyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (200 mg) was dissolved in pyridine (3 mL). Benzoyl chloride (250 μL) was added thereto, and the mixture was stirred for 1 hour at room temperature. Water (1 mL) was added to the reaction solution and the mixture was stirred for 1 hour at room temperature. After slowly adding thereto a 10% aqueous sodium carbonate solution (20 mL), the mixture was further stirred for 1 hour and the produced solid was filtered out. The solid was recrystallized from ethanol/ethyl acetate/hexane (ethanol/ethyl acetate/hexane=1/1/2) to obtain the title compound (209 mg, yield: 76%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 4.46 (t, J=4.8, 2H), 4.81 (t, J=4.8, 2H), 7.44-7.64 (m, 10H), 8.03 (s, 1H), 12.54 (brs, 1H).


ESI/MS m/e: 385.2 (M++H, C22H16N4O3)


Example 7
Synthesis of (tert-butoxy)-N-[2-(7-cyano-4-oxo-6-phenyl(3-hydropyrrolo[3,2-d]pyrimidin-5-yl})ethyl]carboxamide (Compound No: 2-0199)



embedded image


Methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino]ethyl}-4-cyano-5-phenylpyrrole-2-carboxylate (19.7 g) and formamidine acetate (53.6 g) were added to 2-propanol (400 mL) and the mixture was heated to reflux for 30 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure. Water was added to the residue, and the produced solid was filtered out and thoroughly washed with water. The solid was recrystallized (ethanol/ethyl acetate/hexane=1/2/1) to obtain the title compound (11.3 g, yield: 58.2%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.22 (s, 9H), 3.16-3.17 (m, 2H), 4.36 (t, J=5.0, 2H), 6.61 (brs, 1H), 7.59 (s, 5H), 8.03 (s, 1H), 12.44 (brs, 1H).


ESI/MS m/e: 380.2 (M++H, C20H21N5O3)


Example 8
Synthesis of (tert-butoxy)-N-f2-[7-cyano-6-(1-methylpyrrol-2-yl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}carboxamide (Compound No: 2-1958)



embedded image


The title compound was synthesized in the same manner as Example 7 using 3-amino-1-{2-[(tert-butoxy)carbonyl-aminolethyl}-4-cyano-5-(1-methylpyrrol-2-yl)pyrrole-2-carboxylate. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 383.3 (M++H, C19H22N6O3)


Example 9
Synthesis of (tert-butoxy)-N-[2-(7-cyano-6-(2-furyl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]carboxamide (Compound No: 2-1959)



embedded image


The title compound was obtained in the same manner as Example 7 using methyl 3-amino-1-{2-[(tert-butoxy)carbonylaminolethyl}-4-cyano-5-(2-furyl)pyrrole-2-carboxylate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.21 (s, 9H), 3.31 (brs, 2H), 4.66 (m, 2H), 6.80 (m, 2H), 7.22 (m, 1H), 8.01 (m, 2H), 12.43 (brs, 1H).


ESI/MS m/e: 370.3 (M++H, C18H19N5O4)


Example 10
Synthesis of (tert-butoxy)-N-{2-[7-cyano-6-(3-methyl(2-furyl))-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}carboxamide (Compound No: 2-1960)



embedded image


The title compound was obtained in the same manner as Example 7 using methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino)ethyl}-4-cyano-5-(3-methyl(2-furyl))pyrrole-2-carboxylate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CD3OD) δ (ppm): 1.28 (s, 9H), 2.24 (s, 3H), 3.40 (m, 2H), 4.55 (m, 2H), 6.57 (s, 1H), 7.73 (s, 1H), 7.95 (s, 1H).


ESI/MS m/e: 384.4 (M++H, C19H21N5O4)


Example 11
Synthesis of (tert-butoxy)-N-{2-[7-cyano-6-(3-methyl(2-thienyll)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl]ethyl}carboxamide (Compound No: 2-1961)



embedded image


The title compound was synthesized in the same manner as Example 7 using methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino]ethyl}-4-cyano-5-(3-methyl(2-thienyl))pyrrole-2-carboxylate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.22 (s, 9H), 2.17 (s, 3H), 3.23 (brs, 2H), 4.23-4.37 (brs, 2H), 6.60 (m, 1H), 7.13 (d, J=5.2, 11), 7.83 (d, J=4.9, 1H), 8.03 (m, 1H), 12.47 (brs, 1H).


ESI/MS m/e: 400.2 (M++H, C19H21N5O3S)


Example 12
Synthesis of (tert-butoxy)-N-{2-[6-(3-chloro(2-thienyl))-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}carboxamide (Compound No: 2-1962)



embedded image


The title compound was obtained in the same manner as Example 7 using methyl 3-amino-1-{2-[(tert-butoxy)carbonylamino]ethyl}-5-(3-chloro(2-thienyl))-4-cyanopyrrole-2-carboxylate. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 420.2 (M++H, C18H18ClN5O3S)


Example 13
Synthesis of (tert-butoxy)-N-[3-(7-cyano-6-(2-furyl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))propyl]carboxamide (Compound No: 2-1963)



embedded image


The title compound was synthesized in the same manner as Example 7 using methyl 3-amino-1-{3-((tert-butoxy)carbonylamino]propyl}-4-cyano-5-(2-furyl)pyrrole-2-carboxylate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.35 (s, 9H), 1.84 (m, 2H), 2.92 (m, 2H), 4.64 (m, 2H), 6.82 (m, 2H), 7.18 (m, 1H), 7.98-8.08 (m, 2H), 12.45 (brs, 1H).


ESI/MS m/e: 384.5 (M++H, C19H21N5O4)


Example 14
Synthesis of N-[2-(7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl](4-fluorophenyl)carboxamide (Compound No: 2-1952)



embedded image


After adding a 28% solution of sodium methoxide in methanol (40 mL) to a suspension of methyl 3-amino-4-cyano-1-{2-[(4-fluorophenyl)carbonylamino]ethyl}pyrrole-2-carboxylate (7.9 g) in formamide (40 mL), the mixture was stirred for 80 minutes at 100° C. After cooling to 0° C., 2 mol/L hydrochloric acid (45 mL) was added and the precipitated solid was filtered out to obtain the title compound (5.8 g, 74%). The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.68 (m, 2H), 4.53 (m, 2H), 7.27 (m, 2H), 7.79 (m, 2H), 7.97 (s, 1H), 8.14 (s, 1H), 8.53 (m, 1H).


ESI/MS m/e: 326.2 (M++H, C16H12FN5O2)


Example 15
Synthesis of (tert-butoxy]-N-[2-(7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]carboxamide (Compound No: 2-1964)



embedded image


A methyl 3-amino-1-{2-[(tert-butoxy)carbonylaminoethyl}-4-cyanopyrrole-2-carboxylate crude product (9.3 g), formamidine acetate (78.3 g) and 2-propanol (200 mL) were combined, and the mixture was heated to reflux for 14 hours. After cooling to room temperature, the supernatant was collected and concentrated under reduced pressure. This was mixed with the residue, and then ethyl acetate and water were added and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine in that order and then dried over magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound as a crude product (1.69 g). The ESI/MS data for this compound are shown below.


ESI/MS m/e: 304.2 (M++H, C14H17N5O3)


Example 16
Synthesis of N-[2-(7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]benzamide (Compound No: 2-1953)



embedded image


1,4-Dioxane (50 mL), a 4 mol/L hydrochloric acid/dioxane solution (5.6 mL) and methanol (10 mL) were added to a (tert-butoxy)-N-[2-(7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]carboxamide crude product (1.69 g), the mixture was heated to 60° C., methanol (10 mL) was added and the mixture was stirred for 90 minutes. A 4 mol/L hydrochloric acid/dioxane solution (2 mL) and methanol (10 mL) were added, the mixture was stirred for 1 hour, and the solvent was distilled off under reduced pressure. N,N-dimethylformamide (100 mL) and triethylamine (1.7 g) were added to the residue, a solution of benzoyl chloride (1.6 g) in N,N-dimethylformamide (20 mL) was added thereto and the mixture was stirred for 1 hour. After cooling to 0° C., water and ethyl acetate were added and extraction was performed 3 times with ethyl acetate. The solvent was distilled off under reduced pressure, ethyl acetate and hexane were added to the residue, and the precipitated solid was filtered out to obtain the title compound (1.0 g, 59%). The ESI/MS data for this compound are shown below.


ESI/MS m/e: 308.1 (M++H, C16H13N5O2)


Example 17
Synthesis of N-[2-(6-chloro-7-cyano-4-oxo(3-hydroryrrolo[3,2-d]pyrimidin-5-yl))ethyl]benzamide (Compound No: 2-1954)



embedded image


N,N-dimethylformamide (30 mL) and N-chlorosuccinimide (1.3 g) were added to N-[2-(7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]benzamide (1.0 g), and the mixture was stirred for 13 hours at room temperature. After adding 30 mL of water, the mixture was cooled to 0° C. The precipitated solid was filtered out to obtain the title compound (980 mg, 87%). The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.64-3.73 (m, 2H), 4.60-4.67 (m, 2H), 7.37-7.56 (m, 3H), 7.64-7.74 (m, 2H), 8.02 (s, 1H), 8.54-8.60 (m, 1H), 12.6 (brs, 1H).


ESI/MS m/e: 342.1 (M++H, C16H12ClN5O2)


Example 18
Synthesis of N-[2-(6-chloro-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]benzamide (Compound No: 2-1896)



embedded image


Phosphorus oxychloride (55 g) was added to N-[2-(6-chloro-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]benzamide (300 mg), and the mixture was heated to reflux for 30 minutes. After concentration under reduced pressure, toluene was added to the residue and the mixture was further concentrated under reduced pressure. 2-Propanol (20 mL) and thiourea (77 mg) were added to the residue and the mixture was heated to reflux for 30 minutes. The solvent was distilled off under reduced pressure, ethyl acetate and water were added to the residue, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine in that order and then dried over magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the title compound as a crude product (411 mg). The ESI/MS data for this compound are shown below.


ESI/MS m/e: 358.1 (M++H, C16H12ClN5OS)


Example 19
Synthesis of 5-f3-(methylethoxy)propyl]-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0845)



embedded image


After dissolving ethoxymethylenemalononitrile (10.2 g) in acetonitrile (200 mL), 3-isopropoxypropylamine (9.8 g) was added thereto and the mixture was stirred for 10 minutes. Cesium carbonate (68 g) and methyl bromoacetate (32 g) were added and the mixture was heated to reflux for 30 minutes. After cooling to room temperature, the supernatant was separated by decantation, and the solvent was distilled off under reduced pressure. The concentrated residue was combined with the solid portion remaining after decantation, ethyl acetate and water were added, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with saturated brine and then dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was dissolved in ethyl acetate and passed through a silica gel, and then ethyl acetate (200 mL) was added for elution. The eluate was concentrated under reduced pressure to obtain a methyl 3-amino-4-cyano-1-[3-(methylethoxy)propyl]pyrrole-2-carboxylate crude product as a brown oil.


Dimethylsulfoxide (70 mL), formamide (70 mL) and a 28% solution of sodium methoxide in methanol (70 mL) were added thereto and the mixture was stirred at 100° C. for 10 hours. After cooling to room temperature, water (300 mL) and 2 mol/L hydrochloric acid (100 mL) were added to adjust the reaction solution to a pH of 4. After cooling the reaction solution to 0° C., the precipitated solid was filtered out. Ethanol (150 mL) was added to the solid, and the mixture was heated to dissolution and cooled to 0° C. The precipitated solid was filtered out to obtain the title compound (12.3 g, 57%) as light brownish crystals. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 261.4 (M++H, C13H16N4O2)


Example 20
Synthesis of 6-chloro-5-[3-(methylethoxy]propyl]-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0861)



embedded image


N,N-dimethylformamide (50 mL) and N-chlorosuccinimide (6.5 g) were added to 5-[3-(methylethoxy)propyl]-4-oxo-3-hydropyrrolo(3,2-d]pyrimidine-7-carbonitrile (4.3 g), and the mixture was stirred for 3 days at room temperature. After adding 200 mL of water, extraction was performed twice with ethyl acetate. The organic layer was washed with saturated brine and then dried over magnesium sulfate. The solvent was distilled off under reduced pressure to obtain the crude title compound as a brown solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 295.3 (M++H, C13H15ClN4O2)


Example 21
Synthesis of 5-[3-(methylethoxy)propyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0527)



embedded image


Phosphorus oxychloride (25 g) was added to the crude 6-chloro-5-[3-(methylethoxy)propyl]-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile, and the mixture was heated to reflux for 30 minutes. After concentration under reduced pressure, 2-propanol (100 mL) and thiourea (2.1 g) were added to the residue and the mixture was heated to reflux for 30 minutes. The solvent was distilled off under reduced pressure, water (200 mL) was added and extraction was performed twice with ethyl acetate. The organic layer was washed with saturated brine and then dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained brown oil was purified by silica gel column chromatography (hexane/ethyl acetate=7/3) to obtain the title compound (2.1 g, 42%) as a light yellow solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 311.2 (M++H, C13H15ClN4OS)


Example 22
Synthesis of 5-(2-aminoethyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0151)



embedded image


(tert-Butoxy)-N-[2-(7-cyano-4-oxo-6-phenyl(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]carboxamide (8.01 g) was dissolved in a mixed solution of ethanol (50 mL) and 1,4-dioxane (50 mL), and then a 4 mol/L hydrochloric acid/1,4-dioxane solution (50 mL) was added. After stirring for 1 hour at room temperature, the solvent was distilled off under reduced pressure and the residue was recrystallized (ethanol/ethyl acetate=1/2) to obtain the title compound (6.15 g, yield: 92%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.11-3.15 (m, 2H), 4.52 (t, J=6.8, 2H), 7.64 (s, 5H), 8.09 (brs, 3H), 12.7 (brs, 1H).


ESI/MS m/e: 280.1 (M++H, C15H13N5O)


Example 23
Synthesis of 5-(2-aminoethyl)-6-(2-furyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0791)



embedded image


The title compound was obtained in the same manner as Example 22 using (tert-butoxy)-N-[2-(7-cyano-6-(2-furyl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 270.1 (M++H, C13H11N5O2)


Example 24
Synthesis of 5-(2-aminoethyl)-6-(3-methyl(2-furyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0792)



embedded image


The title compound was obtained in the same manner as Example 22 using (tert-butoxy)-N-{2-[7-cyano-6-(3-methyl(2-furyl))-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 284.4 (M++H, C14H13N5O2)


Example 25
Synthesis of 5-(2-aminoethyl)-6-(3-methyl(2-thienyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0793)



embedded image


The title compound was obtained in the same manner as Example 22 using (tert-butoxy)-N-{2-[7-cyano-6-(3-methyl(2-thienyl))-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 300.2 (M++H, C14H13N5OS)


Example 26
Synthesis of 5-(2-aminoethyl)-6-(3-chloro(2-thienyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0794)



embedded image


The title compound was obtained in the same manner as Example 22 using (tert-butoxy)-N-{2-(6-(3-chloro(2-thienyl))-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl}carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 320.0 (M++H, C13H10ClN5OS)


Example 27
Synthesis of 5-(2-aminoethyl)-6-methyl-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0790)



embedded image


The title compound was synthesized in the same manner as Example 22 using (tert-butoxy)-N-[2-(7-cyano-6-methyl-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]carboxamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.49 (s, 3H), 3.10-3.30 (m, 2H), 4.40-4.65 (m, 2H), 7.93 (s, 1H), 8.23 (brs, 1H), 12.48 (brs, 1H).


ESI/MS m/e: 218.1 (M++H, C10H11N5O)


Example 28
Synthesis of 5-[2-aminoethyl)-6-(2,6-difluorophenyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0796)



embedded image


The title compound was synthesized in the same manner as Example 22 using N-{2-[6-(2,6-difluorophenyl)-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}(tert-butoxy)carboxamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.05-3.20 (m, 2H), 4.40-4.55 (m, 2H), 7.40-7.55 (m, 2H), 7.78-7.90 (m, 1H), 8.05-8.30 (m, 4H), 12.79 (brs, 1H).


ESI/MS m/e: 316.1 (M++H, C15H11F2N5O)


Example 29
Synthesis of 5-(2-aminoethyl)-6-(1-methylpyrrol-2-yl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0795)



embedded image


The title compound was synthesized in the same manner as Example 22 using (tert-butoxy)-N-{2-[7-cyano-6-(1-methylpyrrol-2-yl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}carboxamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.05-3.22 (m, 2H), 3.59 (s, 3H), 4.51 (brs, 2H), 6.20-6.35 (m, 1H), 6.48-6.60 (m, 1H), 7.10-7.23 (m, 1H), 7.90-8.18 (m, 4H), 12.67 (brs, 1H).


ESI/MS m/e: 283.1 (M++H, C14H14N6O)


Example 30
Synthesis of 5-(3-aminopropyl)-6-(2-furyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-10811



embedded image


The title compound was synthesized in the same manner as Example 22 using (tert-butoxy)-N-[3-(7-cyano-6-(2-furyl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))propyl]carboxamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 284.5 (M++H, C14H13N5O2)


Example 31
Synthesis of N-[2-(7-cyano-4-oxo-6-phenyl(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (Compound No: 2-1663)



embedded image


Trifluoroacetic anhydride (26.6 g) was added to a solution of 5-(2-aminoethyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (4.00 g) in tetrahydrofuran (150 mL), the mixture was cooled to 0° C., and triethylamine (53 mL) was slowly added dropwise. The reaction mixture was stirred for 4 hours at room temperature, methanol was added dropwise to quench the reaction, and the solvent was distilled off under reduced pressure. Ethyl acetate and water were added to the residue and extraction was performed with ethyl acetate. The organic layer was washed with saturated brine and then dried over anhydrous magnesium sulfate and filtered. The solvent was distilled off under reduced pressure, and the produced solid was filtered out, washed with a small amount of methanol, and collected. The solvent of the filtrate was removed in vacuo again and the produced solid was collected and washed in the same manner and combined with the previously collected solid to obtain the title compound (3.69 g, yield: 78%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.34 (m, 2H), 4.53 (m, 2H), 7.54-7.62 (m, 5H), 8.06 (s, 1H), 9.30 (m, 1H), 12.56 (s, 1H).


ESI/MS m/e: 376.1 (M++H, C17H12F3N5O2)


Example 32
Synthesis of N-[2-(7-cyano-6-(2-furyl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (Compound No: 2-1692)



embedded image


The title compound was obtained in the same manner as Example 31 using 5-(2-aminoethyl)-6-(2-furyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.65 (m, 2H), 4.80 (m, 2H), 6.80 (m, 1H), 7.20 (d, J=3.4, 1H), 7.94-8.06 (m, 2H), 9.44 (m, 1H), 12.58 (s, 1H) ESI/MS m/e: 366.4 (M++H, C15H10F3N5O3)


Example 33
Synthesis of N-{2-[7-cyano-6-(3-methyl(2-furyl))-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-1664)



embedded image


The title compound was obtained in the same manner as Example 31 using 5-(2-aminoethyl)-6-(3-methyl(2-furyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=7.852 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.11 (s, 3H), 3.53 (m, 2H), 4.52 (m, 2H), 6.64 (s, 1H), 7.86 (s, 1H), 8.04 (s, 1H), 9.35 (m, 1H), 12.53 (brs, 1H).


ESI/MS m/e: 380.2 (M++H, C16H12F3N5O3)


Example 34
Synthesis of N-{2-[7-cyano-6-(3-methyl(2-thienyl))-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-1665)



embedded image


The title compound was obtained in the same manner as Example 31 using 5-(2-aminoethyl)-6-(3-methyl(2-thienyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 396.1 (M++H, C16H12F3N5O2S)


Example 35
Synthesis of N-{2-[6-(3-chloro(2-thienyl))-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-1666)



embedded image


The title compound was obtained in the same manner as Example 31 using 5-(2-aminoethyl)-6-(3-chloro(2-thienyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 416.1 (M++H, C15H9ClF3N5O2S)


Example 36
Synthesis of N-{2-[6-(2,6-difluorophenyl)-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-1715)



embedded image


The title compound was synthesized in the same manner as Example 31 using 5-(2-aminoethyl)-6-(2,6-difluorophenyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.48-3.58 (m, 2H), 4.30-4.40 (m, 2H), 7.41 (t, J=8.3, 2H), 7.73-7.85 (m, 1H), 8.09 (s, 1H), 12.65 (brs, 1H).


ESI/MS m/e: 412.0 (M++H, C17H11F5N5O2)


Example 37
Synthesis of N-{2-(7-cyano-6-methyl-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-1691)



embedded image


The title compound was synthesized in the same manner as Example 31 using 5-(2-aminoethyl)-6-methyl-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.35 (s, 3H), 3.58-3.70 (m, 2H), 4.48-4.60 (m, 2H), 7.99 (s, 1H), 9.56 (brs, 1H), 12.44 (brs, 1H).


ESI/MS m/e: 314.1 (M++H, C12H10F3N5O2)


Example 38
Synthesis of N-[2-(7-cyano-6-cyclopropyl-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (Compound No: 2-1668)



embedded image


The title compound was synthesized in the same manner as Example 31 using 5-(2-aminoethyl)-6-cyclopropyl-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 0.98-1.25 (m, 4H), 2.15-2.27 (m, 1H), 3.18-3.33 (m, 2H), 4.65-4.80 (m, 2H), 7.98 (s, 1H), 8.29 (brs, 1H), 12.53 (brs, 1H).


ESI/MS m/e: 340.2 (M++H, C14H12F3N5O2)


Example 39
Synthesis of N-[2-(6-benzo[b]thiophen-2-yl-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (Compound No: 2-1689)



embedded image


The title compound was synthesized in the same manner as Example 31 using 5-(2-aminoethyl)-6-benzo[b]thiophen-2-yl-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.15-3.33 (m, 2H), 4.65-4.83 (m, 2H), 7.45-7.70 (m, 2H), 7.80-8.28 (m, 5H), 12.74 (brs, 1H).


ESI/MS m/e: 432.1 (M++H, C19H12F3N5O2S)


Example 40
Synthesis of N-{2-[7-cyano-6-(1-methylpyrrol-2-yl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-1667)



embedded image


The title compound was synthesized in the same manner as Example 31 using 5-(2-aminoethyl)-6-(1-methylpyrrol-2-yl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 379.2 (M++H, C16H13F3N6O2)


Example 41
Synthesis of N-[2-(4-chloro-7-cyano-6-phenylpyrrolo[3,2-d]pyrimidin-5-yl)]ethyl]-2,2,2-trifluoroacetamide



embedded image


Phosphorus oxychloride (22.6 g) was added to a solution of N-[2-(7-cyano-4-oxo-6-phenyl(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (3.69 g) in acetonitrile (50 mL) and the mixture was stirred at 110° C. overnight. The reaction mixture was cooled to room temperature, and the excess phosphorus oxychloride was distilled off under reduced pressure. The residue was dried under vacuum to obtain the title compound as a crude product. The product was used for the following reaction without purification. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 394.1 (M++H, C17H11ClF3N5O)


Example 42
Synthesis of N-[2-(4-chloro-7-cyano-6-(2-furyl)pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2,2,2-trifluoroacetamide



embedded image


The title compound was obtained in the same manner as Example 41 using N-[2-(7-cyano-6-(2-furyl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 384.3 (M++H, C15H9ClF3N5O2)


Example 43
Synthesis of N-{2-[4-chloro-7-cyano-6-(3-methyl(2-furyl))pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2,2,2-trifluoroacetamide



embedded image


The title compound was obtained in the same manner as Example 41 using N-{2-[7-cyano-6-(3-methyl(2-furyl))-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 398.4 (M++H, C16H11ClF3N5O2)


Example 44
Synthesis of N-{2-[4-chloro-7-cyano-6-(3-methyl(2-thienyl))pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2,2,2-trifluoroacetamide



embedded image


The title compound was obtained in the same manner as Example 41 using N-{2-[7-cyano-6-(3-methyl(2-thienyl))-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 414.2 (M++H, C16H11ClF3N50S)


Example 45
Synthesis of N-{2-[4-chloro-6-(3-chloro(2-thienyl))-7-cyanopyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2,2,2-trifluoroacetamide



embedded image


The title compound was obtained in the same manner as Example 41 using N-{2-[6-(3-chloro(2-thienyl))-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 434.1 (M++H, C15H8Cl2F3N5OS)


Example 46
Synthesis of N-{2-[4-chloro-7-cyano-6-(1-methylpyrrol-2-yl)pyrrolo[3,2-d]pyrimidin-5-yl]}ethyl}-2,2,2-trifluoroacetamide



embedded image


The title compound was synthesized in the same manner as Example 41 using N-{2-[7-cyano-6-(1-methylpyrrol-2-yl)-4-oxo(3-hydropyrrolo[3,2-d)pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 397.3 (M++H, C16H12ClF3N6O)


Example 47
Synthesis of N-[2-(7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (Compound No: 2-0600)



embedded image


Thiourea (2.99 g) was added to a solution of crude N-[2-(4-chloro-7-cyano-6-phenylpyrrolo[3,2-d]pyrimidin-5-yl)]ethyl]-2,2,2-trifluoroacetamide in 1,4-dioxane (100 mL) and 2-propanol (20 mL), and the mixture was stirred at 80° C. for 4 hours. The reaction mixture was cooled to room temperature, and the solvent was distilled off under reduced pressure. Ethyl acetate and water were added to the residue and extraction was performed with ethyl acetate. The organic layer was washed with saturated brine and then dried over anhydrous magnesium sulfate and filtered. The solvent was distilled off under reduced pressure, and then a small and sufficient amount of hexane was added to the residue and the produced solid was filtered, washed with a small amount of methanol, and collected. The solvent of the filtrate was again distilled off under reduced pressure, and the produced solid was filtered and washed in the same manner and combined with the previously collected solid to obtain the title compound (4.24 g, quantitative yield) as a white solid. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=9.171 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.43 (m, 2H), 5.03 (brs, 2H), 7.61 (m, 5H), 8.24 (s, 1H), 9.21 (m, 1H), 13.88 (brs, 1H).


ESI/MS m/e: 392.1 (M++H, C11H12F3N5OS)


Example 48
Synthesis of N-[2-(7-cyano-6-(2-furyl)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (Compound No: 2-1804)



embedded image


The title compound was synthesized in the same manner as Example 47 using N-[2-(4-chloro-7-cyano-6-(2-furyl)pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2,2,2-trifluoroacetamide. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=8.592 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.60 (m, 2H), 5.35 (brs, 2H), 6.83 (m, 1H), 7.30 (m, 1H), 8.06 (s, 1H), 8.19 (m, 1H), 9.36 (m, 1H), 13.83 (brs, 1H)


ESI/MS m/e: 382.3 (M++H, C15H10F3N5O2S)


Example 49
Synthesis of N-{2-[7-cyano-6-(3-methyl(2-furyl))-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-0601)



embedded image


The title compound was synthesized in the same manner as Example 47 using N-{2-[4-chloro-7-cyano-6-(3-methyl(2-furyl))pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2,2,2-trifluoroacetamide. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=9.215 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.12 (s, 3H), 3.55 (m, 2H), 5.03 (brs, 2H), 6.66 (s, 1H), 7.92 (s, 1H), 8.23 (s, 1H), 9.28 (m, 1H), 13.91 (s, 1H)


ESI/MS m/e: 396.5 (M++H, C16H12F3N5O2S)


Example 50
Synthesis of N-(2-{7-cyano-6-(3-methyl(2-thienyl))-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-06021)



embedded image


The title compound was synthesized in the same manner as Example 47 using N-{2-[4-chloro-7-cyano-6-(3-methyl(2-thienyl))pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2,2,2-trifluoroacetamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.18 (s, 3H), 3.50 (brs, 2H), 4.70 (brs, 1H), 5.21 (brs, 1H), 7.16 (d, J=5.1, 1H), 7.91 (d, J=5.1, 1H), 8.22 (s, 1H), 9.29 (m, 1H), 13.89 (s, 1H).


ESI/MS m/e: 412.1 (M++H, C16H12F3NsOS2)


Example 51
Synthesis of N-{2-[6-(3-chloro(2-thienyl))-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-0603)



embedded image


The title compound was synthesized in the same manner as Example 47 using N-{2-[4-chloro-6-(3-chloro(2-thienyl))-7-cyanopyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2,2,2-trifluoroacetamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.54 (brs, 2H), 4.51 (brs, 1H), 5.41 (brs, 1H), 7.39 (m, 1H), 8.16 (m, 1H), 8.24 (s, 1H), 9.31 (m, 1H), 13.97 (brs, 1H).


ESI/MS m/e: 432.1 (M++H, C15H9ClF3N5OS2)


Example 52
Synthesis of N-{2-[7-cyano-6-(1-methylpyrrol-2-yl)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide (Compound No: 2-0604)



embedded image


The title compound was synthesized in the same manner as Example 47 using N-{2-[4-chloro-7-cyano-6-(1-methylpyrrol-2-yl)pyrrolo[3,2-d]pyrimidin-5-yl]}ethyl}-2,2,2-trifluoroacetamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 395.2 (M++H, C16H13F3N6OS)


Example 53
Synthesis of 5-(2-aminoethyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0441)



embedded image


A 5 mol/L aqueous sodium hydroxide solution (4.34 mL) was added dropwise to a solution of N-[2-(7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (4.24 g) in dioxane (100 mL) and methanol (10 mL), and the mixture was stirred for 2 hours at room temperature. A 1 mol/L hydrochloric acid was added to the reaction mixture for neutralization. The solvent was distilled off under reduced pressure, a saturated aqueous sodium bicarbonate solution was added in excess to the residue, and the produced solid was filtered out. The filtered solid was washed with a sufficient amount of water to obtain the title compound (2.69 g, yield: 84%) as a white solid.


The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=4.983 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.88 (m, 2H), 4.94 (m, 2H), 7.62 (m, 5H), 8.21 (s, 1H).


ESI/MS m/e: 296.1 (M++H, C15H13N5S)


Example 54
Synthesis of 5-(2-aminoethyl)-6-(2-furyl)-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0455)



embedded image


The title compound was synthesized in the same manner as Example 53 using N-[2-(7-cyano-6-(2-furyl)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=4.405 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.30 (m, 2H), 5.30 (m, 2H), 6.86 (m, 1H), 7.42 (d, J=3.7, 1H), 8.12 (m, 1H), 8.20 (s, 1H), 9.36 (brs, 2H).


ESI/MS m/e: 286.2 (M++H, C13H11N5OS)


Example 55
Synthesis of 5-(2-aminoethyl)-6-(3-methyl(2-furyl))-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0456)



embedded image


The title compound was synthesized in the same manner as Example 53 using N-{2-[7-cyano-6-(3-methyl(2-furyl))-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=4.966 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.17 (s, 3H), 3.34 (m, 2H), 4.94 (m, 2H), 6.71 (s, 1H), 7.99 (s, 1H), 8.24 (m, 1H), 14.00 (brs, 1H).


ESI/MS m/e: 300.3 (M++H, C14H13N5OS)


Example 56
Synthesis of 5-(2-aminoethyl)-6-(3-methyl(2-thienyl))-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0457)



embedded image


The title compound was synthesized in the same manner as Example 53 using N-{2-[7-cyano-6-(3-methyl(2-thienyl))-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=5.197 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.18 (s, 3H), 2.92 (brs, 2H), 4.64 (brs, 1H), 5.17 (brs, 1H), 7.17 (d, J=5.1, 1H), 7.88 (d, J=4.9, 1H), 8.19 (s, 1H).


ESI/MS m/e: 316.1 (M++H, C14H13N5S2)


Example 57
Synthesis of 5-(2-aminoethyl)-6-(3-chloro(2-thienyl))-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0458)



embedded image


The title compound was synthesized in the same manner as Example 53 using N-{2-[6-(3-chloro(2-thienyl))-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=5.357 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.31 (brs, 2H), 4.52 (brs, 1H), 5.35 (brs, 1H), 7.39 (d, J=5.4, 1H), 8.13 (d, J=5.4, 1H), 8.20 (s, 1H)


ESI/MS m/e: 336.1 (M++H, C13H10ClN5S2)


Example 58
Synthesis of 5-(3-aminopropyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-05031)



embedded image


The title compound was synthesized in the same manner as Example 53 using N-[3-(7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))propyl]-2,2,2-trifluoroacetamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.90-2.10 (m, 2H), 2.50-2.63 (m, 2H), 4.85 (t, J=7.0, 2H), 7.60-7.80 (m, 5H), 8.03 (brs, 3H), 8.22 (d, J=3.7, 1H), 13.96 (brs, 1H).


ESI/MS m/e: 310.2 (M++H, C16H15N5S)


Example 59
Synthesis of 5-(2-aminoethyl)-6-(2,6-difluorophenyl)-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0460)



embedded image


The title compound was synthesized in the same manner as Example 53 using N-{2-[6-(2,6-difluorophenyl)-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}-2,2,2-trifluoroacetamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.06 (t, J=7.1, 2H), 3.20-3.50 (m, 3H), 4.89 (t, J=6.8, 2H), 7.49 (t, J=8.3, 2H), 7.76-7.93 (m, 1H), 8.27 (s, 1H).


ESI/MS m/e: 332.0 (M++H, C15H11F2N5S)


Example 60
Synthesis of 5-(2-aminoethyl)-6-methyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0454)



embedded image


The title compound was synthesized in the same manner as Example 53 using N-[2-(7-cyano-6-methyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl)-2,2,2-trifluoroacetamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.56 (s, 3H), 3.13-3.27 (m, 2H), 4.92-5.06 (m, 2H), 8.08 (s, 1H), 8.49 (brs, 3H), 13.79 (brs, 1H).


ESI/MS m/e: 234.2 (M++H, C10H11N5S)


Example 61
Synthesis of 5-(2-aminoethyl)-6-(1-methylpyrrol-2-yl)-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0459)



embedded image


The title compound was synthesized in the same manner as Example 31, Example 41, Example 47 and Example 53 using 5-(2-aminoethyl)-6-(1-methylpyrrol-2-yl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.06-3.25 (m, 2H), 3.61 (s, 3H), 3.75-4.10 (m, 2H), 6.27-6.35 (m, 1H), 6.55-6.65 (m, 1H), 7.17-7.25 (m, 1H), 8.08-8.35 (m, 4H), 13.98 (brs, 1H).


ESI/MS m/e: 299.1 (M++H, C14H14N6S)


Example 62
Synthesis of 5-(2-aminoethyl)-6-cyclopropyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0440)



embedded image


The title compound was synthesized in the same manner as Example 41, Example 47 and Example 53 using N-[2-(7-cyano-6-cyclopropyl-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.05-1.35 (m, 4H), 2.25-2.37 (m, 1H), 3.25-3.47 (m, 5H), 5.15-5.28 (m, 2H), 8.19 (s, 1H).


ESI/MS m/e: 260.2 (M++H, C12H13N5S)


Example 63
Synthesis of 5-(2-aminoethyl)-6-benzo[b]thiophen-2-yl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0453)



embedded image


The title compound was synthesized in the same manner as Example 41, Example 47 and Example 53 using N-[2-(6-benzo[b]thiophen-2-yl-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.44-2.54 (m, 2H), 3.22-3.28 (m, 2H), 5.08-5.18 (m, 2H), 7.48-7.60 (m, 2H), 8.00 (s, 1H), 8.03-8.20 (m, 2H), 8.27 (s, 1H).


ESI/MS m/e: 352.0 (M++H, C17H13N5S2)


Example 64
Synthesis of N-[3-(7-cyano-6-(2-furyl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))propyl]-2,2,2-trifluoroacetamide (Compound No: 2-1955)



embedded image


The title compound was synthesized in the same manner as Example 31 using 5-(3-aminopropyl)-6-(2-furyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 380.4 (M++H, C16H12F3N5O3)


Example 65
Synthesis of N-[3-(4-chloro-7-cyano-6-(2-furyl)pyrrolo[3,2-d]pyrimidin-5-yl)propyl]-2,2,2-trifluoroacetamide



embedded image


The title compound was synthesized in the same manner as Example 41 using N-[3-(7-cyano-6-(2-furyl)-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))propyl]-2,2,2-trifluoroacetamide. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 398.3 (M++H, C16H11ClF3NsO2)


Example 66
Synthesis of N-[3-(7-cyano-6-(2-furyl)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yll)propyl]-2,2,2-trifluoroacetamide (Compound No: 2-1805)



embedded image


The title compound was synthesized in the same manner as Example 47 using N-[3-(4-chloro-7-cyano-6-(2-furyl)pyrrolo[3,2-d]pyrimidin-5-yl)propyl]-2,2,2-trifluoroacetamide. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=8.987 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.04 (m, 2H), 3.21 (m, 2H), 5.12 (m, 2H), 6.87 (m, 1H), 7.30 (d, J=3.7, 1H), 8.09 (s, 1H), 8.16 (s, 1H), 9.50 (m, 1H), 13.80 (s, 1H).


ESI/MS m/e: 396.5 (M++H, C16H12F3N5O2S)


Example 67
Synthesis of 5-(3-aminopropyl)-6-(2-furyl)-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-1082)



embedded image


The title compound was synthesized in the same manner as Example 53 using N-[3-(7-cyano-6-(2-furyl)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))propyl]-2,2,2-trifluoroacetamide. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=4.966 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.00 (m, 2H), 2.74 (m, 2H), 5.44 (brs, 2H), 6.82 (m, 1H), 7.24 (d, J=3.6, 1H), 8.03-8.15 (m, 2H).


ESI/MS m/e: 300.2 (M++H, C14H13NrOS)


Example 68
Synthesis of N-[2-(7-cyano-4-oxo-6-phenyl(3-hydropyrrolo[-3,2-d]pyrimidin-5-yl))ethyl]benzamide (Compound No: 2-0007)



embedded image


5-(2-Aminoethyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (40 mg) and pyridine (1 mL) were added to N,N-dimethylformamide (1 mL). Benzoyl chloride (44 μL) was added thereto and the mixture was stirred for 1 hour at room temperature. Water (1 mL) was added to the reaction solution and the mixture was stirred for 1 hour at room temperature. A 10% aqueous sodium carbonate solution (10 mL) was slowly added thereto, the mixture was further stirred at room temperature for 1 hour, and the produced solid was filtered out. It was then recrystallized (ethanol/ethyl acetate/hexane=1/1/2) to obtain the title compound (34 mg, yield: 70%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.47-3.51 (m, 2H), 4.54 (t, J=5.3, 2H), 7.35-7.56 (m, 10H), 8.03 (s, 1H), 8.32 (t, J=6.0, 1H), 12.47 (brs, 1H).


ESI/MS m/e: 384.2 (M++H, C22H17N5O2)


Example 69
Synthesis of N-[2-(7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yll)ethyl]benzamide (Compound No: 2-0558)



embedded image


A solution of 5-(2-aminoethyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (30 mg) in N,N-dimethylformamide (2.5 mL) was added to benzoyl chloride (29 mg), and then triethylamine (0.3 mL) was added and the mixture was stirred for 3 hours at room temperature. Water (0.3 mL) was added to the reaction solution, the mixture was further stirred for 2 hours at room temperature, and the solvent was distilled off under reduced pressure. The residue was purified by preparative HPLC to obtain the title compound (8 mg, yield: 20%) as a white solid. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=8.944 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.51 (m, 2H), 5.06 (brs, 2H), 7.31-7.54 (m, 10H), 8.22 (m, 2H), 13.84 (brs, 1H).


ESI/MS m/e: 400.5 (M+H, C22H17N5OS)


Example 70
Synthesis of 3-({N-[2-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)ethyl]carbamoyl}amino)benzoic acid (Compound No: 2-1777)



embedded image


A solution of 5-(2-aminoethyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (40 mg) in N,N-dimethylformamide (0.5 mL) and tetrahydrofuran (1 mL) was added to methyl 3-isocyanatobenzoate (35 mg), and then triethylamine (0.5 mL) was added and the mixture was stirred for 2 hours at room temperature. The solvent was distilled off under reduced pressure, and the residue was purified by preparative HPLC to obtain the reaction product. Dioxane (3 mL) and a 1 mol/L aqueous sodium hydroxide solution (0.5 mL) were added thereto, the mixture was stirred overnight at room temperature, and acetic acid was added until the solution reached neutral to quench the reaction. The solvent was distilled off under reduced pressure and the residue was purified by preparative HPLC to obtain the title compound (9.8 mg, 2-steps yield: 16%) as a white solid. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=7.685 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.37 (m, 2H), 4.93 (brs, 2H), 5.92 (m, 1H), 7.27-7.47 (m, 8H), 7.56 (d, J=7.3, 1H), 7.79 (s, 1H), 8.22 (s, 1H), 8.46 (s, 1H), 13.84 (brs, 1H).


ESI/MS m/e: 459.4 (M++H, C23H11N6O3S)


Example 71
Synthesis of (2-amino-5-methylphenyl)-N-[2-(7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]carboxamide (Compound No: 2-0635)



embedded image


A solution of 5-(2-aminoethyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (20 mg) in N,N-dimethylformamide (2 mL) was added to 2-amino-5-methylbenzoic acid (10 mg), 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride (52 mg) and N-hydroxybenzotriazole (9 mg), and then triethylamine (0.3 mL) was added and the mixture was stirred for 5 hours at room temperature. Water (0.2 mL) was added to the reaction solution and stirring was continued overnight at room temperature. The solvent was distilled off under reduced pressure, and the residue was purified by preparative HPLC to obtain the title compound (8.9 mg, yield: 16%) as a white solid. The HPLC retention-time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=7.941 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.16 (s, 3H), 3.47 (m, 2H), 5.05 (brs, 2H), 6.67 (d, J=8.0, 1H), 7.02 (m, 2H), 7.41-7.55 (m, 5H), 8.01 (brs, 1H), 8.22 (s, 1H), 13.83 (brs, 1H).


ESI/MS m/e: 429.3 (M++H, C23H20N6OS)


Example 72
Synthesis of 5-[2-(2,4-dioxo(1,3-dihydroquinazolin-3-yl))ethyl]-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 2-1849)



embedded image


Triphosgene (57 mg) and triethylamine (0.5 mL) were added to a solution of (2-aminophenyl)-N-[2-(7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]carboxamide (20 mg) in dichloromethane (2 mL), and the mixture was stirred for 2 hours at 50° C. The reaction mixture was cooled to room temperature, N,N-dimethylformamide (0.5 mL) and water (0.05 mL) were added, and the mixture was stirred for 30 minutes at room temperature. The solvent was distilled off under reduced pressure, and the residue was purified by preparative HPLC to obtain the title compound (5.3 mg, yield: 25%) as a white solid. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=8.402 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 4.19 (m, 2H), 5.37 (m, 2H), 7.08 (m, 4H), 7.28 (m, 1H), 7.48 (m, 1H), 7.62 (d, J=8.0, 1H), 7.70 (s, 1H), 7.82 (m, 2H), 8.26 (d, J=3.6, 1H), 13.90 (s, 1H).


ESI/MS m/e: 441.2 (M++H, C23H16N6O2S)


Example 73
Synthesis of 6-(3-methyl(2-thienyl))-4-oxo-5-[2-(quinazolin-4-ylamino)ethyl]-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 2-1951)



embedded image



4-chloroquinazoline (206 mg) was added to a solution of 5-(2-aminoethyl)-6-(3-methyl(2-thienyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (200 mg) in acetonitrile (4 mL), and the mixture was stirred for 8 hours at 90° C. The reaction mixture was cooled to room temperature, and the solvent was distilled off under reduced pressure. The residue was purified by preparative HPLC to obtain the title compound (88 mg, yield: 49%) as a white solid. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=5.735 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.84 (s, 3H), 3.98 (brs, 2H), 4.62 (brs, 1H), 4.95 (brs, 1H), 6.80 (d, J=5.2, 1H), 7.61 (d, J=5.1, 1H), 7.74-7.84 (m, 2H), 8.05 (m, 2H), 8.13 (d, J=8.3, 1H), 8.65 (s, 1H), 9.94 (brs, 1H), 12.57 (brs, 1H).


ESI/MS m/e: 428.2 (M++H, C22H17N7OS)


Example 74
Synthesis of 5-[2-(1,3-dioxoisoindolin-2-yl)ethyl]-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0501)



embedded image


Phthalic anhydride (40 mg) was added to a solution of 5-(2-aminoethyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (20 mg) in acetic acid (2 mL), and the mixture was stirred for 3 hours at 100° C. The reaction solution was cooled to room temperature, water (0.3 mL) was added and the mixture was stirred for about 30 minutes at room temperature, after which the solvent was distilled off under reduced pressure. The residue was purified by preparative HPLC to obtain the title compound (18 mg, yield: 63%) as a white solid. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time=9.542 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.82 (m, 2H), 5.26 (brs, 2H), 7.18 (d, J=7.6, 2H), 7.25 (t, J=7.8, 2H), 7.45 (m, 1H), 7.70 (m, 2H), 7.82 (m, 2H), 8.23 (s, 1H), 13.88 (brs, 1H).


ESI/MS m/e: 426.2 (M++H, C23H15N5O2S)


Example 75
Synthesis of N-(2-{4-[(3,3-dimethyl-3-silabutoxy)methylthiol-7-cyano-6-phenylpyrrolo[3,2-d]pyrimidin-5-yl}ethyl)-2,2,2-trifluoroacetamide



embedded image


A solution of N-[2-(7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]-2,2,2-trifluoroacetamide (2.50 g) in tetrahydrofuran (60 mL) solution was cooled to 0° C. under a nitrogen atmosphere, triethylamine (10 mL) was added thereto, and then 2-(chloromethoxy)ethyltrimethylsilane was added dropwise. The reaction system was returned to room temperature and stirred overnight, and methanol was added to quench the reaction. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate=3/1) to obtain the title compound (1.37 g, yield: 41%) as a oil. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 522.3 (M++H, C23H26F3N5O2SSi)


Example 76
Synthesis of 5-[2-(methylamino)ethyl]-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-1083)



embedded image


A solution of N-(2-{4-[(3,3-dimethyl-3-silabutoxy)methylthio]-7-cyano-6-phenylpyrrolo[3,2-d]pyrimidin-5-yl}ethyl)-2,2,2-trifluoroacetamide (520 mg) in N,N-dimethylformamide (15 mL) was cooled to 0° C. under a nitrogen atmosphere, and then sodium hydride (60 mg) was added. After stirring for 30 minutes at 0° C., methyl iodide (0.124 mL) was added dropwise. The mixture was further stirred for 1 hour at 0° C., and acetic acid was added until the solution reached neutral to quench the reaction. An excess of ethyl acetate and water were added to the reaction solution and extraction was performed with ethyl acetate. The organic layer was washed with saturated brine and then dried over anhydrous magnesium sulfate and filtered. The solvent was distilled off under reduced pressure, a mixed solvent of trifluoroacetic acid and dichloromethane (1:5) (20 mL) was added to the residue and the mixture was stirred for 2 hours at room temperature and then for 4 hours at 60° C. The reaction mixture was cooled to room temperature, ethyl acetate and saturated aqueous sodium bicarbonate were added and extraction was performed with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure. The title compound (253 mg, 3-steps yield: 82%) was obtained as a white solid from the obtained residue by reaction in the same manner as Example 53. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.99 (s, 3H), 2.77 (m, 2H), 4.95 (m, 2H), 7.66 (m, 6H), 8.22 (s, 1H).


ESI/MS m/e: 310.2 (M++H, C16H15N5S)


Example 77
Synthesis of 4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0001)



embedded image


A 28% solution of sodium methoxide in methanol (50 mL) was added to a suspension of methyl 3-amino-4-cyanopyrrole-2-carboxylate (12.5 g) in formamide (100 mL). The reaction mixture was stirred for 23 hours at 100° C. and then cooled to 0° C., and then 2 mol/L hydrochloric acid (140 mL) was added. The precipitated solid was filtered out to obtain the title compound as a crude product (12.9 g). The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 7.97 (s, 1H), 8.18 (s, 1H).


ESI/MS m/e: 161.1 (M++H, C7H4N4O)


Example 78
Synthesis of 6-bromo-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0004)



embedded image


N-bromosuccinimide (36.6 g) was added to a suspension of the crude 4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (12.9 g) in N,N-dimethylformamide (500 mL). The reaction mixture was stirred for 20 hours, water (1 L) was added and the mixture was cooled to 0° C. The precipitated solid was filtered out to obtain the title compound (9.8 g, 54%) as a light brown solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 7.99 (s, 1H), 12.44 (brs, 1H).


ESI/MS m/e: 239.1 (M++H, C7H3BrN4O)


Example 79
Synthesis of 6-(2-methoxyphenyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0038)



embedded image


6-Bromo-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (71.7 mg), 2-methoxyphenylboronic acid (137 mg), palladium acetate (3.4 mg), a 0.005 mol/L triphenylphosphine/2-propanol solution (3 mL) and a 0.2 mol/L aqueous sodium carbonate solution (3 mL) were added to a reactor filled with nitrogen gas, and then the reactor was refilled with nitrogen gas and sealed (the 2-propanol and water used were degassed). The reaction mixture was stirred for 10 hours at 100° C., the insoluble matter was filtered out while the reaction solution was still hot, and the filtrate was concentrated under reduced pressure. The obtained crude product was purified by preparative HPLC to obtain the title compound (25.8 mg, 32%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.85 (s, 3H), 7.09-7.14 (m, 1H), 7.21-7.23 (m, 1H), 7.51-7.55 (m, 2H), 8.00 (s, 1H), 12.33 (brs, 1H), 13.15 (brs, 1H).


ESI/MS m/e: 267.1 (M++H, C14H10N4O2)


Example 80
Synthesis of 6-(2-methoxyphenyl)-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-00039)



embedded image


N,N-dimethylaniline (10.7 mg) and phosphorus oxychloride (338 mg) were added to a suspension of 6-(2-methoxyphenyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (19.6 mg) in acetonitrile (2 mL). The reaction mixture was stirred for 3 hours at 100° C. and then cooled to room temperature, and the solvent was distilled off under reduced pressure. 1,4-Dioxane (1 mL), 2-propanol (1 mL) and thiourea (14.0 mg) were added to the residue and the mixture was stirred for 1 hour at 100° C. After cooling to room temperature. the solvent was distilled off under reduced pressure. The obtained crude product was purified by preparative HPLC to obtain the title compound (6.1 mg, 29%) as a light yellow solid.


The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.86 (s, 3H), 7.11-7.16 (m, 1H), 7.23-7.25 (m, 1H), 7.52-7.61 (m, 2H), 8.18 (s, 1H), 13.19 (brs, 1H), 13.77 (brs, 1H).


ESI/MS m/e: 283.2 (M++H, C14H10N4OS)


Example 81
Synthesis of 6-(3-hydroxyphenyl)-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0698)



embedded image


6-Bromo-4-oxo-3-hydropyrrolo-[3,2-d]pyrimidine-7-carbonitrile (23.9 mg), 3-(methoxymethoxy)phenylboronic acid (36.4 mg), palladium acetate (1.1 mg), a 0.005 mol/L triphenylphosphine/2-propanol solution (1 mL) and a 0.2 mol/L aqueous sodium carbonate solution (1 mL) were added to a reactor filled with nitrogen gas, and then the reactor was refilled with nitrogen gas and sealed (the 2-propanol and water used were degassed). The reaction mixture was stirred for 90 minutes at 100° C., the insoluble matter was filtered out while the reaction solution was still hot, and the filtrate was concentrated under reduced pressure. Phosphorus oxychloride (2 mL) and N,N-dimethylaniline (14.5 mg) were added to the concentrated residue, and the mixture was stirred for 1 hour at 100° C., cooled to room temperature and concentrated under reduced pressure. 1,4-Dioxane (1 mL), 2-propanol (1 mL) and thiourea (11.4 mg) were added to the concentrated residue, and the mixture was stirred for 1 hour at 100° C. The insoluble matter was filtered out while the reaction solution was still hot, and the filtrate was concentrated under reduced pressure. The obtained crude product was purified by preparative HPLC to obtain the title compound (0.5 mg, 2%) as a light yellow solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 269.1 (M++H, C13H8N4OS)


Example 82
Synthesis of 3-(7-cyano-4-thioxo-3-hydropyrrolo[4,5-d]pyrimidin-6-yl)benzoic acid (Compound No: 1-0687)



embedded image


The title compound was synthesized in the same manner as Example 81 using 3-(methoxycarbonyl)phenylboronic acid. The HPLC retention time and ESI/MS data for this compound are shown below.


HPLC retention time: 6.13 (min)


ESI/MS m/e: 297.5 (M++H, C14H6N4O2S)


Example 83
Synthesis of 4-(7-cyano-4-thioxo-3-hydropyrrolo[4,5-d]pyrimidin-6-yl)benzoic acid (Compound No: 1-0688)



embedded image


The title compound was synthesized in the same manner as Example 81 using 4-(methoxycarbonyl)phenylboronic acid. The HPLC retention time and ESI/MS data for this compound are shown below.


HPLC retention time: 5.95 (min)


ESI/MS m/e: 297.4 (M++H, C14H8N4O2S)


Example 84
Synthesis of 6-(2-aminophenyl)-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0753)



embedded image


The title compound was synthesized in the same manner as Example 81 using 2-[(tert-butoxy)carbonylamino]phenylboronic acid. The HPLC retention time and ESI/MS data for this compound are shown below.


HPLC retention time: 4.72 (min)


ESI/MS m/e: 268.5 (M++H, C13H9N5S)


Example 85
Synthesis of 6-[3-(aminomethyl)phenyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0743)



embedded image


The title compound was synthesized in the same manner as Example 81 using 3-{[(tert-butoxy) carbonylamino]methyl}phenyl]boronic acid. The HPLC retention time and ESI/MS data for this compound are shown below.


HPLC retention time: 3.87 (min)


ESI/MS m/e: 282.5 (M++H, C14H11N5S)


Example 86
Synthesis of N-{2-[7-cyano-6-(2-fluorophenyl)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl]benzamide (Compound No: 2-1956)



embedded image


The title compound was synthesized in the same manner as Example 81 using N-[2-(6-chloro-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]benzamide and 2-fluorophenylboronic acid. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time: 9.00 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.55 (m, 2H), 4.69 (m, 1H), 5.27 (m, 1H), 7.11 (m, 1H), 7.25 (m, 1H), 7.34 (m, 1H), 7.42 (m, 2H), 7.50-7.65 (m, 4H), 8.21-8.33 (m, 2H), 13.91 (brs, 1H).


ESI/MS m/e: 418.2 (M++H, C22H16FN5OS)


Example 87
Synthesis of N-{2-[7-cyano-6-(4-ethoxyphenyl)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}benzamide (Compound No: 2-1957)



embedded image


The title compound was synthesized in the same manner as Example 81 using N-[2-(6-chloro-7-cyano-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]benzamide and 4-ethoxyphenylboronic acid. The HPLC retention time and NMR and ESI/MS data for this compound are shown below.


HPLC retention time: 9.75 (min)



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.35 (t, J=7.1 Hz, 3H), 3.51 (m, 2H), 4.02 (q, J=7.1 Hz, 2H), 5.08 (brs, 2H), 6.84 (m, 2H), 7.30 (m, 2H), 7.41 (m, 2H), 7.49-7.60 (m, 3H), 8.20 (m, 2H), 13.78 (brs, 1H).


ESI/MS m/e: 444.3 (M++H, C24H21N5O2S)


Example 88
Synthesis of 6-(2-bromophenyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-1040)



embedded image


After dissolving crude [(2-bromophenyl)methoxymethylene]methane-1,1-dicarbonitrile (1.4 g) in methanol, glycine methyl ester hydrochloride (0.80 g) was added and the mixture was stirred at room temperature while slowly adding dropwise a 28% solution of sodium methoxide in methanol (4.0 g). The reaction mixture was heated to reflux for 1 hour and then cooled to room temperature, formamide (2.0 mL) was added and the mixture was further heated to reflux for 12 hours. After adding 50 mL of water and 50 mL of ethyl acetate to the reaction mixture, the product was extracted with ethyl acetate, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate=1/1) to obtain the title compound (55 mg, 3.3%) as a light yellow solid. The HPLC retention time and ESI/MS data for this compound are shown below.


HPLC retention time: 9.6 (min)


ESI/MS m/e: 315.1, 317.1 (M++H, C13H7BrN4O)


Example 89
Synthesis of 6-(2-bromophenyl)-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0751)



embedded image


The title compound was synthesized in the same manner as Example 80 using 6-(2-bromophenyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile. The HPLC retention time and ESI/MS data for this compound are shown below.


HPLC retention time: 8.2 (min)


ESI/MS m/e: 331.1, 333.2 (M++H, C13H7BrN4O)


Example 90
Synthesis of 6-methyl-4-oxo-5-benzyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0309)



embedded image


Formamide (1 mL) and a 28% solution of sodium methoxide in methanol (1 mL) were added to a solution of methyl 3-amino-4-cyano-1-benzyl-5-methylpyrrole-2-carboxylate (100 mg) in dimethylsulfoxide (2 mL), and the mixture was heated to reflux for 4 hours at 100° C. After cooling to room temperature, water (5 mL) and 2 mol/L hydrochloric acid (5 mL) were added to acidify the solution. After stirring the mixture for a while at room temperature, the produced solid was filtered out. It was then recrystallized (ethanol) to obtain the title compound (68.7 mg, yield: 70%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.39 (s, 3H), 5.74 (s, 2H), 7.10-7.12 (m, 2H), 7.25-7.35 (m, 3H), 7.98 (t, J=3.7, 1H), 12.4 (brs, 1H).


ESI/MS m/e: 265.2 (M++H, C15H12N4O)


Example 91
Synthesis of 6-(3,5-dihydroxyphenyl)-5-[3-(methylethoxy)propyl]-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0863)



embedded image


After dissolving 6-[3,5-bis(phenylmethoxy)phenyl]-5-[3-(methylethoxy)propyl]-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (1.06 g) in ethanol (50 mL), palladium-active carbon (700 mg) was added and the mixture was stirred for 3 hours at 50° C. under a hydrogen atmosphere. After cooling to room temperature, the catalyst was filtered off with celite and the solvent was distilled off to obtain the crude title compound (710 mg, yield: 100%) as a light green liquid. The crude product was purified by preparative HPLC to obtain the title compound as a colorless solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 369.3 (M++H, C19H20N4O4)


Example 92
Synthesis of 5-acetoxy-3-{7-cyano-5-[3-(methylethoxy)propyl]-4-[(trifluoromethyl)sulfonyloxy]pyrrolo[4,5-d]pyrimidin-6-yl}phenyl acetate



embedded image


After dissolving 5-acetoxy-3-{7-cyano-5-[3-(methylethoxy)propyl]-4-oxo(3-hydropyrrolo[4,5-d]pyrimidin-6-yl)}phenylacetate (78.3 mg) in methylene dichloride (2.0 mL), pyridine (48.5 μL) was added dropwise thereto and the mixture was cooled to 0° C. Trifluoromethanesulfonic anhydride (50.5 μL) was added dropwise and the mixture was stirred for 3 hours at room temperature. Water was then added to the reaction solution. The solution was extracted 3 times with ethyl acetate, and the organic layer was washed with saturated brine and dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The title compound (116.9 mg, yield: 100%) was obtained as a colorless oil. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 585.4 (M++H, C24H23F3N4O8S)


Example 93
Synthesis of 5-acetoxy-3-[7-cyano-5-[3-(methylethoxy)propyl]-4-thioxo(3-hydropyrrolo[4,5-d]pyrimidin-6-yl)}phenylacetate (Compound No: 1-1078)



embedded image



5-acetoxy-3-{7-cyano-5-[3-(methylethoxy)propyl]-4-[(trifluoromethyl)sulfonyloxy]pyrrolo[4,5-d]pyrimidin-6-yl}phenylacetate (116.9 mg) was dissolved in 2-propanol (2.0 mL), and then thiourea (22.8 mg) was added and the mixture was stirred for 2 hours at 100° C. The reaction solution was cooled and water was added thereto. The solution was extracted 3 times with ethyl acetate, and the organic layer was washed with saturated brine and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=2/1) to obtain the title compound (6.0 mg, yield: 6%) as a colorless oil.


ESI/MS m/e: 469.4 (M++H, C23H24N4O5S)


Example 94
Synthesis of 6-(3,5-dihydroxyphenyl)-5-[3-(methylethoxy)propyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0529)



embedded image


The title compound was obtained in the same manner as Example 53 using 5-acetoxy-3-{7-cyano-5-[3-(methylethoxy)propyl]-4-thioxo(3-hydropyrrolo[4,5-d]pyrimidin-6-yl)}phenylacetate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 0.88 (d, J=6.1, 6H), 1.79-1.90 (m, 2H), 3.18 (t, J=6.1, 2H), 3.20-3.31 (m, 1H), 4.86 (t, J=6.6, 2H), 6.35-6.47 (m, 3H), 8.17 (d, J=3.6, 1H), 9.77 (brs, 2H), 13.7 (brs, 1H).


ESI/MS m/e: 385.3 (M++H, C19H20N4O3S)


Example 95
Synthesis of 6-(4-aminophenyl)-5-[3-(methylethoxy)propyl]-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0864)



embedded image


5-[3-(methylethoxy)propyl]-6-(4-nitrophenyl)-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (0.381 g) was dissolved in ethanol (10 mL), palladium-active carbon (0.038 g) was added, and the mixture was stirred for 2 days at room temperature under a hydrogen atmosphere. The palladium-active carbon was filtered off with celite, and the solvent was distilled off under reduced pressure. After dissolving the residue in ethyl acetate (20 mL) and adding 1 mol/L hydrochloric acid (20 mL), the mixture was stirred and the aqueous layer was separated off. The organic layer was extracted twice with 1 mol/L hydrochloric acid (20 mL) and the aqueous layer was combined with the previous aqueous layer. The combined aqueous layers were washed with a 1:1 mixed solvent of ethyl acetate and hexane, and then the pH was adjusted to 8 with a 5 mol/L aqueous sodium hydroxide solution. The solution was extracted 3 times with ethyl acetate and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The title compound (0.292 g, yield: 83%) was obtained as a brown solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 352.2 (M++H, C19H21N5O2 HCl)


Example 96
Synthesis of N-(4-{7-cyano-5-[3-(methylethoxy)propyl]-4-oxo(3-hydropyrrolo[4,5-d]pyrimidin-6-yl)}phenyl)-2,2,2-trifluoroacetamide (Compound No: 1-1079)



embedded image


6-(4-aminophenyl)-5-[3-(methylethoxy)propyl]-4-oxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (0.292 g) was suspended in tetrahydrofuran (1.0 mL), trifluoroacetic anhydride (0.344 mL) was added and the mixture was stirred at 0° C. Pyridine (0.403 mL) was added to the solution, and the mixture was stirred for 2 hours at room temperature. Methanol was added to quench the reaction, and the solvent was distilled off under reduced pressure. The residue was diluted with ethyl acetate and water, and then the solution was extracted 3 times with ethyl acetate. The organic layer was washed with saturated brine and then dried over magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. The title compound (0.338 g, yield: 91%) was obtained as a brown solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 448.4 (M++H, C21H20F3N5O3)


Example 97
Synthesis of N-(4-{4-chloro-7-cyano-5-[3-(methylethoxy)propyl]pyrrolo[4,5-d]pyrimidin-6-yl}phenyl)-2,2,2-trifluoroacetamide



embedded image


N-(4-{7-cyano-5-[3-(methylethoxy)propyl]-4-oxo(3-hydropyrrolo[4,5-d]pyrimidin-6-yl)}phenyl)-2,2,2-trifluoroacetamide (36.7 mg) was dissolved in acetonitrile (2.5 mL) and phosphorus oxychloride (5.0 mL), and the mixture was stirred for 2.5 hours at 100° C. The volatile matter was distilled off under reduced pressure to obtain the title compound (0.349 g, yield: 100%) as a brown solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 466.2 (M++H, C21H19ClF3N5O2)


Example 98
Synthesis of N-(4-{7-cyano-5-[3-(methylethoxy)propyl]-4-thioxo(3-hydropyrrolo[4,5-d]pyrimidin-6-yl)}phenyl)-2,2,2-trifluoroacetamide (Compound No: 1-10801



embedded image


N-(4-{4-chloro-7-cyano-5-[3-(methylethoxy)propyl]pyrrolo[4,5-d]pyrimidin-6-yl}phenyl)-2,2,2-trifluoroacetamide (0.349 g) was dissolved in 2-propanol (7.5 mL), and then thiourea (0.086 g) was added and the mixture was stirred for 1.5 hours at 100° C. The reaction mixture was cooled and water was added thereto. After filtering out the solid, it was dried under reduced pressure to obtain the title compound (0.344 g, yield:


99%) as a brown solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 464.3 (M++H, C21H20F3N5O2S)


Example 99
Synthesis of 6-(4-aminophenyl)-5-[3-(methylethoxy)propyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (Compound No: 1-0530)



embedded image


N-(4-{7-cyano-5-[3-(methylethoxy)propyl]-4-thioxo(3-hydropyrrolo[4,5-d]pyrimidin-6-yl)}phenyl)-2,2,2-trifluoroacetamide (0.344 g) was dissolved in methanol (5.0 mL), and then a 5 mol/L aqueous sodium hydroxide solution (2.5 mL) was added dropwise and the mixture was stirred for 1 hour at room temperature. After adding 1 mol/L hydrochloric acid to the reaction solution to adjust the pH to about 6, the solvent was distilled off under reduced pressure. The residue was dissolved in methanol, and the solid was filtered off. The filtrate was concentrated under reduced pressure, and the residue was dried under reduced pressure to obtain the title compound (0.299 g, yield: 100%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 0.42 (d, J=6.1, 6H), 1.25-1.42 (m, 2H), 2.62-2.75 (m, 2H), 2.75-2.85 (m, 1H), 3.15 (brs, 3H), 4.41 (t, J=6.6, 2H), 6.30 (d, J=8.3, 2H), 6.85 (d, J=8.6, 2H), 7.67 (d, J=3.7, 2H), 13.84 (brs, 1H).


ESI/MS m/e: 368.4 (M++H, C19H21N50S HCl)


Example 100
Synthesis of 5-[3-(methylethoxy)propyl]-6-{4-[benzylamino]phenyl}-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0531)



embedded image


6-(4-aminophenyl)-5-[3-(methylethoxy)propyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (40.4 mg) was dissolved in chloroform (0.9 mL) and acetic acid (0.1 mL), and then benzaldehyde (15.9 mg) was added dropwise and the mixture was stirred for 1 hour at room temperature. Sodium triacetoxyborohydride (42.4 mg) was added to the solution, and reaction was stirreded at room temperature for 5 hours. The reaction solution was concentrated under reduced pressure and the residue was purified by preparative HPLC to obtain the title compound (11.2 mg, yield: 20%) as a white solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 458.3 (M++H, C26H27N5OS)


Example 101
Synthesis of N-(4-{7-cyano-5-[3-(methylethoxy)propyl]-4-thioxo(3-hydropyrrolo[4,5-d]pyrimidin-6-yl)}phenyl)-2-methoxyacetamide (Compound No: 1-0536)



embedded image


6-(4-Aminophenyl)-5-[3-(methylethoxy)propyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (40.4 mg) was dissolved in N,N-dimethylformamide (1.0 mL), and then methoxyacetyl chloride (41.0 mg) and triethylamine (83.2 μL) were added and the mixture was stirred for 2 hours at room temperature. Water (1.0 mL) and 2 mol/L aqueous sodium hydroxide (100 μL) were added to the solution and the mixture was stirred for 1 hour at room temperature. After adding 1 mol/L hydrochloric acid to the reaction solution to adjust the pH to about 6, the solvent was distilled off under reduced pressure. The residue was purified by preparative HPLC to obtain the title compound (6.7 mg, yield: 14%) as a white solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 440.3 (M++H, C22H25N5O3S)


Example 102
Synthesis of 3-[(3,3-dimethyl-3-silabutoxy)methyl]-5-(3-hydroxypropyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile



embedded image


A suspension of sodium hydride (143 mg) in tetrahydrofuran (12 mL) was cooled to 0° C. A solution of 5-(3-hydroxypropyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (1.00 g) in N,N-dimethylformamide (17 mL) was then added dropwise thereto. After stirring the reaction mixture at room temperature for 1 hour, it was again cooled to 0° C., and a solution of 2-(chloromethoxy)ethyl-trimethylsilane (0.68 mL) in tetrahydrofuran (5 mL) was added dropwise thereto. After stirring the reaction mixture at room temperature for 2 hours, saturated brine (100 mL) was added to the reaction solution. The solution was extracted 3 times with ethyl acetate and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=1/1) to obtain the title compound (1.28 g, yield: 89%) as a colorless viscous oil. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 0.00 (s, 9H), 0.85-0.99 (m, 2H), 1.72-1.87 (m, 2H), 2.50-2.56 (m, 1H), 3.22-3.32 (m, 2H), 3.66 (t, J=8.0, 2H), 4.35-4.50 (m, 2H), 5.45 (s, 2H), 7.60-7.70 (m, 5H), 8.46 (s, 1H).


ESI/MS m/e: 425.3 (M++H, C22H28N4O3Si)


Example 103
Synthesis of 3-[(3,3-dimethyl-3-silabutoxy) methyl]-4-oxo-6-phenyl-5-(3-phenoxypropyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile



embedded image


A solution of triphenylphosphine (191 mg) in tetrahydrofuran (3.0 mL) was cooled to 0° C. Diethyl azodicarboxylate (327 mg, 40% toluene solution) was added dropwise to the solution and the mixture was stirred for 5 minutes. After further adding dropwise a solution of 3-[(3,3-dimethyl-3-silabutoxy)methyl]-5-(3-hydroxypropyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (212 mg) in tetrahydrofuran (1.0 mL), a solution of phenol (71 mg) in tetrahydrofuran (1.0 mL) was also added dropwise and the mixture was stirred for 4 hours at room temperature. Saturated brine was added to quench the reaction, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with saturated brine and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane/ethyl acetate=3:1) to obtain the title compound (248 mg, yield: 99%) as a white solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 501.4 (M++H, C28H32N4O3Si)


Example 104
Synthesis of 3-{3-[(3,3-dimethyl-3-silabutoxy)methyl]-7-cyano-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidin-5-yl}propyl methylsulfonate



embedded image


Tetrahydrofuran (10 mL) was cooled to 0° C., methanesulfonyl chloride (186 mg) and triethylamine (333 μL) were added dropwise and the mixture was stirred for 5 minutes at room temperature. The reaction mixture was again cooled to 0° C., a solution of 3-[(3,3-dimethyl-3-silabutoxy)methyl]-5-(3-hydroxypropyl)-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (849 mg) in tetrahydrofuran (10 mL) was added dropwise and the mixture was stirred for 4 hours at room temperature. Saturated brine was added to the reaction solution. Extraction was then performed 3 times with ethyl acetate, and the organic layer was washed with saturated brine and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane/ethyl acetate=2:1) to obtain the title compound (891 mg, yield: 89%) as white oil. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 503.4 (M++H, C23H30N4O5SSi)


Example 105
Synthesis of 3-[(3,3-dimethyl-3-silabutoxy)methyl]-5-{3-[2-(2-methoxyethyl)ethoxy]propyl}-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile



embedded image


A suspension of sodium hydride (53 mg) in tetrahydrofuran (3.9 mL) was cooled to 0° C. A solution of 2-(2-methoxyethoxy)ethanol (159 mg) in tetrahydrofuran (2.0 mL) was then added dropwise thereto. After stirring the reaction mixture at 0° C. for 30 minutes, a solution of 3-{3-[(3,3-dimethyl-3-silabutoxy)methyl]-7-cyano-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidin-5-yl}propyl methylsulfonate (445 mg) in tetrahydrofuran (3.0 mL) was added dropwise thereto. The reaction mixture was stirred at room temperature for 15 hours, and saturated brine was added thereto. The solution was extracted 3 times with ethyl acetate and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=1/1) to obtain the title compound (180 mg, yield: 89%) as a colorless rubber substance. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 527.6 (M++H, C27H38N4O5Si)


Example 106
Synthesis of 3-[(3,3-dimethyl-3-silabutoxy) methyl]-4-oxo-6-phenyl-5-(3-phenoxypropyl)-3-hydropyrrolo [3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0537)



embedded image


3-[(3,3-Dimethyl-3-silabutoxy)methyl]-4-oxo-6-phenyl-5-(3-phenoxypropyl)-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (248 mg) was dissolved in a mixed solvent of methylene dichloride (4.0 mL) and trifluoroacetic acid (1.0 mL), and the mixture was stirred for 2 hours at room temperature. The solvent was distilled off under reduced pressure and the residue was purified by preparative HPLC. The purified compound was dissolved in phosphorus oxychloride (2.0 mL) and the mixture was stirred for 1 hour at 100° C. The solvent was distilled off under reduced pressure, the residue was dissolved in 2-propanol (5.0 mL), thiourea (57 mg) was added and the mixture was stirred for 1 hour at 100° C. After cooling the reaction solution, saturated brine was added. The solution was extracted 3 times with ethyl acetate and then washed with saturated brine and dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by preparative HPLC to obtain the title compound (3.2 mg, yield: 2%) as a white solid.


ESI/MS m/e: 387.3 (M++H, C22H18N4OS)


Example 107
Synthesis of 6-phenyl-5-{2-[benzylamino]ethyl}-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 2-1775)



embedded image


5-(3-Aminoethyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile hydrochloride (14.8 mg) was dissolved in chloroform (0.45 mL) and acetic acid (0.05 mL), and then benzaldehyde (8.0 mg) was added dropwise, sodium triacetoxyborohydride (21.2 mg) was added, and reaction was stirred at room temperature for 2 hours. The reaction solution was concentrated under reduced pressure and the residue was purified by preparative HPLC to obtain the title compound (4.9 mg, yield: 20%) as a white solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 386.3 (M++H, C22H19N5S) CL Example 108


Synthesis of 6-phenyl-5-[2-(3-phenyl(1,2,4-oxadiazol-5-yl))ethyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 1-0495)



embedded image


Benzamidoxime (27.2 mg) and 1-ethyl-3-(3′-diethylaminopropyl)carbodiimide hydrochloride (38.3 mg) were added to a solution of 3-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoic acid (32.4 mg) in N,N-dimethylformamide (1.0 mL), and then triethylamine (27.7 μL) was added dropwise and reaction was stirred at room temperature for 2 hours. The reaction solution was then stirred for 2 hours at 100° C., and saturated brine was added thereto. The reaction solution was extracted 3 times with ethyl acetate and then the organic layer was washed with saturated brine and dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure and the residue was purified by preparative HPLC to obtain the title compound (6.1 mg, yield: 14%) as a white solid. The ESI/MS data for this compound are shown below.


ESI/MS m/e: 425.2 (M++H, C23H16N6OS)


Example 109
Synthesis of 4-chloro-6-phenylpyrrolo[3,2-d]pyrimidine-7-carbonitrile



embedded image


4-Oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (2.36 g) was dissolved in acetonitrile (20 mL) and phosphorus oxychloride (20 mL) and the mixture was stirred for 7 hours at 100° C. The reaction mixture as cooled to room temperature, and the precipitated solid was filtered out. The solid was washed with acetonitrile to obtain the title compound (2.32 g, yield: 91%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 7.60-7.80 (m, 3H), 7.97-8.13 (m, 2H), 8.82 (s, 1H), 13.73 (brs, 1H).


ESI/MS m/e: 255.2 (M++H, C13H7ClN4)


Example 110
Synthesis of ethyl 3-(7-cyano-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoate (Compound No: 4-0004)



embedded image


Crude ethyl 3-[4-amino-3-cyano-5-(methoxycarbonyl)-2-phenylpyrrolyl]propanoate (35.31 g) and formamidine acetate (215.2 g) were added to 2-propanol (1500 mL), and the mixture was heated to reflux for 40 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure. Water was added to the residue and the insoluble matter was filtered out. The solid was recrystallized (ethyl acetate/hexane=1/5) to obtain the title compound (20.74 g, 3-steps yield from (methoxyphenylmethylene)methane-1,1-dicarbonitrile: 75%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.03 (t, J=7.1, 3H), 2.75 (t, J=7.3, 2H), 3.90 (dd, J=7.1, 2H), 4.54 (t, J=7.3, 2H), 7.61-7.63 (m, 5H), 8.05 (s, 1H), 12.52 (brs, 1H).


ESI/MS m/e: 337.3 (M++H, C19H16N4O3)


Example 111
Synthesis of ethyl 3-[7-cyano-6-(3-methyl(2-furyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl]propanoate (Compound No: 4-0328)



embedded image


The title compound was synthesized in the same manner as Example 110 using ethyl 3-[4-amino-3-cyano-5-(methoxycarbonyl)-2-(3-methyl(2-furyl)pyrrolyl)propanoate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.07 (t, J=7.1, 3H), 2.12 (s, 3H), 2.74 (t, J=7.3, 2H), 3.94 (q, J=7.1, 2H), 4.58 (t, J=7.3, 2H), 6.68 (d, J=2.0, 1H), 7.95 (d, J=1.7, 1H), 8.04 (s, 1H).


ESI/MS m/e: 341.2 (M++H, C17H16N4O4S)


Example 112
Synthesis of ethyl 3-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoate (Compound No: 4-00051)



embedded image


Phosphorus oxychloride (16.90 g) was added to ethyl 3-(7-cyano-4-oxo-6-phenyl-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoate (935.0 mg), and the mixture was stirred for 1 hour at 100° C. After cooling to room temperature, the phosphorus oxychloride was distilled off under reduced pressure. 2-Propanol (40 mL) and thiourea (262.3 mg) were added to the residue and the mixture was heated to reflux for 1 hour. After cooling to room temperature, the solvent was distilled off under reduced pressure. Ethyl acetate and water were added to the residue, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=3/1→2/1) to obtain the title compound (470.5 mg, yield: 48%) as a light yellow solid compound. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.04 (t, J=7.1, 3H), 2.78 (t, J=7.6, 2H), 3.91 (dd, J=7.1, 2H), 4.95 (t, J=8.0, 2H), 7.60-7.70 (m, 5H), 8.22 (s, 1H), 13.9 (brs, 1H)


ESI/MS m/e: 353.1 (M++H, C18H16N4O2S)


Example 113
Synthesis of ethyl 3-[7-cyano-6-(3-methyl(2-furyl))-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl]propanoate (Compound No: 4-0329)



embedded image


The title compound was synthesized in the same manner as Example 112 using ethyl 3-[7-cyano-6-(3-methyl(2-furyl))-4-oxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl]propanoate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.10 (t, J=6.6, 3H), 2.15 (s, 3H), 2.87 (t, J=7.6, 2H), 3.97 (q, J=7.1, 2H), 4.96 (t, J=7.3, 2H), 6.71 (s, 1H), 7.99 (s, 1H), 8.20 (d, J=3.6, 1H), 13.90 (brs, 1H).


ESI/MS m/e: 357.2 (M++H, C17H16N4O3S


Example 114
Synthesis of 3-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]-pyrimidin-5-yl)propanecarboxylic acid (Compound No: 4-0001)



embedded image


Ethyl 3-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoate (151.4 mg) was dissolved in 1,4-dioxane (4.0 mL), and a 1N aqueous sodium hydroxide solution (4.0 mL) was added while cooling to 0° C. After stirring for 10 minutes at room temperature, 1N aqueous hydrochloric acid (5.0 mL) was added. The precipitated solid was filtered out and washed with water. The solid was dried under reduced pressure to obtain the title compound (134.7 mg, yield: 97%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.72 (t, J=7.8, 2H), 4.87 (t, J=7.8, 2H), 7.52-7.60 (m, 5H), 8.22 (s, 1H), 12.38 (brs, 1H), 13.87 (brs, 1H).


ESI/MS m/e: 325.1 (M++H, C16H12N4O2S)


Example 115
Synthesis of 3-[7-cyano-6-(3-methyl(2-furyl))-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl]propanoic acid (Compound No: 4-0107)



embedded image


The title compound was synthesized in the same manner as Example 114 using ethyl 3-[7-cyano-6-(3-methyl(2-furyl))-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl]propanoate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.14 (s, 3H), 2.78-2.90 (m, 2H), 4.82-4.97 (m, 2H), 6.70 (d, J=1.7, 1H), 8.00 (d, J=1.7, 1H), 8.19 (d, J=3.4, 1H), 12.45 (brs, 1H), 13.96 (brs, 1H).


ESI/MS m/e: 329.2 (M++H, C11H12N4O3S)


Example 116
Synthesis of 3-(7-cyano-6-cyclopropyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoic acid (Compound No: 4-0092)



embedded image


The title compound was synthesized in the same manner as Example 114 using ethyl 3-(7-cyano-6-cyclopropyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoate. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.05-1.25 (m, 4H), 2.26 (m, 1H), 2.85 (t, J=7.8, 2H), 5.13 (t, J=7.8, 2H), 8.11 (s, 1H), 12.49 (brs, 1H), 13.69 (brs, 1H).


ESI/MS m/e: 289.2 (M++H, C13H12N4O2S)


Example 117
Synthesis of 3-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)-N-benzylpropanamide propanoate (Compound No: 3-0116)



embedded image


3-(7-Cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanecarboxylic acid (30.0 mg), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (60.0 mg) and triethylamine (50 μL) were added to dichloromethane (4.0 mL), and the mixture was stirred for 10 minutes at room temperature. Benzylamine (50 μL) was added thereto and stirring was continued for 3 hours at room temperature. Saturated aqueous ammonium chloride solution (4.0 mL) was added to the reaction solution and extraction was performed 3 times with dichloromethane. The organic phase was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate from the organic layer, the solvent was distilled off under reduced pressure. The obtained crude product was purified by preparative HPLC to obtain the title compound (20.7 mg, 54%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.56 (t, J=7.1, 2H), 4.05 (d, J=5.8, 2H), 4.91 (t, J=7.1, 2H), 7.03 (d, J=6.8, 2H), 7.10-7.25 (m, 3H), 7.53-7.58 (m, 5H), 8.15 (s, 1H), 8.21 (t, J=5.9, 1H), 13.7 (brs, 1H).


ESI/MS m/e: 414.3 (M++H, C23H19N5OS)


Example 118
Synthesis of 1-[3-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoyl]piperidine-4-carboxylic acid (Compound No: 3-0231)



embedded image


Ethyl 1-[3-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)propanoyl]piperidine-4-carboxylic acid (50.4 mg) was dissolved in 1,4-dioxane (4.0 mL), and a 1N aqueous sodium hydroxide solution (4.0 mL) was added while cooling to 0° C. After stirring for 30 minutes at room temperature, 1N hydrochloric acid (5.0 mL) was added. Ethyl acetate and water were added thereto, and extraction was performed 3 times with ethyl acetate. The organic layer was washed with water and saturated brine and then dried over anhydrous magnesium sulfate. After filtering off the magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by preparative HPLC to obtain the title compound (23.5 mg, 50%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.


ESI/MS m/e: 436.2 (M++H, C22H21N5O3S)


Example 119
Synthesis of 3-[7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]-N-methoxy-N-methylpropanamide (Compound No: 3-0037)



embedded image


3-(7-cyano-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidin-5-yl)-N-methoxy-N-methylpropanoic acid (0.487 g) was dissolved in methylene chloride (15 mL), and then N,O-dimethylhydroxylamine hydrochloride (0.585 g) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride (1.150 g) were added and the mixture was stirred at 0° C. Triethylamine (0.83 mL) was then added and the mixture was stirred for 4 hours at room temperature. Aqueous saturated brine was added to quench the reaction, and the organic layer was separated off. The aqueous layer was extracted 3 times with ethyl acetate. The organic layer was washed with saturated brine and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure to obtain the title compound (0.551 g, yield: 100%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 2.87 (brt, J=7.6, 2H), 2.96 (s, 3H), 3.50 (s, 3H), 4.90 (brt, J=7.1, 2H), 7.60-7.69 (m, 5H), 8.21 (s, 1H), 13.84 (brs, 1H).


ESI/MS m/e: 368.4 (M++H, C18H17N5O2S)


Example 120
Synthesis of 5-(3-oxoheptyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 5-0181)



embedded image


3-[7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]-N-methoxy-N-methylpropanamide (36.7 mg) was dissolved in tetrahydrofuran (1.0 mL) and the solution was stirred at −78° C. n-Butyllithium (192 μL, 1.56 mol/L hexane solution) was added dropwise to the solution and the mixture was stirred for 1 hour at −78° C. Saturated aqueous brine was added to quench the reaction, and the pH was adjusted to 5 with 1 mol/L hydrochloric acid. The solution was extracted 3 times with ethyl acetate. The organic layer was washed with saturated brine and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The obtained crude product was purified by preparative HPLC to obtain the title compound (18.2 mg, yield: 50%) as a white solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 0.78 (t, J=7.8, 3H), 1.14 (q, J=7.3, 2H), 1.33 (q, J=7.3, 2H), 2.27 (t, J=7.3, 2H), 2.94 (t, J=6.8, 2H), 4.85 (t, J=6.6, 2H), 7.57-7.71 (m, 5H), 8.21 (s, 1H), 13.82 (brs, 1H).


ESI/MS m/e: 365.3 (M++H, C20H20N4OS)


Example 121
Synthesis of 5-(3-oxo-3-phenylpropyl)-6-phenyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 5-0006)



embedded image


3-(7-cyano-6-phenyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)-N-methoxy-N-methylpropanamide (36.7 mg) was dissolved in tetrahydrofuran (1.0 mL), and the mixture was stirred at 0° C. Phenylmagnesium bromide (100 μL, 3.0 mol/L diethyl ether solution) was added dropwise to the solution and the mixture was stirred for 2 hours at 0° C. A saturated aqueous brine solution was added to quench the reaction, and the pH was adjusted to 5 with 1 mol/L hydrochloric acid. The solution was then extracted 3 times with ethyl acetate. The organic layer was washed with saturated brine and then dried over sodium sulfate. After filtering off the sodium sulfate, the solvent was distilled off under reduced pressure. The obtained crude product was purified by preparative HPLC to obtain the title compound (10.1 mg, yield: 26%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 3.60 (t, J=6.8, 2H), 5.02 (t, J=6.6, 2H), 7.47 (t, J=7.6, 2H), 7.58-7.49 (m, 6H), 7.84 (d, J=8.0, 2H), 8.23 (s, 1H), 13.88 (brs, 1H).


ESI/MS m/e: 385.1 (M++H, C22H16N4OS)


Example 122
Synthesis of 6-azaperhydroazepinyl-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 6-0061)



embedded image


Hexamethyleneimine (236 mg) was added to 5-[3-(methylethoxy)propyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (40 mg), and the mixture was stirred for 2 hours at 80° C. After cooling to room temperature, methanol (3 mL) was added to the reaction mixture. The mixture was passed through a cation-exchange resin column and the eluate was collected, after which methanol (3 mL) was passed through and the eluate was collected. The collected eluates were concentrated under reduced pressure to obtain the title compound (10.5 mg, 22%). The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 1.45-1.75 (m, 8H), 3.69 (t, J=6.1, 4H), 7.97 (s, 1H), 8.7 (brs, 1H), 13.9 (brs, 1H).


ESI/MS m/e: 374.3 (M++H, C13H15N5S)


Example 123
Synthesis of 6-(cyclopropylamino)-5-[3-(methylethoxy)propyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (Compound No: 6-0273)



embedded image


Cyclopropylamine (196 mg) was added to 5-[3-(methylethoxy)propyl]-4-thioxo-3-hydropyrrolo[3,2-d]pyrimidine-7-carbonitrile (40 mg), and the mixture was stirred for 4 hours at 80° C. After cooling to room temperature, methanol (3 mL) was added. The mixture was passed through a cation-exchange resin column and the eluate was collected, after which methanol (3 mL) was passed through and the eluate was collected. The collected eluates were concentrated under reduced pressure to obtain the title compound (6.3 mg, 15%). The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 0.68-0.75 (m, 2H), 0.93-0.99 (m, 2H), 1.20 (d, J=6.1, 6H), 2.12 (d, J=6.1, 2H), 2.93 (m, 1H), 3.40 (t, J=5.4, 2H) 3.66 (tt, J=6.1, 1H) 7.88 (s, 1H), 10.4 (brs, 1H).


ESI/MS m/e: 332.3 (M++H, C16H21N5OS)


Example 124
Synthesis of N-{2-[7-cyano-6-(cyclopropylamino)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}benzamide (Compound No: 6-0413)



embedded image


Acetonitrile (3 mL) and cyclopropylamine (3 mL) were added to crude N-[2-(6-chloro-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl]benzamide (136 mg), and the mixture was stirred for 4 hours at 80° C. The crude product obtained by concentration of the reaction mixture under reduced pressure was purified by preparative HPLC to obtain the title compound (10.3 mg, 8%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 0.62 (m, 2H), 0.74-0.79 (m, 2H), 2.79 (m, 1H), 3.55-3.59 (m, 2H), 4.93 (brs, 2H), 7.43-7.55 (m, 3H), 7.76-7.79 (m, 2H), 8.00-8.05 (m, 2H), 8.63 (m, 1H) 13.2 (brs, 1H).


ESI/MS m/e: 379.1 (M++H, C19H18N6OS)


Example 125
Synthesis of N-{2-[6-(dimethylamino)-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}(4-fluorophenyl)carboxamide (Compound No: 6-1029)



embedded image


An aqueous dimethylamine solution (2 mL) was added to crude N-[2-(6-chloro-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl](4-fluorophenyl)carboxamide (80 mg), and the mixture was stirred for 2 hours at 50° C. After cooling to room temperature, the mixture was concentrated under reduced pressure, and the obtained crude product was purified by preparative HPLC to obtain the title compound (7.5 mg, 9%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 2.90 (s, 6H), 3.46 (m, 2H), 4.96 (brs, 2H), 7.27 (m, 2H), 7.77 (m, 2H), 8.10 (s, 1H), 8.34 (m, 1H), 13.46 (brs, 1H).


ESI/MS m/e: 385.3 (M++H, C18H17FN6OS)


Example 126
Synthesis of N-[2-(7-cyano-6-pyrrolidinyl-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl](4-fluorophenyl)carboxamide (Compound No: 6-10311



embedded image


Pyrrolidine (2 mL) was added to crude N-[2-(6-chloro-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl](4-fluorophenyl)carboxamide (80 mg), and the mixture was stirred for 2 hours at 50° C. After cooling to room temperature, the mixture was concentrated under reduced pressure, and the obtained crude product was purified by preparative HPLC to obtain the title compound (7.3 mg, 8%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, CDCl3) δ (ppm): 1.79 (m, 4H), 3.36-3.70 (m, 6H), 5.19 (brs, 2H), 7.29 (m, 2H), 7.79 (m, 2H), 8.06 (m, 1H), 8.39 (m, 1H), 13.25 (brs, 1H).


ESI/MS m/e: 411.3 (M++H, C20H19FN6OS) Example 127.


Synthesis of N-{2-[7-cyano-6-(cyclobutylamino)-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl)]ethyl}(4-fluorophenyl)carboxamide (Compound No: 6-1027)



embedded image


Cyclobutylamine (2 mL) was added to crude N-[2-(6-chloro-7-cyano-4-thioxo(3-hydropyrrolo[3,2-d]pyrimidin-5-yl))ethyl](4-fluorophenyl)carboxamide (70 mg), and the mixture was stirred for 6 hours at 80° C. After cooling to room temperature, the mixture was concentrated under reduced pressure and methanol (3 mL) was added thereto. The mixture was passed through a cation-exchange resin column and the eluate was collected, after which methanol (3 mL) was passed through and the eluate was collected. The collected eluates were concentrated under reduced pressure and the obtained crude product was purified by preparative HPLC to obtain the title compound (4.9 mg, 6%) as a light yellow solid. The NMR and ESI/MS data for this compound are shown below.



1H-NMR (400 MHz, DMSO-d6) δ (ppm): 1.68 (m, 2H), 2.09 (m, 2H), 2.29 (m, 2H), 3.57 (m, 2H), 4.27 (m, 1H), 4.98 (brs, 2H), 7.32 (m, 2H), 7.89 (m, 3H), 8.01 (m, 1H), 8.84 (m, 1H) 23 (brs, 1H).


ESI/MS m/e: 411.3 (M++H, C20H19FN6OS)


Examples 128-1174

The compounds of the invention listed below were synthesized according to the respective methods in Examples 1 to 128 using the corresponding starting materials and reactants. The ESI/MS data from HPLC/mass spectrum analysis of each compound, the retention time and purity of the compound in HPLC under the following conditions and the compound numbers corresponding to the synthesis method carried out are summarized in Tables 215 to 245.


HPLC (High Performance Liquid Chromatography) Conditions




  • System: Hewlett-Packard 1100 HPLC

  • Column: Cadenza CD-C18 (Imtakt) 100 mm×4.6 mm φ

  • Solvent:
    • A: H2O/acetonitrile=95/5
      • 0.05% TFA (trifluoroacetic acid)
    • B: H2O/acetonitrile=5/95
      • 0.05% TFA (trifluoroacetic acid)

  • Flow rate: 1.0 mL/min

  • Gradient:

  • 0-1 min, solvent B: 10% solvent A: 90% 1-14 min, solvent B: 10%→100% solvent A: 90%→0% 14-16 min, solvent B: 100% solvent A: 0%

  • Calculation of purity: Area % of UV absorption (254 nm)



The compound numbers in the following tables represent the compound numbers in Tables 1 to 214 listed as the preferred examples.

TABLE 215Com-Compo-ESI/Pu-Ex-poundsitionalMSHPLCritySynthesisampleNo.formulam/e(min)(%)method1281-0005C13H14N4O243.38.497Example 791291-0006C15H10N4O263.37.896Example 791301-0007C13H8N4O237.26.488Example 11311-0008C13H8N4S253.37.596Example 801321-0009C14H10N4O251.26.7100Example 791331-0012C14H10N4O251.27.299Example 791341-0013C14H10N4O251.27.297Example 791351-0014C15H12N4O265.37.195Example 791361-0015C15H12N4O265.37.399Example 791371-0016C15H12N4S281.18.5100Example 801381-0017C15H12N4O265.38.0100Example 791391-0018C15H12N4O265.37.598Example 791401-0020C17H16N4O293.49.497Example 791411-0021C19H18N4O319.410.794Example 791421-0022C13H7FN4O255.26.296Example 791431-0023C13H7FN4O255.26.892Example 791441-0024C13H7FN4O255.16.8100Example 791451-0025C13H7ClN4O271.36.5100Example 791461-0026C13H7ClN4S287.07.792Example 801471-0028C13H7ClN4O271.17.598Example 791481-0029C13H7ClN4O271.17.694Example 791491-0031C13H6Cl2N4O305.28.695Example 791501-0033C13H6Cl2N4O305.27.5100Example 791511-0035C13H6Cl2N4O305.28.690Example 791521-0036C13H6Cl2N4O305.07.894Example 791531-0037C13H6Cl2N4S321.09.094Example 791541-0040C14H10N4O2267.06.896Example 791551-0041C14H10N4O2267.26.796Example 791561-0042C15H12N4O3297.36.391Example 791571-0043C15H12N4O3297.36.898Example 791581-0044C15H12N4O3297.16.999Example 791591-0045C15H12N4O2S313.28.296Example 801601-0046C15H12N4O3297.26.295Example 791611-0047C15H12N4O2S313.17.3100Example 791621-0048C16H14N4O4327.46.695Example 791631-0049C16H14N4O4327.16.7100Example 11641-0050C16H14N4O3S343.17.8100Example 801651-0051C14H8N4O2265.36.080Example 79















TABLE 216









Com-
Compo-
ESI/

Pu-



Ex-
pound
sitional
MS
HPLC
rity
Synthesis


ample
No.
formula
m/e
(min)
(%)
method





















166
1-0052
C14H8N4O2
265.3
5.8
88
Example 79


167
1-0053
C14H8N4O2
265.3
5.8
75
Example 79


168
1-0054
C14H8N4O3
281.2
5.3
61
Example 79


169
1-0055
C14H8N4O3
281.3
5.0
97
Example 79


170
1-0056
C14H7F3N4O
305.3
7.0
100
Example 79


171
1-0058
C14H7F3N4O
305.3
8.2
97
Example 79


172
1-0059
C14H7F3N4O
305.3
8.4
99
Example 79


173
1-0060
C15H6F6N4O
373.4
9.7
97
Example 79


174
1-0061
C15H10N4O2
279.3
6.1
95
Example 79


175
1-0062
C15H10N4O2
279.3
6.1
79
Example 79


176
1-0063
C15H10N4O2
279.1
6.1
96
Example 79


177
1-0064
C14H7F3N4O2
321.3
8.5
95
Example 79


178
1-0065
C14H7F3N4O2
321.3
8.6
98
Example 79


179
1-0066
C14H7N5O
262.2
6.2
86
Example 79


180
1-0067
C14H7N5O
262.0
6.3
100
Example 79


181
1-0068
C13H9N5O
252.2
2.5
93
Example 79


182
1-0069
C15H13N5O
280.2
6.2
96
Example 79


183
1-0070
C13H7N5O3
282.2
6.7
98
Example 1


184
1-0071
C13H7N5O2S
298.1
7.8
86
Example 80


185
1-0072
C13H8N4O2
253.2
5.2
97
Example 79


186
1-0073
C14H10N4O2
267.3
4.9
97
Example 79


187
1-0074
C14H10N4O2
267.3
4.6
95
Example 79


188
1-0075
C16H13N5O3
324.4
2.4
96
Example 79


189
1-0076
C14H10N4OS
283.3
7.6
94
Example 79


190
1-0077
C15H12N4O3S
328.9
5.9
100
Example 79


191
1-0078
C19H12N4O2
329.1
9.2
99
Example 1


192
1-0079
C19H8N4OS
345.1
10.4
84
Example 80


193
1-0080
C14H8N4O3
281.3
6.4
98
Example 79


194
1-0081
C19H12N4O
313.3
9.1
98
Example 79


195
1-0082
C19H10N4O2
327.4
8.8
96
Example 79


196
1-0083
C17H10N4O
287.4
8.2
97
Example 79


197
1-0084
C17H10N4O
287.4
7.4
92
Example 79


198
1-0085
C21H12N4O
337.4
8.8
84
Example 79


199
1-0086
C11H6N4OS
243.2
6.0
96
Example 79


200
1-0087
C11H6N4S2
259.1
7.1
100
Example 80


201
1-0088
C11H6N4OS
243.2
6.2
95
Example 79


202
1-0089
C12H8N4OS
257.2
6.9
94
Example 79


203
1-0090
C13H8N4O2S
285.3
6.0
94
Example 79






















TABLE 217









Com-
Compo-
ESI/

Pu-



Ex-
pound
sitional
MS
HPLC
rity
Synthesis


ample
No.
formula
m/e
(min)
(%)
method





















204
1-0091
C15H8N4O2
277.1
7.7
97
Example








79


205
1-0092
C15H8N4OS
293.2
8.1
98
Example








79


206
1-0093
C15H8N4OS
293.3
7.5
73
Example








79


207
1-0098
C15H12N4O
265.3
7.4
100
Example








90


208
1-0099
C15H12N4S
281.3
9.2
99
Example








90


209
1-0102
C9H8N4O
189.1
3.7
100
Example 1


210
1-0103
C16H14N4O
279.2
8.5
100
Example 1


211
1-0104
C11H12N4O
217.1
6.0
95
Example








90


212
1-0105
C11H12N4S
233.3
8.2
100
Example 2


213
1-0106
C17H16N4O
293.1
9.2
100
Example 1


214
1-0107
C12H14N4O
231.3
6.9
100
Example








90


215
1-0108
C12H14N4S
247.2
9.1
97
Example 2


216
1-0113
C18H18N4O
307.2
10.0
100
Example








90


217
1-0114
C18H18N4S
323.1
11.9
100
Example 2


218
1-0121
C13H16N4O
245.1
8.1
100
Example








90


219
1-0122
C13H16N4S
261.1
10.2
97
Example 2


220
1-0125
C18H18N4O
307.2
9.9
97
Example 1


221
1-0126
C18H18N4S
323.1
11.7
97
Example 2


222
1-0127
C13H16N4O
245.1
7.8
95
Example








90


223
1-0128
C18H18N4O
307.2
9.8
100
Example 1


224
1-0129
C18H18N4S
323.1
11.6
100
Example 2


225
1-0130
C16H22N4O
287.4
9.6
97
Example








90


226
1-0131
C19H20N4O
321.2
10.4
81
Example








90


227
1-0132
C18H18N4O
307.2
10.1
100
Example








90


228
1-0133
C18H18N4S
323.1
12.1
100
Example 2


229
1-0134
C13H16N4O
245.1
8.1
98
Example








90


230
1-0135
C13H16N4S
261.1
10.3
99
Example 2


231
1-0136
C19H20N4O
321.2
10.7
99
Example








90


232
1-0137
C19H20N4S
337.3
12.5
100
Example 2


233
1-0144
C16H12N4O
277.1
7.7
100
Example 1


234
1-0145
C11H10N4O
215.1
5.1
100
Example








90


235
1-0146
C13H7C1N4O
271.1
7.5
100
Example 1


236
1-0164
C16H15N5O.ClH
294.2
4.9
100
Example








22


237
1-0194
C16H14N4O2
295.1
6.2
100
Example 3


238
1-0207
C16H14N4O2
295.2
7.4
100
Example








90


239
1-0208
C16H14N4OS
311.1
9.3
100
Example 2


240
1-0209
C11H12N4O2
233.2
5.0
100
Example








90


241
1-0214
C17H16N4O2
309.2
8.2
100
Example








90






















TABLE 218









Com-
Compo-
ESI/

Pu-



Ex-
pound
sitional
MS
HPLC
rity
Synthesis


ample
No.
formula
m/e
(min)
(%)
method





















242
1-0215
C17H16N4OS
325.1
10.1
100
Example 2


243
1-0222
C12H14N4O2
247.1
6.0
100
Example 90


244
1-0225
C15H20N4O2
289.4
8.0
100
Example 90


245
1-0226
C18H18N4O2
323.2
8.2
97
Example 90


246
1-0227
C17H16N4O2
309.2
7.7
100
Example 1


247
1-0228
C17H16N4OS
325.1
9.5
100
Example 2


248
1-0229
C12H14N4O2
247.1
5.3
100
Example 90


249
1-0230
C12H14N4OS
263.1
7.2
100
Example 2


250
1-0231
C16H22N4O2
303.4
8.8
100
Example 90


251
1-0232
C19H20N4O2
337.4
9.0
91
Example 90


252
1-0233
C19H20N4OS
353.2
10.9
100
Example 2


253
1-0234
C18H18N4O2
323.1
8.5
100
Example 1


254
1-0235
C18H18N4OS
339.3
10.3
100
Example 2


255
1-0236
C13H16N4O2
261.1
6.2
96
Example 90


256
1-0237
C13H16N4OS
277.1
8.2
100
Example 2


257
1-0238
C17H24N4O2
317.4
10.4
99
Example 90


258
1-0239
C17H24N4OS
333.2
11.7
100
Example 2


259
1-0240
C16H20N4O2
301.2
8.1
100
Example 90


260
1-0241
C16H20N4OS
317.2
10.1
88
Example 2


261
1-0243
C20H22N4O2
351.2
9.7
95
Example 90


262
1-0244
C20H22N4OS
367.2
11.6
100
Example 2


263
1-0245
C21H24N4O2
365.2
10.2
80
Example 90


264
1-0246
C21H24N4OS
381.2
12.1
91
Example 2


265
1-0247
C19H20N4O2
337.3
9.2
100
Example 90


266
1-0248
C19H20N4OS
353.0
11.0
95
Example 2


267
1-0253
C14H18N4O2
275.1
7.1
100
Example 90


268
1-0254
C14H18N4OS
291.3
9.2
83
Example 2


269
1-0263
C17H16N4OS
325.1
8.8
100
Example 90


270
1-0264
C17H16N4S2
341.2
10.6
100
Example 2


271
1-0265
C12H14N4OS
263.1
6.7
100
Example 90


272
1-0272
C16H11N5O
290.1
6.9
99
Example 1


273
1-0273
C16H11N5S
306.0
8.4
99
Example 2


274
1-0274
C17H14N4O
291.2
8.7
100
Example 90


275
1-0275
C17H14N4S
307.2
10.6
100
Example 2


276
1-0280
C20H20N4O
333.3
10.8
100
Example 1


277
1-0281
C20H20N4S
349.1
12.6
99
Example 2


278
1-0288
C15H18N4O
271.1
8.9
100
Example 90


279
1-0289
C15H18N4S
287.1
10.9
100
Example 2






















TABLE 219








Ex-
Com-
Compo-
ESI/

Pu-



am-
pound
sitional
MS
HPLC
rity
Synthesis


ple
No.
formula
m/e
(min)
(%)
method





















280
1-0292
C21H20N4O
345.2
11.0
99
Example 90


281
1-0293
C21H20N4S
361.2
12.9
76
Example 2


282
1-0294
C16H18N4O
283.2
9.2
100
Example 90


283
1-0295
C16H18N4S
299.2
11.4
57
Example 2


284
1-0296
C18H16N4O2
321.1
7.9
100
Example 90


285
1-0297
C18H16N4OS
337.3
9.7
100
Example 2


286
1-0298
C13H14N4O2
259.2
5.6
100
Example 90


287
1-0299
C18H16N4O3
337.3
7.6
98
Example 90


288
1-0300
C14H10N4O
251.2
7.0
100
Example 1


289
1-0301
C14H10N4S
267.1
8.8
100
Example 2


290
1-0302
C18H18N4O
307.0
9.6
89
Example 90


291
1-0303
C17H14N4O
291.2
8.4
98
Example 90


292
1-0304
C17H14N4S
307.2
10.0
90
Example 2


293
1-0305
C21H16N4O
341.4
9.7
94
Example 90


294
1-0306
C22H18N4O
355.2
10.2
87
Example 90


295
1-0307
C20H14N4O
327.1
9.4
100
Example 1


296
1-0308
C20H14N4S
343.1
10.9
93
Example 2


297
1-0310
C15H12N4S
281.2
9.3
100
Example 2


298
1-0311
C21H16N4O
341.2
9.8
100
Example 1


299
1-0312
C21H16N4S
357.1
11.6
100
Example 2


300
1-0313
C16H14N4O
279.1
8.0
79
Example 90


301
1-0314
C16H14N4S
295.0
9.9
100
Example 2


302
1-0315
C20H22N4O
335.4
10.7
86
Example 90


303
1-0316
C20H22N4S
351.0
12.5
95
Example 2


304
1-0317
C19H18N4S
335.2
11.4
90
Example 2


305
1-0318
C23H20N4O
369.4
10.7
89
Example 90


306
1-0319
C24H22N4S
399.2
12.7
91
Example 2


307
1-0320
C22H18N4O
355.1
10.4
100
Example 1


308
1-0321
C22H18N4S
371.1
12.1
97
Example 2


309
1-0322
C17H16N4O
293.1
8.7
97
Example 90


310
1-0323
C17H16N4S
309.3
10.5
100
Example 2


311
1-0324
C19H18N4O
319.2
9.6
64
Example 90


312
1-0325
C24H22N4O
383.2
11.2
60
Example 90


313
1-0326
C23H20N4O
369.3
11.1
97
Example 90


314
1-0327
C27H20N4O
417.2
11.3
99
Example 90


315
1-0328
C27H20N4S
433.1
12.5
100
Example 2


316
1-0329
C14H8BrClN4O
365.3
9.5
95
Example 1


317
1-0334
C20H13FN4O
345.2
9.6
98
Example 90






















TABLE 220








Ex-
Com-
Compo-
ESI/

Pu-



am-
pound
sitional
MS
HPLC
rity
Synthesis


ple
No.
formula
m/e
(min)
(%)
method





















318
1-0345
C21H16N4O2
357.2
9.4
96
Example 90


319
1-0346
C21H15FN4O
359.1
9.9
89
Example 90


320
1-0349
C21H15ClN4O
375.1
10.6
90
Example 90


321
1-0362
C22H18N4O2
371.2
9.6
91
Example 90


322
1-0369
C19H20N4O2
337.4
10.1
62
Example 90


323
1-0370
C22H18N4O2
371.4
10.2
91
Example 90


324
1-0371
C21H16N4O2
357.1
9.7
98
Example 90


325
1-0372
C21H16N4OS
373.1
11.3
100
Example 2


326
1-0393
C18H12N4O2
317.1
8.6
100
Example 1


327
1-0394
C18H12N4OS
333.1
10.2
100
Example 2


328
1-0395
C13H10N4O2
255.1
6.6
100
Example 90


329
1-0396
C13H10N4OS
271.1
8.4
100
Example 2


330
1-0397
C18H12N4OS
333.2
9.1
91
Example 1


331
1-0398
C13H10N4OS
271.1
7.1
97
Example 90


332
1-0399
C19H14N4O2
331.2
9.3
99
Example 1


333
1-0400
C14H12N4O2
269.1
7.5
83
Example 90


334
1-0415
C19H14N4OS
347.1
9.5
98
Example 1


335
1-0416
C19H14N4S2
363.1
11.2
96
Example 2


336
1-0417
C14H12N4OS
285.2
7.6
96
Example 90


337
1-0438
C16H10N4O
275.1
7.7
100
Example 1


338
1-0010
C14H10N4S
267.1
7.9
100
Example 80


339
1-0011
C14H10N4S
267.2
8.5
100
Example 80


340
1-0019
C15H12N4S
281.1
8.7
100
Example 80


341
1-0027
C13H7ClN4S
286.9
8.8
100
Example 80


342
1-0030
C13H7ClN4S
287.1
8.9
98
Example 80


343
1-0032
C13H6C12N4S
320.8
8.8
98
Example 80


344
1-0034
C13H6C12N4S
320.9
8.8
95
Example 80


345
1-0165
C17H17N5O
308.3
5.3
95
Example 22


346
1-0250
C19H19ClN4OS
387.2
11.5
95
Example 2


347
1-0460
C15H11F2N5S
332.2
5.2
97
Example 69


348
1-0473
C17H15FN4OS
343.3
10.1
95
Example 2


349
1-0476
C16H16N4O2S
329.3
9.9
90
Example 2


350
1-0477
C16H16N4OS2
345.2
10.3
90
Example 2


351
1-0493
C24H18N6OS
439.2
12.4
99
Example 108


352
1-0497
C23H15FN6OS
443.3
11.9
99
Example 108


353
1-0499
C19H15N5O2S
378.2
7.5
98
Example 74


354
1-0509
C17H15ClN4OS
359.1
10.0
95
Example 2


355
1-0510
C17H15ClN4OS
359.2
10.6
95
Example 2






















TABLE 221








Ex-
Com-
Compo-
ESI/

Pu-



am-
pound
sitional
MS
HPLC
rity
Synthesis


ple
No.
formula
m/e
(min)
(%)
method





















356
1-0511
C13H16N4OS
277.4
8.6
93
Example 2


357
1-0512
C20H22N4OS
367.3
11.5
80
Example 2


358
1-0514
C19H19FN4OS
371.3
11.0
87
Example 2


359
1-0515
C19H20N4O2S
369.2
9.5
98
Example 94


360
1-0516
C17H18N4OS2
359.2
11.3
100
Example 2


361
1-0517
C17H18N4OS2
359.2
11.3
96
Example 2


362
1-0518
C17H18N4O2S
343.3
11.2
99
Example 2


363
1-0519
C18H20N4O2S
357.2
11.0
95
Example 2


364
1-0521
C18H20N4OS2
373.2
11.3
90
Example 2


365
1-0524
C17H18N4O2S
343.3
11.1
97
Example 2


366
1-0526
C19H18F2N4OS
389.3
11.1
99
Example 2


367
1-0532
C23H25N5O4S
468.3
9.2
100
Example 101


368
1-0533
C23H25N5O4S
468.3
9.2
100
Example 101


369
1-0534
C24H29N5O4S
484.3
9.6
98
Example 101


370
1-0535
C23H28N6O2S
453.3
6.4
100
Example 101


371
1-0543
C23H18N4O3S
431.2
9.7
91
Example 106


372
1-0549
C24H20N4O3S
445.4
11.7
100
Example 106


373
1-0555
C24H22N4OS
415.3
12.6
92
Example 106


374
1-0567
C22H25N5O2S
424.4
6.5
94
Example 106


375
1-0573
C21H24N4O3S
413.5
9.3
97
Example 106


376
1-0585
C25H20N6OS
453.3
12.7
96
Example 108


377
1-0586
C24H18N6OS
439.3
12.0
92
Example 108


378
1-0587
C24H17FN6OS
457.2
12.2
91
Example 108


379
1-0588
C22H22N6O3S2
483.3
9.9
91
Example 108


380
1-0593
C15H12N4S
281.3
9.6
95
Example 2


381
1-0595
C14H9FN4S
285.3
9.0
95
Example 2


382
1-0596
C14H9ClN4S
301.1
9.6
95
Example 2


383
1-0601
C12H8N4S2
273.1
9.2
100
Example 2


384
1-0602
C12H8N4S2
273.2
9.1
99
Example 2


385
1-0607
C12H8N4OS
257.4
8.6
74
Example 2


386
1-0608
C14H16N4S
273.2
10.1
95
Example 2


387
1-0609
C13H10N4OS
271.1
9.0
90
Example 2


388
1-0610
C13H10N4S2
287.2
9.4
90
Example 2


389
1-0612
C12H8N4OS
257.2
8.5
99
Example 2


390
1-0667
C20H13ClN4S
377.1
11.2
95
Example 2


391
1-0668
C21H15ClN4S
391.2
12.1
95
Example 2


392
1-0671
C14H10N4S
267.1
8.5
99
Example 80


393
1-0672
C15H12N4S
281.3
8.3
94
Example 80






















TABLE 222








Ex-
Com-

ESI/

Pu-



am-
pound
Compositional
MS
HPLC
rity
Synthesis


ple
No.
formula
m/e
(min)
(%)
method





















394
1-0673
C15H12N4S
281.4
9.4
73
Example 80


395
1-0674
C17H16N4S
309.4
9.3
100
Example 2


396
1-0675
C19H18N4S
335.1
12.0
98
Example 80


397
1-0676
C13H7FN4S
271.0
7.4
99
Example 80


398
1-0678
C13H7FN4S
271.0
8.0
100
Example 80


399
1-0679
C13H7FN4S
271.2
7.9
100
Example 80


400
1-0680
C13H6Cl2N4S
323.0
10.6
96
Example 80


401
1-0681
C14H10N4OS
283.1
8.0
100
Example 80


402
1-0682
C14H10N4OS
283.1
7.8
100
Example 80


403
1-0683
C15H12N4O2S
313.1
7.5
98
Example 80


404
1-0684
C15H12N4O2S
313.1
8.3
99
Example 80


405
1-0685
C16H14N4O3S
343.4
9.0
100
Example 2


406
1-0686
C14H8N4OS
281.2
6.8
96
Example 2


407
1-0689
C14H7F3N4S
321.1
9.4
100
Example 80


408
1-0690
C14H7F3N4S
321.2
9.5
100
Example 80


409
1-0691
C15H6F6N4S
389.2
9.6
100
Example 2


410
1-0692
C15H10N4OS
295.2
7.1
100
Example 2


411
1-0693
C15H10N4OS
295.3
7.1
99
Example 80


412
1-0694
C14H7F3N4OS
337.4
8.6
98
Example 2


413
1-0695
C14H7F3N4OS
337.4
8.6
99
Example 2


414
1-0696
C14H7N5S
278.2
7.3
100
Example 80


415
1-0697
C15H13N5S
296.2
8.0
100
Example 80


416
1-0699
C14H10N4OS
283.4
5.6
99
Example 2


417
1-0700
C14H10N4OS
283.4
5.4
100
Example 2


418
1-0701
C14H10N4S2
299.2
8.8
100
Example 80


419
1-0702
C15H12N4O2S2
345.2
6.8
86
Example 2


420
1-0703
C14H8N4O2S
297.1
7.6
96
Example 80


421
1-0704
C19H10N4OS
343.3
10.4
97
Example 80


422
1-0705
C17H10N4S
303.0
9.4
96
Example 80


423
1-0706
C17H10N4S
303.4
7.8
100
Example 2


424
1-0707
C21H12N4S
353.2
10.0
98
Example 80


425
1-0708
C11H6N4S2
259.1
7.4
98
Example 80


426
1-0709
C12H8N4S2
273.0
8.1
99
Example 80


427
1-0710
C15H8N4OS
293.3
9.0
98
Example 80


428
1-0715
C16H12N4O2S
325.5
8.8
95
Example 81


429
1-0721
C14H9FN4S
285.5
8.9
89
Example 81


430
1-0722
C13H6F2N4S
289.5
8.5
100
Example 81


431
1-0723
C13H6F2N4S
289.5
8.5
96
Example 81






















TABLE 223








Ex-
Com-

ESI/

Pu-



am-
pound
Compositional
MS
HPLC
rity
Synthesis


ple
No.
formula
m/e
(min)
(%)
method





















432
1-0724
C13H6F2N4S
289.5
7.8
100
Example 81


433
1-0725
C13H6F2N4S
289.5
7.8
100
Example 81


434
1-0726
C16H13N5OS
324.5
6.1
100
Example 81


435
1-0727
C15H13N5S
296.5
6.6
95
Example 81


436
1-0728
C15H12N4OS
297.5
8.8
100
Example 81


437
1-0729
C15H12N4OS
297.5
8.6
100
Example 81


438
1-0730
C15H12N4OS
297.5
9.1
36
Example 81


439
1-0731
C15H12N4OS
297.5
9.0
65
Example 81


440
1-0732
C15H12N4OS
297.5
8.8
100
Example 81


441
1-0733
C14H10N4S2
299.5
8.9
88
Example 81


442
1-0734
C14H9FN4OS
301.5
7.5
90
Example 81


443
1-0735
C14H9ClN4S
301.5
8.9
100
Example 81


444
1-0736
C14H9ClN4OS
317.5
8.9
97
Example 81


445
1-0738
C14H9FN4S
285.4
8.2
99
Example 80


446
1-0739
C14H9FN4S
285.3
8.3
99
Example 80


447
1-0740
C14H9FN4S
285.1
8.2
100
Example 80


448
1-0741
C15H12N4OS
297.4
8.0
100
Example 80


449
1-0742
C13H6Cl2N4S
321.4
10.1
95
Example 81


450
1-0748
C15H12N4S
281.4
8.5
100
Example 80


451
1-0749
C12H8N4S2
273.3
8.2
98
Example 80


452
1-0750
C12H7N5S
254.4
4.0
99
Example 80


453
1-0752
C15H12N4OS
297.5
8.1
100
Example 81


454
1-0759
C20H21N5OS
380.1
6.0
89
Example 106


455
1-0760
C13H12N4S
257.5
7.2
85
Example 2


456
1-0860
C19H18F2N4O2
373.2
9.0
100
Example 1


457
1-0926
C15H12N4O
265.2
7.6
95
Example 3


458
1-0941
C14H16N4O
257.4
8.1
95
Example 3


459
1-1065
C23H20N4O2
385.3
10.4
97
Example 1


460
1-1066
C17H15ClN4O2
343.3
8.2
95
Example 3


461
1-1067
C14H9ClN4O
285.2
7.6
95
Example 3


462
1-1068
C19H19ClN4O2
371.3
9.6
95
Example 3


463
1-1069
C17H15ClN4O2
343.3
8.7
95
Example 3


464
1-1070
C21H15ClN4O
375.1
10.3
95
Example 3


465
1-1071
C20H13ClN4O
361.3
9.7
95
Example 3


466
1-1072
C13H15BrN4O2
339.4
8.2
98
Example 20


467
1-1073
C33H32N4O4
549.5
13.4
99
Example 1


468
1-1074
C18H18N4O2
323.3
8.2
95
Example 3


469
1-1075
C23H20N4OS
401.3
12.3
100
Example 106






















TABLE 224









Com-

ESI/





Exam-
pound
Compositional
MS
HPLC
Purity
Synthesis


ple
No.
formula
m/e
(min)
(%)
method







470
1-1076
C18H18N4OS
339.4
10.0
95
Example 2






















TABLE 225









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















471
2-0010
C22H16ClN5O2
418.2
8.6
100
Example 68


472
2-0015
C22H16ClN5O2
418.3
8.7
100
Example 68


473
2-0016
C23H16N6O2
409.3
7.6
95
Example 68


474
2-0017
C22H16N6O4
429.2
8.0
100
Example 68


475
2-0018
C22H16N6O4
429.2
8.1
99
Example 68


476
2-0019
C23H19N5O3
414.3
7.7
95
Example 68


477
2-0026
C24H19N5O4
442.3
7.9
95
Example 68


478
2-0031
C20H15N5O3
374.1
6.6
100
Example 68


479
2-0032
C20H15N5O2S
390.2
7.4
98
Example 68


480
2-0033
C21H16N6O2
385.2
5.2
100
Example 68


481
2-0034
C21H16N6O2
385.2
5.2
100
Example 68


482
2-0035
C20H14N6O5
419.2
7.4
100
Example 68


483
2-0036
C21H18N6O3
403.3
7.1
99
Example 68


484
2-0037
C27H20ClN5O4S2
578.2
9.8
99
Example 68


485
2-0058
C25H22ClN5O3
476.2
10.0
85
Example 68


486
2-0059
C22H23N5O2
390.3
8.0
96
Example 68


487
2-0060
C23H19N5O2
398.2
8.0
100
Example 68


488
2-0061
C23H18ClN5O2
432.2
8.3
99
Example 68


489
2-0062
C23H18ClN5O2
432.2
9.0
100
Example 68


490
2-0063
C23H18ClN5O2
432.2
9.0
100
Example 68


491
2-0072
C24H18N6O2
423.3
8.0
100
Example 68


492
2-0073
C23H18N6O4
443.3
7.8
93
Example 68


493
2-0074
C23H18N6O4
443.3
8.4
100
Example 68


494
2-0075
C23H18N6O4
443.3
8.5
98
Example 68


495
2-0092
C25H21N5O4
456.2
8.2
98
Example 68


496
2-0093
C22H18N6O2
399.3
5.5
100
Example 68


497
2-0096
C22H18N6O2
399.2
5.5
100
Example 68


498
2-0117
C22H20N6O3
417.3
7.4
100
Example 68


499
2-0146
C24H20FN5O2
430.2
8.4
80
Example 68


500
2-0147
C22H19N5O2S
418.3
7.9
79
Example 68


501
2-0156
C26H24ClN5O3
490.3
10.5
100
Example 68


502
2-0208
C21H23N5O3
394.3
9.1
97
Example 7


503
2-0507
C17H14N4O3
323.1
7.4
100
Example 6


504
2-0509
C22H15ClN4O3
419.2
10.3
99
Example 6


505
2-0514
C24H18N4O5
443.2
9.5
89
Example 6


506
2-0519
C18H16N4O3
337.3
7.6
100
Example 1


507
2-0520
C22H22N4O3
391.2
10.1
95
Example 6


508
2-0521
C23H18N4O3
399.3
9.6
100
Example 6






















TABLE 226









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















509
2-0522
C23H17ClN4O3
433.2
9.9
100
Example 6


510
2-0523
C23H17ClN4O3
433.2
10.6
100
Example 6


511
2-0524
C23H17ClN4O3
433.1
10.7
92
Example 6


512
2-0525
C24H17N5O3
424.2
9.3
100
Example 6


513
2-0526
C23H17N5O5
444.2
9.6
100
Example 6


514
2-0527
C23H17N5O5
444.3
9.8
100
Example 6


515
2-0528
C24H20N4O4
429.2
9.6
98
Example 6


516
2-0529
C25H20N4O5
457.2
9.7
99
Example 6


517
2-0530
C21H16N4O4
389.1
8.3
100
Example 6


518
2-0531
C21H16N4O3S
405.1
9.2
100
Example 6


519
2-0536
C22H17N5O3
400.2
6.6
89
Example 6


520
2-0537
C22H17N5O3
400.3
6.5
100
Example 6


521
2-0538
C21H15N5O6
434.2
8.9
100
Example 6


522
2-0539
C22H19N5O4
418.2
8.8
100
Example 6


523
2-0552
C17H15N5OS
338.3
6.6
97
Example 69


524
2-0557
C24H21N5OS
428.5
9.7
100
Example 69


525
2-0559
C21H17N5O2S
404.5
8.9
96
Example 69


526
2-0560
C21H17N5OS2
420.3
9.1
100
Example 71


527
2-0561
C20H14ClN5OS2
440.1
9.1
95
Example 71


528
2-0562
C21H18N6OS
403.2
8.6
93
Example 69


529
2-0563
C22H16ClN5OS
434.3
9.2
95
Example 69


530
2-0568
C22H16ClN5OS
434.3
9.9
94
Example 69


531
2-0573
C22H16ClN5OS
434.4
9.9
94
Example 69


532
2-0578
C22H16FN5OS
418.4
9.3
98
Example 69


533
2-0586
C23H19N5OS
414.5
9.3
98
Example 69


534
2-0590
C23H19N5O2S
430.2
9.1
91
Example 69


535
2-0595
C23H19N5O2S
430.4
8.9
95
Example 69


536
2-0596
C22H19N5O3S
434.3
8.9
95
Example 69


537
2-0597
C22H19N5O2S2
450.2
9.1
97
Example 71


538
2-0598
C21H16ClN5O2S2
470.1
9.2
99
Example 71


539
2-0599
C22H20N6O2S
433.2
8.6
95
Example 69


540
2-0607
C27H22N6O3S2
543.5
10.5
95
Example 71


541
2-0614
C22H18N6OS
415.2
8.3
96
Example 71


542
2-0616
C21H18N6OS2
435.3
8.5
93
Example 71


543
2-0617
C20H15ClN6OS2
455.0
8.6
98
Example 71


544
2-0618
C21H19N7OS
418.2
7.9
99
Example 69


545
2-0621
C23H20N6OS
429.2
9.1
99
Example 71


546
2-0623
C22H20N6OS2
449.1
9.2
99
Example 71






















TABLE 227









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















547
2-0624
C21H17ClN6OS2
469.2
9.3
95
Example 71


548
2-0625
C22H21N7OS
432.2
8.7
96
Example 69


549
2-0642
C22H17FN6OS
433.2
9.4
100
Example 71


550
2-0643
C21H17FN6O2S
437.1
9.3
96
Example 71


551
2-0644
C21H17FN6OS2
453.2
9.5
92
Example 71


552
2-0645
C20H14ClFN6OS2
473.1
9.6
92
Example 71


553
2-0646
C21H18FN7OS
436.3
9.1
93
Example 69


554
2-0656
C23H19N5O2S
430.5
11.1
100
Example 71


555
2-0671
C23H19N5O2S
430.4
10.5
100
Example 71


556
2-0682
C23H16N6OS
425.4
8.8
98
Example 69


557
2-0687
C23H16N6OS
425.4
8.9
98
Example 69


558
2-0688
C22H17N5O2S
416.5
9.8
94
Example 71


559
2-0694
C21H16FN5O2S
422.4
9.3
97
Example 69


560
2-0695
C21H16FN5OS2
438.2
9.4
96
Example 71


561
2-0696
C20H13ClFN5OS2
458.0
9.5
96
Example 71


562
2-0697
C21H17FN6OS
421.2
9.0
93
Example 69


563
2-0698
C23H19N5O2S
430.0
9.2
97
Example 69


564
2-0703
C22H16N6O4S
461.0
8.8
98
Example 71


565
2-0706
C23H16F3N5O2S
484.2
10.7
97
Example 69


566
2-0708
C22H16N6O3S
445.6
8.8
98
Example 69


567
2-0710
C24H21N5O3S
460.4
9.3
99
Example 69


568
2-0731
C22H16N6O3S
445.6
9.3
98
Example 69


569
2-0740
C23H17N5O3S
444.3
8.8
98
Example 69


570
2-0743
C21H14ClN5O3S2
484.0
9.1
96
Example 71


571
2-0761
C22H16N6O3S
445.6
9.4
97
Example 69


572
2-0772
C23H17N5O3S
444.4
7.7
97
Example 69


573
2-0773
C22H17N5O4S
448.4
7.7
90
Example 69


574
2-0777
C22H17N5O2S
416.3
7.7
79
Example 71


575
2-0782
C22H18N6O3S2
479.1
7.4
87
Example 71


576
2-0787
C22H17N5O2S
416.5
7.5
98
Example 71


577
2-0790
C20H14ClN5O2S2
456.1
7.9
91
Example 71


578
2-0815
C23H16F3N5OS
468.3
10.5
95
Example 69


579
2-0817
C23H19N5OS
414.4
9.5
96
Example 69


580
2-0823
C21H17N5OS2
420.2
9.3
90
Example 71


581
2-0834
C22H15F2N5OS
436.4
9.6
98
Example 69


582
2-0867
C23H16F3N5O2S
484.1
10.7
98
Example 69


583
2-0869
C22H16BrN5OS
480.4
9.4
100
Example 69


584
2-0882
C22H16BrN5OS
480.4
10.2
99
Example 69






















TABLE 228









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















585
2-0884
C24H19N5O3S
458.3
9.1
95
Example 69


586
2-0886
C23H19N5O3S2
478.2
9.3
97
Example 71


587
2-0887
C22H16ClN5O3S2
498.1
9.4
97
Example 71


588
2-0888
C23H20N6O3S
461.1
8.9
95
Example 69


589
2-0893
C22H15Cl2N5OS
468.1
11.1
97
Example 69


590
2-1021
C21H17N5O2S
404.2
8.9
96
Example 71


591
2-1052
C22H15N7O5S
490.4
10.0
96
Example 69


592
2-1053
C22H15Cl2N5OS
468.2
10.9
98
Example 69


593
2-1054
C24H21N5O3S
460.4
8.4
97
Example 69


594
2-1057
C22H18ClN5O3S2
500.2
8.7
99
Example 71


595
2-1059
C24H21N5O3S
460.3
8.4
97
Example 69


596
2-1060
C22H16FN5OS
418.4
9.1
97
Example 69


597
2-1065
C23H16F3N5OS
468.2
9.8
95
Example 69


598
2-1066
C23H16F3N5OS
468.4
10.4
93
Example 69


599
2-1067
C24H21N5O3S
460.3
9.2
97
Example 69


600
2-1068
C23H18N6O3S
459.2
9.3
98
Example 71


601
2-1074
C27H26N6O3S
515.4
12.1
86
Example 71


602
2-1075
C23H16F3N5O2S
484.1
10.1
96
Example 69


603
2-1076
C24H20N6O2S
457.1
7.4
98
Example 71


604
2-1079
C22H17ClN6O2S2
497.1
7.8
93
Example 71


605
2-1083
C22H17N5O3S
432.3
8.4
96
Example 71


606
2-1086
C22H17N5O3S
432.4
8.5
88
Example 71


607
2-1087
C23H20N6OS
429.2
9.3
99
Example 71


608
2-1094
C24H22N6OS
443.4
6.6
97
Example 71


609
2-1101
C24H20N6O2S
457.1
8.8
90
Example 71


610
2-1108
C24H21N7O2S
472.2
6.7
99
Example 71


611
2-1115
C23H20N6OS
429.2
7.8
99
Example 71


612
2-1123
C23H18N6O3S
459.2
9.1
86
Example 71


613
2-1128
C24H19N5O3S
458.1
9.7
98
Example 71


614
2-1133
C22H15ClN6O3S
479.1
9.7
98
Example 71


615
2-1134
C23H19N5OS2
446.2
9.7
99
Example 71


616
2-1135
C24H20N6O2S
457.1
7.5
96
Example 71


617
2-1142
C22H16BrN5OS
480.4
10.2
100
Example 69


618
2-1143
C22H15F2N5OS
436.4
9.6
100
Example 69


619
2-1144
C22H14F3N5OS
454.4
10.1
100
Example 69


620
2-1145
C24H15F6N5OS
536.4
11.1
100
Example 69


621
2-1146
C23H15F4N5OS
486.4
10.7
100
Example 69


622
2-1148
C23H15F4N5OS
486.4
9.9
100
Example 69






















TABLE 229









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















623
2-1149
C23H15F4N5OS
486.4
10.5
100
Example 69


624
2-1150
C23H15F4N5OS
486.5
10.8
100
Example 69


625
2-1151
C24H21N5O2S
444.5
9.7
100
Example 69


626
2-1154
C23H19N5O3S
446.5
7.7
87
Example 71


627
2-1161
C22H16FN5O2S
434.5
10.7
100
Example 71


628
2-1162
C22H13F4N5O2S
488.4
8.8
84
Example 71


629
2-1163
C26H21N7O2S
496.5
7.9
78
Example 71


630
2-1170
C25H19N7OS
466.5
6.3
95
Example 71


631
2-1177
C27H26N6O3S
515.5
10.3
97
Example 71


632
2-1188
C23H19N5O2S
430.1
7.3
96
Example 71


633
2-1195
C23H20N6O2S
445.3
8.9
99
Example 71


634
2-1202
C23H17F3N6OS
483.2
10.8
98
Example 71


635
2-1209
C22H17ClN6OS
449.2
10.3
98
Example 71


636
2-1216
C22H18N6O2S
431.2
7.0
96
Example 71


637
2-1223
C23H20N6O2S
445.4
6.9
92
Example 71


638
2-1226
C22H17FN6OS
433.2
8.6
99
Example 71


639
2-1229
C22H17ClN6OS
449.2
9.7
99
Example 71


640
2-1232
C22H17N7O3S
460.1
9.2
93
Example 71


641
2-1240
C23H20N6OS
429.3
8.2
96
Example 71


642
2-1247
C22H18N6O2S
431.1
6.0
92
Example 71


643
2-1254
C22H17ClN6OS
449.2
9.0
93
Example 71


644
2-1261
C22H17FN6OS
433.0
9.2
97
Example 71


645
2-1268
C23H20N6O2S
445.3
8.4
94
Example 71


646
2-1282
C29H21N5O2S
504.2
10.4
71
Example 71


647
2-1283
C29H21N5O2S
504.2
10.3
91
Example 71


648
2-1284
C28H25N5O2S
496.2
11.1
93
Example 71


649
2-1345
C20H19N5O2S
394.4
9.7
100
Example 71


650
2-1346
C19H17N5O3S
396.4
8.0
100
Example 69


651
2-1347
C19H17N5OS
364.1
7.7
92
Example 71


652
2-1348
C20H15N5O2S
390.4
7.9
93
Example 69


653
2-1350
C19H15N5O2S2
410.1
8.2
98
Example 71


654
2-1351
C18H12ClN5O2S2
430.0
8.3
95
Example 71


655
2-1352
C19H16N6O2S
393.2
7.7
92
Example 69


656
2-1353
C25H18N6O2S
467.5
9.4
100
Example 69


657
2-1354
C23H17N5O2S
428.5
9.9
100
Example 71


658
2-1355
C24H19N5O2S
442.5
10.4
100
Example 71


659
2-1358
C20H15N5OS2
406.2
8.5
97
Example 71


660
2-1365
C20H16N8OS
417.2
8.1
99
Example 71






















TABLE 230









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















661
2-1377
C20H15N5OS2
406.4
8.7
94
Example 69


662
2-1378
C19H15N5O2S2
410.4
8.7
96
Example 69


663
2-1379
C19H15N5OS3
426.2
8.9
97
Example 71


664
2-1380
C18H12ClN5OS3
446.3
9.0
96
Example 71


665
2-1381
C19H16N6OS2
409.2
8.4
93
Example 69


666
2-1382
C20H17N7O2S
420.2
6.9
94
Example 71


667
2-1387
C21H15N5O3S
418.1
7.7
93
Example 71


668
2-1388
C21H15N5O3S
418.2
6.7
92
Example 71


669
2-1389
C22H21N7OS
432.2
8.6
96
Example 71


670
2-1392
C20H18ClN7OS2
472.2
8.9
95
Example 71


671
2-1396
C20H14N6O4S
435.5
8.7
94
Example 69


672
2-1401
C21H15ClN6OS
435.3
7.9
93
Example 69


673
2-1406
C22H19N5O2S
418.5
9.5
87
Example 69


674
2-1411
C22H18N6OS2
447.5
8.6
96
Example 69


675
2-1416
C20H14N6O3S2
451.2
9.2
97
Example 71


676
2-1417
C18H13N7OS2
408.3
7.9
83
Example 69


677
2-1418
C20H16N6OS
389.3
7.1
94
Example 71


678
2-1423
C26H19N5OS
450.2
12.5
99
Example 69


679
2-1424
C21H18N6OS
403.3
9.0
98
Example 69


680
2-1425
C22H17N5O2S2
448.2
8.5
99
Example 71


681
2-1426
C22H19N5O2S2
450.3
9.4
94
Example 71


682
2-1431
C20H16N6O2S
405.4
8.6
92
Example 71


683
2-1438
C20H16N6O2S
405.3
8.2
92
Example 71


684
2-1441
C18H13ClN6O2S2
445.2
8.5
99
Example 71


685
2-1445
C21H17N5OS2
420.1
9.3
95
Example 71


686
2-1452
C20H14ClN5OS2
440.2
9.5
97
Example 71


687
2-1455
C20H14ClN5OS2
440.2
10.1
99
Example 71


688
2-1458
C19H14N8O3S
435.1
7.9
97
Example 71


689
2-1461
C20H16N6OS
389.4
8.0
98
Example 71


690
2-1463
C19H16N6OS2
409.2
8.3
95
Example 71


691
2-1464
C18H13ClN6OS2
429.1
8.3
97
Example 71


692
2-1465
C19H17N7OS
392.3
7.8
84
Example 69


693
2-1466
C26H18ClFN6O2S
533.5
10.5
100
Example 69


694
2-1467
C24H17N5OS2
456.4
10.3
100
Example 69


695
2-1468
C24H17N7OS
452.5
9.3
100
Example 69


696
2-1469
C23H20ClN5O3S3
546.4
9.5
97
Example 69


697
2-1470
C26H17ClF3N7OS
568.4
11.4
98
Example 69


698
2-1471
C27H17ClF3N5O2S
568.4
12.8
94
Example 69






















TABLE 231








Ex-
Com-

ESI/

Pu-



am-
pound
Compositional
MS
HPLC
rity
Synthesis


ple
No.
formula
m/e
(min)
(%)
method





















699
2-1472
C26H19N5OS
450.5
10.3
100
Example 69


700
2-1473
C24H18N6OS
439.5
8.5
100
Example 71


701
2-1474
C23H17N7OS
440.5
6.1
88
Example 71


702
2-1479
C24H18N6OS
439.5
9.7
100
Example 71


703
2-1485
C24H18N6OS
439.5
8.7
100
Example 71


704
2-1486
C25H17N5O3S
468.4
9.7
91
Example 71


705
2-1487
C23H16N6O2S
441.5
9.7
100
Example 71


706
2-1488
C19H14N8O3S
435.2
7.5
98
Example 71


707
2-1489
C21H17N5OS3
452.2
9.8
96
Example 71


708
2-1490
C20H16N6O2S
405.1
9.6
97
Example 71


709
2-1497
C24H22N6O2S
459.1
8.0
98
Example 71


710
2-1498
C20H15N7O3S
434.1
8.2
72
Example 71


711
2-1499
C21H17N7OS
416.3
6.1
45
Example 71


712
2-1516
C19H15N7OS
390.2
5.5
91
Example 71


713
2-1521
C21H16N6OS
401.5
8.4
92
Example 69


714
2-1526
C21H16N6OS
401.4
6.2
97
Example 69


715
2-1531
C21H16N6OS
401.4
6.1
97
Example 69


716
2-1532
C20H16N6O2S
405.5
6.2
94
Example 69


717
2-1534
C19H13ClN6OS2
441.2
6.5
97
Example 71


718
2-1589
C22H23N5OS
406.3
9.5
96
Example 69


719
2-1601
C21H18N6O2S
419.4
8.4
88
Example 69


720
2-1662
C23H19N5OS
414.3
9.0
91
Example 69


721
2-1768
C23H19N5OS
414.3
9.1
95
Example 2


722
2-1769
C25H21N5O3S
472.3
9.3
95
Example 2


723
2-1770
C24H19N5O3S
458.2
7.8
95
Example 114


724
2-1771
C25H23N5O2S
458.2
7.4
88
Example 107


725
2-1772
C23H20N6O2S
445.4
7.5
84
Example 107


726
2-1773
C24H23N5OS
430.3
7.5
86
Example 107


727
2-1774
C24H23N5O2S2
478.2
6.8
64
Example 107


728
2-1776
C22H18N6OS
415.4
9.1
94
Example 70


729
2-1778
C23H20N6OS
429.5
9.4
98
Example 70


730
2-1779
C24H20N6O3S
473.5
7.9
96
Example 70


731
2-1780
C23H29N7S2
468.3
6.7
90
Example 70


732
2-1781
C23H27N7S2
466.4
6.9
91
Example 70


733
2-1782
C22H25N7OS2
468.5
6.4
95
Example 70


734
2-1783
C23H27N7OS2
482.5
6.3
89
Example 70


735
2-1784
C24H31N7S2
482.4
6.8
92
Example 70


736
2-1785
C24H29N7S2
480.4
7.1
96
Example 70






















TABLE 232









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















737
2-1786
C23H27N7OS2
482.3
6.6
98
Example 70


738
2-1787
C24H29N7OS2
496.4
6.5
92
Example 70


739
2-1788
C19H18N6O3S
411.3
6.3
92
Example 70


740
2-1789
C19H18N6O3S
411.4
6.5
95
Example 70


741
2-1790
C20H20N6O3S
425.4
6.5
98
Example 70


742
2-1791
C21H22N6O3S
439.4
6.7
97
Example 70


743
2-1792
C23H18N6O2S2
475.2
8.4
93
Example 70


744
2-1793
C22H17FN6OS
433.3
9.5
92
Example 70


745
2-1794
C22H17FN6OS
433.5
9.3
89
Example 70


746
2-1795
C23H20N6OS
429.3
9.6
90
Example 70


747
2-1796
C23H20N6OS
429.4
9.2
89
Example 70


748
2-1797
C23H20N6O2S
445.6
9.4
81
Example 70


749
2-1798
C26H20N6OS
465.3
9.7
87
Example 70


750
2-1799
C23H17F3N6OS
483.4
10.7
95
Example 70


751
2-1800
C23H17F3N6OS
483.4
10.6
86
Example 70


752
2-1801
C22H17FN6OS
433.3
9.4
81
Example 70


753
2-1802
C26H20N6OS
495.5
10.3
86
Example 70


754
2-1803
C18H17N5OS
352.3
6.9
89
Example 69


755
2-1806
C21H21N5OS
392.4
9.0
77
Example 69


756
2-1807
C20H15N5O2S
390.2
8.4
96
Example 69


757
2-1808
C21H17N5O2S
404.4
8.5
96
Example 69


758
2-1809
C21H17N5O3S
420.4
8.5
96
Example 69


759
2-1810
C18H13N5O2S2
396.4
8.2
97
Example 69


760
2-1811
C19H14N6O2S
391.3
5.7
94
Example 69


761
2-1812
C20H16N6O2S
405.4
8.6
97
Example 70


762
2-1813
C22H18N6O3S
447.5
8.3
97
Example 70


763
2-1814
C21H17N5O2S
404.3
8.8
92
Example 69


764
2-1815
C22H19N5O2S
418.3
8.9
96
Example 69


765
2-1816
C22H19N5O3S
434.4
8.8
97
Example 69


766
2-1817
C19H15N5O2S2
410.4
8.6
96
Example 69


767
2-1818
C20H16N6O2S
405.5
6.0
93
Example 69


768
2-1819
C20H19N5OS
378.3
8.3
98
Example 69


769
2-1820
C21H17N5OS2
420.5
8.7
74
Example 69


770
2-1821
C23H24N6O2S
449.5
6.7
90
Example 69


771
2-1822
C22H16FN5OS
418.5
9.2
95
Example 69


772
2-1823
C20H21N5OS
380.4
8.8
98
Example 69


773
2-1824
C21H16N6O4S
449.4
8.9
96
Example 69


774
2-1825
C22H16N6O2S
429.3
8.9
98
Example 69






















TABLE 233









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















775
2-1826
C22H19N5O2S
418.6
9.0
97
Example 69


776
2-1827
C24H21N5O2S
444.5
8.9
96
Example 69


777
2-1828
C23H19N5OS
414.4
9.5
89
Example 69


778
2-1829
C22H17N5O2S
416.4
8.0
92
Example 69


779
2-1830
C20H19N5O2S
394.4
7.6
95
Example 71


780
2-1831
C20H17N5O3S
408.5
7.1
91
Example 71


781
2-1832
C20H19N5O2S
394.3
7.0
94
Example 71


782
2-1833
C20H18N6O2S
407.4
6.2
91
Example 71


783
2-1834
C22H21N5O3S
436.1
7.9
94
Example 71


784
2-1835
C20H14FN5O2S
408.2
8.9
97
Example 69


785
2-1836
C22H17N5OS2
432.2
9.3
97
Example 94


786
2-1837
C23H17N5O2S
436.3
8.1
90
Example 71


787
2-1838
C20H19N5O3S
410.4
7.5
86
Example 69


788
2-1839
C21H21N5O3S
424.2
8.2
87
Example 69


789
2-1840
C19H20N6OS
381.1
5.7
87
Example 69


790
2-1841
C24H27N5O3S
446.2
9.3
97
Example 69


791
2-1842
C24H18N6OS
439.1
8.1
95
Example 72


792
2-1843
C20H15N7O3S
434.3
6.2
93
Example 71


793
2-1844
C24H21N5O2S
444.3
9.4
95
Example 71


794
2-1845
C19H18N6OS2
411.2
6.1
98
Example 71


795
2-1846
C19H17N5O2S
380.1
6.9
90
Example 71


796
2-1847
C20H16N6OS
389.2
8.2
87
Example 71


797
2-1848
C23H16N6OS
425.1
8.6
88
Example 72


798
2-1850
C20H20N6OS2
425.1
6.1
93
Example 71


799
2-1851
C25H24N6OS
457.2
6.9
95
Example 71


800
2-1852
C20H19N5O2S
394.2
7.1
91
Example 71


801
2-1853
C21H18N6OS
403.2
8.5
96
Example 71


802
2-1854
C25H20N6OS
453.2
8.3
96
Example 72


803
2-1855
C18F3H14N5OS
406.2
9.8
99
Example 69


804
2-1856
C23H19N5OS
414.3
8.5
98
Example 69


805
2-1857
C23H20N6OS
429.2
8.0
99
Example 71


806
2-1858
C24H22N6OS
443.3
8.9
98
Example 71


807
2-1859
C24H21N5O2S
444.3
8.4
97
Example 71


808
2-1860
C25H22C1N5O2S
492.5
11.3
100
Example 69


809
2-1861
C29H23N5OS
490.5
10.9
100
Example 69


810
2-1862
C19H17N5OS
364.3
7.9
97
Example 69


811
2-1863
C21H21N5O3S
424.4
8.5
100
Example 69


812
2-1864
C24H19N5OS
426.4
9.6
94
Example 69






















TABLE 234









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















813
2-1865
C24H21N5O2S
444.5
9.9
100
Example 69


814
2-1866
C18H17N5O2S
368.4
7.3
100
Example 69


815
2-1867
C23H19N5O2S
430.4
9.4
100
Example 69


816
2-1868
C24H21N5O3S
444.5
9.6
100
Example 69


817
2-1869
C20H19N5O3S
410.4
8.0
96
Example 69


818
2-1870
C23H18N5OS
432.4
9.3
98
Example 69


819
2-1871
C22H23N5OS
406.4
9.7
100
Example 69


820
2-1872
C21H21N5O3S
424.4
7.8
100
Example 69


821
2-1873
C24H21N5O2S
444.5
9.1
100
Example 69


822
2-1874
C30H25N5O2S
520.5
11.1
100
Example 69


823
2-1875
C22H15 F2N5OS
436.4
9.9
100
Example 69


824
2-1876
C25H23N5OS
442.5
10.3
93
Example 69


825
2-1877
C23H19N5O2S2
446.5
9.7
100
Example 69


826
2-1878
C20H21N5O3S
412.4
7.4
100
Example 69


827
2-1879
C19H19N5OS
366.4
8.1
100
Example 69


828
2-1880
C20H21N5OS
380.4
8.8
100
Example 69


829
2-1881
C27H23NClN6O2S
531.4
9.3
100
Example 71


830
2-1882
C29H30N6O3S
543.6
11.0
100
Example 71


831
2-1883
C26H24N6O3S
501.5
9.6
97
Example 71


832
2-1884
C25H22N6O3S
487.5
9.1
100
Example 71


833
2-1885
C20H20N6O2S
409.4
6.6
100
Example 71


834
2-1886
C23H26N6O2S
451.4
8.2
100
Example 71


835
2-1887
C26H24N6O3S
501.5
9.5
100
Example 71


836
2-1888
C21H17N7OOS2
448.4
7.8
88
Example 71


837
2-1889
C23H18N6O3S
447.5
7.3
92
Example 71


838
2-1890
C23H19N7O2S
458.5
6.0
100
Example 71


839
2-1891
C21H22N6O2S
423.5
6.8
100
Example 71


840
2-1892
C20H17N5OS
376.2
7.9
93
Example 71


841
2-1893
C24H20N6O2S
457.5
8.1
100
Example 71


842
2-1894
C23H22N8O2S
475.5
5.7
100
Example 71


843
2-1895
C16H13N5OS
324.1
6.8
74
Example 18


844
2-1897
C22H16ClNN5OS
434.0
9.5
85
Example 81


845
2-1898
C23H18N6O3S
459.0
9.0
96
Example 71


846
2-1899
C19H19N5O2S
382.2
7.1
97
Example 71


847
2-1900
C20H19N5OS
378.1
8.4
90
Example 71


848
2-1901
C26H24N6O3S
501.5
9.3
95
Example 71


849
2-1902
C20H19N5OS
378.1
8.4
85
Example 71


850
2-1903
C19H17N5O3S
396.1
6.5
97
Example 71






















TABLE 235









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















851
2-1904
C22H24N6O2S2
469.3
7.5
95
Example 71


852
2-1905
C21H17N5O2S2
436.2
9.1
99
Example 69


853
2-1906
C22H16FN5OS
418.2
9.0
96
Example 81


854
2-1907
C22H16NFN5S
434.1
10.6
96
Example 81


855
2-1908
C24H21N5O2S
444.3
9.8
98
Example 81


856
2-1909
C22H15F2N5OS
436.1
9.1
98
Example 69


857
2-1910
C22H14F3N5OS
454.1
9.4
93
Example 69


858
2-1911
C24H17F2N5O3S
494.3
9.3
97
Example 69


859
2-1912
C23H17F2N5O2S
466.1
9.1
98
Example 69


860
2-1913
C22H16F2N6OS
451.3
8.4
97
Example 69


861
2-1914
C22H15F3N6OS
469.2
9.5
96
Example 69


862
2-1915
C23H18F2N6OS
465.2
9.2
98
Example 69


863
2-1916
C20H13F2N5O2S
426.2
8.1
99
Example 69


864
2-1917
C20H13F2N5OS2
442.3
8.9
96
Example 69


865
2-1918
C20H14F2N6OS
425.1
8.1
98
Example 69


866
2-1919
C25H19N5O2S
454.1
10.8
98
Example 18


867
2-1920
C25H19N5O2S2
470.2
12.5
89
Example 18


868
2-1921
C22H17N5O3S
432.2
6.5
67
Example 53


869
2-1922
C24H19N5O2S
442.3
8.4
96
Example 81


870
2-1923
C24H22N6OS
443.3
8.3
96
Example 81


871
2-1924
C25H23N5O4S
490.2
8.6
90
Example 81


872
2-1925
C23H18FN5OS
432.1
9.7
98
Example 81


873
2-1926
C24H21N5O2S
444.3
9.4
94
Example 81


874
2-1927
C19H14ClN7OS2
456.1
6.4
93
Example 71


875
2-1928
C20H14ClN5O3S2
472.2
8.8
97
Example 71


876
2-1929
C20H14ClN5O2S3
487.9
8.9
91
Example 71


877
2-1930
C28H28N6O3S
529.3
6.4
100
Example 71


878
2-1931
C24H21N5O2S
444.4
7.1
73
Example 107


879
2-1932
C22H18N6O2S
431.2
7.3
85
Example 107


880
2-1933
C23H21N5OS
416.4
7.2
84
Example 107


881
2-1934
C23H21N5O2S2
464.1
6.4
80
Example 107


882
2-1935
C23H189N6S
411.4
6.9
64
Example 107


883
2-1936
C22H18N6O2S
431.3
7.2
100
Example 107


884
2-1937
C23H21N5OS
416.4
7.5
94
Example 107


885
2-1938
C18H16N6O3S
397.2
6.2
97
Example 70


886
2-1939
C20H20N6O3S
425.5
6.4
97
Example 70


887
2-1940
C23H18N6O3S
459.4
7.6
96
Example 70


888
2-1941
C23H20N6OS
429.4
9.6
84
Example 70






















TABLE 236









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















889
2-1942
C24H20N6O2S
457.3
9.8
97
Example 70


890
2-1943
C24H20N6O2S
457.3
8.6
99
Example 70


891
2-1944
C23H20N6OS
429.2
8.1
99
Example 71


892
2-1945
C18H14F3N5OS
406.2
9.4
98
Example 71


893
2-1946
C22H17N7S2
444.3
6.6
99
Example 73


894
2-1947
C18H14F3N5O2
390.3
8.2
95
Example 31


895
2-1948
C22H16FN5O2
402.1
8.0
99
Example 69


896
2-1949
C21H16FN5O3
406.2
7.9
99
Example 69


897
2-1950
C21H16FN5O2S
422.2
8.2
98
Example 68


898
2-2158
C21H15N5O3S
418.4
8.9
100
Example 71


899
2-2159
C21H15ClN6OS
435.4
8.7
93
Example 69






















TABLE 237









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















900
3-0001
C16H13N5OS
324.1
6.4
95
Example 117


901
3-0004
C20H21N5OS
380.2
9.0
98
Example 117


902
3-0009
C19H19N5OS
366.3
8.2
95
Example 117


903
3-0012
C21H23N5OS
394.3
9.5
98
Example 117


904
3-0016
C21H23N5OS
394.3
9.6
95
Example 117


905
3-0019
C18H14F3N5OS
406.2
8.9
95
Example 117


906
3-0020
C21H23N5O2S
410.3
8.2
90
Example 117


907
3-0021
C19H18N6O2S
395.3
6.2
95
Example 117


908
3-0029
C17H15N5O4S2
418.2
5.0
90
Example 117


909
3-0036
C22H26N6OS
423.3
6.0
85
Example 117


910
3-0038
C21H21N5OS
392.3
9.1
95
Example 117


911
3-0053
C23H25N5OS
420.4
10.3
95
Example 117


912
3-0064
C23H26N6OS
435.3
5.8
90
Example 117


913
3-0065
C20H19N5OS
378.2
8.5
85
Example 117


914
3-0073
C22H17N5OS
400.2
9.8
95
Example 117


915
3-0074
C20H15N5O2S
390.3
9.4
100
Example 117


916
3-0081
C23H19N5OS
414.3
9.8
95
Example 117


917
3-0082
C22H16FN5OS
418.4
10.0
95
Example 117


918
3-0083
C22H16ClN5OS
434.2
10.8
95
Example 117


919
3-0084
C23H19N5O2S
430.2
10.1
95
Example 117


920
3-0085
C23H19N5O2S
430.3
9.8
95
Example 117


921
3-0086
C23H19N5OS2
446.4
10.5
95
Example 117


922
3-0087
C24H18N6OS
439.3
9.1
90
Example 117


923
3-0090
C24H19N5O2S
442.3
9.2
95
Example 117


924
3-0091
C24H19N5O2S
442.3
9.2
95
Example 117


925
3-0099
C23H19N5OS
414.2
9.5
98
Example 117


926
3-0100
C24H21N5O2S
444.4
9.6
95
Example 117


927
3-0109
C21H16N6OS
401.3
6.8
95
Example 117


928
3-0110
C21H16N6OS
401.3
6.3
95
Example 117


929
3-0112
C19H14N6OS2
407.3
8.4
90
Example 117


930
3-0115
C25H21N5OS
440.3
9.9
95
Example 117


931
3-0117
C21H17N5O2S
404.4
8.9
100
Example 117


932
3-0118
C23H18ClN5OS
448.3
10.2
90
Example 117


933
3-0119
C24H21N5O2S
444.3
9.2
95
Example 117


934
3-0124
C24H21N5OS
428.3
9.7
95
Example 117


935
3-0125
C21H17N5O2S
404.2
8.6
90
Example 117


936
3-0126
C21H17N5OS2
420.3
9.1
95
Example 117


937
3-0134
C22H18N6OS
415.2
5.9
80
Example 117






















TABLE 238









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















938
3-0135
C20H16N6O2S
405.4
5.4
100
Example 117


939
3-0136
C22H18N6OS
415.2
5.8
85
Example 117


940
3-0137
C20H16N6O2S
405.4
5.3
100
Example 117


941
3-0139
C22H18N6OS
415.3
5.8
85
Example 117


942
3-0140
C20H16N6O2S
405.4
5.3
99
Example 117


943
3-0143
C24H21N5OS
428.2
10.0
98
Example 117


944
3-0148
C20H19N5OS
378.3
8.1
98
Example 117


945
3-0152
C21H21N5OS
392.3
9.3
98
Example 117


946
3-0156
C19H19N5O2S
382.1
8.8
98
Example 117


947
3-0160
C22H23N5OS
406.3
9.8
98
Example 117


948
3-0168
C22H23N5OS
406.4
10.0
98
Example 117


949
3-0175
C22H23N5OS
406.4
10.0
98
Example 117


950
3-0184
C23H25N5OS
420.4
10.8
98
Example 117


951
3-0197
C24H25N5O3S
464.3
10.2
98
Example 117


952
3-0198
C24H25N5O3S
464.3
9.6
95
Example 117


953
3-0206
C24H25N5O3S
464.3
9.3
85
Example 117


954
3-0207
C22H23N5O4S
454.5
9.0
99
Example 117


955
3-0217
C22H22N6O2S
435.3
6.7
95
Example 117


956
3-0220
C22H22N6O2S
435.2
6.4
95
Example 117


957
3-0235
C20H19N5O4S
426.3
6.8
96
Example 117


958
3-0241
C28H25N5O2S
496.4
10.1
98
Example 117


959
3-0242
C26H23N5O3S
486.1
9.9
95
Example 117


960
3-0243
C26H30N6O2S
491.3
8.7
98
Example 117


961
3-0244
C23H23N5O3S
450.3
8.3
90
Example 117


962
3-0294
C20H19N5O2S
394.3
7.6
95
Example 117


963
3-0297
C18H17N5O3S
384.2
7.0
100
Example 117


964
3-0325
C20H18N6O2S
407.3
6.2
80
Example 117


965
3-0331
C21H22N6OS
407.3
5.7
98
Example 117


966
3-0339
C26H24N6OS
469.2
9.6
98
Example 117


967
3-0340
C25H23N7OS
470.3
6.1
98
Example 117


968
3-0348
C28H26N6O2S
511.4
9.2
98
Example 117


969
3-0349
C24H26N6O3S
479.4
6.4
95
Example 117


970
3-0350
C27H26N6OS
483.2
6.9
98
Example 117


971
3-0351
C26H31N7OS
490.3
5.5
98
Example 117


972
3-0352
C28H26N6O3S
527.4
7.0
98
Example 117


973
3-0353
C22H22N6O2S
435.3
6.9
98
Example 117


974
3-0357
C25H22N6O3S
487.3
7.9
98
Example 117


975
3-0362
C23H20N6O4S
477.2
7.6
97
Example 117






















TABLE 239









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















976
3-0397
C23H24N6O3S
465.2
8.7
98
Example 117


977
3-0398
C25H28N6O3S
493.3
10.1
95
Example 117


978
3-0399
C28H26N6O3S
527.4
10.1
98
Example 117


979
3-0430
C23H24N6O2S
449.3
6.9
75
Example 117


980
3-0532
C21H23N5OS
394.3
9.3
95
Example 117


981
3-0541
C22H25N5OS
408.3
10.2
96
Example 117


982
3-0542
C19H19N5O2S
382.4
8.6
99
Example 117


983
3-0543
C22H23N5OS
406.3
9.3
95
Example 117


984
3-0544
C24H28N6OS
449.4
6.1
95
Example 117


985
3-0545
C21H21N5OS
392.3
8.7
95
Example 117


986
3-0550
C24H28N6O2S
465.3
5.9
95
Example 117


987
3-0551
C23H19N5OS
414.3
10.0
98
Example 117


988
3-0552
C23H19N5O2S
430.2
9.4
98
Example 117


989
3-0553
C23H19N5O2S
430.3
8.0
90
Example 117


990
3-0554
C23H19N5O2S
430.3
8.0
98
Example 117


991
3-0555
C23H18FN5OS
432.3
10.3
98
Example 117


992
3-0556
C23H18FN5OS
432.2
10.1
95
Example 117


993
3-0557
C23H18ClN5OS
448.3
10.9
98
Example 117


994
3-0558
C23H18ClN5OS
448.3
10.9
98
Example 117


995
3-0559
C24H21N5O2S
444.4
10.2
95
Example 117


996
3-0560
C24H21N5O2S
444.3
9.9
95
Example 117


997
3-0561
C23H18N6O3S
459.1
10.3
98
Example 117


998
3-0564
C25H20N6OS
453.3
9.2
95
Example 117


999
3-0567
C25H21N5O2S
456.2
9.4
98
Example 117


1000
3-0568
C25H19N5OS
438.2
10.5
98
Example 117


1001
3-0575
C22H18N6OS
415.3
6.9
98
Example 117


1002
3-0577
C22H18N6OS
415.3
6.6
98
Example 117


1003
3-0584
C20H16N6OS2
421.2
8.6
94
Example 117


1004
3-0589
C24H21N5OS
428.2
9.6
95
Example 117


1005
3-0590
C24H20FN5OS
446.4
9.6
98
Example 117


1006
3-0591
C24H20ClN5OS
462.1
10.5
98
Example 117


1007
3-0592
C25H23N5O2S
458.2
9.4
90
Example 117


1008
3-0596
C25H23N5OS
442.4
9.8
95
Example 117


1009
3-0597
C25H22FN5OS
460.2
9.9
98
Example 117


1010
3-0598
C22H19N5O2S
418.3
8.8
90
Example 117


1011
3-0599
C22H19N5OS2
434.3
9.3
95
Example 117


1012
3-0600
C23H20N6OS
429.2
6.0
95
Example 117


1013
3-0605
C22H23N5OS
406.3
9.4
95
Example 117






















TABLE 240









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















1014
3-0615
C23H25N5OS
420.3
10.3
95
Example 117


1015
3-0616
C23H25N5OS
420.3
10.3
95
Example 117


1016
3-0634
C25H27N5O3S
478.2
10.5
98
Example 117


1017
3-0635
C25H27N5O3S
478.3
9.8
95
Example 117


1018
3-0636
C25H27N5O3S
478.3
9.6
90
Example 117


1019
3-0642
C23H24N6O2S
449.3
7.1
98
Example 117


1020
3-0647
C23H24N6O2S
449.3
6.8
95
Example 117


1021
3-0651
C27H32N6O2S
505.3
8.9
98
Example 117


1022
3-0652
C24H25N5O3S
464.1
8.6
90
Example 117


1023
3-0653
C26H30N6OS
475.3
6.4
98
Example 117


1024
3-0654
C24H23N5O4S
478.2
9.6
80
Example 117


1025
3-0680
C21H20N6O2S
421.3
6.6
95
Example 117


1026
3-0682
C22H24N6OS
421.3
6.0
97
Example 117


1027
3-0683
C27H26N6OS
483.3
9.8
90
Example 117


1028
3-0684
C26H25N7OS
484.2
6.5
98
Example 117


1029
3-0685
C29H28N6O2S
525.2
9.5
90
Example 117


1030
3-0686
C28H28N6OS
497.3
7.2
98
Example 117


1031
3-0687
C27H33N7OS
504.4
5.8
98
Example 117


1032
3-0688
C29H28N6O3S
541.3
7.3
98
Example 117


1033
3-0689
C23H24N6O2S
449.3
7.1
98
Example 117


1034
3-0690
C26H24N6O3S
501.3
8.3
95
Example 117


1035
3-0710
C24H26N6O3S
479.3
8.9
98
Example 117


1036
3-0711
C29H28N6O3S
541.2
10.4
98
Example 117


1037
3-0724
C24H26N6O2S
463.3
7.1
95
Example 117


1038
3-0725
C25H22FN5OS
460.2
9.9
98
Example 117


1039
3-0726
C24H21N5O2S
444.3
9.7
90
Example 117


1040
3-0727
C24H21N5OS2
460.2
10.5
90
Example 117


1041
3-0898
C22H23N5OS
406.7
9.8
90
Example 117


1042
3-0909
C25H28N6OS
461.7
6.2
85
Example 117


1043
3-0924
C20H19N5OS2
410.6
9.1
70
Example 117


1044
3-0947
C21H20BrN5OS
470.6
10.0
83
Example 117


1045
3-0949
C22H24N6O2S
437.7
5.9
94
Example 117


1046
3-0950
C25H27N5OS
446.6
11.6
81
Example 117


1047
3-0962
C23H25N5OS
420.6
10.4
68
Example 117


1048
3-0963
C23H25N5OS
420.6
10.6
90
Example 117


1049
3-0965
C29H27N5O2S
510.7
10.5
84
Example 117


1050
3-0966
C26H30N6OS
475.8
6.5
86
Example 117


1051
3-0968
C25H28N6O3S
493.6
9.2
47
Example 117






















TABLE 241









Compound

ESI/MS
HPLC
Purity
Synthesis


Example
No.
Compositional formula
m/e
(min)
(%)
method





















1052
3-0969
C28H25N5O3S
512.7
10.8
88
Example 117


1053
3-0970
C22H21N5O3S
436.7
8.6
80
Example 117


1054
3-0970 (S)
C22H21N5O3S
436.6
8.6
79
Example 117


1055
3-0971
C25H27N5O3S
478.7
10.5
93
Example 117


1056
3-0973
C22H23N5O2S
422.7
8.8
73
Example 117


1057
3-0974
C21H19N5OS
390.6
9.1
64
Example 117


1058
3-0977
C21H21N5O2S
408.6
7.2
81
Example 117


1059
3-0978
C23H25N5OS
420.7
10.6
83
Example 117


1060
3-0979
C23H25N5O2S
436.7
8.3
43
Example 117


1061
3-0980
C22H23N5O2S
422.7
7.5
53
Example 117


1062
3-0981
C25H23N7OS
470.7
6.4
92
Example 117


1063
3-0982
C21H21N5O2S
408.6
6.8
72
Example 117


1064
3-0983
C24H22N8OS
471.7
8.1
71
Example 117


1065
3-0984
C26H23ClN6OS
503.7
11.4
75
Example 117


1066
3-0985
C28H27N5OS
482.7
11.9
79
Example 117


1067
3-0986
C25H27N5OS
446.7
11.8
86
Example 117


1068
3-0987
C25H27N5OS
446.7
11.6
81
Example 117


1069
3-0988
C27H25ClN6OS
517.7
7.8
94
Example 117


1070
3-0989
C27H32N6O3S
521.7
10.2
79
Example 117


1071
3-0990
C28H34N6O3S
535.7
10.4
78
Example 117


1072
3-0991
C26H30N6O3S
507.7
9.8
80
Example 117


1073
3-0992
C28H25N7O2S
524.7
8.6
76
Example 117


1074
3-0993
C22H23N5O2S
422.6
7.1
40
Example 117


1075
3-1776
C21H17N5O2S
404.2
9.7
98
Example 117


1076
3-1777
C21H18N6O2S
419.3
5.6
98
Example 117


1077
3-1778
C23H25N5O4S
468.2
9.4
99
Example 117


1078
3-1779
C20H21N5O2S
396.2
9.2
94
Example 117


1079
3-1780
C26H32N6O3S
509.3
9.6
92
Example 117


1080
3-1781
C23H26N6O3S
467.1
8.8
86
Example 117


1081
3-1782
C26H24N6O3S
501.2
9.1
97
Example 117


1082
3-1783
C20H21N5OS
380.5
9.1
70
Example 117


1083
3-1784
C19H19N5O2S
382.5
7.3
76
Example 117


1084
3-1785
C24H29N5OS
436.7
11.9
84
Example 117


1085
3-1786
C23H28N6OS
423.7
6.4
75
Example 117


1086
3-1787
C23H28N6OS
437.7
6.6
50
Example 117


1087
3-1788
C27H25N5O3S
500.7
10.9
86
Example 117


1088
3-1789
C22H25N5OS
408.6
10.7
98
Example 117


1089
3-1790
C24H29N5OS
436.7
12.2
95
Example 117






















TABLE 242









Compound
Compositional
ESI/MS
HPLC
Purity
Synthesis


Example
No.
formula
m/e
(min)
(%)
method





















1090
3-1791
C17H15N5OS
338.6
7.0
36
Example 117


1091
3-1792
C18H17N5OS
352.6
7.6
93
Example 117


1092
3-1793
C19H19N5OS
366.6
8.4
70
Example 117


1093
3-1794
C21H24N6OS
451.8
6.9
96
Example 117


1094
3-1795
C22H24N6O2S
437.7
6.0
92
Example 117


1095
3-1796
C25H30N6OS
463.8
6.6
93
Example 117


1096
3-1797
C23H26N6O2S
451.7
6.0
98
Example 117


1097
3-1798
C23H26N6OS
435.7
6.3
92
Example 117


1098
3-1799
C18H17N5OS
352.6
7.8
87
Example 117


1099
3-1800
C26H25N5OS
456.7
11.3
74
Example 117


1100
3-1801
C23H25N5O3S
452.7
10.2
94
Example 117


1101
3-1802
C20H17N5OS
376.6
8.8
80
Example 117


1102
3-1803
C20H19N5OS
378.6
9.0
79
Example 117


1103
3-1804
C30H25N5OS
504.7
12.2
94
Example 117


1104
3-1805
C22H24N6OS
421.7
6.2
85
Example 117


1105
3-1806
C21H21N5O3S
424.6
8.2
67
Example 117


1106
3-1807
C21H21N5O3S
424.6
9.0
69
Example 117


1107
3-1808
C24H25N5OS
432.6
11.2
48
Example 117


1108
3-1809
C22H25N5OS
408.6
10.8
81
Example 117


1109
3-1810
C19H19N5OS
366.6
8.5
88
Example 117


1110
3-1811
C23H25N5OS
420.6
10.7
96
Example 117


1111
3-1812
C21H23N5OS
394.6
10.0
79
Example 117


1112
3-1813
C21H23N5OS
394.6
10.0
77
Example 117


1113
3-1814
C20H21N5O2S
396.6
8.2
88
Example 117


1114
3-1815
C20H21N5OS
380.5
9.1
66
Example 117


1115
3-1816
C20H20N6O2S
409.6
6.3
76
Example 117


1116
3-1817
C24H19N5O3S
458.6
10.1
46
Example 117


1117
3-1818
C23H16F3N5O2S
484.6
11.6
94
Example 117


1118
3-1819
C23H19N5OS2
446.6
10.7
87
Example 117


1119
3-1820
C22H18N6O3S2
479.6
8.4
37
Example 117


1120
3-1821
C23H17N5O3S
444.6
9.7
66
Example 117


1121
3-1822
C24H21N5O3S
460.7
10.1
70
Example 117


1122
3-1823
C25H21N5O3S
472.7
10.8
78
Example 117


1123
3-1824
C22H16N6O3S
445.6
10.4
58
Example 117


1124
3-1825
C23H18N6O2S
443.6
7.5
76
Example 117


1125
3-1826
C19H17N5OS
364.3
9.4
99
Example 117






















TABLE 243










Compositional
ESI/MS
HPLC
Purity
Synthesis


Example
Compound No.
formula
m/e
(min)
(%)
method





















1126
4-0002
C14H10N4O3S
315.3
6.8
100
Example 114


1127
4-0007
C16H14N4O3S
343.3
9.4
91
Example 112


1128
4-0029
C17H14N4O2S
339.3
7.7
95
Example 114


1129
4-0030
C19H18N4O3
351.3
8.5
80
Example 110


1130
4-0031
C19H18N4O2S
367.3
10.1
84
Example 112


1131
4-0040
C19H18N4O3
317.3
8.8
89
Example 112






















TABLE 244










Compositional
ESI/MS
HPLC
Purity
Synthesis


Example
Compound No.
formula
m/e
(min)
(%)
method





















1132
5-0001
C17H14N4OS
323.2
8.7
100
Example 120


1133
5-0005
C22H22N4OS
319.2
11.9
98
Example 121


1134
5-0016
C23H18N4OS
399.3
10.8
90
Example 121


1135
5-0041
C18H14N4OS
335.4
9.3
99
Example 121


1136
5-0049
C18H16N4OS
337.3
9.0
100
Example 120


1137
5-0051
C23H24N4OS
405.3
12.3
99
Example 121


1138
5-0054
C23H18N4OS
399.2
11.1
98
Example 121


1139
5-0060
C24H20N4OS
413.2
11.2
95
Example 121


1140
5-0074
C21H22N4OS
379.2
11.5
98
Example 120






















TABLE 245









Compound
Compositional
ESI/MS
HPLC
Purity
Synthesis


Example
No.
formula
m/e
(min)
(%)
method





















1141
6-0055
C9H9N5S
220.2
4.2
99
Example 122


1142
6-0056
C11H11N5S
246.1
5.6
91
Example 122


1143
6-0057
C12H13N5S
260.4
6.6
88
Example 122


1144
6-0058
C12H13N5OS
276.1
4.1
92
Example 122


1145
6-0268
C16H23N5OS
334.5
9.8
100
Example 123


1146
6-0278
C18H25N5OS
360.4
11.0
76
Example 123


1147
6-0283
C19H28N6OS
389.4
5.9
78
Example 123


1148
6-0298
C15H21N5O2S
336.4
6.7
97
Example 123


1149
6-0300
C15H21N5OS
320.4
8.8
97
Example 123


1150
6-0304
C16H23N5OS
334.4
9.9
94
Example 123


1151
6-0308
C17H23N5OS
346.3
10.5
91
Example 123


1152
6-0312
C17H21N5OS
344.4
9.7
70
Example 123


1153
6-0316
C16H23N5O2S
350.3
7.3
94
Example 123


1154
6-0320
C17H23N5OS
346.3
10.1
92
Example 123


1155
6-0324
C17H23N5O2S
362.4
6.9
95
Example 123


1156
6-0328 (R)
C17H24N6OS
361.3
5.1
90
Example 123


1157
6-0328 (S)
C17H24N6OS
361.4
5.1
86
Example 123


1158
6-0333
C18H25N5OS
360.2
10.8
96
Example 123


1159
6-0337
C20H29N5OS
388.4
13.0
97
Example 123


1160
6-0341
C18H25N5O2S
376.3
8.1
96
Example 123


1161
6-0343
C19H28N6OS
389.4
5.7
99
Example 123


1162
6-0345
C22H27N7OS
438.3
6.3
96
Example 123


1163
6-0347
C17H23N5O2S
362.4
8.8
99
Example 123


1164
6-0349
C17H24N6OS
361.3
5.2
97
Example 123


1165
6-0353
C18H26N6OS
375.3
5.4
91
Example 123


1166
6-0366
C23H35N7OS
458.4
5.4
93
Example 123


1167
6-0370
C19H28N6O2S
405.4
5.3
99
Example 123


1168
6-0374
C17H22N6O2S
375.3
6.3
86
Example 123


1169
6-0378
C19H27N5OS
374.3
11.8
96
Example 123


1170
6-0382
C18H26N6OS
375.3
5.7
97
Example 123


1171
6-0390
C16H18N6OS
343.2
6.8
88
Example 123


1172
6-0394
C17H20N6OS
357.4
10.0
49
Example 123


1173
6-0414
C19H18N6S2
395.2
9.5
88
Example 124


1174
6-1033
C20H19FN6O2S
427.3
6.1
96
Example 122









Example 1175

The 1H-NMR spectra (400 MHz, DMSO-d6 or CDCl3) of the compounds of the invention were measured. The data for the chemical shifts (δ: ppm) and coupling constants (J: Hz) are shown in Tables 246 to 262 below. The compound numbers in the tables represent the compound numbers in Tables 1 to 214 listed as the preferred examples, and the examples in the tables represent the examples for synthesis of the corresponding compounds.

TABLE 246Compound No.ExampleNMR δ(ppm)Solvent1-0051280.86-0.96(m, 3H), 1.32-1.48(m, 4H), 2.26-2.31(m,DMSO-d62H), 6.44(d, J=16.1, 1H), 6.88-6.95(m,1H), 7.95(s, 1H), 12.29(brs, 1H),13.06(brs, 1H).1-0061297.16(d, J=16.5, 1H), 7.37-7.47(m, 3H),DMSO-d67.49(d, J=7.3, 2H), 7.76(d, J=16.5, 1H),7.99(d, J=3.4, 1H), 12.38(brs, 1H),13.31(brs, 1H).1-0091322.32(s, 3H), 7.34-7.48(m, 4H), 8.02(s,DMSO-d61H), 12.39(brs, 1H), 13.27(brs, 1H).1-0151362.16(s, 3H), 2.32(s, 1H), 7.24-7.251(m,2H), 7.34-7.36(m, 1H), 8.01(s, 1H),DMSO-d612.36(brs, 1H), 13.23(brs, 1H).1-0161372.18(s, 3H), 2.34(s, 1H), 7.24-7.31(m,DMSO-d62H), 7.37-7.38(m, 1H), 8.20(s, 1H),13.36(brs, 1H), 13.80(brs, 1H).1-0181392.27(s, 3H), 2.34(s, 3H), 7.23-7.31(m,DMSO-d63H), 8.02(d, J=3.4, 1H), 12.39(brs, 1H),13.23(brs, 1H).1-0251457.51-7.70(m, 4H), 8.02(s, 1H), 12.41(brs,DMSO-d61H), 13.49(brs, 1H).1-0261467.51-7.71(m, 4H), 8.22(s, 1H), 13.59(brs,DMSO-d61H), 13.88(brs, 1H).1-0291487.66-7.68(m, 2H), 7.96-8.02(m, 3H),DMSO-d612.35(brs, 1H), 13.53(brs, 1H).1-0311497.55-7.66(m, 2H), 7.87-7.89(m, 1H), 8.04-8.06(m,DMSO-d61H), 12.48(brs, 1H), 13.60(brs,1H).1-0331507.67-7.75(m, 2H), 7.81-7.82(m, 1H), 8.05-8.06(m,DMSO-d61H), 12.47(brs, 1H), 13.60(brs,1H).1-0361527.64-7.70(m, 2H), 7.91(d, J=2.0, 1H),DMSO-d68.05(br, 1H), 12.46(brs, 1H), 13.58(brs,1H).1-0371537.65-7.74(m, 2H), 7.92(d, J=2.0, 1H),DMSO-d68.23(d, J=3.4, 1H), 13.64(brs, 1H),13.93(brs, 1H).1-0441583.83(s, 3H), 3.84(s, 3H), 6.67-6.74(m,DMSO-d62H), 7.44(d, J=8.5, 1H), 7.96(d, J=3.6,1H), 12.28(brs, 1H), 12.98(brs, 1H).1-0451593.86(s, 3H), 3.87(s, 3H), 6.70-6.76(m,DMSO-d62H), 7.52(d, J=8.6, 1H), 8.15(s, 1H)












TABLE 247








Compound No.
Example
NMR δ(ppm)
Solvent







1-086
199
7.26-7.28(m, 1H), 7.84-7.86(m, 1H), 7.95-7.97(m,
DMSO-d6




1H), 8.01(d, 1H), 12.40(brs, 1H),




13.54(brs, 1H).


1-087
200
7.29-7.31(m, 1H), 7.92-7.93(d, J=4.9,
DMSO-d6




1H), 8.17-8.18(m, 28), 13.49(brs, 1H),




13.80(brs, 1H).


1-102
209
2.53(s, 3H), 3.99(s, 3H), 7.95(s, 1H),
DMSO-d6




12.32(brs, 1H).


1-106
213
0.56(d, J=6.8, 6H), 1.71-1.79(m, 1H),
DMSO-d6




4.30(d, J=7.6, 2H), 7.62(s, 5H), 8.03(s,




1H), 12.46(brs, 1H).


1-107
214
0.83(d, J=6.6, 6H), 2.05-2.13(m, 1H),
DMSO-d6




2.49(s, 3H), 4.21(d, J=7.6, 2H), 7.93(d,




J=3.6, 1H), 12.29(brs, 1H).


1-122
219
0.94(d, J=6.6, 6H), 1.58-1.59(m, 2H),
DMSO-d6




1.69-1.76(m, 1H), 2.57(s, 3H), 4.87(t,




J=8.3, 2H), 8.09(s, 1H), 13.63(brs, 1H).


1-125
220
0.50(d, J=6.6, 3H), 0.58(t, J=7.3, 3H),
DMSO-d6




0.78-0.89(m, 1H), 0.97-1.08(m, 1H), 1.48-1.57(m,




1H), 4.30(dd, J=13.4, 8.1, 1H),




4.40(dd, J=13.4, 6.7, 1H), 7.62(s, 5H),




8.03(s, 1H), 12.43(brs, 1H).


1-126
221
0.48(d, J=6.8, 3H), 0.56(t, J=7.3, 3H),
DMSO-d6




0.74-0.86(m, 1H), 0.99-1.09(m, 1H), 1.66-1.75(m,




1H), 4.79-4.80(m, 2H), 7.62-7.67(m,




5H), 8.20(s, 1H), 13.80(brs, 1H).


1-127
222
0.76(d, J=6.8, 3H), 0.85(t, J=7.4, 3H),
DMSO-d6




1.13-1.29(m, 2H), 1.84-1.92(m, 1H),




2.49(s, 3H), 4.18-4.31(m, 2H), 7.93(d,




J=3.7, 1H), 12.28(brs, 1H).


1-129
224
0.59(s, 9H), 4.19(d, J=14.2, 1H), 6.28(d,
DMSO-d6




J=14.2, 1H), 7.61-7.64(m, 3H), 7.74-7.76(m,




2H), 8.21(s, 1H), 13.79(brs, 1H).


1-134
229
0.84(t, J=6.9, 3H), 1.23-1.31(m, 4H),
DMSO-d6




1.66-1.71(m, 2H), 2.49(s, 3H), 4.36(t,




J=7.6, 2H), 7.92(d, J=3.6, 1H),




12.28(brs, 1H).


1-135
230
0.86(t, J=6.8, 3H), 1.30-1.32(m, 4H),
DMSO-d6




1.70-1.72(m, 2H), 2.56(s, 3H), 4.83(t,




J=7.8, 2H), 8.09(s, 1H), 13.63(brs, 1H).



















TABLE 248








Compound No.
Example
NMR δ(ppm)
Solvent







1-144
233
0.53-0.55(m, 2H), 0.84-0.88(m, 2H), 3.77-3.80(m,
DMSO-d6




1H), 7.58-7.60(m, 3H), 7.72-7.74(m,




2H), 7.99(s, 1H), 12.33(brs, 1H).


1-145
234
0.98-1.08(m, 4H), 2.44(s, 3H), 3.30-3.34(m,
DMSO-d6




1H), 7.84(s, 1H), 12.14(brs, 1H).


1-146
235
7.59(s, 4H), 8.07(s, 1H), 8.50(s, 1H),
DMSO-d6




12.52(brs, 1H).


1-164
236
1.89-1.92(m, 2H), 2.52-2.60(m, 2H),
DMSO-d6




4.40(t, J=6.9, 2H), 7.64(s, 5H),




7.79(brs, 3H), 8.07(d, J=3.7, 1H),




12.60(brs, 1H).


1-194
237
1.71-1.78(m, 2H), 3.20-3.25(m, 2H), 4.37-4.41(m,
DMSO-d6




3H), 7.62(s, 5H), 8.03(s, 1H),




12.46(brs, 1H).


1-208
239
2.92(s, 3H), 3.54(t, J=5.6, 2H), 4.98(t,
DMSO-d6




J=5.6, 2H), 7.62-7.65(m, 5H), 8.21(s,




1H), 13.84(s, 1H).


1-209
240
2.49(s, 3H), 3.19(s, 3H), 3.63(t, J=5.2,
DMSO-d6




2H), 4.53(t, J=5.2, 2H), 7.94(d, J=3.6,




1H), 12.33(brs, 1H).


1-215
242
0.87(t, J=7.0, 3H), 3.09(q, J=7.0, 2H),
DMSO-d6




3.58(t, J=5.4, 2H), 4.96(t, J=5.4, 2H),




7.61-7.66(m, 5H), 8.21(s, 1H), 13.83(s,




1H).


1-222
243
0.99(t, J=7.0, 3H), 2.49(s, 3H), 3.34(q,
DMSO-d6




J=7.0, 2H), 3.65(t, J=5.2, 2H), 4.50(t,




J=5.2, 2H), 7.93(d, J=3.6, 1H),




12.32(brs, 1H).


1-299
248
1.94-1.98(m, 2H), 2.50(s, 3H), 3.17(s,
DMSO-d6




3H), 3.24-3.31(m, 2H), 4.39(t, J=7.0,




2H), 7.93(s, 1H), 12.31(brs, 1H).


1-233
252
1.10-1.30(m, 3H), 1.82-1.86(m, 2H), 3.29-3.47(m,
DMSO-d6




4H), 4.33-4.64(m, 4H), 7.20-7.36(m,




5H), 8.11(d, J=2.5, 1H),




13.68(brs, 1H).


1-241
260
0.99-1.07(m, 4H), 1.13-1.37(m, 6H), 1.85-2.14(m,
DMSO-d6




4H), 4.34-4.35(m, 4H), 8.15(d,




J=2.5, 1H), 13.68(brs, 1H).


1-265
271
1.93-1.99(m, 2H), 2.02(s, 3H), 2.44-2.48(m,
DMSO-d6




2H), 2.47(s, 3H), 4.40(t, J=7.3,




2H), 7.91(d, J=3.4, 1H), 12.29(brs, 1H).



















TABLE 249








Compound No.
Example
NMR δ(ppm)
Solvent







1-272
272
2.98(t, J=6.4, 2H), 4.56(t, J=6.4, 2H),
DMSO-d6




7.64(s, 5H), 8.09(d, J=3.4, 1H),




12.62(brs, 1H).


1-275
275
−0.031(d, J=4.9, 2H), 0.24(d, J=6.6, 2H),
DMSO-d6




0.94-0.95(m, 1H), 4.92(d, J=7.1, 2H),




7.64-7.67(m, 5H), 8.22(s, 1H), 13.84(s,




1H).


1-280
276
0.58-0.60(m, 2H), 0.93(brs, 3H), 1.21-1.24(m,
DMSO-d6




2H), 1.44-1.46(m, 4H), 4.31(d,




J=7.3, 2H), 7.62(s, 5H), 8.03(d, J=3.7,




1H), 12.43(brs, 1H).


1-294
282
1.44-1.47(m, 2H), 1.53-1.55(m, 2H),
DMSO-d6




1.84(brs, 2H), 1.94(brs, 2H), 2.28(t,




J=7.0, 2H), 2.50(s, 3H), 4.44(t, J=7.0,




2H), 5.20(brs, 1H), 7.93(d, J=3.6, 1H),




12.30(brs, 1H).


1-298
286
1.55-1.63(m, 1H), 1.77-1.84(m, 2H), 1.90-1.99(m,
DMSO-d6




1H), 2.49(s, 3H), 3.58(dd,




J=14.4, 7.6, 1H), 3.73(dd, J=14.4, 7.0,




1H), 4.31(dd, J=14.0, 8.4, 1H), 4.52(dd,




J=14.0, 3.3, 1H), 7.92(s, 1H), 12.30(brs,




1H).


1-300
288
5.62(s, 2H), 7.28-7.33(m, 5H), 7.98(s,
DMSO-d6




1H), 8.40(s, 1H), 12.42(brs, 1H).


1-301
289
6.20(s, 2H), 7.19-7.32(m, 5H), 8.17(s,
DMSO-d6




1H), 8.63(s, 1H), 13.82(brs, 1H).


1-302
290
0.85(d, J=1.6, 6H), 1.75-1.85(m, 1H),
DMSO-d6




2.66(d, J=1.9, 2H), 5.77(s, 2H), 7.05(d,




J=1.7, 2H), 7.22-7.34(m, 3H), 7.99(s,




1H), 12.38(brs, 1H).


1-303
291
0.95-1.09 (m, 4H), 1.87-1.94(m, 1H),
DMSO-d6




5.84(s, 2H), 7.13(d, J=1.7, 2H), 7.25-7.35(m,




3H), 7.97(s, 1H), 12.35(brs, 1H).


1-306
294
2.69 (t, J=1.8, 2H), 3.07 (t, J=1.8, 2H),
DMSO-d6




5.74(s, 2H), 7.05-7.37 (m, 10H), 8.00(s,




1H), 12.42(brs, 1H).


1-307
295
5.70(s, 2H), 6.78-6.80(m, 2H), 7.18-7.21(m,
DMSO-d6




3H), 7.50-7.57(m, 5H), 8.06(s,




1H), 12.46(brs, 1H).


1-311
298
2.89(t, J=7.1, 2H), 4.54(t, J=7.1, 2H),
DMSO-d6




6.78-6.79(m, 2H), 7.14-7.16(m, 3H), 7.31-7.33(m,




2H), 7.51-7.57(m, 3H), 8.05(d,




J=3.7, 1H), 12.49(brs, 1H).



















TABLE 250








Com-
Ex-




pound
am-




No.
ple
NMR δ(ppm)
Solvent







1-312
299
2.92(t, J=7.4, 2H), 4.97(t, J=7.4, 2H),
DMSO-d6




6.77-6.79(m, 2H), 7.15-7.16(m, 3H),




7.41-7.43(m, 2H), 7.55-7.61(m, 3H),




8.23(s, 1H), 13.88(s, 1H).


1-313
300
2.13(s, 3H), 3.01(t, J=7.1, 2H), 4.55(t,
DMSO-d6




J=7.1, 2H), 7.07-7.09(m, 2H), 7.22-7.28(m,




3H), 7.95(d, J=3.9, 1H),




12.34(brs, 1H).


1-316
303
0.82-0.90(m, 6H), 1.87-1.95(m, 1H),
DMSO-d6




2.01-2.05(t, J=1.8, 2H), 2.60-2.72(m,




2H), 4.31-4.46(m, 4H), 7.15-7.30(m, 5H),




8.27(d, J=3.3, 1H), 13.64(brs, 1H).


1-318
305
1.75(t, J=1.7, 2H), 2.48-2.54(m, 2H),
DMSO-d6




4.20-4.34(m, 4H), 7.02-7.38(m, 10H),




7.98(t, J=1.7, 1H), 12.36(brs, 1H).


1-319
306
1.75(t, J=1.7, 2H), 2.64(t, J=1.9, 2H),
DMSO-d6




2.92 (t, J=1.8, 2H), 3.11 (t, J=1.8,




2H), 4.34-4.48(m, 2H), 7.06-7.27(m,




10H), 8.09(d, J=3.2, 1H), 13.63(brs,




1H).


1-320
307
1.87-1.94(m, 2H), 2.38(t, J=7.5, 2H),
DMSO-d6




4.37(t, J=7.5, 2H), 6.98(d, J=6.8, 2H),




7.10-7.18(m, 3H), 7.58(s, 5H), 8.03(s,




1H), 12.45(brs, 1H).


1-398
331
2.53(s, 3H), 5.88(s, 2H), 6.97(dd,
DMSO-d6




J=5.1, 3.5, 1H), 7.12(d, J=3.5, 1H),




7.47(dd, J=5.1, 1.5, 1H), 7.98(d, J=3.6,




1H), 12.44(brs, 1H).


1-400
333
2.12(s, 3H), 2.43(s, 3H), 5.59(s, 2H),
DMSO-d6




5.93(s, 1H), 6.19(s, 1H), 7.89(d, J=3.4,




1H), 12.30(brs, 1H).


1-417
336
2.17(s, 3H), 3.26(t, J=6.9, 2H), 4.55(t,
DMSO-d6




J=6.9 2H), 6.73-6.74(m, 1H), 6.92-6.95(m,




1H), 7.35-7.36(m, 1H), 7.96(d,




J=3.7, 1H), 12.36(brs, 1H).


2-015
472
3.44-3.49(m, 2H), 4.54(t, J=5.1, 2H),
DMSO-d6




7.38-7.41(m, 4H), 7.47-7.50(m, 3H),




7.55-7.57(m, 2H), 8.03(s, 1H), 8.40(t,




J=5.6, 1H), 12.48(brs, 1H).


2-026
477
3.48-3.50(m, 2H), 3.87(s, 3H), 4.56(t,
DMSO-d6




J=5.0, 2H), 7.34-7.49(m, 5H), 7.66(d,




J=8.5, 2H), 7.98(d, J=8.5, 2H), 8.04(s,




1H), 8.52(t, J=5.6, 1H), 12.48(brs, 1H).



















TABLE 251








Compound No.
Example
NMR δ(ppm)
Solvent







2-031
478
3.39-3.47(m, 2H), 4.49(t, J=5.0, 2H),
DMSO-d6




6.58(dd, J=3.4, 1.7, 1H), 6.86(d, J=3.4,




1H), 7.36-7.37(m, 4H), 7.44-7.49(m, 1H),




7.78(d, J=1.7, 1H), 8.04(s, 1H), 8.17(t,




J=5.9, 1H), 12.48(brs, 1H).


2-033
480
3.47-3.51(m, 2H), 4.58(t, J=5.1, 2H),
DMSO-d6




7.37-7.47(m, 6H), 7.86-7.89(m, 1H),




8.04(s, 1H), 8.53(t, J=6.0, 1H), 8.66-8.71(m,




2H), 12.50(brs, 1H).


2-034
481
3.47-3.51(m, 2H), 4.57(t, J=5.0, 2H),
DMSO-d6




7.35-7.49(m, 7H), 8.04(s, 1H), 8.63-8.67(m,




3H), 12.50(brs, 1H).


2-035
482
3.45-3.46(m, 2H), 4.55(t, J=4.5, 2H),
DMSO-d6




7.13(d, J=3.9, 1H), 7.37-7.46(m, 5H),




7.70(d, J=3.9, 1H), 8.06(s, 1H), 8.66(t,




J=5.6, 1H), 12.50(brs, 1H).


2-062
489
1.85-1.90(m, 2H), 3.05-3.10(m, 2H),
DMSO-d6




4.41(t, J=7.2, 2H), 7.45-7.70(m, 9H),




8.03(s, 1H), 8.43(t, J=5.2, 1H),




12.48(brs, 1H).


2-063
490
1.82-1.89(m, 2H), 3.04-3.09(m, 2H),
DMSO-d6




4.41(t, J=7.4, 2H), 7.49-7.60(m, 7H),




7.70(d, J=8.6, 2H), 8.03(s, 1H), 8.39(t,




J=5.4, 1H), 12.48(brs, 1H).


2-092
495
1.85-1.89(m, 2H), 3.06-3.11(m, 2H),
DMSO-d6




3.87(s, 3H), 4.42(t, J=7.2, 2H), 7.48-7.53(m,




3H), 7.58-7.60(m, 2H), 7.79-7.81(m,




2H), 7.98-8.03(m, 3H), 8.51(t,




J=5.5, 1H)., 12.48(brs, 1H).


2-093
496
1.85-1.90(m, 2H), 3.07-3.11(m, 2H),
DMSO-d6




4.43(t, J=7.3, 2H), 7.45-7.60(m, 6H),




8.01-8.03(m, 2H), 8.51(t, J=5.5, 1H),




8.67-8.68(m, 1H), 8.84-8.85(m, 1H),




12.49(brs, 1H).


2-096
497
1.85-1.88(m, 2H), 3.06-3.10(m, 2H),
DMSO-d6




4.42(t, J=7.4, 2H), 7.49-7.61(m, 7H),




8.03(s, 1H), 8.60(t, J=5.4, 1H), 8.66-8.71(m,




2H), 12.49(brs, 1H).



















TABLE 252








Compound No.
Example
NMR δ(ppm)
Solvent







2-147
500
1.72-1.75(m, 2H), 2.83-2.88(m, 2H),
DMSO-d6




3.46(s, 2H), 4.36(t, J=7.2, 2H), 6.81(d,




J=3.4, 1H), 6.90-6.92(m, 1H), 7.30-7.32(m,




1H), 7.60(s, 5H), 7.93(t, J=5.5,




1H), 8.03(d, J=3.9, 1H), 12.47(brs, 1H).


2-208
502
1.30(s, 9H), 1.68-1.76(m, 2H), 2.71-2.74(m,
DMSO-d6




2H), 4.34(t, J=7.3, 2H), 6.64(t,




J=5.7, 1H), 7.61(s, 5H), 8.03(d, J=3.7,




1H), 12.47(brs, 1H).


2-507
503
1.76(s, 3H), 4.20(t, J=4.9, 2H), 4.60(t,
DMSO-d6




J=4.9, 2H), 7.63(s, 5H), 8.06(s, 1H),




12.54(brs, 1H).


2-509
504
4.45(t, J=4.6, 2H), 4.82(t, J=4.6, 2H),
DMSO-d6




7.49-7.61(m, 8H), 7.70-7.73(m, 1H),




8.04(s, 1H), 12.54(brs, 1H).


2-519
506
1.72(s, 3H), 1.86-1.92(m, 2H), 3.74(t,
DMSO-d6




J=5.7, 2H), 4.46(t, J=7.0, 2H), 7.62(s,




5H), 8.04(s, 1H), 12.49(brs, 1H).


2-521
508
2.04-2.07(m, 2H), 4.05(t, J=5.5, 2H),
DMSO-d6




4.56(t, J=7.1, 2H), 7.44-7.64(m, 10H),




8.02(s, 1H), 12.49(brs, 1H).


2-523
510
2.05-2.08(m, 2H), 4.05(t, J=5.4, 2H),
DMSO-d6




4.57(t, J=6.7, 2H), 7.43-7.59(m, 8H),




7.70-7.73(m, 1H), 8.01(s, 1H), 12.48(brs,




1H).


2-530
517
2.00-2.04(m, 2H), 4.00(t, J=5.6, 2H),
DMSO-d6




4.53(t, J=6.8, 2H), 6.64(dd, J=3.7, 1.7,




1H), 6.96(dd, J=3.7, 0.85, 1H), 7.49-7.59(m,




5H), 7.90(dd, J=1.7, 0.85, 1H),




8.02(s, 1H), 12.49(brs, 1H).


2-147
500
1.72-1.75(m, 2H), 2.83-2.88(m, 2H),
DMSO-d6




3.46(s, 2H), 4.36(t, J=7.2, 2H), 6.81(d,




J=3.4, 1H), 6.90-6.92(m, 1H), 7.30-7.32(m,




1H), 7.60(s, 5H), 7.93(t, J=5.5,




1H), 8.03(d, J=3.9, 1H), 12.47(brs, 1H).


2-208
502
1.30(s, 9H), 1.68-1.76(m, 2H), 2.71-2.74(m,
DMSO-d6




2H), 4.34(t, J=7.3, 2H), 6.64(t,




J=5.7, 1H), 7.61(s, 5H), 8.03(d, J=3.7,




1H), 12.47(brs, 1H).


2-507
503
1.76(s, 3H), 4.20(t, J=4.9, 2H), 4.60(t,
DMSO-d6




J=4.9, 2H), 7.63(s, 5H), 8.06(s, 1H),




12.54(brs, 1H).


2-509
504
4.45(t, J=4.6, 2H), 4.82(t, J=4.6, 2H),
DMSO-d6




7.49-7.61(m, 8H), 7.70-7.73(m, 1H),




8.04(s, 1H), 12.54(brs, 1H).



















TABLE 253








Compound No.
Example
NMR δ(ppm)
Solvent







2-519
506
1.72(s, 3H), 1.86-1.92(m, 2H), 3.74(t,
DMSO-d6




J=5.7, 2H), 4.46(t, J=7.0, 2H), 7.62(s,




5H), 8.04(s, 1H), 12.49(brs, 1H).


2-521
508
2.04-2.07(m, 2H), 4.05(t, J=5.5, 2H),
DMSO-d6




4.56(t, J=7.1, 2H), 7.44-7.64(m, 10H),




8.02(s, 1H), 12.49(brs, 1H).


2-523
510
2.05-2.08(m, 2H), 4.05(t, J=5.4, 2H),
DMSO-d6




4.57(t, J=6.7, 2H), 7.43-7.59(m, 8H),




7.70-7.73(m, 1H), 8.01(s, 1H), 12.48(brs,




1H).


2-530
517
2.00-2.04(m, 2H), 4.00(t, J=5.6, 2H),
DMSO-d6




4.53(t, J=6.8, 2H), 6.64(dd, J=3.7, 1.7,




1H), 6.96(dd, J=3.7, 0.85, 1H), 7.49-7.59(m,




5H), 7.90(dd, J=1.7, 0.85, 1H),




8.02(s, 1H), 12.49(brs, 1H).


2-147
500
1.72-1.75(m, 2H), 2.83-2.88(m, 2H),
DMSO-d6




3.46(s, 2H), 4.36(t, J=7.2, 2H), 6.81(d,




J=3.4, 1H), 6.90-6.92(m, 1H), 7.30-7.32(m,




1H), 7.60(s, 5H), 7.93(t, J=5.5,




1H), 8.03(d, J=3.9, 1H), 12.47(brs, 1H).


2-208
502
1.30(s, 9H), 1.68-1.76(m, 2H), 2.71-2.74(m,
DMSO-d6




2H), 4.34(t, J=7.3, 2H), 6.64(t,




J=5.7, 1H), 7.61(s, 5H), 8.03(d, J=3.7,




1H), 12.47(brs, 1H).


2-519
506
1.72(s, 3H), 1.86-1.92(m, 2H), 3.74(t,
DMSO-d6




J=5.7, 2H), 4.46(t, J=7.0, 2H), 7.62(s,




5H), 8.04(s, 1H), 12.49(brs, 1H).


2-521
508
2.04-2.07(m, 2H), 4.05(t, J=5.5, 2H),
DMSO-d6




4.56(t, J=7.1, 2H), 7.44-7.64(m, 10H),




8.02(s, 1H), 12.49(brs, 1H).


2-523
510
2.05-2.08(m, 2H), 4.05(t, J=5.4, 2H),
DMSO-d6




4.57(t, J=6.7, 2H), 7.43-7.59(m, 8H),




7.70-7.73(m, 1H), 8.01(s, 1H), 12.48(brs,




1H).


2-530
517
2.00-2.04(m, 2H), 4.00(t, J=5.6, 2H),
DMSO-d6




4.53(t, J=6.8, 2H), 6.64(dd, J=3.7, 1.7,




1H), 6.96(dd, J=3.7, 0.85, 1H), 7.49-7.59(m,




5H), 7.90(dd, J=1.7, 0.85, 1H),




8.02(s, 1H), 12.49(brs, 1H).


2-147
500
1.72-1.75(m, 2H), 2.83-2.88(m, 2H),
DMSO-d6




3.46(s, 2H), 4.36(t, J=7.2, 2H), 6.81(d,




J=3.4, 1H), 6.90-6.92(m, 1H), 7.30-7.32(m,




1H), 7.60(s, 5H), 7.93(t, J=5.5,




1H), 8.03(d, J=3.9, 1H), 12.47(brs, 1H).



















TABLE 254








Compound No.
Example
NMR δ(ppm)
Solvent







2-208
502
1.30(s, 9H), 1.68-1.76(m, 2H), 2.71-2.74(m,
DMSO-d6




2H), 4.34(t, J=7.3, 2H), 6.64(t,




J=5.7, 1H), 7.61(s, 5H), 8.03(d, J=3.7,




1H), 12.47(brs, 1H).


2-507
503
1.76(s, 3H), 4.20(t, J=4.9, 2H), 4.60(t,
DMSO-d6




J=4.9, 2H), 7.63(s, 5H), 8.06(s, 1H),




12.54(brs, 1H).


2-509
504
4.45(t, J=4.6, 2H), 4.82(t, J=4.6, 2H),
DMSO-d6




7.49-7.61(m, 8H), 7.70-7.73(m, 1H),




8.04(s, 1H), 12.54(brs, 1H).


2-519
506
1.72(s, 3H), 1.86-1.92(m, 2H), 3.74(t,
DMSO-d6




J=5.7, 2H), 4.46(t, J=7.0, 2H), 7.62(s,




5H), 8.04(s, 1H), 12.49(brs, 1H).


2-521
508
2.04-2.07(m, 2H), 4.05(t, J=5.5, 2H),
DMSO-d6




4.56(t, J=7.1, 2H), 7.44-7.64(m, 10H),




8.02(s, 1H), 12.49(brs, 1H).


2-523
510
2.05-2.08(m, 2H), 4.05(t, J=5.4, 2H),
DMSO-d6




4.57(t, J=6.7, 2H), 7.43-7.59(m, 8H),




7.70-7.73(m, 1H), 8.01(s, 1H),12.48(brs,




1H).


2-530
517
2.00-2.04(m, 2H), 4.00(t, J=5.6, 2H),
DMSO-d6




4.53(t, J=6.8, 2H), 6.64(dd, J=3.7, 1.7,




1H), 6.96(dd, J=3.7, 0.85, 1H), 7.49-7.59(m,




5H), 7.90(dd, J=1.7, 0.85, 1H),




8.02(s, 1H), 12.49(brs, 1H).


3-012
903
0.68(t, J=7.6, 6H), 1.10-1.23(m, 2H),
DMSO-d6




1.26-1.36(m, 2H), 2.53(brq, J=5.7, 2H),




3.32-3.42(m, 1H), 4.92(t, J=7.6, 2H),




7.43(d, J=8.6, 1H), 7.55-7.69(m, 5H),




8.20(s, 1H), 13.81(brs, 1H)


3-073
914
2.77(t, J=7.3, 2H), 5.04(t, J=7.3, 2H),
DMSO-d6




7.01(t, J=7.4, 1H), 7.25(t, J=7.9, 2H),




7.41(d, J=7.8, 2H), 7.53-7.62(m, 5H),




8.23(s, 1H), 9.81(s, 1H), 13.83(brs, 1H)


3-099
925
2.51(br, 2H), 3.02(brs, 3H), 4.85(brt,
DMSO-d6




J=7.1, 2H), 7.05(brd, J=7.1, 2H), 7.24-7.38(m,




3H), 7.55-7.68(m, 5H), 8.15(d,




J=3.4, 1H), 13.71(brs, 1H)



















TABLE 255








Compound No.
Example
NMR δ(ppm)
Solvent







3-148
944
1.62-1.79(m, 4H), 2.71(brt, J=7.8, 2H),
DMSO-d6




3.15(q, J=6.6, 4H), 4.92(brt, J=7.6, 2H),




7.62-7.68(m, 5H), 8.21(d, J=3.7, 1H), 13.83(brs, 1H)


3-152
945
1.28-1.36(m, 4H), 1.45-1.53(m, 2H),
DMSO-d6




2.77(t, J=7.8, 2H), 3.14-3.18(m, 2H),




3.26-3.30(m, 2H), 4.88(t, J=7.6, 2H),




7.62-7.66(m, 5H), 8.21(s, 1H), 13.8(brs,




1H)


3-156
946
1.41-1.43(m, 4H), 1.54-1.56(m, 2H),
DMSO-d6




2.95(t, J=7.8, 6H), 3.31-3.42(m, 4H),




5.20-5.23(m, 2H), 6.87-6.88(m, 1H),




7.34(d, J=3.7, 1H), 8.14(s, 1H), 8.17(s,




1H), 13.79(s, 1H)


3-206
953
1.16(t, J=7.1, 3H), 1.20-1.39(m, 2H),
DMSO-d6




1.73(brt, J=9.5, 2H), 2.61(brt, J=10.5,




1H), 2.72-2.93(m, 3H), 3.57(brd, J=13.7,




1H), 4.00-4.10(m, 3H), 4.83-4.92(m, 2H),




7.60-7.68(m, 5H), 8.21(s, 1H), 13.82(brs,




1H)


3-148
944
1.62-1.79(m, 4H), 2.71(brt, J=7.8, 2H),
DMSO-d6




3.15(q, J=6.6, 4H), 4.92(brt, J=7.6, 2H),




7.62-7.68(m, 5H), 8.21(d, J=3.7, 1H),




13.83(brs, 1H)


3-152
945
1.28-1.36(m, 4H), 1.45-1.53(m, 2H),
DMSO-d6




2.77(t, J=7.8, 2H), 3.14-3.18(m, 2H),




3.26-3.30(m, 2H), 4.88(t, J=7.6, 2H),




7.62-7.66(m, 5H), 8.21(s, 1H), 13.8(brs,




1H)


3-156
946
1.41-1.43(m, 4H), 1.54-1.56(m, 2H),
DMSO-d6




2.95(t, J=7.8, 6H), 3.31-3.42(m, 4H),




5.20-5.23(m, 2H), 6.87-6.88(m, 1H),




7.34(d, J=3.7, 1H), 8.14(s, 1H), 8.17(s,




1H), 13.79(s, 1H)



















TABLE 256








Compound No.
Example
NMR δ(ppm)
Solvent







3-206
953
1.16(t, J=7.1, 3H), 1.20-1.39(m, 2H),
DMSO-d6




1.73(brt, J=9.5, 2H), 2.61(brt, J=10.5,




1H), 2.72-2.93(m, 3H), 3.57(brd, J=13.7,




1H), 4.00-4.10(m, 3H), 4.83-4.92(m, 2H),




7.60-7.68(m, 5H), 8.21(s, 1H), 13.82(brs,




1H)


3-220
956
1.17-1.35(m, 2H), 1.61(brt, J=10.2, 2H),
DMSO-d6




2.24(tt, J=11.2, J=3.9, 1H), 2.40-2.50(m,




1H), 2.72-2.87(m, 3H), 3.63(brd, J=13.4,




1H), 4.18(brd, J=13.0, 1H), 4.88(t,




J=7.0, 2H), 6.76(brs, 1H), 7.23(brs, 1H),




7.62-7.68(m, 5H), 8.21(d, J=3.7, 1H),




13.84(brs, 1H)


3-241
958
1.20-1.43(m, 2H), 1.72(brt, J=14.4, 2H),
DMSO-d6




2.67(brt, J=11.7, 1H), 2.74-2.80(m, 2H),




3.01(brt, J=11.5, 1H), 3.60-3.74(m, 2H),




4.24(brd, J=13.4, 1H), 4.82-4.97(m, 2H),




7.53(t, J=7.6, 2H), 7.61-7.68(m, 6H),




7.97(d, J=8.0, 2H), 8.21(s, 1H),




13.84(brs, 1H)


3-294
962
2.78(brt, J=7.6, 2H), 3.21(brt, J=4.9,
DMSO-d6




2H), 3.25-3.35(m, 2H), 3.38-3.48(m, 4H),




4.91(brt, J=7.1, 2H), 7.62-7.68(m, 5H),




8.21(s, 1H), 13.75(brs, 1H)


3-353
973
1.97(s, 3H), 2.81-2.83(m, 2H), 3.19-3.30(m,
DMSO-d6




8H), 4.89-4.93(m, 2H), 7.64-7.66(m,




5H), 8.22(d, J=3.9, 1H),




13.84(brs, 1H)


3-560
996
1.90(m, 2H), 2.11(t, J=7.6, 2H), 3.69(s,
DMSO-d6




3H), 4.87(t, J=6.6, 2H), 6.57(d, J=7.8,




1H), 6.96(d, J=8.2, 1H), 7.10-7.20(m,




2H), 7.55-7.59(m, 3H), 7.65-7.67(m, 2H),




8.19(s, 1H), 9.70(s, 1H), 13.8(brs, 1H)



















TABLE 257








Compound No.
Example
NMR δ(ppm)
Solvent







3-577
1002
1.90-1.97(m, 2H), 2.30(t, J=7.0, 2H),
DMSO-d6




4.92(t, J=7.1, 2H), 7.56-7.57(m, 3H),




7.67-7.69(m, 2H), 7.85(d, J=5.6, 2H),




8.20(d, J=3.4, 1H), 8.64(d, J=6.6, 2H),




11.05(s, 1H), 13.83(s, 1H)


3-600
1012
1.85(tt, J=7.1, 2H), 2.00(t, J=7.3, 2H),
DMSO-d6




4.26(d, J=5.6, 2H), 4.84(t, J=7.6, 2H),




7.32(d, J=8.0, 1H), 7.40(m, 1H), 7.60-7.68(m,




5H), 7.90-7.95(m, 1H), 8.20(d,




3.64, 1H), 8.36(t, J=5.8, 1H), 8.54(d,




J=5.1, 1H)13.8(brs, 1H)


3-616
1015
0.70-0.97(m, 5H), 1.51(brt, J=14.4, 3H),
DMSO-d6




1.73-1.85(m, 2H), 2.00-2.20(m, 2H),




2.32(td, J=10.7, J=1.5, 1H), 2.79(t,




J=13.2, 1H), 3.50-3.62(m, 1H), 4.14(d,




J=12.7, 1H), 4.84(t, J=8.1, 2H), 7.52-7.59(m,




5H), 8.20(d, J=3.6, 1H),




13.81(brs, 1H)


4-029
1128
1.78-1.85(m, 2H), 2.04(t, J=7.2, 2H),
DMSO-d6




4.83(t, J=7.3, 2H), 7.63-7.65(m, 5H),




8.20(s, 1H), 12.03(brs, 1H), 13.81(brs,




1H)


4-030
1129
1.05(t, J=7.1, 3H), 1.77-1.87(m, 2H),
DMSO-d6




2.09(t, J=7.1, 2H), 3.82(q, J=7.3, 2H),




4.42(t, J=6.8, 2H), 7.55-7.69(m, 5H),




8.04(s, 1H), 12.48(brs, 1H)


4-031
1130
1.05(t, J=7.1, 3H), 1.79-1.89(m, 2H),
DMSO-d6




2.12(t, J=7.3, 2H), 3.84(q, J=7.1, 2H),




4.85(t, J=7.1, 2H), 7.57-7.71(m, 5H),




8.20(s, 1H), 13.83(brs, 1H)



















TABLE 258








Compound No.
Example
NMR δ(ppm)
Solvent







1-0460
347
3.06(t, J=7.1, 2H), 3.20-3.50(m, 3H),
DMSO-d6




4.89(t, J=6.8, 2H), 7.49(t, J=8.3, 2H),




7.76-7.93(m, 1H), 8.27(s, 1H)


1-0499
353
2.27(s, 4H), 3.55(m, 2H), 5.08(brs, 2H),
DMSO-d6




7.56(m, 5H), 8.17(d, J=3.2, 1H),




13.83(brs, 1H)


1-0511
356
1.10-1.40(m, 6H), 1.85-2.15(m, 4H),
DMSO-d6




3.87(s, 3H), 4.30-4.40(m, 4H), 8.10(d,




J=2.5, 1H), 13.60(brs, 1H).


1-0526
366
0.92-0.93(m, 6H), 1.93(m, 1H), 3.27-3.35(m,
CDC13




4H), 4.80(t, J=7.1, 2H), 7.13(t,




J=8.0, 2H), 7.57-7.61(m, 1H), 8.15(s,




1H), 11.60(brs, 1H).


1-0674
395
0.90-1.10(m, 9H), 7.30-7.40(m, 4H), 7.50-7.60(m,
DMSO-d6




4H), 8.10(d, J=2.5, 1H),




13.20(brs, 1H), 13.60(brs, 1H).


1-0685
405
3.50-3.80(m, 9H), 6.50(d, J=1.7, 1H),
DMSO-d6




7.00(d, J=1.7, 1H), 7.50-7.60(m, 4H),




8.10(d, J=2.5, 1H), 13.40(brs, 1H),




13.60(brs, 1H).


1-0686
406
7.50-7.80(m, 7H), 8.00(s, 1H), 8.15(d,
DMSO-d6




J=2.5, 1H), 9.50-9.70(m, 1H), 13.40(brs,




1H), 13.60(brs, 1H).


1-0691
409
3.10-3.40(m, 4H), 7.00-7.20(m, 3H),
DMSO-d6




8.00(s, 1H), 13.40(brs, 1H), 13.60(brs,




1H).


1-0692
410
2.52-2.65(m, 3H), 7.50-7.70(m, 6H),
DMSO-d6




8.00(t, J=1.8, 2H), 8.15(d, J=2.5, 1H),




13.40(brs, 1H), 13.60(brs, 1H).


1-0694
412
6.90-7.35(m, 4H), 8.10(d, J=2.5, 1H),
DMSO-d6




13.40(brs, 1H), 13.60(brs, 1H).


1-0695
413
6.80-6.90(m, 2H), 7.35-7.40(m, 2H),
DMSO-d6




8.15(d, J=2.5, 1H), 13.40(brs, 1H),




13.60(brs, 1H).


1-0699
416
4.60-4.75(m, 2H), 7.10-7.35(m, 4H),
DMSO-d6




8.15(d, J=2.5, 1H), 13.40(brs, 1H),




13.60(brs, 1H).


1-0700
417
4.50-4.70(m, 2H), 7.20-7.40(m, 4H),
DMSO-d6




8.10(d, J=2.5, 1H), 13.30(brs, 1H),




13.50(brs, 1H).


1-0702
419
1.10-1.30(m, 3H), 3.30-3.40(m, 2H), 7.50-7.60(m,
DMSO-d6




4H), 7.70-7.80(m, 2H), 7.95-8.05(m,




2H), 8.15(d, J=2.2, 1H),




13.40(brs, 1H), 13.60(brs, 1H).


1-0706
423
7.30(d, J=5.0, 2H), 7.40-7.60(m, 9H),
DMSO-d6




8.15(d, J=2.5, 1H), 13.20(brs, 1H),




13.50(brs, 1H)



















TABLE 259








Compound No.
Example
NMR δ(ppm)
Solvent







1-0738
445
2.33(s, 3H), 7.22(m, 1H), 7.31(m, 1H),
DMSO-d6




7.54(m, 1H), 8.21(s, 1H), 13.39(brs, 1H),




13.87(brs, 1H).


1-0739
446
2.22(m, 3H), 7.31-7.46(m, 3H), 8.22(s,
DMSO-d6




1H), 13.47(brs, 1H), 13.88(brs, 1H).


1-0740
447
2.29(s, 3H), 7.31-7.40(m, 2H), 7.46(m,
DMSO-d6




1H), 8.22(s, 1H), 13.45(brs, 1H),




13.88(brs, 1H).


1-0741
448
2.32(s, 3H), 3.83(s, 3H), 6.91-7.01(m,
DMSO-d6




2H), 7.40(m, 1H), 8.17(s, 1H).


1-0749
451
2.29(s, 3H), 7.48(s, 1H), 8.00(s, 1H),
DMSO-d6




8.14(s, 1H), 13.30-13.80(brs, 2H).


1-0860
456
0.89-0.97(m, 6H), 1.90-1.96(m, 1H),
CDC13




3.24(t, J=6.0, 2H), 3.29-3.35(m, 2H),




4.41(t, J=7.1, 2H), 7.12(t, J=7.6, 2H),




7.50-7.59(m, 1H), 7.98(s, 1H), 10.1(brs,




1H).


1-1072
466
1.04-1.12(m, 6H), 2.04-2.10(m, 1H), 3.44-3.53(m,
CDC13




4H), 4.63(t, J=7.1, 2H), 7.97(brs, 1H).


2-0559
525
1.63(s, 3H), 3.57(m, 2H), 5.14(brs, 2H),
DMSO-d6




6.41(s, 1H), 7.39(m, 2H), 7.49(m, 1H),




7.58(m, 2H), 7.82(m, 1H), 8.22(m, 1H),




8.28(m, 1H), 13.85(brs, 1H)


2-0560
526
1.93(s, 3H), 3.57(brs, 2H), 4.89(brs,
DMSO-d6




1H), 5.17(brs, 1H), 6.99(d, J=5.1, 1H),




7.34-7.62(m, 5H), 7.78(d, J=5.2, 1H),




8.20(s, 1H), 8.30(m, 1H), 13.84(brs, 1H)


2-0568
530
3.50(m, 2H), 5.09(brs, 2H), 7.33-7.40(m,
DMSO-d6




4H), 7.45-7.52(m, 4H), 7.58(m, 1H),




8.23(s, 1H), 8.36(m, 1H), 13.86(brs, 1H)


2-0596
536
1.61(s, 3H), 3.49(brs, 2H), 3.73(s, 3H),
DMSO-d6




5.07(brs, 2H), 6.37(s, 1H), 6.87(m, 2H),




7.49(m, 2H), 7.75(s, 1H), 8.07(m, 1H),




8.16(m, 1H),


2-0597
537
1.94(s, 3H), 3.55(brs, 2H), 3.79(s, 3H),
DMSO-d6




4.86(brs, 1H), 5.15(brs, 1H), 6.92(d,




J=8.6, 2H), 6.99(d, J=5.1, 1H), 7.56(d,




J=8.5, 2H), 7.78(d, J=4.8, 1H), 8.14(m,




1H), 8.20(s, 1H), 13.84(brs, 1H)



















TABLE 260








Compound No.
Example
NMR δ(ppm)
Solvent







2-0623
546
1.98(s, 3H), 2.01(s, 3H), 3.52(brs, 2H),
DMSO-d6




3.80(brs, 2H), 4.86(brs, 1H), 5.14(brs,




1H), 6.40(t, J=7.6, 1H), 7.01-7.17(m,




3H), 7.79(d, J=5.1, 1H), 8.03(m, 1H),




8.20(d, J=3.7, 1H), 13.83(brs, 1H)


2-0645
552
3.53(brs, 2H), 4.49(brs, 1H), 5.41(brs,
DMSO-d6




1H), 6.23(m, 1H), 6.38(m, 1H), 6.53(brs,




2H), 7.28(m, 2H), 8.01(m, 2H), 8.22(m,




1H), 13.91(brs, 1H)


2-0694
559
1.62(s, 3H), 3.51(m, 2H), 5.09(brs, 2H),
DMSO-d6




6.38(s, 1H), 7.18(m, 2H), 7.59(m, 2H),




7.76(m, 1H), 8.16(m, 1H), 8.26(m, 1H)


2-0696
561
3.59(m, 2H), 4.59(brs, 1H), 5.41(brs,
DMSO-d6




1H), 7.17-7.30(m, 3H), 7.67(m, 2H),




7.99(m, 1H), 8.22(s, 1H), 8.36(m, 1H), 13.92(brs, 1H)


2-0731
568
3.53(m, 2H), 5.13(brs, 2H), 7.29-7.45(m,
DMSO-d6




5H), 7.74(m, 1H), 7.95(m, 1H), 8.23(s,




1H), 8.35(m, 2H), 8.63(m, 1H), 13.86(brs,




1H)


2-0761
571
3.52(m, 2H), 5.10(brs, 2H), 7.32-7.47(m,
DMSO-d6




5H), 7.74(m, 2H), 8.26(m, 3H), 8.57(m,




1H), 13.84(brs, 1H)


2-0772
572
3.51(m, 2H), 5.08(brs, 1H), 7.32-7.49(m,
DMSO-d6




5H), 7.62(m, 2H), 7.96(m, 2H), 8.22(s,




1H), 8.40(m, 1H), 13.20(brs, 1H),




13.85(brs, 1H)


2-0773
573
1.60(s, 3H), 3.53(m, 2H), 5.09(brs, 2H),
DMSO-d6




6.40(s, 1H), 7.62(m, 2H), 7.77(s, 1H),




7.90(m, 2H), 8.17(m, 1H), 8.41(m, 1H)


2-0886
586
1.95(s, 3H), 3.58(brs, 2H), 3.87(s, 3H),
DMSO-d6




4.87(brs, 1H), 5.20(brs, 1H), 7.00(d,




J=5.1, 1H), 7.72(d, J=8.3, 2H), 7.79(d,




J=5.1, 1H), 7.98(d, J=8.3, 2H), 8.20(s,




1H), 8.51(m, 1H), 13.84(brs, 1H)


2-0887
587
3.61(m, 2H), 3.87(s, 3H), 4.60(brs, 1H),
DMSO-d6




5.42(brs, 1H), 7.26(m, 1H), 7.72(m, 2H),




7.93-8.05(m, 3H), 8.22(m, 1H), 8.54(m,




1H), 13.92(m, 1H)


2-1087
607
2.72(s, 3H), 3.46(m, 2H), 5.04(brs, 2H),
DMSO-d6




6.49(t, J=7.4, 1H), 6.58(d, J=8.6, 1H),




7.20-7.38(m, 6H), 7.49(m, 1H), 7.97(m,




1H), 8.22(d, J=3.4, 1H), 13.82(brs, 1H)



















TABLE 261








Compound No.
Example
NMR δ(ppm)
Solvent







2-1351
654
3.55(m, 2H), 4.54(brs, 1H), 5.35(brs,
DMSO-d6




1H), 6.56(m, 1H), 6.89(m, 1H), 7.27(m,




1H), 7.76(m, 1H), 8.00(m, 1H), 8.18-8.26(m,




2H), 13.91(brs, 1H)


2-1378
662
1.71(s, 3H), 3.54(m, 2H), 5.11(brs, 2H),
DMSO-d6




6.43(s, 1H), 7.07(m, 1H), 7.45(m, 1H),




7.70(m, 1H), 7.81(s, 1H), 8.22(m, 1H),




8.28(m, 1H), 8.28(m, 1H), 13.87(brs, 1H)


2-1406
673
2.21(s, 6H), 3.40(m, 2H), 4.99(brs, 2H),
DMSO-d6




6.12(s, 1H), 7.38(m, 4H), 7.52(m, 2H),




8.22(s, 1H), 13.83(brs, 1H)


2-1461
689
3.47(m, 2H), 4.97(brs, 2H), 6.05(m, 1H),
DMSO-d6




6.52(m, 1H), 6.79(m, 1H), 7.35(m, 4H),




7.49(m, 1H), 7.73(m, 1H), 8.22(s, 1H),




11.21(brs, 1H), 13.84(brs, 1H)


2-1779
730
1.82(m, 2H), 2.91(m, 2H), 4.83(m, 2H),
DMSO-d6




6.23(m, 1H), 7.31(m, 1H), 7.45-7.65(m,




7H), 7.97(s, 1H), 8.19(s, 1H), 8.55(s,




1H)


2-1792
743
3.80(brs, 2H), 5.09(brs, 2H), 7.42-7.64(m,
DMSO-d6




8H), 7.83(m, 2H), 8.23(m, 1H),




9.67(s, 1H), 12.74(brs, 1H), 13.85(brs,




1H)


2-1803
754
1.61(s, 3H), 2.82(m, 2H), 4.78(m, 2H),
DMSO-d6




7.63(m, 6H), 8.19(s, 1H)


2-1807
756
3.66(m, 2H), 5.38(brs, 2H), 6.53(m, 1H),
DMSO-d6




7.25(m, 1H), 7.36(m, 2H), 7.47(m, 1H),




7.57(m, 2H), 7.95(s, 1H), 8.17(m, 1H),




8.42(m, 1H), 13.78(brs, 1H)


2-1809
758
3.64(m, 2H), 3.78(s, 3H), 5.35(brs, 2H),
DMSO-d6




6.70(m, 1H), 6.91(m, 2H), 7.26(m, 1H),




7.56(m, 2H), 7.94(m, 1H), 8.18(m, 1H),




8.28(m, 1H), 13.79(brs, 1H)


2-1812
761
3.52(m, 2H), 5.22(brs, 2H), 6.22(m, 1H),
DMSO-d6




6.76(m, 1H), 6.88(m, 1H), 7.19(m, 2H),




7.26(m, 2H), 7.47(m, 1H), 8.03(m, 1H),




8.17(m, 1H), 8.33(s, 1H), 13.78(brs, 1H)


2-1822
771
3.44(m, 2H), 5.01(brs, 2H), 7.17-7.43(m,
DMSO-d6




7H), 7.54(m, 2H), 8.17(m, 2H), 13.78(brs,




1H)



















TABLE 262








Compound No.
Example
NMR δ(ppm)
Solvent







2-1835
784
3.59(m, 2H), 5.33(brs, 2H), 6.64(m, 1H),
DMSO-d6




7.13-7.19(m, 3H), 7.58(m, 2H), 7.88(m,




1H), 8.12(s, 1H), 8.39(m, 1H), 13.71(brs,




1H)


2-1842
791
1.98(s, 3H), 4.32(brs, 2H), 5.44(brs,
DMSO-d6




2H), 7.11-7.18(m, 4H), 7.33(t, J=7.3,




1H), 7.41(t, J=7.6, 1H), 7.50(d, J=8.0,




1H), 7.75(m, 2H), 8.21(d, J=3.4, 1H),




13.90(brs, 1H)


2-1855
803
2.70(s, 3H), 3.63(m, 2H), 5.20(m, 2H),
DMSO-d6




7.65(m, 5H), 8.22(m, 1H), 13.88(brs, 1H)


2-1903
850
2.02-2.23(m, 4H), 3.27(m, 2H), 4.89(brs,
DMSO-d6




2H), 7.60(m, 6H), 8.22(m, 1H), 13.82(brs,




1H)


2-1906
853
3.55(m, 2H), 4.69(m, 1H), 5.27(m, 1H),
DMSO-d6




7.11(m, 1H), 7.25(m, 1H), 7.34(m, 1H),




7.42(m, 2H), 7.50-7.65(m, 4H), 8.21-8.33(m,




2H), 13.91(brs, 1H).


2-1908
855
1.35(t, J=7.1, 3H), 3.51(m, 2H), 4.02(q,
DMSO-d6




J=7.1, 2H), 5.08(brs, 2H), 6.84(m, 2H),




7.30(m, 2H), 7.41(m, 2H), 7.49-7.60(m,




3H), 8.20(m, 2H), 13.78(brs, 1H).


2-1930
877
3.21-3.97(m, 12H), 4.41(brs, 2H),
DMSO-d6




5.03(brs, 2H), 7.03(m, 2H), 7.31-7.59(m,




6H), 8.09(m, 1H), 8.23(m, 1H), 10.10(brs,




1H), 13.84(brs, 1H)


2-1940
887
3.34(m, 2H), 4.94(brs, 2H), 6.02(m, 1H),
DMSO-d6




7.28(m, 2H), 7.40(m, 3H), 7.56(m, 2H),




7.77(m, 2H), 8.23(s, 1H), 8.64(m, 1H)


2-1946
893
1.86(s, 3H), 4.02(m, 2H), 5.11(brs, 1H),
DMSO-d6




5.49(brs, 1H), 6.78(m, 1H), 7.62(m, 1H),




7.77(m, 2H), 8.06-8.23(m, 3H), 8.64(m,




1H), 9.91(brs, 1H), 13.94(brs, 1H)


2-1948
895
3.47(m, 2H), 4.54(m, 2H), 7.15-7.70(m,
DMSO-d6




9H), 8.03(s, 1H), 8.34(t, J=5.6, 1H),




12.49(brs, 1H)


2-1949
896
1.72(s, 3H), 3.54(m, 2H), 4.61(brs, 2H),
DMSO-d6




6.43(s, 1H), 7.23(m, 2H), 7.65(m, 2H),




7.76(s, 1H), 8.03(m, 1H), 8.38(m, 1H),




12.53(brs, 1H)









Example 1176
Measurement of GSK-3 Enzyme Activity Inhibition

After adding 25 μL of phospho-glycogen synthase peptide-2 substrate solution [6 μM phospho-glycogen synthase peptide-2, 20 μM ATP, 16 mM MOPS buffer (pH 7.0), 0.2 mM EDTA, 20 mM magnesium acetate, 0.1 μCi [γ-32P]ATP (specific activity: approximately 110 TBq/mmol)] to 5 μL of the test compound using 5% dimethylsulfoxide as the solvent, reaction was initiated by further addition of 20 μL of a GSK-3β enzyme solution [10 mU recombinant human GSK-3β, 20 mM MOPS buffer (pH 7.0), 1 mM EDTA, 0.1% polyoxyethylene lauryl ether (23 Lauryl Ether; Brij 35), 5% glycerol, 0.1% β-mercaptoethanol]. After conducting the reaction for 20 minutes at room temperature, an equivalent volume of a 200 mM phosphoric acid solution was added to quench the reaction, and 90 μL of the reaction product was adsorbed onto a MultiScreen PH plate (Millipore) and rinsed with a 100 mM phosphoric acid solution. After drying the plate, 30 μL of MicroScint-O (Packard BioScience) was added, and the cpm was measured with a scintillation counter to determine the inhibiting activity. Phospho GS Peptide2 is Tyr-Arg-Arg-Ala-Ala-Val-Pro-Pro-Ser-Pro-Ser-Leu-Ser-Arg-His-Ser-Ser-Pro-His-Gln-Ser(P)-Glu-Asp-Glu-Glu-Glu. As a result of measuring the GSK-3 enzyme inhibiting activity (IC50) of the compounds of the invention in this manner, inhibiting activity of IC50<10 nM was found for Compound Nos. 2-0559, 2-0560, 2-0561, 2-0562, 2-0596, 2-0597, 2-0598, 2-0599, 2-0616, 2-0617, 2-0618, 2-0623, 2-0624, 2-0625, 2-0643, 2-0644, 2-0645, 2-0646, 2-0694, 2-0695, 2-0696, 2-0697, 2-0743, 2-0773, 2-0790, 2-0886, 2-0887, 2-0888, 2-1057, 2-1079, 2-1350, 2-1351, 2-1378, 2-1379, 2-1380, 2-1392, 2-1441, 2-1463, 2-1464, 2-1532, 2-1534, 2-1824, 2-1825, 2-1927, 2-1928, 2-1929, 2-1946, 3-0137, 3-0152, 3-0156, 3-0207, 3-0231, 3-0235, 3-1777, 3-1778 and 3-1779.


Inhibiting activity of 10 nM≦IC50<30 nM was found for Compound Nos. 1-0026, 1-0529, 1-0595, 1-0610, 1-0698, 2-0595, 2-0601, 2-0607, 2-0614, 2-0621, 2-0642, 2-1076, 2-1108, 2-1170, 2-1352, 2-1381, 2-1499, 2-1807, 2-1809, 2-1810, 2-1811, 2-1826, 2-1829, 2-1835, 2-1836, 2-1906, 2-1907, 2-1909, 2-1910, 2-1911, 2-1912, 2-1913, 2-1914, 2-1915, 2-1917, 2-1919, 3-0004, 3-0074, 3-0160, 3-0168, 3-0175, 3-0206, 3-0220, 3-0242, 3-0297, 3-0362, 3-0898, 3-0974, 3-0978, 3-0982, 3-1776, 3-1810, 4-0092 and 6-0413.


Inhibiting activity of 30 nM≦IC50<100 nM was found for Compound Nos. 1-0010, 1-0016, 1-0037, 1-0047, 1-0241, 1-0514, 1-0515, 1-0516, 1-0518, 1-0519, 1-0521, 1-0596, 1-0601, 1-0602, 1-0609, 1-0676, 1-0678, 1-0686, 1-0699, 1-0700, 1-0708, 1-0724, 1-0725, 1-0728, 1-0738, 1-0739, 1-0740, 1-0741, 1-0749, 1-0751, 2-0558, 2-0573, 2-0578, 2-0604, 2-0635, 2-0671, 2-0682, 2-0687, 2-0688, 2-0708, 2-0740, 2-0761, 2-0772, 2-0787, 2-0817, 2-0823, 2-0834, 2-0869, 2-0882, 2-0884, 2-1021, 2-1054, 2-1060, 2-1065, 2-1068, 2-1075, 2-1083, 2-1087, 2-1101, 2-1115, 2-1133, 2-1135, 2-1143, 2-1151, 2-1188, 2-1195, 2-1202, 2-1209, 2-1216, 2-1223, 2-1226, 2-1229, 2-1247, 2-1261, 2-1348, 2-1358, 2-1365, 2-1377, 2-1389, 2-1406, 2-1411, 2-1416, 2-1418, 2-1425, 2-1438, 2-1445, 2-1452, 2-1455, 2-1461, 2-1465, 2-1467, 2-1473, 2-1474, 2-1497, 2-1498, 2-1531, 2-1601, 2-1777, 2-1788, 2-1804, 2-1808, 2-1812, 2-1822, 2-1828, 2-1855, 2-1867, 2-1871, 2-1877, 2-1916, 2-1918, 2-1920, 2-1921, 2-1925, 2-1926, 2-1930, 2-1940, 2-1942, 3-0016, 3-0029, 3-0038, 3-0065, 3-0090, 3-0110, 3-0117, 3-0135, 3-0136, 3-0140, 3-0148, 3-0217, 3-0241, 3-0294, 3-0351, 3-0353, 3-0357, 3-0397, 3-0924, 3-0947, 3-0962, 3-0977, 3-0981, 3-0983, 3-0986, 3-0989, 3-0990, 3-0991, 3-1783, 3-1792, 3-1793, 3-1799, 3-1803, 3-1812, 3-1815, 3-1820, 4-0002, 6-0414, 6-1029, 6-1031 and 6-1033.


Inhibiting activity of 100 nM≦IC50<1 μM was found for Compound Nos. 1-0008, 1-0011, 1-0019, 1-0027, 1-0030, 1-0032, 1-0034, 1-0039, 1-0045, 1-0046, 1-0049, 1-0050, 1-0071, 1-0072, 1-0087, 1-0101, 1-0108, 1-0122, 1-0135, 1-0228, 1-0230, 1-0235, 1-0240, 1-0248, 1-0250, 1-0264, 1-0273, 1-0314, 1-0473, 1-0476, 1-0477, 1-0509, 1-0510, 1-0511, 1-0512, 1-0517, 1-0524, 1-0526, 1-0527, 1-0530, 1-0531, 1-0532, 1-0533, 1-0534, 1-0535, 1-0536, 1-0543, 1-0549, 1-0567, 1-0573, 1-0588, 1-0593, 1-0607, 1-0608, 1-0612, 1-0671, 1-0674, 1-0679, 1-0681, 1-0682, 1-0684, 1-0685, 1-0688, 1-0689, 1-0690, 1-0692, 1-0693, 1-0696, 1-0697, 1-0701, 1-0702, 1-0703, 1-0705, 1-0706, 1-0709, 1-0710, 1-0721, 1-0722, 1-0723, 1-0726, 1-0727, 1-0729, 1-0731, 1-0732, 1-0733, 1-0734, 1-0735, 1-0736, 1-0743, 1-0748, 1-0750, 1-0752, 1-0860, 1-0863, 1-1068, 1-1076, 2-0552, 2-0557, 2-0563, 2-0568, 2-0586, 2-0590, 2-0600, 2-0656, 2-0698, 2-0703, 2-0706, 2-0710, 2-0731, 2-0777, 2-0782, 2-0815, 2-0867, 2-1052, 2-1053, 2-1066, 2-1067, 2-1086, 2-1094, 2-1123, 2-1134, 2-1142, 2-1144, 2-1146, 2-1148, 2-1149, 2-1150, 2-1154, 2-1161, 2-1162, 2-1163, 2-1177, 2-1232, 2-1240, 2-1254, 2-1268, 2-1282, 2-1283, 2-1284, 2-1346, 2-1347, 2-1354, 2-1382, 2-1387, 2-1388, 2-1396, 2-1401, 2-1417, 2-1423, 2-1424, 2-1431, 2-1458, 2-1466, 2-1468, 2-1469, 2-1470, 2-1472, 2-1479, 2-1485, 2-1487, 2-1488, 2-1489, 2-1490, 2-1516, 2-1521, 2-1526, 2-1589, 2-1662, 2-1768, 2-1770, 2-1776, 2-1779, 2-1780, 2-1782, 2-1783, 2-1785, 2-1786, 2-1787, 2-1789, 2-1790, 2-1791, 2-1792, 2-1793, 2-1794, 2-1795, 2-1796, 2-1797, 2-1801, 2-1803, 2-1805, 2-1806, 2-1813, 2-1814, 2-1815, 2-1816, 2-1817, 2-1818, 2-1819, 2-1820, 2-1821, 2-1823, 2-1827, 2-1830, 2-1831, 2-1832, 2-1833, 2-1834, 2-1837, 2-1838, 2-1839, 2-1841, 2-1842, 2-1845, 2-1846, 2-1847, 2-1848, 2-1850, 2-1852, 2-1856, 2-1862, 2-1863, 2-1864, 2-1865, 2-1866, 2-1868, 2-1869, 2-1870, 2-1872, 2-1873, 2-1874, 2-1875, 2-1878, 2-1879, 2-1880, 2-1881, 2-1883, 2-1884, 2-1885, 2-1887, 2-1888, 2-1889, 2-1890, 2-1891, 2-1892, 2-1893, 2-1895, 2-1896, 2-1897, 2-1898, 2-1899, 2-1900, 2-1901, 2-1902, 2-1903, 2-1905, 2-1908, 2-1922, 2-1923, 2-1938, 2-1939, 2-1941, 2-1943, 2-1944, 2-1945, 2-1949, 2-1950, 2-1951, 2-2158, 2-2159, 3-0001, 3-0009, 3-0012, 3-0019, 3-0020, 3-0037, 3-0053, 3-0064, 3-0073, 3-0082, 3-0083, 3-0085, 3-0086, 3-0087, 3-0091, 3-0109, 3-0112, 3-0115, 3-0116, 3-0118, 3-0119, 3-0124, 3-0125, 3-0126, 3-0134, 3-0139, 3-0143, 3-0184, 3-0197, 3-0198, 3-0243, 3-0244, 3-0325, 3-0331, 3-0339, 3-0340, 3-0348, 3-0349, 3-0350, 3-0352, 3-0398, 3-0399, 3-0430, 3-0532, 3-0541, 3-0542, 3-0543, 3-0545, 3-0551, 3-0552, 3-0553, 3-0554, 3-0555, 3-0556, 3-0559, 3-0560, 3-0564, 3-0567, 3-0575, 3-0577, 3-0584, 3-0589, 3-0596, 3-0597, 3-0598, 3-0599, 3-0600, 3-0605, 3-0615, 3-0616, 3-0635, 3-0636, 3-0642, 3-0647, 3-0651, 3-0652, 3-0653, 3-0654, 3-0680, 3-0683, 3-0684, 3-0685, 3-0686, 3-0689, 3-0690, 3-0710, 3-0711, 3-0724, 3-0725, 3-0726, 3-0909, 3-0949, 3-0950, 3-0963, 3-0966, 3-0968, 3-0970, 3-0973, 3-0979, 3-0980, 3-0985, 3-0987, 3-0992, 3-0993, 3-1780, 3-1781, 3-1782, 3-1784, 3-1791, 3-1795, 3-1797, 3-1801, 3-1802, 3-1806, 3-1807, 3-1809, 3-1811, 3-1813, 3-1814, 3-1816, 3-1817, 3-1819, 3-1821, 3-1824, 3-1825, 3-1826, 4-0001, 4-0007, 4-0029, 4-0031, 5-0001, 5-0006, 5-0041, 5-0049, 5-0060, 5-0074, 6-0055, 6-0056, 6-0057, 6-0058, 6-0061, 6-0268, 6-0273, 6-0278, 6-0283, 6-0298, 6-0300, 6-0304, 6-0308, 6-0312, 6-0316, 6-0320, 6-0324, 6-0333, 6-0341, 6-0347, 6-0374, 6-0378 and 6-1027.


Inhibiting activity of 1 μM≦IC50<10 μM was found for Compound Nos. 1-0006, 1-0007, 1-0009, 1-0012, 1-0015, 1-0018, 1-0020, 1-0022, 1-0023, 1-0024, 1-0025, 1-0033, 1-0036, 1-0038, 1-0040, 1-0041, 1-0043, 1-0044, 1-0048, 1-0052, 1-0054, 1-0055, 1-0056, 1-0061, 1-0062, 1-0063, 1-0068, 1-0069, 1-0070, 1-0073, 1-0074, 1-0076, 1-0077, 1-0079, 1-0082, 1-0084, 1-0086, 1-0088, 1-0090, 1-0091, 1-0093, 1-0099, 1-0100, 1-0105, 1-0113, 1-0114, 1-0129, 1-0132, 1-0133, 1-0136, 1-0137, 1-0194, 1-0208, 1-0215, 1-0225, 1-0226, 1-0227, 1-0231, 1-0232, 1-0233, 1-0234, 1-0236, 1-0237, 1-0238, 1-0239, 1-0243, 1-0244, 1-0245, 1-0246, 1-0247, 1-0253, 1-0254, 1-0263, 1-0274, 1-0275, 1-0292, 1-0293, 1-0294, 1-0295, 1-0297, 1-0299, 1-0301, 1-0303, 1-0304, 1-0308, 1-0312, 1-0315, 1-0316, 1-0317, 1-0319, 1-0320, 1-0321, 1-0323, 1-0324, 1-0325, 1-0326, 1-0328, 1-0349, 1-0362, 1-0372, 1-0394, 1-0396, 1-0416, 1-0459, 1-0460, 1-0493, 1-0495, 1-0497, 1-0499, 1-0501, 1-0537, 1-0555, 1-0585, 1-0586, 1-0587, 1-0667, 1-0672, 1-0673, 1-0675, 1-0683, 1-0687, 1-0694, 1-0695, 1-0707, 1-0715, 1-0730, 1-0753, 1-0759, 1-0760, 1-0926, 1-0941, 1-1040, 1-1065, 1-1066, 1-1067, 1-1072, 1-1074, 1-1075, 2-0016, 2-0018, 2-0032, 2-0034, 2-0036, 2-0037, 2-0060, 2-0072, 2-0092, 2-0093, 2-0096, 2-0117, 2-0147, 2-0208, 2-0519, 2-0521, 2-0523, 2-0529, 2-0530, 2-0531, 2-0536, 2-0537, 2-0539, 2-0893, 2-1059, 2-1074, 2-1128, 2-1345, 2-1353, 2-1355, 2-1471, 2-1486, 2-1664, 2-1769, 2-1771, 2-1772, 2-1773, 2-1774, 2-1775, 2-1778, 2-1781, 2-1784, 2-1799, 2-1800, 2-1802, 2-1840, 2-1843, 2-1844, 2-1849, 2-1851, 2-1853, 2-1854, 2-1857, 2-1858, 2-1859, 2-1860, 2-1861, 2-1876, 2-1882, 2-1886, 2-1894, 2-1904, 2-1924, 2-1931, 2-1932, 2-1933, 2-1934, 2-1935, 2-1936, 2-1947, 2-1948, 3-0021, 3-0036, 3-0081, 3-0099, 3-0100, 3-0544, 3-0550, 3-0561, 3-0568, 3-0591, 3-0634, 3-0682, 3-0687, 3-0688, 3-0727, 3-0965, 3-0969, 3-0970(S), 3-0971, 3-0984, 3-0988, 3-1785, 3-1786, 3-1787, 3-1788, 3-1794, 3-1796, 3-1798, 3-1800, 3-1805, 3-1808, 3-1818, 3-1822, 3-1823, 4-0005, 4-0030, 5-0005, 5-0016, 5-0038, 5-0051, 5-0054, 6-0328(R), 6-0328(S), 6-0337, 6-0343, 6-0345, 6-0349, 6-0353, 6-0370, 6-0382, 6-0390 and 6-0394. The compound numbers represent the compound numbers in Tables 1 to 214 listed as the preferred examples.


The pyrrolopyrimidine derivatives of the invention thus exhibit powerful GSK-3 inhibiting activity. It was therefore demonstrated that they may be clinically useful as GSK-3 activity inhibitors to be used for prevention and/or treatment of various diseases associated with GSK-3.


Example 1177
Preparation of Tablets

Tablets were prepared each having the following composition.

Compound(Example 1)50 mgLactose230 mg Potato starch80 mgPolyvinylpyrrolidone11 mgMagnesium stearate 5 mg


The compound of the invention (compound of Example 1), lactose and potato starch were combined, and the mixture was evenly moistened with a 20% ethanol solution containing the polyvinylpyrrolidone and passed through a 20 nm mesh screen, dried at 45° C. and passed through a 15 nm mesh screen. The granules obtained in this manner were mixed with the magnesium stearate and compressed into tablets.


INDUSTRIAL APPLICABILITY

The pyrrolo[3,2-d]pyrimidine derivatives represented by formula (I) and their medically acceptable salts exhibit GSK-3 inhibiting activity. Drugs comprising the compounds as effective ingredients are therefore expected to be useful as therapeutic or prophylactic agents for conditions in which GSK-3 is implicated, such as diabetes, diabetes complications, Alzheimer's disease, neurodegenerative diseases, manic depression, traumatic encephalopathy, alopecia, inflammatory diseases, cancer and immune deficiency.

Claims
  • 1. A pyrrolo[3,2-d]pyrimidine derivative represented by formula (I), or a medically acceptable salt thereof.
  • 2. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1, wherein X is an oxygen atom.
  • 3. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1, wherein X is a sulfur atom.
  • 4. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 3, wherein A1 is —(CH2)2—.
  • 5. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 3, wherein A1 is —(CH2)3—.
  • 6. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-O-G1.
  • 7. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-OC(═O)-G1.
  • 8. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NR104-G1.
  • 9. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NR105C(═O)-G1.
  • 10. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NR106S(═O)2-G1.
  • 11. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NR107C(═O)O-G1.
  • 12. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NR108C(═O)NR109-G1.
  • 13. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)-G1.
  • 14. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)O-G1.
  • 15. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)NR101-G1.
  • 16. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═S)NR102-G1.
  • 17. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═NR103)-G1.
  • 18. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NR110C(═S)-G1.
  • 19. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NR111C(═S)NR112-G1.
  • 20. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-S-G1.
  • 21. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-S(═O)-G1.
  • 22. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-S(═O)2-G1.
  • 23. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-S(═O)2NR113-G1.
  • 24. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NH-G1
  • 25. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NHC(═O)-G1.
  • 26. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NHS(═O)2-G1.
  • 27. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NHC(═O)O-G1.
  • 28. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NHC(═O)NH-G1.
  • 29. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)NH-G1.
  • 30. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═S)NH-G1.
  • 31. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═NH)-G1.
  • 32. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-NHC(═S)-G1.
  • 33. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-S(═O)2NH-G1.
  • 34. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A2 is a single bond.
  • 35. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is a single bond.
  • 36. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is a substituted or unsubstituted C6-14 aromatic hydrocarbon group.
  • 37. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is a substituted or unsubstituted C3-8 alicyclic hydrocarbon group.
  • 38. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 39. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is an unsubstituted C6-14 aromatic hydrocarbon group.
  • 40. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is an unsubstituted C3-8 alicyclic hydrocarbon group.
  • 41. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is an unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 42. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is a substituted C6-14 aromatic hydrocarbon group.
  • 43. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is a substituted C3-8 alicyclic hydrocarbon group.
  • 44. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is a substituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 45. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is an unsubstituted aromatic heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 46. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is a substituted aromatic heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 47. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted furan, unsubstituted pyrrole, unsubstituted pyrrolidine, unsubstituted thiophene, unsubstituted oxazole, unsubstituted thiazole, unsubstituted isooxazole, unsubstituted isothiazole, unsubstituted pyrazole, unsubstituted imidazole, unsubstituted pyridine, unsubstituted pyrimidine, unsubstituted pyrazine, unsubstituted benzothiophene, unsubstituted benzofuran, unsubstituted benzimidazole, unsubstituted indole, unsubstituted quinoline, unsubstituted isoquinoline, unsubstituted quinazoline, unsubstituted purine, unsubstituted phthalazine, unsubstituted cinnoline, unsubstituted 1,8-naphthylidine or unsubstituted pteridine.
  • 48. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted furan, substituted pyrrole, substituted pyrrolidine, substituted thiophene, substituted oxazole, substituted thiazole, substituted isooxazole, substituted isothiazole, substituted pyrazole, substituted imidazole, substituted pyridine, substituted pyrimidine, substituted pyrazine, substituted benzothiophene, substituted benzofuran, substituted benzimidazole, substituted indole, substituted quinoline, substituted isoquinoline, substituted quinazoline, substituted purine, substituted phthalazine, substituted cinnoline, substituted 1,8-naphthylidine or substituted pteridine.
  • 49. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted benzene.
  • 50. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted benzene.
  • 51. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted thiophene.
  • 52. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted thiophene.
  • 53. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted pyridine.
  • 54. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted pyridine.
  • 55. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted furan.
  • 56. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted furan.
  • 57. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted pyrrole.
  • 58. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted pyrrole.
  • 59. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted thiazole.
  • 60. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted thiazole.
  • 61. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted isooxazole.
  • 62. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted isooxazole.
  • 63. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted pyrazole.
  • 64. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted pyrazole.
  • 65. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted pyrimidine.
  • 66. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted pyrimidine.
  • 67. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent substituted quinazoline.
  • 68. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 6 to 34, wherein G1 is divalent unsubstituted quinazoline.
  • 69. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent unsubstituted pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine or piperazine, bonded to A1-C(═O) through the nitrogen atom.
  • 70. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent substituted pyrrolidine, piperidine, morpholine, thiomorpholine, homopiperidine, homopiperazine, 1,2,3,6-tetrahydropyridine or piperazine, bonded to A1-C(═O) through the nitrogen atom.
  • 71. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent substituted piperidine, bonded to A1-C(═O) through the nitrogen atom.
  • 72. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent unsubstituted piperidine, bonded to A1-C(═O) through the nitrogen atom.
  • 73. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent substituted piperazine, bonded to A1-C(═O) through the nitrogen atom.
  • 74. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 5, wherein A1-A2-G1 bond in the form of A1-C(═O)-G1, and G1 is divalent unsubstituted piperazine, bonded to A1-C(═O) through the nitrogen atom.
  • 75. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 35 to 74, wherein A3 is a single bond.
  • 76. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 35 to 74, wherein A3 is —CH2—.
  • 77. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 35 to 74, wherein A3 is —(CH2)2—.
  • 78. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 35 to 74, wherein A3 is —(CH2)3—.
  • 79. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A4 is a single bond.
  • 80. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-C(═O)O-G2.
  • 81. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-C(═O)-G2.
  • 82. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-C(═O)NR21-G2.
  • 83. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-O-G2.
  • 84. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-NR124-G2.
  • 85. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-NR125C(═O)-G 2.
  • 86. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-NR126S(═O)2-G2
  • 87. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-NR127C(═O)O-G2.
  • 88. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 75 to 78, wherein A3-A4-G2 bond in the form of A3-NR128C(═O)NR129G2.
  • 89. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 79 to 88, wherein G2 is a hydrogen atom.
  • 90. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 79 to 88, wherein G2 is a substituted or unsubstituted C1-10 aliphatic hydrocarbon group.
  • 91. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 79 to 88, wherein G2 is a substituted or unsubstituted C3-8 alicyclic hydrocarbon group.
  • 92. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 79 to 88, wherein G2 is a substituted or unsubstituted C6-14 aromatic hydrocarbon group.
  • 93. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 79 to 88, wherein G2 is a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 94. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 36 to 74, wherein -A3-A4-G2 collectively represent hydrogen.
  • 95. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 36 to 93, wherein -A3-A4-G2 collectively represent a group other than hydrogen.
  • 96. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 94, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, and G1 is substituted divalent benzene.
  • 97. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 93, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, G1 is unsubstituted divalent benzene, and A3-A4-G2 are collectively a group other than hydrogen.
  • 98. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 94, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, and G1 is a divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 99. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 94, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, and G1 is a substituted divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 100. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 93, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NHC(═O)-G1, and G1 is an unsubstituted divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and A3-A4-G2 are collectively a group other than hydrogen.
  • 101. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 94, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NH-G1, and G1 is substituted divalent benzene.
  • 102. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 93, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NH-G1, G1 is unsubstituted divalent benzene, and A3-A4-G2 are collectively a group other than hydrogen.
  • 103. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 94, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NH-G1, and G1 is a substituted divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 104. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 93, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-NH-G1, and G1 is an unsubstituted divalent monocyclic or bicyclic C2-9 aromatic heterocyclic group having in the ring 1 to 3 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and A3-A4-G2 are collectively a group other than hydrogen.
  • 105. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 94, wherein X is sulfur, A, is —(CH2)2—, A1-A2-G1 bond in the form of A1-C(═O)-G1, G1 is a divalent monocyclic C2-9 heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and G1 is bonded to A1-C(═O)— through a nitrogen atom.
  • 106. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 94, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-C(═O)-G1, G1 is a substituted divalent monocyclic C2-9 heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms, and G* is bonded to A1-C(═O)— through a nitrogen atom.
  • 107. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 1 or any one of claims 75 to 93, wherein X is sulfur, A1 is —(CH2)2—, A1-A2-G1 bond in the form of A1-C(═O)-G1, G1 is an unsubstituted divalent monocyclic C2-9 heterocyclic group having in the ring 1 or 2 atoms selected from the group consisting of oxygen, nitrogen and sulfur, G1 is bonded to A1-C(═O)— through a nitrogen atom, and A3-A4-G2 are collectively a group other than hydrogen.
  • 108. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 107, wherein A1 is a single bond.
  • 109. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 107, wherein A5 is a group binding the carbon atom of the pyrrole ring to which A1 is bonded and R2 in the form of R2—NR201-pyrrole ring carbon.
  • 110. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 109, wherein R2 is a hydrogen atom.
  • 111. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 108, wherein R2 is fluorine, chlorine, bromine or iodine.
  • 112. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 108 or 109, wherein R2 is a substituted or unsubstituted C1-10 aliphatic hydrocarbon group.
  • 113. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 108 or 109, wherein R2 is a substituted or unsubstituted C3-aliphatic hydrocarbon group.
  • 114. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 108 or 109, wherein R2 is a substituted or unsubstituted C6-14 aromatic hydrocarbon group.
  • 115. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to claim 108 or 109, wherein R2 is a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 116. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 107, wherein R2-A5- is substituted or unsubstituted isopropylamino, substituted or unsubstituted cyclopropylamino, substituted or unsubstituted cyclopentylamino, substituted or unsubstituted dimethylamino, substituted or unsubstituted N-methyl-ethylamino, substituted or unsubstituted N-methyl-2-propenylamino, substituted or unsubstituted N-methyl-2-propynylamino, substituted or unsubstituted 1-pyrrolidinyl, substituted or unsubstituted 1-piperazinyl, substituted or unsubstituted 1-piperidino, substituted or unsubstituted 1-morpholino or substituted or unsubstituted 1-homopiperidinyl.
  • 117. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 107, wherein R2-A5- is substituted or unsubstituted cyclopropyl, substituted or unsubstituted phenyl, substituted or unsubstituted furyl, substituted or unsubstituted thienyl, substituted or unsubstituted pyrrolyl, substituted or unsubstituted pyrazolyl, substituted or unsubstituted oxazolyl, substituted or unsubstituted isooxazolyl, substituted or unsubstituted thiazolyl, substituted or unsubstituted isothiazolyl, substituted or unsubstituted imidazolyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrazinyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted pyridazinyl, substituted or unsubstituted benzofuranyl or substituted or unsubstituted benzothiophenyl.
  • 118. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 107, wherein R2-A5- is substituted or unsubstituted 2-furyl, substituted or unsubstituted 2-thienyl, substituted or unsubstituted 2-pyrrolyl, substituted or unsubstituted 2-imidazolyl, substituted or unsubstituted 5-imidazolyl, substituted or unsubstituted 2-oxazolyl, substituted or unsubstituted 5-oxazolyl, substituted or unsubstituted 5-isooxazolyl, substituted or unsubstituted 2-thiazolyl, substituted or unsubstituted 5-thiazolyl, substituted or unsubstituted 5-isothiazolyl, substituted or unsubstituted 3-isothiazolyl, substituted or unsubstituted 2-pyridyl, substituted or unsubstituted 2-pyrimidinyl, substituted or unsubstituted 2-benzofuranyl or substituted or unsubstituted 2-benzothiophenyl.
  • 119. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 107, wherein R2-A5- is substituted or unsubstituted 2-furyl, substituted or unsubstituted 2-thienyl or substituted or unsubstituted 2-pyrrolyl.
  • 120. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 107, wherein R2-A5- is 3-methyl(2-furyl), 3-chloro(2-furyl), 3-methyl(2-thienyl), 3-chloro(2-thienyl) or 1-methylpyrrol-2-yl.
  • 121. A pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 107, wherein A1 is a group binding the carbon atom of the pyrrole ring to which A1 is bonded and R2 in the form of R2—NR201-pyrrole ring carbon, and R2 is a substituted or unsubstituted heterocyclic group having in the ring 1 to 4 atoms selected from the group consisting of oxygen, nitrogen and sulfur atoms.
  • 122. A pharmaceutical composition comprising a pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 121, and a pharmaceutically acceptable carrier.
  • 123. A GSK-3 inhibitor comprising a pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 121.
  • 124. A therapeutic or prophylactic agent for a GSK-3 associated disease, comprising a pyrrolo[3,2-d]pyrimidine derivative or a medically acceptable salt thereof according to any one of claims 1 to 121.
  • 125. A therapeutic or prophylactic agent according to claim 124, wherein said GSK-3 associated disease is selected from the group consisting of diabetes, diabetes complications, Alzheimer's disease, neurodegenerative diseases, manic depression, traumatic encephalopathy, alopecia, inflammatory diseases, cancer and immune deficiency.
  • 126. A pyrrolo[3,2-d]pyrimidine derivative represented by formula (2):
  • 127. A pyrrolo[3,2-d]pyrimidine derivative according to claim 126, wherein X1 is chlorine or trifluoromethanesulfonyloxy.
  • 128. A pyrrolo[3,2-d]pyrimidine derivative represented by formula (1c):
Priority Claims (3)
Number Date Country Kind
2002-46128 Feb 2002 JP national
2002-365196 Dec 2002 JP national
2002-379827 Dec 2002 JP national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/JP03/01977 2/24/2003 WO 8/16/2004